Citrus Sinensis ID: 003759
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 797 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.943 | 0.903 | 0.418 | 1e-172 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.952 | 0.870 | 0.312 | 1e-101 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.890 | 0.856 | 0.324 | 1e-101 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.898 | 0.876 | 0.318 | 3e-96 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.929 | 0.894 | 0.315 | 4e-89 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.846 | 0.846 | 0.316 | 1e-87 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.874 | 0.799 | 0.307 | 2e-78 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.371 | 0.360 | 0.442 | 7e-69 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.887 | 0.848 | 0.271 | 1e-65 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.875 | 0.840 | 0.281 | 7e-65 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 606 bits (1562), Expect = e-172, Method: Compositional matrix adjust.
Identities = 335/801 (41%), Positives = 474/801 (59%), Gaps = 49/801 (6%)
Query: 25 NVSRGESLMAEDDM---SSWKSTSGEFAFGFQHIE-NGNYLLTIYFNKIPERTIIWSANG 80
+V GESL A + SSW+S SG+FAFGF+ I+ N + L+I+F+KI ++TI+W A
Sbjct: 31 SVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPNDGFTLSIWFDKISDKTIVWHAQA 90
Query: 81 KTP----VERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVL---AG 133
V GSKV LT DG LV+ D G+E+W +G +++ D GNFVL
Sbjct: 91 VNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRA-LSGGSVSRGRFTDDGNFVLFRDGS 149
Query: 134 PDSFP-LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTA 192
DS LW SF++PTDTLLP Q + LS+ ++ ++ GR+ L ++ DGNL L++
Sbjct: 150 EDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQLHSLN 209
Query: 193 FPFESANSVYW------STQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDL 246
S + +Y + P +Q+ FN+SG I L N + S+
Sbjct: 210 AETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVLQRNNSRFVVKDRDPDFSIAAP 269
Query: 247 YQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNS 306
+ T GFL + PK + + SP+D + G CG+N+
Sbjct: 270 FYIST----GFLLSTIIPKEARRIVGGCLLGLCRDNMCSPDDAL-------GNMACGYNN 318
Query: 307 YCSLGNDQRPTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQ----EVDLYDLVEMEY 362
CSLGN++RP C CP+ +V D ++ C F Q C NQ +V+LY+ + +E
Sbjct: 319 ICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEK 378
Query: 363 TDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIF---RNGECWKKKNPLTNGRMAPDIEG 419
T+WP+ DYE + + C+ +C+ DC C IF R+ +CWKKK PL++G +P +
Sbjct: 379 TNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDS 438
Query: 420 KALIKIRRGNSTLKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYH 479
IK+R + P + KK+ + SVLL +S F+ F
Sbjct: 439 DTFIKVRNRSIADVPVTGNRAKKLDWL-IIACSVLLGTSAFVIFDTSCSYRKTKKSKNMM 497
Query: 480 KTKMDQTGPVMPST-----NLQIFSYKELEKATQGFKDELGRGAFATVHKGVL--AYENK 532
K + G +T NL++F+Y EL +AT+ F +ELGRGAF V+KG L A ++
Sbjct: 498 KNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSE 557
Query: 533 ICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLA 592
+ VAVKKLD + +KEF+ EV IGQ +H+NLV+L+GFCNE Q +++VYEF+ G LA
Sbjct: 558 VTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLA 617
Query: 593 GFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652
FLF+ P+PSW R IA IARG+ YLHEEC+ QIIHCDIKPQNILLD+ +T RISDFG
Sbjct: 618 NFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFG 677
Query: 653 LAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712
LAK+L +QT T T IRGT+GYVAPEWF++ PIT KVD+YS+GVMLLE++CC+K V
Sbjct: 678 LAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKA----V 733
Query: 713 ENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
+ E+ +IL++WAYDC+ +L L E+D EA++DM +++YV IAIWCIQE+ +RP M+
Sbjct: 734 DLEDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMR 793
Query: 773 KVTLMLEGVVEVPIPPDPSSF 793
VT MLEGV++V PP+PS +
Sbjct: 794 NVTQMLEGVIQVFDPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (952), Expect = e-101, Method: Compositional matrix adjust.
Identities = 261/836 (31%), Positives = 416/836 (49%), Gaps = 77/836 (9%)
Query: 11 FSLLLLMPIS-ATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIE-NGNYLLTIYFNK 68
FS +S AT ++ G L A + +W S +G FA GF + +LL+I+F +
Sbjct: 14 FSFFCFFLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQ 73
Query: 69 IP-ERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSG 127
+P + TI+WS N +PV + + ++L G LVL+D VW +T+ + A M +SG
Sbjct: 74 LPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNTSNHGVESAVMSESG 132
Query: 128 NFVLAGPDSFP---LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAM---Q 181
NF+L G + +W+SF P+DTLLP Q L +L+++ S + G Y L M
Sbjct: 133 NFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRH--GHYSLKMLQQH 190
Query: 182 SDGNLVLYTTAFPFESANSVYWSTQPVGS-------------SLQVEFNRS--GNI-IYL 225
+ +L L AN YWS + + S ++ + S G + +Y
Sbjct: 191 TSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYK 250
Query: 226 TAKNRSIIYMLSSSASSMQD-LYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFN 284
+ + Y SS+ ++ + +R+ LE +G LR Y + N+ + S W
Sbjct: 251 NPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRW-----DNDMNGSSQWVPEWAA 305
Query: 285 SPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLCPQGYVPLDRNDLTKGCK-QSFLSQ 343
N C I G+G C+ + CLC G V L + K C S L Q
Sbjct: 306 VSNPCDIAGICGNGVCNLD-------RTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQ 358
Query: 344 NCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGV----RLQWCREACMRDCFCTVAIF--- 396
C+ + + ++ T++ + + + + ++ C E C+ DC C +++
Sbjct: 359 ECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLD 418
Query: 397 -RNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTDSKKKVHSTSVFVVSVLL 455
CW K+ G P G L R N + ++ K + VL+
Sbjct: 419 DEKPYCWILKSLNFGGFRDP---GSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLV 475
Query: 456 CSSVFLNFLLQLGTFLLVFIFG---YHKTKMDQTGPVMPSTNLQI------FSYKELEKA 506
V +G +LV + G Y+ +T +L + F+Y++L+
Sbjct: 476 IPIV-------VGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNC 528
Query: 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
T F LG G F TV+KG +A E VAVK+LD +S G++EF TEVN IG +H NL
Sbjct: 529 TNNFSQLLGSGGFGTVYKGTVAGET--LVAVKRLDRALSHGEREFITEVNTIGSMHHMNL 586
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS----WYRRMQIAFGIARGLFYLHE 622
V+L G+C+ED HRLLVYE++ NG L ++F + + + W R +IA A+G+ Y HE
Sbjct: 587 VRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHE 646
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+C +IIHCDIKP+NILLDD+F ++SDFGLAK++ + + T IRGTRGY+APEW +
Sbjct: 647 QCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSN 706
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
PIT+K D+YS+G++LLE++ R+ + + + E+ WAY + V+ +
Sbjct: 707 RPITVKADVYSYGMLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVDKRLQ 765
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV-EVPIPPDPSSFISSI 797
+ + + K + +A WCIQ++ S+RP+M +V +LEG E+ +PP P + + I
Sbjct: 766 GVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILELI 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (947), Expect = e-101, Method: Compositional matrix adjust.
Identities = 259/797 (32%), Positives = 398/797 (49%), Gaps = 87/797 (10%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTI--YFNKIPERTIIWSANGKTPVER 86
G + A +W S + F+ F + N L + +P IWSA T R
Sbjct: 30 GSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSAG--TVDSR 83
Query: 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHP 146
GS ++L G L LT+ +G VW+ T + S+ D+G F+L S P+W SFD+P
Sbjct: 84 GS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNP 142
Query: 147 TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLY--TTAFPFESANSVYWS 204
TDT++ +Q + K +G Y ++ GNL L T+A + + +S
Sbjct: 143 TDTIVQSQNFT---------AGKILRSGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSFS 193
Query: 205 TQPVGSSLQVEFNRSGNIIYLTAKN----RSIIYMLSSSASSMQDLYQRVTLEFDGFLRH 260
+ L ++ N ++ + N I+Y S + ++ + L+ DG LR
Sbjct: 194 SNLSSPRLSLQTN---GVVSIFESNLLGGAEIVY---SGDYGDSNTFRFLKLDDDGNLRI 247
Query: 261 YVYPKSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLC 320
Y S+S N+ + HWS + + C++ CG CS ND P C C
Sbjct: 248 Y---SSASRNSGPVNAHWS-----AVDQCLVYGY-------CGNFGICSY-NDTNPICSC 291
Query: 321 P-QGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRLQ 379
P + + +D ND KGCK+ +C +DL Y D P + G
Sbjct: 292 PSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSE-SFFAGSSP- 349
Query: 380 WCREACMRDCFCTVAIFRN---GECWKKK-NPLTNGRMAPDIEGKALIKI---RRGNSTL 432
CR C+ C ++ + G CW+K G P + + +K+ N+
Sbjct: 350 -CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLE 408
Query: 433 KP-EDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVF-------IFGYHKTKMD 484
+ + D+ KVH +++V+V + + + +++G + H T ++
Sbjct: 409 RATKGDDNNSKVH---LWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLE 465
Query: 485 --QTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDN 542
PV F+YKEL++ T+ FK++LG G F TV++GVL N+ VAVK+L+
Sbjct: 466 YASGAPVQ-------FTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLEG 516
Query: 543 MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP- 601
+ G+K+FR EV I T+H NLV+L+GFC++ +HRLLVYEF+ NG L FLF
Sbjct: 517 -IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAK 575
Query: 602 --SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659
+W R IA G A+G+ YLHEEC I+HCDIKP+NIL+DD+F A++SDFGLAK+L
Sbjct: 576 FLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNP 635
Query: 660 DQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
R +++RGTRGY+APEW +LPIT K D+YS+G++LLEL+ ++ F+ + E N
Sbjct: 636 KDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHK 694
Query: 719 ILVDWAYDCYIDEKLHLLVEN--DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
WAY+ + +++ E+ DM ++ + V + WCIQE P RPTM KV
Sbjct: 695 KFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQ 754
Query: 777 MLEGVVEVPIPPDPSSF 793
MLEG+ E+ P P +
Sbjct: 755 MLEGITEIKNPLCPKTI 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (906), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 269/845 (31%), Positives = 407/845 (48%), Gaps = 129/845 (15%)
Query: 13 LLLLMPISATAQNV-SRGESLMAED-DMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIP 70
+ L P +A+++++ G SL+ E + S+ +S+ G F+ GF + + +++++K
Sbjct: 18 FIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAFTFSVWYSKTE 77
Query: 71 -----ERTIIWSANGKTPVE-RGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASM 123
+TI+WSAN PV R S + L DG +VLTD G VW D + A +
Sbjct: 78 AAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARL 137
Query: 124 LDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSD 183
LD+GN V+ +W+SFD PTDT LPTQ++ +L + ++ S G Y
Sbjct: 138 LDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVP--TTQSRSPGNYIFRFS-- 193
Query: 184 GNLVLYTTAFPFESANSVYWST--QPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSAS 241
+L + + + + +YW Q + + ++N S + LT + SS +
Sbjct: 194 -DLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYN-STRLGMLTDSG----VLASSDFA 247
Query: 242 SMQDLY---------QRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCMIT 292
Q L +R+TL+ DG LR Y S S WS + C I
Sbjct: 248 DGQALVASDVGPGVKRRLTLDPDGNLRLYSMNDSDGS--------WSVSMVAMTQPCNIH 299
Query: 293 DETGSGACDCGFNSYCSLGNDQRPTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEV 352
CG N C PTC CP GY + + T+GC + ++ CD ++
Sbjct: 300 GL-------CGPNGICHY--SPTPTCSCPPGYATRNPGNWTEGC-MAIVNTTCDRYDKRS 349
Query: 353 DLYDLVEMEYTDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFR--NGECWKKKNPLTN 410
V + TD+ D +H V L+ CR+ C+ DC C ++ G C+ K L +
Sbjct: 350 --MRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAY-LFS 406
Query: 411 GRMAPDIEGKAL-IKIRRG--------------NSTLKPEDTDSKKK--------VHSTS 447
GR P + + + +K+ G +S + D D K VH T
Sbjct: 407 GRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTG 466
Query: 448 V----------FVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQI 497
F+ + + F++F F+L + + G ++N +
Sbjct: 467 GGESKWFYFYGFIAAFFVVEVSFISFAW---FFVLKRELRPSELWASEKGYKAMTSNFRR 523
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
+SY+EL KAT+ FK ELGRG TV+KGVL E+ VAVKKL+N V G + F+ E++
Sbjct: 524 YSYRELVKATRKFKVELGRGESGTVYKGVL--EDDRHVAVKKLEN-VRQGKEVFQAELSV 580
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK---NPKPSWYRRMQIAFGIA 614
IG+ NH NLV++ GFC+E HRLLV E++ NG LA LF N W R IA G+A
Sbjct: 581 IGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVA 640
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL-KADQTRTTTAIRGTRG 673
+GL YLH EC +IHCD+KP+NILLD +F +I+DFGL K+L + T+ + +RGT G
Sbjct: 641 KGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLG 700
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE--------------------QNVE 713
Y+APEW SLPIT KVD+YS+GV+LLEL+ + E +E
Sbjct: 701 YIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLE 760
Query: 714 NENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773
E Q + D Y+D KL+ V + ++ + + +A+ C++ED S RPTM+
Sbjct: 761 GEEQSWI-----DGYLDSKLNRPV--------NYVQARTLIKLAVSCLEEDRSKRPTMEH 807
Query: 774 VTLML 778
L
Sbjct: 808 AVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 262/831 (31%), Positives = 395/831 (47%), Gaps = 90/831 (10%)
Query: 1 MASFLEHHLWFSLLLLMPISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGF-QHIENGN 59
M SFL +F + + S+ +S +L + + S + G + GF + + N
Sbjct: 1 MVSFLTLTSFFFICFFIHGSSAVDTISGDFTLSGDQTIVS---SDGTYEMGFFKPGSSSN 57
Query: 60 YLLTIYFNKIPERTIIWSANGKTPV-ERGSKVQLTVDGRLVLTDLTGKE-VWNP---DTA 114
+ + +++ ++ + TI+W AN V ++ S V +G L+L D + VW+ T+
Sbjct: 58 FYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTS 116
Query: 115 GAAIAYASMLDSGNFVL-AGPDSFP---LWESFDHPTDTLLP------TQILNPRNKLSA 164
+ A + D GN VL G S LW+SFDHP DT LP + +L++
Sbjct: 117 SVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTS 176
Query: 165 HYSDKNYSTGRYELAM-QSDGNLVLYTTAFPFESANSVYWSTQP-------VGSSLQVEF 216
S ++ S G + L + +S +L+ + ++ YWS+ P S ++
Sbjct: 177 WKSLEDPSPGLFSLELDESTAYKILW-------NGSNEYWSSGPWNPQSRIFDSVPEMRL 229
Query: 217 NRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSM 276
N N + + N + Y S + + R ++ G ++ + + + NK+W++
Sbjct: 230 NYIYNFSFFS--NTTDSYFTYSIYNQLN--VSRFVMDVSGQIKQFTWLE----GNKAWNL 281
Query: 277 HWSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLCPQGYVPL-----DRND 331
WS P C + CG CS + P C CPQG+ P+ D D
Sbjct: 282 FWSQP----RQQCQVYRY-------CGSFGICS--DKSEPFCRCPQGFRPMSQKDWDLKD 328
Query: 332 LTKGC-KQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRLQWCREACMRDCF 390
+ GC +++ L + D NQ + L M+ D + E L C AC DC
Sbjct: 329 YSAGCVRKTELQCSRGDINQ---FFRLPNMKLAD----NSEVLTRTSLSICASACQGDCS 381
Query: 391 CTVAIFRNG--ECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTDSKKKVHSTSV 448
C + G +C + N + D + I R ++ P S K + +
Sbjct: 382 CKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLI 441
Query: 449 FVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQIFSYKELEKATQ 508
F + + L L+ + K D T L FSY+EL+ AT+
Sbjct: 442 FGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGT--------LSAFSYRELQNATK 493
Query: 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
F D+LG G F +V KG L + I AVK+L+ +S G+K+FRTEV IG H NLV+
Sbjct: 494 NFSDKLGGGGFGSVFKGALPDSSDI--AVKRLEG-ISQGEKQFRTEVVTIGTIQHVNLVR 550
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-----SWYRRMQIAFGIARGLFYLHEE 623
L GFC+E +LLVY+++ NG L LF N W R QIA G ARGL YLH+E
Sbjct: 551 LRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDE 610
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
C IIHCDIKP+NILLD F +++DFGLAK++ D +R T +RGTRGY+APEW +
Sbjct: 611 CRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGV 670
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI-DEKLHLLVENDEE 742
IT K D+YS+G+ML EL+ R+ EQ+ ENE WA D + LV+ E
Sbjct: 671 AITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSWAATILTKDGDIRSLVDPRLE 729
Query: 743 A-LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSS 792
D+ + + +A WCIQ++ S RP M +V +LEGV+EV PP P S
Sbjct: 730 GDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRS 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 240/759 (31%), Positives = 365/759 (48%), Gaps = 84/759 (11%)
Query: 48 FAFGFQHIENG--NYLLTIYFNKIPERTIIWSANGKTPVER--GSKVQLTVDGRLVLTDL 103
F GF NG N+ L I + +P T +W AN PV S ++LT G L++++L
Sbjct: 40 FRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGYLIVSNL 99
Query: 104 TGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLS 163
VW D + ++GN +L D P+W+SFD+PTDT LP + ++
Sbjct: 100 RDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAMT 158
Query: 164 AHYSDKNYSTGRYELAMQSDGN--LVLYTTAFPFESANSVYWSTQP-VG-SSLQVEFNRS 219
+ S + S G Y L + N ++Y P+ S + W+ + VG + + +
Sbjct: 159 SWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGN--WTGEAFVGVPEMTIPYIYR 216
Query: 220 GNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWS 279
+ + S Y++ S + R + +G L+ Y + +SW+M W
Sbjct: 217 FHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTW----DPQTQSWNMFWL 272
Query: 280 TPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLCPQGYVPLD-----RNDLTK 334
P + C + + CG +CS ++ C C +G+ P + +D +
Sbjct: 273 QP----EDPCRVYNL-------CGQLGFCS--SELLKPCACIRGFRPRNDAAWRSDDYSD 319
Query: 335 GCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGV---RLQWCREACMRDCFC 391
GC++ D ++ D ++ V D + V RLQ + +C + C
Sbjct: 320 GCRR-----ENGDSGEKSDTFEAVG---------DLRYDGDVKMSRLQVSKSSCAKTCLG 365
Query: 392 TVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTDSKKKVHSTSVFVV 451
+ G K+K+ L K L++ P + + K S S+ ++
Sbjct: 366 NSSCV--GFYHKEKSNLC----------KILLE--------SPNNLKNSKGNISKSIIIL 405
Query: 452 SVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQIFSYKELEKATQGFK 511
++ S L F L L +L+ K Q NL++FS+KEL+ AT GF
Sbjct: 406 CSVVGSISVLGFTL-LVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFS 464
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
D++G G F V KG L + VAVK+L+ SG + EFR EV IG H NLV+L G
Sbjct: 465 DKVGHGGFGAVFKGTLPGSSTF-VAVKRLERPGSG-ESEFRAEVCTIGNIQHVNLVRLRG 522
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFK-NPKP-SWYRRMQIAFGIARGLFYLHEECTTQII 629
FC+E+ HRLLVY+++ G L+ +L + +PK SW R +IA G A+G+ YLHE C II
Sbjct: 523 FCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCII 582
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
HCDIKP+NILLD + A++SDFGLAK+L D +R +RGT GYVAPEW LPIT K
Sbjct: 583 HCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKA 642
Query: 690 DIYSFGVMLLELICCRKKF--------EQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741
D+YSFG+ LLELI R+ E+ E E + WA I + +V++
Sbjct: 643 DVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPE-KWFFPPWAAREIIQGNVDSVVDSRL 701
Query: 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780
++ + + +AIWCIQ++ +RP M V MLEG
Sbjct: 702 NGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 246/800 (30%), Positives = 361/800 (45%), Gaps = 103/800 (12%)
Query: 45 SGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLT 104
+G F+ G G Y ++ + + IWS+N +PV + LT G V+ D
Sbjct: 59 AGLFSPGGDDSSTGFYFSVVH---VDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIED-- 113
Query: 105 GKE---VWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNK 161
GK VW+ + + + D+GN +L + LWESFD PTD+++ Q L
Sbjct: 114 GKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMF 173
Query: 162 LSAHYSDKNYSTGRYE-LAMQSDGNLVLYTTAFPFESANSVYWSTQPVGSSLQVEFNRSG 220
LS S ++STG Y+ L +SDG + + YW + + + N
Sbjct: 174 LSGSVSRSDFSTGDYKFLVGESDGLM---------QWRGQNYWKLR-----MHIRANVDS 219
Query: 221 N--IIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHW 278
N + YLT + M A + + RV L R S +S
Sbjct: 220 NFPVEYLTVTTSGLALM----ARNGTVVVVRVALPPSSDFRVAKMDSSGKFIVSRFSGKN 275
Query: 279 STPLFNSPND-CMITDETGSGACDCGFNSYCSLGN-DQRPTCLCPQGYVPLDRNDLTKGC 336
F+ P D C I CG C+L N + +C CP R D KG
Sbjct: 276 LVTEFSGPMDSCQI-------PFVCGKLGLCNLDNASENQSCSCPDEM----RMDAGKGV 324
Query: 337 ----KQSF-LSQNCDDPNQEVDLYDL-VEMEYTDWPYFDYEHHQGVRLQWCREACMRDCF 390
QS L +C+ N + +L + + Y + D H G+ L C + C ++C
Sbjct: 325 CVPVSQSLSLPVSCEARN--ISYLELGLGVSYFSTHFTDPVEH-GLPLLACHDICSKNCS 381
Query: 391 CTVAIFRNGE--CWKKKNP------LTNGRMAPDIEGKALIKIRRGNSTLKPEDTDSKKK 442
C + N C+ K+ + N D+ G + IR+ N+ +P +++
Sbjct: 382 CLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNA--QPPGNNNRGG 439
Query: 443 VHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTG--------------- 487
S V + +L CS FL L L + + Y + Q
Sbjct: 440 -SSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHI 498
Query: 488 PVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG 547
P +P Q F ++ELE+AT+ FK ++G G F +V+KG L E I AVKK+ N G
Sbjct: 499 PGLP----QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLI--AVKKITNHGLHG 552
Query: 548 DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYR 605
+EF TE+ IG H NLVKL GFC + LLVYE++++G L LF P W
Sbjct: 553 RQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQE 612
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665
R IA G ARGL YLH C +IIHCD+KP+NILL D F +ISDFGL+K+L +++
Sbjct: 613 RFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLF 672
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK------KFEQNVENENQ-- 717
T +RGTRGY+APEW + I+ K D+YS+G++LLEL+ RK + E+ NQ
Sbjct: 673 TTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNH 732
Query: 718 ----------MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSL 767
+ +A D + + L + E +K V IA+ C+ E+P+L
Sbjct: 733 SSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPAL 792
Query: 768 RPTMKKVTLMLEGVVEVPIP 787
RPTM V M EG + + P
Sbjct: 793 RPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 135/305 (44%), Positives = 195/305 (63%), Gaps = 9/305 (2%)
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
F+YK+L+ AT F +LG+G F +V++G L +++ AVKKL+ + G KEFR EV+
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRL--AVKKLEG-IGQGKKEFRAEVSI 539
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS----WYRRMQIAFGI 613
IG +H +LV+L GFC E HRLL YEF+S G L ++F+ W R IA G
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
A+GL YLHE+C +I+HCDIKP+NILLDD+F A++SDFGLAK++ +Q+ T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
Y+APEW + I+ K D+YS+G++LLELI RK ++ + E + +A+ + KL
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKL 718
Query: 734 HLLVENDEEALHDM-MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSS 792
+V+ + + R+++ + A+WCIQED RP+M KV MLEGV V PP S+
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
Query: 793 FISSI 797
S +
Sbjct: 779 MGSRL 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 219/806 (27%), Positives = 365/806 (45%), Gaps = 99/806 (12%)
Query: 43 STSGEFAFGFQHIENGNY-LLTIYFNKIPERTIIWSANGKTPVERGSK-VQLTVDGRLVL 100
S FAFGF + + + I++ +I ++TI+W AN P+ S V+ + G L +
Sbjct: 36 SAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPINDTSGMVKFSNRGNLSV 95
Query: 101 --TDLTGKEVWNPDTAGAAIA---YASMLDSGNFVLAGP-DSFPLWESFDHPTDTLLPTQ 154
+D + +W+ + + + + A++ D GN VL P WESFDHPTDT LP
Sbjct: 96 YASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRSFWESFDHPTDTFLPFM 155
Query: 155 ILNPRNK------LSAHYSDKNYSTGRYELAMQSDG--NLVLYTTAFPFESANSV---YW 203
L K L++ S + +G L M+ G L+LY P+ S W
Sbjct: 156 RLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHRW 215
Query: 204 S---TQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRH 260
S P+G F + + + T Y ++ ++ + R + G +
Sbjct: 216 SGVPEMPIGYIFNNSFVNNEDEVSFT-------YGVTDAS-----VITRTMVNETGTMHR 263
Query: 261 YVYPKSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLC 320
+ + + +K W+ WS P E CG N YC + + C C
Sbjct: 264 FTWI----ARDKRWNDFWSVP-----------KEQCDNYAHCGPNGYCDSPSSKTFECTC 308
Query: 321 PQGYVP-LDRN----DLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQG 375
G+ P R+ D + GC + + C + + V L M+ D D
Sbjct: 309 LPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLK---RMKIPDTS--DASVDMN 363
Query: 376 VRLQWCREACMRDCFCTVAIFRNGE-------CWKKKNPLTNGRMAPDIEGKALIKIRRG 428
+ L+ C++ C+++C C E C K + + R + I++ +
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKE 423
Query: 429 NSTLKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGP 488
+ S K+ V ++ + L ++V L ++ H++ P
Sbjct: 424 ELARWNRNGLSGKR----RVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAP 479
Query: 489 V--------------MPSTNLQIFSYKELEKATQGF--KDELGRGAFATVHKGVLAYENK 532
V + L +F + AT F +++LG G F V+KGVL +N+
Sbjct: 480 VPFDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVL--QNR 537
Query: 533 ICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLA 592
+ +AVK+L G +EF+ EV I + HRNLV++LG C E + ++LVYE++ N L
Sbjct: 538 MEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLD 597
Query: 593 GFLFKNPKPS---WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649
F+F + + W +RM+I GIARG+ YLH++ +IIH D+K NILLD +IS
Sbjct: 598 YFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKIS 657
Query: 650 DFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF 708
DFG+A+I +Q T+ + GT GY+APE+ ++K D+YSFGV++LE+I +K
Sbjct: 658 DFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNS 717
Query: 709 EQNVENENQMILVDWAYDCYIDEKLHLLVEN--DEEALHDMMRLKKYVMIAIWCIQEDPS 766
+ E+ N LV +D + + + +++N D+E +D + K + I + C+QE+ S
Sbjct: 718 AFHEESSN---LVGHIWDLWENGEATEIIDNLMDQET-YDEREVMKCIQIGLLCVQENAS 773
Query: 767 LRPTMKKVTLML-EGVVEVPIPPDPS 791
R M V +ML +P P P+
Sbjct: 774 DRVDMSSVVIMLGHNATNLPNPKHPA 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 228/810 (28%), Positives = 366/810 (45%), Gaps = 112/810 (13%)
Query: 43 STSGEFAFGF-QHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSK-VQLTVDGRLVL 100
S F FGF + + I+FN IP +T++W AN +P+ S V ++ +G LV+
Sbjct: 39 SNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVV 98
Query: 101 TDLTGKEVWNPDT---AGAAIAYASMLDSGNFVLAGPDSFP---LWESFDHPTDTLLPTQ 154
D G+ W+ + A YA +L++GN VL G + LWESF+HP + LPT
Sbjct: 99 MDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLPTM 158
Query: 155 ILNPRNK------LSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPV 208
L K L + S + S GRY S G + L + + W + P
Sbjct: 159 SLATDTKTGRSLKLRSWKSPFDPSPGRY-----SAGLIPLPFPELVVWKDDLLMWRSGPW 213
Query: 209 GSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDG--FLRHYVYPKS 266
+ N+ Y R ++ L+ S+ D V++ + G L H++
Sbjct: 214 NGQYFIGL---PNMDY-----RINLFELTLSS----DNRGSVSMSYAGNTLLYHFLLDSE 261
Query: 267 SSSNNKSWSM---HWSTPLFNSPNDCMITDETGSGACD----CGFNSYCSLGNDQRPTCL 319
S + W++ W T L + S CD CG + C P C+
Sbjct: 262 GSVFQRDWNVAIQEWKTWL-----------KVPSTKCDTYATCGQFASCRFNPGSTPPCM 310
Query: 320 C-----PQGYVPLDRNDLTKGC--KQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEH 372
C PQ Y + + T+GC K ++ D+ + V ++ P+
Sbjct: 311 CIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPH--NPQ 368
Query: 373 HQGVRLQWCREACMRDCFCTVAIFRNG-ECWKKKNPLTNGRMAPDIEGKALIKIRRGNST 431
G Q C E+C+++C CT F G C L + + + G ++
Sbjct: 369 RSGANEQDCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQ---EFSGTGVVFY------ 419
Query: 432 LKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQT----- 486
++ D++ KK+ + + V V++L+ + FL L ++ H+ K T
Sbjct: 420 IRLADSEFKKRTNRSIVITVTLLVGA-----FLFAGTVVLALWKIAKHREKNRNTRLLNE 474
Query: 487 ----------GPVMPS----TNLQIFSYKELEKATQGFK--DELGRGAFATVHKGVLAYE 530
G ++ + L +F ++ L AT F ++LG+G F V+KG L +
Sbjct: 475 RMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRL--Q 532
Query: 531 NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590
+ +AVK+L G +EF EV I + HRNLV+LLGFC E + R+LVYEF+ C
Sbjct: 533 EGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENC 592
Query: 591 LAGFLFKNPKP---SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR 647
L +LF K W R I GI RGL YLH + +IIH D+K NILLD++ +
Sbjct: 593 LDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPK 652
Query: 648 ISDFGLAKILKADQTRTTTA-IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK 706
ISDFGLA+I + ++ +T + GT GY+APE+ + K D++S GV+LLE++ R+
Sbjct: 653 ISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRR 712
Query: 707 K--FEQNVENENQMILVDWAYDCYIDEKLHLLVEND--EEALHDMMRLKKYVMIAIWCIQ 762
F + +N N L +A+ + + LV+ EE + +R + V + + C+Q
Sbjct: 713 NSSFYNDGQNPN---LSAYAWKLWNTGEDIALVDPVIFEECFENEIR--RCVHVGLLCVQ 767
Query: 763 EDPSLRPTMKKVTLMLEGV-VEVPIPPDPS 791
+ + RP++ V ML +P P P+
Sbjct: 768 DHANDRPSVATVIWMLSSENSNLPEPKQPA 797
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 797 | ||||||
| 225435578 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.969 | 0.972 | 0.630 | 0.0 | |
| 224057533 | 812 | predicted protein [Populus trichocarpa] | 0.976 | 0.958 | 0.613 | 0.0 | |
| 255544748 | 797 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.983 | 0.983 | 0.575 | 0.0 | |
| 147862348 | 761 | hypothetical protein VITISV_004992 [Viti | 0.927 | 0.971 | 0.605 | 0.0 | |
| 225435585 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.956 | 0.952 | 0.591 | 0.0 | |
| 225435588 | 816 | PREDICTED: G-type lectin S-receptor-like | 0.972 | 0.949 | 0.577 | 0.0 | |
| 225435582 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.963 | 0.955 | 0.585 | 0.0 | |
| 147811981 | 771 | hypothetical protein VITISV_011718 [Viti | 0.930 | 0.962 | 0.576 | 0.0 | |
| 449503632 | 859 | PREDICTED: G-type lectin S-receptor-like | 0.967 | 0.897 | 0.550 | 0.0 | |
| 449523037 | 832 | PREDICTED: G-type lectin S-receptor-like | 0.954 | 0.914 | 0.546 | 0.0 |
| >gi|225435578|ref|XP_002283186.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 995 bits (2572), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/780 (63%), Positives = 593/780 (76%), Gaps = 7/780 (0%)
Query: 19 ISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSA 78
I+ T N++ G SL A+++ S W S SGEFAFGFQ + G +LL I+FNKIPE+TIIWSA
Sbjct: 22 IAQTYSNITLGSSLTAQNNGSFWASPSGEFAFGFQQVGAGGFLLAIWFNKIPEKTIIWSA 81
Query: 79 NGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFP 138
NG + +R S VQLT DG+LVLTD GK++W+ AG+ ++YA+M+D+GNFVL G DS
Sbjct: 82 NGNSLGQRRSIVQLTADGQLVLTDPKGKQIWD---AGSGVSYAAMVDTGNFVLVGQDSVT 138
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
LWESF PTDT+LPTQ LN KL A +S+ NYS GR+ +Q+DGNLV+YT FP +S
Sbjct: 139 LWESFGEPTDTILPTQELNQGGKLVARFSETNYSNGRFMFTLQADGNLVMYTRDFPMDST 198
Query: 199 NSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFL 258
N YWSTQ VGS QV FN+SG I+ LTA+N+SI+ ++SSS +S +D YQR LE+DG
Sbjct: 199 NFAYWSTQTVGSGFQVIFNQSGYIV-LTARNKSILNLVSSSETSTEDFYQRAILEYDGVF 257
Query: 259 RHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACDCGFNSYCSLGNDQRPT 317
R YVYPKS+ S++ W M WS N CM IT+ TG GAC GFNSYC LG+DQRP
Sbjct: 258 RQYVYPKSAGSSSGRWPMAWSPSPSIPGNICMRITENTGGGAC--GFNSYCILGDDQRPN 315
Query: 318 CLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVR 377
C CP GY LD++D GCKQ+F++QNCD ++E D + EM TDWP DY + Q V
Sbjct: 316 CKCPTGYDFLDQSDKMSGCKQNFVTQNCDQASRETDQFYFQEMPNTDWPLSDYGYFQPVS 375
Query: 378 LQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDT 437
WCREAC+ DCFC VAIFR+G CWKKK PL+NGR+ P + GKALIK+R+GNST KP D
Sbjct: 376 EDWCREACLTDCFCAVAIFRDGNCWKKKIPLSNGRIDPSVGGKALIKLRQGNSTTKPGDG 435
Query: 438 DSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQI 497
DS KK ST + SVLL SSVFLNFL L T L +F F KTKM T NL+
Sbjct: 436 DSNKKHQSTLILTGSVLLGSSVFLNFLFFLATVLFIFRFNNRKTKMLHTYLSTLGMNLRS 495
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
F+Y EL++AT GFK+ELGRGAFATV+KGVLAYE VAVKK + M+ ++EF+TEV A
Sbjct: 496 FTYNELDEATDGFKEELGRGAFATVYKGVLAYEKGKLVAVKKFEKMMRENEQEFQTEVKA 555
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
IGQTNH+NLV+LLGFC E +HRLLVYEF+SNG L FLF N +P+W++R+QIAFGIARGL
Sbjct: 556 IGQTNHKNLVQLLGFCKEGEHRLLVYEFMSNGSLEKFLFGNSRPNWHKRIQIAFGIARGL 615
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
FYLHEEC+TQIIHCDIKPQNILLDDSF+ARISDFGLAK+LK DQTRTTT IRGT+GYVAP
Sbjct: 616 FYLHEECSTQIIHCDIKPQNILLDDSFSARISDFGLAKLLKTDQTRTTTGIRGTKGYVAP 675
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
EWFKS+PIT+KVD+YSFG++LLELICCRK E ++E QMIL DWAYDCY L +LV
Sbjct: 676 EWFKSMPITVKVDVYSFGILLLELICCRKNLEFEAKDETQMILADWAYDCYKGGLLEVLV 735
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFISSI 797
D+EA+ +M RL+K+VMIAIWCIQEDPSLRPTMKKVT MLEG VEV +PPDP SFISSI
Sbjct: 736 GYDQEAIVEMKRLEKFVMIAIWCIQEDPSLRPTMKKVTQMLEGAVEVSVPPDPCSFISSI 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057533|ref|XP_002299254.1| predicted protein [Populus trichocarpa] gi|222846512|gb|EEE84059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/789 (61%), Positives = 584/789 (74%), Gaps = 11/789 (1%)
Query: 9 LWFSLLLLMPISATAQN---VSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIY 65
L F ++L P ATA++ ++ G SL A ++ SW+S SGEFAFGFQ + +LL I+
Sbjct: 18 LLFLVILPQPFPATAESYKKITLGLSLTASNN-DSWQSPSGEFAFGFQQVAVDGFLLAIW 76
Query: 66 FNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLD 125
F+KIPE+TI+WSAN V+RG KV+L DG+LVL D GK++W DTAG+ +AYA+MLD
Sbjct: 77 FDKIPEKTILWSANRNNLVQRGDKVKLMKDGQLVLNDRKGKQIWRADTAGSRVAYAAMLD 136
Query: 126 SGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGN 185
SGNFVLA DS LWESF PTDTLLPTQ + +KL A YS N STGRY+ +QSDGN
Sbjct: 137 SGNFVLARHDSVNLWESFREPTDTLLPTQTFSQGSKLVAGYSSMNRSTGRYQFTLQSDGN 196
Query: 186 LVLYTTAFPFESANSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQD 245
LVLYT AFP S NS YWS++ G+ + FN+SGNI YL AKN ++ MLSS D
Sbjct: 197 LVLYTLAFPIGSVNSPYWSSKTEGNGFLLSFNQSGNI-YLAAKNGRMLVMLSSDPPPTSD 255
Query: 246 LYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWS--TPLFNSPNDCM-ITDETGSGACDC 302
Y R LE+DG RHYVYPKS + W + WS T F PN C I + G GAC
Sbjct: 256 FYHRAILEYDGVFRHYVYPKSMNPGAAGWPLRWSPLTSSFIPPNICTSIRENNGCGAC-- 313
Query: 303 GFNSYCSLGNDQRPTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEY 362
GFNSYCSLGNDQ+P C CP GY LD ND+ KGCKQ+F+SQNC++ +QE +L+ L + E
Sbjct: 314 GFNSYCSLGNDQKPKCSCPPGYTFLDPNDVMKGCKQNFVSQNCEEASQETELFYLEQKEN 373
Query: 363 TDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKAL 422
TDWP D EH V +WCR+AC+ DCFC VAIFR+G CWKKK PL+NGR P + G+AL
Sbjct: 374 TDWPLSDSEHFSTVTEEWCRKACLSDCFCAVAIFRDGNCWKKKIPLSNGRFDPSVGGRAL 433
Query: 423 IKIRRGNSTLKPEDTD-SKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKT 481
IKIR+ NSTL P D D K K ST + + S+L+ SSV LNFL L FL V FGY KT
Sbjct: 434 IKIRQDNSTLNPADDDVPKNKSRSTIIIIGSLLVISSVSLNFLFILRAFLDVLQFGYEKT 493
Query: 482 KMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD 541
K P P L+ F++ ELEKAT F++ELG GAFATV+KG L ++ + VAVK LD
Sbjct: 494 KKRYLEPTDPGVTLRSFTFSELEKATGNFEEELGSGAFATVYKGTLDFDERTFVAVKNLD 553
Query: 542 NMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP 601
MV +KEF+ EVNAIG+TNH+NLVKLLGFCNE +HRLLVYE I NG LA FLF NP+
Sbjct: 554 KMVRDCEKEFKAEVNAIGRTNHKNLVKLLGFCNEGEHRLLVYELIRNGNLANFLFGNPRL 613
Query: 602 SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661
+W++RMQIAFG+ARGLFYLHEEC+TQIIHCDIKPQNILLD+SF A ISDFG+AK+LKADQ
Sbjct: 614 NWFKRMQIAFGVARGLFYLHEECSTQIIHCDIKPQNILLDESFRAIISDFGIAKLLKADQ 673
Query: 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
TRT+TAIRGT+GY+APEWFK+LP+T+KVD+YSFG++LLELICCRK FE V+NE+QM+L
Sbjct: 674 TRTSTAIRGTKGYLAPEWFKNLPVTVKVDVYSFGILLLELICCRKNFEPEVKNEDQMVLA 733
Query: 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781
WAYDCY D K LLV ND++A+ DM R+ K+VMIAIWCIQEDPSLRPTMKKVTLMLEG
Sbjct: 734 YWAYDCYRDGKAGLLVANDDDAVLDMKRVVKFVMIAIWCIQEDPSLRPTMKKVTLMLEGT 793
Query: 782 VEVPIPPDP 790
VEV PPDP
Sbjct: 794 VEVSAPPDP 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544748|ref|XP_002513435.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223547343|gb|EEF48838.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/797 (57%), Positives = 591/797 (74%), Gaps = 13/797 (1%)
Query: 9 LWFSLL--LLMPISATAQ---NVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLT 63
L+F LL IS AQ N+S G SL A+ D S W S SG+FAFGFQ ++ YLL
Sbjct: 3 LFFLLLASFAAVISTNAQTHTNISLGSSLTAQKDDSFWVSPSGDFAFGFQLVDKNGYLLA 62
Query: 64 IYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASM 123
I+FN++PE+TI+WSAN V RGSKVQLT DGRLVL D + +++W+ ++A ++YA+M
Sbjct: 63 IWFNEVPEKTIVWSANRNNLVGRGSKVQLTTDGRLVLNDQSNRQLWSANSAADGVSYAAM 122
Query: 124 LDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSD 183
LD+GNFVLA DS LWESFD PTDT+LPTQ ++ +L A YS+ NYS GR++ +Q+D
Sbjct: 123 LDTGNFVLADKDSITLWESFDEPTDTILPTQTMDQGGELIARYSETNYSDGRFKFMLQTD 182
Query: 184 GNLVLYTTAFPFESANSVYWSTQ-PVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASS 242
GNL+LYT +P +++N+ YWSTQ +GS QV FN+SG II L A+N SI+ + S+ +S
Sbjct: 183 GNLLLYTRKYPLDTSNAAYWSTQTSIGSGFQVIFNQSGYII-LIARNGSILNDVFSNEAS 241
Query: 243 MQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACD 301
+D YQR T++ DG RHYVYPK+++S+ W + W+ F N CM I ETGSGAC
Sbjct: 242 TRDFYQRATIDHDGVFRHYVYPKNATSSAGKWPLAWTVLSFIPGNICMRIGGETGSGAC- 300
Query: 302 CGFNSYCSLGNDQRPTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEME 361
GFNSYC LG+DQRP C CP G+ LD ND +KGCKQ+F++QNCD +QE D +DL+EM
Sbjct: 301 -GFNSYCRLGDDQRPNCQCPPGHTLLDPNDESKGCKQNFVAQNCDAESQETDSFDLMEMP 359
Query: 362 YTDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKA 421
TDWP DYE+ V WCR+AC+ DC+C+VAI+RN CWKKK PL+NGRM P + GKA
Sbjct: 360 NTDWPLSDYEYFDTVTEDWCRQACLSDCYCSVAIYRNQGCWKKKIPLSNGRMDPSVGGKA 419
Query: 422 LIKIRRGNSTLKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKT 481
LIK+RR NST KKK ST + + SV L SSVFLN LL + T + + + K+
Sbjct: 420 LIKVRRDNSTSGATSC-YKKKDQSTLILIGSVFLGSSVFLNVLLLVATLVFFYRWSRQKS 478
Query: 482 KMDQT-GPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKI-CVAVKK 539
K+ Q VM + N + F+Y ELE AT GFK+ELG GAF TV+KGV+ N +AVKK
Sbjct: 479 KIVQPHTQVMLAMNPRSFTYNELEVATGGFKEELGSGAFGTVYKGVVIESNSTKFIAVKK 538
Query: 540 LDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNP 599
L +V+ G+KEF TEV+ IG TNH+NL KLLGFCNE QHR+LVYE++SNGCLA FLF +
Sbjct: 539 LKKVVAEGEKEFETEVDIIGGTNHKNLAKLLGFCNEGQHRMLVYEYMSNGCLADFLFGDS 598
Query: 600 KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659
+P+WY+RMQIAFGIARGL YLHEEC++QIIHCDIKPQN+LLD+S TARISDFGLAK+LK
Sbjct: 599 RPNWYKRMQIAFGIARGLSYLHEECSSQIIHCDIKPQNVLLDESLTARISDFGLAKLLKT 658
Query: 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
DQ++T TAIRGT+GYVAPEWF+++PIT KVD+YSFG++LLELICC++ E++ + +I
Sbjct: 659 DQSQTMTAIRGTKGYVAPEWFRNMPITSKVDVYSFGILLLELICCKRSVEKDTKERYPII 718
Query: 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L DWAYD Y + ++LLVE+DEEA D+ R++++VM+A+WCIQ+DPSLRP MKKV MLE
Sbjct: 719 LADWAYDRYKEGSVNLLVEDDEEATDDVKRVERFVMVAMWCIQDDPSLRPAMKKVIHMLE 778
Query: 780 GVVEVPIPPDPSSFISS 796
G V+V IPPDP SFIS+
Sbjct: 779 GAVQVAIPPDPDSFIST 795
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147862348|emb|CAN84023.1| hypothetical protein VITISV_004992 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2424), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/780 (60%), Positives = 560/780 (71%), Gaps = 41/780 (5%)
Query: 19 ISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSA 78
I+ T N++ G SL A+++ S W S SGEFAFGFQ + G +LL I+FNKIPE+TIIWSA
Sbjct: 22 IAQTYSNITLGSSLTAQNNGSFWASPSGEFAFGFQQVGAGGFLLAIWFNKIPEKTIIWSA 81
Query: 79 NGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFP 138
NG +R S VQLT DG+LVLTD GK++W+ AG+ ++YA+M D+GNFVL G DS
Sbjct: 82 NGNNLGQRISIVQLTADGQLVLTDPKGKQIWD---AGSGVSYAAMXDTGNFVLVGQDSVT 138
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
LWESF PTDT+LPTQ LN KL A +S+ NYS GR+ +Q+DGNLV+YT FP +S
Sbjct: 139 LWESFGEPTDTILPTQELNQGGKLVARFSETNYSNGRFMFTLQADGNLVMYTRDFPMDST 198
Query: 199 NSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFL 258
N YWSTQ VGS +QR LE+DG
Sbjct: 199 NFAYWSTQTVGSG-----------------------------------FQRAILEYDGVF 223
Query: 259 RHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACDCGFNSYCSLGNDQRPT 317
R YVYPKS+ S++ W M WS N CM IT+ TG GAC GFNSYC LG+DQRP
Sbjct: 224 RQYVYPKSAGSSSGRWPMAWSPSPSIPGNICMRITENTGGGAC--GFNSYCILGDDQRPN 281
Query: 318 CLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVR 377
C CP GY LD++D GCKQ+F++QNCD ++E D + EM TDWP DY + Q V
Sbjct: 282 CKCPTGYDFLDQSDKMSGCKQNFVTQNCDQASRETDQFYFQEMPNTDWPLSDYGYFQPVS 341
Query: 378 LQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDT 437
WCREAC+ DCFC VAIFR+G CWKKK PL+NGR+ P + GKALIK+R+GNST KP D
Sbjct: 342 EDWCREACLTDCFCAVAIFRDGNCWKKKIPLSNGRIDPSVGGKALIKLRQGNSTTKPGDG 401
Query: 438 DSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQI 497
DS KK S + SVLL SSVFLNFL L T L +F F KTKM T NL+
Sbjct: 402 DSNKKHQSXLILTGSVLLGSSVFLNFLFFLATVLFIFRFNNRKTKMLHTYLSTLGMNLRS 461
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
F+Y EL++AT GFK+ELGRGAFATV+KGVLAYE VAVKK + M+ D+EF+TEV A
Sbjct: 462 FTYNELDEATDGFKEELGRGAFATVYKGVLAYEKGKLVAVKKFEKMMRENDQEFQTEVKA 521
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
IGQTNH+NLV+LLGFC E +HRLLVYEF+SNG L FLF N +P+W +R+QIAFG ARGL
Sbjct: 522 IGQTNHKNLVQLLGFCKEGEHRLLVYEFMSNGSLEKFLFGNSRPNWLKRIQIAFGTARGL 581
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
FYLHEEC+TQIIHCDIKPQNILLDDSF+ARISDFGLAK+LK DQTRTTT IRGT+GYVAP
Sbjct: 582 FYLHEECSTQIIHCDIKPQNILLDDSFSARISDFGLAKLLKTDQTRTTTGIRGTKGYVAP 641
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
EWFKS+PIT+KVD+YSFG++LLELICCRK E ++E QMIL DWAYDCY L +LV
Sbjct: 642 EWFKSMPITVKVDVYSFGILLLELICCRKNLEFEAKDETQMILADWAYDCYKGGLLEVLV 701
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFISSI 797
D+EA+ M RL+K+VMIAIWCIQEDPSLRPTMKKVT MLEG VEV +PPDP SFISSI
Sbjct: 702 GYDQEAIXXMKRLEKFVMIAIWCIQEDPSLRPTMKKVTQMLEGAVEVSVPPDPCSFISSI 761
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435585|ref|XP_002283213.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/772 (59%), Positives = 558/772 (72%), Gaps = 10/772 (1%)
Query: 21 ATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANG 80
++ N++ G SL A D+ SW S SGEFAFGFQ I G +LL I+F+KIPE+TI+WSANG
Sbjct: 26 SSGNNITLGSSLTARDN-DSWASPSGEFAFGFQEIIPGGFLLAIWFDKIPEKTIVWSANG 84
Query: 81 KTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLW 140
V+ GS+V+LT +G VL D +GKEVW D+ G ++YA+MLD+GNFVLA +S LW
Sbjct: 85 DNLVQTGSRVELTSNGEFVLNDPSGKEVWRADSGGTEVSYAAMLDTGNFVLASQESSNLW 144
Query: 141 ESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANS 200
ESF HPTDT+LPTQILN ++L A + + NYS GR+ A+QSDGNLVLYTT FP +S N
Sbjct: 145 ESFSHPTDTILPTQILNLGSQLVARFLETNYSNGRFMFALQSDGNLVLYTTDFPMDSNNF 204
Query: 201 VYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIY-MLSSSASSMQDLYQRVTLEFDGFLR 259
YWSTQ + S QV FN+SG I YL +NRSI+ +LS+ + +D YQR LE+DG R
Sbjct: 205 AYWSTQTMDSGFQVIFNQSGRI-YLIGRNRSILNDVLSNEVNMREDFYQRAILEYDGVFR 263
Query: 260 HYVYPKSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACDCGFNSYCSLGNDQRPTC 318
YVYPKS++S +WS S F N C I TG GAC GFNSYC LG++QRP+C
Sbjct: 264 QYVYPKSAASGTMAWS---SLSKFIPENICTRIGASTGGGAC--GFNSYCRLGDNQRPSC 318
Query: 319 LCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRL 378
CP GY LD D GC+Q+F+ Q CD QE L+ EM DWPY DY+H +GV
Sbjct: 319 HCPPGYTWLDPLDSLGGCRQNFVQQRCDAGTQEAGLFYFSEMLGVDWPYADYQHFKGVTQ 378
Query: 379 QWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTD 438
WCR+AC+ DCFC VAIFR+G+CW KK PL+NGR E +A+IK+R+ NSTL P D
Sbjct: 379 DWCRQACLGDCFCAVAIFRDGDCWMKKVPLSNGRYDLSNERRAMIKVRKDNSTLPPIDEG 438
Query: 439 SKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQIF 498
SK K ST + SVLL SS F NFL L L + + KT + QT P M TNL+ F
Sbjct: 439 SKGKDQSTLILTGSVLLSSSAFFNFLFLLAIVLFIRRCKHRKTSVLQTSPAMEGTNLRSF 498
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKEFRTEVNA 557
+Y+ELE+AT GF+DELG GAFATV+KG L +++ I +AVKKL+ M GDKEF EV A
Sbjct: 499 TYEELEEATNGFRDELGSGAFATVYKGALPHDDGINLIAVKKLERMEKEGDKEFGAEVKA 558
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
IG+TNH+NLV+LLG+CNE QHRLLVYEF+SNG LA FLF N +P W +R +I G ARGL
Sbjct: 559 IGRTNHKNLVQLLGYCNEGQHRLLVYEFMSNGSLATFLFGNSRPDWCKRTRIILGTARGL 618
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YLHEEC+TQIIHCDIKPQNILLDD TARISDFGLAK+LK DQTRT T IRGT+GYVAP
Sbjct: 619 LYLHEECSTQIIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTRTMTGIRGTKGYVAP 678
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
EWFK++P+T KVD+YSFG++LLE+I CRK FE +V +E+QMIL DW DCY +++L LLV
Sbjct: 679 EWFKTVPVTAKVDVYSFGIVLLEIIFCRKNFEPDVRDESQMILADWVQDCYKEKRLDLLV 738
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
NDEE DM +L+K+VMIAIWC QEDPS RPTMKKV MLEG EV IPPD
Sbjct: 739 GNDEEVFGDMEKLEKFVMIAIWCTQEDPSRRPTMKKVVQMLEGAAEVSIPPD 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435588|ref|XP_002283224.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2364), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/781 (57%), Positives = 566/781 (72%), Gaps = 6/781 (0%)
Query: 19 ISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSA 78
++ T + G SL A D+ S S SGEFAFGFQ I +G +LL I+FNKIPE+TIIWSA
Sbjct: 27 VAKTPVKFTLGSSLTAIDNSSYLASPSGEFAFGFQQIGSGRFLLAIWFNKIPEKTIIWSA 86
Query: 79 NGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFP 138
NG V+RGSK++LT DG +L D TGK++W D +++A+MLD+GNFVLA DS
Sbjct: 87 NGNNLVQRGSKIRLTSDGEFMLNDPTGKQIWKADPVSPGVSHAAMLDTGNFVLASQDSTL 146
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
LWESF+HPTDT+LPTQILN KL A SD +YS+GR+ +Q DGNLVL F S
Sbjct: 147 LWESFNHPTDTILPTQILNQGGKLVARISDMSYSSGRFLFTLQDDGNLVLSHRDFRKGST 206
Query: 199 NSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFL 258
++ YWS+Q G QV FN+SG++ YL+ +N SI+ + S+A+S +D +QR LE DG
Sbjct: 207 STAYWSSQTEGGGFQVIFNQSGHV-YLSGRNSSILNGVFSTAASTKDFHQRAILEHDGVF 265
Query: 259 RHYVYPKSSS-SNNKSWSMHWST-PLFNSPNDCMITD-ETGSGACDCGFNSYCSLGNDQR 315
R YVYPK ++ S+ SW M W++ + C I + ETGSGAC GFNSYC LG+DQR
Sbjct: 266 RQYVYPKKAAVSSAGSWPMTWTSLASIATEKICTIINAETGSGAC--GFNSYCILGDDQR 323
Query: 316 PTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQG 375
P C CP GY LD +D KGCKQ+F+ Q+C+ ++E + +D M DWP DYEH +
Sbjct: 324 PYCKCPPGYTFLDPHDEKKGCKQNFVPQSCNQESRETNEFDFENMTNVDWPLADYEHFKE 383
Query: 376 VRLQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPE 435
V + WCR AC+ DCFC VAIF +G+CWKKKNPL+NGR P ALIK+ +GN T P
Sbjct: 384 VTVDWCRNACLDDCFCAVAIFGDGDCWKKKNPLSNGRYDPSNGRLALIKVGKGNFTWPPN 443
Query: 436 DTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNL 495
KKK ST + SVLL SSVFLN LL L + +F K+K + P M NL
Sbjct: 444 WEGFKKKDRSTLITTGSVLLGSSVFLNLLLLLAAIMFIFYLNDRKSKAVEPRPAMEGANL 503
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEV 555
+ F+Y ELE AT GFK E+GRGAFATV+KG LA++N VAVK+LD V G++EF TE
Sbjct: 504 RSFTYSELEVATDGFKHEIGRGAFATVYKGTLAHDNGDFVAVKRLDRKVVEGEQEFETEA 563
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR 615
+ IG+TNH+NLV+LLGFCNE QH+LLVYEF+SNG L+ FLF +PSWY R+QI G AR
Sbjct: 564 SVIGRTNHKNLVQLLGFCNEGQHQLLVYEFMSNGSLSAFLFGKSRPSWYHRIQIILGTAR 623
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
GL YLHEEC+TQIIHCDIKPQNILLDD FTARIS+FGLAK+LK+DQTRT T IRGTRGY+
Sbjct: 624 GLLYLHEECSTQIIHCDIKPQNILLDDGFTARISNFGLAKLLKSDQTRTMTGIRGTRGYL 683
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735
APEWFK++PIT+KVD+YSFG++LLELI CRK FE +E+E+Q++L DWAYDCY + KL
Sbjct: 684 APEWFKTVPITVKVDVYSFGILLLELIFCRKNFELELEDEDQVVLADWAYDCYKEGKLDQ 743
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFIS 795
++END+EAL+D+ ++K++MIA WCIQEDPS RPTMK VT MLEG +EV +PPDPSSFIS
Sbjct: 744 ILENDKEALNDIETVRKFLMIAFWCIQEDPSKRPTMKTVTQMLEGALEVSVPPDPSSFIS 803
Query: 796 S 796
S
Sbjct: 804 S 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435582|ref|XP_002283204.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/782 (58%), Positives = 558/782 (71%), Gaps = 14/782 (1%)
Query: 19 ISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSA 78
++ N + G SL A D SW S SGEFAFGFQ I G YLL ++FNKI E+T++WSA
Sbjct: 30 VAQAYSNKTLGSSLTAGDS-ESWASESGEFAFGFQEIGTGGYLLAVWFNKISEKTVVWSA 88
Query: 79 NGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFP 138
NG V++GSKVQLT DG VL D G+++W D+ +AYA+MLDSGNFVL DS
Sbjct: 89 NGGNLVKKGSKVQLTSDGNFVLNDQEGEKIWPVDSTITGVAYAAMLDSGNFVLVRQDSIN 148
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
LWESFD+PTDT+LPTQ LN +KL A S+KNYS+GR+ ++S+G+L +YTT FP +S
Sbjct: 149 LWESFDNPTDTILPTQALNQGSKLVARLSEKNYSSGRFMFKLRSNGSLTMYTTDFPQDSE 208
Query: 199 NSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFL 258
N YWS+Q G QV FN+SG+I YL A+N S + + ++ +S +D YQR LE+DG
Sbjct: 209 NFPYWSSQTTG--FQVIFNQSGSI-YLMARNGSKLMDVLTNEASTEDYYQRAILEYDGVF 265
Query: 259 RHYVYPKSSSSNNKSWSMHWST-PLFNSPNDCM-ITDETGSGACDCGFNSYCSLGNDQRP 316
R YVYPKS+ S+ M WS+ F N C I E GSGAC GFNSYC++GND RP
Sbjct: 266 RQYVYPKSAGSSAGR-PMAWSSLTSFVPKNICKSIRAEIGSGAC--GFNSYCTMGNDDRP 322
Query: 317 TCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGV 376
C CP Y LD D GCKQ+F+ ++C + +QE L+ EM DWP DY H V
Sbjct: 323 YCQCPPRYTFLDPQDDMSGCKQNFVPESCSEESQEKGLFGFEEMTDVDWPLSDYGHFTKV 382
Query: 377 RLQWCREACMRDCFCTVAIFRNGE-CWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPE 435
WCR+AC+ DCFC VAIF +G CWKK+ PL+NGR + LIK+R+ NST +P
Sbjct: 383 TEDWCRQACLDDCFCDVAIFGDGGGCWKKRTPLSNGRTESNNGRTILIKVRKDNSTWEPR 442
Query: 436 DTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNL 495
+K + ST + SVLL SVFLN LL L F+ +IF K+K Q M NL
Sbjct: 443 SEGNKDQ--STLIITESVLLGGSVFLNCLLLLSAFM--YIFRKRKSKTLQPHQAMVGANL 498
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEV 555
+ FSYK LE AT GFKDELGRGAF+TV+KG LA++N VA KKLD MV G + EF TEV
Sbjct: 499 KNFSYKALEVATDGFKDELGRGAFSTVYKGTLAHDNGKLVAAKKLDRMVRGVEVEFETEV 558
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR 615
+AIG+TNH+NLV+LLGFCNE+QHRLLVYEF+SNG LA FLF N +P WYRR QI G AR
Sbjct: 559 SAIGRTNHKNLVQLLGFCNEEQHRLLVYEFMSNGSLATFLFGNSRPDWYRRTQIILGTAR 618
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
GL YLHEEC+TQ IHCDIKPQNILLDD TARISDFGLAK+LK DQT+TTT IRGT+GYV
Sbjct: 619 GLLYLHEECSTQTIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTQTTTGIRGTKGYV 678
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735
APEWFK++P+T KVD+YSFG++LLELI CRK FE VE+ENQM+L DWAYD Y++ KL L
Sbjct: 679 APEWFKTVPVTAKVDVYSFGIVLLELIFCRKNFEPAVEDENQMVLADWAYDSYLERKLDL 738
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFIS 795
LVE D+EAL +M +L+K+VMIAIWCIQEDPS RPTMKKVT MLEG +EVP+PPDPS F
Sbjct: 739 LVEKDQEALDNMEKLEKFVMIAIWCIQEDPSQRPTMKKVTQMLEGAIEVPLPPDPSPFSK 798
Query: 796 SI 797
S
Sbjct: 799 SF 800
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147811981|emb|CAN59767.1| hypothetical protein VITISV_011718 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/772 (57%), Positives = 542/772 (70%), Gaps = 30/772 (3%)
Query: 21 ATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANG 80
++ N++ G SL A D+ SW S SGEFAFGFQ I G +LL I+F+KIPE+TI+WSANG
Sbjct: 26 SSGNNITLGSSLTARDN-DSWASPSGEFAFGFQEIIPGGFLLAIWFDKIPEKTIVWSANG 84
Query: 81 KTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLW 140
V+ GS+V+LT +G VL D +GKEVW D+ G ++YA+MLD+GNFVLA +S LW
Sbjct: 85 DNLVQTGSRVELTSNGEFVLNDPSGKEVWRADSGGTXVSYAAMLDTGNFVLASQESSNLW 144
Query: 141 ESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANS 200
ESF HPTDT+LPTQILN ++L A + + NYS GR+ A+QSDGNLVLYTT FP +S N
Sbjct: 145 ESFXHPTDTILPTQILNLGSQLVARFLETNYSNGRFMFALQSDGNLVLYTTDFPMDSNNF 204
Query: 201 VYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIY-MLSSSASSMQDLYQRVTLEFDGFLR 259
YWST + S QV FN+SG I YL +NRSI+ +LS+ + +D YQR LE+DG R
Sbjct: 205 AYWSTXTMDSGFQVIFNQSGRI-YLIGRNRSILNDVLSNEVNMREDFYQRAILEYDGVFR 263
Query: 260 HYVYPKSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACDCGFNSYCSLGNDQRPTC 318
YVYPKS++S +WS S F N C I TG GAC GFNSYC LG+BQRP+C
Sbjct: 264 QYVYPKSAASGTMAWS---SLSKFIPENICTSIGASTGGGAC--GFNSYCRLGDBQRPSC 318
Query: 319 LCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRL 378
CP GY LD D GC+Q+F+ Q CD QE L+ EM DWPY DY+H +GV
Sbjct: 319 QCPPGYTWLDPLDSLGGCRQNFVQQRCDAGTQEAGLFYFSEMLGVDWPYADYQHFKGVTQ 378
Query: 379 QWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTD 438
WCREAC+ DCFC VAIFR+G+CW KK PL+NGR E +A+IK+R+ NSTL P D
Sbjct: 379 DWCREACLGDCFCAVAIFRDGDCWMKKVPLSNGRYDLSNERRAMIKVRKDNSTLPPIDEG 438
Query: 439 SKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPSTNLQIF 498
SK K ST + SVLL SS F NFL L L + + KT + QT P M TNL+ F
Sbjct: 439 SKGKDQSTLILTGSVLLSSSAFFNFLFLLAIVLFIRRCKHRKTSVLQTSPAMEGTNLRSF 498
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKEFRTEVNA 557
+Y+ELE+AT GF+DELG GAFATV+KG L +++ I +AVKKL+ M GDKEF EV A
Sbjct: 499 TYEELEEATNGFRDELGSGAFATVYKGALPHDDGINLIAVKKLERMEKEGDKEFGAEVKA 558
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
IG+TNH+NLV+LLG+CNE QHRLLVYEF+SNG LA FLF N +P W +R +I G ARGL
Sbjct: 559 IGRTNHKNLVQLLGYCNEGQHRLLVYEFMSNGSLATFLFGNSRPDWCKRTRIILGTARGL 618
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YLHEEC+TQIIHCDIKPQNILLDD TARISDFGLAK+LK DQTRT T IRGT+GYVAP
Sbjct: 619 LYLHEECSTQIIHCDIKPQNILLDDFLTARISDFGLAKLLKTDQTRTMTGIRGTKGYVAP 678
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
EWFK++P+T KVD+YSFG++LLE+I CRK FE +V +E+QMIL DW DCY +++L LLV
Sbjct: 679 EWFKTVPVTAKVDVYSFGIVLLEIIFCRKNFEPDVRDESQMILADWVQDCYKEKRLDLLV 738
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
NDEE EDPS RPTMKKV MLEG EV IPPD
Sbjct: 739 GNDEE--------------------EDPSRRPTMKKVVQMLEGAAEVSIPPD 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503632|ref|XP_004162099.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2241), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/783 (55%), Positives = 557/783 (71%), Gaps = 12/783 (1%)
Query: 22 TAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGK 81
T+ N++ G+SL A S W S SG+FAFGF+ G+YLL I+FNKI E+T++WSAN
Sbjct: 80 TSPNITLGKSLTAHSGDSFWSSASGDFAFGFRQAVGGDYLLAIWFNKIDEKTVVWSANRD 139
Query: 82 TPVERGSKVQLTVDGRLVLTDLTGKEVWNPD--TAGAAIAYASMLDSGNFVLAGPDSFPL 139
GS V L G+LVL D GK++W+ ++++A +LD+GNF+LA DS +
Sbjct: 140 KLAPGGSTVLLKTSGQLVLNDPAGKQIWSSTFTATNQSVSFAVLLDNGNFILAANDSEIV 199
Query: 140 WESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESAN 199
W+SFD PTDT+LP+QIL NKL A YS+ NYS+GR+E MQ+DGNLVLYT FP ++ +
Sbjct: 200 WQSFDDPTDTILPSQILKKGNKLVASYSETNYSSGRFEFYMQTDGNLVLYTRNFPSDAIS 259
Query: 200 SVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLR 259
+ YWST V QV FN SG+I+ L A+N++I+ LSS+ + Q YQR L+ DG R
Sbjct: 260 NHYWSTDTVNVGFQVVFNLSGSIV-LIAENKTILDTLSSNNPTAQTFYQRAILDHDGVFR 318
Query: 260 HYVYPKSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCL 319
HY+YP+ + N SW WS N C+ + GS + CGFNSYC LG+DQ+P C
Sbjct: 319 HYIYPRGGTGRNSSWPKAWSVSKSIPSNICLAISQ-GSDSGACGFNSYCKLGDDQKPFCT 377
Query: 320 CPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRLQ 379
CP+GYV D ND+T+ CK +F+ Q+C P E+D +D V M+ TDWP DY H+ V
Sbjct: 378 CPEGYVLFDPNDVTQSCKPNFVPQSCAFP--EIDDFDFVSMDNTDWPQADYGHYLPVDED 435
Query: 380 WCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTDS 439
WCR C+ DC C+ AIFR+G CWKKK PL+ GRM + GKALIK+RRGNSTL+ ++ D
Sbjct: 436 WCRNECLNDCLCSAAIFRDGNCWKKKFPLSFGRMDYSVGGKALIKVRRGNSTLQSQNLDR 495
Query: 440 KKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKT-KMDQTGPVMPSTNLQIF 498
K + T + + SVLL S+FLN LL L T L+ + F K K + P + NL+ F
Sbjct: 496 NCK-NKTKIIIGSVLLGISLFLNILLFLLTLLIGYRFSKRKLLKFNGGDPFILGVNLRAF 554
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVL--AYENKICVAVKKLDNMV--SGGDKEFRTE 554
SY+EL KAT+GFK++LG GAFATV+KG + ++ VAVKKL+N+V G+ EF+ E
Sbjct: 555 SYEELNKATKGFKEQLGSGAFATVYKGTTLGSVDDNNLVAVKKLENIVKEGSGENEFKAE 614
Query: 555 VNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIA 614
V+AI +TNH+NLVKL+GFCNE +HR+LVYEF+ NG LA F+FK KP+WY R+Q+ GIA
Sbjct: 615 VSAIARTNHKNLVKLVGFCNEGEHRMLVYEFMENGSLADFIFKPSKPTWYTRIQLVLGIA 674
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
RGL YLHEEC+TQIIHCDIKPQNILLDDS+ A+I+DFGLAK+LK DQTRT TAIRGTRGY
Sbjct: 675 RGLSYLHEECSTQIIHCDIKPQNILLDDSYGAKIADFGLAKLLKKDQTRTMTAIRGTRGY 734
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734
VAPEWF+SLPIT+KVD+YSFG++LLE+ICCRK FE ENE++MIL DW YDC + K+
Sbjct: 735 VAPEWFRSLPITVKVDVYSFGILLLEMICCRKNFEMETENEDEMILSDWVYDCMNERKME 794
Query: 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFI 794
L+ DEE DM R++++V I IWCIQE+PSLRP+MKKV MLEG V+V PPDPSSFI
Sbjct: 795 TLMREDEEGRSDMKRVERFVKIGIWCIQEEPSLRPSMKKVVQMLEGAVDVSTPPDPSSFI 854
Query: 795 SSI 797
S+I
Sbjct: 855 SAI 857
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523037|ref|XP_004168531.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2209), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/785 (54%), Positives = 557/785 (70%), Gaps = 24/785 (3%)
Query: 24 QNVSRGESLMA---EDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANG 80
+NV+ G SL A D + W S SG+FAFGF + +LL I+F++I E+T++WSAN
Sbjct: 56 KNVTLGSSLTATQLNDHHNYWVSQSGDFAFGFLPLGTNTFLLAIWFDRIDEKTVLWSANR 115
Query: 81 KTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGA-----AIAYASMLDSGNFVLAGPD 135
V +GS Q T G+LVL D G ++W + + +++YA+MLDSGNFVLA D
Sbjct: 116 DNLVPKGSTFQFTNGGQLVLNDPGGNQIWTATVSSSGNSNRSVSYAAMLDSGNFVLAAAD 175
Query: 136 SFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPF 195
S LW+SFD PTDT+LP+Q LN L A YS+ Y +GR++L MQ+DGNLV+Y AFP
Sbjct: 176 SEILWQSFDVPTDTILPSQTLNMGGTLVARYSESTYKSGRFQLVMQTDGNLVIYPRAFPL 235
Query: 196 ESANSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFD 255
+ A++ YW++ +GS Q+ FN SG++ + A N +++ + S+ S ++ Y R LE +
Sbjct: 236 DKASNAYWASNTMGSGFQLVFNLSGSVDVI-ANNNTVLSTVLSTTLSPRNFYLRAILEHN 294
Query: 256 GFLRHYVYPK--SSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGND 313
G Y YPK SSS ++WS + +S N C++ +TG G+ CGFNSYC LG+D
Sbjct: 295 GIFGLYAYPKPTHSSSMPRAWSQ-----VSDSINICILV-QTGWGSGVCGFNSYCRLGDD 348
Query: 314 QRPTCLCPQGYVPLDRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDYEHH 373
QRP C CP GY+ LD ND KGC +F++Q+CD E D ++ V ME T+WP +Y +
Sbjct: 349 QRPFCSCPPGYILLDPNDEIKGCIPNFVAQSCDQSFHETDNFEFVAMENTNWPSANYGYF 408
Query: 374 QGVRLQWCREACMRDCFCTVAIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRRGNSTLK 433
+ V +WCR C+ DCFC VA FRNGECWKK+ PL +GRM P + G+AL+K+R+ NS+ +
Sbjct: 409 KVVSEEWCRNECLNDCFCAVAFFRNGECWKKRFPLGDGRMDPSVGGRALLKVRKQNSSFQ 468
Query: 434 PEDTDSKKKVHSTSVFVV-SVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTGPVMPS 492
P D VH ++ VV SVLL SSVFLNF L L T + + K+K Q P +
Sbjct: 469 PNDL-----VHKPTIVVVGSVLLGSSVFLNFFLFLLTLFIGYRLKKRKSKPVQRDPSILD 523
Query: 493 TNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEF 551
NL+IFSY+EL KAT GF +LGRG+FATV+KG + E N VAVKKLDN+V GD+EF
Sbjct: 524 VNLRIFSYEELNKATSGFIHQLGRGSFATVYKGTIDSEDNNNLVAVKKLDNLVQEGDQEF 583
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF 611
+ EV+AI TNH+NLV+LLGFCNE +HR+LVYEF+ NG LA FLF KP+WY R+Q+
Sbjct: 584 KAEVSAIVGTNHKNLVRLLGFCNEGEHRMLVYEFMHNGSLADFLFGTSKPNWYTRIQLIL 643
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671
GIARGL YLHEEC+TQ IHCDIKP NILLDDSFTARI+DFGLAK+LK DQTRT TAIRGT
Sbjct: 644 GIARGLCYLHEECSTQTIHCDIKPHNILLDDSFTARIADFGLAKLLKKDQTRTLTAIRGT 703
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731
+GYVAPEWF+SLPIT+KVD+YSFG+++LE+ICCR+ +E+ VE+E QM+L DWAYDC+ D
Sbjct: 704 KGYVAPEWFRSLPITVKVDVYSFGIIMLEIICCRRSYEKKVEDEEQMVLTDWAYDCFKDM 763
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPS 791
K+ +LVENDEEA D+ R+KK+VMIAIWCIQE+PSLRPTMKKV MLEG +EV PPDP
Sbjct: 764 KVEMLVENDEEAKMDLKRVKKFVMIAIWCIQEEPSLRPTMKKVLQMLEGAIEVSFPPDPC 823
Query: 792 SFISS 796
SF SS
Sbjct: 824 SFTSS 828
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 797 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.355 | 0.341 | 0.450 | 1.1e-94 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.353 | 0.343 | 0.430 | 2.5e-85 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.358 | 0.345 | 0.447 | 2.8e-82 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.262 | 0.239 | 0.469 | 5.2e-70 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.362 | 0.340 | 0.354 | 2e-62 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.341 | 0.347 | 0.359 | 2e-57 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.347 | 0.333 | 0.360 | 2.1e-57 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.350 | 0.329 | 0.351 | 5.6e-57 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.350 | 0.330 | 0.344 | 6.7e-55 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.352 | 0.330 | 0.348 | 1.1e-54 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 1.1e-94, Sum P(3) = 1.1e-94
Identities = 132/293 (45%), Positives = 190/293 (64%)
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
F+YKEL++ T+ FK++LG G F TV++GVL N+ VAVK+L+ + G+K+FR EV
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLEG-IEQGEKQFRMEVAT 530
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIA 614
I T+H NLV+L+GFC++ +HRLLVYEF+ NG L FLF +W R IA G A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA-DQXXXXXXXXXXXX 673
+G+ YLHEEC I+HCDIKP+NIL+DD+F A++SDFGLAK+L D
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
Y+APEW +LPIT K D+YS+G++LLEL+ ++ F+ + + ++ + WAY+ +
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSI-WAYEEFEKGNT 709
Query: 734 HLLVEN--DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784
+++ E+ DM ++ + V + WCIQE P RPTM KV MLEG+ E+
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEI 762
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 2.5e-85, Sum P(3) = 2.5e-85
Identities = 126/293 (43%), Positives = 183/293 (62%)
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA 557
F+YK+L+ AT F +LG+G F +V++G L +++ AVKKL+ + G KEFR EV+
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRL--AVKKLEG-IGQGKKEFRAEVSI 539
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS----WYRRMQIAFGI 613
IG +H +LV+L GFC E HRLL YEF+S G L ++F+ W R IA G
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXXXXXX 673
A+GL YLHE+C +I+HCDIKP+NILLDD+F A++SDFGLAK++ +Q
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
Y+APEW + I+ K D+YS+G++LLELI RK ++ + E + +A+ + KL
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKL 718
Query: 734 HLLVENDEEALHDMM--RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784
+V+ + + D+ R+++ + A+WCIQED RP+M KV MLEGV V
Sbjct: 719 MDIVDGKMKNV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPV 770
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 2.8e-82, Sum P(3) = 2.8e-82
Identities = 133/297 (44%), Positives = 176/297 (59%)
Query: 495 LQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTE 554
L FSY+EL+ AT+ F D+LG G F +V KG L + I AVK+L+ +S G+K+FRTE
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDI--AVKRLEG-ISQGEKQFRTE 536
Query: 555 VNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS-----WYRRMQI 609
V IG H NLV+L GFC+E +LLVY+++ NG L LF N W R QI
Sbjct: 537 VVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQI 596
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXX 669
A G ARGL YLH+EC IIHCDIKP+NILLD F +++DFGLAK++ D
Sbjct: 597 ALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMR 656
Query: 670 XXXXYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
Y+APEW + IT K D+YS+G+ML EL+ R+ EQ+ ENE WA
Sbjct: 657 GTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSWAATILT 715
Query: 730 -DEKLHLLVENDEEA-LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784
D + LV+ E D+ + + +A WCIQ++ S RP M +V +LEGV+EV
Sbjct: 716 KDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEV 772
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.2e-70, Sum P(4) = 5.2e-70
Identities = 100/213 (46%), Positives = 132/213 (61%)
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEV 555
Q F ++ELE+AT+ FK ++G G F +V+KG L E I AVKK+ N G +EF TE+
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLI--AVKKITNHGLHGRQEFCTEI 560
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGI 613
IG H NLVKL GFC + LLVYE++++G L LF P W R IA G
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXXXXXX 673
ARGL YLH C +IIHCD+KP+NILL D F +ISDFGL+K+L ++
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRG 680
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRK 706
Y+APEW + I+ K D+YS+G++LLEL+ RK
Sbjct: 681 YLAPEWITNAAISEKADVYSYGMVLLELVSGRK 713
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.0e-62, Sum P(3) = 2.0e-62
Identities = 106/299 (35%), Positives = 161/299 (53%)
Query: 487 GPVMPSTNLQIFSYKELEKATQGF--KDELGRGAFATVHKGVLAYENKICVAVKKLDNMV 544
G + ++ L +FS + AT F ++ELGRG F V+KGVL E+ +AVK+L
Sbjct: 506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVL--EDGREIAVKRLSGKS 563
Query: 545 SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS-- 602
G EF+ E+ I + HRNLV+LLG C E + ++LVYE++ N L FLF K +
Sbjct: 564 GQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALI 623
Query: 603 -WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661
W R I GIARGL YLH + +IIH D+K N+LLD +ISDFG+A+I +Q
Sbjct: 624 DWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQ 683
Query: 662 XXXXXXXXXXXX-YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
Y++PE+ ++K D+YSFGV+LLE++ ++ ++ + L
Sbjct: 684 NEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN--TSLRSSEHGSL 741
Query: 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ +A+ Y + LV+ + + +A+ C+Q+ + RP M V LMLE
Sbjct: 742 IGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 2.0e-57, Sum P(3) = 2.0e-57
Identities = 102/284 (35%), Positives = 167/284 (58%)
Query: 503 LEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ 560
+ +AT GF ++LG+G F V+KG LA + VAVK+L G +EF+ E+ I +
Sbjct: 458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQE--VAVKRLSRTSRQGVEEFKNEIKLIAK 515
Query: 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIARGL 617
HRNLVK+LG+C +++ R+L+YE+ N L F+F + W +R++I GIARG+
Sbjct: 516 LQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGM 575
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXXXXXX-YVA 676
YLHE+ +IIH D+K N+LLD A+ISDFGLA+ L D+ Y++
Sbjct: 576 LYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMS 635
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-LVDWAYDCYIDEKLHL 735
PE+ ++K D++SFGV++LE++ R+ + NE + L+ A+ ++++K +
Sbjct: 636 PEYQIDGYFSLKSDVFSFGVLVLEIVSGRRN--RGFRNEEHKLNLLGHAWRQFLEDKAYE 693
Query: 736 LVEND-EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+++ E+ D+ + + + I + C+Q+DP RP M V LML
Sbjct: 694 IIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLML 737
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 2.1e-57, Sum P(3) = 2.1e-57
Identities = 106/294 (36%), Positives = 160/294 (54%)
Query: 495 LQIFSYKELEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR 552
L +F ++ L AT F ++LG+G F V+KG L + + +AVK+L G +EF
Sbjct: 497 LPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRL--QEGLDIAVKRLSRTSGQGVEEFV 554
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQI 609
EV I + HRNLV+LLGFC E + R+LVYEF+ CL +LF K W R I
Sbjct: 555 NEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNI 614
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXX 669
GI RGL YLH + +IIH D+K NILLD++ +ISDFGLA+I + ++
Sbjct: 615 IDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRV 674
Query: 670 XXXX-YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK--FEQNVENENQMILVDWAYD 726
Y+APE+ + K D++S GV+LLE++ R+ F + +N N L +A+
Sbjct: 675 VGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPN---LSAYAWK 731
Query: 727 CYIDEKLHLLVEND--EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+ + LV+ EE + +R + V + + C+Q+ + RP++ V ML
Sbjct: 732 LWNTGEDIALVDPVIFEECFENEIR--RCVHVGLLCVQDHANDRPSVATVIWML 783
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 5.6e-57, Sum P(3) = 5.6e-57
Identities = 104/296 (35%), Positives = 159/296 (53%)
Query: 495 LQIFSYKELEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR 552
L + +K L AT F ++LG+G F V+KG+L +I AVK+L M S G EF
Sbjct: 508 LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI--AVKRLSKMSSQGTDEFM 565
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS---WYRRMQI 609
EV I + H NLV+LLG C + ++L+YE++ N L LF + S W +R I
Sbjct: 566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXX 669
GIARGL YLH++ +IIH D+K N+LLD + T +ISDFG+A+I ++
Sbjct: 626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685
Query: 670 XXXX-YVAPEWFKSLPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAY-- 725
Y++PE+ +MK D++SFGV+LLE+I R K N + ++ W +
Sbjct: 686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745
Query: 726 ---DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+ I + +++ + E H+++R + I + C+QE RP M V +ML
Sbjct: 746 EGKELEIVDPINIDALSSEFPTHEILRC---IQIGLLCVQERAEDRPVMSSVMVML 798
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 411 (149.7 bits), Expect = 6.7e-55, Sum P(3) = 6.7e-55
Identities = 102/296 (34%), Positives = 157/296 (53%)
Query: 495 LQIFSYKELEKATQGFKDE--LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR 552
L + + L AT F ++ LG+G F V+KG L +I AVK+L M S G EF
Sbjct: 504 LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI--AVKRLSKMSSQGTDEFM 561
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPS---WYRRMQI 609
EV I + H NLV+LLG C + ++L+YE++ N L LF + S W +R I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXX 669
GIARGL YLH++ +IIH D+K N+LLD + T +ISDFG+A+I ++
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 670 XXXX-YVAPEWFKSLPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAY-- 725
Y++PE+ +MK D++SFGV+LLE+I R K N + ++ W +
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741
Query: 726 ---DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+ I + +++ + + H+++R + I + C+QE RP M V +ML
Sbjct: 742 EGNELEIVDPINIDSLSSKFPTHEILRC---IQIGLLCVQERAEDRPVMSSVMVML 794
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 1.1e-54, Sum P(3) = 1.1e-54
Identities = 102/293 (34%), Positives = 155/293 (52%)
Query: 495 LQIFSYKELEKATQGFKD--ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR 552
L + ++E+ AT F + +LG+G F V+KG L ++ AVK+L G EF+
Sbjct: 511 LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM--AVKRLSKTSVQGTDEFK 568
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF---KNPKPSWYRRMQI 609
EV I + H NLV+LL C + ++L+YE++ N L LF +N K +W R I
Sbjct: 569 NEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDI 628
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQXXXXXXXX 669
GIARGL YLH++ +IIH D+K NILLD T +ISDFG+A+I D+
Sbjct: 629 INGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKV 688
Query: 670 XXXX-YVAPEWFKSLPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAYDC 727
Y++PE+ +MK D++SFGV+LLE+I R K N + + ++ W +
Sbjct: 689 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWR-NW 747
Query: 728 YIDEKLHLL--VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+ L ++ + D + + + + I + C+QE RPTM V LML
Sbjct: 748 KEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4182 | 0.9435 | 0.9038 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024694001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (795 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 797 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-25 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-19 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 7e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-08 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-05 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 4e-49
Identities = 91/266 (34%), Positives = 129/266 (48%), Gaps = 19/266 (7%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+LG G+F TV+K KI VAVK L + S D+ R E+ + + +H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI-VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+L+ + H LV E+ G L +L + S +IA I RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW-FKSLPIT 686
IIH D+KP+NILLD++ +I+DFGLAK L + TT GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
KVD++S GV+L EL+ + F +Q+ L I L +E DE
Sbjct: 178 PKVDVWSLGVILYELLTGKPPF-SGENILDQLQL--------IRRILGPPLEFDEPKWSS 228
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMK 772
K ++ C+ +DPS RPT +
Sbjct: 229 GSEEAKDLI--KKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 71/269 (26%), Positives = 112/269 (41%), Gaps = 27/269 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
++LG G+F V+ K+ VA+K + D+E E+ + + H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK--PSWYRRMQIAFGIARGLFYLHEECTT 626
L ++ LV E+ G L L K + R I L YLH +
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSK--- 116
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
I+H D+KP+NILLD+ +++DFGLA+ L + TT GT Y+APE
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYG 174
Query: 687 MKVDIYSFGVMLLELICCRKKFE-QNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
VDI+S GV+L EL+ + F + E + E + EA
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-----DISPEAKD 229
Query: 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ + + +DP R T ++
Sbjct: 230 LIRK----------LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 5e-48
Identities = 70/197 (35%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLLGF 572
LG G F TV+ K VA+K + S E E+ + + NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKK-VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQIIHC 631
++ H LV E+ G L L +N S ++I I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 632 DIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPITMKV 689
D+KP+NILLD D+ +++DFGL+K+L I GT Y+APE + K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 690 DIYSFGVMLLELICCRK 706
DI+S GV+L EL +
Sbjct: 176 DIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 510 FKDELGRGAFATVHKGVL---AYENKICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRN 565
+LG GAF V+KG L + VAVK L + +EF E + + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+V+LLG C + + +V E++ G L FL K+ K + +Q+A IA+G+ YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTA----IRGTRGYVAPEW 679
+H D+ +N L+ ++ +ISDFGL++ I + D R I+ ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 680 FKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV- 737
K T K D++SFGV+L E+ + + + NE +++ +++ L
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNE-EVLE-------LLEDGYRLPRP 226
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
EN + L+++M C DP RPT
Sbjct: 227 ENCPDELYELMLQ---------CWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 510 FKDELGRGAFATVHKGVL---AYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRN 565
+LG GAF V+KG L + K+ VAVK L S +EF E + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+VKLLG C E++ +V E++ G L +L KN PK S + A IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV---APEWFK 681
IH D+ +N L+ ++ +ISDFGL++ L D RG + + APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPESLK 176
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL-LVEND 740
T K D++SFGV+L E+ ++ + NE +++ Y+ L N
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-EVLE-------YLKNGYRLPQPPNC 228
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
L+D+M C EDP RPT ++ +L
Sbjct: 229 PPELYDLML---------QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 31/278 (11%)
Query: 510 FKDELGRGAFATVHKGVL---AYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRN 565
+LG GAF V+KG L ++ VAVK L S +EF E + + +H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEE 623
+VKLLG C E++ ++V E++ G L +L KN S + A IARG+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV---APEWF 680
IH D+ +N L+ ++ +ISDFGL++ L D ++G + + APE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAPESL 176
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740
K T K D++SFGV+L E+ ++ + N ++++ Y K N
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKKGYRLPK----PPNC 229
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
L+ +M C EDP RPT ++ +L
Sbjct: 230 PPELYKLML---------QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 512 DELGRGAFATVHKGVL--AYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVK 568
+LG GAF V+KG L VAVK L S + K+F E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFL---------FKNPKPSWYRRMQIAFGIARGLFY 619
LLG C E++ LV E++ G L +L + S + A IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA-----IRGTRGY 674
L + + +H D+ +N L+ + +ISDFGL++ + D IR +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734
+APE K T K D++SFGV+L E+ + NE ++++ Y K
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRKGYRLPKP- 229
Query: 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E + L+++M C Q DP RPT ++ LE
Sbjct: 230 ---EYCPDELYELML---------SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 34/267 (12%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
LGRG+F +V+ + ++ +AVK L + E+ + H N+V+ G
Sbjct: 8 LGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 572 FC--NEDQHRLLVYEFISNGCLAGFLFKNPKPS-----WYRRMQIAFGIARGLFYLHEEC 624
E + E++S G L+ L K K Y R I GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-----ILEGLAYLHSN- 120
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILK-ADQTRTTTAIRGTRGYVAPEWFKSL 683
I+H DIK NIL+D +++DFG AK L + T ++RGT ++APE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
DI+S G ++E+ + + E N M + + + + E+ E
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWS---ELGNPMAAL-YKIGS--SGEPPEIPEHLSEE 232
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPT 770
D +R C++ DP RPT
Sbjct: 233 AKDFLRK---------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLV 567
D +GRGAF V+KG+ VA+K++ + K E++ + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEEC 624
K +G ++ E+ NG L + K + +A + + +GL YLHE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHEQ- 118
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+IH DIK NIL +++DFG+A L D ++ ++ GT ++APE +
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744
+ DI+S G ++EL+ + + N M L +V++D L
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPY----YDLNPM------------AALFRIVQDDHPPL 219
Query: 745 HDMMR--LKKYVMIAIWCIQEDPSLRPTMKK 773
+ + LK ++M C Q+DP+LRPT K+
Sbjct: 220 PEGISPELKDFLMQ---CFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
+++G+G F V+K VA+K + ++ E+ + + H N+VK
Sbjct: 5 LEKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRM---QIAF---GIARGLFYLHEE 623
G + L +V EF S G L L K S + + QIA+ + +GL YLH
Sbjct: 64 G-SYLKKDELWIVMEFCSGGSLKD-LLK----STNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
IIH DIK NILL ++ DFGL+ L + R T GT ++APE
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGK 172
Query: 684 PITMKVDIYSFGVMLLELI 702
P K DI+S G+ +EL
Sbjct: 173 PYDYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 80/289 (27%), Positives = 139/289 (48%), Gaps = 45/289 (15%)
Query: 512 DELGRGAFATVHKGVLA----YENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNL 566
ELG+G+F V++G+ E + VA+K ++ S ++ EF E + + + N ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARG 616
V+LLG + Q L+V E ++ G L +L P+ + +Q+A IA G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTAIRGTRG-- 673
+ YL + +H D+ +N ++ + T +I DFG+ + I + D R +G +G
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLL 183
Query: 674 ---YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730
++APE K T K D++SFGV+L E+ ++ Q + NE + V ID
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------ID 236
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L EN + L ++MR+ C Q +P +RPT ++ L+
Sbjct: 237 GGHLDLPENCPDKLLELMRM---------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 77/276 (27%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNH-RNLVK 568
+LG G+F V+ ++ VA+K L + KE F E+ + NH N+VK
Sbjct: 7 KLGEGSFGEVYLA----RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIARGLFYLHEECT 625
L F ++ LV E++ G L L K + S + I I L YLH +
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 626 TQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRT-----TTAIRGTRGYVAPEW 679
IIH DIKP+NILLD D ++ DFGLAK+L + + + GT GY+APE
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 680 FKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
L + DI+S G+ L EL+ FE + + + L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
++ E + K + + +DP R +
Sbjct: 240 SPSNPE-----LISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEF-RTEVNAIGQTNHRNLV 567
++G+G+F V+ + K+ V K++D NM S ++E EV + + NH N++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVL-KEIDLSNM-SEKEREDALNEVKILKKLNHPNII 62
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFL----FKNPKPSWYRRMQIAFGIARGLFYLHEE 623
K E +V E+ G L+ + + + + + L YLH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
+I+H DIKPQNI L + ++ DFG++K+L + T + GT Y++PE ++
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNK 178
Query: 684 PITMKVDIYSFGVMLLELICCRKKFE 709
P K DI+S G +L EL + FE
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+G+G F V G Y + VAVK L + + F E + + H NLV+L
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQL 65
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG--IARGLFYLHEECTTQ 627
LG + +V E+++ G L +L + Q+ F + G+ YL E+
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+H D+ +N+L+ + A++SDFGLAK Q ++ T APE + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 688 KVDIYSFGVMLLEL 701
K D++SFG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 513 ELGRGAFATVHKGVLAYEN--KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
ELG G F +V KGV ++ ++ VAVK L ++ G KEF E + + Q +H +V+L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
+G C + +LV E G L +L K + ++A +A G+ YL E +
Sbjct: 62 IGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL-ESK--HFV 117
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTAIRGTRGYVAPEWFKSLPITM 687
H D+ +N+LL + A+ISDFG+++ L A R TTA R + APE +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 688 KVDIYSFGVMLLE 700
K D++S+GV L E
Sbjct: 178 KSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR----TEVNAIGQTNHRNLV 567
LG+G+ V+K KI A+KK+ ++ GD+EFR E+ + +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKI-YALKKI-HVD--GDEEFRKQLLRELKTLRSCESPYVV 62
Query: 568 KLLG-FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
K G F E + + V E++ G LA L K K IA I +GL YLH
Sbjct: 63 KCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KR 119
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
IIH DIKP N+L++ +I+DFG++K+L+ + T + GT Y++PE + +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 687 MKVDIYSFGVMLLEL 701
DI+S G+ LLE
Sbjct: 179 YAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 44/282 (15%)
Query: 513 ELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKL 569
+G G F V +G L K I VA+K L S + +F TE + +GQ +H N+++L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQI 628
G + + +++ E++ NG L FL +N K + + + + GIA G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY--- 127
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILK-ADQTRTTTA----IRGTRGYVAPEWFKSL 683
+H D+ +NIL++ + ++SDFGL++ L+ ++ T TT IR T APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAYR 183
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLV 737
T D++SFG+++ E++ ++ ++ N++ + V+ Y DC
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDC---------- 233
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
AL+ +M + C Q+D + RPT ++ L+
Sbjct: 234 ---PSALYQLM---------LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-24
Identities = 37/89 (41%), Positives = 49/89 (55%), Gaps = 2/89 (2%)
Query: 71 ERTIIWSANGKTPVE-RGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASMLDSGN 128
+T++W AN P+ + L DG LVL D G+ VW+ +T+G + A + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 129 FVLAGPDSFPLWESFDHPTDTLLPTQILN 157
VL LW+SFDHPTDTLLP Q
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDG 89
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKLD--NMVSGGDKEF-RTEVNAIGQTNHRNL 566
LG+G+F V K K+ A+K L ++ + E TE N + + NH +
Sbjct: 1 LGKGSFGKVLLVRKKD----TGKL-YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 567 VKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPK--PSWYRRMQIAFGIARGLFYLHEE 623
VKL + + + +L LV E+ G L L K + R A I L YLH
Sbjct: 56 VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLHSL 112
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
II+ D+KP+NILLD +++DFGLAK L ++ +RT T GT Y+APE
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
VD +S GV+L E++ + F E+ ++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYA--EDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 502 ELEKATQGFKDELGRGAFATVHKG--VLAYENKIC--VAVKKLDNMVSGG-DKEFRTEVN 556
E+ + F +ELG GAF V+KG E VA+K L +EFR E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN---------------PKP 601
+ H N+V LLG C ++Q +++E++++G L FL +N
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 602 SWYRRM-QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKA 659
IA IA G+ YL + +H D+ +N L+ + T +ISDFGL++ I A
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 660 D----QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
D Q+++ +R ++ PE T + DI+SFGV+L E+
Sbjct: 178 DYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
F ELG G F VH G + KI VA+K + D +F E + + +H NLV+L
Sbjct: 8 FLKELGSGQFGVVHLG--KWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQL 64
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG----IARGLFYLHEECT 625
G C + + +V E+++NGCL +L + + + + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
IH D+ +N L+ + ++SDFGLA+ + DQ ++ + + PE F
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
+ K D++SFGV++ E+ K + N +V+ Y + L ++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSAGYRLYRPKLA----PTEVY 231
Query: 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+M C E P RP KK+
Sbjct: 232 TIMYS---------CWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 80/288 (27%), Positives = 142/288 (49%), Gaps = 45/288 (15%)
Query: 513 ELGRGAFATVHKGV----LAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLV 567
ELG+G+F V++G + E + VAVK ++ S ++ EF E + + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFK----------NPKPSWYRRMQIAFGIARGL 617
+LLG ++ Q L+V E +++G L +L P P+ +Q+A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTAIRGTRG--- 673
YL+ + + +H D+ +N ++ FT +I DFG+ + I + D R +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 674 --YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731
++APE K T D++SFGV+L E+ ++ Q + NE + V Y+D+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV--MDGGYLDQ 242
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+N E + D+MR+ C Q +P +RPT ++ +L+
Sbjct: 243 P-----DNCPERVTDLMRM---------CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-23
Identities = 103/376 (27%), Positives = 169/376 (44%), Gaps = 49/376 (13%)
Query: 428 GNSTLKPEDTDSK----KKVHSTSV--FVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKT 481
GN L DT S K+V T F ++ L + + +L L F VFI G +
Sbjct: 603 GNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFL----VLALVAFGFVFIRGRNNL 658
Query: 482 KMDQTGPVMPSTNLQIFSYKELEKAT-----QGFKDE--LGRGAFATVHKGVLAYENKIC 534
++ + + LQ F K + T K+E + RG +KG + +N +
Sbjct: 659 ELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGK-SIKNGMQ 717
Query: 535 VAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGF 594
VK+++++ S +E+ +G+ H N+VKL+G C ++ L++E+I L+
Sbjct: 718 FVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773
Query: 595 LFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
L SW RR +IA GIA+ L +LH C+ ++ ++ P+ I++D + L
Sbjct: 774 L---RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714
+L D ++ YVAPE ++ IT K DIY FG++L+EL+ K + E
Sbjct: 830 GLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLT--GKSPADAEF 882
Query: 715 ENQMILVDWAYDCYIDEKLHLLVE---------NDEEALHDMMRLKKYVMIAIWCIQEDP 765
+V+WA CY D L + ++ N E + M +A+ C DP
Sbjct: 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-------NLALHCTATDP 935
Query: 766 SLRPTMKKVTLMLEGV 781
+ RP V LE
Sbjct: 936 TARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
E+G G F V G + K VA+K + + +S +++F E + + +H LV+
Sbjct: 8 LVQEIGSGQFGLVWLG--YWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQ 63
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFL-FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
L G C E LV+EF+ +GCL+ +L + K S + + + G+ YL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH D+ +N L+ ++ ++SDFG+ + + DQ ++T + + +PE F +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 688 KVDIYSFGVMLLEL 701
K D++SFGV++ E+
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 495 LQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYE---NKICVAVKKLDNMVS-GGDKE 550
L+I ELEK LG GAF TV+KGV E KI VA+K L S +KE
Sbjct: 1 LRILKETELEKIKV-----LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
E + +H ++V+LLG C Q L+ + + GCL ++ +N K + + +
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV-RNHKDNIGSQYLLN 113
Query: 611 FG--IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT---- 664
+ IA+G+ YL E+ +++H D+ +N+L+ +I+DFGLAK+L D+
Sbjct: 114 WCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 665 -TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
I+ ++A E T K D++S+GV + EL+
Sbjct: 171 GKVPIK----WMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGDKEFRTEVNA 557
YK LEK +G GA V+K A + VA+KK M + +N
Sbjct: 21 YKNLEK--------IGEGASGEVYK---ATDRATGKEVAIKK---MRLRKQNKELI-INE 65
Query: 558 IG---QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM---QIAF 611
I H N+V +V E++ G L + +N RM QIA+
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV-----RMNEPQIAY 120
Query: 612 ---GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668
+ +GL YLH + +IH DIK NILL + +++DFG A L ++++ + +
Sbjct: 121 VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-V 176
Query: 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
GT ++APE K KVDI+S G+M +E+
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 43/237 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--------- 560
F +G G+F+TV NK A+K LD K + +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKE-YAIKILD-------KRQLIKEKKVKYVKIEKEVLT 56
Query: 561 --TNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
H ++KL + +D+ L V E+ NG L ++ K A I L
Sbjct: 57 RLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---------------- 661
YLH + IIH D+KP+NILLD +I+DFG AK+L +
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 662 ---TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
R + GT YV+PE P D+++ G ++ +++ + F + E
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 82/280 (29%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 510 FKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNL 566
+ +G GA A V+ A N VA+K++D E R EV A+ Q NH N+
Sbjct: 5 LIEVIGVGATAVVYA---AICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFL-FKNPKPSWYRRMQIAF---GIARGLFYLHE 622
VK LV ++S G L + P+ IA + +GL YLH
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATVLKEVLKGLEYLHS 120
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA---IRGTRGYVAPEW 679
IH DIK NILL + + +I+DFG++ L RT GT ++APE
Sbjct: 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 680 FKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738
+ + K DI+SFG+ +EL + + L L ++
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPY----------------SKYPPMKVLMLTLQ 221
Query: 739 NDEEALHDMMRLKKYV-----MIAIWCIQEDPSLRPTMKK 773
ND +L KKY MI++ C+Q+DPS RPT ++
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISL-CLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 45/283 (15%)
Query: 513 ELGRGAFATVH----KGVLAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLV 567
ELG+G+F V+ KGV+ E + VA+K ++ S ++ EF E + + + N ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFK-------NPK---PSWYRRMQIAFGIARGL 617
+LLG ++ Q L++ E ++ G L +L NP PS + +Q+A IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTAIRGTRG--- 673
YL+ + +H D+ +N ++ + FT +I DFG+ + I + D R +G +G
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 674 --YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731
+++PE K T D++SFGV+L E+ ++ Q + NE + V ++
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-------MEG 237
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
L +N + L ++MR+ C Q +P +RP+ ++
Sbjct: 238 GLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
LG G F V G + VAVK L M S F E + + H LV+L
Sbjct: 14 LGAGQFGEVWMGT--WNGTTKVAVKTLKPGTM-SPEA--FLQEAQIMKKLRHDKLVQLYA 68
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ---IAFGIARGLFYLHEECTTQI 628
C+E++ +V E++S G L FL K+ + R Q +A IA G+ YL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR---GYVAPEWFKSLPI 685
IH D+ +NIL+ ++ +I+DFGLA++++ D+ TA G + + APE
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYGRF 181
Query: 686 TMKVDIYSFGVMLLELI 702
T+K D++SFG++L E++
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 513 ELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSGGDK---EFRTEVNAIGQTNHRNL 566
+LG G F V VAVK L+ SG ++ +F E+ + +H N+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEEQHRSDFEREIEILRTLDHENI 68
Query: 567 VKLLGFCNEDQHR---LLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHE 622
VK G C E L+ E++ +G L +L ++ + + R + + I +G+ YL
Sbjct: 69 VKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG---TRGYVAPEW 679
+ + IH D+ +NIL++ +ISDFGLAK+L D+ G Y APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 680 FKSLPITMKVDIYSFGVMLLEL 701
++ + D++SFGV L EL
Sbjct: 184 LRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 514 LGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
LG GAF V++G+ + ++ VAVK L S D+ F E + + NH+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPS--WYRRMQ----IAFGIARGLFYLH 621
L+G E R ++ E ++ G L FL +N P+P M+ A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 622 EECTTQIIHCDIKPQNILLDD---SFTARISDFGLAK-ILKADQTRTTTAIRGTRG---- 673
E IH DI +N LL A+I+DFG+A+ I +A R +G R
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR-----KGGRAMLPI 185
Query: 674 -YVAPEWFKSLPITMKVDIYSFGVMLLEL 701
++ PE F T K D++SFGV+L E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNA 557
Y+ LE +G+G+F TV K + KI + K++D NM ++ +EVN
Sbjct: 2 YEVLET--------IGKGSFGTVRKVRRKSDGKI-LVWKEIDYGNMTEKEKQQLVSEVNI 52
Query: 558 IGQTNHRNLVKLLG-FCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRM-------- 607
+ + H N+V+ + L +V E+ G LA + K ++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK------CKKERKYIEEEF 106
Query: 608 --QIAFGIARGLFYLH--EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663
+I + L+ H + ++H D+KP NI LD + ++ DFGLAKIL D +
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
T + GT Y++PE + K DI+S G ++ EL
Sbjct: 167 AKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 32/284 (11%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIG 559
E+++ + +LG G F V +G+ + N VAVK L M K+F E +
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGL--WNNTTPVAVKTLKPGTM---DPKDFLAEAQIMK 56
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI--AFGIARGL 617
+ H L++L C ++ +V E + G L +L + I A +A G+
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YL + IH D+ +N+L+ ++ +++DFGLA+++K D + + AP
Sbjct: 117 AYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY--DCYIDEKLHL 735
E ++K D++SFG++L E++ + + N + VD Y C
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-------- 225
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ L+D+M + C +EDP RPT + + LE
Sbjct: 226 -PPGCPKELYDIM---------LDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 55/194 (28%), Positives = 106/194 (54%), Gaps = 14/194 (7%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
+LG G F V +G+ ++N++ VA+K K D+++ D F+ EV A+ + H++L+ L
Sbjct: 13 KLGSGYFGEVWEGL--WKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLF 68
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR---MQIAFGIARGLFYLHEECTTQ 627
C+ + ++ E + G L FL ++P+ + +A +A G+ YL E+
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH D+ +NIL+ + +++DFGLA+++K + ++ + + APE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 688 KVDIYSFGVMLLEL 701
K D++SFG++L E+
Sbjct: 184 KSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIG 559
E+E+ K +LG G + V++GV + VAVK L D M +EF E +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEV---EEFLKEAAVMK 57
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSW--YRRMQIAFGIARGL 617
+ H NLV+LLG C + ++ EF++ G L +L + + + +A I+ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR---GY 674
YL ++ IH D+ +N L+ ++ +++DFGL++++ D T TA G + +
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKW 171
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLEL 701
APE ++K D+++FGV+L E+
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 31/272 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT----EVNAIGQTNHRNLV 567
ELG G V K + KI +AVK + ++ + E++ + + N +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKI-MAVKT---IRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM-QIAFGIARGLFYLHEECTT 626
G + + E++ G L L + R + +IA + +GL YLHE
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KH 120
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+IIH D+KP NIL++ ++ DFG++ L +T GT Y+APE + +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYS 177
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQ---MILVDWAYDCYIDEKLHLLVENDEEA 743
+K DI+S G+ L+EL R + EN I E L +V
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY----PPENDPPDGIF----------ELLQYIVNEPPPR 223
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
L + C+ +DP RP+ K++
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNL 566
F ELG G F V G + + VA+K M+ G + EF E + + +H L
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIK----MIKEGSMSEDEFIEEAKVMMKLSHEKL 61
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFL---FKNPKPSWYRRMQIAFGIARGLFYLHEE 623
V+L G C + + +V E++SNGCL +L K +PS + +++ + G+ YL
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLE-- 117
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
+ Q IH D+ +N L+DD ++SDFGL++ + D+ ++ + + PE
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 684 PITMKVDIYSFGVMLLEL 701
+ K D+++FGV++ E+
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 51/293 (17%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + T +LG G F V G Y VA+K L S + F E N + Q
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGY--YNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNP---KPSWYRRMQIAFGIARGLF 618
H LV+L + + ++ E++ NG L FL K P K + + + +A IA G+
Sbjct: 59 QHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR---GYV 675
++ + IH D++ NIL+ ++ +I+DFGLA++++ ++ TA G + +
Sbjct: 117 FIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWT 170
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELIC---------CRKKFEQNVENENQMILVDWAYD 726
APE T+K D++SFG++L E++ + QN+E +M D
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
N E L+++MRL C +E P RPT + + +LE
Sbjct: 227 ------------NCPEELYELMRL---------CWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 67/281 (23%), Positives = 137/281 (48%), Gaps = 37/281 (13%)
Query: 514 LGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKLL 570
+G G F V +G+L + + VA+K L + + +F +E + +GQ +H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQII 629
G + + +++ E++ NG L +L + S Y+ + + GIA G+ YL + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKAD--QTRTTTAIRGTRGYVAPEWFKSLPITM 687
H D+ +NIL++ + ++SDFGL+++L+ D T TT+ + + APE T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVENDE 741
D++SFG+++ E++ ++ ++ N M ++ + DC
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC-------------P 236
Query: 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782
A++ +M + C Q+D + RP + +L+ ++
Sbjct: 237 SAVYQLM---------LQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 510 FKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHR 564
K ELG GAF V G + +K VAVK L S K+F E + H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFL---------FKNPKPSWYR-----RMQIA 610
N+VK G C E ++V+E++ +G L FL K+P +QIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTAIR 669
IA G+ YL + +H D+ +N L+ +I DFG+++ + D R +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VG 181
Query: 670 GTR----GYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
G ++ PE T + D++SFGV+L E+
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 515 GRGAFATV-------HKGVLA--YENKI-CVAVKKLDNMVSGGDKEFRTEVNAIGQTNHR 564
G+GAF V K + A Y NK CV + N+++ E + + NH
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN--------ERRILQELNHP 60
Query: 565 NLVKL-LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
LV L F +E+ + LV + + G L L + K S + I L YLH +
Sbjct: 61 FLVNLWYSFQDEE-NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
IIH DIKP NILLD+ I+DF +A + D T+T+ GT GY+APE
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQ 174
Query: 684 PITMKVDIYSFGVMLLELICCRKKFE 709
++ VD +S GV E + ++ +
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G G F V+ V ++ +AVK ++ + KE E+ + H NLVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 572 FCNEDQHRLLVY---EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
+ HR VY E+ S G L L + + GL YLH I
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG---YVAPEWFKSLPI 685
+H DIKP NI LD + ++ DFG A LK + T ++ G Y+APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 686 TMK---VDIYSFGVMLLELICCRKKFEQNVENENQ 717
DI+S G ++LE+ ++ + + ++NE Q
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSE-LDNEFQ 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 52/284 (18%)
Query: 509 GFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAI---GQTNH 563
FK +LG+G++ +V+K V + A+K++D + S KE VN I NH
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNH 58
Query: 564 RNLVKLLGFCNE---DQHRL-LVYEFISNGCLAGFL-----FKNPKPS---WYRRMQIAF 611
N++ E D ++L +V E+ G L+ + + P W +I
Sbjct: 59 PNIISY----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFI 110
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671
+ RGL LHE+ +I+H D+K NILL + +I D G++K+LK + +T GT
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GT 164
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE-QNVENENQMILVDWAYDCYID 730
Y+APE +K P + K DI+S G +L E+ FE +++++ +
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------QR 215
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
K + + L + +R +Q P LRP K+
Sbjct: 216 GKYPPIPPIYSQDLQNFIR---------SMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 38/104 (36%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 43 STSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102
S + F GF + N I + RT++W AN PV + L DG LVL D
Sbjct: 12 SGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYD 70
Query: 103 LTGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWESFDH 145
G+ VW+ +T GA Y +LD GN V+ D LW+SFD+
Sbjct: 71 GDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNA 557
YK L + +G GA V K + VA+KK L + G + E+ A
Sbjct: 2 YKILGR--------IGEGAHGIVFKAKDRETGET-VALKKVALRRLEGGIPNQALREIKA 52
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP------SWYRRMQIAF 611
+ H +VKLL +LV E++ + L+ L +P Y RM
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM---- 107
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671
+ +G+ Y+H I+H D+KP N+L+ +I+DFGLA++ ++ R + T
Sbjct: 108 -LLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
Query: 672 RGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
R Y APE + + VD+++ G + EL+ F
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE--FRT-- 553
Y++LEK LG G + V+K +I VA+KK LDN ++E T
Sbjct: 1 YEKLEK--------LGEGTYGVVYKARDKKTGEI-VALKKIRLDN-----EEEGIPSTAL 46
Query: 554 -EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK---PSWYRRMQI 609
E++ + + H N+VKLL + ++ LV+E+ L +L K P P+ + I
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKS--I 103
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669
+ + RGL Y H +I+H D+KPQNIL++ +++DFGLA+ T +
Sbjct: 104 MYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160
Query: 670 GTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
T Y APE S + VDI+S G + E+I
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+++G+G+F V K V+ +K A+K++D M +E E + + + +++
Sbjct: 5 LNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFL---FKNPKPS---WYRRMQIAFGIARGLFYLHE 622
+ +V E+ NG L L P P W +QI G+A +LH
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLHS 119
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+ +I+H DIK N+ LD +I D G+AK+L +D T I GT Y++PE +
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCED 175
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
P K D+++ GV+L E CC K + N+ +IL
Sbjct: 176 KPYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 24/280 (8%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + + +LG G F V G Y N VAVK L + + F E N +
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY--YNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG--IARGLFY 619
H LV+L +++ ++ E+++ G L FL + I F IA G+ Y
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
+ + IH D++ N+L+ +S +I+DFGLA++++ ++ + + APE
Sbjct: 119 IERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739
T+K D++SFG++L E++ K + N + M + Y +EN
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------PRMEN 228
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ L+D+M+ C +E RPT + +L+
Sbjct: 229 CPDELYDIMKT---------CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFR--------TEVNAIG-Q 560
+ LG GAF V+K + +A+K+++ N G DK R +EV I Q
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-----SWYRRMQIAFGIAR 615
H N+V+ E+ +V + I G G F + K + R I +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLI-EGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
L YLH+E +I+H D+ P NI+L + I+DFGLAK K +++ T+ + GT Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYS 180
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735
PE K+ P K D+++FG +L ++ + F N + L
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----NMLSLAT------------K 224
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
+VE E L + M + + C+ D RP + +V+ M+
Sbjct: 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 72/285 (25%), Positives = 136/285 (47%), Gaps = 45/285 (15%)
Query: 514 LGRGAFATVHKGVLAYENK--ICVAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
+G G F V G L K I VA+K L ++F +E + +GQ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQII 629
G + + ++V E++ NG L FL K+ + + + + + GIA G+ YL + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG------YVAPEWFKSL 683
H D+ +NIL++ + ++SDFGL+++L+ D T TRG + APE
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEAIAYR 184
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLV 737
T D++S+G+++ E++ ++ + N++ + ++ Y DC
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA-------- 236
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782
ALH +M + C Q+D + RP +++ +L+ ++
Sbjct: 237 -----ALHQLM---------LDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
F ELG G F VH G + +I VA+K + N + +++F E + + +H LV+L
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQI 628
G C + + +V EF+ NGCL +L + K S + + + G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSF 121
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH D+ +N L+ + ++SDFG+ + + D+ +++ + + PE F + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 689 VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748
D++SFGV++ E+ K + N + ++ + Y + L E
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---RPKLASMTVYE------ 232
Query: 749 RLKKYVMIAIWCIQEDPSLRPTMKKVT 775
VM + W E P RPT ++
Sbjct: 233 -----VMYSCW--HEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 513 ELGRGAFATVHKGVLAY---ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
ELG G F TV KG+ E + V + K DN E E N + Q ++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
+G C E + +LV E G L FL KN + ++ ++ G+ YL E T +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTAIRGTRGYVAPEWFKSLPITM 687
H D+ +N+LL A+ISDFGL+K L AD+ + T + + APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 688 KVDIYSFGVMLLE 700
K D++SFGV++ E
Sbjct: 178 KSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-19
Identities = 36/102 (35%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 46 GEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTG 105
G F Q + +Y L +Y RT++W AN P + L DG LV+ D +G
Sbjct: 20 GFFKLIMQ---SRDYNLILY-KGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG 74
Query: 106 KEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWESFDHP 146
VW+ +T Y +LD GN VL D LW+SFD+P
Sbjct: 75 TVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 7/199 (3%)
Query: 514 LGRGAFATVH--KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+GRGAF VH + A + + + ++ M + E + +H N+++
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHC 631
ED+ ++V E+ G LA ++ K S I + L LH T I+H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 632 DIKPQNILLDDSFTA-RISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVD 690
D+K QNILLD +I DFG++KIL + +++ T + GT Y++PE + P K D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCEGKPYNQKSD 183
Query: 691 IYSFGVMLLELICCRKKFE 709
I++ G +L EL ++ FE
Sbjct: 184 IWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 72/283 (25%), Positives = 139/283 (49%), Gaps = 39/283 (13%)
Query: 514 LGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLL 570
+G G F V +G L K I VA+K L + + ++F +E + +GQ +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQII 629
G + + +++ EF+ NG L FL +N + + + + + GIA G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT-TAIRGTR---GYVAPEWFKSLPI 685
H D+ +NIL++ + ++SDFGL++ L+ D + T T+ G + + APE
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVEN 739
T D++S+G+++ E++ ++ ++ N++ + ++ Y DC
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC------------ 236
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782
ALH +M + C Q+D + RP ++ L+ ++
Sbjct: 237 -PTALHQLM---------LDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 44/294 (14%)
Query: 510 FKDELGRGAFATVHK---GVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
F +LG+G F +V L VAVKKL + + ++F E+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 567 VKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKNPKPSWYRRM-QIAFGIARGLFYLHEE 623
VK G C R LV E++ G L +L K+ + +R++ A I +G+ YL +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG--YVAPEWFK 681
+ +H D+ +NIL++ +I DFGL K+L D+ G + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 682 SLPITMKVDIYSFGVMLLELICCRKK-------FEQNVENENQ--MILVDWAYDCYIDEK 732
++ D++SFGV+L EL K F + + N+ Q MI+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV------------ 232
Query: 733 LHLLVENDEEALHDMMRL-------KKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
HL+ E L + RL + I C DPS RP+ ++ L +E
Sbjct: 233 YHLI-----ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL-G 571
ELG GAF V+K E + A K + ++F E++ + + H N+V L
Sbjct: 12 ELGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEECTTQ 627
+ E++ +L+ EF G L + + + QI + + R L +LH +
Sbjct: 71 YFYENKLWILI-EFCDGGALDSIMLELERG--LTEPQIRY-VCRQMLEALNFLHSH---K 123
Query: 628 IIHCDIKPQNILLDDSFTARISDFGL-AKILKADQTRTTTAIRGTRGYVAP-----EWFK 681
+IH D+K NILL +++DFG+ AK Q R T GT ++AP E FK
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181
Query: 682 SLPITMKVDIYSFGVMLLEL 701
P K DI+S G+ L+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT----EVNAIGQT---NHR 564
E+G GA+ TV+K + VA+KK+ V ++ E+ + Q H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRF-VALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 565 NLVKLLGFC-NEDQHR----LLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGL 617
N+V+LL C R LV+E + LA +L K PKP + + RG+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
+LH + +I+H D+KPQNIL+ +I+DFGLA+I + T+ + T Y AP
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAP 175
Query: 678 EWFKSLPITMKVDIYSFGVMLLEL 701
E VD++S G + EL
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 514 LGRGAFATVHKGVLAYENK-----ICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLV 567
LG G F V K A+ K VAVK L S + ++ +E N + Q NH +++
Sbjct: 8 LGEGEFGKVVKAT-AFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK--PSWYRR------------------- 606
KL G C++D LL+ E+ G L FL ++ K PS+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 607 ---MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQT 662
+ A+ I+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ + + D
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD 722
+ R ++A E T + D++SFGV+L E++ + E L+
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
Query: 723 WAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
Y ++ EN E ++++M C +++P RPT ++ LE
Sbjct: 244 TGYR--MERP-----ENCSEEMYNLMLT---------CWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-----KEFRTEVNAIGQTNHRNLVK 568
LG G+F +V++G+ + AVK++ G K+ E+ + + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFF-AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEE 623
LG E+ + + E + G LA L F P Y R I GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR 121
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
+H DIK NIL+D + +++DFG+AK + + +G+ ++APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIAQQ 176
Query: 684 -PITMKVDIYSFGVMLLEL 701
+ DI+S G +LE+
Sbjct: 177 GGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 514 LGRGAFATVHK----GVLAYENKICVAVKKLDNMVSGGDKEFRTEVN------AIGQTNH 563
LG GAF V K G+ VAVK L + +K+ V+ IG+ H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK--H 75
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRR---------------M 607
+N++ LLG C ++ +V E+ ++G L FL P + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTT 666
A+ +ARG+ +L + + IH D+ +N+L+ + +I+DFGLA+ I D R TT
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
R ++APE T + D++SFGV+L E+
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 512 DELGRGAFATVHKGVLAYEN--KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+LG G+F V +G + I VAVK L + +S +F E + +H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSW--YRRMQIAFGIARGLFYLHEECTT 626
L G ++V E G L L K+ + A IA G+ YL +
Sbjct: 61 LYGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILK--ADQTRTTTAIRGTRGYVAPEWFKSLP 684
+ IH D+ +NILL +I DFGL + L D ++ + APE ++
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 685 ITMKVDIYSFGVMLLEL 701
+ D++ FGV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT---------EVNAIGQTNHR 564
+G G+F +V+ G+ A ++ +AVK+++ + R E+ + + H
Sbjct: 8 IGSGSFGSVYLGMNASSGEL-MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFY 619
N+V+ LG + H + E++ G +A L F+ + R I +GL Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-----ILKGLNY 121
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT-----AIRGTRGY 674
LH IIH DIK NIL+D+ +ISDFG++K L+A+ T T +++G+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELI 702
+APE K T K DI+S G +++E++
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--------EVNAIGQT 561
F LG G+F V V + A+K L K + E +
Sbjct: 5 FIKTLGTGSFGRVML-VRHKGSGKYYALKILSK-----AKIVKLKQVEHVLNEKRILQSI 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
H LV L G +D + LV E++ G L L K+ + A + L YLH
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
I++ D+KP+N+LLD +I+DFG AK +K RT T + GT Y+APE
Sbjct: 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYT-LCGTPEYLAPEIIL 171
Query: 682 SLPITMKVDIYSFGVMLLELIC 703
S VD ++ G+++ E++
Sbjct: 172 SKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 11/226 (4%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E E G + LG+G + V+ ++ +A+K++ S + E+
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL 62
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLF 618
HRN+V+ LG +E+ + E + G L+ L P I F I GL
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 619 YLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YLH+ QI+H DIK N+L++ S +ISDFG +K L A T GT Y+AP
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAP 178
Query: 678 EWFKSLP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
E P DI+S G ++E+ + F + E + M V
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKL 569
+ +G G + V+K ++ VA+K +D + ++E + E N + + +NH N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQL-VAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATF 68
Query: 570 LG-------FCNEDQHRL-LVYEFISNGCLA----GFLFKNPKPSWYRRM---QIAF--- 611
G N+DQ L LV E G + G K +R+ IA+
Sbjct: 69 YGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILR 120
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671
RGL YLHE ++IH DIK QNILL + ++ DFG++ L + R T I GT
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 672 RGYVAPEWF--KSLP---ITMKVDIYSFGVMLLEL 701
++APE P + D++S G+ +EL
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 514 LGRGAFATVHKGVL-----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLV 567
LG GAF V++G I VAVK L + +K EF E + + NH N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGLFYL 620
KLLG C ++ + ++ E + G L +L F P + + I +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 621 HEECTTQIIHCDIKPQNILL-----DDSFTARISDFGLAK-ILKADQTRTTTAIRGTR-- 672
+ IH D+ +N L+ D +I DFGLA+ I K+D R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEGLL 175
Query: 673 --GYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
++APE T + D++SFGV++ E++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 72/281 (25%), Positives = 125/281 (44%), Gaps = 27/281 (9%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + + +LG+G F V G K+ + K M+ + F E + +
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP---EAFLQEAQIMKKL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI---AFGIARGLF 618
H LV L +E+ +V EF+ G L FL K + + Q+ A IA G+
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
Y+ IH D++ NIL+ D+ +I+DFGLA++++ ++ + + APE
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 679 WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738
T+K D++SFG++L EL+ + + N + V+ Y +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC----- 228
Query: 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E+LH++M+L C ++DP RPT + + LE
Sbjct: 229 --PESLHELMKL---------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLLGF 572
+G+G F V+KGVL + VAVK + + K F E + Q +H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVL--KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR-MQIAFGIARGLFYLHEECTTQIIHC 631
C + Q +V E + G L FL K ++ +Q++ A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR----GYVAPEWFKSLPITM 687
D+ +N L+ ++ +ISDFG++ + ++ T G + + APE T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 688 KVDIYSFGVMLLE 700
+ D++S+G++L E
Sbjct: 175 ESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 37/229 (16%)
Query: 514 LGRGAFAT------VHKGVLAYENKICVAVKKLD---NMVSGGDK---EFRTEVNAIGQT 561
LG GAF++ V G L +AVK++ N S ++ R E+ + +
Sbjct: 8 LGTGAFSSCYQARDVKTGTL-------MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARG 616
NH +++++LG ED H L E+++ G ++ L FK Y + RG
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-----LLRG 115
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQTRT---TTAIRGTR 672
L YLHE QIIH D+K N+L+D + RI+DFG A L A T + GT
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
++APE + D++S G +++E+ K ++ N + L+
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEM-ATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++LG G++ +V+K + E VA+K + V +E E++ + Q + +VK
Sbjct: 7 ILEKLGEGSYGSVYKA-IHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTT 626
G ++ +V E+ G ++ + K +IA +GL YLH +
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SN 118
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+ IH DIK NILL++ A+++DFG++ L + T I GT ++APE + +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 177
Query: 687 MKVDIYSFGVMLLEL 701
K DI+S G+ +E+
Sbjct: 178 NKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 73/296 (24%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 510 FKDELGRGAFATVH----KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
K ELG GAF V + ++KI VAVK L + K+F E + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK-----------NP--KPSWYRRMQIAFG 612
+VK G C E ++V+E++ +G L FL N + + + + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTR----TTTA 667
IA G+ YL + +H D+ +N L+ ++ +I DFG+++ + D R T
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
IR ++ PE T + D++S GV+L E+ K+ + N N++I +C
Sbjct: 186 IR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVI------EC 234
Query: 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
++ + ++D+M + C Q +P +R +K++ +L+ + +
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLM---------LGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 40/276 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRT----EVNAIGQTNHRNLV 567
+G+G F+ V+K + + ++ VA+KK+ M+ D + R E++ + Q +H N++
Sbjct: 10 IGKGQFSVVYKAICLLDGRV-VALKKVQIFEMM---DAKARQDCLKEIDLLKQLDHPNVI 65
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFL--FKN-----PKPS-WYRRMQIAFGIARGLFY 619
K L E+ +V E G L+ + FK P+ + W +Q+ L +
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
+H + +I+H DIKP N+ + + ++ D GL + + +T ++ GT Y++PE
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739
K DI+S G +L E+ + F + N L C + L ++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEKC---DYPPLPADH 232
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
E L D++ CI DP RP + V
Sbjct: 233 YSEELRDLVSR---------CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
L+K T G + +G G F V +G + VAVK + V+ + F E + +
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYTGQK---VAVKNIKCDVTA--QAFLEETAVMTKL 56
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFY 619
+H+NLV+LLG +V E +S G L FL + S + +Q + +A G+ Y
Sbjct: 57 HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI--LKADQTRTTTAIRGTRGYVAP 677
L + +++H D+ +NIL+ + A++SDFGLA++ + D ++ + AP
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAP 166
Query: 678 EWFKSLPITMKVDIYSFGVMLLEL 701
E K + K D++S+GV+L E+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG+G F V + K+ A KKLD G++ E + + + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKM-YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTTQI 628
LV ++ G L ++ +P R + A I GL +LH+ +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
++ D+KP+N+LLDD RISD GLA LK + GT GY+APE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 689 VDIYSFGVMLLELICCRKKFEQ---NVENE--NQMILVD 722
VD ++ G L E+I R F Q VE E + L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKL-----DNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+G GA+ V K +I VA+KK D V K EV + Q H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVK---KTALREVKVLRQLRHENIV 63
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK---PSWYRRMQIAFGIARGLFYLHEEC 624
L LV+E++ L L +P P R + + + + Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRS--YIWQLLQAIAYCHSH- 119
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF-KSL 683
IIH DIKP+NIL+ +S ++ DFG A+ L+A T TR Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 684 PITMKVDIYSFGVMLLELI 702
VD+++ G ++ EL+
Sbjct: 178 NYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 15/172 (8%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+IA + +GL YLH +IIH DIKP NILL ++ DFG++ L T T
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
GT Y+APE + P ++ D++S G+ LLE+ R F E E + ++
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP--EGEPPLGPIELL--S 218
Query: 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
YI + ++++ K + C+++DP+ RPT MLE
Sbjct: 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQ--CLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G G+F ++ +++ CV +K++D M + + EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 572 FCNEDQHRLLVYEFISNGCLA-------GFLFKNPKP-SWYRRMQIAFGIARGLFYLHEE 623
E+ +V E+ G L G LF + SW+ +QI+ G L ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKHIHDR 120
Query: 624 CTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+I+H DIK QNI L + A++ DFG+A+ L D GT Y++PE ++
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQN 176
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
P K DI+S G +L EL + FE N N +Q++L
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 10/195 (5%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++G G + V+K +I VA+KK L G K E+ + + NH N++KL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
L LV+EF+ L + + + + +GL + H I
Sbjct: 64 LDVFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPITM 687
+H D+KP+N+L++ +++DFGLA+ + R T TR Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 688 KVDIYSFGVMLLELI 702
VDI+S G + EL+
Sbjct: 179 PVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 514 LGRGAF--ATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNLVK 568
LG+GAF AT+++ E+ V K++ N+ +KE R E+ + H N++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 569 LLGFCNEDQHRLLVYEFISNGCLA-------GFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
+D L+ E+ + G L G LF+ WY F I + Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIH 118
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ I+H DIK NI L + ++ DFG++KIL ++ + T + GT Y++PE +
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQ 174
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC-YIDEKLHLLVEND 740
+ K DI++ G +L EL+ ++ F+ N + LV Y V
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKIVQGNYTPV-----VSVY 225
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
L ++ +Q+DP RPT +V
Sbjct: 226 SSELISLVHS---------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 46/122 (37%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 597 KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656
+NP R I GL +LH+ +II+ D+KP+N+LLD+ RISD GLA
Sbjct: 90 ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146
Query: 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE---QNVE 713
LK Q++ T GT G++APE + VD ++ GV L E+I R F + VE
Sbjct: 147 LKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
Query: 714 NE 715
N+
Sbjct: 206 NK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 58/198 (29%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 514 LGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLL 570
+G+G F V+ G L + KI AVK L+ + + ++F E + +H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 571 GFC-NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG--IARGLFYLHEECTTQ 627
G C + L+V ++ +G L F+ ++ + + I FG +A+G+ YL + +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTRGYVAPEWFKSLP 684
+H D+ +N +LD+SFT +++DFGLA+ + + T + ++A E ++
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 685 ITMKVDIYSFGVMLLELI 702
T K D++SFGV+L EL+
Sbjct: 179 FTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 67/311 (21%)
Query: 510 FKDELGRGAFATVH----KGVLAYENKIC-----------VAVKKL-DNMVSGGDKEFRT 553
F ++LG G F VH G+ + K VAVK L + ++F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-----------PKPS 602
EV + + + N+ +LLG C D ++ E++ NG L FL K+ S
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 603 WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL-KAD- 660
+ + +A IA G+ YL +H D+ +N L+ ++T +I+DFG+++ L +D
Sbjct: 129 FSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 661 ---QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL--ICCRKKFE-----Q 710
Q R IR ++A E T K D+++FGV L E+ +C + +E Q
Sbjct: 186 YRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 711 NVENENQMILVDWAYDCYIDEKLHLLVE---NDEEALHDMMRLKKYVMIAIWCIQEDPSL 767
+EN + D+ + + N + ++++M C + D
Sbjct: 242 VIENAGHF---------FRDDGRQIYLPRPPNCPKDIYELMLE---------CWRRDEED 283
Query: 768 RPTMKKVTLML 778
RPT +++ L L
Sbjct: 284 RPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 39/291 (13%)
Query: 514 LGRGAFATVHKGVLAY--EN-KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
LG GAF TV+KG+ EN KI VA+K L +N +KE E + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM-QIAFGIARGLFYLHEECTTQI 628
LG C +L V + + GCL ++ +N + + IA+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI--- 685
+H D+ +N+L+ +I+DFGLA++L D+T G V +W I
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE----YHADGGKVPIKWMALESILHR 186
Query: 686 --TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
T + D++S+GV + EL+ K YD ++ L+E E
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAK----------------PYDGIPAREIPDLLEKGERL 230
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFI 794
+ MI + C D RP +++ + DPS F+
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR-----DPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 513 ELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKLL 570
ELG G F V KGV K I VA+K L N + E E + Q ++ +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
G C E + +LV E S G L FL K + + +++ ++ G+ YL + +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTAIRGTRGYVAPEWFKSLPITM 687
H D+ +N+LL + A+ISDFGL+K L AD + + +A + + APE +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 688 KVDIYSFGVMLLE 700
+ D++S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 505 KATQGFKDE-LGRGAFATVHKGVLAYEN---KICVAVKKLDNMVS-GGDKEFRTEVNAIG 559
K T+ K + LG GAF TV+KG+ E KI VA+K+L S +KE E +
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM-QIAFGIARGLF 618
++ ++ +LLG C +L + + + GCL ++ ++ + + IA+G+
Sbjct: 65 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
YL E +++H D+ +N+L+ +I+DFGLAK+L AD+ G V +
Sbjct: 124 YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE----KEYHAEGGKVPIK 176
Query: 679 WFKSLPI-----TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
W I T + D++S+GV + EL+ K YD ++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASEI 220
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
++E E + MI + C D RP +++
Sbjct: 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 39/287 (13%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + + +LG G F V G K+ V K M + F E + +
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI---AFGIARGLF 618
H LV+L +E+ +V E++S G L FL K+ + + + A +A G+
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
Y+ IH D++ NIL+ D +I+DFGLA++++ ++ + + APE
Sbjct: 117 YIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 679 WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEK 732
T+K D++SFG++L EL+ + + N + V+ Y DC I
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI--- 230
Query: 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+LH++M + C ++DP RPT + + LE
Sbjct: 231 ----------SLHELM---------LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-16
Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 495 LQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSG--GDK 549
L+I EL++ LG GAF TV+KG+ E KI VA+K L N +G +
Sbjct: 1 LRILKETELKRVKV-----LGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANV 54
Query: 550 EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI 609
EF E + +H +LV+LLG C +L V + + +GCL ++ ++ K + ++ +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEH-KDNIGSQLLL 112
Query: 610 AF--GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-TTT 666
+ IA+G+ YL E +++H D+ +N+L+ +I+DFGLA++L+ D+
Sbjct: 113 NWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+ ++A E T + D++S+GV + EL+
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRT---EVNAIGQTNHRNLVKL 569
LG+GA+ TV+ G+ I V +LD + V +KE+ EV+ + H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
LG C +D + EF+ G ++ L P Y + QI G+A YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKIL-----KADQTRTTTAIRGTRGYVAPEW 679
++H DIK N++L + ++ DFG A+ L + ++ GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 680 FKSLPITMKVDIYSFGVMLLEL 701
K DI+S G + E+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 57/300 (19%)
Query: 513 ELGRGAFATVHK----GVLAYENKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLV 567
++G+GAF V + G+L YE VAVK L S +F+ E + + +H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY----------------------- 604
KLLG C + L++E+++ G L FL P
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 605 RRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTR 663
++ IA +A G+ YL E + +H D+ +N L+ ++ +I+DFGL+ I AD +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 664 TTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
+ IR ++ PE T + D++++GV+L E+ + + +E +
Sbjct: 188 ASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
V D + +N L+++MRL C + PS RP+ + +L+
Sbjct: 244 YVR-------DGNVLSCPDNCPLELYNLMRL---------CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+ +G+G+F V+KG+ ++ VA+K +D + + E + E+ + Q + + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
G + ++ E++ G L P Y I I +GL YLH E + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-ATILREILKGLDYLHSE---RKIH 124
Query: 631 CDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVD 690
DIK N+LL + +++DFG+A L Q + T + GT ++APE K K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 691 IYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750
I+S G+ +EL K E + + M + L L+ +N L
Sbjct: 184 IWSLGITAIEL----AKGEPPNSDLHPMRV------------LFLIPKNSPPTLEGQYS- 226
Query: 751 KKYVMIAIWCIQEDPSLRPTMKKV 774
K + C+ +DP RPT K++
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF-RTEVNAIGQTNHRNLVKLLG 571
+G+G+F V+K + N++ VA+K +D + + E + E+ + Q + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQV-VAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQI 628
+ ++ E+ G L KP IAF + GL YLHEE
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH DIK NILL + +++DFG++ L + ++ T + GT ++APE K K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 689 VDIYSFGVMLLELI 702
DI+S G+ +EL
Sbjct: 179 ADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 26/275 (9%)
Query: 514 LGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+G G F V++GV KI VAVK N S +E F E + Q +H ++VKL+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI-AFGIARGLFYLHEECTTQII 629
G + +V E G L +L N + + ++ ++ L YL + + +
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
H DI +N+L+ ++ DFGL++ L+ + + + ++APE T
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189
Query: 690 DIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL-LVENDEEALHDMM 748
D++ FGV + E++ K Q V+N N +I I+ L + N L+ +M
Sbjct: 190 DVWMFGVCMWEILMLGVKPFQGVKN-NDVIGR-------IENGERLPMPPNCPPTLYSLM 241
Query: 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
C DPS RP ++ L +++
Sbjct: 242 TK---------CWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT----EVNAIGQTNHRNLVKL 569
+G G++ V K +I VA+KK + S DK + E+ + Q H NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQI-VAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGLFYLHEECTTQI 628
+ + LV+EF+ + L L K P R++ F I RG+ + H + I
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH DIKP+NIL+ S ++ DFG A+ L A T + TR Y APE +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGR 180
Query: 689 -VDIYSFGVMLLELI 702
VDI++ G ++ E++
Sbjct: 181 AVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGG-DKEFRTEVNAIGQTNHRNLVKLL 570
LG G F V + +N+ A+K + ++V G + +E + + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRT-FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQII 629
+ ++ ++ E+ G L L + R IA + YLH II
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR---GII 115
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
+ D+KP+N+LLD + ++ DFG AK LK+ Q +T T GT YVAPE + V
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFSV 173
Query: 690 DIYSFGVMLLELICCRKKFEQNVENENQMI 719
D +S G++L EL+ R F + ++E+ M
Sbjct: 174 DYWSLGILLYELLTGRPPFGE--DDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 38/241 (15%)
Query: 510 FKDELGRGAFATVH----KGVLAY---------ENKICVAVKKL-DNMVSGGDKEFRTEV 555
K++LG G F VH +G+ + + VAVK L ++ +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN------------PKPSW 603
+ + + N+++LLG C D ++ E++ NG L FL + P S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 604 YRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD--- 660
+ +A IA G+ YL + +H D+ +N L+ + +T +I+DFG+++ L +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 661 --QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
Q R IR ++A E T D+++FGV L E+ K+ ++ ++ Q+
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 719 I 719
I
Sbjct: 242 I 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 535 VAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLVYEFISNGCL 591
VAVK L + ++ E+N + H N+VK G C+E + L+ E++ G L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651
+L K+ K + + + A I G+ YLH + IH D+ +N+LLD+ +I DF
Sbjct: 96 RDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 652 GLAKILKADQTRTTTAIRGTRG--YVAPEWFKSLPITMKVDIYSFGVMLLELIC-C---- 704
GLAK + G + A E K + D++SFGV L EL+ C
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 705 --RKKFEQNVE-NENQMILV 721
KKFE+ + + QM +V
Sbjct: 212 SPPKKFEEMIGPKQGQMTVV 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSGGDKEFR 552
+I EL K LG G F TVHKG+ E KI VA+K + + G + F+
Sbjct: 2 RILKETELRKLKL-----LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQ 54
Query: 553 TEVN---AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQ 608
+ A+G +H +V+LLG C +L V + G L + ++ R +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT-TA 667
IA+G++YL E ++H ++ +NILL +I+DFG+A +L D + +
Sbjct: 114 WCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
+ ++A E T + D++S+GV + E++ + +
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM-------------------SYGAEP 211
Query: 728 YIDEKLH----LLVENDEEALHDMMRLKKY-VMIAIWCIQEDPSLRPTMKKV 774
Y + H LL + + A + + Y VM+ W I E+ +RPT K++
Sbjct: 212 YAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN--VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 510 FKDELGRGAFATVH----KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
K ELG GAF V +L ++K+ VAVK L ++F+ E + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN--------------PKPSWYRRM-QIA 610
+V+ G C E + L+V+E++ +G L FL + P +M IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQ----TRTT 665
IA G+ YL + +H D+ +N L+ +I DFG+++ I D RT
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
IR ++ PE T + DI+SFGV+L E+
Sbjct: 186 LPIR----WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC 573
+G+G F V G Y VAVK + N + + F E + + Q H NLV+LLG
Sbjct: 14 IGKGEFGDVMLG--DYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 574 NEDQHRL-LVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTTQIIH 630
E++ L +V E+++ G L +L + ++ + + + YL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 631 CDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVD 690
D+ +N+L+ + A++SDFGL K + Q ++ T APE + + K D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSD 181
Query: 691 IYSFGVMLLEL 701
++SFG++L E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGD-KEFRTEVNAIGQT-NHRNL 566
F+D +G G F V + ++ + K+ A+K L S D ++F E+ + + +H N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN----PKPSWYRR------------MQIA 610
+ LLG C + + E+ G L FL K+ P++ + +Q A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+A G+ YL E+ Q IH D+ +N+L+ ++ ++I+DFGL++ ++
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175
Query: 671 TRGYVAPEWF--KSLP---ITMKVDIYSFGVMLLELI 702
T G + W +SL T K D++SFGV+L E++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG+G F V V A KKLD G+K E + + N +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTTQI 628
H LV ++ G L ++ + R + + I G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
++ D+KP+N+LLDD R+SD GLA LK +T T A GT GY+APE K P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYP 174
Query: 689 VDIYSFGVMLLELICCRKKFEQNVE 713
VD ++ G + E++ R F+ + E
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGD--KEFRTEVNAIGQTNHRNLVK 568
+G G + V+K ++ VA+K KL+ GD + + E++ + + H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGEL-VAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVA 64
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEEC 624
G +V E+ G L P +QIA+ + R GL YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAY-VCRETLKGLAYLHE-- 119
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF---K 681
T IH DIK NILL + +++DFG++ L A + + I GT ++APE +
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVER 177
Query: 682 SLPITMKVDIYSFGVMLLEL 701
K DI++ G+ +EL
Sbjct: 178 KGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 27/281 (9%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + + + +LG+G F V G ++ + K M + F E + +
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI---AFGIARGLF 618
H LV+L +E+ +V E++S G L FL K + R Q+ A IA G+
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
Y+ +H D++ NIL+ ++ +++DFGLA++++ ++ + + APE
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 679 WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738
T+K D++SFG++L EL + + N + V+ Y +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----- 228
Query: 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E+LHD+M C +++P RPT + + LE
Sbjct: 229 --PESLHDLM---------CQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 49/303 (16%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVL---AYENKICVAVKKLDNMVSGGD-KEFRTEVNA 557
EL + F +ELG AF ++KG L ++ VA+K L ++ + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-FKNP--------------KPS 602
+ + +H N+V LLG ++Q +++E+++ G L FL ++P K S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 603 WYRR--MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKA 659
+ IA IA G+ YL +H D+ +NIL+ + +ISD GL++ I A
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 660 D----QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
D Q ++ IR ++ PE + DI+SFGV+L E+ + N+
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
+ +V + L+ E+ M L M W QE PS RP K +
Sbjct: 234 EVIEMV----------RKRQLLPCSEDCPPRMYSL----MTECW--QEGPSRRPRFKDIH 277
Query: 776 LML 778
L
Sbjct: 278 TRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRT---EVNAIGQTNHRNLVK 568
LG G +A V+K +I VA+KK L D T E+ + + H N++
Sbjct: 8 LGEGTYAVVYKARDKETGRI-VAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 569 LLGFCNEDQHRLLVYEF--------ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL 620
LL + LV+EF I + + + Y M RGL YL
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLM-----TLRGLEYL 118
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPE- 678
H I+H D+KP N+L+ +++DFGLA+ + + T + TR Y APE
Sbjct: 119 HSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPEL 173
Query: 679 WFKSLPITMKVDIYSFGVMLLELI 702
F + + VD++S G + EL+
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 54/190 (28%), Positives = 98/190 (51%), Gaps = 9/190 (4%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGF 572
LG+G F V KG L ++K VAVK +++ +F +E + Q +H N+VKL+G
Sbjct: 3 LGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM-QIAFGIARGLFYLHEECTTQIIHC 631
C + Q +V E + G FL K +++ + A A G+ YL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR-GYVAPEWFKSLPITMKVD 690
D+ +N L+ ++ +ISDFG+++ + D +++ ++ + APE + + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 691 IYSFGVMLLE 700
++S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 30/267 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+ +G+G+F V KG+ ++ VA+K +D + + E + E+ + Q + + K
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQ 627
G + ++ E++ G L P + QIA I +GL YLH E +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSE---K 121
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH DIK N+LL + +++DFG+A L Q + T + GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K DI+S G+ +EL K E + + M ++ + N +
Sbjct: 181 KADIWSLGITAIEL----AKGEPPNSDMHPMRVL-----------FLIPKNNPPTLTGEF 225
Query: 748 MRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ K + A C+ +DPS RPT K++
Sbjct: 226 SKPFKEFIDA--CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 514 LGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
LG G F +V +G L+ ++ K+ V KLD +EF +E + +H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 570 LGFCNEDQHR------LLVYEFISNGCLAGFLFK-----NPKPSWYRRM-QIAFGIARGL 617
+G C E +++ F+ +G L FL P+ + + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVA 676
YL IH D+ +N +L + T ++DFGL+ KI D R + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 677 PEWFKSLPITMKVDIYSFGVMLLEL 701
E T K D+++FGV + E+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 34/269 (12%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLL 570
+++G+G+F V KG+ K+ VA+K +D + + ++ + E+ + Q + + K
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQ 627
G +D ++ E++ G L +P QIA I +GL YLH E +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 121
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH DIK N+LL + +++DFG+A L Q + T + GT ++APE K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 180
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K DI+S G+ +EL K E + M + L L+ +N+ L
Sbjct: 181 KADIWSLGITAIEL----AKGEPPHSELHPM------------KVLFLIPKNNPPTLEGN 224
Query: 748 MR--LKKYVMIAIWCIQEDPSLRPTMKKV 774
LK++V C+ ++PS RPT K++
Sbjct: 225 YSKPLKEFVEA---CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 510 FKDELGRGAFATVH----KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
K ELG GAF V + ++K+ VAVK L + K+F+ E + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-----------PKPS-----WYRRMQI 609
+VK G C + ++V+E++ +G L FL + P+ + + + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTR----T 664
A IA G+ YL + +H D+ +N L+ + +I DFG+++ + D R T
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
IR ++ PE T + D++SFGV+L E+
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 74/304 (24%), Positives = 137/304 (45%), Gaps = 62/304 (20%)
Query: 510 FKDELGRGAFATVHKGVLAYEN-KICVAVKKLDNMVSGGD-KEFRTEVNAIGQTN-HRNL 566
F+D +G G F V K + + ++ A+K++ S D ++F E+ + + H N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN----PKPSW------------YRRMQIA 610
+ LLG C + L E+ +G L FL K+ P++ + + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ARG+ YL ++ Q IH D+ +NIL+ +++ A+I+DFGL++ ++
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 180
Query: 671 TRGYVAPEWF--KSLP---ITMKVDIYSFGVMLLELIC------CRKKFEQNVENENQMI 719
T G + W +SL T D++S+GV+L E++ C + E Q
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240
Query: 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
++ +C D+E ++D+MR C +E P RP+ ++ + L
Sbjct: 241 RLEKPLNC------------DDE-VYDLMR---------QCWREKPYERPSFAQILVSLN 278
Query: 780 GVVE 783
++E
Sbjct: 279 RMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 497 IFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKIC-------VAVKKLDNM-VSGGD 548
F L++ T LGRG F V LA I V VK L
Sbjct: 1 AFPRSNLQEITT-----LGRGEFGEV---FLAKAKGIEEEGGETLVLVKALQKTKDENLQ 52
Query: 549 KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN--------PK 600
EFR E++ + +H+N+V+LLG C E + ++ E+ G L FL P
Sbjct: 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112
Query: 601 P-SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILK 658
P S +++ + IA G+ +L + +H D+ +N L+ ++S L+K +
Sbjct: 113 PLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169
Query: 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
++ + A+ R ++APE + + K D++SFGV++ E+
Sbjct: 170 SEYYKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
+ +GRG F V G L +N VAVK + + +F E + Q +H N+V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTP-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFL-FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
G C + Q +V E + G FL + P+ +Q+ A G+ YL + I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---I 116
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR----GYVAPEWFKSLPI 685
H D+ +N L+ + +ISDFG+++ + D +T G + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTG--GMKQIPVKWTAPEALNYGRY 173
Query: 686 TMKVDIYSFGVMLLE 700
+ + D++SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 514 LGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKEF-RTEVNAIGQT-NHRNLVKLL 570
LG+G+F V L +++ V V K D ++ D E TE + H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
C + + RL V E+++ G L + F P+ +Y A I GL +LHE
Sbjct: 63 S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY-----AAEIVLGLQFLHER- 115
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKS 682
II+ D+K N+LLD +I+DFG+ K IL T T GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEILSY 170
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
P VD ++ GV+L E++ + FE + E+E
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 77/288 (26%), Positives = 118/288 (40%), Gaps = 42/288 (14%)
Query: 512 DELGRGAFATVHKG-VLAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKL 569
DE+G G F V G +K V VK+L + ++ F EV + NH N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKN-------PKPSWYRRMQIAFGIARGLFYLHE 622
LG C E LLV EF G L +L N + +RM A +A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ 118
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVAPEW-- 679
IH D+ +N L + +I D+GLA + D T ++APE
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 680 -----FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE---NQMILVDWAYDCYIDE 731
T K +I+S GV + EL + ++ +E Q++ ++
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---------EQ 226
Query: 732 KLHLLVENDEEALHDMMRLKKY-VMIAIWCIQEDPSLRPTMKKVTLML 778
+ L + D + Y VM W DP RPT ++V +L
Sbjct: 227 DIKLPKPQLDLKYSD----RWYEVMQFCWL---DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGF 572
ELG GAF V+K E + A K +D +++ E++ + +H N+VKLL
Sbjct: 12 ELGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG-IARGLFYLHEECTTQIIHC 631
+ + ++ EF + G + + + +P ++++ L YLHE +IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTT---AIRGTRGYVAPEWF-----KSL 683
D+K NIL +++DFG++ A TRT + GT ++APE K
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 684 PITMKVDIYSFGVMLLEL 701
P K D++S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-KEFRTEVN 556
F+ ++L+ E+GRGAF TV+K + I +AVK++ + V + K +++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTI-MAVKRIRSTVDEKEQKRLLMDLD 54
Query: 557 AIGQTNH-RNLVKLLG---------FCNE------DQHRLLVYEFISNGCL-AGFLFKNP 599
+ +++ +VK G C E D+ VYE + + L K
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK-- 111
Query: 600 KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659
IA + L YL EE +IIH D+KP NILLD + ++ DFG++ L
Sbjct: 112 ---------IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160
Query: 660 DQTRTTTAIRGTRGYVAPEW---FKSLPITMKVDIYSFGVMLLEL 701
+T A G R Y+APE ++ D++S G+ L E+
Sbjct: 161 SIAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 67/283 (23%), Positives = 124/283 (43%), Gaps = 31/283 (10%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E+ + + + +LG G F V K+ V K +M + F E N +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTL 58
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARG 616
H LVKL ++ ++ EF++ G L FL K P P + + + IA G
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP---KLIDFSAQIAEG 114
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676
+ ++ + IH D++ NIL+ S +I+DFGLA++++ ++ + + A
Sbjct: 115 MAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
PE T+K D++SFG++L+E++ + + N + ++ Y
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------R 224
Query: 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
EN E L+++M + C + P RPT + + +L+
Sbjct: 225 PENCPEELYNIM---------MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 511 KDEL-GRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE--------FRTEVNAIG 559
K EL G+G + V+ + ++ +AVK+ L ++G R+E+ +
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIA 614
+H N+V+ LGF +++ + E++ G + L F+ ++ Q+ G+A
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLA 122
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK----ILKADQTRTTTAIRG 670
YLH + I+H D+K N+L+D +ISDFG++K I DQ +++G
Sbjct: 123 ----YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQG 172
Query: 671 TRGYVAPEWF--KSLPITMKVDIYSFGVMLLELICCRK 706
+ ++APE S + KVDI+S G ++LE+ R+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 47/214 (21%)
Query: 604 YRRMQIAFGIARGLFYLHEEC-------TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656
Y F R +FY E +I++ D+KP+NILLDD RISD GLA
Sbjct: 92 YNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
Query: 657 LKADQTRTTTAIR---GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
+ +T IR GT GY+APE K+ T D + G ++ E+I + F Q E
Sbjct: 152 IPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
Query: 714 NENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYV-MIAIWCIQEDPSLR---- 768
V E++ V+ D+E + + + I + +DP R
Sbjct: 207 K------VKR-------EEVERRVKEDQEEYSE--KFSEAARSICRQLLTKDPGFRLGCR 251
Query: 769 ----------PTMKKVTL--MLEGVVEVPIPPDP 790
P + + G++E P PDP
Sbjct: 252 GEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 69/260 (26%), Positives = 104/260 (40%), Gaps = 43/260 (16%)
Query: 514 LGRGAFATVHKGVLAYENKIC---VAVKKL-------DNMVSGGDKEFRTEVNAIGQTNH 563
+ +GA+ V LA + K A+K + N V + TE + + Q
Sbjct: 1 ISKGAYGRVF---LA-KKKSTGDIYAIKVIKKADMIRKNQV----DQVLTERDILSQAQS 52
Query: 564 RNLVKLL-GFCNEDQHRLLVYEFISNGCLAGFL--FKNPKPSWYRRMQIAFGIARGLFYL 620
+VKL F + + LV E++ G LA L + R I L YL
Sbjct: 53 PYVVKLYYSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVAR--IYIAEIVLALEYL 109
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-------ILKADQTRTTTAIRGTRG 673
H IIH D+KP NIL+D + +++DFGL+K I D + I GT
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELIC---------CRKKFEQNVENENQMILVDWA 724
Y+APE + VD +S G +L E + + F+ + + +
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226
Query: 725 YDCYIDEKLHLLVENDEEAL 744
D ID LLV + E+ L
Sbjct: 227 SDEAIDLISKLLVPDPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--------EVNAIGQ-TNH 563
+LG G F +V+ E VA+KK+ K+F + EV ++ + H
Sbjct: 6 QLGDGTFGSVYLAR-NKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGLFYLHE 622
N+VKL E+ V+E++ + KP ++ I + I +GL ++H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF-K 681
H D+KP+N+L+ +I+DFGLA+ +++ T TR Y APE +
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRAPEILLR 172
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKF 708
S + VDI++ G ++ EL R F
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 11/175 (6%)
Query: 535 VAVKKLDNMVSGGDK--EFRTEVNAIGQTNHRNLVKLLGFCNEDQHR--LLVYEFISNGC 590
VAVK L SGG+ + + E+ + H N+VK G C ED L+ EF+ +G
Sbjct: 36 VAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 591 LAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649
L +L +N K + ++++ A I +G+ YL + Q +H D+ +N+L++ +I
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIG 151
Query: 650 DFGLAKILKADQTRTTTA--IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
DFGL K ++ D+ T + + APE + D++SFGV L EL+
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++G G + V+K ++ VA+KK+ +N G E+ + + H N+V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGEL-VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 570 LGFCNEDQHR--LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIA----------RGL 617
+V+E++ + L G L ++ F + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHD-LTGLL---------DSPEVKFTESQIKCYMKQLLEGL 113
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YLH I+H DIK NIL+++ +++DFGLA+ + T T Y P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 678 E-WFKSLPITMKVDIYSFGVMLLELI 702
E + +VD++S G +L EL
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 573 CNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
C + RL V E+++ G L + FK P +Y A IA GLF+LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-----AAEIAIGLFFLH---SK 120
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
II+ D+K N++LD +I+DFG+ K I TRT GT Y+APE P
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEIIAYQP 177
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
VD ++FGV+L E++ + F+ E+E
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 64/277 (23%), Positives = 124/277 (44%), Gaps = 23/277 (8%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGDKE-FRTEVNAI 558
EL+ + + LG G F + +G L +K + VA+ L S + F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 559 GQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGL 617
GQ +H N+V+L G ++V E++SNG L FL K+ + + M + G+A G+
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YL E +H + +L++ +IS F + K++ TT + + + AP
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
E + + D++SFG+++ E++ ++ ++ ++ + V+ + +L
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------RLPAPR 231
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
N LH +M + C Q++ RP ++
Sbjct: 232 -NCPNLLHQLM---------LDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 84/307 (27%), Positives = 123/307 (40%), Gaps = 59/307 (19%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG+G F V + K+ A KKL+ G+ E + + N R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKM-YACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT---- 625
+ E + L LV ++ G L K Y + F R +FY E C
Sbjct: 66 AYAYETKDALCLVLTLMNGGDL--------KFHIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 626 ---TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+I++ D+KP+NILLDD RISD GLA + QT GT GY+APE K+
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 175
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQ---NVENENQMILVDWAYDCYIDEKLHLLVEN 739
T D ++ G +L E+I + F+Q ++ E LV + E+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-----EVQEEYSEKFSP 230
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLR--------------PTMKKVTL--MLEGVVE 783
D +L M+ K DP R P K++ + G++E
Sbjct: 231 DARSLCKMLLCK------------DPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLE 278
Query: 784 VPIPPDP 790
P PDP
Sbjct: 279 PPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+++G G + V+KG +I VA+KK L++ G E++ + + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQI-VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEECTT 626
++ L++EF+S L +L PK + + + I +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPI 685
+++H D+KPQN+L+D+ +++DFGLA+ R T T Y APE S
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVE 713
+ VDI+S G + E+ + F + E
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGF 572
ELG GAF V+K E A K ++ +++ E+ + NH +VKLLG
Sbjct: 19 ELGDGAFGKVYKAK-NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGLFYLHEECTTQIIHC 631
D ++ EF G + + + + ++Q I + L YLH + +IIH
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 632 DIKPQNILLDDSFTARISDFGL-AKILKADQTRTTTAIRGTRGYVAP-----EWFKSLPI 685
D+K N+LL +++DFG+ AK +K Q R + GT ++AP E K P
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPY 192
Query: 686 TMKVDIYSFGVMLLEL 701
K DI+S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 8/113 (7%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIR 669
+ RGL Y+H +IH D+KP N+L+++ RI DFG+A+ L + T
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 670 GTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFE-QNVENENQMIL 720
TR Y APE SLP T +D++S G + E++ R+ F +N ++ ++IL
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 34/273 (12%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKL---DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++GRG F+ V++ + K VA+KK+ + M + ++ E++ + Q NH N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL--FKNPK---PS---WYRRMQIAFGIARGLFYLH 621
L ED +V E G L+ + FK K P W +Q+ + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE----HMH 123
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ +++H DIKP N+ + + ++ D GL + + T + + GT Y++PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741
K DI+S G +L E+ + F ++M L + L E+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
E L +++ + CI DP RP + V
Sbjct: 235 EKLRELVSM---------CIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-------NHRNL 566
LG+GAF V+ + +AVK++ E + EVNA+ H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE-LAVKQVP--FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLA------GFLFKNPKPSWYRRMQIAFGIARGLFYL 620
V+ G +D+ + E++ G + G L + + R+ I G+ YL
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYL 120
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTRGYVAPE 678
H + I+H DIK NIL D + ++ DFG +K L+ + T ++ GT +++PE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 679 WFKSLPITMKVDIYSFGVMLLELI 702
K D++S G ++E++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 15/173 (8%)
Query: 549 KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK---NPKPSWYR 605
+E R EV + H N+V+ E+ + +V ++ C G L+K + +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY----CEGGDLYKKINAQRGVLFP 99
Query: 606 RMQIA---FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662
QI I L ++H+ +I+H DIK QNI L T ++ DFG+A++L +
Sbjct: 100 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156
Query: 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQ-NVEN 714
T I GT Y++PE ++ P K DI++ G +L E+ + FE N++N
Sbjct: 157 LARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 38/218 (17%)
Query: 514 LGRGAFATVHKGVLAYE--------NKIC-VAVKKLDNMVSGGD-KEFRTEVNA---IGQ 560
LG G F V V+A N++ VAVK L + + D + +E+ IG+
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP----------------SWY 604
H+N++ LLG C +D ++ E+ S G L +L P S+
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 605 RRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTR 663
+ A+ +ARG+ YL + + IH D+ +N+L+ + +I+DFGLA+ I D +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
TT R ++APE T + D++SFGV+L E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
LG+G+F V KG + + + K D ++ D E E + + +
Sbjct: 8 LGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 569 LLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHE 622
L C + RL V E+++ G L + FK P +Y A IA GLF+LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY-----AAEIAIGLFFLH- 118
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+ II+ D+K N++LD +I+DFG+ K D TT GT Y+APE
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAY 175
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
P VD ++FGV+L E++ + FE E+E
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 509 GFKDELGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNL 566
F LG+G+F V +++ + + K D ++ D E E + +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 567 VKLLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYL 620
+ L C + RL V E+++ G L + FK P+ +Y A I+ GLF+L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFL 117
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H II+ D+K N++LD +I+DFG+ K D TT GT Y+APE
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEII 173
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
P VD +++GV+L E++ + F+ E+E
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 513 ELGRGAFATVHKGVLAYENKI--CVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
++G G+ V +A + VAVKK+D + EV + H N+V++
Sbjct: 26 KIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM---QIAF---GIARGLFYLHEEC 624
+V EF+ G L + RM QIA + + L +LH
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLH--- 132
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+IH DIK +ILL ++SDFG + + R + + GT ++APE LP
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLP 191
Query: 685 ITMKVDIYSFGVMLLELI 702
+VDI+S G+M++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 512 DELGRGAFATVHKGVLAYEN-KICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHR-NLVK 568
D +G G F V K + + ++ A+K++ S D ++F E+ + + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKN----PKPSWYRR------------MQIAFG 612
LLG C + L E+ +G L FL K+ P++ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
+ARG+ YL ++ Q IH D+ +NIL+ +++ A+I+DFGL++ ++ T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 170
Query: 673 GYVAPEWF--KSLP---ITMKVDIYSFGVMLLELI 702
G + W +SL T D++S+GV+L E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 514 LGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
LG+G F +V + L E+ K+ V + K D S +EF E + + +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 570 LGFC--NEDQHRL----LVYEFISNGCLAGFL---------FKNPKPSWYRRMQIAFGIA 614
+G + + RL ++ F+ +G L FL F P + R M IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM---IDIA 123
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRG 673
G+ YL + IH D+ +N +L+++ T ++DFGL+ KI D R A +
Sbjct: 124 SGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID-EK 732
++A E T D+++FGV + E++ + VEN Y+ I +
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGNR 233
Query: 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781
L + E+ ++++M C +P RP+ + + LE +
Sbjct: 234 LKQPPDCLED-VYELM---------CQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNLVKL 569
E+G G+F V+ ++ N++ VAVKK+ +++++ EV + Q H N ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEECTT 626
G ++ LV E+ G + L + KP + ++IA G +GL YLH
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL--- 683
+IH DIK NILL + +++DFG A + + GT ++APE ++
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDEG 195
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
KVD++S G+ +EL + + + N N M L+ + +ND
Sbjct: 196 QYDGKVDVWSLGITCIEL----AERKPPLFNMNAM------------SALYHIAQNDSPT 239
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPT 770
L + +C+Q+ P RP
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 38/230 (16%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLA--------YENK-ICVAVKKLDNMVSGGDKEFR 552
EL + LG G F V V+A NK + VAVK L + DK+
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKD--DATDKDLS 62
Query: 553 TEVNAIGQTN----HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP------- 601
V+ + H+N++ LLG C +D ++ E+ S G L +L P
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 602 ---------SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652
++ + A+ +ARG+ YL + + IH D+ +N+L+ + +I+DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 653 LAK-ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
LA+ + D + TT R ++APE T + D++SFGV+L E+
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQ-TNHRNLVKLLG 571
+G G + V+KG ++ A+K +D V+G ++E + E+N + + ++HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQL-AAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 572 -FCNE-----DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHE 622
F + D LV EF G + L KN K + + IA+ I RGL +LH+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK- 681
++IH DIK QN+LL ++ ++ DFG++ L R T I GT ++APE
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 185
Query: 682 ----SLPITMKVDIYSFGVMLLEL 701
K D++S G+ +E+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 47/139 (33%), Positives = 71/139 (51%), Gaps = 4/139 (2%)
Query: 577 QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQ 636
+H V EF++ G L + + YR A I GL +LH + II+ D+K
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLD 125
Query: 637 NILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGV 696
N++LD +I+DFG+ K R +T GT Y+APE + L T VD +SFGV
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 697 MLLELICCRKKFEQNVENE 715
+L E++ + F + E+E
Sbjct: 185 LLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 514 LGRGAFATVHKGVLAY-------ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN---- 562
LG G F V + AY + + VAVK L + + DK+ ++ +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKD--NATDKDLADLISEMELMKLIGK 76
Query: 563 HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL--FKNPKP--------------SWYRR 606
H+N++ LLG C ++ ++ E+ + G L FL + P P S+
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTT 665
+ A+ +ARG+ YL + + IH D+ +N+L+ + +I+DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
+ R ++APE T + D++SFG+++ E+
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNA 557
Y+++EK G G + V+K N+ +A+KK L+ G E++
Sbjct: 4 YEKVEKI--------GEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIREISL 54
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF--GIAR 615
+ + H N+V+L + ++ LV+E++ L + +P + R+ + I R
Sbjct: 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLD-LKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTA-RISDFGLAKILKADQTRTTTAIRGTRGY 674
G+ Y H + +++H D+KPQN+L+D A +++DFGLA+ RT T T Y
Sbjct: 114 GIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWY 169
Query: 675 VAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
APE S + VDI+S G + E++ + F + E
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209
|
Length = 294 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT---EVNAIGQTNHRNL 566
DELG+G + +V+K VL + +A+K++ + + +F E++ + + +
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPYI 61
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCL----AGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
V G + + E++ G L AG + P R +I + + +GL +L E
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKE 120
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
E IIH D+KP N+L++ + ++ DFG++ L A +T G + Y+APE KS
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKS 175
Query: 683 ------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
T++ D++S G+ +LE+ R + Y I +L +
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET------------YAN-IFAQLSAI 222
Query: 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
V+ D L +A C+ + P+ RPT
Sbjct: 223 VDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 47/226 (20%)
Query: 514 LGRGAFATVHKGVLAYEN--KICVAVKKL---DNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+GRGAF V L + A+K L D + R E + + + +VK
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 569 LLGFCN-EDQHRL-LVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEEC 624
L + + +D+ L LV E++ G L L + R F IA + L
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETAR-----FYIAELVLALDSVH 118
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK---------------ILKADQTRTTTAIR 669
IH DIKP NIL+D +++DFGL K + R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 670 -------------GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
GT Y+APE + P ++ D +S GV+L E++
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I RGL YLH + I+H DIKP N+L++ + +I DFGLA++ + D+++ T T+
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 673 GYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQN 711
Y APE T VDI+S G + EL+ R F+
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA---------IGQTNHR 564
+G GA+ V + VA+KKL + F++ ++A + +H
Sbjct: 23 VGSGAYGQVCSAFDT-KTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 565 NLVKLLG-FC----NED-QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
N++ LL F ED Q LV + G + K K S + + I RGL
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLK 132
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
Y+H + IIH D+KP NI +++ +I DFGLA+ + T GYVA
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT----------GYVATR 179
Query: 679 WFKSLPI-------TMKVDIYSFGVMLLELICCRKKF 708
W+++ I VDI+S G ++ EL+ + F
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 24/198 (12%)
Query: 514 LGRGAFATV--HKGVLAYENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKL 569
+G GAF V + L +N VA+KK+ S RT E+ + H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQN---VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 570 LG-FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
F + + V E + L L P + + + I RGL Y+H + +
Sbjct: 75 SDIFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFIQY-FLYQILRGLKYVH---SAGV 129
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE----WFKSLP 684
+H D+KP NIL++++ +I DFGLA+I Q T TR Y APE W K
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQK--- 182
Query: 685 ITMKVDIYSFGVMLLELI 702
++VDI+S G + E++
Sbjct: 183 YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 514 LGRGAFATVHKGVLAYENKIC-VAVKKLDNMVSGGDK--EFRTEVNAIGQTNHRNLVKLL 570
LG G F +V +G L ++ I VAVK + + + +F +E + + +H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 571 GFCNEDQHR------LLVYEFISNGCLAGFLFKN---PKPSWY-RRMQIAF--GIARGLF 618
G C + +++ F+ +G L FL + P + +M + F IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVAP 677
YL + IH D+ +N +L+++ ++DFGL+ KI D R + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 678 EWFKSLPITMKVDIYSFGVMLLEL 701
E T K D++SFGV + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 514 LGRGAFATVHKGVLAY---------ENKICVAVKKL-DNMVSGGDKEFRTEVNAIGQT-N 562
LG G F V V+A + + VAVK L D+ + +E+ +
Sbjct: 23 LGEGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 563 HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA------------ 610
H+N++ LLG C +D ++ E+ S G L +L P IA
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 611 ----FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTT 665
+ +ARG+ YL + + IH D+ +N+L+ ++ +I+DFGLA+ + D + T
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
T R ++APE T + D++SFGV++ E+
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 65/263 (24%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+++ LG G TV+K +I +AVK LD V K+ +E+ + + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRI-LAVKVIPLDITVEL-QKQIMSELEILYKCDSPYII 62
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
G + + EF+ G L + K P+ R IA + +GL YL + +
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGR---IAVAVVKGLTYL---WSLK 115
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
I+H D+KP N+L++ ++ DFG++ L +T GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYGI 172
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
D++S G+ +EL R + Q +N+ ++ + + L +V+ D L
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---------QLLQCIVDEDPPVLPVG 223
Query: 748 MRLKKYVMIAIWCIQEDPSLRPT 770
+K+V C+++ P RP
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 64/257 (24%)
Query: 510 FKDELGRGAFATVH--------------------KGVLAYENKICVAVKKL-DNMVSGGD 548
FK++LG G F VH KG + VAVK L +
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-----RPLLVAVKILRPDANKNAR 63
Query: 549 KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN---------- 598
+F EV + + N+++LLG C ++ ++ E++ NG L FL +
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 599 ---------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649
P S+ + +A IA G+ YL + +H D+ +N L+ ++ T +I+
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 650 DFGLAKILKAD-----QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLE-LIC 703
DFG+++ L A Q R IR ++A E T D+++FGV L E L+
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILML 236
Query: 704 CRKK------FEQNVEN 714
C+++ EQ +EN
Sbjct: 237 CKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMV------SGG--DKEFRTEVNAIGQTNHRN 565
LG+G F ++KGVL ++ + + + V S F + + Q +H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYR-RMQIAFGIARGLFYLHEEC 624
LVKL G C D++ ++V E++ G L FL + ++ +A +A L YL ++
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK- 120
Query: 625 TTQIIHCDIKPQNILL-----DDSFT--ARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
+++H ++ +NIL+ ++ + ++SD G+ + + + R ++AP
Sbjct: 121 --KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWIAP 173
Query: 678 EWFKSLP--ITMKVDIYSFGVMLLELICCRKK 707
E ++ +T+ D +SFG LLE IC +
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLE-ICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 512 DELGRGAFATVHKGVLAYENKIC---VAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNL 566
+++G G + V+K NK+ VA+KK LD G E++ + + NH N+
Sbjct: 6 EKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEE 623
VKLL + + LV+EF+ L F+ +P S I F + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKS 682
+++H D+KPQN+L++ +++DFGLA+ RT T T Y APE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 175
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
+ VDI+S G + E++ R F + E
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 53/223 (23%)
Query: 514 LGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGDKEF---RT--EVNAIGQTNHRNL 566
+G GA+ V A + VA+KK +S + + RT E+ + + H N+
Sbjct: 13 IGEGAYGMV---CSATHKPTGVKVAIKK----ISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 567 VKLL------GFCN------------EDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ 608
+ +L F + D ++L+ + +SN + FL++
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----------- 114
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI--LKADQTRTTT 666
I RGL Y+H + ++H D+KP N+LL+ + +I DFGLA+I + D T T
Sbjct: 115 ----ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 667 AIRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
TR Y APE S T +DI+S G +L E++ R F
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-12
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 15/163 (9%)
Query: 549 KEFRTEVNAIGQTNHRNLVKLL--GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR 606
FR E + H N+V LL G V+E++ L L +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAGET 81
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKIL----KA 659
++ + L H + I+H D+KPQNI++ A++ DFG+ +L A
Sbjct: 82 GRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 660 DQTRTT--TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLE 700
D T T + GT Y APE + P+T D+Y++G++ LE
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNLV 567
K +GRG F V I A+K + V + F E + + +N +
Sbjct: 6 KSLVGRGHFGEVQVVREKATGDIY-AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+L + + LV E+ G L L + + F +A + +H
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ--FDEDMAQFYLAELVLAIHSVHQMG 122
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+H DIKP+N+L+D + +++DFG A L A++ + GT Y+APE ++
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 688 K------VDIYSFGVMLLELICCRKKFEQ 710
K D +S GV+ E+I R F +
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 22/229 (9%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVN 556
++K+LEK LG G +ATV+KG +I VA+K LD R E++
Sbjct: 1 NFKQLEK--------LGEGTYATVYKGRNRTTGEI-VALKEIHLDAEEGTPSTAIR-EIS 50
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI---AFGI 613
+ + H N+V+L + + +LV+E++ L ++ + + + +
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
+G+ + HE +++H D+KPQN+L++ +++DFGLA+ + + T
Sbjct: 110 LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLW 165
Query: 674 YVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
Y AP+ S + +DI+S G ++ E+I R F NE+Q++ +
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF-PGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 497 IFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-----KEF 551
+FS + EK + E+G G+F V+ N++ VA+KK+ SG ++
Sbjct: 7 LFSKDDPEKLFTDLR-EIGHGSFGAVYFARDVRTNEV-VAIKKMS--YSGKQSNEKWQDI 62
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA- 610
EV + Q H N ++ G + LV E+ G + L + KP + ++IA
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVEIAA 119
Query: 611 --FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668
G +GL YLH IH DIK NILL + T +++DFG A ++ +
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----F 171
Query: 669 RGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLEL 701
GT ++APE ++ KVD++S G+ +EL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNA 557
Y+++EK +G G + V+K +I VA+KK L+ G E++
Sbjct: 1 YQKVEK--------IGEGTYGVVYKARDKLTGEI-VALKKIRLETEDEGVPSTAIREISL 51
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF--GIAR 615
+ + NH N+V+LL + + LV+EF+ L ++ +P + ++ + +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
G+ Y H + +++H D+KPQN+L+D +++DFGLA+ RT T T Y
Sbjct: 111 GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVVTLWYR 166
Query: 676 APEW-----FKSLPITMKVDIYSFGVMLLELI 702
APE S P VDI+S G + E++
Sbjct: 167 APEILLGSRQYSTP----VDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 64/206 (31%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 513 ELGRGAFATVHKG-VLAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKLL 570
E+G G F V G V + V VK+L S ++ +F E H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGLFYLHEE 623
G C E LLV EF G L G+L P P+ +RM A IA GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKN 119
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKI-LKADQTRTTTAIRGTRGYVAPEWFKS 682
IH D+ +N LL T +I D+GL+ K D T + ++APE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 683 LPITMKV-------DIYSFGVMLLEL 701
+ + V +++S GV + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 510 FKDELGRGAFATVH----KGVLAYENKIC-----------VAVKKL-DNMVSGGDKEFRT 553
FK++LG G F VH +G+ + +K VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL----FKNPKP-------S 602
E+ + + N+++LL C ++ E++ NG L FL + S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 603 WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL-KADQ 661
+ + +A IA G+ YL + +H D+ +N L+ ++T +I+DFG+++ L D
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 662 TRTTTAIRGTRGYVAPEWFKSLPI-----TMKVDIYSFGVMLLE-LICCRKK------FE 709
R I+G R + W I T D+++FGV L E L C+++ E
Sbjct: 186 YR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 710 QNVEN 714
Q +EN
Sbjct: 241 QVIEN 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKL---DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++GRG F+ V++ + VA+KK+ D M + + E++ + Q NH N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVP-VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL--FKN------PKPSWYRRMQIAFGIARGLFYLH 621
ED +V E G L+ + FK K W +Q+ L ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ +++H DIKP N+ + + ++ D GL + + +T ++ GT Y++PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIH 179
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKF 708
K DI+S G +L E+ + F
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 514 LGRGAFATVHKGVLAYENKI--CVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
LG+G F V + K+ C ++K G+ E + + N + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 572 FCNEDQHRL-LVYEFISNGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
+ E + L LV ++ G L ++ NP R + A I GL LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123
Query: 629 IHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
++ D+KP+NILLDD RISD GLA KI + + R GT GY+APE + T+
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQRYTL 180
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVE 713
D + G ++ E+I + F E
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 535 VAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGF 594
VAVKK+D + EV + +H N+V + +V EF+ G L
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 595 LFKNPKPSWYRRM---QIA---FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648
+ + RM QIA + R L YLH +IH DIK +ILL ++
Sbjct: 110 VT-------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKL 159
Query: 649 SDFGL-AKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
SDFG A++ K R + + GT ++APE LP +VDI+S G+M++E+I
Sbjct: 160 SDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 514 LGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKEFR-TEVNAIG-QTNHRNLVKLL 570
LG+G+F V L ++ V V K D ++ D E TE + NH L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 571 GFCNEDQHRLL-VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
C + RL V EF++ G L + K+ + R A I L +LH++ II
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GII 118
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
+ D+K N+LLD +++DFG+ K +TT+ GT Y+APE + + V
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 690 DIYSFGVMLLELICCRKKFEQNVENENQM 718
D ++ GV+L E++C FE ENE+ +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFE--AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 512 DELGRGAFATVHKGVLAY-ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
D+LG G +ATV KG EN + + +L++ R EV+ + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI-AFGIARGLFYLHEECTTQII 629
+ ++ LV+E++ + L +L ++I F + RGL Y H+ +I+
Sbjct: 70 DIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPITMK 688
H D+KPQN+L+++ +++DFGLA+ K+ T+T + T Y P+ S +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 689 VDIYSFGVMLLELICCRKKF 708
+D++ G +L E+ R F
Sbjct: 185 IDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 37/228 (16%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGG-DKEFRTEVN 556
E+ +T F +ELG F V+KG L E VA+K L + G +EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-FKNP---------------- 599
+ H N+V LLG ++Q +++ + S+ L FL ++P
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 600 -KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-IL 657
+P+ + + I IA G+ +L ++H D+ +N+L+ D +ISD GL + +
Sbjct: 121 LEPADF--VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 658 KADQTR----TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
AD + + IR +++PE ++ DI+S+GV+L E+
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 510 FKDELGRGAF-----ATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQT-N 562
F LG GAF AT + G+ + + VAVK L ++E +E+ + N
Sbjct: 39 FGKTLGAGAFGKVVEATAY-GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 563 HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYL 620
H N+V LLG C L++ E+ G L FL + + + + ++ +A+G+ +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG-TR---GYVA 676
+ IH D+ +N+LL +I DFGLA+ + D + ++G R ++A
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMA 211
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
PE + T + D++S+G++L E+ F M +D K + L
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEI------FSLGSNPYPGMP---------VDSKFYKL 256
Query: 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
++ + I C DP RPT K++ ++
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLA-------GFLF-KNPKPSW 603
R E + + H N+V D H +V E+ G L G LF ++ W
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 604 YRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663
+ +M + G+ ++HE+ +++H DIK +NI L + ++ DFG A++L +
Sbjct: 106 FVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQN 711
T + GT YV PE ++++P K DI+S G +L EL + F+ N
Sbjct: 157 ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 512 DELGRGAFATVHKGVLAY-ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
++LG G +ATV KG EN + + +L++ R EV+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 571 GFCNEDQHRLLVYEFIS-------NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ D+ LV+E++ + C N K Y+ I RGL Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQ-------ILRGLAYCHRR 123
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKS 682
+++H D+KPQN+L+++ +++DFGLA+ K+ T+T + T Y P+ S
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFE-QNVENENQMIL 720
+ ++D++ G + E+ R F VE+E +I
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTN---HRNLV 567
E+G GA+ V K VA+K++ T EV + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 568 KLLGFC-----NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM--QIAFGIARGLFYL 620
+L C + + LV+E + L +L K P+P + F + RGL +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H +++H D+KPQNIL+ S +++DFGLA+I T+ + T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVL 181
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQN 711
VD++S G + E+ + F +
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 537 VKKLDNMVSGGDKEFRT---EVNAIGQTNHRNLVKLL-GFCNEDQHRLLVYEFISNGCL- 591
+KKL N+ + +E + E + Q H N+V + ED +V F G L
Sbjct: 30 IKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY 88
Query: 592 -------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644
L +N W+ + IA L YLHE+ I+H D+K QN+ L +
Sbjct: 89 HKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHEK---HILHRDLKTQNVFLTRTN 139
Query: 645 TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC 704
++ D G+A++L+ +T I GT Y++PE F + P K D+++ G + E+
Sbjct: 140 IIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198
Query: 705 RKKFEQNVENENQMI 719
+ F N ++ N ++
Sbjct: 199 KHAF--NAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 572 FCN--EDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
FC +H V E+++ G L + + + R A I GL +LH II
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGII 118
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
+ D+K N+LLD +I+DFG+ K + + +T GT Y+APE K V
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNESV 177
Query: 690 DIYSFGVMLLELICCRKKFEQNVENE 715
D +SFGV+L E++ + F E+E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 596 FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655
F P+ +Y A IA L YLH II+ D+KP+NILLD ++DFGL K
Sbjct: 93 FPEPRARFY-----AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
Query: 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+ ++TT+ GT Y+APE + P VD + G +L E++
Sbjct: 145 -EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKLLGF 572
+G G + V+KG ++ A K+ ++ ++E + E+N + + ++HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQL--AAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 573 ------CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEE 623
D LV EF G + L KN K + + IA+ I RGL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK-- 681
++IH DIK QN+LL ++ ++ DFG++ L R T I GT ++APE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 682 ---SLPITMKVDIYSFGVMLLEL 701
+ DI+S G+ +E+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAI-GQTNHRNLVKL 569
+G+G+F V + K C AVK L + KE + E N + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGK-CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+ V +F++ G L L F P+ +Y A IA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLH--- 113
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKS 682
+ I++ D+KP+NILLD ++DFGL K I ++D TTT GT Y+APE +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYLAPEVIRK 170
Query: 683 LPITMKVDIYSFGVMLLELI 702
P VD + G +L E++
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGF 572
++G G+ V + K+ VAVKK+D + EV + H N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM---QIA---FGIARGLFYLHEECTT 626
+V EF+ G L + + RM QIA + + L LH +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVT-------HTRMNEEQIAAVCLAVLKALSVLHAQ--- 135
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGL-AKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
+IH DIK +ILL ++SDFG A++ K R + + GT ++APE LP
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPY 193
Query: 686 TMKVDIYSFGVMLLELI 702
+VDI+S G+M++E++
Sbjct: 194 GPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 44/219 (20%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL-DNMVSGGD--KEFRTEVNAIGQ-TNHRNLVKL 569
LG+GA+ V K + K VA+KK+ D + D + FR E+ + + +H N+VKL
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 570 LGFCNEDQHR-------LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
L + + LV+E++ L + N ++R I + + + L Y+H
Sbjct: 73 L-----NVIKAENDKDIYLVFEYMETD-LHAVIRANILEDVHKRY-IMYQLLKALKYIH- 124
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG------YVA 676
+ +IH D+KP NILL+ +++DFGLA R+ + + YVA
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLA--------RSLSELEENPENPVLTDYVA 174
Query: 677 PEWFKSLPI-------TMKVDIYSFGVMLLELICCRKKF 708
W+++ I T VD++S G +L E++ + F
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF---RTEVNAIGQ-TNHRNLVKL 569
+GRG++A V L +I A+K + + D++ +TE + Q +NH LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERI-YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 570 LGFCNEDQHRLL-VYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQ 627
C + + RL V E+++ G L + + K P + R A I+ L YLHE
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER---G 116
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
II+ D+K N+LLD +++D+G+ K + D TT+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDY 173
Query: 686 TMKVDIYSFGVMLLELICCRKKFE 709
VD ++ GV++ E++ R F+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEV---NAIGQTNHRNLV 567
E+G GA+ TV+K + VA+K ++ G EV + +H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHF-VALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 568 KLLGFC-----NEDQHRLLVYEFISNGCLAGFLFKNPKPSW----YRRMQIAFGIARGLF 618
+L+ C + + LV+E + L +L K P P + + F RGL
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQF--LRGLD 122
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
+LH C I+H D+KP+NIL+ +++DFGLA+I T + T Y APE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPE 177
Query: 679 WFKSLPITMKVDIYSFGVMLLEL 701
VD++S G + E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++G G + V+K ++ A+KK LDN G E+ + Q NHRN+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELV-ALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 570 LGFCNEDQHRL----------LVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFG 612
+ Q L LV+E++ + L G L ++ S+ +++
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHD-LMGLLESGLVHFSEDHIKSFMKQL----- 125
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
GL Y H+ +H DIK NILL++ +++DFGLA++ ++++R T T
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 673 GYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
Y PE +D++S G +L EL + F+ N E
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 512 DELGRGAFATVHKGVLAY-ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
D+LG G +ATV+KG +N + + +L++ R EV+ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 571 GFCNEDQHRLLVYEFIS-------NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ ++ LV+E++ + C N K F + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-------LFLFQLLRGLNYCHRR 123
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKS 682
+++H D+KPQN+L+++ +++DFGLA+ K+ T+T + T Y P+ S
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFE-QNVENENQMIL 720
+ ++D++ G + E+ R F VE + I
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAI----------GQTNH 563
LGRG F V ++ A+K L GD R EV ++ H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELY-AIKALKK----GDIIARDEVESLMCEKRIFETANSERH 61
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL----FKNPKPSWYRRMQIAFGIARGLFY 619
LV L + H V E+ + G L + F P+ +Y A + GL Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY-----AACVVLGLQY 116
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LHE +I++ D+K N+LLD +I+DFGL K RT+T GT ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV 172
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
T VD + GV++ E++ F + E E
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+I+ + RGL YL E+ +I+H D+KP NIL++ ++ DFG++ L +
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
GTR Y++PE + T++ DI+S G+ L+E+
Sbjct: 160 --GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVSGGDKEFRTEVNA 557
SY++LEK LG G++ATV+KG K + + V +L R E +
Sbjct: 6 SYEKLEK--------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASL 56
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI-AFGIARG 616
+ H N+V L + + LV+E++ L ++ K+P +++ F + RG
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676
L Y+H+ I+H D+KPQN+L+ D+ +++DFGLA+ K+ + T + T Y
Sbjct: 116 LSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRP 171
Query: 677 PE-WFKSLPITMKVDIYSFGVMLLELI 702
P+ S + +D++ G + +E+I
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA----DQTRTTTAIRGTR 672
L +H + +IH DIK NILL + ++ DFG +K+ A D RT GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTP 209
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709
YVAPE ++ P + K D++S GV+L EL+ ++ F+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 17/154 (11%)
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQ 608
E + + +H +++L ++ + ++ E++ G L +L F N +Y
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY---- 106
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668
A I L YLH + +I++ D+KP+NILLD +++DFG AK L+ D+T T +
Sbjct: 107 -ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT---L 158
Query: 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
GT Y+APE +S VD ++ G+++ E++
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
++ I + L YL E+ +IH D+KP NILLD S ++ DFG++ L + +T +A
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 668 IRGTRGYVAPEWFKSLPITMKVDI----YSFGVMLLEL 701
G Y+APE K DI +S G+ L+EL
Sbjct: 176 --GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG+G F V + K+ A KKL+ G+ E + + N R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKM-YACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT---- 625
+ E + L LV ++ G L ++ P F R +FY E C
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP--------GFDEQRAIFYAAELCCGLED 117
Query: 626 ---TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+I++ D+KP+NILLDD RISD GLA ++ + T GT GY+APE +
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
T D + G ++ E+I + F + E
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 514 LGRGAFATVHKGVLAYENKIC--VAVKKLD---NMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+G GA V AY+ VA+KKL V+ + +R E+ + NH+N++
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 569 LLGF------CNEDQHRLLVYEFI-SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
LL E Q LV E + +N C + + + Y Q+ GI +LH
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----HLH 135
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ IIH D+KP NI++ T +I DFGLA+ T + TR Y APE
Sbjct: 136 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 190
Query: 682 SLPITMKVDIYSFGVMLLELIC 703
+ VDI+S G ++ E+I
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
++ N +KL + +L+ ++I +G L L K K S +I + L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 622 EECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
+ IIH DIK +N+L D + + D+GL KI+ GT Y +PE
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKI 178
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
K + D ++ GV+ EL+ + F+++ + E
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+IA + GL YL+ +I+H DIKP NIL++ ++ DFG++ L T
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV- 163
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN----QMILVDW 723
GT Y++PE + T+K D++S G+ ++EL + F + +++ M ++D
Sbjct: 164 --GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 724 AYDCYIDEKLHLLVEND-EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777
+ E L +D E L D + C+ +DP+ RPT +++ M
Sbjct: 222 LQ-QIVQEPPPRLPSSDFPEDLRDFVDA---------CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNL 566
F LG G+F V E+ VA+K+ + K+ +E + NH
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
V L G ++ + LV EF+ G FL +N + + F A+ + +
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSL 150
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
I++ D+KP+N+LLD +++DFG AK++ TRT T + GT Y+APE ++
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHG 206
Query: 687 MKVDIYSFGVMLLELICCRKKFEQN 711
D ++ G+ + E++ F N
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYAN 231
|
Length = 340 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
+A L +LH + II+ D+KP+NILLD+ +++DFGL+K D + + GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 162
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-QMIL 720
Y+APE T D +SFGV++ E++ F+ E MIL
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVN 556
S E EK + +G G + V++ +I VA+KK +DN G E+
Sbjct: 5 SVTEFEKL-----NRIGEGTYGIVYRARDTTSGEI-VALKKVRMDNERDGIPISSLREIT 58
Query: 557 AIGQTNHRNLVKLLGFCNEDQ--HRLLVYEFISNGC---LAGFLFKNPKPSWYRRMQ--- 608
+ H N+V+L LV E+ C LA L P P + Q
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEY----CEQDLASLLDNMPTP--FSESQVKC 112
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK-ADQTRTTTA 667
+ + RGL YLHE IIH D+K N+LL D +I+DFGLA+ + T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 668 IRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
+ T Y APE T +D+++ G +L EL+
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 67/237 (28%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE----- 550
++ Y+ L K LG G F V+K + VA+KK+ K+
Sbjct: 6 KLRDYEILGK--------LGEGTFGEVYKAR-QIKTGRVVALKKILMHNE---KDGFPIT 53
Query: 551 -FRTEVNAIGQTNHRNLVKLLGFCNE--DQH---RLLVY--EFISNGCLAGFLFKNPK-- 600
R E+ + + H N+V L+ E D+ R VY + L+G L +NP
Sbjct: 54 ALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVK 111
Query: 601 --PSWYRRM--QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656
S + Q+ GI YLHE I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 112 LTESQIKCYMLQLLEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 657 L----------KADQTRTTTAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELI 702
TR T + TR Y PE T VDI+ G + E+
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF---RTEVNAIGQTNHRNLVKLL 570
+GRG++A V L ++I A+K + + D++ +TE + Q + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQI-YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQI 628
C + RL LV E+++ G L + + K P + R A I L +LHE I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHER---GI 117
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
I+ D+K N+LLD +++D+G+ K + D TT+ GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYG 174
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENEN 716
VD ++ GV++ E++ R F+ +N +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 512 DELGRGAFATVHKGV-LAYENKICVAVKKLDNMVSGGDKEFR-TEVNAIGQTNHRNLVKL 569
+++G+GA TV+ + +A + VA+K++ N+ KE E+ + + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE--VAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEECT 625
L +V E+++ G L + + + QIA + R L +LH +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLH---S 133
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
Q+IH DIK NILL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 686 TMKVDIYSFGVMLLELI 702
KVDI+S G+M +E++
Sbjct: 193 GPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVN 556
Y++L+ ++G GA+ TV L VA+KKL + +R E+
Sbjct: 17 YRDLK--------QVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELR 66
Query: 557 AIGQTNHRNLVKLLGFCNEDQHR------LLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
+ H N++ LL D LV F+ G G L K+ K S R +
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV 124
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ + +GL Y+H IIH D+KP N+ +++ +I DFGLA+ + D T +
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV-- 177
Query: 671 TRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQN 711
TR Y APE + + T VDI+S G ++ E++ + F+ +
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 47/138 (34%), Positives = 64/138 (46%), Gaps = 6/138 (4%)
Query: 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640
LV FI+ G L L + + R F A L L +I+ D+KP+NILL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRA---RFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 641 DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLE 700
D + DFGL K+ D +T T GT Y+APE T VD ++ GV+L E
Sbjct: 127 DYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAVDWWTLGVLLYE 185
Query: 701 LICCRKKFEQNVENENQM 718
++ F EN N+M
Sbjct: 186 MLTGLPPFYD--ENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 514 LGRGAFATVHKGVLAYENKI-CVAVKKLDNMVSGGDKEFR-TEVNAIGQTNHRNLVKLLG 571
LG+G+F V L +++ + V K D ++ D + TE + + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 572 FCNEDQHRLL-VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
C + + RL V E+++ G L + ++ K R A + L +LH +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIY 119
Query: 631 CDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
D+K NILLD +++DFG+ K IL TTT GT Y+APE + L
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 689 VDIYSFGVMLLELICCRKKFEQNVENE 715
VD ++ GV++ E++ + FE + E++
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 513 ELGRGAFATVH--KGVLAYENKICVAVKKLDNMVSGGDKEFRTE-VNAIGQTNHRNLVKL 569
+ +GAF +V+ K + +KK D + + E + Q + KL
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 570 L-GFCNEDQHRLLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
F ++D + LV E+++ G A + P + + IA + G+ LH+
Sbjct: 63 YYSFQSKD-YLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR---G 117
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IIH DIKP+N+L+D + +++DFGL++ ++ GT Y+APE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDK 172
Query: 688 KVDIYSFGVMLLELICCRKKFEQN 711
D +S G ++ E + F
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF---RTEVNAIGQ-TNHRNLVKL 569
+GRG++A V L +I A+K + + D++ +TE + +NH LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRI-YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 570 LGFCNEDQHRL-LVYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQ 627
C + + RL V EF+S G L + + K P + R A I+ L +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHER---G 116
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
II+ D+K N+LLD +++D+G+ K I D TT+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDY 173
Query: 686 TMKVDIYSFGVMLLELICCRKKF---------EQNVEN 714
VD ++ GV++ E++ R F +QN E+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+++ + RGL YL E+ QI+H D+KP NIL++ ++ DFG++ L +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCR 705
GTR Y++PE + +++ DI+S G+ L+EL R
Sbjct: 164 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKLL 570
+ +G+G + V+K V ++ AVK LD +S D+E E N + NH N+VK
Sbjct: 28 ETIGKGTYGKVYK-VTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 571 G-FCNEDQ----HRLLVYEFISNGCLA----GFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
G F D+ LV E + G + G L + I +G GL +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+IIH D+K NILL ++ DFG++ L + + R T++ GT ++APE
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 682 -----SLPITMKVDIYSFGVMLLEL 701
+ D++S G+ +EL
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+IA I + L YLH +IH D+KP N+L++ + ++ DFG++ L +T A
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 668 IRGTRGYVAPEWFKSLPIT------MKVDIYSFGVMLLEL 701
G + Y+APE + P +K D++S G+ ++EL
Sbjct: 165 --GCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 9e-10
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 47/215 (21%)
Query: 514 LGRGAFATVHKGVLAYENKIC---VAVKKLDNMVSGGDKEFRTEVNA---------IGQT 561
+G GA+ V A +K VA+KK+ N+ F ++A +
Sbjct: 8 IGSGAYGVV---CSAV-DKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHL 56
Query: 562 NHRNLVKLLG-FCNEDQHRL----LVYEFI-SNGCLAGFLFKNPKPSWYRRMQ-IAFGIA 614
H N++ LL +V E + ++ L + K+P+P +Q + I
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHK-VIKSPQPLTDDHIQYFLYQIL 113
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTR 672
RGL YLH + +IH D+KP NIL++ + +I DFGLA+ + D+ T TR
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 673 GYVAPE----WFK-SLPITMKVDIYSFGVMLLELI 702
Y APE + + I DI+S G + EL+
Sbjct: 171 WYRAPELLLSSSRYTKAI----DIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL----DNMVSGGDKEFRTE 554
S ELE+ + +G GA TV+K V+ A+K + ++ V ++ E
Sbjct: 72 SLSELERVNR-----IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVR---RQICRE 122
Query: 555 VNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM--QIAFG 612
+ + NH N+VK + + ++ EF+ G L G + +A
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG------THIADEQFLADVARQ 176
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I G+ YLH I+H DIKP N+L++ + +I+DFG+++IL +++ GT
Sbjct: 177 ILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232
Query: 673 GYVAPEWFKSLPITMKV----------DIYSFGVMLLE 700
Y++PE I + DI+S GV +LE
Sbjct: 233 AYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVNA 557
SY LEK LG G++ATV+KG+ + N VA+K + G E +
Sbjct: 6 SYLNLEK--------LGEGSYATVYKGI-SRINGQLVALKVISMKTEEGVPFTAIREASL 56
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNP---KPSWYRRMQIAFGIA 614
+ H N+V L + + V+E++ LA ++ ++P P Y F +
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHP--YNVRLFMFQLL 113
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
RGL Y+H + I+H D+KPQN+L+ +++DFGLA+ K+ ++T ++ T Y
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWY 169
Query: 675 VAPE-WFKSLPITMKVDIYSFGVMLLELI 702
P+ + + +DI+ G + +E++
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 596 FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655
F P+ +Y A +A + YLH + II+ D+KP+NILLD ++DFGL K
Sbjct: 93 FLEPRARFY-----AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
Query: 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+ TT+ GT Y+APE + P VD + G +L E++
Sbjct: 145 -EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVN 556
Y++LEK +G G + TV K ++I VA+K+ LD+ G E+
Sbjct: 1 KYEKLEK--------IGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREIC 51
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
+ + H+N+V+L + D+ LV+E+ F N F + +G
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676
L + H ++H D+KPQN+L++ + +++DFGLA+ R +A T Y
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRP 167
Query: 677 PE-WFKSLPITMKVDIYSFGVMLLEL 701
P+ F + + +D++S G + EL
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 511 KDELGRGAFATV----HKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
+ LG G+F V HKG Y C+ KK + + + E + + + +H +
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCL--KKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 567 VKLL-GFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYR-RMQIAFGIARGLFY 619
V ++ F +E++ L+ EF+ G L L F N +Y + +AF Y
Sbjct: 81 VNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------Y 133
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LH + II+ D+KP+N+LLD+ +++DFG AK + T + GT Y+APE
Sbjct: 134 LHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEV 186
Query: 680 FKSLPITMKVDIYSFGVMLLELI 702
+S VD ++ GV+L E I
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+++G+GA TV+ + VA+K+++ + E+ + + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEECTTQ 627
+V E+++ G L + + + QIA + R L +LH + Q
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALDFLH---SNQ 135
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH DIK NILL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 688 KVDIYSFGVMLLELI 702
KVDI+S G+M +E++
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 33/205 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK--EFRTEVNAIGQTNH---RNLVK 568
+GRGA+ V++G ++ VA+K + N+ + D + + EV + Q N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRV-VALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY-----RRMQIAFGIARGLFYLHEE 623
G + ++ E+ G + + P Y R + +A L Y+H+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA------LKYIHK- 119
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
+IH DIK NIL+ ++ ++ DFG+A +L + ++ +T + GT ++APE
Sbjct: 120 --VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE----- 171
Query: 684 PIT------MKVDIYSFGVMLLELI 702
IT K DI+S G+ + E+
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRR 606
TE + T H L L + + RL V E+ + G L L F + +Y
Sbjct: 44 TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-- 100
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
I L YLH +++ D+K +N++LD +I+DFGL K +D T
Sbjct: 101 ---GAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153
Query: 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF-EQNVENENQMILVD 722
GT Y+APE + VD + GV++ E++C R F Q+ E ++IL++
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 512 DELGRGAFATVHKGV---LAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+++G+GA TV + E VA+K+++ + E+ + + + N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQE----VAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEEC 624
L +V E+++ G L + + + QIA + R L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIA-AVCRECLQALEFLH--- 132
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
Q+IH DIK N+LL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 685 ITMKVDIYSFGVMLLELI 702
KVDI+S G+M +E++
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 491 PSTNLQIFSYKELEKATQGFKD----------ELGRGAFATVHKGVLAYENKICVAVKKL 540
PST+ + S K+ E A FK+ E+G G+F V+ N++ VA+KK+
Sbjct: 1 PSTS-RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEV-VAIKKM 58
Query: 541 DNMVSGGDKEFR---TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK 597
+++++ EV + + H N ++ G + LV E+ G + L
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV 117
Query: 598 NPKPSWYRRMQIA---FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
+ KP + ++IA G +GL YLH +IH DIK NILL + +++DFG A
Sbjct: 118 HKKP--LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLEL 701
I + GT ++APE ++ KVD++S G+ +EL
Sbjct: 173 SIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 535 VAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGF 594
VAVK +D + EV + H+N+V++ + ++ EF+ G L
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 595 LFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651
+ + + QIA + + L YLH + +IH DIK +ILL ++SDF
Sbjct: 109 VSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDF 161
Query: 652 GLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
G + D + + + GT ++APE P +VDI+S G+M++E++
Sbjct: 162 GFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT------NHRNLV 567
LG+G+F V L N+ A+K L V D + E + + H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQF-FAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLT 59
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHE 622
L ++ V E+++ G L + F P+ ++Y A I GL +LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AAEIICGLQFLH- 113
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
+ I++ D+K NILLD +I+DFG+ K +T T GT Y+APE
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
VD +SFGV+L E++ + F + E E
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 19/198 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
+G+G+F V E K AVK L + +K +E N + + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKF-YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
F + +L V ++I+ G L L F P+ +Y A IA L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLH--- 113
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+ I++ D+KP+NILLD ++DFGL K + TT+ GT Y+APE P
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 685 ITMKVDIYSFGVMLLELI 702
VD + G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 12/193 (6%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT----EVNAIGQTNHRNLVKL 569
+G GA+ V K E K VA+KK + S ++E + E+ + N+V+L
Sbjct: 9 VGEGAYGVVLK-CRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGLFYLHEECTTQI 628
LV+E++ L L + P +++ + + + + + H+ I
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDI 121
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
+H DIKP+N+L+ + ++ DFG A+ L T TR Y +PE P
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 689 VDIYSFGVMLLEL 701
VD++S G +L EL
Sbjct: 182 VDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVNA 557
+YK+L+K LG G++ATV+KG ++ VA+K++ G E +
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASL 56
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI-AFGIARG 616
+ H N+V L + + LV+E++ L ++ +++ F + RG
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676
L Y H+ +++H D+KPQN+L+ + +++DFGLA+ K+ ++T + T Y
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRP 171
Query: 677 PE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
P+ S + +D++ G + E+ R F + + E+Q+ +
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNLVKL 569
E+G G+F V+ +++ VA+KK+ +++++ EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEECTT 626
G + LV E+ G + L + KP + ++IA G +GL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL--- 683
+IH D+K NILL + ++ DFG A I+ GT ++APE ++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEG 189
Query: 684 PITMKVDIYSFGVMLLEL 701
KVD++S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG-- 670
I GL Y+H + ++H D+KP N+L++ +I DFGLA+ + +
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 671 -TRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFE 709
TR Y APE S T +D++S G +L EL+ + F+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKEF-RTEVNAIGQTNHRNLVKLL 570
+GRGAF V K+ A+K L M+ D F E + + N +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
+D++ +V E++ G L + P + R F A + L + IH
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR----FYTAEVVLALDAIHSMGFIH 165
Query: 631 CDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVAPEWFKSLP----I 685
D+KP N+LLD S +++DFG K+ K R TA+ GT Y++PE KS
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 686 TMKVDIYSFGVMLLELI 702
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR---GLFYLHEECTTQIIHCDIKPQN 637
L+ ++++ G L L++ + ++ IA L +LH+ II+ DIK +N
Sbjct: 82 LILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 638 ILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI--TMKVDIYSFG 695
ILLD ++DFGL+K A++ + GT Y+APE + VD +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 696 VMLLELICCRKKF----EQNVENE 715
V+ EL+ F EQN ++E
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKEF-RTEVNAIGQTNHRNLVKLL 570
+GRGAF V V ++ A+K L M+ D F E + + N +V+L
Sbjct: 51 IGRGAFGEVQL-VRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
+D++ +V E++ G L + P + + F A + L + +IH
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK----FYTAEVVLALDAIHSMGLIH 165
Query: 631 CDIKPQNILLDDSFTARISDFGLAKILKADQT---RTTTAIRGTRGYVAPEWFKSLP--- 684
D+KP N+LLD +++DFG +K D+T R TA+ GT Y++PE KS
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 685 -ITMKVDIYSFGVMLLELI 702
+ D +S GV L E++
Sbjct: 223 YYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 20/105 (19%)
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ I RGL Y+H + IIH D+KP N+ +++ +I DFGLA+ + T
Sbjct: 127 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-------- 175
Query: 671 TRGYVAPEWFKSLPITMK-------VDIYSFGVMLLELICCRKKF 708
GYVA W+++ I + VDI+S G ++ EL+ R F
Sbjct: 176 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 533 ICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLLGF------CNEDQHRLLVYE 584
I VAVKKL R E+ + NH+N++ LL E Q LV E
Sbjct: 47 INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106
Query: 585 FI-SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643
+ +N C + + + Y Q+ GI +LH + IIH D+KP NI++
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLH---SAGIIHRDLKPSNIVVKSD 159
Query: 644 FTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
T +I DFGLA+ + T + TR Y APE + VDI+S G ++ EL+
Sbjct: 160 CTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAI-GQTNHRNLVKLL 570
+ +G+G + V K VL +N AVK LD + D+E E N + ++H N+VK
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 571 GF------CNEDQHRLLVYEFISNGCLA----GFLFKNPKPSWYRRMQIAFGIARGLFYL 620
G N DQ LV E + G + GFL + + I GL +L
Sbjct: 82 GMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H T IH D+K NILL ++ DFG++ L + + R T++ GT ++APE
Sbjct: 141 HVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 681 ---KSLPITM--KVDIYSFGVMLLEL 701
+ L T + D++S G+ +EL
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+++G+GA TV+ + + VA+++++ + E+ + + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE-VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEECTTQ 627
+V E+++ G L + + + QIA + R L +LH + Q
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIA-AVCRECLQALEFLH---SNQ 136
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH DIK NILL + +++DFG + +Q++ +T + GT ++APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 688 KVDIYSFGVMLLELI 702
KVDI+S G+M +E+I
Sbjct: 196 KVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 20/101 (19%)
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668
+ + + RGL Y+H + IIH D+KP N+ +++ RI DFGLA+ +AD T
Sbjct: 123 LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT---- 173
Query: 669 RGTRGYVAPEWFKSLPITMK-------VDIYSFGVMLLELI 702
GYVA W+++ I + VDI+S G ++ EL+
Sbjct: 174 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF V + + +I A+K L+ M+ + FR E N + + + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERI-YAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFL--FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
++ + LV ++ G L L F++ P R F IA + +H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQLHY 123
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM- 687
+H DIKP N+LLD + R++DFG + D T ++ GT Y++PE +++ M
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 688 ----KVDIYSFGVMLLELI 702
+ D +S GV + E++
Sbjct: 184 KYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 5/152 (3%)
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGI 613
E+ + + N +V G D + E + G L L K + +++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
+GL YL E+ +I+H D+KP NIL++ ++ DFG++ L + GTR
Sbjct: 113 IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRS 167
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCR 705
Y++PE + +++ DI+S G+ L+E+ R
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAF 611
TE + + T LVKLL +D++ L E++ G L + R +A
Sbjct: 50 TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE 109
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK--ILKADQTRTTTAIR 669
+ LHE IH D+KP+N L+D S +++DFGL+K + A+ ++
Sbjct: 110 MFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN------SVV 159
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723
G+ Y+APE + VD +S G ML E +C F + NE L W
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 553 TEVNAIGQTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAF 611
TE + T H L L + + + RL V E+++ G L L + S R
Sbjct: 44 TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA 102
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671
I L YLH + +I++ D+K +N++LD +I+DFGL K D T GT
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFCGT 158
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF-EQNVENENQMILVD 722
Y+APE + VD + GV++ E++C R F Q+ E ++IL++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT----EV 555
Y++L K +G G++ V K E VA+KK + S D + E+
Sbjct: 3 YEKLSK--------IGEGSYGVVFK-CRNRETGQIVAIKKF--VESEDDPVIKKIALREI 51
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK--PSWYRRMQIAFGI 613
+ Q H NLV L+ + LV+E+ + L L KNP+ P + +I +
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPE-HLIKKIIWQT 109
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
+ + + H+ IH D+KP+NIL+ ++ DFG A+IL T + TR
Sbjct: 110 LQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165
Query: 674 YVAPEWF-KSLPITMKVDIYSFGVMLLELIC 703
Y APE VD+++ G + EL+
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 46/127 (36%), Positives = 68/127 (53%), Gaps = 11/127 (8%)
Query: 581 LVYEFISNGCLAGFLFKNPKPSWYR-RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639
LV +++S G L L K + S R + IA + L +LH+ I++ D+KP+NIL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY---DIVYRDLKPENIL 128
Query: 640 LDDSFTARISDFGLAKILKADQT--RTTTAIRGTRGYVAPE-WFKSLPITMKVDIYSFGV 696
LD + + DFGL+ KA+ T +TT GT Y+APE T VD +S GV
Sbjct: 129 LDATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 697 MLLELIC 703
++ E+ C
Sbjct: 186 LVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G+G F V K +I VA+KK ++N G E+ + H N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQI-VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 572 FCN-----EDQHR---LLVYEFISNGCLAGFLFKNPK-----PSWYRRMQIAFGIARGLF 618
C ++++ LV+EF + LAG L N + M++ + GL+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL-SNKNVKFTLSEIKKVMKM---LLNGLY 133
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK---ILKADQTRTTTAIRGTRGYV 675
Y+H +I+H D+K NIL+ +++DFGLA+ + K + T T Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 676 APE 678
PE
Sbjct: 191 PPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 12/215 (5%)
Query: 514 LGRGAFATVHKGVLAYENKI----CVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
LG+G F V +L E + + K + +V+ + N + Q + +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 570 LGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
L + + RL V E+ + G L L + S R I L YLH E +
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
++ D+K +N++LD +I+DFGL K D T GT Y+APE +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 689 VDIYSFGVMLLELICCRKKF-EQNVENENQMILVD 722
VD + GV++ E++C R F Q+ E ++IL++
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAI-GQTNHRNLVKLL 570
+GRGAF V V +K A+K L M+ D F E I N +V+L
Sbjct: 51 IGRGAFGEVQL-VRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
+D++ +V E++ G L + P + R A + L +H + IH
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA-EVVLALDAIH---SMGFIH 165
Query: 631 CDIKPQNILLDDSFTARISDFGLAKILKAD-QTRTTTAIRGTRGYVAPEWFKSLPIT--- 686
D+KP N+LLD S +++DFG + A+ R TA+ GT Y++PE KS
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 687 -MKVDIYSFGVMLLELI 702
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 5/90 (5%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I GL YLH + +IIH D+K +NI ++D I D G A+ A GT
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTV 220
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
APE K DI+S G++L E++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 16/118 (13%)
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ + R L Y+H T + H D+KP+NIL + +I DFGLA++ D T TAI
Sbjct: 110 YQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFW 163
Query: 671 TRGYVAPEWFKSLPI--------TMKVDIYSFGVMLLELICCRKKFE-QNVENENQMI 719
T YVA W+++ + T +DI+S G + E++ + F +NV ++ +I
Sbjct: 164 T-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 7/99 (7%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I GL ++H +++ D+KP NILLD+ RISD GLA + + GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 159
Query: 673 GYVAPEWF-KSLPITMKVDIYSFGVMLLELICCRKKFEQ 710
GY+APE K + D +S G ML +L+ F Q
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 39/233 (16%)
Query: 514 LGRGAFATVHKGVLAYENKIC--VAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
LG G+ V V ++ VAVKK+ K E+ I + +H N+VK+
Sbjct: 13 LGCGSNGLVFSAV---DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 572 FCNEDQHRL--------------LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
L +V E++ LA L + P + R+ + + RGL
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-FMYQLLRGL 127
Query: 618 FYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKAD--------QTRTTTAI 668
Y+H + ++H D+KP N+ ++ + +I DFGLA+I+ + T
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
R R ++P + T +D+++ G + E++ + F E E QM L+
Sbjct: 185 RSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
G+ Y+H+ +I+H D+K +NI L ++ +I DFG++++L TT GT Y+
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYYM 172
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709
+PE K K DI+S G +L E+ C FE
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 514 LGRGAFATVHKGVLAYENKIC--VAVKKLDNMVSGGDKEFRTEVNAI-------GQTNHR 564
LGRGAF V+ L Y+ +AVK++ +E EVNA+ H
Sbjct: 10 LGRGAFGEVY---LCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 565 NLVKLLGFCNED--QHRLLVY-EFISNGCLA------GFLFKNPKPSWYRRMQIAFGIAR 615
+V+ G C D + +L ++ E++ G + G L +N + R+ I +
Sbjct: 65 RIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQ 117
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTRG 673
G+ YLH + I+H DIK NIL D + ++ DFG +K ++ T ++ GT
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+++PE K D++S ++E++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 20/119 (16%)
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ + RGL Y+H + ++H D+KP N+LL+ + +I DFGLA RTT+
Sbjct: 115 YQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA--------RTTSEKGD 163
Query: 671 -------TRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
TR Y APE + T +D++S G + EL+ RK + +Q+ L+
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLI 221
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I GL ++H +++ D+KP NILLD+ RISD GLA + + GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 159
Query: 673 GYVAPEWF-KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
GY+APE K D +S G ML +L+ F Q+ + I
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-07
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 343 QNCDDPNQEVDLYDLVEMEYTDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFRNGE-- 400
NC + +++ P + L+ CREAC+ +C CT + NG
Sbjct: 3 LNCG---GDGSTDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGG 58
Query: 401 CWKKKNPLTNGRMAPDIEGKALIKI 425
C L N R G +++
Sbjct: 59 CLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 18/178 (10%)
Query: 535 VAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLLGF------CNEDQHRLLVYEFI 586
VA+KKL R E+ + NH+N++ LL E Q +V E +
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 587 -SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT 645
+N C + + + Y Q+ GI +LH + IIH D+KP NI++ T
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLH---SAGIIHRDLKPSNIVVKSDCT 164
Query: 646 ARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
+I DFGLA+ T + TR Y APE + VDI+S G ++ E+I
Sbjct: 165 LKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 514 LGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNL 566
LG+GAF V+ L Y+ ++ V + D KE E+ + H +
Sbjct: 10 LGQGAFGRVY---LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 567 VKLLGFCNEDQHRLL--VYEFISNGCLA------GFLFKNPKPSWYRRMQIAFGIARGLF 618
V+ G + R L E + G + G L +N + R+ I G+
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVS 120
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTRGYVA 676
YLH + I+H DIK NIL D ++ DFG +K L+ T ++ GT +++
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELI 702
PE K DI+S G ++E++
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 5/111 (4%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I L YLH +++ DIK +N++LD +I+DFGL K +D T GT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTP 159
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF-EQNVENENQMILVD 722
Y+APE + VD + GV++ E++C R F Q+ E ++IL++
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 512 DELGRGAFATVHKGVL-----------AYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ 560
+ LGRG ++ G+L +YE +I V +K LD F + + Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIARGL 617
+H+++V L G C D ++V EF+ G L F+ + W + ++A +A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118
Query: 618 FYLHEECTTQIIHCDIKPQNILL-------DDSFTARISDFGLAKILKADQTRTTTAIRG 670
YL ++ ++H ++ +NILL + ++SD G+ + + Q
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 671 TRGYVAPEWFK-SLPITMKVDIYSFGVMLLELIC 703
++APE + S +++ D +SFG L E IC
Sbjct: 173 --PWIAPECVEDSKNLSIAADKWSFGTTLWE-IC 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 44/229 (19%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF V I A+KKL M+ R E + + + ++ +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHI-YAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630
++ + L+ E++ G + L K + + F IA + + IH
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT---EEETRFYIAETILAIDSIHKLGYIH 124
Query: 631 CDIKPQNILLDDSFTARISDFGLAKILKADQT---------------------------R 663
DIKP N+LLD ++SDFGL LK +
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 664 TTTAIR----------GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
T R GT Y+APE F + D +S GV++ E++
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 32/190 (16%)
Query: 530 ENKICVAVKKLDN--------MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581
E ++ V K D V+GG K E++ + +HR ++ L+
Sbjct: 105 EGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIH---------- 153
Query: 582 VYEFISNGCLAGFLFKNPKPSWYRRM-----QIAFGIARGLF----YLHEECTTQIIHCD 632
Y + S C+ +K ++ R + A I R L YLH IIH D
Sbjct: 154 AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRD 210
Query: 633 IKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDI 691
+K +NI LD+ A + DFG A K+ T GT +PE P K DI
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270
Query: 692 YSFGVMLLEL 701
+S G++L E+
Sbjct: 271 WSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILK-ADQTRTTTA 667
+F +ARG+ +L + + IH D+ +NILL ++ +I DFGLA+ I K D R +A
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
R ++APE T + D++SFGV+L E+
Sbjct: 237 -RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA--- 646
CL ++ K+ S QI F L Y H E ++H D+KP+NIL++ S T
Sbjct: 217 CLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274
Query: 647 -------------RISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYS 693
RI D G D+ + TAI TR Y +PE L D++S
Sbjct: 275 VTNRALPPDPCRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 694 FGVMLLELICCRKKFE--QNVENENQM------ILVDWAYDCYIDE 731
G ++ EL + ++ N+E+ + M + +WA C +E
Sbjct: 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEE 376
|
Length = 467 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 9/170 (5%)
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
RTE N + + L + + + +L L+ +++S G + L++ + ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVR 108
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
F + L I++ DIK +NILLD ++DFGL+K +++ T + G
Sbjct: 109 FYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 671 TRGYVAPEWFKSLPITMK-VDIYSFGVMLLELICCRKKF----EQNVENE 715
T Y+APE + K VD +S G+++ EL+ F E+N ++E
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 535 VAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLLGF------CNEDQHRLLVYEFI 586
VA+KKL R E+ + NH+N++ LL E Q LV E +
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 587 -SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT 645
+N C + + + Y Q+ GI +LH + IIH D+KP NI++ T
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLH---SAGIIHRDLKPSNIVVKSDCT 157
Query: 646 ARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+I DFGLA+ A + T TR Y APE + VDI+S G ++ E++
Sbjct: 158 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF V L +K+ A+K L+ M+ + FR E + + +++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKV-FAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFL--FKNPKPS-----WYRRMQIAFGIARGLFYLHEE 623
++ + LV ++ G L L F++ P + M IA L Y+H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR- 126
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
DIKP NIL+D + R++DFG L D T ++ GT Y++PE +++
Sbjct: 127 --------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 684 P-----ITMKVDIYSFGVMLLELI 702
+ D +S GV + E++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF 611
R+E++ + +H +VK D LL+ E+ S G L K K +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN----KQIKQRLKEHLPFQE 168
Query: 612 GIARGLFY-----LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTT 665
LFY L E + +++H D+K NI L + ++ DFG +K +
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725
++ GT Y+APE ++ + K D++S GV+L EL+ + F+ + E ++ Y
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 726 D---CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
D C + + L++ + ++P+LRPT +++
Sbjct: 289 DPFPCPVSSGMKALLDP--------------------LLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLL 570
+G GA+ +V + VA+KKL + +R E+ + H N++ LL
Sbjct: 23 VGSGAYGSVCSAI-DKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 571 ----------GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL 620
F +D + ++ Y + G K + + + + GL Y+
Sbjct: 81 DVFTSAVSGDEF--QDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYI 133
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H + IIH D+KP N+ +++ +I DFGLA+ AD T + TR Y APE
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVI 186
Query: 681 KS-LPITMKVDIYSFGVMLLELICCRKKFE 709
+ + VDI+S G ++ E++ + F+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 8/170 (4%)
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
RTE + + L + + +L L+ ++I+ G L L + + + +QI
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-EQEVQIY 110
Query: 611 FG-IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669
G I L +LH+ II+ DIK +NILLD + ++DFGL+K D+ +
Sbjct: 111 SGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 670 GTRGYVAPEWFKSLPI--TMKVDIYSFGVMLLELICCRKKFEQNVENENQ 717
GT Y+AP+ + VD +S GV++ EL+ F + E +Q
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILK-ADQTRTTTA 667
+F +ARG+ +L + + IH D+ +NILL ++ +I DFGLA+ I K D R A
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
R ++APE T + D++SFGV+L E+
Sbjct: 236 -RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 35/95 (36%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAI 668
++ + R L Y+H + I H D+KPQN+L+D ++ T ++ DFG AK L A Q R+ + I
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI 231
Query: 669 RGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
+R Y APE + T +D++S G ++ E+I
Sbjct: 232 -CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 27/161 (16%)
Query: 515 GRGAFATVHKGV-LAYENKICVAVKKLDNMVSGGDKEFRT--------EVNAIGQTNHRN 565
GRG + V+K ++ A+KK GDKE T E+ + + H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 566 LVKLLGFCNEDQHRL--LVYEFISNGCLA--GFLFKNPKPSWYRRM--QIAFGIARGLFY 619
+V L+ E + L++++ + F + + S M + + I G+ Y
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 620 LHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKI 656
LH ++H D+KP NIL+ + +I D GLA++
Sbjct: 124 LHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILK-ADQTRTTTA 667
+F +A+G+ +L + + IH D+ +NILL ++ +I DFGLA+ I K D R A
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
R ++APE T++ D++SFGV+L E+
Sbjct: 242 -RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/235 (19%), Positives = 94/235 (40%), Gaps = 28/235 (11%)
Query: 551 FRTEVNAIGQTNHRNLVKLLGF----CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR 606
E+ + + + N++K+ GF ++ L+ E+ + G L L K S+ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
+ +A +GL+ L++ + ++ + L+ +++ +I GL KIL + +
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 667 AIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724
+ Y + + + T+K DIYS GV+L E+ + FE E ++++
Sbjct: 183 FM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN 238
Query: 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ L ++ I C D RP +K++ L
Sbjct: 239 NSLKLPLDCPLEIKC----------------IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 39/184 (21%)
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
++ + +A+G+ +L + IH D+ +N+LL D A+I DFGLA+ + D
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 667 A-IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL----------ICCRKKFEQNVENE 715
R ++APE T++ D++S+G++L E+ I KF + V+
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331
Query: 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
QM D+A + I C +P+ RPT +++
Sbjct: 332 YQMSRPDFA-------------------------PPEIYSIMKMCWNLEPTERPTFSQIS 366
Query: 776 LMLE 779
+++
Sbjct: 367 QLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 514 LGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNL 566
LG+GAF V+ L Y+ ++ + D KE E+ + H +
Sbjct: 10 LGQGAFGRVY---LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 567 VKLLGFCNEDQHRLLV--YEFISNGCLA------GFLFKNPKPSWYRRMQIAFGIARGLF 618
V+ G + + L E++ G + G L ++ + R+ I G+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMS 120
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTRGYVA 676
YLH + I+H DIK NIL D + ++ DFG +K L+ T ++ GT +++
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELI 702
PE K D++S G ++E++
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
+ ++ +A+G+ +L + IH D+ +NILL +I DFGLA+ ++ D
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 667 A-IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725
R ++APE + T + D++S+G++L E+ F M VD +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI------FSLGSSPYPGMP-VDSKF 326
Query: 726 DCYIDEKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
I E +L E ++D+M+ C DP RPT K++ ++E
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMKS---------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 25/120 (20%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ----------- 661
I + Y+H + ++H D+KP NILL I D+G A K ++
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 662 ----TRTTT--AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC-----RKKFEQ 710
+ T I GT Y+APE +P + DIY+ GV+L +++ RKK +
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 53/231 (22%)
Query: 513 ELGRGAFATVHKGVLAYENKICV--AVKKLD-NMVSGGDKEFR--TEVNAIGQTNHRNLV 567
LG+G V L A+K LD + +K R TE + +H L
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR--------GLFY 619
L + + LV ++ G L L + P + + +AR L Y
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPG----KCLSEE--VARFYAAEVLLALEY 118
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR---------- 669
LH I++ D+KP+NILL +S +SDF L+K + + A+R
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 670 ------------------GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
GT Y+APE VD ++ G++L E++
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 58/250 (23%), Positives = 94/250 (37%), Gaps = 47/250 (18%)
Query: 514 LGRGAFATVH------KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+GRGAF V G + Y KI ++K D + R E + + + + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHI-YAMKI---LRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
K+ + ++ L+ EF+ G + L K S F IA + +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS---EEATQFYIAETVLAIDAIHQLG 121
Query: 628 IIHCDIKPQNILLDDSFTARISDFGL---------------------------------- 653
IH DIKP N+LLD ++SDFGL
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 654 AKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
A+ K ++ + + GT Y+APE F D +S GV++ E++ F
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 714 NENQMILVDW 723
E +++W
Sbjct: 242 QETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVN 556
+Y++LEK +G G + V+K K+ VA+KK L+ G E++
Sbjct: 2 AYEKLEK--------IGEGTYGKVYKARDKNTGKL-VALKKTRLEMDEEGIPPTALREIS 52
Query: 557 AIGQTNHRN-LVKLLGFCNEDQHR-----LLVYEFISNGCLAGFLFKN--------PKPS 602
+ + +V+LL + ++ LV+E++ + L F+ N P +
Sbjct: 53 LLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKT 111
Query: 603 WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA-RISDFGLAKILKADQ 661
M + + +G+ + H+ ++H D+KPQN+L+D +I+D GL +
Sbjct: 112 IKSFM---YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165
Query: 662 TRTTTAIRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
T I T Y APE S + VDI+S G + E+
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 512 DELGRGAFATVHKG----VLAYE--NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
+ LG+G F + KG V Y +K V +K LD + F + + Q +H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIARGLFYLHE 622
LV G C ++V E++ G L +L KN SW ++++A +A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED 118
Query: 623 ECTTQIIHCDIKPQNILL---DDSFTA-----RISDFGLAKILKADQTRTTTAIRGTRGY 674
+ + H ++ +N+LL +D T ++SD G++ + + +
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI-----PW 170
Query: 675 VAPEWFK-SLPITMKVDIYSFGVMLLELIC 703
V PE + +++ D +SFG L E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 56/249 (22%), Positives = 92/249 (36%), Gaps = 45/249 (18%)
Query: 514 LGRGAFATVH-----KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+GRGAF V Y KI ++K D + R E + + + + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKI---LRKADMLEKEQVGHIRAERDILVEADSLWVVK 65
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
+ + + L+ EF+ G + L K + + F IA + +
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT---EEETQFYIAETVLAIDSIHQLGF 122
Query: 629 IHCDIKPQNILLDDSFTARISDFGL----------------------------------A 654
IH DIKP N+LLD ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714
+ K ++ + + GT Y+APE F D +S GV++ E++ F
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 715 ENQMILVDW 723
E +++W
Sbjct: 243 ETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 46/205 (22%), Positives = 74/205 (36%), Gaps = 22/205 (10%)
Query: 513 ELGRGAF--ATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+G+ VH VAVKK LD+ K + E+ Q H N++
Sbjct: 5 LIGKCFEDLMIVHLA-KHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECT 625
+ D +V ++ G L K P + IAF + L Y+H +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK-- 120
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTAIRGTRG------YVAPE 678
IH +K +ILL +S + ++K + R + +++PE
Sbjct: 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK-RQRVVHDFPKSSVKNLPWLSPE 178
Query: 679 WFKS--LPITMKVDIYSFGVMLLEL 701
+ K DIYS G+ EL
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKE-FRTEVNAIGQTNHRNLVKL 569
+GRGAF V V+ +N V K+ N M+ + FR E + + + R + L
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL--FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
++ + LV ++ G L L F++ P R F +A + +
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQLG 122
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+H DIKP N+LLD + R++DFG L AD T + GT Y++PE +++
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 688 -----KVDIYSFGVMLLELI 702
+ D +S GV + E++
Sbjct: 183 GRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 9/121 (7%)
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
+ I + R + YLHE +IIH DIK +NI ++ + DFG A
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK-FEQ-----NVENENQMIL 720
GT APE P VDI+S G++L E+ C FE+ + +++ Q+ L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 721 V 721
+
Sbjct: 302 I 302
|
Length = 391 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 19/63 (30%), Positives = 26/63 (41%), Gaps = 8/63 (12%)
Query: 172 STGRYELAMQSDGNLVLYTTAFPFESANSVYWS--TQPVGSSLQVEFNRSGNIIYLTAKN 229
+ Y L +QSDGNLVLY + V WS T GS GN++
Sbjct: 15 TDSSYTLILQSDGNLVLY------DGNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYDNSG 68
Query: 230 RSI 232
+ +
Sbjct: 69 KVL 71
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 25/87 (28%)
Query: 244 QDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACD-- 301
+Y R+TL +G L + + N++ W++ WS P D+ CD
Sbjct: 43 NSIYSRLTLSSEGSLERFTW----IPNSQDWNLFWSAP----------KDQ-----CDVY 83
Query: 302 --CGFNSYCSLGNDQRPTCLCPQGYVP 326
CG YC + P C C +G+VP
Sbjct: 84 GRCGPYGYCDVNTS--PKCNCIKGFVP 108
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 35/218 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNM-VSGGDKEFRTEVNAIG------------- 559
LG G + V K KI VA+KK+ + +S + R V G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 560 QTNHRNLVKLLG-FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
+ H N++ L+ + D LV + I L + + + + + I I GL
Sbjct: 76 EIKHENIMGLVDVYVEGD-FINLVMD-IMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-------------KILKADQTRTT 665
LH+ +H D+ P NI ++ +I+DFGLA K +
Sbjct: 134 VLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 666 TAIRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
T+ T Y APE + VD++S G + EL+
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 37/117 (31%), Positives = 54/117 (46%), Gaps = 15/117 (12%)
Query: 591 LAGFLFKNPKPSWYRRMQIAFGIARGLF----YLHEECTTQIIHCDIKPQNILLDDSFTA 646
L +L +P Q+ +AR L Y+H E IIH DIK +N+L++
Sbjct: 246 LYTYLGARLRP--LGLAQVT-AVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDI 299
Query: 647 RISDFGLAKILKADQTRTTTAIRGTRGYV---APEWFKSLPITMKVDIYSFGVMLLE 700
+ DFG A + + +T G G V APE P T VDI+S G+++ E
Sbjct: 300 CLGDFGAACFARG--SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 28/154 (18%)
Query: 572 FCNED--QHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
FC+ + +H +V E++ G A L KN P RM A + L YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAETVL-ALEYLH---NYG 121
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT----------------AIRGT 671
I+H D+KP N+L+ +++DFGL+KI + TT + GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLE-LICC 704
Y+APE VD ++ G++L E L+ C
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF-RTEVNAIGQTNHRNLVKLLGF 572
+G G + V+K + ++ A K+ + G D + E+ + + H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGEL--AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQII 629
+ + E+ G L ++ P +QIA+ +GL YLH + +
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAYLH---SKGKM 128
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF---KSLPIT 686
H DIK NILL D+ +++DFG+A + A + + I GT ++APE K+
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 687 MKVDIYSFGVMLLEL 701
DI++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 513 ELGRGAFATVHKGVLAYENKIC-VAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
E+G G F V + + + V VK+L N S EF + + H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR-------MQIAFGIARGLFYLHEE 623
G C E LLV+E+ G L +L + W+RR ++A IA G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKI-LKADQTRTTTAIRGTRGYVAPEWFKS 682
+H D+ +N L T ++ D+G+ K D T ++APE
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 683 L-------PITMKVDIYSFGVMLLELICCRKK 707
T ++++ GV L EL +
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQ 207
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 42/137 (30%)
Query: 629 IHCDIKPQNILLDDSFTARISDFGLA---------------------------------- 654
IH DIKP NIL+D +++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 655 ---KILKA----DQTRTTT-AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK 706
K L+ R ++ GT Y+APE T D +S GV+L E++ +
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 707 KFEQNVENENQMILVDW 723
F + E Q+ +++W
Sbjct: 243 PFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 516 RGAFATVHKGVLAYENKICV--AVKKLD----NMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
RGAF V+ G +K+ VKK D NMV + + E +A+ + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH----QVQAERDALALSKSPFIVHL 69
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+ LV E++ G + L F Y I+ +A L YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY----IS-EVALALDYLHRH- 123
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656
IIH D+KP N+L+ + +++DFGL+K+
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 44/186 (23%), Positives = 67/186 (36%), Gaps = 60/186 (32%)
Query: 618 FYLHEECTTQI--------IHCDIKPQNILLDDSFTARISDFGLA-------------KI 656
FY+ EC I IH DIKP NIL+D ++SDFGL+ K+
Sbjct: 105 FYM-AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 657 LKADQTRTTTAIR---------------------------------GTRGYVAPEWFKSL 683
L+ + R GT Y+APE F
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
+ D +S G ++ E + F +E +++W Y + +HL VE +
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAE--- 280
Query: 744 LHDMMR 749
D++R
Sbjct: 281 --DLIR 284
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I+ L +LH++ II+ D+KP+NILLD +++DFGL K + T T T GT
Sbjct: 109 ISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTI 164
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
Y+APE VD +S G ++ +++
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 29/159 (18%)
Query: 562 NHRNLVKLLGFCNEDQHRLLV-YEFISNGCLAGFLFKNPKPSWYRRMQ---------IAF 611
+H+N++ +L C ED V Y +++ G L FL + + Q +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMAI 124
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK--------ILKADQTR 663
IA G+ YLH+ +IH DI +N ++D+ +I+D L++ L ++ R
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
++ ++A E + + D++SFGV+L EL+
Sbjct: 182 ---PVK----WMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
G+ +LH+ I+H D+K N+LL++ +I DFGLA+ + T + T Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWY 172
Query: 675 VAPEWFKSLPI-TMKVDIYSFGVMLLELI 702
APE + +D++S G + EL+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 40/199 (20%)
Query: 554 EVNAIGQTNHRNLVKLLG-FCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIA- 610
EVN + + H+N+V+ + F N+ +L ++ EF C AG L +N + + +I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF----CDAGDLSRNIQKCYKMFGKIEE 117
Query: 611 ---FGIARGLFYLHEECTT--------QIIHCDIKPQNILLDDSF--------------- 644
I R L + C +++H D+KPQNI L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 645 --TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF--KSLPITMKVDIYSFGVMLLE 700
A+I DFGL+K + + + GT Y +PE ++ K D+++ G ++ E
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 701 LICCRKKFEQNVENENQMI 719
L + F + N +Q+I
Sbjct: 236 LCSGKTPFHK-ANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF-RTEVNAIGQTNHRNLVKLLGF 572
+G G + V+K ++ A K+ + G D + E+ + H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGEL--AAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR----GLFYLHEECTTQI 628
+ EF G L ++ P QIA+ ++R GL+YLH +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAY-VSRETLQGLYYLHSKGK--- 127
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF---KSLPI 685
+H DIK NILL D+ +++DFG++ + A + + I GT ++APE +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGY 186
Query: 686 TMKVDIYSFGVMLLEL 701
DI++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK--EFRTEVNAIGQ-TNHRNLVK 568
++G G F+ V K + + A+K + ++ R E+ A+ + + H N+++
Sbjct: 5 GKIGEGTFSEVLK-AQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILR 62
Query: 569 LLGFCNEDQHRLL----------VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
L+ + + L +YE I K P P R + + + L
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGR-------KRPLPE-KRVKSYMYQLLKSLD 114
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
++H I H DIKP+NIL+ D +++DFG + T TR Y APE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPE 168
Query: 679 WFKSLPITM-----KVDIYSFGVMLLELI 702
+T K+DI++ G + E++
Sbjct: 169 CL----LTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 38/150 (25%), Positives = 58/150 (38%), Gaps = 46/150 (30%)
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTT 666
QI F + LH +T I+H D+KPQNI+ + S + +I D G A L+
Sbjct: 263 QILFALDG----LH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 667 AIRGTRGYVAPEWF---------KSLPITM-------------KVDIYSFGVMLLE---- 700
Y APE + S P+ + DIYS G++ L+
Sbjct: 316 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP 375
Query: 701 -------LICCRKKFEQNVENENQMILVDW 723
LI ++ ++N + LV W
Sbjct: 376 NLRSDSNLIQFNRQLKRNDYD-----LVAW 400
|
Length = 566 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 63/274 (22%), Positives = 100/274 (36%), Gaps = 71/274 (25%)
Query: 514 LGRGAFATVHKGVLA--YENKICVAVKKL---DNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
LG GAF V LA + K A+K L D ++ + E + + + ++ +V+
Sbjct: 9 LGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQ 627
L + + V ++I G + L RM I F FY+ E C +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLI---------RMGI-FPEDLARFYIAELTCAVE 115
Query: 628 ------IIHCDIKPQNILLDDSFTARISDFGLAKILK----------ADQTRTTT----- 666
IH DIKP NIL+D +++DFGL + D R +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 667 -------------------------------AIRGTRGYVAPEWFKSLPITMKVDIYSFG 695
++ GT Y+APE T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 696 VMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
V+L E++ + F E QM +++W +I
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 29/118 (24%), Positives = 61/118 (51%), Gaps = 12/118 (10%)
Query: 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648
+ ++P S+ + ++ +A G+ +L + +H D+ +N+L+ + +I
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKI 280
Query: 649 SDFGLAKILKADQTRTTTAIRGTR----GYVAPE-WFKSLPITMKVDIYSFGVMLLEL 701
DFGLA+ + D + +G+ ++APE F +L T+ D++SFG++L E+
Sbjct: 281 CDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLS-DVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
+ + +ARG+ +L + +H D+ +N+LL +I DFGLA+ + D +
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS- 295
Query: 667 AIRGTR----GYVAPE-WFKSLPITMKVDIYSFGVMLLEL 701
+G+ ++APE F +L T+ D++S+G++L E+
Sbjct: 296 --KGSTFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 38/156 (24%), Positives = 58/156 (37%), Gaps = 46/156 (29%)
Query: 629 IHCDIKPQNILLDDSFTARISDFGL----------------------------------- 653
IH DIKP NIL+D +++DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 654 ---AKILKADQTRTTT--------AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
LK + R T ++ GT Y+APE T D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 703 CCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738
+ F E Q+ +++W +I ++ L E
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPE 278
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 797 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.11 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.11 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.76 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.76 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.67 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.82 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.69 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.2 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.17 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.79 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.27 | |
| PLN02236 | 344 | choline kinase | 95.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.77 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.29 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.28 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.07 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.86 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=458.79 Aligned_cols=287 Identities=46% Similarity=0.737 Sum_probs=249.6
Q ss_pred CccccCHHHHHHHHHhhh--hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcc
Q 003759 494 NLQIFSYKELEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571 (797)
Q Consensus 494 ~~~~~~~~el~~~~~~f~--~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g 571 (797)
....|++.||..||++|. +.||+|+||.||+|.+.++ ..||||++.....+..++|.+|+.++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~--~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG--TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC--CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 567899999999999997 5899999999999999765 569999887644331567999999999999999999999
Q ss_pred cccccC-ceeeeeecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 572 FCNEDQ-HRLLVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 572 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
||.+.+ +.+||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 5999999999999999998765 8999999999999999999999998889999999999999999999999
Q ss_pred EeecCcccccc-CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh
Q 003759 649 SDFGLAKILKA-DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 649 ~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
+|||+|+.... ........ .||.+|+|||++.....+.|+|||||||+|+||+||+.+.+.... .....+.+|++..
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHHH
Confidence 99999976544 22211111 699999999999999999999999999999999999998876542 2233378999888
Q ss_pred hccccccccccchhh-hhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 728 YIDEKLHLLVENDEE-ALHDM-MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+.++.+.+++|+... ..... .++.++.++|++|++.+|++||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 888899999999865 33332 6788899999999999999999999999999776554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=384.01 Aligned_cols=251 Identities=33% Similarity=0.483 Sum_probs=205.9
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccC-ceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-HRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~Ey~~ 587 (797)
.+.||+|+||+||+|.+... ..||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 45699999999999999643 339999997644333 458999999999999999999999999988 7999999999
Q ss_pred CCchhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCCEEEcCCC-cEEEEeecCccccccCCCc
Q 003759 588 NGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQ-IIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTR 663 (797)
Q Consensus 588 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 663 (797)
+|+|.+++++ ...+++..+++++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999988 57899999999999999999999998 6 99999999999999997 99999999998755432 2
Q ss_pred ccccccccCccccccccc--cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 664 TTTAIRGTRGYVAPEWFK--SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~--~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
..+...||+.|||||++. ...++.|+||||||++||||+||+.||....... .+......+....+...
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------~~~~v~~~~~Rp~~p~~-- 270 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------VASAVVVGGLRPPIPKE-- 270 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcCCCCCCCcc--
Confidence 333467999999999999 5699999999999999999999999998765421 11111111222111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+..++.+||+.||++||++.+|+.+|+.+..
T Consensus 271 -------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 -------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22345667778999999999999999999986544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.99 Aligned_cols=257 Identities=27% Similarity=0.359 Sum_probs=209.8
Q ss_pred cCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhccccccc
Q 003759 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED 576 (797)
Q Consensus 498 ~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 576 (797)
.+..||+. .+.||+|..|+|||+.++.++ +.+|+|.+.... ....+++.+|+++++..+||+||.++|.|...
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~-~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTG-KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCC-eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 45566655 468999999999999998765 469999995432 33457899999999999999999999999988
Q ss_pred C-ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 577 Q-HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 577 ~-~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
. ...|+||||++|||++++...+++++...-+|+.++++||.|||+. .+||||||||+|||++..|++||+|||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 5999999999999999998888899999999999999999999963 399999999999999999999999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccc-cchhhHHHHHHhhhcccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN-ENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 734 (797)
.+-.. ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... .....+..+
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----------- 293 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----------- 293 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-----------
Confidence 76544 345567999999999999999999999999999999999999999765211 111222221
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+++..++.........++.+++-.||++||.+||++.|++++
T Consensus 294 -Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 -IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122112111111234567788999999999999999998864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=376.40 Aligned_cols=263 Identities=27% Similarity=0.395 Sum_probs=218.5
Q ss_pred HHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 501 KELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 501 ~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
-++.+....+.++||+|-||.||.|.+.... .||+|.++.. .-..++|.+|+.+|++|+|+|||+++|+|..++..+
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~--~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGST--KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCC--cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 4556666677899999999999999997543 4999999864 345678999999999999999999999999998999
Q ss_pred eeeecccCCchhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 581 LVYEFISNGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
||||||+.|+|.++|.. ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999986 46788999999999999999999998 99999999999999999999999999999766
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.+.........-+..|.|||.+....++.|||||||||+||||+| |+.|+......+- -..+..+......
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------~~~le~GyRlp~P 426 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------LELLERGYRLPRP 426 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------HHHHhccCcCCCC
Confidence 666666666667889999999999999999999999999999999 8888876644321 1112222222222
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~ 786 (797)
+..+ ..+.++...||..+|++|||++.+...|+.+.....
T Consensus 427 ~~CP---------~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 427 EGCP---------DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCCC---------HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 2223 345566777999999999999999999988765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=357.52 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=203.6
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-------hHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-------DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-------~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
..|-+.+.||+|+||.|-+|..+.++ +.||||++.+..... ....++|+++|++++|||||++++++++.+.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tg-k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTG-KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccC-cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34556788999999999999887655 459999997533221 2235799999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CcEEEEeecCcc
Q 003759 579 RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS---FTARISDFGLAK 655 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~ 655 (797)
.|||||||++|.|.+.+-.++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999999899989999999999999999999 99999999999999755 789999999999
Q ss_pred ccccCCCcccccccccCccccccccccCCC---CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPI---TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
... ....+....|||.|.|||++.++.. ..+.|+||+||+||-+++|.+||......... .+.+..++
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl-------~eQI~~G~ 398 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL-------KEQILKGR 398 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH-------HHHHhcCc
Confidence 875 3445666789999999999987643 34789999999999999999999776443311 11122222
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... + ..-..-.++..+++.+||+.||++|||+.|+++
T Consensus 399 y~f~--p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YAFG--P----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccc--C----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2111 0 011122356788999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=353.25 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=178.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.++||+|+||+||+|+++..+ .+||||.+.... ....+-+..|+.+|+.++|||||++++++..++..+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~-~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSG-TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCC-ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 344667999999999999999776 679999997652 23345578899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC------CcEEEEeecCcccccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS------FTARISDFGLAKILKA 659 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~Dfgla~~~~~ 659 (797)
|.+|+|.+++++.+.+++.....++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999999999999999999999999999998 99999999999999764 4689999999998863
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
........|+|-|||||++...+|+.|+|+||.|++||++++|+.||.....
T Consensus 168 --~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 168 --GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred --hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 2334556799999999999999999999999999999999999999986544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=368.04 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=207.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
.+|...+.||+|||+.||.++....++ .||+|++.+.. ....+...+|+++.+.|+|||||+++++|++.+..|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge-~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE-VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc-EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 345556789999999999999865554 59999997632 23345688999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
.|+|++++|.+++.+++.+++.+++.++.||+.||.|||+. +|+|||||..|++|+++.++||+|||||..+..+..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999999889999999999999999999999998 999999999999999999999999999998876644
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
+. ....|||.|+|||++....++..+||||+||+||.||.|++||+...-.+.. ..+....... +.
T Consensus 174 rk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety--------~~Ik~~~Y~~-----P~ 239 (592)
T KOG0575|consen 174 RK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY--------NKIKLNEYSM-----PS 239 (592)
T ss_pred cc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH--------HHHHhcCccc-----cc
Confidence 43 3467999999999999999999999999999999999999999876433321 1111111100 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.-...+.+++..+|++||.+|||+++|+..
T Consensus 240 -----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 -----HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111235577888999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=383.62 Aligned_cols=265 Identities=28% Similarity=0.452 Sum_probs=218.8
Q ss_pred HHHHHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccc
Q 003759 501 KELEKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNE 575 (797)
Q Consensus 501 ~el~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 575 (797)
.++.+....|.++||+|+||+||+|.... ..++.||||.+++.... ..++|++|+++++.++|||||+|+|.|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34455555677899999999999998653 34578999999886665 56789999999999999999999999999
Q ss_pred cCceeeeeecccCCchhhhcccC----------C----CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKN----------P----KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD 641 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~----------~----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~ 641 (797)
++..+||+|||.+|+|.+||... . +++..+.+.||.|||.||+||.++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999532 2 277889999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccc-ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhh
Q 003759 642 DSFTARISDFGLAKIL-KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMI 719 (797)
Q Consensus 642 ~~~~~kl~Dfgla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 719 (797)
++..+||+||||++.. ..+..+....-.-..+|||||.|...+||.+||||||||+|||++| |+.|+.+...++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 9999999999999864 3443333323335779999999999999999999999999999999 999998765543
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
+-..+..+++....+..+ .++..|.+.||+.+|++||+++||-..|+......
T Consensus 714 ----VIe~i~~g~lL~~Pe~CP---------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ----VIECIRAGQLLSCPENCP---------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ----HHHHHHcCCcccCCCCCC---------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 223344555544444444 34566777899999999999999999998865544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=376.89 Aligned_cols=270 Identities=24% Similarity=0.442 Sum_probs=222.0
Q ss_pred cccCHHHHHHHHHhhh-----------hhhCcccceeEEEEEEecCC--cEEEEEEEecccCCCc-hHHHHHHHHHhhcc
Q 003759 496 QIFSYKELEKATQGFK-----------DELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGG-DKEFRTEVNAIGQT 561 (797)
Q Consensus 496 ~~~~~~el~~~~~~f~-----------~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l 561 (797)
..++|+|--.|-..|. ++||.|.||.|++|.++..+ +..||||.++....+. ..+|+.|+.+|+++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 4578887777776664 35899999999999998544 4789999998765443 45899999999999
Q ss_pred CcCchhhhcccccccCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 562 ~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
+||||++|.|+.......+||.|||+||+|+.||+.+ .++.+.+...+..+||.||.||.+. ++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheee
Confidence 9999999999999999999999999999999999866 6799999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCccccccCCCcccc--cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccch
Q 003759 641 DDSFTARISDFGLAKILKADQTRTTT--AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQ 717 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 717 (797)
+.+...||+||||++.+..+.....+ .-.-..+|.|||.+...++|.++||||||++|||.++ |.+|+-.....+ .
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-V 843 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-V 843 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-H
Confidence 99999999999999988666532222 2234578999999999999999999999999999888 999986554322 1
Q ss_pred hhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 718 MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
...++ ++ .+--.++.....+.+|++.|||+|-.+||.+.+|+.+|++++..|
T Consensus 844 IkaIe-------~g---------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 844 IKAIE-------QG---------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHH-------hc---------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 11111 11 111123344556788999999999999999999999999866543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.42 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=203.1
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchHHHHHHHHHhhccCcCchhhhcc-cccccCc-e
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDKEFRTEVNAIGQTNHRNLVKLLG-FCNEDQH-R 579 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g-~~~~~~~-~ 579 (797)
..+.+.+.++||+|.||+|||+....++ ..||.|.+.-. .....++...|+.+|++|+|||||++++ -+.++++ .
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g-~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDG-KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCc-chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3455677889999999999999887654 46999988632 2233356889999999999999999999 4555555 8
Q ss_pred eeeeecccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 580 LLVYEFISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECT-TQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
+|||||+..|+|...++ ..+.+++..+++++.|++.||.++|.... .-|+||||||.||+|+++|.+||+||||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999885 34678999999999999999999998421 23999999999999999999999999999
Q ss_pred cccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
+.+..... .....+|||.||+||.+...+|+.|+||||+||++|||...+.||.+.. ...+.. .+..+...
T Consensus 176 r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----~~~L~~----KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----LLSLCK----KIEQGDYP 246 (375)
T ss_pred hHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----HHHHHH----HHHcCCCC
Confidence 98876543 3445679999999999999999999999999999999999999998762 122211 12222222
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.+ ........+..++..|+..||+.||+...+++.+.
T Consensus 247 ~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 PL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11 11223345666778899999999999655555443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.41 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=205.5
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccccc
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNED 576 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 576 (797)
.+.|+......+.+.||+|.||+||+|.+-.+ ||||++...... ..+.|++|+..+++-+|.||+-+.|||.++
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd----VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD----VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc----eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34445555555678899999999999999642 999999764443 346799999999999999999999999998
Q ss_pred CceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 577 QHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
.. .||..++++.+|+.+|+-. ..+...+.++||.|||+||.|||.+ +|||+|||..||+|.++++|||+||||+.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 88 9999999999999999854 5788889999999999999999998 99999999999999999999999999987
Q ss_pred ccccC-CCcccccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 656 ILKAD-QTRTTTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 656 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
.-..- .........|...|||||++.. .+|++.+||||||+++|||+||..||..... ++...+ +.+-....
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifm--VGrG~l~p 612 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFM--VGRGYLMP 612 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEE--ecccccCc
Confidence 54322 1122223347889999999953 4799999999999999999999999983221 111110 00000001
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
++..+. ......+.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 613 d~s~~~---------s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSKIR---------SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchhhh---------ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111 1122356677888999999999999999999988766
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=315.36 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=204.5
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
..++|+|+||+|||.+.+++++ .||||++-.... ...+-..+|+++|++++|+|+|.++.+|......+||+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~Tgq-IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQ-IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCccc-EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 4579999999999999987654 699999965432 2234568899999999999999999999999999999999998
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
.-|.++-+.....+.....+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+... ...-+..
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTDY 161 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTDY 161 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhhh
Confidence 87777766667788899999999999999999998 9999999999999999999999999999988752 2334455
Q ss_pred cccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh-------hc-cccccccccc
Q 003759 669 RGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC-------YI-DEKLHLLVEN 739 (797)
Q Consensus 669 ~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~~~ 739 (797)
+.|.-|+|||.+.+ .+|....||||.||++.||++|.+.|.+.++-++...+....... +. .+.+..+.-+
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 67999999999987 689999999999999999999999998887665544333221111 10 1111111111
Q ss_pred hhhhh-----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 740 DEEAL-----HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 740 ~~~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.++.. .-+....-+++++..|++.||.+|++-++++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111 11111235788999999999999999998874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.26 Aligned_cols=264 Identities=23% Similarity=0.264 Sum_probs=207.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhccccccc--Cceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E 584 (797)
.-.++||+|.||.||||+....++ .||+|+++-.. .+......+|+.+|++|+||||++|.+...+. ...|||+|
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgk-ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGK-IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCc-EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 335689999999999999886655 59999987544 33445678899999999999999999988776 68999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||++ +|.-++... -.++..++..++.|++.||+|+|.+ +|+|||||.+|||||.+|.+||+|||||+++......
T Consensus 199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9977 566666553 4789999999999999999999998 9999999999999999999999999999998887777
Q ss_pred ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH----hhhcccccc--cc
Q 003759 664 TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----DCYIDEKLH--LL 736 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~--~~ 736 (797)
..+..+-|.-|+|||++.+. .|+.+.|+||.||||.||+.|++.+.+..+.++...+...-. ..+...++. ..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 77777789999999999875 699999999999999999999999998877665443332110 011101111 11
Q ss_pred c---cchhhhhhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 V---ENDEEALHD--MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~---~~~~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+ .+..+.+.+ ..-....++|+..+|..||.+|.|+.++++.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 111111111 1112456778888999999999999998853
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.39 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=199.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC--ceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ--HRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~Ey 585 (797)
....+.||+|+||+||++...+. +...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~-g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKT-GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhccccCccceEEEEEEecCC-CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34467899999999999998764 3459999987653333566899999999999999999999855444 68999999
Q ss_pred ccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCcccccc--CC
Q 003759 586 ISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKA--DQ 661 (797)
Q Consensus 586 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~--~~ 661 (797)
+++|+|.+++.+.. .+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999998766 799999999999999999999998 9999999999999999 79999999999987763 22
Q ss_pred CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
........||+.|||||++.+. ....++|||||||++.||+||+.||..... ..++............+.+.
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~------~~~~~~~ig~~~~~P~ip~~- 247 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE------EAEALLLIGREDSLPEIPDS- 247 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc------hHHHHHHHhccCCCCCCCcc-
Confidence 2334457799999999999963 334599999999999999999999976411 11111111111111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
-.....+++..|++.||++|||++++++..-
T Consensus 248 --------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 248 --------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --------cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1134556788899999999999999998763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=337.05 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=201.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
++||+|+.|.||.|.....+ ..||||++........+-+.+|+.+|+..+|+|||++++-+..+++.|+|||||++|+|
T Consensus 279 ~kigqgaSG~vy~A~~~~~~-~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTK-QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeeeeccCC-ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 57999999999999877554 46999999876656666789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccccc
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
.+.+.+ ..+++.++..|..++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+........ ..+||
T Consensus 358 TDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~-TmVGT 432 (550)
T KOG0578|consen 358 TDVVTK-TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS-TMVGT 432 (550)
T ss_pred hhhhhc-ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc-cccCC
Confidence 999854 4488999999999999999999998 999999999999999999999999999988776655433 44699
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH-HHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM-MRL 750 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 750 (797)
|.|||||++....|.+|.||||||++++||+-|++||-....-.....+ ...+.. .+... .-.
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------a~ng~P---------~lk~~~klS 496 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTP---------KLKNPEKLS 496 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------hhcCCC---------CcCCccccC
Confidence 9999999999999999999999999999999999999653221111111 011111 11111 112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 751 KKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 751 ~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+.+++.+||+.|+++||++.|+|+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 356678889999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=370.83 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=208.4
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc----EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK----ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~----~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
..-.+.+.||+|+||.||.|...+..+ ..||||.+++... +...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 333445679999999999999875543 4599999987544 34468999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC-------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 581 LVYEFISNGCLAGFLFKN-------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
|++|||++|+|..+|++. ..++....+.++.+||+|+.||+++ +.|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999865 3578889999999999999999998 999999999999999999999999999
Q ss_pred cccc-ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccc
Q 003759 654 AKIL-KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 654 a~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
|+.+ ..+..+......-...|||||.+....++.|+|||||||+|||++| |..||......+- .. .....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v----~~---~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV----LL---DVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH----HH---HHHhCC
Confidence 9944 3333333222234578999999999999999999999999999999 7888865543321 11 111222
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
++. .+....+++.+|+..||+.+|++||++..|++.++.+..
T Consensus 922 RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 222 122344567788999999999999999999998877554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.28 Aligned_cols=239 Identities=26% Similarity=0.303 Sum_probs=196.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||+||.++.++. ++.+|+|++++... ...+...+|..+|.+++||.||++.-.|++++..|||+||
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt-~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDT-GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeccCCceEEEEEEccc-CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 3467899999999999988854 45699999976432 2345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+.||.|..+|++...+++....-++..|+.||.|||++ +||||||||+|||||++|.++|+||||++...... ...
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t 182 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DAT 182 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Ccc
Confidence 99999999999999999999999999999999999998 99999999999999999999999999998654332 334
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
..+.||+.|||||++.+..++..+|.||+|+++|||++|.+||......+.. +.+..+++.....
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~--------~~I~~~k~~~~p~------- 247 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY--------DKILKGKLPLPPG------- 247 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH--------HHHhcCcCCCCCc-------
Confidence 4478999999999999999999999999999999999999999876443221 1111222111000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRP 769 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RP 769 (797)
.......+++...++.||++|-
T Consensus 248 --~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 --YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --cCCHHHHHHHHHHhccCHHHhc
Confidence 0112345677778999999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=325.07 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=205.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.|++.++||.|.-++||+|.....++ .||||++.-..... .+.+++|+..++.++||||++++..|..+...|+||.|
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e-~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNE-VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCC-EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 46667899999999999999887774 69999996544333 47899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|.+||+.+++... ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||....+.....+
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999754 5588999999999999999999998 9999999999999999999999999987655433222
Q ss_pred c---cccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 664 T---TTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 664 ~---~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
. ...++||+.|||||++.. ..|+.|+||||||++..||.+|..||......+- .+. .+ .+....+..
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~-----tL-qn~pp~~~t 254 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLL-----TL-QNDPPTLLT 254 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHH-----Hh-cCCCCCccc
Confidence 1 145679999999999643 4699999999999999999999999976643321 111 01 111111111
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..............+.+++..||+.||++|||++++++.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 112222233333467888999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=343.01 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=199.6
Q ss_pred HHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccC-
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ- 577 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~- 577 (797)
...+.+.+.||+|+||.||+|.... ..+..||||++..... ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 3455667889999999999997532 2235699999875432 2235689999999999 8999999999887644
Q ss_pred ceeeeeecccCCchhhhcccC-----------------------------------------------------------
Q 003759 578 HRLLVYEFISNGCLAGFLFKN----------------------------------------------------------- 598 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 598 (797)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988642
Q ss_pred ---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cccccccccCcc
Q 003759 599 ---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGY 674 (797)
Q Consensus 599 ---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y 674 (797)
..+++...+.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++....... .......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2366778889999999999999998 999999999999999999999999999986543322 112223456789
Q ss_pred ccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHH
Q 003759 675 VAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKY 753 (797)
Q Consensus 675 ~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (797)
+|||++.+..++.++||||||+++|||++ |..||......+. + ......+....... .....+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~~~~~---------~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---F----CQRLKDGTRMRAPE---------NATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---H----HHHHhcCCCCCCCC---------CCCHHH
Confidence 99999999899999999999999999997 9999976432211 1 01111111111000 112346
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 754 VMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 754 ~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.+++..||+.||++|||+.||+++|+.+.+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 788999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.44 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=209.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH-HHHHHHHHhhccC-cCchhhhcccccccC-ceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTN-HRNLVKLLGFCNEDQ-HRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~-~f~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lV 582 (797)
..|...++||.|.||+||+|+-...++. ||||+.++....-++ .=++|++.|++++ ||||+++.+++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~-VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGEL-VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCce-eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4577788999999999999998876664 999999765443222 2367999999998 999999999998877 99999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+ .+|+.++.++ ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||||+.+....
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 99995 5789888755 6789999999999999999999998 99999999999999999999999999999775433
Q ss_pred CcccccccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc---------
Q 003759 662 TRTTTAIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE--------- 731 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 731 (797)
+.+..+.|+-|+|||++. ..-|+.+.|+|++|||++|+.+-++.|.+..+.++-..+.+....-..+.
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 345566899999999874 56789999999999999999999999998877765555544322111000
Q ss_pred ----cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 732 ----KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 732 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
++..........+... ...++++++..|++.||.+|||++|.+++-
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0111111111222222 446788999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.54 Aligned_cols=245 Identities=29% Similarity=0.475 Sum_probs=199.4
Q ss_pred cCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC
Q 003759 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 498 ~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 577 (797)
..+++|.. .+=||.|+.|.||.|++.. ..||||+++... ..+++-|++|+|+||+.+.|+|....
T Consensus 121 iPFe~IsE-----LeWlGSGaQGAVF~Grl~n---etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 121 IPFEEISE-----LEWLGSGAQGAVFLGRLHN---ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred CCHHHhhh-----hhhhccCcccceeeeeccC---ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 44555543 2459999999999999963 349999987532 24788899999999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
.+||||||+..|.|..+|+....+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999999999999999999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
... .....+.||..|||||++++.+.++|+|||||||||||||||..||........ +|.. -...+...+
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGV-GsNsL~Lpv 332 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGV-GSNSLHLPV 332 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEec-cCCcccccC
Confidence 543 344557799999999999999999999999999999999999999976533211 1110 011111111
Q ss_pred -cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 738 -ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 738 -~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
...++ -+.-+++.||+..|..||++++|+..|+
T Consensus 333 PstcP~---------GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 333 PSTCPD---------GFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cccCch---------HHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 11122 2333567799999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.60 Aligned_cols=264 Identities=28% Similarity=0.396 Sum_probs=207.9
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCc--EE-EEEEEecc---cCCCchHHHHHHHHHhhccCcCchhhhcccccccC
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENK--IC-VAVKKLDN---MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~--~~-vavK~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 577 (797)
.+..-.+.++||+|+||.||+|++...+. .. ||||..+. ......++|.+|++++++++|||||+++|++...+
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 33333445789999999999999987644 23 89999875 22344568999999999999999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..++|||++.+|+|.++|.+.+ .++..+++.++.+.|.||+|||++ +++||||..+|+|++.++.+||+||||++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999999876 599999999999999999999998 999999999999999999999999999875
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
-... ........-...|+|||.+....++.++|||||||++||+.+ |..|+.+....+... ++ ...+....
T Consensus 312 ~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~----kI---~~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA----KI---VKNGYRMP 383 (474)
T ss_pred Ccce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH----HH---HhcCccCC
Confidence 4311 111111235678999999999999999999999999999999 888997764432111 11 01111111
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
.... ....+..+...|++.+|++||+|.+|.+.|+.+.....+
T Consensus 384 ~~~~---------~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 IPSK---------TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCC---------CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111 122344566689999999999999999999876655443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.53 Aligned_cols=268 Identities=25% Similarity=0.410 Sum_probs=215.1
Q ss_pred HHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch-HHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 500 ~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
..|+.+..-.|.++||+|.||.|....... ...||||.++....... .+|.+|+++|.+++||||++++|+|..++.
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecC--ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 456666666788999999999999988753 46799999987655444 789999999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 579 RLLVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
+++|+|||++|+|..++.++. ...-....+|+.||+.||+||.+. .+|||||.++|+|+|.++++||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999998763 334566778999999999999998 999999999999999999999999999995
Q ss_pred cc-cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh--CCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 657 LK-ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC--CRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 657 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
+- .+..+.....+-..+|||||.+...++|.++|||+||++|||+++ ...||....++. .++-+...+.+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----VVENAGEFFRDQGR 762 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----HHHhhhhhcCCCCc
Confidence 43 344444445567789999999999999999999999999999765 678887654432 22222222222222
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
...+. .+......+.++++.||..|-++||+++++...|....
T Consensus 763 ~~~l~------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 QVVLS------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ceecc------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 21111 12234456778999999999999999999999987643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.94 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=205.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|.||.||||+.+.+. ..||+|.+.+..+.. .+.+.+|+++++.++|||||.+++.|+...+.++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~-~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTI-QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccccce-eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 455688999999999999987654 569999998754432 34588999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+.+ +|..+|.....+++.....|+.++..||.|||+. +|+|||+||.|||++..+.+|++|||+|+.+... ....
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 977 9999999999999999999999999999999998 9999999999999999999999999999987653 3455
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
+.+.|||-|||||+..+.+|+..+|.||+||++||+.+|++||...... ..+.....++... ..
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~v~~-p~-------- 221 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDPVKP-PS-------- 221 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCCCCC-cc--------
Confidence 6678999999999999999999999999999999999999999654322 2222222221111 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+..++...+++||..|.+..+++..
T Consensus 222 --~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 --TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112345667777899999999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.44 Aligned_cols=272 Identities=21% Similarity=0.250 Sum_probs=207.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.-.+.||+|.||.||||++...++ .||||+++.... .......+|++.|+.++|+||+.+++.|...+..-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~-~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGK-RVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCc-EEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4445789999999999999876655 599999975422 2345678999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+ .+|+..++.+ ..++..+...++.++++|++|||.+ .|+||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 83 m~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 95 4788888765 5678889999999999999999998 99999999999999999999999999999887655433
Q ss_pred cccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc---cccccc--
Q 003759 665 TTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK---LHLLVE-- 738 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 738 (797)
... +-|.-|+|||.+.+. .|+...|+||.||++.||+-|.+-|.+..+-++-..+.+. .....+.. +..+.+
T Consensus 159 ~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~-LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA-LGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH-cCCCCcccCccccccccHH
Confidence 333 568899999988764 6999999999999999999999888877665443222211 11001110 000000
Q ss_pred -------chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003759 739 -------NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 739 -------~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~ 788 (797)
+.... .-......+++++..++..||.+|++++|++++= -....|.|.
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt 291 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPT 291 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCC
Confidence 00011 1111224568899999999999999999998763 344444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.23 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=197.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc--cCcCchhhhcccccccC----ceeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--TNHRNLVKLLGFCNEDQ----HRLLVY 583 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~ 583 (797)
+.+.||+|+||.||||.+.. +.||||++.. +....|++|-++.+. ++|+||+++++.-..+. +++||+
T Consensus 214 l~eli~~Grfg~V~KaqL~~---~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN---RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hHHHhhcCccceeehhhccC---ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 45789999999999999963 5699999975 345678888777665 58999999999876665 899999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC------TTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
||.+.|+|.++|. ...++|....+|+..+++||+|||+.. .++|+|||||++||||.+|++..|+|||||..+
T Consensus 288 ~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999994 456899999999999999999999763 578999999999999999999999999999988
Q ss_pred ccCCC-cccccccccCccccccccccCC-CC-----ccCceehHHHHHHHHHhCCcCCCccccccchhhHH---------
Q 003759 658 KADQT-RTTTAIRGTRGYVAPEWFKSLP-IT-----MKVDIYSFGVMLLELICCRKKFEQNVENENQMILV--------- 721 (797)
Q Consensus 658 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~t-----~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~--------- 721 (797)
..... ......+||.+|||||++.+.- +. .+.||||+|.|||||++...-.......+.+..+-
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 75443 2233367999999999997752 22 46899999999999999765443211111111000
Q ss_pred HHHHhhhc-cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 722 DWAYDCYI-DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 722 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
+-.+.... +.....+.+. -....-+.-+.+.+..||+.||+.|.|+.=|-+.+.++..+.
T Consensus 447 e~mq~~VV~kK~RP~~p~~----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDA----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhhccCCCChhh----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 00111111 1111111111 111123445778889999999999999999988887765554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=324.15 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=204.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
.+.||+|.||.||||.....++ .||+|++.-.... ..+++++|+.+|.+++++||.+++|.+..+...+++||||.+|
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k-~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKK-VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred chhccccccceeeeeeeccccc-eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 4789999999999999987654 5999999754333 3467899999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 669 (797)
++.+.|.....+.+....-|+.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+.....+. ..++
T Consensus 97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred chhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 9999998777778888888999999999999998 99999999999999999999999999999887666555 5677
Q ss_pred ccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHH
Q 003759 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMR 749 (797)
Q Consensus 670 gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (797)
|||.|||||+++...|+.|+||||||++.+||++|.+|+...........+ .......++. ..
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------pk~~PP~L~~--------~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------PKSAPPRLDG--------DF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------cCCCCCcccc--------cc
Confidence 999999999999889999999999999999999999999765442211111 1111111111 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 750 LKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 750 ~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..-+.+++..||++||+.||++.++++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2235567777999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.12 Aligned_cols=250 Identities=28% Similarity=0.315 Sum_probs=204.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 582 (797)
.+.|.+.||+|+|++|++|+....+ .++|||++.+... ...+-...|-.+|.+| .||.|++|+-.|.++..+|+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~-keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATG-KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hcchhheeccccceeEEEeeecCCC-ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4567899999999999999988754 5699999976322 2234567788899999 899999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+||+++|+|.++|.+-+.+++.....++.+|+.||+|||.. |||||||||+|||||+|+.+||+|||-|+.+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999998 999999999999999999999999999998754221
Q ss_pred c----------c--cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 663 R----------T--TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 663 ~----------~--~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
. . ...++||..|.+||++.....+..+|+|+|||+||+|+.|.+||....+-..-..++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-------- 301 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-------- 301 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--------
Confidence 1 1 1447899999999999999999999999999999999999999977543211111111
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
+--..++.. .+.+.+|+...|..||.+|+|..+|-+..
T Consensus 302 -----l~y~fp~~f-----p~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 -----LDYEFPEGF-----PEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----hcccCCCCC-----CHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 000111111 13456677888999999999999988754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.99 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=203.0
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
....+.+.+.||+|+||.||+|++.. ..+..||+|.++..... ..+.|.+|+.++.+++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34556677899999999999998753 33567999998764322 2356899999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 5789999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ +... ..++......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~~----~~~~~~~~~~- 230 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIKA----VEDGFRLPAP- 230 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH----HHCCCCCCCC-
Confidence 22111222235678999999999999999999999999999775 999996543221 1111 1111110000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......+.+++..||+.+|++||++++|++.|+++
T Consensus 231 --------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 --------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01123466788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=337.51 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=200.3
Q ss_pred HHHHhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 578 (797)
...+.+.+.||+|+||.||+|+.. .+.+..||||+++.... ...+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 445667889999999999999752 23345799999875332 2345688999999999 89999999999999999
Q ss_pred eeeeeecccCCchhhhcccC------------------------------------------------------------
Q 003759 579 RLLVYEFISNGCLAGFLFKN------------------------------------------------------------ 598 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 598 (797)
.++||||+++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999888532
Q ss_pred ---------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 599 ---------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 599 ---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
..+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1367788899999999999999998 9999999999999999999999999999866433221
Q ss_pred -ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 664 -TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 664 -~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
......++..|+|||.+.+..++.++||||||+++|||++ |..||........ .... +..+..... +
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~~----~~~~~~~~~--~-- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYKM----IKEGYRMLS--P-- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHHH----HHhCccCCC--C--
Confidence 1122335668999999999999999999999999999998 8888865432211 1111 111110000 0
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.....++.+++..|++.||++||+|.||+++|++.
T Consensus 340 -----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 -----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.24 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=196.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccc----cCceeeeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLLVYE 584 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~E 584 (797)
..||+|++|.||+|.+. +..||||+++...... .+.|.+|+.++++++||||++++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEEC---CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 36899999999999983 4569999997654333 3567899999999999999999999866 346789999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++...+.++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++.+....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999998888899999999999999999999973 278899999999999999999999999988654321
Q ss_pred cccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 665 TTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. .. ............
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~----~~----~i~~~~~~~~~~---- 244 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI----YD----LIINKNNSLKLP---- 244 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH----HH----HHHhcCCCCCCC----
Confidence 22347889999999976 6799999999999999999999999976432211 11 110010000010
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
......+.+++..||+.||++|||++||++.|+.+.
T Consensus 245 ----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 ----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011234667889999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.31 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=202.5
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc----CC-CchHHHHHHHHHhhccC-cCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM----VS-GGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~----~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|.||+|+.|.....+ ..||+|.+++. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~-~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTG-EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCC-CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34566788999999999999887655 46999977653 11 23456778999999998 99999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILK 658 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~ 658 (797)
++||||+.+|+|.+++.+..++.+.....++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999988999999999999999999999998 99999999999999999 999999999999774
Q ss_pred cCCCcccccccccCccccccccccCC-CC-ccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLP-IT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ....+..+.....
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------LYRKIRKGEFKIP 243 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------HHHHHhcCCccCC
Confidence 2233445567999999999999987 85 88999999999999999999998732211 1111222221110
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
.... ...+..++..|++.||.+|+++.+|+
T Consensus 244 -----~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 244 -----SYLL----SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -----CCcC----CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0000 23456788889999999999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=374.51 Aligned_cols=269 Identities=27% Similarity=0.480 Sum_probs=207.6
Q ss_pred cCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC
Q 003759 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 498 ~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 577 (797)
++++++..+ ....+.||+|+||.||+|+.... +..||||+++..... ..+|++.+++++|||||+++++|.+++
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKN-GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCC-CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 344444432 22345799999999999998654 456999998753222 234688899999999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
..++||||+++|+|.++++ .++|.++.+|+.|+++||+|||..+.++|+||||||+||+++.++.+++. ++.+...
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999999999999995 37899999999999999999997777799999999999999999988876 6665443
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
... ....+++.|+|||++.+..++.++|||||||++|||+||+.|+...... ...+.+|++............
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhhee
Confidence 221 1224789999999999999999999999999999999999999543222 223445554433333333333
Q ss_pred cchhhh--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 738 ENDEEA--LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 738 ~~~~~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
++.... .....+..++.+++.+|++.||++||+|+||+++|+++..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 332211 1233455678899999999999999999999999998755
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.34 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=198.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEec---------------CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhh
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY---------------ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKL 569 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~---------------~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l 569 (797)
..+.+.++||+|+||.||++.+.. +....||+|.+...... ...+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 445667889999999999998643 22346999998754322 33579999999999999999999
Q ss_pred cccccccCceeeeeecccCCchhhhcccC-------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeee
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKN-------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIH 630 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 630 (797)
++++.+.+..++||||+++++|.+++... ..+++...+.++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999988532 2357788999999999999999998 9999
Q ss_pred cCCCCCCEEEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh--CCcC
Q 003759 631 CDIKPQNILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC--CRKK 707 (797)
Q Consensus 631 ~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt--G~~p 707 (797)
+||||+|||+++++.+||+|||+++.+..... .......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543222 12222345788999999988899999999999999999987 4566
Q ss_pred CCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 708 FEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
|......+ .................... .......+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ----VIENAGEFFRDQGRQVYLFR------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH----HHHHHHHHhhhccccccccC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65432221 11111111111100000000 00112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.76 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=200.4
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccccC
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 577 (797)
....+.+.+.||+|+||.||+|+.... ....||+|++...... ..+.+.+|+.+++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 344566778999999999999986422 2346999999754322 234688999999999 8999999999999999
Q ss_pred ceeeeeecccCCchhhhcccC-----------------------------------------------------------
Q 003759 578 HRLLVYEFISNGCLAGFLFKN----------------------------------------------------------- 598 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 598 (797)
..++||||+++|+|.+++.+.
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999988532
Q ss_pred -----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc-ccc
Q 003759 599 -----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-TTT 666 (797)
Q Consensus 599 -----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~ 666 (797)
..+++.+.++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1356778899999999999999998 9999999999999999999999999999765433221 111
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++..|+|||++.+..++.++||||||+++|||++ |+.||............ ...+........
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~------ 339 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-------VKRGYQMSRPDF------ 339 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-------HHcccCccCCCC------
Confidence 2235678999999998899999999999999999997 99999764332211111 011100000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++||++.+|+++|+++.
T Consensus 340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1234667888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.91 Aligned_cols=249 Identities=21% Similarity=0.350 Sum_probs=209.5
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH---HHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK---EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~---~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
+..|.|.+.||+|.||.|-+|..... ++.||||.+++.....+. .+.+|+++|..++||||+.++.+|+..+...|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~s-gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKS-GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccC-CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678889999999999999987543 467999999876555444 47899999999999999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||..+|.|++++.+.+.+++.+...++.||..|+.|+|.+ +++|||||.+|||||+|+++||+||||+-++..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 999999999999999999999999999999999999999998 999999999999999999999999999987654
Q ss_pred CcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....+.+.|+|-|.+||++.+.+| .+..|-|||||+||.|+.|..||++.+... ++ +.+..+...+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----lv----rQIs~GaYrE----- 272 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----LV----RQISRGAYRE----- 272 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----HH----HHhhcccccC-----
Confidence 344567789999999999999998 588999999999999999999998764321 11 1111221111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
+.......-++.|||-.||++|.|+.+|...-
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11223345688999999999999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.00 Aligned_cols=265 Identities=20% Similarity=0.230 Sum_probs=200.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+++.... +..||+|++..... ...+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKET-KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCC-CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 34567899999999999998754 45699999865322 2345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++.|..+......+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99988876665556788999999999999999999998 999999999999999999999999999987654333333
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH--------Hhhhccccccccc
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA--------YDCYIDEKLHLLV 737 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 737 (797)
....+++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... .............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 34568999999999998889999999999999999999999997654322111111100 0000000000000
Q ss_pred cch------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 END------EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~------~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+. ............+.+++..||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000000011245788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.98 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=192.1
Q ss_pred hhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.||.|.||.||+|.+. ...+..|+||.+...... ..++|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999998 223577999999653322 357899999999999999999999999988889999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-C
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-T 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~ 662 (797)
+++|+|.++|... ..+++.++..|+.||++||+|||+. +++|++|+++||+++.++.+||+|||++....... .
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 7789999999999999999999998 99999999999999999999999999998763222 1
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ +.... .++........
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~----~~~~~~~~~~~-- 229 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKL----KQGQRLPIPDN-- 229 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHH----HTTEETTSBTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc----cccccceeccc--
Confidence 22233346778999999999889999999999999999999 678876542211 11111 11111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
....+.+++..||+.||++||+|.+|++.|
T Consensus 230 -------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 -------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 123456788899999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.80 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=218.2
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
+--|+.+....+.++||-|.||.||.|+++... ..||||.++... -..++|++|+.+|+.++|||+|+|+|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys-lTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccc-eeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 445666666667889999999999999998654 459999998643 345789999999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 579 RLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
.|||+|||.+|+|.++|.+. ..++....+.+|.||+.||+||..+ .+|||||..+|+|+.++..+||+||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999864 3466677889999999999999998 999999999999999999999999999999
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
+..+.............|.|||.+....++.|+|||+|||+||||.| |..|+.+..-. .++..+..+-..+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLEKGYRMD 486 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHhcccccc
Confidence 98887766666667889999999999999999999999999999999 77888665321 2233332222222
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
-.+. +..++.++++.||+.+|.+||++.|+-+.+|.+.
T Consensus 487 ~PeG---------CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 GPEG---------CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCC---------CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 2222 3345677788899999999999999999987643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.54 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=203.9
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+....+.+.+.||+|++|.||+|.... ...||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN--TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC--CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 344556777899999999999998753 3469999987533 3457799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 583 YEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|||+++++|.+++.... .+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999997643 689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
..........+..|+|||++.+..++.++||||||++++||++ |+.||....... ... ..........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~----~~~~~~~~~~--- 225 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQ----QVDQGYRMPC--- 225 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH----HHHcCCCCCC---
Confidence 2222222223457999999999899999999999999999999 999986543211 111 1111100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.......+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 ------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001124567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.70 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=201.9
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+|+....+ ..|++|.+... ....+++.+|++++++++|+||+++++++..++..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCC-ceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34556778999999999999987544 45999998753 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999998653 4578999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.......+..|+|||.+.+..++.++||||||+++|||++ |..|+......+. .. ............
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----~~----~~~~~~~~~~~~---- 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YE----LLEKGYRMERPE---- 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH----HHHCCCCCCCCC----
Confidence 2222234668999999999999999999999999999998 8889865432211 01 111100000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.....+.+++.+|++.+|++||++.+++++|+.+
T Consensus 229 -----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 -----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0123467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=294.69 Aligned_cols=260 Identities=25% Similarity=0.293 Sum_probs=205.4
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC-----cee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----HRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 580 (797)
.+|.+.++||+|||.-||.++.-..+ ..+|+|++.....++.+..++|++..++++|||+++++++...+. ..|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~-~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTG-HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcc-cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 34567789999999999998855443 469999998877677778899999999999999999999986544 489
Q ss_pred eeeecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 581 LVYEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
|+++|...|+|.+.+.. ...+++.+.+.|+.+|++||++||+. .+++.|+||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999864 34689999999999999999999997 34699999999999999999999999999876
Q ss_pred cccCCC--------cccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH
Q 003759 657 LKADQT--------RTTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725 (797)
Q Consensus 657 ~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (797)
...... ........|..|+|||.+. +..+++++|||||||+||+|+.|..||+...+.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------- 251 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------- 251 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-------
Confidence 532211 1122335789999999985 3467999999999999999999999997654422211
Q ss_pred hhhccccccccccc-hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 726 DCYIDEKLHLLVEN-DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 726 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
...+.+ ....-.+....+.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 252 --------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 --------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 0000001113456788999999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.26 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=200.6
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||.||+|+....+ ..||+|++..... ...+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTG-EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCC-CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 45678999999999999987544 4699999875321 2345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..... ..
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999999998878889999999999999999999998 999999999999999999999999999976543 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+..+.. .+........
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~---- 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TLQRPVYDDP---- 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------cccCCCCCcc----
Confidence 344589999999999999999999999999999999999999976543222111111100 0000000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..|++.+|++||++.++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01112356678889999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.03 Aligned_cols=240 Identities=25% Similarity=0.288 Sum_probs=191.9
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||.||++.....+ ..||+|++.... ......+..|+.++.+++||||+++++++.+++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ-RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999987554 469999986432 2234567889999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccc
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 670 (797)
|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 999998888899999999999999999999998 99999999999999999999999999987543222 22234568
Q ss_pred cCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHH
Q 003759 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750 (797)
Q Consensus 671 t~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (797)
|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ . ... ....... ... ...
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~---~~~-~~~~~~~-~~~---------~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----M---YRK-ILQEPLR-FPD---------GFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----H---HHH-HHcCCCC-CCC---------cCC
Confidence 999999999999999999999999999999999999997543211 1 111 1111110 000 011
Q ss_pred HHHHHHHHHhcccCCCCCCCH---HHHHH
Q 003759 751 KKYVMIAIWCIQEDPSLRPTM---KKVTL 776 (797)
Q Consensus 751 ~~~~~l~~~Cl~~dP~~RPs~---~eVl~ 776 (797)
..+.+++..||+.||++||++ .|++.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 345678889999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.15 Aligned_cols=242 Identities=25% Similarity=0.276 Sum_probs=194.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|+||.||+++....+ ..||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG-KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999987654 4699999875321 2234678899999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
++|.+++.....+++.+...++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 99999998888899999999999999999999998 9999999999999999999999999998753222 1222345
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. ....+... ... .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~----~~~~~~~~-~p~---------~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFE----LILMEEIR-FPR---------T 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHH----HHHcCCCC-CCC---------C
Confidence 68999999999999999999999999999999999999996543211 111 11111110 000 0
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123456788999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.65 Aligned_cols=248 Identities=25% Similarity=0.293 Sum_probs=195.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
..+.||+|+||.||++.....+ ..||+|.+..... .....+.+|+.++.+++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCC-ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3567999999999999987654 4699999864321 22346788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999998887543 4688999999999999999999998 99999999999999999999999999998654322 1
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+. ......... ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~-~~~------ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----RRVKEDQEE-YSE------ 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----HHhhccccc-CCc------
Confidence 233458999999999999999999999999999999999999997654322111111 111111100 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
.....+.+++..||+.||++||+ ++++++.
T Consensus 227 ---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 227 ---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01234567889999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=315.04 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=202.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||+||+|+.... ....||||.++..... ..++|.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 455678899999999999998643 2457999998754332 3457899999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++... ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999998654 4689999999999999999999998 999999999999999999999999999987752221
Q ss_pred -cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ........
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~---- 229 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAV----EDGYRLPP---- 229 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHH----HcCCCCCC----
Confidence 12222335678999999999899999999999999999998 999986543221 11111 11100000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
. ......+.+++.+|++.+|++||++.||+++|+++
T Consensus 230 ~-----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 P-----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.91 Aligned_cols=244 Identities=22% Similarity=0.267 Sum_probs=197.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISE-HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCC-CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 345678999999999999987554 4699999864321 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999865432
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. .....+.... +.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~--------~~i~~~~~~~-----~~-- 219 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY--------EKILAGKLEF-----PR-- 219 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHHhCCcCC-----Cc--
Confidence 12345899999999999989999999999999999999999999764322111 1111111110 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
.....+.+++..||+.||.+||+ ++++++.
T Consensus 220 ---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 ---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00124567889999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.32 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=198.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
..+.++||+|+||.||++.... +..+|+|.+... ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred cEEeeEecCCcCceEEEEEecc--CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4456789999999999998754 345999988643 2345689999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+|+|.+++... ..+++..+..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||++............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999998753 4688999999999999999999998 9999999999999999999999999998865433322222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+... ..+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~----~~~i----~~~~~~--~~~------ 223 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV----VEMI----SRGFRL--YRP------ 223 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH----HCCCCC--CCC------
Confidence 3335668999999998889999999999999999999 8899865432211 1111 111100 000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 224 -~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 -KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001235678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.31 Aligned_cols=199 Identities=25% Similarity=0.355 Sum_probs=172.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||+++....+ ..||+|.+..... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCC-cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 3445678999999999999987544 5699999875422 2235789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++..+..++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---c
Confidence 99999999998878889999999999999999999985 269999999999999999999999999987653321 2
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
....+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2345899999999999989999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.75 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=202.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCC----cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYEN----KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
...+.+.||+|+||.||+|...... ...|++|.+..... ....+|.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 3456788999999999999876443 25699999865332 223568999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc
Q 003759 582 VYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT 645 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 645 (797)
+|||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 99999999999998653 3467788899999999999999998 9999999999999999999
Q ss_pred EEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHH
Q 003759 646 ARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 646 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 723 (797)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ +..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----~~~- 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----VIE- 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH-
Confidence 99999999986533221 22233346788999999988899999999999999999998 999987643321 111
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.+..+...... .....++.+++..||+.||++||+++||++.|+++
T Consensus 238 ---~i~~~~~~~~~---------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 ---MIRSRQLLPCP---------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---HHHcCCcCCCc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111 11224567889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.93 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=201.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN--STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC--CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 344556889999999999998753 3459999886532 2356899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++.+. ..+++.+++.++.+++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999998653 5678889999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......++..|+|||++....++.++||||||+++|+|+| |+.||......+. ..... ..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~----~~~~~----~~~~~~~~~~--- 228 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV----MSALQ----RGYRMPRMEN--- 228 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH----HHHHH----cCCCCCCCCC---
Confidence 2233345678999999988889999999999999999998 9999865432211 11111 1100000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
....+.+++.+|++.+|++||+++++.++|+++
T Consensus 229 ------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 229 ------CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 113467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.95 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=200.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
..+.+.+.||+|+||.||+|+....+...||+|++.... ....+.+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 345667889999999999999876555679999986432 22345688999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++|+|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999999999998888899999999999999999999998 9999999999999999999999999999865432
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+.... +.
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--------~~~i~~~~~~~-----p~ 249 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--------YQKILEGIIYF-----PK 249 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--------HHHHhcCCCCC-----CC
Confidence 2234589999999999998899999999999999999999999976432211 11111111110 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
. ....+.+++..|++.||++|+ +++++++.
T Consensus 250 ~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 F-----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C-----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 012345788899999999995 89988765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.21 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=205.4
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+..+.+.++||+|+||.||+|.... +..+++|.+.........++..|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456678899999999999999876 44699999987655456789999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+++++|.+++.+. ..+++.++..++.+++.||.|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 4678999999999999999999998 999999999999999999999999999987644322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.. ....++..|+|||.+.+..++.++||||||+++++|++ |+.||......+ ...... .+.....
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----~~~~~~----~~~~~~~----- 225 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQIT----AGYRMPC----- 225 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHH----hCCcCCC-----
Confidence 22 23345678999999988889999999999999999998 889996543221 111111 1100000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.......+.+++.+|++.||++|||+.++++.|+++
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.14 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=206.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||.|+-|.|-.|++..++ +.+|||.+.+... .....+..|+-+|+.+.|||++++++++++..++|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TG-qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETG-QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhccccc-ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 345678999999999999998654 4699999976522 223457889999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|-|.++|.+++++++.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-.. ...
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence 999999999999999999999999999999999999998 999999999999999999999999999976433 233
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
...-+|+|.|.|||++.+.+| ..++||||+|||||.||||+.||+++.-. .+. ..+..|..+.. ...
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir----~LL----lKV~~G~f~MP-s~I--- 235 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR----VLL----LKVQRGVFEMP-SNI--- 235 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH----HHH----HHHHcCcccCC-CcC---
Confidence 445579999999999999998 58899999999999999999999743211 111 11122222211 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCC
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPI 786 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~ 786 (797)
..++-+++..|+..||++|.|+.||++. |.+-..++.
T Consensus 236 ------s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 236 ------SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred ------CHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 1234567788999999999999999986 344444443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.67 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=200.2
Q ss_pred HHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhccC-cCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+|+.... ....||||+++..... ..+.|.+|+++++++. ||||++++++|.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 3455678999999999999986422 2346999999754332 2356899999999995 99999999999999999
Q ss_pred eeeeecccCCchhhhcccC-------------------------------------------------------------
Q 003759 580 LLVYEFISNGCLAGFLFKN------------------------------------------------------------- 598 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------- 598 (797)
+|||||+++|+|.++|.+.
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999887532
Q ss_pred -----------------------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 599 -----------------------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 599 -----------------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
..+++..++.++.|+++||+|||+. +|+|+||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 1356777889999999999999998 99999999999999999
Q ss_pred CcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHH
Q 003759 644 FTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILV 721 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 721 (797)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---- 349 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---- 349 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH----
Confidence 99999999999865433221 1222346778999999998899999999999999999997 88998654322111
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
......+..... .......+.+++..||+.||++||++.+|+++|+.+..
T Consensus 350 ---~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ---YNKIKSGYRMAK---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHhcCCCCCC---------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 011111100000 00112356788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.71 Aligned_cols=192 Identities=23% Similarity=0.290 Sum_probs=167.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||.||++.....+ ..||+|... .+.+.+|+.++++++||||+++++++..+...++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~-~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTC-EHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCC-CEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 555678999999999999987654 459999753 2457889999999999999999999999999999999985
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 78888887777889999999999999999999998 99999999999999999999999999997543322223334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCc
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQ 710 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~ 710 (797)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 5699999999999998999999999999999999999988754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.32 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=174.8
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
|....+.+.++||+|+||.||++.....+ ..+|+|.+..... ...+++.+|++++++++|+||+++++++.+++..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCC-cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 33455667789999999999999987544 4589998875422 223568999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++++|.+++.+...+++.....++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999999998877888999999999999999999974 279999999999999999999999999987653221
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
.....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22345889999999999988999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.94 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=197.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+++....+ ..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTG-EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCC-CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 456688999999999999987554 469999986532 1233568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 999999999998888889999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ......+.... .. .
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------~~~i~~~~~~~--p~---~- 237 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--------YEKILAGRLKF--PN---W- 237 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--------HHHHhcCCcCC--CC---C-
Confidence 234589999999999999999999999999999999999999965432111 11111111110 00 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
...++.+++..||+.||++||+ +.+++..
T Consensus 238 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 ----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1124567889999999999997 6777644
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.82 Aligned_cols=261 Identities=24% Similarity=0.299 Sum_probs=192.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc---CcCchhhhccccc-----ccC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT---NHRNLVKLLGFCN-----EDQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 577 (797)
|.+.+.||+|+||.||+|+....++..||+|+++..... ....+.+|+.+++.+ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 455678999999999999986555667999998653322 234566777777665 6999999999874 345
Q ss_pred ceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..++||||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 6888888643 4578899999999999999999998 99999999999999999999999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc-
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH- 734 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 734 (797)
..... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.+.... ..+....
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~ 235 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR 235 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChhhchh
Confidence 65433 2233445899999999998889999999999999999999999999865443322222111100 0000000
Q ss_pred ------ccccch----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 735 ------LLVEND----EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 735 ------~~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...... .+.. .......+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000 0011234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.85 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=204.7
Q ss_pred HHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
.+.+.+.||+|+||.||+++... .....+++|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 34456789999999999998643 23456899998765544456799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcE
Q 003759 583 YEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA 646 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~ 646 (797)
|||+++++|.+++... ..+++..++.++.+|+.||+|||++ +|+|+||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 9999999999998643 2378899999999999999999998 99999999999999999999
Q ss_pred EEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHH
Q 003759 647 RISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWA 724 (797)
Q Consensus 647 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 724 (797)
||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ..+
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~-- 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIE-- 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH--
Confidence 9999999976543221 22223346788999999999899999999999999999999 999986543221 111
Q ss_pred HhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+....... .....+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 237 --~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 --CITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HHhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111111 112356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.97 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=204.0
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
...++.+.+.||+|+||.||+|..... ....||||.+...... ..+.|.+|++++.+++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 345677789999999999999987532 2357999998765443 34689999999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccC--------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 579 RLLVYEFISNGCLAGFLFKN--------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
.++||||+++++|.+++... ..+++.....++.+++.|++|||+. +++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 99999999999999998643 2467888899999999999999998 999999999999999999
Q ss_pred cEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHH
Q 003759 645 TARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVD 722 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 722 (797)
.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~ 235 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIE 235 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH
Confidence 999999999976533221 11223335778999999999999999999999999999999 999986543321 111
Q ss_pred HHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 723 WAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. ..+....... .....+.+++..||+.||++||++.||++.|++
T Consensus 236 ~~----~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CI----TQGRLLQRPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH----HcCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 1111111111 112346788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.92 Aligned_cols=242 Identities=25% Similarity=0.269 Sum_probs=194.7
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
.||+|+||.||++..... +..||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 2 LLGKGTFGKVILVREKAS-GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred eeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999988654 45699999975322 23356788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 669 (797)
+|.+++.....+++.+...++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 9999998878899999999999999999999998 99999999999999999999999999987543221 1223356
Q ss_pred ccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHH
Q 003759 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMR 749 (797)
Q Consensus 670 gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (797)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .. ........ +.. ..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----~~----~~~~~~~~-~p~---------~~ 218 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FE----LILMEDIK-FPR---------TL 218 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----HH----HhccCCcc-CCC---------CC
Confidence 89999999999998999999999999999999999999965432211 00 00011110 000 01
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 750 LKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 750 ~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
...+.+++..||+.||++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23456788899999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.29 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=200.3
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccc-cC
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNE-DQ 577 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~~ 577 (797)
...+.+.+.||+|+||.||+|..... ....||+|+++..... ..+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34567788999999999999975432 2357999998754322 234678899999999 89999999998764 45
Q ss_pred ceeeeeecccCCchhhhcccC-----------------------------------------------------------
Q 003759 578 HRLLVYEFISNGCLAGFLFKN----------------------------------------------------------- 598 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 598 (797)
..++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999888532
Q ss_pred --CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cccccccccCccc
Q 003759 599 --PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYV 675 (797)
Q Consensus 599 --~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ 675 (797)
..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578889999999999999999998 999999999999999999999999999987643322 1222334667899
Q ss_pred cccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHH
Q 003759 676 APEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYV 754 (797)
Q Consensus 676 aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (797)
|||++.+..++.++|||||||++|||++ |..||......+. +. .....+..... .......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC----RRLKEGTRMRA---------PEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH----HHHhccCCCCC---------CccCCHHHH
Confidence 9999999999999999999999999998 9999865432211 10 01111111000 001124567
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 755 MIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 755 ~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
+++.+|++.+|++||++.||+++|+.+.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 88999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=326.89 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=200.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+|.....+ ..||+|++.... ......+.+|++++..++|+||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTG-QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCC-CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 345678999999999999987544 469999987532 1334568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC---
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ--- 661 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~--- 661 (797)
|+++++|.+++.+...++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998665433
Q ss_pred -------------------------CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc
Q 003759 662 -------------------------TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN 716 (797)
Q Consensus 662 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~ 716 (797)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 1122334589999999999999999999999999999999999999976543222
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT-MKKVTLM 777 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~eVl~~ 777 (797)
...+..+. .......... ....+.+++..|++ ||.+||+ +.++++.
T Consensus 239 ~~~i~~~~------~~~~~p~~~~--------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWK------ESLRFPPDPP--------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccC------CcccCCCCCC--------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111110 0000000000 12345677888997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=322.88 Aligned_cols=242 Identities=25% Similarity=0.262 Sum_probs=193.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|+||.||++..... +..||+|++..... .....+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 3589999999999988654 45699999875322 2234677899999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|+|..++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987532221 122334
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ........ . +. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~--------~~~~~~~~-~----p~-----~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--------LILMEEIR-F----PR-----T 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH--------HHhcCCCC-C----CC-----C
Confidence 58999999999999899999999999999999999999996543221110 00011110 0 00 0
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123456788899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.58 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=199.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
..+...+.||+|+||.||+|++...++ ..||+|+++.... ...++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 344556789999999999998764433 3489999875332 3346789999999999999999999999875 5679
Q ss_pred eeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 582 VYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
++||+++|+|.+++... ..+++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999764 4688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcc-cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QTRT-TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+ +.... ..+.....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~----~~~~~~~~-- 232 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL----EKGERLPQ-- 232 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH----hCCCCCCC--
Confidence 3221 122234668999999999999999999999999999998 999986543221 11111 11100000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
. ......+.+++..||+.+|++||++.+++..|..+..
T Consensus 233 ~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 P-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 0011345678899999999999999999999976544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.64 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=191.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC-----ceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----HRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~Ey~ 586 (797)
+.+|+|+||.||+|++... +..||||++-...+.. ..|+.+|+++.|||||+|+-+|.... ...+|||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeecccceEEEEEEcCC-CceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 5799999999999999876 4569999986543322 35899999999999999998875422 446899999
Q ss_pred cCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~ 661 (797)
+. +|++.+.. +..++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|+.+....
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 75 67777763 56778888889999999999999997 99999999999999976 899999999999887655
Q ss_pred CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH----hhhcc------
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----DCYID------ 730 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~~------ 730 (797)
.. .....|+.|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..++...+..... +.+..
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 44 334478899999988764 799999999999999999999999988665544333322111 00000
Q ss_pred -ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 -EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+...............+.++++..+++.+|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00111111100011112223467789999999999999999988854
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.71 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=199.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||+||+|.... +..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC--CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35567889999999999998753 3359999987532 34567999999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++... ..+++..++.++.+|+.||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999754 4689999999999999999999998 999999999999999999999999999886544332222
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ..+.......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~------ 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEKV----SQGLRLYRPH------ 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH----hcCCCCCCCC------
Confidence 22335678999999988889999999999999999999 999986543221 11111 1111100000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.....+.+++..||+.+|++||++.+|++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01245678899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.69 Aligned_cols=247 Identities=29% Similarity=0.399 Sum_probs=195.2
Q ss_pred hhCcccceeEEEEEEe-cCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 513 ELGRGAFATVHKGVLA-YENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~-~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
+||+|+||.||+|++. ...+..+|+|+++..... ..+++.+|+.+++.++|+||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999764 233567999998644322 2457899999999999999999999885 45678999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc--ccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT--TTA 667 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 667 (797)
+|.+++.....+++.....++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777889999999999999999999998 99999999999999999999999999998765433211 122
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..++..|+|||.+....++.++||||||+++|||++ |..||......+ +..... .+.......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~i~----~~~~~~~~~-------- 221 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMIE----SGERMECPQ-------- 221 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----CCCCCCCCC--------
Confidence 234578999999988889999999999999999998 999997543221 111111 111111101
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++.+|++.||++||++++|++.|++
T Consensus 222 -~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 -RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 112345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.40 Aligned_cols=259 Identities=25% Similarity=0.451 Sum_probs=204.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
..+.+.+.||+|+||.||++.... .....+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 344567889999999999997532 2345689999876544445679999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccC-------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 582 VYEFISNGCLAGFLFKN-------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 99999999999998633 2478999999999999999999998 9999999999999999999999
Q ss_pred EeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHh
Q 003759 649 SDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYD 726 (797)
Q Consensus 649 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (797)
+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ |..||......+ ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~---- 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIE---- 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----
Confidence 99999986543221 12222335678999999998899999999999999999999 888886543221 111
Q ss_pred hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
....+........ ....+.+++..|++.||.+|||+.||++.|+++...
T Consensus 234 ~i~~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQRPRT---------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCCCCC---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111110 113467899999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=293.82 Aligned_cols=196 Identities=30% Similarity=0.382 Sum_probs=178.0
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+...||.|+||.|...+.+.. +..+|+|++++...-. .+...+|..+|+.+.||.++++.+-+.+.+..+|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~-g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHS-GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEccC-CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 356899999999999998865 5679999997643322 245678999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|-|..+|++.++++.....-+|.+|+.||+|||+. +|++|||||+|||||.+|.+||+|||.|+..... .-
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 9999999999999999999999999999999999998 9999999999999999999999999999976543 45
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
...|||.|+|||.+..+++..++|-|||||++|||+.|.+||.....
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 57799999999999999999999999999999999999999987654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.51 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=193.9
Q ss_pred hhhCcccceeEEEEEEec--CCcEEEEEEEecccC----CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.||+|+||.||++.... ..+..||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 469999999999998643 235679999987532 12234578899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.+...+.+.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999999998888888889999999999999999998 999999999999999999999999999875432221 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....|++.|+|||++.+..++.++||||||+++|||++|+.||........ . .....+... + ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----~----~~~~~~~~~-~-~~------ 221 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----I----DKILKGKLN-L-PP------ 221 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----H----HHHHcCCCC-C-CC------
Confidence 334689999999999988899999999999999999999999976432211 0 111111110 0 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
.....+.+++..|++.||++|| ++.++++
T Consensus 222 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 --YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0113456788999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.40 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=194.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
|.+.++||+|+||+||+|.....+ ..||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCC-CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 445678999999999999887544 4699999865332 23456789999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++ +|.+++... ..+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 75 888888654 4578889999999999999999998 999999999999999999999999999876433221 22
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhc-ccccccc
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYI-DEKLHLL 736 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~ 736 (797)
....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... .... .......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23457899999998865 5689999999999999999999999976543322111111000 0000 0000000
Q ss_pred ccchh----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 VENDE----EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ~~~~~----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..+.. ...........+.+++..|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.70 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=207.2
Q ss_pred hhhhCcccceeEEEEEEecCCc---EEEEEEEeccc-CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 511 KDELGRGAFATVHKGVLAYENK---ICVAVKKLDNM-VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.++||+|+||+||||.+-..++ .+||+|++... ..+..++|++|+.+|.+++|||+++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 4689999999999999875543 67999998653 3345679999999999999999999999998876 88999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+.|+|.++++.+ ..+-.+..+.+..|||+||.|||++ +++||||..+|||+..-..+||.|||+++.+..+...-.
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999754 6788889999999999999999998 999999999999999999999999999999877654322
Q ss_pred -ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 666 -TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 666 -~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
....-.+.|||-|.+....++.++|||||||.+||++| |..|+++....+....+ ..+ .+-
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll--------e~g---------eRL 919 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL--------EKG---------ERL 919 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH--------hcc---------ccC
Confidence 22334678999999999999999999999999999999 99999877554432221 111 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
..+......+..++..||-.|+..||+++++...+.+.+
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 123334456777889999999999999999998886643
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.42 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=196.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+.||+|+||+||+|+....+. ..+++|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 345789999999999999864443 2478888764322 123567888889999999999999998864 45778999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|+++|+|.+++... ..+++.....++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999999754 5689999999999999999999998 999999999999999999999999999986543322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||....... +.+.. ..+.......
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~--- 234 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLL----EKGERLAQPQ--- 234 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH----HCCCcCCCCC---
Confidence 22233456778999999998899999999999999999998 999986543221 11111 1111110000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++..|++.||++|||+.|+++.|+.+..
T Consensus 235 ------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 011245667889999999999999999999988665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.00 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=198.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--------------chHHHHHHHHHhhccCcCchhhhcc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--------------GDKEFRTEVNAIGQTNHRNLVKLLG 571 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--------------~~~~f~~E~~~l~~l~h~niv~l~g 571 (797)
+.|.+.++||+|.||.|-+|.....+ ..||||++.+.... ..+..++|+.+|++++|||||+|+.
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~-~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDG-KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCC-cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 34566789999999999999887654 56999999753211 1246789999999999999999999
Q ss_pred cccc--cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 572 FCNE--DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 572 ~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
+..+ .+..|||+||+..|.+...=-....++..+.++++.++..||+|||.+ +||||||||+|+||+++|.+||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 9876 468899999999988765443333488999999999999999999999 99999999999999999999999
Q ss_pred eecCccccccC----CCcccccccccCccccccccccCC----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHH
Q 003759 650 DFGLAKILKAD----QTRTTTAIRGTRGYVAPEWFKSLP----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721 (797)
Q Consensus 650 Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 721 (797)
|||.+...... .........|||.|+|||...+.. ...+.||||+||+||.|+.|+.||..+...+.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l----- 327 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL----- 327 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-----
Confidence 99999866321 112233367999999999987632 36789999999999999999999977644322
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
+..+....+..... .+.-+.+.++++.+|++||+.|.+..+|....=-
T Consensus 328 ---~~KIvn~pL~fP~~--------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 328 ---FDKIVNDPLEFPEN--------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ---HHHHhcCcccCCCc--------ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 12222222221111 1233456678999999999999999999877643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.85 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=193.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.||+|+||.||+|+....+ ..||+|.+..... .....|.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCC-ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999987554 4699998765332 234579999999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc-cccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT-TTAI 668 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 668 (797)
|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99998654 4688999999999999999999998 99999999999999999999999999987644221111 1111
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..+..|+|||.+.+..++.++||||||+++|||++ |..||......... . ........... .
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~----~----~~~~~~~~~~~---------~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----E----AIEQGVRLPCP---------E 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH----H----HHHcCCCCCCc---------c
Confidence 23457999999998889999999999999999998 88888643321110 0 00000000000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.....+.+++..|++.+|++||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11235677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.60 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=197.5
Q ss_pred hhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccccc--Cceeee
Q 003759 509 GFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 582 (797)
.+.+.||+|+||+||++... ...+..||+|.++.... ...+.|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 55678999999999887642 22345799999875432 2346788999999999999999999987653 457899
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++++|.+++.+. .+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998654 589999999999999999999998 999999999999999999999999999986643222
Q ss_pred c--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 R--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 ~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
. ......++..|+|||.+.+..++.++||||||++++||++|..|+.......... .................+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM--IGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh--hcccccccchhhhhhhhhcC
Confidence 1 1122235667999999988889999999999999999999999986543211100 00000000000000000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
............+.+++..|++.+|++|||+++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000111245778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=306.97 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=197.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
..+.+.||+|+||.||++.... +..+|+|.+.... ....+|.+|++++++++|+||+++++++...+..++|+||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRG--KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEecC--CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4567899999999999998753 3458999986432 234578899999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999754 4678999999999999999999998 9999999999999999999999999998765433222222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ... ....... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~----~~~~~~~--~------- 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV----ESV----SAGYRLY--R------- 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH----HHH----HcCCcCC--C-------
Confidence 2224457999999998899999999999999999999 78888654322111 101 1110000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.......+.+++.+|++.+|++||||.||++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0012235678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.46 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=201.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
++.+.||+|.||.||.|+.+... -.||+|++.+.. .+.+.++.+|+++-..|+||||++++++|.+....||++||
T Consensus 25 eigr~LgkgkFG~vYlarekks~-~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSL-FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred cccccccCCccccEeEeeeccCC-cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 34678999999999999987654 469999986532 23456899999999999999999999999999999999999
Q ss_pred ccCCchhhhcc--cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLF--KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
.+.|.|...|. ...+++......++.|+|.||.|+|.. +++||||||+|+|++.++..||+|||.+..-. ..
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 99999999998 557789999999999999999999998 99999999999999999999999999987543 22
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||..|++||...+..++...|+|++|++.||++.|.+||+.....+....+ ..-++...
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--------~k~~~~~p------- 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--------RKVDLKFP------- 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--------HHccccCC-------
Confidence 234456999999999999999999999999999999999999999876533221111 11111100
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..-...+.+++..|+..+|.+|.+..||+..
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0111345678889999999999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.97 Aligned_cols=240 Identities=27% Similarity=0.348 Sum_probs=188.8
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.||+|+||.||+|+....+ ..||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTN-EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred eeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 6899999999999987554 469999987532 12234455666676654 899999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|+|..++.....++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999997643322 223345
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. . .+...... ... .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~----~----~i~~~~~~--~~~--------~ 218 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF----D----SILNDRPH--FPR--------W 218 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH----H----HHHcCCCC--CCC--------C
Confidence 6899999999999989999999999999999999999999765332111 1 00011000 000 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTMK-KVT 775 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~~-eVl 775 (797)
....+.+++..||+.||++||++. +++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112356788899999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.28 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=193.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||+||+|+....+ ..||+|++.... ....+.+..|+.++.+++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTH-ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCC-CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4568999999999999987654 569999996532 122356889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC----
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT---- 662 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---- 662 (797)
++|+|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999998888889999999999999999999998 999999999999999999999999999764321000
Q ss_pred ------------------------------------------cccccccccCccccccccccCCCCccCceehHHHHHHH
Q 003759 663 ------------------------------------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLE 700 (797)
Q Consensus 663 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~e 700 (797)
.......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999998899999999999999999
Q ss_pred HHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 003759 701 LICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIW--CIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 701 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--Cl~~dP~~RPs~~eVl~~ 777 (797)
|++|+.||......+....+..+. .... . ..... ....+.+++.. |+..+|..||++.|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~------~~~~-~-~~~~~------~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWE------NTLH-I-PPQVK------LSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccc------cccC-C-CCCCC------CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999997654332222111110 0000 0 00000 01223344544 667778789999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.15 Aligned_cols=272 Identities=21% Similarity=0.289 Sum_probs=196.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc-----Ccee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 580 (797)
|.+.+.||+|+||.||+|+....+ ..||||++..... ....++.+|+.++++++||||+++++++... ...+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCC-CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 345678999999999999987544 4699999874322 2335688999999999999999999987543 3579
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||++ ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999988777899999999999999999999998 9999999999999999999999999999865332
Q ss_pred CC--cccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhc
Q 003759 661 QT--RTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYI 729 (797)
Q Consensus 661 ~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~ 729 (797)
.. .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+... ..+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 12233468999999999876 5789999999999999999999999965432211100000000 0000
Q ss_pred ccccccccc----chhh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCC
Q 003759 730 DEKLHLLVE----NDEE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEV 784 (797)
Q Consensus 730 ~~~~~~~~~----~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~ 784 (797)
.......+. .... ..........+.+++..||+.||++|||++|+++. ++++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 000000000 0000 00000012346789999999999999999999965 4444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=333.96 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=198.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|......+..|++|.+..........+..|+.+++.++||||+++++++..++..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 55678899999999999987766455688887754433334567889999999999999999999999999999999999
Q ss_pred CCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 588 NGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 588 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
+|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988753 34578889999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.. . ...+..... +.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~---~-~~~~~~~~~----~~ 293 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQ---Q-VLYGKYDPF----PC 293 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---H-HHhCCCCCC----Cc
Confidence 22334568999999999999999999999999999999999999996543211 111 1 111111100 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++||++.+++.
T Consensus 294 -----~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 -----PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01134667888999999999999998864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.14 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=192.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|.....+ ..||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNG-KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCC-CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 455678999999999999987544 4699999875432 22346788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+ ++|.+++... ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5677666543 5688889999999999999999998 99999999999999999999999999987543221 122
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc--------------c
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI--------------D 730 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------------~ 730 (797)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..................... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 33457899999998865 45789999999999999999999999764332211111110000000 0
Q ss_pred ccccccccchhhh-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 731 EKLHLLVENDEEA-LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 731 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
............. .........+.+++..|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 000011234668899999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=305.61 Aligned_cols=250 Identities=29% Similarity=0.416 Sum_probs=198.5
Q ss_pred hhhCcccceeEEEEEEecCC--cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
++||+|+||.||+|+....+ ...+|+|.+...... ..+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876544 257999998764432 4467899999999999999999999876 4568999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc--cc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT--TT 666 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~ 666 (797)
++|.+++.....+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999998 99999999999999999999999999998764433221 11
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +...... ........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~----~~~~~~~----~~~~~~~~------- 221 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----VIAMLES----GERLPRPE------- 221 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHc----CCcCCCCC-------
Confidence 2224567999999998899999999999999999998 999986543211 1111111 11000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 222 --~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.74 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=198.9
Q ss_pred HhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..+.++||+|+||.||++... ...+..+++|.+........+.|.+|+++++.++|+||+++++++..++..++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345678999999999999753 2334579999987655555668999999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC---------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 584 EFISNGCLAGFLFKN---------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 999999999998653 2478889999999999999999998 9999999999999999999999
Q ss_pred EeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHh
Q 003759 649 SDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYD 726 (797)
Q Consensus 649 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (797)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ..
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~--- 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----EC--- 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----HH---
Confidence 99999876543221 11222235678999999999899999999999999999998 88888654322111 10
Q ss_pred hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
...+........ ....+.+++.+||+.||++||++.||++.|++
T Consensus 237 -~~~~~~~~~~~~---------~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 -ITQGRELERPRT---------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHcCccCCCCCC---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 011110000000 11345678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.45 Aligned_cols=262 Identities=22% Similarity=0.366 Sum_probs=201.2
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCCc-hHHHHHHHHHhhccC-cCchhhhcccccc
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTN-HRNLVKLLGFCNE 575 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~-h~niv~l~g~~~~ 575 (797)
++......+.+.||+|+||.||+|++.. ..+..||+|+++...... .+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3344445567899999999999998642 234579999997643332 346889999999997 9999999999999
Q ss_pred cCceeeeeecccCCchhhhcccCC--------------------------------------------------------
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKNP-------------------------------------------------------- 599 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 599 (797)
.+..++|+||+++|+|.+++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999886421
Q ss_pred ------------------------------------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 003759 600 ------------------------------------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQN 637 (797)
Q Consensus 600 ------------------------------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~N 637 (797)
.+++...+.++.||+.||+|||+. +++|+||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 245667788999999999999987 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCcccccc
Q 003759 638 ILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENE 715 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~ 715 (797)
||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11222346788999999998889999999999999999998 888886543221
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.. ......+.... .+ ......+.+++..||+.+|++||+++||++.|+++.
T Consensus 350 ~~-------~~~~~~~~~~~--~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QF-------YNAIKRGYRMA--KP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH-------HHHHHcCCCCC--CC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 01111110000 00 011235677888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.54 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=198.1
Q ss_pred HHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
...+.+.++||+|+||.||+|.... ..+..||+|++..... ....+|.+|+.+++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 3445667889999999999998642 2345699999864322 2335688999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccC----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 580 LLVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
++||||+++++|.+++.+. ..+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998642 2356788899999999999999998 99999999999999999999999
Q ss_pred eecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 650 DFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 650 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~----~ 233 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLR----F 233 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH----H
Confidence 9999876543222 11112235678999999998889999999999999999999 688886543221 111 1
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
............ ....+.+++.+|++.||++|||+.|++++|++
T Consensus 234 ~~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111111111 12346778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.85 Aligned_cols=243 Identities=25% Similarity=0.313 Sum_probs=193.4
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|+....+ ..||+|++.... ....+.+..|.+++..+ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCC-CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36899999999999987544 469999987532 22234577888888866 89999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|...+.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 999999998888899999999999999999999998 99999999999999999999999999987543222 22234
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. . ....+.... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~----~i~~~~~~~--p~-------- 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF----E----SILHDDVLY--PV-------- 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH----H----HHHcCCCCC--CC--------
Confidence 45899999999999989999999999999999999999999765432111 1 111111100 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRP-------TMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RP-------s~~eVl~~ 777 (797)
.....+.+++..||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0113456788899999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.66 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=201.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCc--EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~--~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+...+.||+|+||.||+|++...++ ..+++|.++.... ...+++.+|++++++++|+||+++++++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 34456789999999999999875433 4699999875432 23457899999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++.+. ..+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999999754 5689999999999999999999998 999999999999999999999999999886643322
Q ss_pred ccc--ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 RTT--TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 ~~~--~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
... .....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ +.. .+.........
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~----~i~~~~~~~~~-- 232 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----VMK----AINDGFRLPAP-- 232 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHH----HHhcCCCCCCC--
Confidence 111 11223457999999988889999999999999999998 999996543211 111 11111000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 233 -------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 -------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01124567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=291.17 Aligned_cols=276 Identities=22% Similarity=0.250 Sum_probs=205.9
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccc--ccCceeeeeecc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCN--EDQHRLLVYEFI 586 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~Ey~ 586 (797)
.+.|++|.||.||+|++..+++ .||+|+++-.... -.-.-++|+.+|.+.+|||||.+..+.. +-+..||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~e-IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDE-IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HhhcccCcceeEEEeccCCcce-eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 4679999999999999987766 4999999753321 1224588999999999999999988654 446799999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++ +|..++... +++...+..-++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||||+.+... ....
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~ 234 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPY 234 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccC
Confidence 76 688888765 4788999999999999999999998 9999999999999999999999999999988765 3345
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhcccc-----
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYIDEK----- 732 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~----- 732 (797)
+..+-|.-|+|||.+.+. .|+...|+||+|||+.||+++++.|.+..+.++...+.... |..+.+-.
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 556679999999998775 59999999999999999999999998876655433332111 10000000
Q ss_pred -ccccccchhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCCc
Q 003759 733 -LHLLVENDEEALHDMM-RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSF 793 (797)
Q Consensus 733 -~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~~p~~~ 793 (797)
.........+...... -.+.-.+++-..+..||.+|.|++|.++. +-..+.|.|..|..+
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMF 376 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhc
Confidence 0000001111111111 11345567777899999999999998764 236666766666544
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.28 Aligned_cols=252 Identities=23% Similarity=0.241 Sum_probs=196.3
Q ss_pred hhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccC----CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceee
Q 003759 509 GFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 581 (797)
.+.+.||+|+||.||++.... ..+..||+|++.... ....+.+..|+.++.++ +|+||+++++++..++..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 456789999999999987642 234679999986422 12234678899999999 59999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++|+|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999998888899999999999999999999998 99999999999999999999999999998654443
Q ss_pred CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. . ....... +..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~-~~~~~~~--~~~- 232 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---R-ILKCDPP--FPS- 232 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---H-HhcCCCC--CCC-
Confidence 3333445689999999999875 478999999999999999999999975433222111111 1 1110000 000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
.....+.+++..||+.||++|| +++++++.
T Consensus 233 -------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 233 -------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0112456788899999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.43 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=198.5
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
...+.+.++||+|+||.||+|....+ ..||+|.+..... ..+.|.+|+.++++++|+|++++++++.+ ...+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGN--TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCC--ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 34566778999999999999987633 3489999875432 45679999999999999999999998854 56889999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+++++|.+++.+. ..+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999998753 4578999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~----- 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----VLEQV----ERGYRMPC----- 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----HcCCCCCC-----
Confidence 22222335668999999988889999999999999999999 888886543211 11111 11100000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.......+.+++.+|++++|++|||+.++++.|++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.98 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=201.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
...||+|+||.||.++-++.++ .+|+|++++..- ...+..+.|-.+|...+++.||+|+-.|.+.+.+||||||++
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~-iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGE-IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred heeeccccceeEEEEEEccCCc-EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4679999999999999887655 599999986432 233568899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc----C---
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA----D--- 660 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~----~--- 660 (797)
||++..+|.+...+++.....++.+++.|++.||+. |+|||||||+|+|||..|.+||+||||+..+.. +
T Consensus 225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 999999999999999999999999999999999998 999999999999999999999999999864311 0
Q ss_pred --------------CCcc-------------------------cccccccCccccccccccCCCCccCceehHHHHHHHH
Q 003759 661 --------------QTRT-------------------------TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701 (797)
Q Consensus 661 --------------~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~el 701 (797)
.... ....+|||.|||||++.+..|+..+|.||||||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 0000 0113599999999999999999999999999999999
Q ss_pred HhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 003759 702 ICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT---MKKVTLM 777 (797)
Q Consensus 702 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~eVl~~ 777 (797)
|.|.+||......+.-..++.|......+.... ...++.+++.+|+. ||++|.- +.||-++
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 999999998877665555655543221111110 01455678888888 9999975 5555543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.67 Aligned_cols=236 Identities=27% Similarity=0.369 Sum_probs=189.4
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.||+|+||+||+|+....+ ..||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 2 VLGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred eeeeCCCeEEEEEEEcCCC-CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 6899999999999987544 469999987532 22335677888888776 799999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|+|.+++.+...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987543221 122334
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .. .+..+.... .. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~----~i~~~~~~~-~~---------~ 218 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FE----AILNDEVVY-PT---------W 218 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HH----HHhcCCCCC-CC---------C
Confidence 689999999999999999999999999999999999999976433211 11 111111100 00 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
....+.+++..|++.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 12345678899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.17 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||+||+++....+ ..||||++.... ......+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTG-HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 34578999999999999987654 469999997532 22334678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-- 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 663 (797)
+++|+|.+++.+...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999998888899999999999999999999998 9999999999999999999999999998754321100
Q ss_pred -----------------------------------ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCC
Q 003759 664 -----------------------------------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF 708 (797)
Q Consensus 664 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~ 708 (797)
......||+.|+|||++....++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011235899999999999989999999999999999999999999
Q ss_pred CccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 003759 709 EQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT---MKKVTLM 777 (797)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~eVl~~ 777 (797)
......+....+..+. ..+. .... . .....+.+++..|+. +|.+|++ +.|+++.
T Consensus 240 ~~~~~~~~~~~i~~~~------~~~~-~~~~-~------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 240 CSDNPQETYRKIINWK------ETLQ-FPDE-V------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCHHHHHHHHHcCC------CccC-CCCC-C------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 7654322111111110 0000 0000 0 011234566777886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.65 Aligned_cols=243 Identities=24% Similarity=0.267 Sum_probs=193.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|+||.||++..... +..||+|.+..... .....+..|++++..++||||+++.+++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3589999999999987654 45699999975322 2234677899999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|+|..++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 9999999888889999999999999999999997 5 999999999999999999999999999875432221 2233
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .... ...... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i----~~~~~~-~p~~-------- 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELI----LMEEIR-FPRT-------- 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----HHHH----hcCCCC-CCCC--------
Confidence 4589999999999998999999999999999999999999965432211 1100 011110 0000
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
....+.+++..||+.||++|+ ++.++++.
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 -LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112456788899999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.61 Aligned_cols=244 Identities=24% Similarity=0.329 Sum_probs=189.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||++.....+ ..||+|.++.... ...+.+..|+.++.++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36899999999999987654 4699999875422 2234577888888776 89999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|..++.+...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 999999988878899999999999999999999998 99999999999999999999999999987532221 12233
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc-hhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-QMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+........... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~p~-------- 226 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IPR-------- 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-CCC--------
Confidence 5689999999999999999999999999999999999999964221111 001111122211111111 000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPT 770 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs 770 (797)
.....+.+++..||+.||++||+
T Consensus 227 -~~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 227 -SLSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred -CCCHHHHHHHHHHhcCCHHHcCC
Confidence 01234567889999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.55 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=199.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc-EEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|++...+. ..+++|.++.... ...+.|.+|+.++.++ +||||+++++++.+.+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3456789999999999999875543 3478888874322 2345789999999999 79999999999999999999999
Q ss_pred cccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 585 FISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 585 y~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
|+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999998643 2477889999999999999999998 9999999999999999999999
Q ss_pred EeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 649 SDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 649 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+ ... .
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~~~----~ 230 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----LYE----K 230 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH----H
Confidence 9999986432111 1111123457999999998889999999999999999998 999996543221 111 1
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~ 788 (797)
...+...... ......+.+++..|++.+|.+||++++|++.|+++.+...+.
T Consensus 231 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 231 LPQGYRMEKP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 1111000000 011234667899999999999999999999998877655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.18 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=188.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.++||+|+||.||+|+....+ ..||||++...... ..+.+.+|+++++.++|+||+++++++.+++..++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTG-RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCC-CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 4578999999999999887544 46999998653322 235789999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
++|.... .........++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus 157 ~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 157 GSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred Ccccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 9986543 345677788999999999999998 999999999999999999999999999987643322 12334
Q ss_pred cccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 669 RGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 669 ~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+... +.. .... ......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-~~~---~~~~-~~~~~~------- 296 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS-LMC---AICM-SQPPEA------- 296 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHH---HHhc-cCCCCC-------
Confidence 58999999998853 234568999999999999999999997432221111 110 0000 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..||+.||++||++.||++.
T Consensus 297 --~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 --PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112346788899999999999999999986
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.08 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=197.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCc-EEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||.||+|.....+. ..+++|++..... ...++|.+|++++.++ +|+||+++++++.+++..++|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 34567889999999999999865433 4578888765332 2345788999999999 8999999999999999999999
Q ss_pred ecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEE
Q 003759 584 EFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR 647 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k 647 (797)
||+++++|.+++.+. ..+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 999999999998643 2467889999999999999999998 999999999999999999999
Q ss_pred EEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHh
Q 003759 648 ISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYD 726 (797)
Q Consensus 648 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (797)
|+|||++....... .......+..|+|||++.+..++.++||||||++++||+| |..||......+. ..
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~---- 234 (303)
T cd05088 165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YE---- 234 (303)
T ss_pred eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH----HH----
Confidence 99999986432111 1111224567999999988889999999999999999998 9999865432211 01
Q ss_pred hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
........... ......+.+++.+|++.+|++||++.+++++|+.+.+
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 KLPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHhcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111000000 0012346788999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.94 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=199.6
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
...+.+.++||+|+||.||+|+.... ..||+|+++... ...++|..|+.++++++|+||+++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~--~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC--ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 34567788999999999999987543 349999987532 335678999999999999999999998754 56799999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+++++|.+++.+. ..+++..+..++.++++||+|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999753 4578899999999999999999998 999999999999999999999999999986654332
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......++..|+|||+..+..++.++||||||+++|||++ |..||......+. .. ..........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~~----~~~~~~~~~~----- 224 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LD----QVERGYRMPC----- 224 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----HH----HHhcCCCCCC-----
Confidence 22223346678999999988889999999999999999999 7888865432211 11 0101100000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.......+.+++..|++.+|++||++.++++.|+..
T Consensus 225 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011224567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.68 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=198.2
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecC-------------CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhh
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYE-------------NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKL 569 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~-------------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l 569 (797)
.+..+.+.+.||+|+||.||++..... ....||+|.++..... ...+|.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 344567778999999999999876532 2235899998754222 23468999999999999999999
Q ss_pred cccccccCceeeeeecccCCchhhhcccC------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKN------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQN 637 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~N 637 (797)
++++...+..++||||+++++|.+++... ..+++..++.++.+++.||+|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 99999999999999999999999988543 1367888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh--CCcCCCccccc
Q 003759 638 ILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC--CRKKFEQNVEN 714 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt--G~~p~~~~~~~ 714 (797)
|++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543221 11222335678999999988889999999999999999998 55676543322
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
+. .................. . .......+.+++.+|++.||++||+|++|++.|+
T Consensus 240 ~~----~~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QV----IENTGEFFRNQGRQIYLS-Q-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH----HHHHHHhhhhccccccCC-C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11 111111000000000000 0 0011245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.26 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=213.7
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecC---CcEEEEEEEecc-cCCCchHHHHHHHHHhhccCcCchhhhcccccccC
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYE---NKICVAVKKLDN-MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~---~~~~vavK~~~~-~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 577 (797)
+|.++.-.+.+.||.|-||.||+|+.... ....||||.-+. ......+.|.+|+.++++++||||++++|+|.+ +
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34455555678899999999999987643 346799998876 334456679999999999999999999999987 5
Q ss_pred ceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..+||||.++-|-|.++|+.+ ..++......++.||+.||+|||+. ..|||||..+|||+....-+||+||||++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 789999999999999999865 5688889999999999999999998 999999999999999999999999999999
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
+..+.....+...-...|||||.+.-.++|.++|||-|||.+||+++ |..||.+....+-- ..+..+....
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------~~iEnGeRlP 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------GHIENGERLP 612 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------EEecCCCCCC
Confidence 98887766666667889999999999999999999999999999987 99999876443211 1112222222
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+..+ ..+..+...||..+|.+||.+.|+...|+.+.+
T Consensus 613 ~P~nCP---------p~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 613 CPPNCP---------PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCC---------hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233333 344556677999999999999999988866443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.12 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=197.3
Q ss_pred HHhhhhhhCcccceeEEEEEEec---CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY---ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~---~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
...+.++||+|+||.||+|+... ..+..|++|.+..... ....+|.+|+.++++++||||+++++++..++..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 34566889999999999998632 2345799999875332 2235788999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC-----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc
Q 003759 583 YEFISNGCLAGFLFKN-----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT 645 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 645 (797)
|||+++++|.+++... ..+++.+.+.++.+++.||+|||+. +++|+||||+||++++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 9999999999998422 2467888899999999999999998 9999999999999999999
Q ss_pred EEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHH
Q 003759 646 ARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 646 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 723 (797)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+ +.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~----~~~~ 238 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----VIEM 238 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH
Confidence 99999999986543221 12222335678999999988889999999999999999999 888886543211 1111
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. .......... ...++.+++..|++.||++||++.+|.++|.+
T Consensus 239 ~~----~~~~~~~~~~---------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR----KRQLLPCSED---------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCcCCCCCC---------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 1111111011 11345678889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.19 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=196.5
Q ss_pred hhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCc------e
Q 003759 510 FKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH------R 579 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 579 (797)
+.+.||+|+||.||+|++.... ...||+|+++..... ...++..|+..++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999986533 356999998753322 23578999999999999999999998866554 7
Q ss_pred eeeeecccCCchhhhcccC------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 580 LLVYEFISNGCLAGFLFKN------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
++++||+++++|..++... ..+++.....++.|++.||+|||+. +++|+||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999888432 3578889999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccc
Q 003759 654 AKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 654 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
++.+...... .......+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~----~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYL----RHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcC
Confidence 9866433221 1222234678999999998899999999999999999999 888886543211 11111 111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
....... .....+.+++..|++.||++||++.||++.|+++
T Consensus 232 ~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111101 1223567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.85 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=201.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..++||.+..... ...+++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCC-ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 556788999999999999976544 4699998764322 223578899999999999999999999999999999999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+++++|.+++.. ...+++.....++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998853 34578999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||........ .... ..........
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~~~~~~~---- 228 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCK----KIEQCDYPPL---- 228 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhh----hhhcCCCCCC----
Confidence 22 12234578899999999988899999999999999999999999965432111 1100 0000000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
. .......+.+++..|++.||++||||.+|+++++++.
T Consensus 229 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 0112235677889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.51 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=201.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc---------------EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhh
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK---------------ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKL 569 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~---------------~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l 569 (797)
..+.+.++||+|+||.||+++....++ ..||+|.+..... ...+++.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345667899999999999998764332 4589999875432 234578899999999999999999
Q ss_pred cccccccCceeeeeecccCCchhhhcccCC-----------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNP-----------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
++++..++..++++||+++++|.+++.+.. .+++..++.++.|++.||+|||+. +|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999987654 688999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh--CCcCCCcccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC--CRKKFEQNVENE 715 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt--G~~p~~~~~~~~ 715 (797)
+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ +..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876543321 22223346778999999988889999999999999999998 666775432211
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.................... .......+.+++.+|++.||++|||+.||++.|+.
T Consensus 242 ----~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 ----VIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ----HHHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111110100 01112457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=305.01 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=201.8
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+...++.+.++||+|+||.||+|.... +..||+|.+.... ....+|.+|+.++++++|+||+++++++. .+..+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~--~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG--HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC--CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 455677788899999999999998654 3469999987543 34568999999999999999999999874 4678999
Q ss_pred eecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 583 YEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|||+++++|.+++... ..+++.++..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998653 4678899999999999999999987 9999999999999999999999999999876533
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.........++..|+|||++....++.++||||||++++||++ |+.||......+. .... ...........
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~----~~~~~~~~~~~ 227 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV----IQNL----ERGYRMPRPDN 227 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH----HHHH----HcCCCCCCCCC
Confidence 3322233345678999999998889999999999999999999 9999965432211 1111 11100000010
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
....+.+++.+|++.+|++||+++++++.|+.
T Consensus 228 ---------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 ---------CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12357788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.58 Aligned_cols=251 Identities=20% Similarity=0.227 Sum_probs=196.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||++.....+ ..||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATG-DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 345678999999999999887654 4699999875322 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++|+|.+++.+. ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999765 6789999999999999999999998 9999999999999999999999999999876544433
Q ss_pred ccccccccCccccccccc------cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 664 TTTAIRGTRGYVAPEWFK------SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
......||+.|+|||++. ...++.++||||||+++|||++|+.||...........+. .........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~~~~~~ 231 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------NFQRFLKFP 231 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH-------cCCCccCCC
Confidence 333456899999999986 4567899999999999999999999997543322111110 000000000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. ......+.+++..|++ +|++||++.++++.
T Consensus 232 ~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 ED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0011335567778998 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=322.13 Aligned_cols=260 Identities=25% Similarity=0.291 Sum_probs=196.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC-----ceeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----HRLLV 582 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV 582 (797)
+.+.||+|+||.||++..... +..||+|++..... ...+++.+|+.+++.++|+||+++++++...+ ..++|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRD-GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEECCC-CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 356899999999999988654 44699999865322 23357889999999999999999999998776 78999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+||+. ++|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99996 57888887777899999999999999999999998 999999999999999999999999999986544433
Q ss_pred cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH---------------HHh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW---------------AYD 726 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~---------------~~~ 726 (797)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.+. ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333444578999999998774 4799999999999999999999999765432211111110 000
Q ss_pred hhccccccccccchhhhh--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 727 CYIDEKLHLLVENDEEAL--HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+....... +..... ......+.+.+++..||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKP---PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCC---CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000 000113457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.98 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=201.3
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 578 (797)
...+.+.+.||+|+||.||++..... ....+|+|.+..... ....++.+|+.++.++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 34455567899999999999987642 235799999875322 2234688999999999 89999999999999999
Q ss_pred eeeeeecccCCchhhhccc----------------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 003759 579 RLLVYEFISNGCLAGFLFK----------------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~ 642 (797)
.+++|||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 9999999999999999853 24578889999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhH
Q 003759 643 SFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMIL 720 (797)
Q Consensus 643 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 720 (797)
++.+||+|||+++.+..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----
Confidence 99999999999987654322 11222335678999999988899999999999999999998 8888865432111
Q ss_pred HHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
......+..... .......+.+++..|++.||++|||+.||++.|+++.
T Consensus 244 ----~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----FKLLKEGYRMEK---------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111110000 0111235678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.96 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=199.5
Q ss_pred HHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
..+.+.++||+|+||.||+|..... ....||+|++....... .+.|.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4566778999999999999987532 24679999997543322 356889999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 581 LVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+++||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998421 2467788899999999999999998 999999999999999999
Q ss_pred cEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHH
Q 003759 645 TARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVD 722 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 722 (797)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ +.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence 999999999886543222 11222345778999999988889999999999999999998 778886543221 111
Q ss_pred HHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 723 WAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
...........+. ....+.+++..|++.+|++||++.+|++.|+.
T Consensus 238 ----~i~~~~~~~~~~~---------~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ----MIRNRQVLPCPDD---------CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHcCCcCCCCCC---------CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111111 12346678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=323.02 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=196.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
..+.+.+.||+|+||.||+++....+ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSK-QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 34556678999999999999987654 469999986421 22334578899999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++|+|.+++... .++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999988543 577888889999999999999998 999999999999999999999999999987654333
Q ss_pred cccccccccCccccccccccC----CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKSL----PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+..........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------~~i~~~~~~~~~~ 269 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--------SKIMDHKNSLTFP 269 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH--------HHHHcCCCcCCCC
Confidence 233345689999999998653 3789999999999999999999999764332111 1111110000000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSL--RPTMKKVTLM 777 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~eVl~~ 777 (797)
. .......+.+++..||+.+|++ ||++.|+++.
T Consensus 270 ~------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 D------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0011234567888899999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=307.13 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=194.1
Q ss_pred hhhCcccceeEEEEEEecCCc-EEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|+||.||+|.+..++. ..+++|.+..... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999876543 4578898875332 3345788999999999 899999999999999999999999999
Q ss_pred CchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeec
Q 003759 589 GCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652 (797)
Q Consensus 589 gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 652 (797)
++|.+++.... .+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 467889999999999999999997 99999999999999999999999999
Q ss_pred CccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccc
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
++...... ........+..|+|||++....++.++||||||++++||++ |..||......+ ... .....
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~----~~~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE----KLPQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH----HHH----HHhCC
Confidence 98632211 11111223567999999988889999999999999999997 999996542211 101 11111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
...... ......+.+++..|++.+|.+|||+.++++.|+++.
T Consensus 228 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000000 011234678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.81 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=201.4
Q ss_pred HHHhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+++.. ......||+|+++.... ...+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34556789999999999999753 22345699999875432 2235689999999999 899999999999999999
Q ss_pred eeeeecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 580 LLVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+++|||+++++|.+++.... .+++.++..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||++...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997543 378999999999999999999998 9999999999999999999999999999865
Q ss_pred ccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 658 KADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 658 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+... . ....+....
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~---~----~~~~~~~~~ 264 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---K----LIKEGYRMA 264 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH---H----HHHcCCcCC
Confidence 433221 1122345678999999998889999999999999999998 999986543321111 1 111110000
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.. ......+.+++..|++.+|++||++.||++.|+.+
T Consensus 265 ~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 QP---------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 01123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=321.81 Aligned_cols=200 Identities=25% Similarity=0.308 Sum_probs=172.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||+||++..... +..||+|++..... .....+..|+.++.+++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDT-GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCC-CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 3457899999999999988754 45699999865321 2234678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC---
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--- 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--- 662 (797)
+++|+|.+++.+...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred -------------------------------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 663 -------------------------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 663 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999765
Q ss_pred c
Q 003759 712 V 712 (797)
Q Consensus 712 ~ 712 (797)
.
T Consensus 240 ~ 240 (363)
T cd05628 240 T 240 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.72 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=200.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+ ..||||.+..... .....+.+|+.+++.++||||+++++++...+..++++|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCC-CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 445678999999999999987654 4699998764222 223468899999999999999999999999999999999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+++++|.+++.. ...++......++.++++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988752 34578888999999999999999998 9999999999999999999999999998876433
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+.. . .........
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--~~~~---~-~~~~~~~~~---- 228 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--SLCQ---K-IEQCDYPPL---- 228 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--HHHH---H-HhcCCCCCC----
Confidence 22 12234578899999999888899999999999999999999999865432111 1111 1 111010000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0111224567888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=307.22 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=200.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc--EEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~--~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.+.||+|+||.||+|.+...++ ..||||.+.... ....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 345667889999999999999875443 469999987542 22345799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999998754 5688999999999999999999998 99999999999999999999999999987654322
Q ss_pred Ccc--ccccc--ccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 662 TRT--TTAIR--GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 662 ~~~--~~~~~--gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i~~---~~~~~~~ 233 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAIEQ---DYRLPPP 233 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHHHc---CCcCCCc
Confidence 211 11111 2357999999998899999999999999999887 999986543221 1111111 0000000
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......+.+++..|++.+|++||++.+|+.+|+++
T Consensus 234 ----------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 ----------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.23 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=193.7
Q ss_pred hhCcccceeEEEEEEecC-CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+||+|+||.||+|++... .+..||+|++...... ..++|.+|+.++++++|+||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999987633 3456999998754322 23568999999999999999999998864 57899999999999
Q ss_pred hhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--cccc
Q 003759 591 LAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--TTTA 667 (797)
Q Consensus 591 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 667 (797)
|.+++.. ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999874 45789999999999999999999998 9999999999999999999999999999865433221 1111
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..++..|+|||.+....++.++||||||+++|||++ |..||......+ ..... ..+......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~~--------- 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VMSFI----EQGKRLDCP--------- 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH----HCCCCCCCC---------
Confidence 223578999999988889999999999999999996 999997543221 11111 111111000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......+.+++..||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 01124556788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.48 Aligned_cols=245 Identities=27% Similarity=0.338 Sum_probs=192.0
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||+||++.....+ ..||+|.+...... ..+.+..|+.+++.++|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATG-KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCC-cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999887544 46999998643222 22457789999999999999999999999999999999999999
Q ss_pred hhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 591 LAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 591 L~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
|..++.. ...+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++..+..... ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 9887742 35688999999999999999999998 999999999999999999999999999976543322 223
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+. ......... . .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~-~---------~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRILNDSVT-Y---------P 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----HhhcccCCC-C---------c
Confidence 3468999999999999999999999999999999999999997643321111111 111111100 0 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
......+.+++..|++.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 01123466788899999999999 77888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.44 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=199.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|+.... +..||+|++..........+.+|+.++.+++||||+++++++..++..++|+||+
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~-~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHT-GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCC-CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 456678999999999999998654 4569999987554444567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++..+..... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 9999999998777889999999999999999999998 999999999999999999999999999986543221 122
Q ss_pred cccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 667 AIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
...+++.|+|||.+. ...++.++||||||++++||++|+.|+......+..... ....... .....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~---~~~~~ 233 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNFQP---PKLKD 233 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCCCC---CCCcc
Confidence 345788999999884 345788999999999999999999998643221111000 0000000 00000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
.......+.+++..||+.+|++||++++|++.|
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001123567889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.93 Aligned_cols=240 Identities=24% Similarity=0.278 Sum_probs=191.6
Q ss_pred hhhCcccceeEEEEEEec--CCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||++.... ..+..||+|++..... .....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 469999999999987642 3456799999975322 223457789999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.+...+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++....... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998878899999999999999999999998 99999999999999999999999999987654332 22234
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ... ....... + +.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~----i~~~~~~-~----p~----- 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTM----ILKAKLG-M----PQ----- 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----HHH----HHcCCCC-C----CC-----
Confidence 5689999999999988899999999999999999999999975432211 110 1111110 0 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
.....+.+++..||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01124567888999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.36 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=194.1
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.||+|+||.||++.....+ ..||+|+++.... ...+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTR-RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred eEeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 5899999999999987544 4699999975322 2234578899999888 799999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|+|.+++.+...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 99999998778899999999999999999999998 99999999999999999999999999987432211 122335
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc-hhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-QMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .....++........... +...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~-------- 227 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-IPRS-------- 227 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-CCCC--------
Confidence 689999999999999999999999999999999999999964322110 000111122222222111 0000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPT------MKKVTL 776 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs------~~eVl~ 776 (797)
....+.+++..||+.||++||+ +.++++
T Consensus 228 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 -LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1134567889999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.03 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=203.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCc-eeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH-RLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~E 584 (797)
|...+.+|+|+||.++..+++..+. .+++|++.-.. ....+..++|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~-~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDK-LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCc-eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 5567889999999999988876555 58888885432 2333467899999999999999999999999888 999999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|++||+|.+.+.+. ..+++.+...++.|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+|+.+..+..
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999765 4578899999999999999999987 999999999999999999999999999999887653
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
. .....||+.||+||.+.+.+|..|+|||||||++|||++-+++|....-......+.. +. ..+.+
T Consensus 162 ~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~--------~~----~~Plp- 227 (426)
T KOG0589|consen 162 L-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR--------GL----YSPLP- 227 (426)
T ss_pred h-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh--------cc----CCCCC-
Confidence 3 3445699999999999999999999999999999999999999977643322211111 11 11111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+..++..|++.+|+.||++.+++.+
T Consensus 228 ----~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 ----SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122345667888999999999999999876
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=314.62 Aligned_cols=242 Identities=26% Similarity=0.309 Sum_probs=190.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhc-cCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQ-TNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|.....+ ..||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN-QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC-CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36899999999999987654 459999987532 2233456677777776 499999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.....+++.+...++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 999999998777889999999999999999999998 99999999999999999999999999987532211 12233
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +..... ..... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~i~----~~~~~--~~~-------- 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQSIR----MDNPC--YPR-------- 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHH----hCCCC--CCc--------
Confidence 458999999999999899999999999999999999999997543221 111110 00000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMK-KVTL 776 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~-eVl~ 776 (797)
.....+.+++..||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0113456788999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=307.88 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=187.7
Q ss_pred hhCcccceeEEEEEEecC-----------------------CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhh
Q 003759 513 ELGRGAFATVHKGVLAYE-----------------------NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-----------------------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l 569 (797)
.||+|+||.||+|++... .+..|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999986421 224689999876444445678899999999999999999
Q ss_pred cccccccCceeeeeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---- 644 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---- 644 (797)
++++.+....++||||+++|+|..++.+ ...+++..+..++.||++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 45688999999999999999999998 999999999999997643
Q ss_pred ---cEEEEeecCccccccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHH-hCCcCCCccccccchhh
Q 003759 645 ---TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMI 719 (797)
Q Consensus 645 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~ell-tG~~p~~~~~~~~~~~~ 719 (797)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-- 231 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH--
Confidence 37999999876432221 1236778999998865 56899999999999999985 688888654322111
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
..... ..... .. ....+.+++..||+.+|++||+|.+|++.|+
T Consensus 232 --~~~~~---~~~~~---~~---------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 --RFYEK---KHRLP---EP---------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHh---ccCCC---CC---------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10000 00000 00 0124677889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.07 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=194.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.||+|+||.||+|.... +..+|+|++...... ....|.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD--KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecC--CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 368999999999998653 456999998754332 23468899999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 669 (797)
|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99998654 4578999999999999999999998 9999999999999999999999999998754433222222223
Q ss_pred ccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 670 gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
++..|+|||++....++.++||||||+++|||++ |..||......... . ............ .
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~----~~~~~~~~~~~~---------~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR----E----QVEKGYRMSCPQ---------K 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----H----HHHcCCCCCCCC---------C
Confidence 4667999999998889999999999999999998 99998654322111 1 011110000000 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
....+.+++..|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1245678899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.74 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=200.8
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
...+.+.+.||+|+||.||+|..... ....||+|.+..... .....+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 34455668899999999999987642 235699999865432 2234688999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccC----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 580 LLVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998642 2367888999999999999999988 99999999999999999999999
Q ss_pred eecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 650 DFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 650 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~---- 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKF---- 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHHH----
Confidence 9999986543322 12223346788999999988889999999999999999998 888886543221 1111
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
...+........ ....+.+++..|++.+|++|||+.++++.|++
T Consensus 234 ~~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCCCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111111 12456788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.72 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=201.1
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
..+.+.+.||+|+||.||+|+....+ ...+|+|.++.... ...+.|..|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34556788999999999999875333 34699999875332 2235789999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++++|.+++.+. ..+++.+.+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 4678999999999999999999998 99999999999999999999999999998765432
Q ss_pred Cccc--ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 662 TRTT--TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 662 ~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.... ....++..|+|||.+.+..++.++||||||+++||+++ |..||......+. .... .++......
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~----~~~~----~~~~~~~~~- 231 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV----IKAI----EEGYRLPAP- 231 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH----HHHH----hCCCcCCCC-
Confidence 2111 11223567999999998899999999999999999887 9999865432211 1111 111000000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......+.+++..|++.+|++||+|.++++.|+++
T Consensus 232 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 --------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01123456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.71 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=200.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
...+.+.||+|+||+||+|+....+. ..||+|++..... ...+++.+|+.++..++|+||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 34456789999999999998764443 2589999865332 2345788999999999999999999998754 56799
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.+....
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999999764 5689999999999999999999998 99999999999999999999999999998765332
Q ss_pred Cc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 662 TR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 662 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... +..... ........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~----~~~~~~~~-- 233 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----IPDLLE----KGERLPQP-- 233 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH----CCCcCCCC--
Confidence 21 1112234678999999998899999999999999999998 888886532211 111111 11100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
......+.+++..||+.||++||++.++++.|+.+...+
T Consensus 234 -------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 -------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011234567889999999999999999999998876655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.27 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=193.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||+||++.....+ ..||+|+++... ......+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999987554 459999987532 22334567888888877 79999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|..++.+...+++.....++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999999998888899999999999999999999998 999999999999999999999999999875322221 2233
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. ......... . .
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~----~i~~~~~~~--~--------~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQ----SILEDEVRY--P--------R 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HH----HHHcCCCCC--C--------C
Confidence 4589999999999999999999999999999999999999975432211 11 111111100 0 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTM-----KKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~-----~eVl~~ 777 (797)
.....+.+++..||+.||++||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 012346778899999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.85 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=196.5
Q ss_pred HhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc--cCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 582 (797)
+.+.+.||+|+||.||++... ...+..|++|++........+.|.+|++++++++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 345678999999999999853 23345799999876554455688999999999999999999997643 3468899
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999654 4689999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccch--------hhHHHHHHhhhccc
Q 003759 662 TR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQ--------MILVDWAYDCYIDE 731 (797)
Q Consensus 662 ~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 731 (797)
.. ......++..|+|||.+.+..++.++||||||++++||++|..++......... ..............
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 21 111122345699999998888999999999999999999988765432211000 00000000000000
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.... ........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 243 ~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 0001123577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=322.25 Aligned_cols=250 Identities=22% Similarity=0.260 Sum_probs=192.3
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||+||++.....+ ..||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTG-KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCC-CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 34578999999999999887654 469999986432 12235688899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC---
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--- 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--- 662 (797)
+++|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999998878889999999999999999999998 999999999999999999999999999864321100
Q ss_pred ----------c---------------------------------ccccccccCccccccccccCCCCccCceehHHHHHH
Q 003759 663 ----------R---------------------------------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLL 699 (797)
Q Consensus 663 ----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ 699 (797)
. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001245899999999999989999999999999999
Q ss_pred HHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 003759 700 ELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLR---PTMKKVTL 776 (797)
Q Consensus 700 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~eVl~ 776 (797)
||++|+.||......+....+..+. ..+. ..+. ......+.+++..|++ +|.+| |++.|+++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~------~~~~-~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWR------ETLY-FPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccC------CccC-CCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999997644322111111110 0000 0000 0011235567778887 66665 59998887
Q ss_pred H
Q 003759 777 M 777 (797)
Q Consensus 777 ~ 777 (797)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=320.49 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=192.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||.||+++....+ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQ-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4455678999999999999987654 469999986421 123346889999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++... .++......++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999998543 578888999999999999999998 9999999999999999999999999999876443332
Q ss_pred ccccccccCccccccccccCC----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 664 TTTAIRGTRGYVAPEWFKSLP----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........... +...........
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~--------i~~~~~~~~~p~ 270 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK--------IMDHKNSLNFPE 270 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCcccCCCC
Confidence 333456999999999997643 78899999999999999999999976533211111 111000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSL--RPTMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~eVl~~ 777 (797)
.......+.+++..|++.++.+ ||++.|+++.
T Consensus 271 ------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 ------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011123455677788755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.65 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=197.2
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|++|.||++...... .+++|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT--KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc--eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 44566788999999999999876442 48999886532 33567899999999999999999999875 4568899999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++.+. ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999754 3478899999999999999999998 9999999999999999999999999999866443322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...... ........
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~----~~~~~~~~----- 225 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQVE----RGYRMPCP----- 225 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----cCCCCCCC-----
Confidence 2223345678999999988889999999999999999999 888986543221 111111 11000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
......+.+++.+|++.||++||++.+|++.|+.
T Consensus 226 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112346778899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.11 Aligned_cols=264 Identities=24% Similarity=0.367 Sum_probs=204.4
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEec------CCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhccccc
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCN 574 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 574 (797)
+....+.+.+.||+|+||.||+++... .....||+|.+..... ...+++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 344556677899999999999997531 1234699999875332 3345789999999999 8999999999999
Q ss_pred ccCceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 575 EDQHRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
.....+++|||+++++|.+++... ..+++.++..++.||++||+|||+. +++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999998643 2467788999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENEN 716 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~ 716 (797)
++++++.+||+|||+++.+...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 9999999999999999876443221 1222345678999999988889999999999999999998 778875442211
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~ 786 (797)
+.. ....+...... ......+.+++..||+.+|++||+|.||++.|+++..+..
T Consensus 248 ---~~~----~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 248 ---LFK----LLKEGHRMDKP---------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ---HHH----HHHcCCcCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111 11111110000 0112346678999999999999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=314.21 Aligned_cols=241 Identities=27% Similarity=0.361 Sum_probs=190.1
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|.....+ ..||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG-EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36899999999999987654 469999987532 22334566777777754 89999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|..++.....+++.+...++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 999999998777889999999999999999999998 99999999999999999999999999987432211 22334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+ +.+.. ...... . +.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~----~~~~~~-~----~~----- 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESI----RVDTPH-Y----PR----- 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhCCCC-C----CC-----
Confidence 568999999999999999999999999999999999999997543221 11111 011000 0 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMK-KVT 775 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~-eVl 775 (797)
.....+.+++..||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0112456788899999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.81 Aligned_cols=239 Identities=24% Similarity=0.408 Sum_probs=190.4
Q ss_pred hhhCcccceeEEEEEEecCC---------cEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 512 DELGRGAFATVHKGVLAYEN---------KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~---------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.||+|+||.||+|++...+ ...|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999997544 135788887654333 6789999999999999999999999988 788999
Q ss_pred eecccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-------cEEEEeecCc
Q 003759 583 YEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-------TARISDFGLA 654 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~Dfgla 654 (797)
+||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999997665 789999999999999999999998 999999999999999887 7999999998
Q ss_pred cccccCCCcccccccccCccccccccccC--CCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccc
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+... . . . ..
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~---~-~---~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-F---Y-Q---DQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-H---H-h---cC
Confidence 86543 1123356789999999876 78999999999999999999 566775543211110 0 0 0 00
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.... .. ....+.+++..|++.+|++||++.+|++.|+
T Consensus 223 ~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 0145678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.38 Aligned_cols=241 Identities=24% Similarity=0.405 Sum_probs=189.2
Q ss_pred hhhCcccceeEEEEEEecC-----------CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 512 DELGRGAFATVHKGVLAYE-----------NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-----------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
+.||+|+||.||+|+.... ....|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986432 22458999887655555567899999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc-------EEEEeec
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT-------ARISDFG 652 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~Dfg 652 (797)
+||||+++++|..++... ..+++..++.++.||++||+|||+. +|+|+||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988754 5689999999999999999999998 9999999999999987664 8999999
Q ss_pred CccccccCCCcccccccccCccccccccc-cCCCCccCceehHHHHHHHHH-hCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+.. .+ ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~--------~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RF--------YE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HH--------Hh
Confidence 98754322 1234678899999886 467899999999999999998 577777543221110 00 00
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
... ....+ ....+.+++..||+.||++||++.+|++.|+
T Consensus 224 ~~~-~~~~~---------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-MLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-cCCCC---------ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 00111 1234677899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.56 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=197.1
Q ss_pred hhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.||+|+||.||+|+.... ....+++|.+...... ..+++.+|+.+++.++||||+++++.+...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 457899999999999987532 2246889988654322 23578899999999999999999999999999999999
Q ss_pred cccCCchhhhcccC------------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 585 FISNGCLAGFLFKN------------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 585 y~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
|+.+++|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 99999999987532 2467888999999999999999988 99999999999999
Q ss_pred cCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchh
Q 003759 641 DDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQM 718 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 718 (797)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 99999999999999865332221 1222335678999999988889999999999999999999 999986543211
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+.+.... ....... ......+.+++..|++.+|++||++.|+++.|+++.
T Consensus 238 -~~~~~~~----~~~~~~~---------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -LFNLLKT----GYRMERP---------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHhC----CCCCCCC---------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111111 1000000 011235678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.89 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=194.5
Q ss_pred hhhhhCcccceeEEEEEEecCCc-EEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Ccee
Q 003759 510 FKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHRL 580 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 580 (797)
+.+.||+|+||.||+|+....+. ..||+|.++.... ...+.|..|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999875544 3589998865322 2345688999999999999999999987432 2568
Q ss_pred eeeecccCCchhhhccc------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 581 LVYEFISNGCLAGFLFK------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
+++||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988732 23478899999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 655 KILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 655 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
+.+..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +. .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~----~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IY----DYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HH----HHHHcCC
Confidence 87643322 11222335678999999999999999999999999999999 788886532211 11 1111111
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
...... .....+.+++.+||+.||++|||+.+|++.|+++
T Consensus 232 ~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQPP---------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111000 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.11 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=190.0
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||.||++.....+ ..+|+|++..... ...+.+..|++++++++||||+++++++..+...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG-KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCC-cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999987654 4699999864221 223456679999999999999999999999999999999999999
Q ss_pred hhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 591 LAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 591 L~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888644 3578888899999999999999998 99999999999999999999999999987654322 22234
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.+++.|+|||++.+..++.++|||||||++|||++|+.||............ .... .......... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~~~~~---------~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRT-LEDEVKFEHQ---------N 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHh-hccccccccc---------c
Confidence 5889999999999888999999999999999999999999754322111111 1111 1111110000 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++||++.|+++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1234577889999999999999976654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=315.70 Aligned_cols=238 Identities=27% Similarity=0.305 Sum_probs=187.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHH-HhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVN-AIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||+||+|+....+ ..||+|++..... ...+++..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG-KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 35899999999999987544 4699999865321 22234555544 5677899999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...... ......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 999999998888899999999999999999999998 9999999999999999999999999998753222 122334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ......... . ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~i~~~~~~-~-~~-------- 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY--------DNILNKPLR-L-KP-------- 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH--------HHHHcCCCC-C-CC--------
Confidence 56899999999999999999999999999999999999999754322110 111111110 0 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMK 772 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~ 772 (797)
.....+.+++..|++.||++||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0123466788899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.11 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=197.8
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhccccccc-
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNED- 576 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~- 576 (797)
....+.+.+.||+|+||.||+|+... .....||||+++..... ....+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 34556778899999999999997532 23467999999754322 234688899999999 789999999988654
Q ss_pred CceeeeeecccCCchhhhcccC----------------------------------------------------------
Q 003759 577 QHRLLVYEFISNGCLAGFLFKN---------------------------------------------------------- 598 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------------------------- 598 (797)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999888532
Q ss_pred ---------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cccccc
Q 003759 599 ---------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTTTAI 668 (797)
Q Consensus 599 ---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~ 668 (797)
..+++.++..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 1356778889999999999999998 999999999999999999999999999986533222 112223
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
.++..|+|||.+.+..++.++||||||+++|||++ |..||......+. +.. ....+.......
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~~~~~~--------- 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR----RLKEGTRMRAPD--------- 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HHH----HHhccCCCCCCC---------
Confidence 35678999999988899999999999999999997 8888865422211 101 111111100000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++..||+.||++||++.||++.|+.+.+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011346788899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=301.23 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=187.5
Q ss_pred hhCcccceeEEEEEEecC-CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
.||+|+||.||+|+.... ....+++|+++.... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 589999999999987543 335699999875433 233578899999999999999999999999999999999999999
Q ss_pred hhhhcccC-----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cc
Q 003759 591 LAGFLFKN-----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RT 664 (797)
Q Consensus 591 L~~~l~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 664 (797)
|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998643 2356677889999999999999998 999999999999999999999999999875433222 11
Q ss_pred cccccccCccccccccccC-------CCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 665 TTAIRGTRGYVAPEWFKSL-------PITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-------~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+... .. ..... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~----~~---~~~~~-~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT----YT---VREQQ-LKL 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH----HH---hhccc-CCC
Confidence 2234467889999998642 35889999999999999996 999996543222110 00 00000 001
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
..+.... ...+.+.+++..|+ .+|++|||++||+..|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111000 01123455677798 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.13 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=198.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH--HHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK--EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~--~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||+||+++....+ ..+|+|.+......... ....|+.++++++||||+++++++......++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNG-QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTT-EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCC-eEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 35678999999999999988654 46999999865333222 2355999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999998778889999999999999999999998 99999999999999999999999999987642 2223334
Q ss_pred cccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++..|+|||++. +..++.++||||+|+++++|++|..||...........+...... ........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~------ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-----PLPSSSQQ------ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-----HHHHHTTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-----cccccccc------
Confidence 455889999999998 888999999999999999999999999865211111111100000 00000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......+.+++..||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000156788999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=323.12 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=192.3
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||.||+++.... +..||||++.... ......+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDT-NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCC-CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 4457899999999999998765 4569999986432 12345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC----
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---- 661 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---- 661 (797)
+++|+|.+++.+...++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999998888888889999999999999999998 99999999999999999999999999975331000
Q ss_pred --------------------------------------CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh
Q 003759 662 --------------------------------------TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703 (797)
Q Consensus 662 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt 703 (797)
........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 001123468999999999999999999999999999999999
Q ss_pred CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 003759 704 CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRP---TMKKVTLM 777 (797)
Q Consensus 704 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP---s~~eVl~~ 777 (797)
|+.||......+....+..+. .... . ..... ....+.+++..|+ .+|.+|+ ++.|+++.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~------~~~~-~-~~~~~------~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWE------TTLH-I-PSQAK------LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccC------cccc-C-CCCCC------CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999997654332211111110 0000 0 00000 0112344555555 4999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.35 Aligned_cols=262 Identities=21% Similarity=0.360 Sum_probs=197.1
Q ss_pred HHHhhhhhhCcccceeEEEEEEe---------------cCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhh
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA---------------YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKL 569 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~---------------~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l 569 (797)
..+.+.+.||+|+||.||++... ..+...||+|++..... ....+|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34566788999999999998532 12335699999875432 234579999999999999999999
Q ss_pred cccccccCceeeeeecccCCchhhhcccCC-----------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNP-----------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
++++..++..++||||+++++|.+++.... .+++.+...++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999986532 356778999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh--CCcCCCcccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC--CRKKFEQNVENE 715 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt--G~~p~~~~~~~~ 715 (797)
++++++.++|+|||++..+...... ......+++.|+|||......++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865433221 1122234678999999888889999999999999999998 667775433221
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. ................ +.+ ......+.+++.+||+.||++||++.||++.|+.
T Consensus 242 ~~----~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI----ENTGEFFRDQGRQVYL-PKP-----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH----HHHHHHHhhccccccC-CCC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111111110000000 000 0112456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.18 Aligned_cols=263 Identities=24% Similarity=0.388 Sum_probs=202.1
Q ss_pred HHhhhhhhCcccceeEEEEEEec---CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccc--cCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY---ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~---~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 580 (797)
.+.+.+.||+|+||.||+++... ..+..||||.+...... ..++|.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 34456789999999999998753 23567999999765433 35689999999999999999999999877 56789
Q ss_pred eeeecccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++|||+++++|.+++.... .+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997654 689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh-------hHHHHHHhhhcc
Q 003759 660 DQTR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM-------ILVDWAYDCYID 730 (797)
Q Consensus 660 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~-------~~~~~~~~~~~~ 730 (797)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2221 1112234567999999988899999999999999999999999986533221100 000000000000
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
..... ........+.+++.+|++.+|++||+|.||+++|+++
T Consensus 242 ~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLP---------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCC---------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000 0011124577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.40 Aligned_cols=200 Identities=23% Similarity=0.295 Sum_probs=170.8
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||+||+|+....+ ..||+|++.... ....+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTK-ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCC-CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 4568999999999999987554 469999986532 122346889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-----
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ----- 661 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~----- 661 (797)
++|+|.+++.+...++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998777888889999999999999999998 99999999999999999999999999975332100
Q ss_pred -----------------------------------------CcccccccccCccccccccccCCCCccCceehHHHHHHH
Q 003759 662 -----------------------------------------TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLE 700 (797)
Q Consensus 662 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~e 700 (797)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000122468999999999999999999999999999999
Q ss_pred HHhCCcCCCcccc
Q 003759 701 LICCRKKFEQNVE 713 (797)
Q Consensus 701 lltG~~p~~~~~~ 713 (797)
|++|+.||.....
T Consensus 241 lltG~~Pf~~~~~ 253 (382)
T cd05625 241 MLVGQPPFLAQTP 253 (382)
T ss_pred HHhCCCCCCCCCH
Confidence 9999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=292.11 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=199.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCc-hhhhcccccccC------c
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRN-LVKLLGFCNEDQ------H 578 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~------~ 578 (797)
+...++||+|.||+||+|+....+ ..||+|+++-... .......+|+.+++.++|+| |+++++++...+ .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g-~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTG-KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCC-CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 444567999999999999998766 4599999975433 34456788999999999999 999999998877 7
Q ss_pred eeeeeecccCCchhhhcccCC----CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 579 RLLVYEFISNGCLAGFLFKNP----KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
.+||+||+ .-+|..++.... .++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 88999998 557888886543 466678999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc-
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK- 732 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 732 (797)
+.+.-... ..+..+.|.-|.|||++.+. .|+...||||+||++.||+++++.|.+..+.++...+.+.... ..+..
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt-P~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT-PNEKDW 245 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC-CCccCC
Confidence 96653332 24445678899999999876 7999999999999999999999999887764433332221110 00000
Q ss_pred --cccccc------ch--hhhhhhHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 --LHLLVE------ND--EEALHDMMR--LKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 --~~~~~~------~~--~~~~~~~~~--~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...+.+ .. +........ .....+++.+|++.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000 00 111111000 1367788999999999999999999986
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.70 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=197.9
Q ss_pred hhhCcccceeEEEEEEecCCc--EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~--~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|++|.||+|.+...++ ..||+|.+..... ...+.|..|+.++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999865333 3699999987555 445689999999999999999999999988 889999999999
Q ss_pred CchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--c
Q 003759 589 GCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--T 664 (797)
Q Consensus 589 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~ 664 (797)
++|.+++.+.. .+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 688999999999999999999998 9999999999999999999999999999876442211 1
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.. ..... ........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~---~~~~~~~~------ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL----KKIDK---EGERLERP------ 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHh---cCCcCCCC------
Confidence 122346788999999998899999999999999999999 99998654322111 10000 00000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
......+.+++.+|++.+|++||++.+|++.|.
T Consensus 224 ---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 ---EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011235677899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.88 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
...+.+.+.||+|+||.||+|+.... ....|+||...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34455678899999999999987643 23468999886543 2334579999999999999999999998875 45789
Q ss_pred eeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 582 VYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
||||+++++|.+++.+. ..+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999764 4589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.........++..|+|||.+....++.++||||||++++||++ |..||......+.. ... ..+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~~----~~~~~~~~~~- 231 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GRI----ENGERLPMPP- 231 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHH----HcCCcCCCCC-
Confidence 3222223334568999999988889999999999999999996 99999665432211 111 1111000001
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 232 --------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 232 --------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112346678899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.24 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=202.3
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
....+.+.+.||+|+||.||+|.... ...|+||.+.... ...+++.+|+.++++++|+||+++++++..+...++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~--~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG--TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC--CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 34455667899999999999998753 3459999987533 34568999999999999999999999999989999999
Q ss_pred ecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 584 EFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||+++++|.+++... ..+++.++..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999764 3688999999999999999999998 99999999999999999999999999988765432
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.........+..|+|||.+.+..++.++||||||++++||++ |+.||....... ......... ... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~~~~~---~~~-~---- 225 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQVERGY---RMP-R---- 225 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC---CCC-C----
Confidence 222222334668999999998889999999999999999999 999986543211 111110000 000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 ~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PP-----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 012356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.79 Aligned_cols=240 Identities=27% Similarity=0.328 Sum_probs=195.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..|..+||+|.||+|+++.++..++ .+|||.+++...-. .+....|.+++... +||.+++++..|...++.+.||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e-~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNE-YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCc-EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456789999999999999987766 69999998754332 34567788887777 6999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+.+|++. ++.+...+++....-+|..|+.||.|||++ +||+||||.+|||||.+|.+||+||||++.--. ...
T Consensus 449 ey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g~ 523 (694)
T KOG0694|consen 449 EYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QGD 523 (694)
T ss_pred EecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC-CCC
Confidence 999999943 334557899999999999999999999998 999999999999999999999999999986332 233
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.+..+.|||.|||||++.+..|+..+|-|||||+|||||.|..||.++++++.-..+ .......
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--------~~d~~~y-------- 587 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--------VNDEVRY-------- 587 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------hcCCCCC--------
Confidence 566788999999999999999999999999999999999999999987665432211 1111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
+.--..+.+.++...+.++|++|.-+
T Consensus 588 --P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 --PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCcccHHHHHHHHHHhccCcccccCC
Confidence 11112345667778899999999876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.13 Aligned_cols=240 Identities=26% Similarity=0.311 Sum_probs=190.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCc-CchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNH-RNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+.||+|+||.||+|+....+ ..||+|++.... ....+.+..|..++..++| ++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTD-ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 45678999999999999987544 469999987532 2234567889999999865 568889999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 999999999998878889999999999999999999998 99999999999999999999999999987432211 12
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ....... ...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--------i~~~~~~-~~~------ 222 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS--------IMEHNVS-YPK------ 222 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCC-CCC------
Confidence 2334589999999999999999999999999999999999999975433211111 1111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
.....+.+++..|++.||++||+.
T Consensus 223 ---~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 ---SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011345678889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.70 Aligned_cols=238 Identities=25% Similarity=0.290 Sum_probs=186.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHH-HhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVN-AIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|+....+ ..||+|++..... ....++..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG-SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC-CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999987544 4699999864321 22234555554 5788899999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|...+.+...++......++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999999988777888899999999999999999998 99999999999999999999999999987532221 22334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||....... +. ......... +. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~----~~i~~~~~~-~~---------~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MY----DNILHKPLQ-LP---------G 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HH----HHHhcCCCC-CC---------C
Confidence 568999999999999899999999999999999999999997643211 11 111111111 00 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMK 772 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~ 772 (797)
.....+.+++.+|++.||++||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123466789999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.32 Aligned_cols=240 Identities=26% Similarity=0.311 Sum_probs=190.3
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+.||+|+||.||+|+.... +..||+|.+..... ...+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 3457899999999999998754 45699999875322 2223566778887777 68999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999987543222 12
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .+....... +.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~----~----~i~~~~~~~-----p~-- 222 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----Q----SIMEHNVAY-----PK-- 222 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH----H----HHHhCCCCC-----CC--
Confidence 23456899999999999999999999999999999999999999764332111 1 111111110 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
.....+.+++..|++.||++|++.
T Consensus 223 ---~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 ---SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---cCCHHHHHHHHHHcccCHHhcCCC
Confidence 012345678899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=299.63 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=196.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-----chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-----GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
...+.||+|++|.||++.....+ ..|++|.+...... ..+.+.+|+.++++++||||+++++++.+++..++|+
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~-~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTG-RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred cccceecCCCceEEEEEEEcCCC-cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 44678999999999999876543 46999988643221 1246888999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++++|.+++.....++......++.+++.||.|||+. +|+|+||+|+||++++++.++|+|||++.........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999998777888999999999999999999998 9999999999999999999999999998765432221
Q ss_pred cc--ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 664 TT--TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 664 ~~--~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ............
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~---- 229 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-------KIATQPTNPQLP---- 229 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-------HHhccCCCCCCC----
Confidence 11 23447789999999999889999999999999999999999986532211100 000000000000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..|++.+|++||++.++++.
T Consensus 230 -----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 -----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0112345678889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.44 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCC---cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc-cCce
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHR 579 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~---~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 579 (797)
...+.+.+.||+|+||.||+|.....+ +..|++|++..... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 445566789999999999999987522 56799999875432 224568899999999999999999998766 5678
Q ss_pred eeeeecccCCchhhhcccC--------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEee
Q 003759 580 LLVYEFISNGCLAGFLFKN--------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 651 (797)
++++||+++++|.+++... ..+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643 3578999999999999999999998 9999999999999999999999999
Q ss_pred cCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhc
Q 003759 652 GLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 652 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +..+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~--- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MAAYLKD--- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----HHHHHHc---
Confidence 999865433221 1122335678999999998889999999999999999999 999996542211 1111111
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....... ......+.+++.+|++.||++|||+.+|++.|+.+.
T Consensus 235 ~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRLAQP----------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCCCCC----------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0010000 001234678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.31 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=195.4
Q ss_pred HhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.||+|++|.||+|.+... .+..|++|.+...... ....|..|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 44457899999999999998751 3456999988654322 235689999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCC-------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEeec
Q 003759 583 YEFISNGCLAGFLFKNP-------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDFG 652 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfg 652 (797)
|||+++++|.+++.+.. .+++..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999986542 478899999999999999999998 999999999999998754 59999999
Q ss_pred CccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcc
Q 003759 653 LAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 653 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+ +...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~---~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEFVTG---G 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHc---C
Confidence 99866322211 1112223567999999998899999999999999999997 999987543221 1111100 1
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
..... + ......+.+++..|++.+|++||++.+|++.|+
T Consensus 238 ~~~~~-----~-----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDP-----P-----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCC-----C-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11100 0 011235677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.83 Aligned_cols=241 Identities=27% Similarity=0.279 Sum_probs=187.8
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHH-HHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEV-NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||+||+++....+ ..||+|++.... .....++..|. .+++.++|+||+++++++.+++..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE-KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999987544 469999986432 12223444444 45677899999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.....++......++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 999999998877888888899999999999999998 99999999999999999999999999987543222 22334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ....... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~----i~~~~~~--~~~-------- 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DN----ILNKPLQ--LKP-------- 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH----HH----HHhCCcC--CCC--------
Confidence 56899999999999999999999999999999999999999754322111 11 1111110 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
.....+.+++..|++.||.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0113456788889999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.15 Aligned_cols=249 Identities=27% Similarity=0.303 Sum_probs=195.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
...+.||+|+||+||++..... +..||+|++..... .....+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCC-CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 3456799999999999987654 45699999865321 2234578899999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888643 4588999999999999999999998 999999999999999999999999999886543222
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+ ...+...... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~-~------- 224 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKEDQEE-Y------- 224 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HHHhhhcccc-c-------
Confidence 22345889999999999888999999999999999999999999764332111111 1111110000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
.......+.+++..|++.||++|| ++.++++.
T Consensus 225 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 --SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011123456788999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.96 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=199.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|... +..||+|.+..... ..+++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 4556788999999999999874 34599999976543 4578999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997654 689999999999999999999998 999999999999999999999999999987632221
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
....+..|+|||.+....++.++||||||++++||++ |..||......+ +..... .........
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~----~~~~~~~~~----- 222 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVE----KGYRMEAPE----- 222 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHh----cCCCCCCcc-----
Confidence 2234567999999988889999999999999999997 999986543221 111111 110000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.....+.+++.+|++.+|++||+++|++++|+.+
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 ----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1124567889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=298.52 Aligned_cols=248 Identities=31% Similarity=0.447 Sum_probs=201.0
Q ss_pred hhhCcccceeEEEEEEecC--CcEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.||+|+||.||+|+.... .+..|++|.+....... .+++.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3689999999999998753 24569999997654433 56889999999999999999999999999999999999999
Q ss_pred CchhhhcccC---------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 589 GCLAGFLFKN---------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 589 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++|.+++... ..+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 6789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 660 DQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 660 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+. .. ....+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~----~~~~~~~~~~~ 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----LE----YLRKGYRLPKP 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH----HH----HHHcCCCCCCC
Confidence 331 22233457889999999988889999999999999999999 5899876532211 11 11111110000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
......+.+++..|++.+|++|||+.|+++.|+
T Consensus 230 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 ---------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.22 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=190.1
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.||+|+||+||++.....+ ..||+|+++.... ...+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKND-QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred eeeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 6899999999999987654 4699999975422 2234578899998888 699999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 99999988778899999999999999999999998 99999999999999999999999999987532211 122335
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..+............ + +. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~-~----p~-----~ 225 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIR-I----PR-----F 225 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCC-C----CC-----C
Confidence 68999999999999999999999999999999999999996533221110 011111111111111 0 00 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
....+.+++..||+.||++||++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 11335678889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.28 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=199.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+|+.... +..||+|.++.........+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNT-GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCC-CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4566778999999999999988654 456999998765444445688899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++.+.+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999987654322 122
Q ss_pred ccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 666 TAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
....|+..|+|||++. ...++.++|||||||++|||++|..||............ ........... .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~----~--- 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TKSNFQPPKLK----D--- 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hccCCCCCccc----c---
Confidence 3345889999999974 446889999999999999999999998654322111100 00000000000 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..|++.+|++||++++|++.
T Consensus 234 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 ---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00011346678999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.32 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=199.2
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..+.+.+.++||+|+||.||++..... ..+++|.+... ....+.|.+|+.++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~--~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKH--TKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCC--ccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 345566778999999999999986533 34899988653 2234678999999999999999999999887 7789999
Q ss_pred ecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 584 EFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||+++++|.+++.+. ..+++.++..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999753 4578889999999999999999998 99999999999999999999999999997664433
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
........++..|+|||++....++.++||||||++++++++ |+.||....... +.... ..+.......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~-- 226 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRAL----ERGYRMPRPE-- 226 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----hCCCCCCCcc--
Confidence 222223345677999999998889999999999999999999 888986543221 11111 1111000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++.+|++.+|++||++.+++++|+.
T Consensus 227 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 -------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.27 Aligned_cols=243 Identities=25% Similarity=0.311 Sum_probs=188.7
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHh---hccCcCchhhhcccccccCceeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAI---GQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.||+|+||.||+|.....+ ..||||+++... ....+.+..|+.++ +.++||||+++++++...+..++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTG-ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 4568999999999999887544 469999997532 12234566666554 5678999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++++|...+.+ ..+++.....++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999988854 5689999999999999999999998 99999999999999999999999999987533222 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.... +...... . +.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~--------i~~~~~~-~----p~- 222 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS--------IVNDEVR-Y----PR- 222 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCC-C----CC-
Confidence 22345689999999999999999999999999999999999999976533211110 1111110 0 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
.....+.+++..||+.||++|| ++.++++
T Consensus 223 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 ----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0123456788999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.88 Aligned_cols=270 Identities=23% Similarity=0.271 Sum_probs=204.5
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc-----cCceeeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-----DQHRLLVY 583 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~ 583 (797)
.+.||+|+||.|.+++....+ ..||||++.+... ...++..+|+++|+.++|+||+.+++.+.. -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~-~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTG-EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCC-CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 367999999999999998766 4599999975333 334678899999999999999999998755 45789999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-C
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-T 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~ 662 (797)
|+| ..+|...++.++.++......+..||++||.|+|+. +|+||||||+|+|++.+..+||+|||||+...... .
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999 678999998888899999999999999999999998 99999999999999999999999999999875431 2
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDEKLH 734 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 734 (797)
...+..+.|.-|.|||++.. ..||...||||.|||+.||++|++.|.+...-++-..+.+... ..+......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 33455668999999998754 5799999999999999999999999987655433222222110 000000000
Q ss_pred ccccch-------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCC
Q 003759 735 LLVEND-------EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPI 786 (797)
Q Consensus 735 ~~~~~~-------~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~ 786 (797)
..+.+. ...... ..-..+++++.+||..||.+|+|++|.++. |+...++..
T Consensus 262 ~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 000000 001100 111356788999999999999999999874 444444443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=297.03 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=198.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|++|.||+++....+ ..|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADK-RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCC-cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 34578999999999999987554 45999988643 2234467889999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++... ..+++.+...++.+++.||.|||+. +++|+||||+||++++++.+||+|||++..+..... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 999999999764 5688899999999999999999998 999999999999999999999999999886654322 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||++.+..++.++||||||++++||++|+.||....... .... ...+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----~~~~~~~~~~~------ 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----LILK----IIRGVFPPVSQ------ 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHcCCCCCCcc------
Confidence 233457889999999999899999999999999999999999997554211 1111 11111111110
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++.+|++.+|++||++.++++.
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112356788999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.49 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=202.0
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhccc-ccc------cCceee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGF-CNE------DQHRLL 581 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~l 581 (797)
+.+.|.+|||+.||.|.+..++ ..+|+|++-...+...+...+|+++|++|+ |+|||.+++. ... .-+.+|
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~-~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGG-KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCC-ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3567999999999999987654 569999986655666678999999999996 9999999993 211 136789
Q ss_pred eeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 582 VYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
.||||++|.|-+++..+ ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.|.....
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999744 5699999999999999999999986 77899999999999999999999999999874322
Q ss_pred CCCcc--------cccccccCcccccccc---ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhh
Q 003759 660 DQTRT--------TTAIRGTRGYVAPEWF---KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 660 ~~~~~--------~~~~~gt~~y~aPE~~---~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
..... .-...-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+...... +
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----I-------- 266 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----I-------- 266 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----E--------
Confidence 22100 0011268999999987 56789999999999999999999999997653211 1
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
..++.... .......++..||..||++||++||++-+|+..+-.++..+.|
T Consensus 267 lng~Y~~P--------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 267 LNGNYSFP--------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred EeccccCC--------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 11111111 1123345677888899999999999999999999887766543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.37 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=188.4
Q ss_pred hhhCcccceeEEEEEEecCC------cEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 512 DELGRGAFATVHKGVLAYEN------KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.||+|+||.||+|.....+ ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46899999999999875322 234888888655444456789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc--------EEEEeecCccc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT--------ARISDFGLAKI 656 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~Dfgla~~ 656 (797)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+|+||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999765 4578999999999999999999998 9999999999999987765 59999998865
Q ss_pred cccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCC-cCCCccccccchhhHHHHHHhhhcccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCR-KKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
.... ....+++.|+|||++.+. .++.++||||||+++|||++|. .|+....... .... . ....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~~---~-----~~~~- 222 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQF---Y-----EDRH- 222 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHHH---H-----Hccc-
Confidence 4321 223477889999999874 5799999999999999999995 4543322111 1000 0 0000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.+.. .....+.+++..||+.||++|||+++|++.|+
T Consensus 223 ~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 QLPA---------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cCCC---------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 01134678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.85 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=200.6
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecC------CcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccc
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYE------NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNE 575 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 575 (797)
....+.+.+.||+|+||.||++..... ....+|+|.++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 345567788999999999999986432 124599999875422 2335688899999999 79999999999999
Q ss_pred cCceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NIL 639 (797)
.+..++||||+++++|.+++... ..+++.++++++.|++.||+|||+. +++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 99999999999999999999643 2478889999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccch
Q 003759 640 LDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQ 717 (797)
Q Consensus 640 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 717 (797)
+++++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 99999999999999876543221 11112224568999999998889999999999999999998 888886533211
Q ss_pred hhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 718 MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
+.. ........... ......+.+++..|++.+|++||+|.+|++.|+.+.+
T Consensus 251 --~~~----~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 --LFK----LLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --HHH----HHHcCCCCCCC---------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111 11111110000 0112356678899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.09 Aligned_cols=241 Identities=29% Similarity=0.318 Sum_probs=188.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHH-HhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVN-AIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+++....+ ..||+|++..... ...+++..|.. +++.++||||+++++.+..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG-KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36899999999999887544 5699999865321 22344555554 4677899999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|..++.+...+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 999999998888899999999999999999999998 99999999999999999999999999987532221 22234
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ........... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--------~~~~~~~~~~~--~~-------- 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--------YDNILHKPLVL--RP-------- 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--------HHHHHcCCccC--CC--------
Confidence 5689999999999999999999999999999999999999975432211 01111111110 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
.....+.+++..|++.+|++||++.+.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0113456788889999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=312.85 Aligned_cols=244 Identities=27% Similarity=0.340 Sum_probs=198.7
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchh
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLA 592 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (797)
+||+|.||+||.|++... +..+|||.+........+.+.+|+.+-++++|+|||+++|.+.+++..-+.||.+++|+|.
T Consensus 582 VLGKGTYG~VYA~RD~~t-qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT-QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccc-eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 599999999999998765 4569999998766666677899999999999999999999999999999999999999999
Q ss_pred hhcccC-CCC--ChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCccccccCCCcccccc
Q 003759 593 GFLFKN-PKP--SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 593 ~~l~~~-~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
++|... +++ ++.+.--+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||-++.+..- ...+..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 999755 555 6777888899999999999998 999999999999996 4688999999999876432 3344556
Q ss_pred cccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 669 RGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
.||..|||||++..+ .|..++|||||||++.||.||++||............+. ... ..+.. +
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG---myK--------vHP~i----P 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG---MYK--------VHPPI----P 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---cee--------cCCCC----c
Confidence 799999999999876 489999999999999999999999976544332221111 100 11111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..-..++..++++|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 112245667999999999999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.66 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=200.4
Q ss_pred HHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
...+.+.+.||+|+||.||+|...+ ..+..||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4456667899999999999997653 23457999998643322 234688899999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccC----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 580 LLVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. +|+|+||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999642 2345667889999999999999998 99999999999999999999999
Q ss_pred eecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 650 DFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 650 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .. ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~----~~ 233 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VL----KF 233 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HH----HH
Confidence 9999886543222 11222235678999999998899999999999999999999 778886543221 11 11
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
...+....... .....+.+++.+|++.||++|||+.++++.|++....
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 234 VMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHcCCCCCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 11111111000 1124577889999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.95 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=201.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+.... +..|++|.++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLD-GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCC-CCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 45678899999999999998754 4469999886422 2224578999999999999999999999999999999999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+++++|.+++.. ...+++.++..++.++++||+|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998853 24578899999999999999999998 9999999999999999999999999998765433
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... .....+.....
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~~---- 228 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLC----KKIEKCDYPPL---- 228 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--HHHH----hhhhcCCCCCC----
Confidence 22 1223457889999999998889999999999999999999999986543211 0011 11111111100
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+ .......+.+++..|++.+|++||++.+|+++|+.+.
T Consensus 229 ~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 P----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 1112235678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=301.45 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=195.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|..... +..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKET-GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCC-CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 45567899999999999988754 45689999875444445678899999999999999999999999999999999999
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|..++.+ ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999988765 45689999999999999999999998 99999999999999999999999999987643222 1222
Q ss_pred cccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 667 AIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
...+++.|+|||++. +..++.++|||||||++|||++|+.||......+..... . . ........+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~----~-~~~~~~~~~-- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI---A----K-SEPPTLAQP-- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH---h----h-cCCCCCCCc--
Confidence 345889999999984 445788999999999999999999998654322111110 0 0 000000000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..||+.||++||++.++++.
T Consensus 232 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 -----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112346788899999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=298.67 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=191.0
Q ss_pred hhhCcccceeEEEEEEecC--CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccc-ccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCN-EDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|..... ....||+|++..... ...+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 3689999999999987532 346799999864322 23457889999999999999999999775 4556899999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC---c
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT---R 663 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---~ 663 (797)
+++|.+++.+. ..+++...+.++.++++||+|||+. +++|+||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999754 4567788899999999999999998 999999999999999999999999999976533211 1
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCC-cCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCR-KKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......++..|+|||.+.+..++.++||||||+++|||++|. .|+...... ....... .+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~---- 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLL----QGRRLLQPE---- 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHh----cCCCCCCCC----
Confidence 112234567899999998889999999999999999999964 555432211 1111111 111000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++..||+.+|++||++.+|++.|+++.
T Consensus 226 -----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 -----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01134667899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.83 Aligned_cols=255 Identities=20% Similarity=0.228 Sum_probs=193.9
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
...+.+.+.||+|+||.||++.....+ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+++..++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCC-cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 344556678999999999999987654 469999986421 1223457889999999999999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999998543 578888889999999999999998 99999999999999999999999999998765433
Q ss_pred CcccccccccCccccccccccCC----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLP----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
........||+.|+|||++.... ++.++|||||||++|||++|+.||.......... ............
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~~~~~ 269 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-------KIMNHKNSLTFP 269 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH-------HHHcCCCcccCC
Confidence 33334456999999999987543 7899999999999999999999997643221111 100000000000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSL--RPTMKKVTLML 778 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~eVl~~L 778 (797)
+. ......+.+++..|++.++.+ ||++.|+++..
T Consensus 270 ~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 270 DD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred Cc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00 011233556778899844443 78999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=302.89 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred HHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
.+.+.+.||+|+||.||++.... .....||+|++..... ...++|.+|+.++++++||||+++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 34456789999999999998753 2346799999875432 234578999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccC----------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 003759 582 VYEFISNGCLAGFLFKN----------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NIL 639 (797)
|+||+++++|.+++... ..+++..++.++.+++.||+|||+. +++|+||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 99999999999998632 2367788899999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccch
Q 003759 640 LDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQ 717 (797)
Q Consensus 640 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 717 (797)
+++++.+||+|||++..+..... ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-- 240 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-- 240 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999876533221 11222234667999999998899999999999999999998 888886543221
Q ss_pred hhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 718 MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. .....+....... ....++.+++.+|++.+|++|||+.||++.|++
T Consensus 241 --~~----~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VI----YYVRDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHhcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 1111121111111 112456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.49 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=197.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.+.||+|+||.||++.....+ ..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++|+||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSG-LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCC-eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34578999999999999887544 4689998865322 223468899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.+...+++.....++.|+++||.|||+. .+++|+||||+||++++++.+||+|||++....... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 999999998878889999999999999999999973 289999999999999999999999999987543221 223
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc------c-------
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL------H------- 734 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~------- 734 (797)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ............ .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF-GRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh-cCccccccccCCcccccCCCCCccch
Confidence 45788999999998888999999999999999999999998644321111000 000000000000 0
Q ss_pred --------ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 --------LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 --------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..................+.+++.+|++.+|++||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000112357789999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.03 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=184.2
Q ss_pred hhCcccceeEEEEEEecC-CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+||+|+||.||+|..... ....+++|.+..... .....|.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 689999999999976533 335688898764332 223568899999999999999999999999999999999999999
Q ss_pred hhhhcccCC-----CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cc
Q 003759 591 LAGFLFKNP-----KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RT 664 (797)
Q Consensus 591 L~~~l~~~~-----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 664 (797)
|.+++.... ..++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999996542 245677889999999999999998 999999999999999999999999999865432211 11
Q ss_pred cccccccCcccccccccc-------CCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 665 TTAIRGTRGYVAPEWFKS-------LPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.....+++.|+|||++.. ..++.++||||||+++|||++ |..||......+. +. ........ .+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~----~~~~~~~~-~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK----QVVREQDI-KL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH----HHhhccCc-cC
Confidence 122335678999998743 356889999999999999999 7778765432211 11 11111110 01
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
..+.... .....+.+++..|+ .||++||++++|+++|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111000 11123344566687 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.82 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=198.2
Q ss_pred HHhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccccc--Ccee
Q 003759 507 TQGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 580 (797)
++...+.||+|+||.||++... ...+..||+|.++.... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4455678999999999999753 22346799999875432 2345789999999999999999999998775 5688
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+||||+++++|.+++.+. ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++..+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999654 4589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc--------chhhHHHHHHhhhc
Q 003759 660 DQTR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE--------NQMILVDWAYDCYI 729 (797)
Q Consensus 660 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~ 729 (797)
.... ......++..|+|||++.+..++.++||||||+++|||++++.|........ ......... ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHH
Confidence 3221 1223446778999999988889999999999999999999877653221100 000000000 0011
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.+...... ......+.+++..|++.+|++||++.+|++.|+++
T Consensus 241 ~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRP---------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11100000 01124577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.08 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=197.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|+....+ ..|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~-~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCC-cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 344567999999999999876443 4699999876555556778999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.+ ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......... ...
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~ 175 (296)
T cd06654 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175 (296)
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCc
Confidence 9999999854 4578899999999999999999998 9999999999999999999999999998765433221 223
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ +. .....+.. . ... . .
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~----~~~~~~~~-~-~~~-~-----~ 240 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LY----LIATNGTP-E-LQN-P-----E 240 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HH----HHhcCCCC-C-CCC-c-----c
Confidence 3578899999999988899999999999999999999999965432111 10 00001100 0 000 0 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++.+|++.+|++||++.||++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111345678899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.00 Aligned_cols=260 Identities=23% Similarity=0.285 Sum_probs=203.8
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
....+.+.+.||+|+||+||++.....+ ..||+|.+.... ....+++.+|+++++.++||||+++++++...+..++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTG-TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCC-cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3455677889999999999999886544 468999876432 23356789999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++++|.+++.+...+++.....++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999999998777889999999999999999999973 279999999999999999999999999986543221
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc----hhhHHHHHHhhhcccccccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN----QMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+. ...+.+.......+. ...
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 232 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPR--- 232 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCC---
Confidence 1234588999999999888899999999999999999999999976543211 111111111111110 000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
.........+.+++.+|++.||++||++.||+++.
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 -----LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00011223567788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.41 Aligned_cols=240 Identities=26% Similarity=0.322 Sum_probs=190.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 584 (797)
++.+.||+|+||+||++.....+ ..||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTD-ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45678999999999999887554 469999987532 223345778888888874 6788889999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999987543222 12
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... . .+....... +.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~----~----~i~~~~~~~-----p~-- 222 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----Q----SIMEHNVSY-----PK-- 222 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH----H----HHHhCCCCC-----Cc--
Confidence 23345899999999999989999999999999999999999999765332111 1 111111110 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
.....+.+++..|++.+|.+|++.
T Consensus 223 ---~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ---SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---cCCHHHHHHHHHHcccCHhhCCCC
Confidence 011345678889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.33 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=197.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+...+.||+|+||.||+|+.... +..||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRT-KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCC-CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3455567899999999999988654 4569999987433 2234578999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.. ..+++..+..++.++++|+.|||+. +++|+||+|+||++++++.+||+|||++..+..... .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999998854 5678899999999999999999998 999999999999999999999999999876543221 1
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~-------- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNSPPTL-------- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCCCCCC--------
Confidence 222357889999999999889999999999999999999999986443221100 0001110000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..|++.+|++||+|.+|+++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 -EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00112346788899999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.25 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=198.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc--cCcCchhhhcccccccC----ceeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--TNHRNLVKLLGFCNEDQ----HRLLVY 583 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~ 583 (797)
+.+.||+|.||.||+|.++.+ .||||++.. .+++.+.+|.+++.. |+|+||+.+++.-..++ +.+||.
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe---~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGE---DVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEecCccccceeeccccCC---ceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 346699999999999999744 399999864 345667777777766 59999999998765543 679999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE-----CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
+|.++|||+|+|.+ ..++....++++..+|.||+|||.+ ..+.|.|||||+.|||+..++...|+|+|||....
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999976 6788999999999999999999954 46789999999999999999999999999998776
Q ss_pred cCCC---cccccccccCccccccccccCC----C--CccCceehHHHHHHHHHhC----------CcCCCccccccchhh
Q 003759 659 ADQT---RTTTAIRGTRGYVAPEWFKSLP----I--TMKVDIYSFGVMLLELICC----------RKKFEQNVENENQMI 719 (797)
Q Consensus 659 ~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--t~~sDVwS~Gvll~elltG----------~~p~~~~~~~~~~~~ 719 (797)
.+.. ......+||.+|||||++...- + -..+||||||.|+||+... +.||......+....
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 5532 3344567999999999996531 1 2459999999999998743 345554433332221
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
-+ ++.+-..++...+. ........+..+.+++..||..+|.-|-|+--|-+.|.++...+
T Consensus 448 eM---rkVVCv~~~RP~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 448 EM---RKVVCVQKLRPNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred HH---hcceeecccCCCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 11 11111111211111 22233445667889999999999999999999999988776543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.61 Aligned_cols=201 Identities=23% Similarity=0.305 Sum_probs=171.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+++....+ ..||+|.+.... ......+.+|..++..++|+||+++++++.+++..++|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTE-RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 345678999999999999887544 469999986421 1223457889999999999999999999999999999999
Q ss_pred cccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++|+|.+++.+ ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999976 46788899999999999999999998 9999999999999999999999999999876544333
Q ss_pred ccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 664 TTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
......|++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 3334568999999999875 467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.52 Aligned_cols=267 Identities=21% Similarity=0.217 Sum_probs=198.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-----chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-----GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.||+|++|.||+|.....+ ..|+||++...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETG-RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCC-cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 34567999999999999987544 46999999754322 2345778999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+ +++|.+++.... .+++..+..++.||++||+|||++ +|+|+||||+||+++.++.+||+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 999999997765 789999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh----hhc-ccccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD----CYI-DEKLHLL 736 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~ 736 (797)
. .....+++.|+|||.+.+ ..++.++||||||++++||++|..+|......+....+...... .+. .......
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 158 K-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred c-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 1 122346788999998855 46789999999999999999998777654332211111110000 000 0000000
Q ss_pred cc-----chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 003759 737 VE-----NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGV 781 (797)
Q Consensus 737 ~~-----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~ 781 (797)
.. ..............+.+++..|++.||++|||+.||++. +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00 000000011123567889999999999999999999986 5443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.96 Aligned_cols=263 Identities=20% Similarity=0.213 Sum_probs=198.8
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecC-CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
...+.+.+.||+|+||.||++..... .+..|++|.+... +.+.+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 34566778899999999999976432 3467899987642 34568999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|++. ++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9985 67888887677899999999999999999999998 999999999999999999999999999976544322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc----
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE---- 738 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 738 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ............
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccchh
Confidence 222345689999999999999999999999999999999999999976543221111111111 000000000000
Q ss_pred -------------c---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 739 -------------N---DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 739 -------------~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. .++..........+.+++..|++.||++|||+.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000112346678899999999999999999876
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.94 Aligned_cols=264 Identities=25% Similarity=0.298 Sum_probs=197.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|..... +..||+|++...... ..+.+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCC-CCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 34567899999999999998754 346999987643222 345788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.++......+++.+++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 99999998877666789999999999999999999998 99999999999999999999999999988654332 222
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhh-------cccc-----
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCY-------IDEK----- 732 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~----- 732 (797)
....++..|+|||++.+ ..++.++||||||++++||++|+.||......+....+........ ....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 33447889999999875 4578899999999999999999999865433221111111110000 0000
Q ss_pred -ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 -LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 -~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....................+.+++..||+.+|++||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000000011346788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.69 Aligned_cols=264 Identities=26% Similarity=0.367 Sum_probs=203.9
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecC------CcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccc
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYE------NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFC 573 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 573 (797)
++....+.+.+.||+|+||.||++..... ....||+|.++.... ...+++.+|+.++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 44555677788999999999999975421 124689998875332 2345789999999999 899999999999
Q ss_pred cccCceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 003759 574 NEDQHRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQN 637 (797)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~N 637 (797)
..++..++++||+++|+|.+++.+. ..+++.+++.++.|++.||+|||+. +++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999998642 2467888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCcccccc
Q 003759 638 ILLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENE 715 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~ 715 (797)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865432211 1222234567999999999899999999999999999998 888886543221
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
.. ..+..+....... .....+.+++..|++.+|++||++.|+++.|+.+....
T Consensus 245 ~~--------~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LF--------KLLKEGHRMDKPA---------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH--------HHHHcCCCCCCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 1111111110000 11234668899999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=282.89 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=195.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecc--cCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..+.+.++||+|.|+.||+......+ +..|+|.+.. ....+.+++.+|+.+.+.++||||+++.+-..++...+||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg-~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccch-HHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 34667789999999999998776544 3477777642 23345678899999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCccccccC
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKAD 660 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~ 660 (797)
|+|+++.|..-+-.+...++...-..+.||+++|.|+|.+ +|||||+||+|+||. ..--+||+|||+|..++
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999876655545556667778899999999999998 999999999999994 33458999999999887
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.........|||+|||||+++..+++..+|||+.||+||-|+.|..||.+...... ++.++.+... -.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl--------ye~I~~g~yd----~~ 232 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--------YEQIKAGAYD----YP 232 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH--------HHHHhccccC----CC
Confidence 33444556799999999999999999999999999999999999999977543221 2222222211 11
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+.... -.+...+++.+||..||.+|.|+.|.+.
T Consensus 233 ~~~w~~--is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDT--VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCc--CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 101000 1123456788899999999999998764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=299.36 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=194.1
Q ss_pred hhCcccceeEEEEEEecC-----CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 513 ELGRGAFATVHKGVLAYE-----NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.||+|+||.||+|+..+. ++..+++|.+..... ....+|.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 589999999999987532 235699998865432 34567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-----cEEEEeecCc
Q 003759 587 SNGCLAGFLFKN-------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-----TARISDFGLA 654 (797)
Q Consensus 587 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~Dfgla 654 (797)
++++|.+++... ..+++.+++.++.+++.||+|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998642 3467889999999999999999987 999999999999999887 8999999999
Q ss_pred cccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 655 KILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 655 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ..... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~~----~~~~ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----VLQHV----TAGG 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHHH----hcCC
Confidence 76543221 11122235678999999999999999999999999999998 999986432211 11111 1111
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
..... ......+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccCCc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000 0112356788999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=307.28 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=193.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.++||+|+||.||+|+....+ ..||+|+++.... .....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCC-CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 445678999999999999887544 4699999875432 23346788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++ +|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 75 777777544 4578889999999999999999998 999999999999999999999999999876433222 12
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhccccccccc
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYIDEKLHLLV 737 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 737 (797)
....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+.... +..+.........
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 22347889999998865 468999999999999999999999997654332211111100 0000000000000
Q ss_pred c---chhhh--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 E---NDEEA--LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~---~~~~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
+ ..... .........+.+++..|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00000 000011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=299.02 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=196.4
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch---------HHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---------KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~---------~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
.+...||+|++|.||+|..... +..||+|.+........ +.+..|+.++++++||||+++++++.+.+..
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASS-GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred cccceeecCCCeEEEEEEecCC-CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 3557899999999999987654 34699998865433221 4578899999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++++||+++++|.+++.....+++.....++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998777888999999999999999999998 999999999999999999999999999987653
Q ss_pred CCC-----cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 660 DQT-----RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 660 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ + ... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~----~~~-~~~~~~ 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I----FKI-GENASP 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H----HHH-hccCCC
Confidence 211 111223478899999999988899999999999999999999999975432111 0 000 000000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... ......+.+++..||+.||++||++.||++
T Consensus 231 ~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 EIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 011234667888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.41 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=192.0
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
..||+|+||.||+|+.... +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~-~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLST-QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCC-CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 4799999999999988654 456999998765545566899999999999999999999999999999999999999999
Q ss_pred hhhcccC-CCC--ChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCCCccccc
Q 003759 592 AGFLFKN-PKP--SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 592 ~~~l~~~-~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
.+++... ..+ +...+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999754 344 7788889999999999999998 9999999999999976 67999999999876543221 2223
Q ss_pred ccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 668 IRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
..+++.|+|||++... .++.++||||||+++|+|++|+.||.......... +.... ...... +
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~--~~~~~~-~-------- 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGM--FKIHPE-I-------- 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhh--hccCCC-C--------
Confidence 3478899999998664 37899999999999999999999986532211110 00000 000000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+.+++.+||+.+|++|||+.||++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00112346678899999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.49 Aligned_cols=192 Identities=23% Similarity=0.209 Sum_probs=164.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||++.....+ ..||||... ...+.+|+.++++++|+||+++++++..++..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~-~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYP-QRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCC-CEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 344578999999999999987654 469999643 2346789999999999999999999999999999999995
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-ccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTT 665 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~ 665 (797)
++|.+++... ..+++.+++.|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6888887654 5689999999999999999999998 999999999999999999999999999986643322 122
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCc
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQ 710 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~ 710 (797)
....||+.|+|||++.+..++.++|||||||+||||++|..++..
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 345689999999999999999999999999999999998876643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.01 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=183.7
Q ss_pred hhCcccceeEEEEEEecCC-cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYEN-KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~-~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+||+|+||.||+|...... ...+++|.+..... ...+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999765433 23467777664332 334679999999999999999999999999999999999999999
Q ss_pred hhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-Cccc
Q 003759 591 LAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRTT 665 (797)
Q Consensus 591 L~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~ 665 (797)
|.+++.+. ...+......++.||++||+|||+. +++|+||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753 2345667789999999999999998 99999999999999999999999999986432211 1122
Q ss_pred ccccccCcccccccccc-------CCCCccCceehHHHHHHHHHhC-CcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 666 TAIRGTRGYVAPEWFKS-------LPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||......+. + . ..... ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~-~---~~~~~-~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---L-N---HVIKD-QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---H-H---HHHhh-cccccC
Confidence 23457889999998853 2457899999999999999975 567754322111 1 1 11111 111111
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
++..... ...++.+++..|+ .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111100 1134456777798 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.26 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=192.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccccccc------Cce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNED------QHR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~------~~~ 579 (797)
.+.+.+.||+|+||.||+|..... +..||+|++... .....++..|+.++.++ +|+||+++++++... ...
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~-~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCC-CcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 345567899999999999988754 456999998653 23456788999999998 799999999998653 457
Q ss_pred eeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 580 LLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999998753 4678999999999999999999998 9999999999999999999999999998865
Q ss_pred ccCCCcccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
..... ......|++.|+|||++. +..++.++|||||||++|||++|+.||............ ....
T Consensus 162 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--------~~~~ 232 (272)
T cd06637 162 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNP 232 (272)
T ss_pred ccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH--------hcCC
Confidence 43222 223345889999999986 345788999999999999999999999654322111100 0000
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... .....+.+++.+||+.+|.+|||+.+|++
T Consensus 233 ~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000 11134677889999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.17 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=199.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|+....+ ..+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||+
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETG-QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCC-cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3556788999999999999987643 4699999875432 678999999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++.. ...+++.....++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 99999999865 45689999999999999999999998 999999999999999999999999999887644321 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....++..|+|||.+.+..++.++||||||+++++|++|+.||............ .. ........
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~-~~~~~~~~------ 221 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PN-KPPPTLSD------ 221 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------cc-CCCCCCCc------
Confidence 2334788999999999989999999999999999999999999754332111100 00 00000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......+.+++..|++.||++|||++||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1111235677889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.30 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=198.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEec------CCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccC
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 577 (797)
..+.+.+.||+|+||.||+++... .....+|+|.+..... ....++..|+.++.++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 445567899999999999997531 2335689999875332 2235688999999999 6999999999999999
Q ss_pred ceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD 641 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~ 641 (797)
..++++||+++|+|.+++... ..+++.+...++.|++.||.|||++ +++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999998542 3478888999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhh
Q 003759 642 DSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMI 719 (797)
Q Consensus 642 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 719 (797)
+++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999986543221 11112224567999999988889999999999999999999 888886543211
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+.. ....+....... .....+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 245 ~~~----~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 LFK----LLREGHRMDKPS---------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHH----HHHcCCCCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 111111110000 11234567889999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.67 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=201.9
Q ss_pred hhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.++||+|.||+|++|.+...+ ...||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4588999999999999887544 367999999876554 56789999999999999999999999887 7889999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc-
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR- 663 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 663 (797)
+.|+|.+.|++. ..+.......++.|||.||.||..+ ++|||||..+|+||-..-.+||+||||.+.+......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999873 4567778889999999999999998 9999999999999999999999999999988654432
Q ss_pred ccc-cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 664 TTT-AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 664 ~~~-~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.+. ...-...|.|||.++...++.++|||+|||+||||+| |+.||.+....... ..+|...
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-----------------~~iD~~e 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-----------------KNIDAGE 332 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-----------------Hhccccc
Confidence 222 2234568999999999999999999999999999999 78899765432211 1112111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+-.......+++.++++.||..+|++|||+..|.+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 111233455778889999999999999999999743
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.26 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=198.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|+.... +..||+|++..... ...+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRET-GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCC-CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 34557899999999999998754 45699998864322 2345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|..++.....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887777789999999999999999999998 999999999999999999999999999987644321 12
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hhccccc-ccc
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CYIDEKL-HLL 736 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~ 736 (797)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... .+..... ...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 22346788999999876 45789999999999999999999999765433221111110000 0000000 000
Q ss_pred ccchhhhhhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 VENDEEALHD-----MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..+....... ......+.+++..|++.+|++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.29 Aligned_cols=195 Identities=22% Similarity=0.346 Sum_probs=159.1
Q ss_pred hhhCcccceeEEEEEEecC-CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc--cCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~Ey~~~ 588 (797)
.+||+|+||+||+|+.... ....||+|.+... .....+.+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 5799999999999987542 3467999998753 234567889999999999999999998754 4567899999864
Q ss_pred Cchhhhccc---------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCcEEEEeecCcc
Q 003759 589 GCLAGFLFK---------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAK 655 (797)
Q Consensus 589 gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~ 655 (797)
+|.+++.. ...++......++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 67766632 12478888999999999999999998 99999999999999 456789999999998
Q ss_pred ccccCCC--cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 656 ILKADQT--RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 656 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
.+..... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7654322 122345689999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.90 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=197.8
Q ss_pred hhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..+.||+|+||.||+|+.... ....|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 346799999999999987532 2356999988754332 34679999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCC---------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 585 FISNGCLAGFLFKNP---------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 585 y~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997554 689999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
..............++..|+|||.+.+..++.++||||||+++++|++ |..||....... .... ...+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~----~~~~~~~ 237 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNR----LQAGKLE 237 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----HHHH----HHcCCcC
Confidence 543332222233346778999999988889999999999999999999 778885432211 1111 1111111
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
..... .....+.+++.+|++.+|++||++.|+++.|.+
T Consensus 238 ~~~~~--------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LPVPE--------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCC--------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00000 112356778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=320.29 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=186.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccccc--------Cce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--------QHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 579 (797)
+.+.+.||+|+||.||+|+....+ ..||||++... .....+|+.+++.++||||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~-~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTS-EKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCC-CEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 455678999999999999987544 46999988542 23345799999999999999998875321 246
Q ss_pred eeeeecccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCc
Q 003759 580 LLVYEFISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLA 654 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla 654 (797)
++||||+++ +|.+++. ....+++.....++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999985 5665553 346788999999999999999999998 999999999999999665 7999999999
Q ss_pred cccccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH----hhh-
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----DCY- 728 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~- 728 (797)
+.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||......+....+..... ..+
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86643322 2234579999999998654 689999999999999999999999976543322111111000 000
Q ss_pred ------ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 729 ------IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 729 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+-.....................+.+++..||+.||.+|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000000000111122467889999999999999999999843
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.05 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=196.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC----------CchHHHHHHHHHhhc-cCcCchhhhcccccccC
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS----------GGDKEFRTEVNAIGQ-TNHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~ 577 (797)
.+.+.||+|+||.||+|......+..+|+|.+..... ....++..|+.++.+ ++||||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 4567899999999999998874556799998753211 122357778888865 79999999999999999
Q ss_pred ceeeeeecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 578 HRLLVYEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999988742 35688889999999999999999963 2899999999999999999999999999
Q ss_pred ccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 654 AKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ....+..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~----~~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----AT----KIVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HH----HHhhccC
Confidence 98654432 23344578899999999988899999999999999999999999864422111 11 0111111
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
..... ......+.+++.+|++.||++||++.||..++++
T Consensus 231 ~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11100 0112346778889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=323.31 Aligned_cols=250 Identities=24% Similarity=0.277 Sum_probs=195.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC-------
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------- 577 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------- 577 (797)
.|.+.+.||+|+||+||++.....+ ..||||++..... .....+.+|+..+..++|+||+++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDG-EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCC-CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4566788999999999999887544 4699999865322 22346788999999999999999988764432
Q ss_pred -ceeeeeecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeec
Q 003759 578 -HRLLVYEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652 (797)
Q Consensus 578 -~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 652 (797)
..++||||+++|+|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 367999999999999988642 4678889999999999999999998 99999999999999999999999999
Q ss_pred CccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 653 LAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 653 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ... ...+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~---~~~-~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----V---MHK-TLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----H---HHH-HhcC
Confidence 9987643222 22334568999999999999999999999999999999999999997543211 1 111 1111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.. .....+.+++..||+.||++||++.+++++
T Consensus 261 ~~~~~~~---------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLPP---------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 112346678899999999999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.74 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=189.6
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc---CcCchhhhcccccc-----cCc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT---NHRNLVKLLGFCNE-----DQH 578 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 578 (797)
.+.+.||+|+||+||+|..... +..||+|.++..... ....+.+|+.++..+ +||||+++++++.. ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCC-CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 4457899999999999998765 456999998753322 234566777777665 79999999998754 345
Q ss_pred eeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 579 RLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
.+++|||+++ +|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7999999974 788887653 3478999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc---ccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID---EKL 733 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 733 (797)
..... ......+++.|+|||++.+..++.++|||||||++|||++|++||......+....+.......... ...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 54322 2223457889999999998899999999999999999999999997654332211111111000000 000
Q ss_pred ---cccccch-hh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 ---HLLVEND-EE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ---~~~~~~~-~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... .. ........+.+.+++..|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 00 0000112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=331.35 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=196.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.++||+|+||.||+|+....+ ..||+|++...... ..++|.+|++++++++||||+++++++.+++..++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg-~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCS-RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCC-cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 345678999999999999887544 46999998753322 23568999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 585 FISNGCLAGFLFKN-----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 585 y~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
|+++++|.+++... ...++...+.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988531 2345677889999999999999998 999999999999999999999999999
Q ss_pred ccccccCCC-----------------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc
Q 003759 654 AKILKADQT-----------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN 716 (797)
Q Consensus 654 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~ 716 (797)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986621110 011224589999999999999999999999999999999999999965322111
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRP-TMKKVTLMLEGVVE 783 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~eVl~~Le~~~~ 783 (797)
. . ........ . . .+ .......+.+++.+|++.||++|| +++++++.|+...+
T Consensus 240 ~--~----~~~i~~P~-~-~-~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 S--Y----RDVILSPI-E-V-AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h--h----hhhccChh-h-c-cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 00000000 0 0 00 001123456788999999999995 67778887776433
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.64 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=192.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.+.||+|+||.||+|+....+ ..||+|.+.... ....++|.+|++++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCC-cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 34578999999999999886544 469999986532 2234578899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|..+. .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (279)
T cd06619 83 GGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKT 152 (279)
T ss_pred CCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccC
Confidence 99987553 467888889999999999999998 99999999999999999999999999997654321 223
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..++..|+|||++.+..++.++||||||+++|+|++|+.||................ ............ ..
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDEDPPVLP--------VG 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccCCCCCC--------CC
Confidence 458899999999999899999999999999999999999996543222111100110 111111000000 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112346788899999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=296.42 Aligned_cols=249 Identities=26% Similarity=0.445 Sum_probs=197.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||++.... +..+++|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEeC--CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4556789999999999998753 3359999886532 335679999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++... ..+++..+..++.+++.|++|||+. +++|+||||+||+++.++.+||+|||++............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999998754 4678999999999999999999998 9999999999999999999999999998765433222222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...++.+|+|||.+.+..++.++||||||+++|||++ |..||......+ +... ...+. ....+.
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~~--~~~~~~----- 224 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----VVET----INAGF--RLYKPR----- 224 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHH----HhCCC--CCCCCC-----
Confidence 2234678999999998889999999999999999998 899986543211 1110 01110 000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.....+.+++.+||+.+|++||++.||++.|.
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 01245778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.70 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=200.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||.|+||.||++.....+ ..+++|.+........+.+.+|+.++++++||||+++++++..++..+++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATG-ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCC-CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 445678999999999999987654 4599999986555556789999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++... ..++..+...++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK 159 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence 99999998766 6789999999999999999999998 999999999999999999999999999876543221 122
Q ss_pred cccccCccccccccccC---CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 667 AIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+..... ......... ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~~~~~~~~~----~~----- 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---SKSNFPPPK----LK----- 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCCCcc----cc-----
Confidence 34578889999999877 7899999999999999999999999754322211100 000000000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
........+.+++.+|++.+|.+||++++|+.
T Consensus 228 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 -DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01112345778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.88 Aligned_cols=240 Identities=26% Similarity=0.352 Sum_probs=195.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch---HHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~---~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
++||+|+||.||-|......+ .||||+..-...+.. .++++|+..|.+++|||++.+.|++..+...||||||| -
T Consensus 32 rEIGHGSFGAVYfArd~~n~e-vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSE-VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHhcCCccceeEEeeccCccc-eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 579999999999999886655 599999875443332 46899999999999999999999999999999999999 4
Q ss_pred Cchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
||-.|++. ..+++....+..|..+.+.||+|||+. +.||||||..||||++.|.+||+|||.|.... +...
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PAns 181 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PANS 181 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC-----chhc
Confidence 56666664 346788889999999999999999998 99999999999999999999999999987654 3455
Q ss_pred ccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 668 IRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 668 ~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
++|||.|||||++. .+.|+-|+||||||++..||...++|+...... +..+. +..+..+.+
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYH---------IAQNesPtL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH---------IAQNESPTL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHH---------HHhcCCCCC
Confidence 77999999999984 457999999999999999999999998654322 11111 111122222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...+....+..++-.||++-|.+|||..++++.
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 344455677888899999999999999988865
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.75 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=193.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccc-cccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC-NEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||++... +..|++|.++.. ...+.|.+|+.++++++|+|++++++++ .+++..++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4455678999999999999764 335899988643 3356799999999999999999999975 455678999999
Q ss_pred ccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++.+.. .+++..++.++.+++.||+|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999987543 478899999999999999999998 99999999999999999999999999987543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ +...... +......+
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~~----~~~~~~~~---- 222 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEK----GYKMDAPD---- 222 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhc----CCCCCCCC----
Confidence 12234568999999998899999999999999999998 888886432211 1111111 10000001
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.....+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 223 -----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 -----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1123456788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.86 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=195.1
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
++||+|+||.||++.... +..|++|.+...... ..++|.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999865 446999998764433 34679999999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc-ccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT-TAI 668 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 668 (797)
|.+++.+. ..+++...+.++.+++.||+|||++ +++|+||||+||+++.++.+||+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99998653 4678889999999999999999998 999999999999999999999999999876542221111 112
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..+..|+|||.+.+..++.++||||||++++||+| |..||......... ..... ..... . ..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----~~~~~---~~~~~-~---------~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----ERIES---GYRMP-A---------PQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----HHHhc---CCCCC-C---------Cc
Confidence 23567999999988889999999999999999999 78888654322111 10000 00000 0 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++..|++.+|++||++.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 112356788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.81 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=197.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEec--ccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCc--eeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH--RLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~--~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV 582 (797)
.|.++||+|+|=+||||.+.. .+.+||--.++ +.... ..+.|..|+++|+.|+|+||++++.++.+... ..+|
T Consensus 43 k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 356789999999999999864 45567744332 22222 23679999999999999999999999987665 7789
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~ 661 (797)
+|.|..|+|..++.+.+..+.+....++.||++||.|||.+ .++|||||||.+||+|+. .|.+||+|+|||..++...
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999999999999999999999999999999997 789999999999999974 5899999999999876544
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.. .+.|||.|||||.+. ..|.+.+||||||+.|+||+|+..||..-... ..+++.+..|.-...+.
T Consensus 201 ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl~--- 266 (632)
T KOG0584|consen 201 AK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAALS--- 266 (632)
T ss_pred cc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHhh---
Confidence 32 367999999999998 78999999999999999999999999654322 11233333332221111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...-..+.+++..|+.. .++|||+.|++.
T Consensus 267 -----kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 -----KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11123566788999999 999999999986
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=302.02 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=201.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|+....+ ..|++|+++... ....+.+.+|++++++++|+||+++++++..++..+++|||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATG-EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCC-cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 445678999999999999987654 469999986532 22346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++.|..+..+...+++.+...++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99988887776667789999999999999999999998 999999999999999999999999999987655443233
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hh-ccc-----
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CY-IDE----- 731 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~-~~~----- 731 (797)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+...... .. ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345578899999999887 7899999999999999999999999754332211111100000 00 000
Q ss_pred cccccccchh-hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVENDE-EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......... +..........+.+++..||+.+|++||++++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 00011111456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.17 Aligned_cols=198 Identities=19% Similarity=0.212 Sum_probs=164.1
Q ss_pred hhhhhCcc--cceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 510 FKDELGRG--AFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G--~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.++||+| +|++||+++...++ ..||+|+++..... ..+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG-EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccC-cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 78999999987654 45999998754322 234577899999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998643 4588999999999999999999998 999999999999999999999999986543321111
Q ss_pred -----cccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 663 -----RTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 663 -----~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 01112236678999999976 46899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.22 Aligned_cols=252 Identities=28% Similarity=0.312 Sum_probs=207.4
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch---HHHHHHHHHhhccC-cCchhhhcccccccCcee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~---~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 580 (797)
...|.+.++||+|.||.||+++.+.+ +..+|+|.+.+...... +.+.+|+.+|+++. |||||.+.+.++..+..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~t-g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKST-GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCC-CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34566778999999999999998865 45699999977555433 57899999999998 999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC----CCcEEEEeecCccc
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD----SFTARISDFGLAKI 656 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla~~ 656 (797)
+|||++.+|.|.+.+.+. .+++.....++.|++.+++|||+. +|+||||||+|+|+.. ++.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999776 489999999999999999999998 9999999999999953 35799999999998
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
... .......+||+.|+|||++...+++..+||||+||++|.|++|..||....+.+....+ ..+.....
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--------~~~~~~f~ 258 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--------LRGDFDFT 258 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--------HcCCCCCC
Confidence 776 44566678999999999999999999999999999999999999999877654432211 11221100
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.... ....+.+-+++..|+..||.+|+|+.++++.
T Consensus 259 ~~~w------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 SEPW------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCc------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0000 0112345567888999999999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.77 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=197.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+++....+ ..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATG-QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCC-CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3445678999999999999876544 469999997655555567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.+ ..+++.++..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++......... ..
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~ 173 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cC
Confidence 99999999854 4578889999999999999999998 9999999999999999999999999998765433221 22
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||........... ....+. . .... .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~~-~-~~~~------~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGT-P-ELQN------P 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCCC-C-CCCC------c
Confidence 33578899999999998899999999999999999999999965432211000 000000 0 0000 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
......+.+++..|++.+|++||++.+|++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011233567889999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.88 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=198.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||.|++|.||+|+.... +..|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRT-NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCC-CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 45567899999999999998754 4569999987543 233457889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++... .+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999998755 789999999999999999999998 999999999999999999999999999987654322 222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...+++.|+|||.+.+..++.++||||||+++|+|+||+.||......... . .........+...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~----~----~~~~~~~~~~~~~------- 221 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----F----LIPKNNPPSLEGN------- 221 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH----H----HhhhcCCCCCccc-------
Confidence 345788999999999888999999999999999999999999654321110 0 0001111111000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..|++.+|++||+++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 012346678889999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.41 Aligned_cols=249 Identities=31% Similarity=0.477 Sum_probs=199.3
Q ss_pred hhhhhCcccceeEEEEEEecCC---cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~---~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.||+|+||.||+++....+ ...||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987643 367999999764433 456899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCC--CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKNPK--PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++..... +++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976543 89999999999999999999998 9999999999999999999999999999876544322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+.+..++.++||||||+++++|++ |+.||....... ..... ...........
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~~--- 228 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE----VLEYL----KKGYRLPKPEN--- 228 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----hcCCCCCCCCc---
Confidence 2222336789999999988889999999999999999999 778876532211 11111 11111100000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
....+.+++.+|++.+|++|||+.++++.|
T Consensus 229 ------~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 ------CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 223567789999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.13 Aligned_cols=200 Identities=25% Similarity=0.315 Sum_probs=170.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+++....+ ..||+|++... .....+.|.+|+.++..++|+||+++++++.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTG-QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCC-CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 345678999999999999987654 46999998642 12233568899999999999999999999999999999999
Q ss_pred cccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999975 45688899999999999999999998 9999999999999999999999999998765543333
Q ss_pred ccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 664 TTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 3333458999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=314.93 Aligned_cols=200 Identities=26% Similarity=0.317 Sum_probs=172.3
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||.||+++....+ ..||+|++.... ......+.+|+.++..++|+||+++++.+.+++..++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTG-HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCC-CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 4568999999999999987654 469999986432 223456888999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC----
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT---- 662 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---- 662 (797)
++|+|.+++.+...++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 663 ------------------------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 663 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00123468999999999999999999999999999999999999997654
Q ss_pred c
Q 003759 713 E 713 (797)
Q Consensus 713 ~ 713 (797)
.
T Consensus 241 ~ 241 (360)
T cd05627 241 P 241 (360)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.29 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=195.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.++||+|+||.||+|.....+ ..|++|.+........+++.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCC-ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4566788999999999999887544 469999987654445567889999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|..++.+ ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 99999888754 35689999999999999999999998 99999999999999999999999999987543221 112
Q ss_pred ccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 666 TAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....+++.|+|||++. ...++.++||||||+++|||++|+.||........ ... . ..........
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~----~-~~~~~~~~~~-- 237 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLK----I-AKSEPPTLSQ-- 237 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHH----H-hcCCCccCCC--
Confidence 2344788999999984 34578899999999999999999999865432111 101 0 0000000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..||+.+|++||++.+|++.
T Consensus 238 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 -----PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111245678899999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=286.51 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=205.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.+.++||+|+||.||||.++.. +..||||++.. ....+++.+|+.++.+.+.|++|+++|.+.....+++|||||.-
T Consensus 36 Di~~KLGEGSYGSV~KAIH~Es-G~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRES-GHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhcc-CcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 4467899999999999999865 45699999875 35678899999999999999999999999999999999999999
Q ss_pred Cchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|+..+.++ +++++++.+...++..-++||+|||.. .-+|||||..||||+.+|.+||+|||.|..+....... ..
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-NT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-NT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-Cc
Confidence 99999997 457899999999999999999999998 88999999999999999999999999998765433332 33
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh-h
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH-D 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 746 (797)
+.|||-|||||++..-.|..++||||||+...||..|++|+........ +.-+....++... .
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPPTFKKP 252 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCCCCCCh
Confidence 5599999999999999999999999999999999999999976533211 1111112222222 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+....+-+++..||-++|++|-|+.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 3344678889999999999999999887764
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.57 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=195.9
Q ss_pred hhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.||+|+||.||+|+....++ ..||+|.+...... ...++.+|+.+++.++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 34679999999999998865443 35789988654322 234688999999999999999999998754 46789999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc-
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR- 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 663 (797)
+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.+......
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 9999999998764 4678899999999999999999998 9999999999999999999999999999876533221
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...... .+..... .
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~----~~~~~~~--~--- 233 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLE----KGERLPQ--P--- 233 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----CCCCCCC--C---
Confidence 1222335678999999999899999999999999999998 889986542211 111111 1110000 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
......+.+++..|+..+|++||++.++++.|+.+..
T Consensus 234 ----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 234 ----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0012346778899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.11 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=194.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
..||+|+||.||++.....+ ..||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTG-KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECCCC-CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 56999999999999886544 46999998765445556789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccccc
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
.+++.. ..+++.+...++.+|+.||+|||+. +|+|+||||+||++++++.+||+|||++........ ......++
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 998844 4688999999999999999999998 999999999999999999999999999876543222 12234578
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLK 751 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (797)
..|+|||.+.+..++.++||||||++++||++|+.||........ ........ ..... . ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~----~------~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA----MRRIRDNL-PPRVK----D------SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcC-CCccc----c------ccccCH
Confidence 899999999888899999999999999999999999965332111 11011100 00000 0 001122
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 752 KYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 752 ~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+..++..|++.||++|||+.|+++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 45567888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.15 Aligned_cols=189 Identities=23% Similarity=0.252 Sum_probs=160.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|+.... +..||+|.... .....|+.++++++|+||+++++++.+++..++|+||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~-~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQ-PDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCC-CceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 45567899999999999998754 34689997543 234569999999999999999999999999999999995
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|.+++.. ...+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 678777754 46789999999999999999999998 9999999999999999999999999998753322 1223
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
...||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 3458999999999999999999999999999999999766553
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.57 Aligned_cols=247 Identities=20% Similarity=0.290 Sum_probs=197.2
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
+.+.||.|++|.||+|+....+ ..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATG-QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCC-cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 4467999999999999876544 469999987655555677899999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 669 (797)
+|.+++.+ ..+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .....
T Consensus 102 ~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 102 SLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 99998854 4589999999999999999999998 9999999999999999999999999998765433221 22345
Q ss_pred ccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHH
Q 003759 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMR 749 (797)
Q Consensus 670 gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (797)
+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .. ..... ... . ...
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~----~~~~~-~~~-~-----~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT----NGTPE-LQN-P-----EKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh----cCCcc-cCC-c-----ccC
Confidence 788999999999888999999999999999999999999765432211100 00 00000 000 0 001
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 750 LKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 750 ~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...+.+++..||+.||++||++.+|+..
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1245678889999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.55 Aligned_cols=262 Identities=23% Similarity=0.249 Sum_probs=191.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Cc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QH 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 578 (797)
.+.+.+.||+|+||.||++.....+ ..||||++..... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCC-cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 3455678999999999999876544 4699999875322 2345688899999999999999999987543 35
Q ss_pred eeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 579 RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 7999999975 56666642 477888899999999999999998 99999999999999999999999999998654
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH--------------
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------------- 724 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------------- 724 (797)
... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 178 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 322 2233458999999999999999999999999999999999999997654322111111000
Q ss_pred -Hhhhccc-cc-----cccccchh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 725 -YDCYIDE-KL-----HLLVENDE---EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 725 -~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....... .. ........ ...........+.+++.+|++.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 00000000 000011112456789999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=278.64 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=197.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC----ch----HHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG----GD----KEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~----~~----~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
.-++.||+|..++|.+..++.+++ +.|+|++...... .. +.-.+|+.+|+++ .||+|+.+.++++.+.-.
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~-e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGK-EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred ChHHHhcccchhhhhhhhhccccc-ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 336789999999999988876654 5888888643221 12 2356799999998 799999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++|+|.|+.|.|.|+|.+.-.++++...+|+.|+.+|++|||.. .||||||||+|||+|++.++||+|||.+..+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999888999999999999999999999998 999999999999999999999999999997765
Q ss_pred CCCcccccccccCcccccccccc------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
.. ......|||+|+|||.++- ..|+...|+|++||+||.|+.|.+||--.. +... .+.+.+++.
T Consensus 176 Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----QmlM----LR~ImeGky 245 (411)
T KOG0599|consen 176 GE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QMLM----LRMIMEGKY 245 (411)
T ss_pred ch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHHH----HHHHHhccc
Confidence 43 4556789999999998852 358899999999999999999999995321 1111 122233333
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..-..... ......-+++.+||+.||.+|.|++|+++
T Consensus 246 qF~speWa------dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 QFRSPEWA------DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccCCcchh------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 21111111 11123456788899999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.08 Aligned_cols=262 Identities=24% Similarity=0.268 Sum_probs=190.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC------c
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------H 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 578 (797)
.|.+.+.||+|+||.||++..... +..||+|++..... ...+.+.+|+.+++.++||||+++++++...+ .
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVL-GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCC-CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 345567899999999999988654 45699999865322 23456889999999999999999999886443 5
Q ss_pred eeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 579 RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
.++||||+++ +|...+. ..++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 7999999975 4555543 2477888889999999999999998 99999999999999999999999999997543
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH---------------H
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD---------------W 723 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~---------------~ 723 (797)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.. .
T Consensus 175 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 322 22334588999999999999999999999999999999999999976532211000000 0
Q ss_pred HHhhhccc-cc-----cccccch---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 724 AYDCYIDE-KL-----HLLVEND---EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 724 ~~~~~~~~-~~-----~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........ .. .+..... ............+.+++..||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 0000000 0000001112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.96 Aligned_cols=199 Identities=24% Similarity=0.317 Sum_probs=169.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||.||+++....+ ..+|+|.+.+.. ......|.+|+.++..++|+||+++++.+.+++..++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCC-CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 45578999999999999987554 469999986421 12234588899999999999999999999999999999999
Q ss_pred ccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++|+|.+++.+ ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999976 46788999999999999999999998 99999999999999999999999999987654433333
Q ss_pred cccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 665 TTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 33456899999999986 345789999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.30 Aligned_cols=247 Identities=27% Similarity=0.295 Sum_probs=193.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
..+.||+|+||.||++.....+ ..||+|.+...... ..+.+.+|+.++++++|+|++++++.+.+.+..++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCC-ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3467999999999999987654 46999998653222 2345788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++... ..+++.++..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988543 4588899999999999999999998 999999999999999999999999999876543222
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||............. ....... .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~----~~~~~~~-~~~~~------ 226 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----RLVKEVQ-EEYSE------ 226 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH----hhhhhhh-hhcCc------
Confidence 123358999999999999899999999999999999999999997643221111110 0000000 00000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
.....+.+++..||+.||++||| +.|+++
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 ---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01234567888899999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.06 Aligned_cols=247 Identities=25% Similarity=0.294 Sum_probs=193.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.||+|+||+||+|.....+ ..||+|.+...... ....+.+|+.++++++|+||+++.+.+..++..+++|||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATG-KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEECCCC-cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 467999999999999987654 46999998653221 23457889999999999999999999999999999999999
Q ss_pred CCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 588 NGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 588 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++|.+++... ..+++.....++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence 99999888643 4689999999999999999999998 99999999999999999999999999987653322 12
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....|+..|+|||++.+..++.++|+||||+++|||++|..||...........+ ......... .. .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~----~~~~~~~~~-~~-~------- 225 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV----DRRVLETEE-VY-S------- 225 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHhhhcccc-cc-C-------
Confidence 2345899999999999889999999999999999999999999754322111111 111111100 00 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
......+.+++..|++.||++||+ +.++++.
T Consensus 226 -~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 -AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 001123567888899999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.78 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=200.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
..+.+.+.||+|+||.||+|+....++ ..+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 344566889999999999999765432 4689998875433 233578899999999999999999999987 78899
Q ss_pred eeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 582 VYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+||+++|+|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999764 4688999999999999999999997 9999999999999999999999999999876533
Q ss_pred CCcc-cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QTRT-TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.... .....++..|+|||.+....++.++||||||++++|+++ |+.||......+ +.... ..+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~-- 232 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDLL----EKGERLPQ-- 232 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHH----hCCCCCCC--
Confidence 2211 111223567999999988889999999999999999999 999997643221 11111 11110000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
+ ......+.+++..||..+|++||++.++++.|+.+..
T Consensus 233 ~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 P-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0011245678889999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.82 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=197.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||++..... +..||+|.+........+.|..|++++++++|+||+++++++..+...++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKET-GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCC-CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 366778999999999999998753 4569999987554444567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++.+. ..+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 999999998764 5689999999999999999999998 999999999999999999999999999875433222 12
Q ss_pred ccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 666 TAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||......+. +... ...... .+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~~-~~~~- 230 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---LLKI-----LKSEPP-TLDQ- 230 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---HHHH-----hcCCCC-CcCC-
Confidence 2345788999999874 34578899999999999999999999965432111 1110 000000 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..||+.+|++||++.+|++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 -----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00011245678889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=298.32 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=195.0
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
..||+|+||.||++.....+ ..||+|.+........+.+.+|+.++..++||||+++++++..++..++++||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSG-RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCC-CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 47999999999999886543 46999998754445556788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccccc
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
..++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ......++
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 987744 5688999999999999999999998 999999999999999999999999999876543322 12234588
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLK 751 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (797)
..|+|||++.+..++.++||||||++++||++|+.||......+.. .... ..... .... ......
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~~----~~~~~-~~~~------~~~~~~ 245 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRLR----DSPPP-KLKN------AHKISP 245 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHh----ccCCC-Cccc------cCCCCH
Confidence 9999999999888999999999999999999999999754322111 1000 00000 0000 000113
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 752 KYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 752 ~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+.+++..|++.+|++||++++|++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 45678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.16 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=190.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccccc------Cce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 579 (797)
+.+.+.||+|+||.||++.....+ ..||||++...... ..+.+.+|+.+++.++||||+++++++... ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCC-ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 445678999999999999876544 46999998754322 235678899999999999999999987543 357
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 999999975 5655553 2477888899999999999999998 999999999999999999999999999986533
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH---------------H
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW---------------A 724 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~---------------~ 724 (797)
.. ......+|+.|+|||++.+..++.++||||||+++|||++|+.||......+........ .
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred cc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22 223345899999999999999999999999999999999999999754322211111000 0
Q ss_pred Hhhhcc-cccccc-----c-cchh--hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 725 YDCYID-EKLHLL-----V-ENDE--EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 725 ~~~~~~-~~~~~~-----~-~~~~--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... ...... . +... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000000 0 0000 000011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.48 Aligned_cols=261 Identities=26% Similarity=0.330 Sum_probs=200.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-c-----CchhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-H-----RNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 580 (797)
+|.+.+.||+|.||.|-|+.....++ .||||++++.. .-..+-..|+.+|..++ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e-~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE-IVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc-EEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 55667899999999999999886655 59999998632 22345677999999986 4 49999999999999999
Q ss_pred eeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC--CcEEEEeecCccc
Q 003759 581 LVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS--FTARISDFGLAKI 656 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~ 656 (797)
||+|.+ .-+|+++|..+ ..++......|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+..
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999998 56899999866 4688999999999999999999998 99999999999999643 3799999999986
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-----------
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----------- 725 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----------- 725 (797)
....-. ...-++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.++-..+++...
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 543222 33357789999999999999999999999999999999998887766554333332110
Q ss_pred ---hhhcc-cc------ccc-----------------ccc---c-h---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 726 ---DCYID-EK------LHL-----------------LVE---N-D---EEALHDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 726 ---~~~~~-~~------~~~-----------------~~~---~-~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
..+.. .. ... ..+ + . .........-..+++++..|++.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00000 00 000 000 0 0 0111111334568999999999999999999
Q ss_pred HHHHHH
Q 003759 772 KKVTLM 777 (797)
Q Consensus 772 ~eVl~~ 777 (797)
.+.++.
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.80 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=195.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-----CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-----GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..+.||+|++|.||+|+.... +..|++|.+..... +..+.+.+|+.+++.++|+||+++++++..+...++++|
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDD-GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEcCC-CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 457799999999999998744 34699998865321 233578899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.+...+++..+..++.++++||+|||+. +++|+||+|+||+++.++.+||+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 999999999998777789999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred cccccccCccccccccccCC-CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....++..|+|||.+.... ++.++|+||||+++|+|++|+.||........ ..... ..........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~----~~~~~~~~~~----- 225 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---VFKIG----RSKELPPIPD----- 225 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---HHHHH----hcccCCCcCC-----
Confidence 23345788999999987766 89999999999999999999999965432111 10100 0011111100
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++.+|++.+|++||++.++++
T Consensus 226 ----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ----HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01234567888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.98 Aligned_cols=241 Identities=26% Similarity=0.268 Sum_probs=185.5
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhcc---CcCchhhhcccccccCceeeeeeccc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQT---NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
||+|+||+||+|+....+ ..||||++...... ....+..|..++.+. +||||+++++.+.+.+..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR-RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCC-CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999987544 46999998643211 122345566666654 79999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.+...+++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 999999998888899999999999999999999998 99999999999999999999999999987543222 22234
Q ss_pred ccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+. ...+..+.... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~-~~~------- 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--------YRNIAFGKVRF-PKN------- 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--------HHHHHcCCCCC-CCc-------
Confidence 5689999999998764 489999999999999999999999975432211 11111111110 000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRP----TMKKVTL 776 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RP----s~~eVl~ 776 (797)
.....+.+++..||+.||++|| ++.++++
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0123456788899999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.22 Aligned_cols=194 Identities=22% Similarity=0.354 Sum_probs=158.3
Q ss_pred hhhCcccceeEEEEEEecC-CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccc--ccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCN--EDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~Ey~~~ 588 (797)
.+||+|+||.||+|+.... .+..||+|.+... .....+.+|+.++++++||||+++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 4799999999999997643 3467999998753 23456788999999999999999999874 45678999999875
Q ss_pred Cchhhhccc---------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCcEEEEeecCcc
Q 003759 589 GCLAGFLFK---------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAK 655 (797)
Q Consensus 589 gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~ 655 (797)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66666531 12477888999999999999999998 99999999999999 567799999999998
Q ss_pred ccccCCC--cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 656 ILKADQT--RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 656 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
....... .......+|+.|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7654322 122334578999999998764 5799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=291.60 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=197.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
...+.||+|+||.||+|+....+ ..|++|.+...... ..+++.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCC-cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 34578999999999999886544 46999998765443 4567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.+...+++..+..++.++++||+|||+. +|+|+||+|+||++++++.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998877788999999999999999999998 9999999999999999999999999999876544332221
Q ss_pred ---cccccCccccccccccCC---CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 667 ---AIRGTRGYVAPEWFKSLP---ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 667 ---~~~gt~~y~aPE~~~~~~---~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
...+++.|+|||++.+.. ++.++||||||++++||++|+.||........ . .... .......+ ..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~---~~~~-~~~~~~~~-~~- 229 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---I---MFHV-GAGHKPPI-PD- 229 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---H---HHHH-hcCCCCCC-Cc-
Confidence 345788999999998766 89999999999999999999999965432111 0 0000 00000000 00
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......+.+++..|++.+|++||++.+++.
T Consensus 230 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001234567889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.42 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=196.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.+.||+|+||.||++.....+ ..+++|.++... ....+.+.+|+.++++++|+||+++++.+..++..+++|||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCC-ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 35678999999999999887554 459999886432 2334678899999999999999999999999999999999999
Q ss_pred CCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 588 NGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 588 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++|.+++... ..++......++.+++.||.|||+. +|+|+||||+||++++++.++|+|||++........ ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999988542 4578888999999999999999998 999999999999999999999999999876543222 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....+++.|+|||++.+..++.++||||||+++|+|++|..||........ . .....+........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~~~------ 223 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------I-LKVCQGSYKPLPSH------ 223 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------H-HHHhcCCCCCCCcc------
Confidence 234588899999999998999999999999999999999999975432111 0 01111111111110
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++.+||+.||++||++.||+..
T Consensus 224 ---~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 ---YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11245678889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=293.33 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=197.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+...+.||.|+||.||+|+....+ ..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCC-EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 445578999999999999887544 469999987432 233457889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.. ..+++.+...++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 99999998864 4678888999999999999999998 999999999999999999999999999976543221 222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ......... ..
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~---------~~ 222 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------LIPKNNPPT---------LT 222 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------hhhcCCCCC---------Cc
Confidence 3457888999999988889999999999999999999999997543221110 000000000 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1123456788999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.50 Aligned_cols=261 Identities=23% Similarity=0.253 Sum_probs=190.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Cc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QH 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 578 (797)
.+...+.||+|+||.||+|.....+ ..||||++..... ...+.+.+|+.++++++|+||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCC-CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3445678999999999999887544 4699999875322 2235678899999999999999999987543 45
Q ss_pred eeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 579 RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
.++++|++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 68999987 788887774 45689999999999999999999998 99999999999999999999999999998654
Q ss_pred cCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYID 730 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 730 (797)
.. .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+..... ..+..
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 32 223458899999999877 5689999999999999999999999965432211111110000 00000
Q ss_pred cccccc---ccchhh-hhhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 EKLHLL---VENDEE-ALHD--MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ~~~~~~---~~~~~~-~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... +..... .... ......+.+++..|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 0000 0001236788999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.03 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=198.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||.+.....+ ..+++|++.... ....+++.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDD-SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCC-cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45678999999999999877554 459999876432 334467899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++.+. ..+++.++..++.++++||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999764 4678899999999999999999998 999999999999999999999999999986644332 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+..++.++||||||++++||++|+.||......+. ... ...+......
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~~~-~~~~~~~~~~------- 222 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-------VVK-IVQGNYTPVV------- 222 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHH-HHcCCCCCCc-------
Confidence 2334588999999999988899999999999999999999999965432211 111 1111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
......+.+++..|++.+|++||++.++++.+
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 --SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123466788899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.05 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=194.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC----------chHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG----------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~----------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
.+.||+|+||.||+|..... +..||+|.++..... ..+.+..|+.++++++|+|++++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTT-GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCC-CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 46799999999999987654 446999987532111 1135788999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+|+||+++++|.+++.+...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 9999999999999998878889999999999999999999998 9999999999999999999999999999765432
Q ss_pred CC-cccccccccCccccccccccCC--CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 661 QT-RTTTAIRGTRGYVAPEWFKSLP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 661 ~~-~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.. .......++..|+|||.+.... ++.++||||||++++||++|..||......+. ..+ ... .......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~~-~~~~~~~ 233 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFK----LGN-KRSAPPI 233 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHH----hhc-cccCCcC
Confidence 21 1223345788999999987654 78999999999999999999999954322111 100 000 0000000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ........+.+++..|++.+|++||++.+|++.
T Consensus 234 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Ccc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 001122456778899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=295.52 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=198.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|+.... +..|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRET-GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCC-CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 34567899999999999998654 4569999987543 23346799999999999999999999999999999999999
Q ss_pred ccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+ +++|.+++.. ...+++.++..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999864 35689999999999999999999998 99999999999999999999999999998765443323
Q ss_pred cccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcc----cc
Q 003759 665 TTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYID----EK 732 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~----~~ 732 (797)
.....++..|+|||.+.+. .++.++||||+|++++||++|..+|......+....+..... ....+ ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3344588899999998654 468999999999999999999887765433221111111000 00000 00
Q ss_pred ccccccc--hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 LHLLVEN--DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 ~~~~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+...... ..... .......+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEI-FPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHh-CCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00000 01122567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=319.70 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=188.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc------Cchhhhccccccc-Cce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH------RNLVKLLGFCNED-QHR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h------~niv~l~g~~~~~-~~~ 579 (797)
.+.+.++||+|+||+||+|..... +..||||+++... ...+++..|+.++..++| .+++++++++..+ .+.
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKR-KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCC-CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 355567899999999999998754 4569999986432 223445667766666644 5588888888654 578
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---------------
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF--------------- 644 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~--------------- 644 (797)
++|||++ +++|.+++.+...+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8999987 778888888778899999999999999999999973 2899999999999998765
Q ss_pred -cEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH-
Q 003759 645 -TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD- 722 (797)
Q Consensus 645 -~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~- 722 (797)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 285 ~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 285 CRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred ceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 49999999875422 222345689999999999999999999999999999999999999976543221111111
Q ss_pred -------HHHh--------hhc-cccccccccchh-------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 723 -------WAYD--------CYI-DEKLHLLVENDE-------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 723 -------~~~~--------~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
|... .+. .+.+....+... ...........+.+++..||+.||++|||++|+++
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 000 000000000000 00011112345779999999999999999999987
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=296.39 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=191.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|++|.||+|+....+ ..||+|++..... ...+.+.+|+.++.+++||||+++++++.+++..++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTG-QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred eEeeEecccCceEEEEEEECCCC-cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 34568999999999999986544 5699999864322 23457889999999999999999999999999999999999
Q ss_pred cCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+ ++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6788877542 4688999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc---c------
Q 003759 664 TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK---L------ 733 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 733 (797)
......+++.|+|||.+.+. .++.++||||||++++||+||+.||.................. ..+.. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGVTSLPDY 235 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC-CChhhhhcchhhHHH
Confidence 12223468899999988654 5789999999999999999999999765332211111100000 00000 0
Q ss_pred cccccchhhh---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEEA---LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......... ........++.+++..||+.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000001235668999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.50 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=195.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc-cCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 584 (797)
|.+.+.||+|++|.||+++...++ ..|++|++..... ...+.+.+|+.++++++|+|++++++.+.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDG-KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCC-cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 345678999999999999987554 4699999865322 234568899999999999999999988764 446789999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+++++|.+++... ..+++.++..++.+++.|+++||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998753 4588999999999999999999998 999999999999999999999999999986643322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+.+..++.++||||||+++++|++|+.||........ ... ...+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-------~~~-~~~~~~~~~~----- 223 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-------VYR-IIEGKLPPMP----- 223 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------HHH-HHhcCCCCCc-----
Confidence 22334578899999999999999999999999999999999999865332111 111 1111111110
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..|++.+|++||++.++++.
T Consensus 224 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 ----KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122356788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=294.15 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=193.6
Q ss_pred hhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC------ce
Q 003759 510 FKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 579 (797)
+.+.||+|+||.||+|.+... .+..||||++..... ...+++.+|+.++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 457899999999999987643 346799999875432 23456889999999999999999999876532 24
Q ss_pred eeeeecccCCchhhhcccC------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 580 LLVYEFISNGCLAGFLFKN------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
++++||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999998887422 2467888999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccc
Q 003759 654 AKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 654 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
++....... .......+++.|++||.+....++.++||||||+++|||++ |+.||......+ ....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~---~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYLIK---GN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH----HHHHHHc---CC
Confidence 986543321 11222335678999999998889999999999999999999 888886543211 1111110 01
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.... . ......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~~~---~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLKQ---P-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCC---C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0 01224577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.56 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=193.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||++..... +..||+|.+..... ....++.+|+.++.+++|+||+++++.+..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPT-GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCC-CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 45678899999999999988754 45699998865322 22357889999999999999999999999999999999999
Q ss_pred cCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
++++|..++... ..+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999988753 3689999999999999999999963 389999999999999999999999999987653222
Q ss_pred ccccccccCccccccccccCC------CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 664 TTTAIRGTRGYVAPEWFKSLP------ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~------~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+ .....+.....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~- 230 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-----SAIVDGDPPTL- 230 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-----HHHhhcCCCCC-
Confidence 12234788999999986543 588999999999999999999999653221110000 00111111110
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++.+|++.+|++||++.+++..
T Consensus 231 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 --------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00122345678899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.31 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=194.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..+.||+|+||+||+|... ++..+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..++++
T Consensus 4 ~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 4567999999999999764 3446999988643211 1245888999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC--
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-- 661 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-- 661 (797)
||+++++|.+++.+...+++.....++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999998777788999999999999999999998 99999999999999999999999999987653211
Q ss_pred ---CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 662 ---TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 662 ---~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
........++..|+|||.+.+..++.++||||||+++++|++|+.||............ . . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~-~--~~~~~~~~~~ 232 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---G-A--HRGLMPRLPD 232 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---h-h--ccCCCCCCCC
Confidence 11222345788999999999988999999999999999999999999654322111100 0 0 0011111111
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++.+|++.+|++||++.|+++
T Consensus 233 ---------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 233 ---------SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11234567889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.20 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=198.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|++|.||++.....+ ..|++|++..... ...+++.+|++++++++||||+++++.+..++..++++||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTG-KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCC-cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 345678999999999999987544 4599999876432 33457899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++... ..++......++.+++.||+|||+ . +++|+||||+||++++++.+||+|||.+..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999999765 678889999999999999999998 6 99999999999999999999999999987654322211
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
..++..|+|||.+.+..++.++||||||+++++|++|+.||......... ..+...... ......+
T Consensus 159 ---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~~~~-------- 224 (265)
T cd06605 159 ---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQYIV-NEPPPRL-------- 224 (265)
T ss_pred ---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHHHh-cCCCCCC--------
Confidence 45788999999999889999999999999999999999999654321111 111111111 1110000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........+.+++..|+..||++||++.+++..
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000022346778899999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.40 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=195.8
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..+.||+|++|.||+|.....+ ..||+|++...... ..+.+..|++++++++|+||+++++++.+.+..++|+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~-~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTG-TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred ccceecCcCceEEEEEEEcCCC-cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3467999999999999876544 46999998643321 2356889999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++.+...+++.....++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999998777889999999999999999999998 999999999999998775 599999999887654321
Q ss_pred ---cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 ---RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 ---~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.......++..|+|||.+.+..++.++||||+|+++++|++|+.||............ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~----- 230 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTAP----- 230 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----HHHhccCCCC-----
Confidence 1122345788999999998888999999999999999999999999644322111111 1100000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.........+.+++.+|++.+|++||++.|+++
T Consensus 231 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112245667889999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.07 Aligned_cols=246 Identities=19% Similarity=0.256 Sum_probs=188.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-----CchHHHHHHHHHhhccCcCchhhhcccccc--cCceeee
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-----GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLV 582 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 582 (797)
..+.||+|+||.||+|.....+ ..|++|++..... ...+.+.+|+.++++++||||+++++++.+ +...+++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTG-RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCC-cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 3578999999999999887544 4699998864321 122458889999999999999999998765 3567899
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+||+++++|.+++.....+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999998777789999999999999999999988 999999999999999999999999999876543211
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. + ......... ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~----~~~~~~~~~-----~~ 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---I----FKIATQPTN-----PQ 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---H----HHHhcCCCC-----CC
Confidence 112234478899999999998899999999999999999999999975422111 0 011000000 00
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. ......+..+ +.|+..+|++||+|+||++
T Consensus 230 ~~----~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 LP----SHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred Cc----hhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 00 0001122233 3688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.17 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=193.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.++||+|+||.||+|.....+ ..||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCC-cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 445678999999999999887544 4699999864332 23456788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+ ++|.+++... ..+++.....++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++........ ..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 7 5888887653 5678889999999999999999998 999999999999999999999999999876433221 12
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhccc-cc---
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYIDE-KL--- 733 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~-~~--- 733 (797)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... +...... ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 223468899999988654 57889999999999999999999997654322111111100 0000000 00
Q ss_pred --cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 --HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 --~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......... ........+.+++.+|++.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHh-hcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 00011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.17 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=204.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
-|.+.+.||+|.|..|-.|++.-.++ .||||++++..-.. ..++.+|++.|+.++|||||+|+.+.......|||+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGe-kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccc-eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 35667889999999999998876655 49999998754432 3468899999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~ 662 (797)
.-++|+|++++-+. ..+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++-.+....
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 99999999999655 5688999999999999999999998 999999999999874 56889999999987765543
Q ss_pred cccccccccCccccccccccCCCC-ccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
..+...|+..|-|||++.+..|+ ++.||||||||||.|++|+.||+...+.+....+++..+.
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------------- 237 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------------- 237 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---------------
Confidence 34456799999999999998885 6789999999999999999999887666544333321111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+-....++.+++..||+.||++|.+.+||+..
T Consensus 238 ---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 238 ---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 011123467788999999999999999999864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.41 Aligned_cols=262 Identities=19% Similarity=0.231 Sum_probs=191.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||+|+....+ ..|++|+++.... .....+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g-~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCC-cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 34578999999999999987654 4699999864322 22356788999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+ ++|.+++.+ ...+++.....++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY 156 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence 7 477777654 46689999999999999999999998 999999999999999999999999999986543222 12
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhh-HHHHH-------Hhhh---ccccc
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-LVDWA-------YDCY---IDEKL 733 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~-~~~~~-------~~~~---~~~~~ 733 (797)
....+++.|+|||.+.+. .++.++||||||+++|||+||+.|+......+.... +.... +... .....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 233468899999998764 478999999999999999999988654322211110 00000 0000 00000
Q ss_pred cccccchhh-hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEE-ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
......... ..........+.+++..||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000 0000111245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.63 Aligned_cols=253 Identities=19% Similarity=0.194 Sum_probs=197.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||.||++...... ..|++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~-~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETR-QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCC-cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 34578999999999999987554 4699999875432 2234688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC----
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---- 661 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---- 661 (797)
+++++|.+++.....+++.....++.+++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999998777889999999999999999999998 99999999999999999999999999986421100
Q ss_pred ----------CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 662 ----------TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 662 ----------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
........++..|+|||.+.+..++.++||||||+++|||++|..||......+ +.. ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~----~~~----~~~~~ 231 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFG----QVISD 231 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhc
Confidence 001112347889999999988889999999999999999999999996543211 101 00111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
........ ......+.+++.+|++.||++||++.++.+.|+.
T Consensus 232 ~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIEWPEGD-------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccCCCCcc-------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11000000 0112345678999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=288.78 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=192.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|||++++++++... ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYT---GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccC---CCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4566788999999999998753 345999998653 2346789999999999999999999998764 479999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999999754 3578889999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+......+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~----~~~~~~~~~~----- 220 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----KECV----EKGYRMEPPE----- 220 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----HHHH----hCCCCCCCCC-----
Confidence 11224567999999988899999999999999999998 8999865432211 1111 1111000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++..|++.+|++||++.+|++.|++
T Consensus 221 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112346678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=294.09 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=190.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccccc-----ccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCN-----EDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 581 (797)
+.+.+.||+|+||.||+++....+ ..+|+|.+... .....++.+|+.++..+ +|+||+++++++. .++..++
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~-~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNG-SKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCC-ceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 344578999999999999987654 46999988653 23346788999999999 7999999999873 4457899
Q ss_pred eeecccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 582 VYEFISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 999999999998874 235678888999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCcccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
..... ......+++.|+|||++.. ..++.++|||||||++|||++|+.|+........ +... ....
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~~-----~~~~ 245 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFKI-----PRNP 245 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hhhc-----cccC
Confidence 43221 2223458899999999853 4578999999999999999999999965432111 1000 0000
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+ ......+.+++..|++.||++||++.||++.
T Consensus 246 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000 0012346778899999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=289.29 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=196.3
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||++.....+ ..|++|++.... ....+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDG-KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCC-CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 44678999999999999987644 469999986432 223457899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++... ..+++.+.+.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 999999988654 3578889999999999999999998 9999999999999999999999999999765432221
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||++.+..++.++||||||+++++|++|+.||......+ . .... ..+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~---~~~~-~~~~~~~~-------- 221 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----L---VLKI-IRGSYPPV-------- 221 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----H---HHHH-hcCCCCCC--------
Confidence 223347889999999998889999999999999999999999986532211 1 1111 11111110
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++.+|++.+|++||+|.+|++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01112346778899999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.38 Aligned_cols=261 Identities=22% Similarity=0.249 Sum_probs=196.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhccccccc--Cceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~Ey 585 (797)
+.+.||+|++|.||+|+.... +..+++|++.... ....+.+.+|+.++++++|+|++++++++... +..++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKT-GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEECCC-CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 456799999999999998754 3569999997653 23345788999999999999999999999887 899999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++ +|.+++.+. ..+++..++.++.++++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 975 888888665 5789999999999999999999998 99999999999999999999999999998765543322
Q ss_pred cccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc---c-------
Q 003759 665 TTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK---L------- 733 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~------- 733 (797)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+...... ..... .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-PTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-Cchhhccccccchhhh
Confidence 333446788999998765 46799999999999999999999999765432211111110000 00000 0
Q ss_pred ----cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 ----HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ----~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...................+.+++..|++.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111111112456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.50 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=195.4
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
+.||+|++|.||++..... +..+++|++........+.+.+|+.+++.++|+||+++++++..++..++++||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDKST-GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEECCC-CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 5799999999999987654 346999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccccc
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
.+++.. ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++......... .....++
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 178 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGT 178 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccCC
Confidence 999876 5688999999999999999999998 9999999999999999999999999988765433221 2234578
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLK 751 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (797)
+.|+|||.+.+..++.++||||||++++||++|+.||......+ ...... ......... ......
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~----~~~~~~----~~~~~~~~~-------~~~~~~ 243 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ----AMKRIR----DNLPPKLKN-------LHKVSP 243 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHH----hcCCCCCcc-------cccCCH
Confidence 89999999988889999999999999999999999986532211 111111 110000000 000123
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 752 KYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 752 ~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+.+++.+|++.+|++||++.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 5678899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=326.60 Aligned_cols=254 Identities=21% Similarity=0.265 Sum_probs=192.7
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc--cCc
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQH 578 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~ 578 (797)
+....+.+.+.||+|+||+||++..... +..||+|.+..... .....|..|+.++.+++|||||++++++.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~t-g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRT-QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCC-CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3344566678899999999999998764 45699998864322 234568899999999999999999998744 456
Q ss_pred eeeeeecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcC----CCCeeecCCCCCCEEEcC--------
Q 003759 579 RLLVYEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEEC----TTQIIHCDIKPQNILLDD-------- 642 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~----~~~ivH~Dlkp~NILl~~-------- 642 (797)
.+|||||+++++|.++|.. ...+++..++.|+.||+.||+|||+.. ..+|+|+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999864 256899999999999999999999852 135999999999999964
Q ss_pred ---------CCcEEEEeecCccccccCCCcccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCcc
Q 003759 643 ---------SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQN 711 (797)
Q Consensus 643 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~ 711 (797)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654322 1233468999999999854 45899999999999999999999999654
Q ss_pred ccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 712 VENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..... +.. .+.... ..... .....+.+++..||+.+|.+||++.+++.
T Consensus 247 ~~~~q---li~----~lk~~p-~lpi~---------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQ---LIS----ELKRGP-DLPIK---------GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHH---HHH----HHhcCC-CCCcC---------CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32111 111 111110 00000 01234677889999999999999999983
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.15 Aligned_cols=248 Identities=23% Similarity=0.223 Sum_probs=194.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|++|+||++.....+ ..||+|.+...... ..+.+.+|++++..++|+||+++++.+..++..++||||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTG-KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCC-cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 34567999999999999887644 46999998754322 335688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
+.+++|.+++... ..+++.....++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998754 5688899999999999999999998 999999999999999999999999999875432211
Q ss_pred ---------------------------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc
Q 003759 663 ---------------------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715 (797)
Q Consensus 663 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~ 715 (797)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01112357889999999998889999999999999999999999997543321
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT----MKKVTL 776 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~eVl~ 776 (797)
... . .......... .......+.+++.+|++.||++||+ +.|++.
T Consensus 240 ~~~---~-----~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 TFS---N-----ILKKEVTFPG--------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH---H-----HhcCCccCCC--------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 0 0111110000 0002345678899999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.21 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=193.4
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.||+|++|.||+|.....+ ..|++|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTG-EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCC-CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4578999999999999987544 569999986533 2233578899999999999999999999999999999999995
Q ss_pred CCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 588 NGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 588 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++|.+++.... .+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 68999887654 689999999999999999999998 9999999999999999999999999999765432211 1
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh---------hccc---c
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC---------YIDE---K 732 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---------~~~~---~ 732 (797)
....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.+..... ...+ .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 222467889999988664 57899999999999999999999997653322211111110000 0000 0
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......... .........+.+++.+|++.||++||+++|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000111245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.08 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=192.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|++|.||+|.....+ ..||+|.+...... ....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCC-cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 344578999999999999886544 46999998654322 2346788999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++ +|.+++.+. ..+++.....++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TY 160 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cc
Confidence 85 898888654 4678899999999999999999998 999999999999999999999999999875432211 11
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc----------c
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL----------H 734 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 734 (797)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......................... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 22236788999998865 458899999999999999999999996543221111110000000000000 0
Q ss_pred ---cccc-chhhh-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 735 ---LLVE-NDEEA-LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 735 ---~~~~-~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... ..... .........+.+++..|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 001111245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.33 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=191.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
..+.||+|++|.||+|+....+ ..|+||++..... ...+.+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTG-EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCC-CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 3467999999999999987544 4699998864322 233578899999999999999999999999999999999996
Q ss_pred CCchhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 588 NGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 588 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++|.+++.. ...+++.....++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 688888754 35678999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred ccccccCccccccccccCC-CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh----------hcc--cc
Q 003759 666 TAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC----------YID--EK 732 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----------~~~--~~ 732 (797)
....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||...........+.+..... ... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678899999887644 6889999999999999999999997654322111111100000 000 00
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
............. ......+.+++..|++.||++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHHHc-ccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 0012345688999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.06 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=195.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccC---cCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|+....+ ..|++|.+..... ...+++.+|+.++++++ |||++++++++..+...++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTG-RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCC-cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 345678999999999999986544 4699999865432 33457889999999986 999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++++|.+++.. ..+++...+.++.+++.||.|||+. +|+|+||+|+||++++++.++|+|||++..+......
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999999865 4788999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... .........+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~--- 225 (277)
T cd06917 158 -RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------LIPKSKPPRLEDN--- 225 (277)
T ss_pred -cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------ccccCCCCCCCcc---
Confidence 233458889999998865 457899999999999999999999996543211100 0000000000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..|++.||++||++.|+++.
T Consensus 226 -----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 -----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 012346678899999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.59 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc--cCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E 584 (797)
.+.+.||.|+||.||++.....+ ..|++|++..... ...+++..|+.++++++|+||+++++++.. +...+++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDG-KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCC-CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 44578999999999999887654 4699998864322 223568889999999999999999997753 456789999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEEC--TTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
|+++++|.+++.. ...+++...+.++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999999864 357889999999999999999999332 3399999999999999999999999999998765
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
..... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||......+ +.. ....+....+.
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~~~- 231 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LAS----KIKEGKFRRIP- 231 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----HHH----HHhcCCCCCCc-
Confidence 43321 223457899999999998889999999999999999999999997653211 111 11111111111
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..|++.+|++||++.+|+++
T Consensus 232 --------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 --------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0112456788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=316.51 Aligned_cols=269 Identities=18% Similarity=0.219 Sum_probs=186.2
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEec--------------c---cCCCchHHHHHHHHHhhccCcCchh
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD--------------N---MVSGGDKEFRTEVNAIGQTNHRNLV 567 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~--------------~---~~~~~~~~f~~E~~~l~~l~h~niv 567 (797)
...|.+.++||+|+||+||++..+...+..+++|.+. + .......++.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456677899999999999987754433222222110 0 0111234688999999999999999
Q ss_pred hhcccccccCceeeeeecccCCchhhhcccC-----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 003759 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642 (797)
Q Consensus 568 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~ 642 (797)
++++++...+..++|+|++. ++|.+++... ......+...|+.||+.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 4666665432 2234556778999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH
Q 003759 643 SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD 722 (797)
Q Consensus 643 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 722 (797)
++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..++...........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987654433333345689999999999999999999999999999999998864432221111111111
Q ss_pred HHHhh-----------------hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 723 WAYDC-----------------YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 723 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..... +....+...................+.+++.+||+.||++|||+.|+++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 00000000000000000111112345667889999999999999999864
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=285.78 Aligned_cols=246 Identities=26% Similarity=0.289 Sum_probs=196.7
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||.|+||.||++.....+ ..||+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTK-KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCC-cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 34578999999999999986544 4599999875332 2346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....++......++.++++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 99999999998777889999999999999999999998 99999999999999999999999999987654332 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..+ ........ ... +
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~~-~~~----~---- 222 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQI----RAKQETAD-VLY----P---- 222 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHH----HHHhcccc-ccC----c----
Confidence 334578899999999988899999999999999999999999976543211 111 11111000 000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTM--KKVT 775 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~--~eVl 775 (797)
......+.+++..|++.||.+||++ +|++
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 -ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0112456788899999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.94 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=197.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||++.....+ ..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATG-QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCC-CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 3445678999999999999876543 459999986544445567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.+ ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~ 173 (293)
T cd06647 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (293)
T ss_pred CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence 99999999864 3578889999999999999999998 999999999999999999999999999876543322 222
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...+++.|+|||.+....++.++||||||+++|++++|+.||......+..... ...+... ... .
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~~~--~~~------~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTPE--LQN------P 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCCCC--CCC------c
Confidence 335788999999998888999999999999999999999999654322111100 0000000 000 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112345678899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.27 Aligned_cols=248 Identities=20% Similarity=0.218 Sum_probs=189.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--C---chHHHHHHHHHhhccCcCchhhhccccccc--Cceee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--G---GDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLL 581 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 581 (797)
...+.||+|+||.||+|.....+ ..|++|.+..... . ..+.+.+|+.++.+++|+||+++++++.+. ...++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~-~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTG-RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCC-cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 34578999999999999887544 4699998753221 1 124678899999999999999999988663 46789
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+|||+++++|.+++.+...+++...++++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999999999997777788889999999999999999998 99999999999999999999999999988654321
Q ss_pred C--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 662 T--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 662 ~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ +. ........ .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~----~~~~~~~~-----~ 228 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---IF----KIATQPTN-----P 228 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---HH----HHhcCCCC-----C
Confidence 1 112234578899999999888899999999999999999999999965422111 10 10000000 0
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. ........+.+++..|+. +|++||+++||++.
T Consensus 229 ~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 V----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 011112345567777885 89999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=287.70 Aligned_cols=253 Identities=27% Similarity=0.353 Sum_probs=197.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||.|+||+||+|..... +..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|+|++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPN-NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCC-CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 34567899999999999987654 4569999986432 224567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
++++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999753 4578999999999999999999998 9999999999999999999999999998866543322
Q ss_pred ---ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 664 ---TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 664 ---~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
......++..|+|||.+... .++.++||||||++++||++|+.||......+. ....... ...... .
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~--~~~~~~----~ 229 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LMLTLQN--DPPSLE----T 229 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HHHHhcC--CCCCcC----C
Confidence 22334578899999998776 789999999999999999999999975433221 1111100 000000 0
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. ........+.+++..|++.||++||++.+|++
T Consensus 230 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 00111245678889999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=279.59 Aligned_cols=249 Identities=24% Similarity=0.241 Sum_probs=199.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
++.+.||.|.-|+||++.+...+ ...|+|++++.... ...+.+.|.+||+.++||.++.|++.++.+...||+|||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~-~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTN-CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCC-ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 34578999999999999998655 57999999874433 234577899999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc----
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA---- 659 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~---- 659 (797)
|++|+|..+++++ +.++.....-++..++-||+|||.. |||.|||||+||||.++|.+.|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999865 5688999999999999999999998 999999999999999999999999998764310
Q ss_pred ----C------------------------C-C----------------------cccccccccCccccccccccCCCCcc
Q 003759 660 ----D------------------------Q-T----------------------RTTTAIRGTRGYVAPEWFKSLPITMK 688 (797)
Q Consensus 660 ----~------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~t~~ 688 (797)
. . . .....++||-.|+|||++++...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0 01122469999999999999999999
Q ss_pred CceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCC
Q 003759 689 VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLR 768 (797)
Q Consensus 689 sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 768 (797)
+|.|+|||+||||+.|..||.+....+.-..+ +.+ .+... ........+.++|...|.+||++|
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---v~~-----~l~Fp--------~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---VGQ-----PLKFP--------EEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---hcC-----CCcCC--------CCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999987654432211 111 11000 011222346678888999999999
Q ss_pred CC----HHHHHHH
Q 003759 769 PT----MKKVTLM 777 (797)
Q Consensus 769 Ps----~~eVl~~ 777 (797)
.- +.||-+.
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 98 8888763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=286.30 Aligned_cols=243 Identities=27% Similarity=0.329 Sum_probs=193.8
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||.|++|.||+++....+ ..|++|++..... ...+.+.+|+.++++++|+||+++++++.+++..++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN-RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCC-cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999987544 4699999865332 234578999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccc
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 670 (797)
|.+++.+...++...+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999998877889999999999999999999998 99999999999999999999999999998764432 1223357
Q ss_pred cCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHH
Q 003759 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750 (797)
Q Consensus 671 t~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (797)
++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ... ..+...... .....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~---~~~-~~~~~~~~~--------~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIY---NDI-LKGNGKLEF--------PNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHH---HHH-hccCCCCCC--------CcccC
Confidence 889999999988889999999999999999999999997654211 1111 111 100000000 00013
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 751 KKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 751 ~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
..+.+++..||+.+|++||+ +.|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 45678899999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=289.06 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=196.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||+|..... +..||+|.+..... ...+.+.+|+.++.+++|+||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCC-CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 345567899999999999987654 35699998764322 2335788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.. ..+++.....++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..+..... ..
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999999998854 4678999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....++..|+|||.+.+..++.++||||||+++++|++|..|+....... ... ......... +.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~-~~------- 222 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLF----LIPKNNPPT-LE------- 222 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHH----HHhcCCCCC-CC-------
Confidence 22357889999999988889999999999999999999999996533211 100 001111110 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++..|++.+|++||++.++++.
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 -GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0112345678899999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=290.40 Aligned_cols=264 Identities=19% Similarity=0.206 Sum_probs=194.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc--Cceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 582 (797)
.+.+.+.||+|+||.||+|..... +..+++|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKT-GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCC-CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 355668899999999999998754 45699999864332 2234577899999999999999999998777 899999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||++ ++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 4898888654 4589999999999999999999998 99999999999999999999999999988765432
Q ss_pred CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhcc---
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYID--- 730 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~--- 730 (797)
. ......+++.|+|||.+.+. .++.++|+||||++++||++|..||...........+.... +..+..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12223468889999998764 46899999999999999999999997554322111111100 000000
Q ss_pred ---ccccccccchhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 731 ---EKLHLLVENDEEALHDMM-RLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 731 ---~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.................. ....+.+++..|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000 1345678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=285.51 Aligned_cols=251 Identities=26% Similarity=0.318 Sum_probs=201.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.+.||+|++|.||+++....+ ..|++|++..... ...+++.+|+..+.+++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~-~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTG-KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCC-cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 34578999999999999988644 4699999876443 345689999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++.....++...++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 99999999877889999999999999999999999 7 99999999999999999999999999998765433222 2
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ....... ...........
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~----~~~~~~~~~~~------- 226 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-FELMQAI----CDGPPPSLPAE------- 226 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-HHHHHHH----hcCCCCCCCcc-------
Confidence 34478899999999998999999999999999999999999976542111 1111111 11111111000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..|++.+|++||++.++++.
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 022456778889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=289.07 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=198.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|++|.||+|.....+ ..|++|++..... ..+.+.+|++.+++++|+|++++++++..++..++++||++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATG-KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCC-cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 345578999999999999987544 4699999876433 45678999999999999999999999999999999999999
Q ss_pred CCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 999999998776 889999999999999999999997 999999999999999999999999999875543221 112
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... ... ..........
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---~~~-----~~~~~~~~~~------- 239 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---LIT-----TKGIPPLKNP------- 239 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-----hcCCCCCcch-------
Confidence 2346789999999988889999999999999999999999986543221111 000 0111100000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++.+|++.+|.+||++.+|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0012346678999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=292.96 Aligned_cols=243 Identities=25% Similarity=0.287 Sum_probs=196.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSG-KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 345678999999999999987644 5699999865321 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.+...++...+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999998876443
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||........ ......+... +. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~-~~----~~- 220 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--------YEKILEGKVR-FP----SF- 220 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhcCCcc-CC----cc-
Confidence 2234578999999999888899999999999999999999999965432110 0111111111 00 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||.+|| +++|+++
T Consensus 221 ----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 ----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 123456788999999999999 6666663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=291.07 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=190.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|.....++ .|++|++..... .....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~-~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQ-LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCc-EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3445789999999999998876544 599999865432 23346788999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
. ++|.+++.. ...+.+.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 160 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TY 160 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CC
Confidence 6 566666543 35577888899999999999999998 999999999999999999999999999875432211 11
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc-------------cc
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI-------------DE 731 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~ 731 (797)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||........... . ....+. +.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE--K-IWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH--H-HHHHcCCCChhhhhhhhhccc
Confidence 223468899999998764 578899999999999999999999975433211100 0 000000 00
Q ss_pred ccccccc----chhhh-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVE----NDEEA-LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~----~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... ..... .........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 00000 000111245667899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=288.71 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=193.8
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc--cCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~Ey~ 586 (797)
+.+.||.|++|.||++..... +..+|+|.+..... ....++.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNT-GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEeccCCceEEEEEEECCC-CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 356899999999999998754 45699999875332 234678999999999999999999998854 34689999999
Q ss_pred cCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
++++|.+++.. ...++......++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999987643 34578889999999999999999998 999999999999999999999999999875432221
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc-chhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE-NQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......+... .....+.+. .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE-P 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC-C
Confidence 12346788999999998899999999999999999999999997653211 11111111111 011111000 0
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .......+.+++.+||+.+|++|||+.||++
T Consensus 233 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 0112345778999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=282.19 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=194.6
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||++..... +..+++|++.... ....+.+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKAD-QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred eEEEEecccCceEEEEEEEcCC-CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 4457899999999999988754 4569999986532 223457899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~ 663 (797)
++++|.+++... ..+++..+..++.++++||+|||++ +++|+||+|+||+++++ +.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 999999999754 4578899999999999999999998 99999999999999855 468999999998664332
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......++..|+|||.+.+..++.++||||||+++++|++|+.||....... ..... .......+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~---- 224 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKI----MSGTFAPISDR---- 224 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHHHH----HhcCCCCCCCC----
Confidence 1223457889999999998889999999999999999999999996543211 11110 01111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.+|++|||+.|+++.
T Consensus 225 -----~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 -----YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 12345678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=285.97 Aligned_cols=247 Identities=24% Similarity=0.297 Sum_probs=196.4
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||.||+++....+ ..+++|.+..... ...+.+.+|+.++.+++|+||+++++.+..++..++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG-DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCC-CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999987544 4699999865433 334578899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-------c
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-------R 663 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-------~ 663 (797)
|.+++.+...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998777889999999999999999999998 999999999999999999999999999876433211 1
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......++..|+|||.+.....+.++||||||++++||++|..||......+. .. ....+.... +..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~----~~~~~~~~~-----~~~ 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQ----NILNGKIEW-----PED 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HH----HHhcCCcCC-----Ccc
Confidence 22334578899999999888899999999999999999999999965432211 11 011111100 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
......+.+++..|++.+|++|||+.+|.+.|+.
T Consensus 224 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 224 ---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0012456788999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=296.62 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=199.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+++...||.|+||.||||+.+. .+...|.|++........++|.-|+++|....||+||+|++.+..++.++|+.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhccc-chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4566789999999999999874 455678898887666667789999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
||-.+.++..- ..+...++.-++.+++.||.|||++ .|||||||..|||++-+|.++|+|||.+....... ....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hhhc
Confidence 99999887654 5688999999999999999999998 99999999999999999999999999875432211 2223
Q ss_pred cccccCcccccccc-----ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 667 AIRGTRGYVAPEWF-----KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 667 ~~~gt~~y~aPE~~-----~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.+.|||.|||||+. +..+|+.++||||||++|.||..+.+|-....... .+...+ .....-+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---VllKia-----KSePPTL----- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIA-----KSEPPTL----- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHHHHh-----hcCCCcc-----
Confidence 45699999999986 56689999999999999999999999875432211 011100 0111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+-.....+.+++..||.+||..||+++++++.
T Consensus 256 --lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 --LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1122233457788899999999999999998864
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=290.51 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=190.4
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccccccc-----Cceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNED-----QHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lV 582 (797)
.+.+.||+|+||.||++.....+ ..+|+|.+... .....++.+|+.++.++ +|||++++++++... +..++|
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~-~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDG-SLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCC-CEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 34568999999999999886544 46999998653 22346788899999998 899999999998653 358999
Q ss_pred eecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 583 YEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998752 35688999999999999999999998 99999999999999999999999999988654
Q ss_pred cCCCcccccccccCccccccccccC-----CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSL-----PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
..... .....++..|+|||.+... .++.++||||||+++|||++|+.||......+. +... .....
T Consensus 180 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~-----~~~~~ 250 (291)
T cd06639 180 STRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKI-----PRNPP 250 (291)
T ss_pred ccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHH-----hcCCC
Confidence 32221 1223478899999998643 368999999999999999999999975432211 1111 00111
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... ......+.+++..|++.+|++||++.|+++.
T Consensus 251 ~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 PTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111010 0112346788999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=282.24 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=199.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
..+.||+|++|.||++..... +..+++|++........+++.+|+..+++++|+|++++++++...+..++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRT-GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEECCC-CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 346799999999999998754 4469999997655445678999999999999999999999999999999999999999
Q ss_pred chhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 590 CLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 590 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
+|.+++... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999766 5789999999999999999999997 999999999999999999999999999887654432 2334
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.++..|+|||.+.+..++.++||||||+++++|++|+.|+............ . .......... ..
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~----~~~~~~~~~~-------~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI----A----TNGPPGLRNP-------EK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----H----hcCCCCcCcc-------cc
Confidence 5788999999998888999999999999999999999999654321111100 0 0001101000 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..|++.||++|||+.++++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12356778899999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=290.38 Aligned_cols=244 Identities=25% Similarity=0.296 Sum_probs=190.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+ ..||+|++...... ..+++.+|+++++.++||||+++++++..++..++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCC-cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 555678999999999999987544 46999988643322 22468899999999999999999999999999999999
Q ss_pred cccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|++ |+|.+++. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 56666654 345689999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 664 TTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||......... ... ........
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-------~~~-~~~~~~~~---- 234 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHI-AQNDSPTL---- 234 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-------HHH-hcCCCCCC----
Confidence 2234788999999874 356889999999999999999999998654321110 000 00000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........+.+++..||+.+|++||++.+|+..
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 ----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011122456788999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=287.01 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=192.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccC------ce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~------~~ 579 (797)
.+.+.+.||+|++|.||+|.....+ ..+++|.+.... ...+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~-~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTG-QLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCC-cEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 3455688999999999999987544 469999987543 2346799999999999 7999999999986544 48
Q ss_pred eeeeecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 580 LLVYEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999998864 35788999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCCcccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
....... ......++..|+|||.+.. ..++.++||||||+++++|++|+.||........ +.. ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~-----~~~ 232 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---LFK-----IPR 232 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---HHH-----hhc
Confidence 6543221 2223447889999998753 3468899999999999999999999964322111 101 011
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... ........+.+++.+||+.||++|||+.+|++
T Consensus 233 ~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111000 01112345678899999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=291.40 Aligned_cols=252 Identities=25% Similarity=0.280 Sum_probs=193.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+...+.||+|+||.||+|+....+ ..||+|++...... ..+++.+|+.++++++|+|++++++++.+++..++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCC-cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 445678999999999999986544 46999998643222 23468889999999999999999999999999999999
Q ss_pred cccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++ +|.+.+.. ...+++.++..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9974 67666643 45689999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 664 TTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....+++.|+|||++. ...++.++||||||+++|||++|+.||.......... ... ........
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~----~~~~~~~~---- 245 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA----QNESPTLQ---- 245 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH---HHH----hccCCCCC----
Confidence 2234788999999974 4568999999999999999999999986542211110 110 01100000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
.......+.+++.+|++.+|++||++.+|++.+--....+
T Consensus 246 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 246 -----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0011234677889999999999999999998765444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=294.63 Aligned_cols=271 Identities=24% Similarity=0.280 Sum_probs=203.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccC-----ceee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----HRLL 581 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 581 (797)
.+.+.||+|++|.||+|+.... +..|++|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRT-GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCC-CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 4567899999999999998654 3469999987644 334567899999999999999999999998775 7899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+|||++ ++|.+++.+...+++..+..++.+++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999998 58999988777899999999999999999999998 99999999999999999999999999998765433
Q ss_pred C--cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh-------hccc
Q 003759 662 T--RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC-------YIDE 731 (797)
Q Consensus 662 ~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 731 (797)
. .......+++.|+|||.+.+. .++.++||||||+++++|++|+.||......+....+....... ....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 122334578899999999887 78999999999999999999999997654332211111100000 0000
Q ss_pred cccccccc---h-hh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCC
Q 003759 732 KLHLLVEN---D-EE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEV 784 (797)
Q Consensus 732 ~~~~~~~~---~-~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~ 784 (797)
.....+.. . .. ..........+.+++..||+.+|++||++.++++. +++..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000000 0 00 00000113457789999999999999999999985 6655544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=287.11 Aligned_cols=243 Identities=24% Similarity=0.240 Sum_probs=186.0
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhh---ccCcCchhhhcccccccCceeeeeecc
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIG---QTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.||+|+||.||++..... +..+|+|.+...... ....+.+|..++. ..+|+||+.+.+++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCC-CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 389999999999988654 456999988653221 1233445544433 347999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++.....++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999999998878899999999999999999999998 99999999999999999999999999987553322 12
Q ss_pred cccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...+++.|+|||.+. +..++.++||||||++++||++|+.||......... .+.... ..... .+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~----~~~~~-~~~-------- 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT----LTVNV-ELP-------- 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh----hcCCc-CCc--------
Confidence 235899999999886 456899999999999999999999999754322111 111100 00000 000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
......+.+++..|++.||++|| +++|+++.
T Consensus 220 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 -DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01123566788899999999999 59999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=286.92 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=190.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccc------cCce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNE------DQHR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 579 (797)
.+.+.+.||+|+||.||+|..... +..+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCC-CcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 345567899999999999998754 4569999986532 2345788899999998 79999999999853 4578
Q ss_pred eeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 580 LLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+++|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999998643 4577888889999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCcccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
..... ......+++.|+|||.+. ...++.++||||||+++|||++|..||...........+ ....
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--------~~~~ 242 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNP 242 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--------hhCC
Confidence 32221 222345788999999885 346788999999999999999999999654321111100 0000
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..... .......+.+++..||+.||.+||++.||++
T Consensus 243 ~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 PPKLK--------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCc--------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 0011235678899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.38 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=194.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|++|+||+|+....+ ..|+||++...... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETG-ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCC-cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 35678999999999999987544 46999998654332 2234567899999998 999999999999999999999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++|.+++.... .+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889998887654 789999999999999999999998 999999999999999999999999999976543222
Q ss_pred cccccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH---------HHHhhhcccccc
Q 003759 665 TTAIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD---------WAYDCYIDEKLH 734 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 734 (797)
.....++..|+|||.+. ...++.++||||||++++||++|+.||......+....... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 12334788899999875 44579999999999999999999999965543222111111 000000000110
Q ss_pred ccccchh-hhhhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 LLVENDE-EALHD--MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 ~~~~~~~-~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+.... ..... ......+.+++..|++.+|++||+++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000 0113567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=293.26 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=194.5
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhcc-CcCchhhhccccccc--Ccee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNED--QHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 580 (797)
..+.+.+.||+|+||.||+|.....+ ..+|+|++.... ......+..|+.++.++ +|+||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTK-EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCC-eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 44666789999999999999987544 569999885422 22334677899999999 999999999988653 4689
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||++ ++|..++.+. .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5898888665 778899999999999999999998 9999999999999999999999999999866433
Q ss_pred CC----cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhh
Q 003759 661 QT----RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCY 728 (797)
Q Consensus 661 ~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~ 728 (797)
.. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+..... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22 12233458889999998765 4578999999999999999999999965433221111111000 000
Q ss_pred cccccccccc----chhh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 729 IDEKLHLLVE----NDEE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 729 ~~~~~~~~~~----~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........++ .... ..........+.+++.+|++.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 0000 00000123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=287.76 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=194.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
.+||+|+||.||++..... +..||+|++........+.+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSS-GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCC-CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 6799999999999988754 446999998654444556789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccccc
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 998743 4578899999999999999999998 999999999999999999999999999876543221 22334578
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLK 751 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (797)
+.|+|||.+.+..++.++||||||+++|+|++|..||......+. ........ ...+.. ... ...
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~----~~~~~~~~-~~~~~~-~~~---------~~~ 244 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNL-PPKLKN-LHK---------VSP 244 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhhC-CcccCC-ccc---------CCH
Confidence 899999999888899999999999999999999999865432211 11111100 001100 000 112
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 752 KYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 752 ~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+.+++.+||+.+|.+||++.+|++.
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 35567888999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=313.71 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=205.3
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecC------CcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccc
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYE------NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFC 573 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~ 573 (797)
|+.+..-.+.+.||+|.||.|++|..... ....||||.++..... ..+.+..|+++++.+ +|+||+.++|.|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 33333334566899999999999986522 2567999999865544 345799999999998 799999999999
Q ss_pred cccCceeeeeecccCCchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 003759 574 NEDQHRLLVYEFISNGCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQN 637 (797)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~N 637 (797)
.+.+..++|.||++.|+|.++|++.+ .++....+.++.|||.|++||++. +++||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997654 377888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccccCCCccccccc--ccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccc
Q 003759 638 ILLDDSFTARISDFGLAKILKADQTRTTTAIR--GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVEN 714 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~ 714 (797)
||+.++..+||+|||+|+............-. -...|||||.+....|+.|+|||||||+||||+| |..|+.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999965554443322211 2456999999999999999999999999999999 77888652211
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
++ + ...+.++...+..... ..++.++++.||+.+|++||+++++++.|+.
T Consensus 529 ~~---l----~~~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EE---L----LEFLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH---H----HHHHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 1 2233333332222222 2345567778999999999999999999987
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=267.49 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=189.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
...||.|..|.|+|.+....+ ..+|||...+.. .+..+.++..+.++...+ +|.||+.+|||..+...++.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~-~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTG-HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccc-eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 467999999999999998654 569999987543 233456777888877764 8999999999999999999999984
Q ss_pred CchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
-.++.+|.+. .++++.-.-++...+.+||.||.++ ++|+|||+||+|||+|+.|++|++|||++..+-... ..+.
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ahtr 250 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTR 250 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--cccc
Confidence 3455555443 4577777778999999999999987 599999999999999999999999999998765433 3344
Q ss_pred ccccCccccccccccC---CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 668 IRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
..|.+.|||||.+.-. .|+.++||||||+.|+||.||+.||.....+-+... .+.+ +. ...+....
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---kvln---~e--PP~L~~~~--- 319 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---KVLN---EE--PPLLPGHM--- 319 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH---HHHh---cC--CCCCCccc---
Confidence 4589999999999643 689999999999999999999999987543222111 1111 10 01111110
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.-...+.+++..||++|+.+||.-.++++.
T Consensus 320 ---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 ---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 022456778889999999999999887753
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=288.31 Aligned_cols=266 Identities=23% Similarity=0.250 Sum_probs=193.9
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC-----
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ----- 577 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----- 577 (797)
...+.+.+.||+|+||.||+|+....+ ..||+|+++.... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTG-ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCC-cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 344556788999999999999997654 4699999865322 23356788999999999999999999887654
Q ss_pred -----ceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEee
Q 003759 578 -----HRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651 (797)
Q Consensus 578 -----~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 651 (797)
..++|+||+++ +|...+... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 566666543 5689999999999999999999998 9999999999999999999999999
Q ss_pred cCccccccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 652 GLAKILKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 652 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
|++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||......+....+....... ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP-CP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Ch
Confidence 9998765443322233345778999998865 457899999999999999999999997543322111111110000 00
Q ss_pred cccccc--------ccc------hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 EKLHLL--------VEN------DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ~~~~~~--------~~~------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+ .+. ....... .....+.+++..||+.+|++||++.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000 0000000 012457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=284.83 Aligned_cols=243 Identities=28% Similarity=0.324 Sum_probs=190.0
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||+||++..... +..|++|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKAT-GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCC-CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999987654 4469999986432 1223457789999999999999999999999999999999999999
Q ss_pred hhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 591 LAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 591 L~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|.+++.+.. .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999997654 688999999999999999999998 99999999999999999999999999987654321 12233
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.++..|+|||.+.+..++.++||||||+++++|++|+.||...........+.. ....... ... ..
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-~~~---------~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLEMAV-EYP---------DK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----ccccccc-cCC---------cc
Confidence 477899999999888899999999999999999999999965533211111110 0000000 000 00
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 123456788999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=283.64 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=194.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||++.....++ .||+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSE-HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCc-eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345789999999999999876544 58999986532 123457889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 663 (797)
++++|.+++.+.. .+++..+..++.++++||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999986543 578999999999999999999998 999999999999999885 469999999886643322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......+++.|+|||++.+..++.++||||||++++||++|+.||......+. .... ..+.......
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~-~~~~~~~~~~----- 224 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-------VLKI-CQGYFAPISP----- 224 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHH-hcccCCCCCC-----
Confidence 22233578899999999888899999999999999999999999865432111 1111 1111111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++.+|++.+|++|||+.||++.
T Consensus 225 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 ----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111346678899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=291.39 Aligned_cols=264 Identities=20% Similarity=0.245 Sum_probs=192.8
Q ss_pred hhhhhhCcccceeEEEEEEecC-CcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhccccccc--Cceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 582 (797)
.+.+.||+|+||.||+|+.... .+..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 4456799999999999998762 34579999997633 33346778899999999999999999999887 789999
Q ss_pred eecccCCchhhhcccC-----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC----CCcEEEEeecC
Q 003759 583 YEFISNGCLAGFLFKN-----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD----SFTARISDFGL 653 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgl 653 (797)
|||+++ +|.+++... ..++......++.|++.||.|||+. +|+|+||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 555555321 3578888999999999999999998 9999999999999999 99999999999
Q ss_pred ccccccCCC--cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccch------hhHHHHH
Q 003759 654 AKILKADQT--RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQ------MILVDWA 724 (797)
Q Consensus 654 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~------~~~~~~~ 724 (797)
+........ .......+++.|+|||.+.+ ..++.++||||||++++||++|+.||......... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI- 237 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH-
Confidence 986543322 12223457889999998866 45789999999999999999999999765433200 000000
Q ss_pred Hhhhcc--------------------cccccccc-chhhhhhhH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 725 YDCYID--------------------EKLHLLVE-NDEEALHDM--MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 725 ~~~~~~--------------------~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...+.. ........ ......... ....++.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00000000 000010111 122467889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.81 Aligned_cols=255 Identities=23% Similarity=0.234 Sum_probs=197.7
Q ss_pred hhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccC----CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceee
Q 003759 509 GFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 581 (797)
.+.+.||+|++|.||+++... ..+..||||.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 345789999999999998653 234579999986432 12335688999999999 69999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++++|.+++.....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999998777788999999999999999999997 99999999999999999999999999988765443
Q ss_pred CcccccccccCccccccccccCC--CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
........++..|+|||.+.+.. .+.++||||||++++||++|..||...........+ ....... .. ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~-~~-~~--- 231 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRILKS-KP-PF--- 231 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHHHcc-CC-CC---
Confidence 33333345788999999987665 788999999999999999999999643221111111 1111000 00 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
+.. ....+.+++.+|++.||++|||+.++.+.|+.
T Consensus 232 -~~~-----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 232 -PKT-----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -Ccc-----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 11235678889999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=287.15 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=186.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHH-hhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNA-IGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||+++.... +..||+|+++.... ....++..|+.. ++..+||||+++++++..++..+++|||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPT-GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCC-CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 3457899999999999998754 45699999875432 233456666665 55669999999999999999999999999
Q ss_pred cCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+ ++|.+++.. ...+++..++.++.|++.||+|||++ .+++|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 677776643 34688999999999999999999974 379999999999999999999999999988654322
Q ss_pred cccccccccCcccccccccc----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKS----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||......... + .... .+.......
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~----~~~~-~~~~~~~~~ 230 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--L----KQVV-EEPSPQLPA 230 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH--H----HHHH-hcCCCCCCc
Confidence 1222347889999998865 45689999999999999999999999643221111 1 0100 110000000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. .....+.+++..||+.+|++||++.+|++
T Consensus 231 ~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 E--------KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01234677889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.67 Aligned_cols=260 Identities=20% Similarity=0.230 Sum_probs=189.4
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccC-cCchhhhccccccc--Cceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTN-HRNLVKLLGFCNED--QHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~Ey 585 (797)
+.++||+|+||.||+|+....+ ..||+|+++.... ........|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~-~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTG-KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEcCCC-cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4567999999999999987544 4699999875432 22234557888888884 99999999999887 889999999
Q ss_pred ccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++ ++|.+++.. ...+++.++..++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 577777765 35689999999999999999999998 9999999999999999 9999999999986643322
Q ss_pred cccccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhcccccccc
Q 003759 665 TTAIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYIDEKLHLL 736 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 736 (797)
.....+++.|+|||.+. +..++.++|||||||++|||++|..||......+....+.+.. ............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 12234788999999764 4557899999999999999999999997653322111111000 000000000000
Q ss_pred c--cchhhhhh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 V--ENDEEALH--DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~--~~~~~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. ........ .......+.+++..||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 00000000 01124678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.96 Aligned_cols=261 Identities=22% Similarity=0.264 Sum_probs=196.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
..+.||+|++|.||++....+ +..+++|++...... ....+..|+.++++++|+||+++++++..++..++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLT-GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCC-CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 346799999999999998654 456999998754332 34578889999999999999999999999999999999997
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+ +|.+++.. ...+++..+..++.+++.||.|||+. +|+|+||||+||++++++.+||+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 77777765 35789999999999999999999998 99999999999999999999999999998765443 1222
Q ss_pred cccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcc---ccccc
Q 003759 667 AIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYID---EKLHL 735 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~ 735 (797)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.+... ..... .....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 23477889999998776 789999999999999999999999966543221111111000 00000 00000
Q ss_pred cccchhh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 LVENDEE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 ~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... ..........+.+++..||+.||.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0011122456789999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.33 Aligned_cols=258 Identities=18% Similarity=0.165 Sum_probs=181.5
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCCch-----------HHHHHHHHHhhccCcCchhhhccc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGD-----------KEFRTEVNAIGQTNHRNLVKLLGF 572 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~~~-----------~~f~~E~~~l~~l~h~niv~l~g~ 572 (797)
..+.+.+.||+|+||+||+|...... ...+++|.......... .....+...+..++|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 44666789999999999999986541 23466665332211110 112233445566789999999987
Q ss_pred ccccC----ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 573 CNEDQ----HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 573 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
+.... ..++++|+.. .++.+.+......++.....|+.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 65443 3467777764 35555555444567888899999999999999998 9999999999999999999999
Q ss_pred EeecCccccccCCC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhH--
Q 003759 649 SDFGLAKILKADQT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL-- 720 (797)
Q Consensus 649 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~-- 720 (797)
+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999987643221 1122346999999999999999999999999999999999999999765332211110
Q ss_pred HHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.++. ..+..+... ... ....+.+++..|++.+|++||++.++++.|+
T Consensus 248 ~~~~-~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFI-KRLHEGKIK--IKN---------ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHH-HHhhhhhhc--cCC---------CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0111 111111110 000 1234667888899999999999999998874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=288.49 Aligned_cols=263 Identities=23% Similarity=0.262 Sum_probs=190.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|++|.||+|+....+ ..|++|++..... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCC-cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 344578999999999999987544 4699999865322 2335788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCCC
Q 003759 586 ISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQT 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~ 662 (797)
++ ++|.+++.... .+++.....++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++........
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 96 57777775443 246777889999999999999998 9999999999999985 56799999999976543221
Q ss_pred cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc---cc--ccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI---DE--KLHLL 736 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~ 736 (797)
......+++.|+|||++.+. .++.++||||||+++|+|+||+.||......+.............. .+ .+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 12223468899999988664 5789999999999999999999999765332221111110000000 00 00000
Q ss_pred -------ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 -------VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 -------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... .........+.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0011112456789999999999999999999863
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.40 Aligned_cols=261 Identities=20% Similarity=0.211 Sum_probs=189.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhcc-CcCchhhhcccccccCc-----ee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQH-----RL 580 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~ 580 (797)
.+.+.||+|+||.||+|..... +..||+|+++.... ...+.+.+|+.+++.+ +|+||+++++++...+. .+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~-~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNT-GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred eEeeEecccCCeEEEEEEECCC-CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 3457899999999999998754 45699998765322 2345788899999999 56999999999877665 89
Q ss_pred eeeecccCCchhhhcccC-----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCc
Q 003759 581 LVYEFISNGCLAGFLFKN-----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLA 654 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla 654 (797)
+||||+++ +|.+++... ..+++...+.++.||++||.|||+. +|+|+||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 788877532 3578999999999999999999998 9999999999999998 889999999998
Q ss_pred cccccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...... ......
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVW 236 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhC
Confidence 765332211 112236788999998865 45799999999999999999999999764332221111110000 000000
Q ss_pred cc---------cc--cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HL---------LV--ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~---------~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .. .+.............+.+++..||+.||++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00 000000000112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=284.20 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=194.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.+.||+|++|.||+|+.... +..||||+++..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTT-GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECCC-CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 3457899999999999998754 456999998754332 34567889999999999999999999999999999999998
Q ss_pred CCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 788877543 3578999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred cccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcc-ccccc
Q 003759 665 TTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYID-EKLHL 735 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~ 735 (797)
.....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+....+.+... ..+.. .....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2223468889999988654 578999999999999999999999976543322111111100 00000 00000
Q ss_pred cccch---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 LVEND---EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 ~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..... ............+.+++..|++.||.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000001112346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=272.04 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=197.7
Q ss_pred CccccCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcc
Q 003759 494 NLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLG 571 (797)
Q Consensus 494 ~~~~~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g 571 (797)
....|+-++|+. ..+||.|+||+|+|-.++..+ +..|||+++.... ..+++++.|.+...+- ++||||+++|
T Consensus 57 ~~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk~sg-~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-----LGEIGNGAFGTVNKMLHKPSG-KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccccchHHH-----HHHhcCCcchhhhhhhcCccC-cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 445566666665 357999999999999888655 5699999986554 4556788898887665 7999999999
Q ss_pred cccccCceeeeeecccCCchhhhcc-----cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcE
Q 003759 572 FCNEDQHRLLVYEFISNGCLAGFLF-----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA 646 (797)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~ 646 (797)
.+..++..|+.||.|+ -||+.+.. ....+++.-.-.|+.....||.||.+. ..|||||+||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence 9999999999999994 45554442 235677777788888999999999986 589999999999999999999
Q ss_pred EEEeecCccccccCCCcccccccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH
Q 003759 647 RISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724 (797)
Q Consensus 647 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 724 (797)
||+|||++..+.... ..+.-.|...|||||.+... .|+.++||||||++|+|+.||..|+......-++..+
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~---- 281 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ---- 281 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH----
Confidence 999999988765432 23344588899999999643 5899999999999999999999999765442222111
Q ss_pred HhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+..+....+..+ .+ .......+.+++-.|+.+|.++||...++.++
T Consensus 282 ---Vv~gdpp~l~~~-~~---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 ---VVIGDPPILLFD-KE---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---HHcCCCCeecCc-cc---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112222222211 11 11122345667777999999999999887653
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=284.41 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=188.4
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeeccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.++||+|+||.||+++.... +..||+|++..... .....+.+|+.++.++. |+||+++++++..+...+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPS-GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCC-CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 457899999999999998754 45699999875332 23457889999999995 9999999999999999999999986
Q ss_pred CCchhhh---cc--cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 588 NGCLAGF---LF--KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 588 ~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
. +|.++ +. ....+++.....++.+++.||+|||+. .+++||||||+||+++.++.+||+|||++..+.....
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 44433 22 235688999999999999999999973 3899999999999999999999999999976543222
Q ss_pred cccccccccCccccccccccC---CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
. ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... .+...... .+....+...
T Consensus 164 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~~~ 234 (288)
T cd06616 164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------FDQLTQVV-KGDPPILSNS 234 (288)
T ss_pred c--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH------HHHHhhhc-CCCCCcCCCc
Confidence 1 223478899999999776 6899999999999999999999999654311 01111110 1110000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........+.+++.+|++.+|++|||+.+|++.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 -----EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122356788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.62 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=199.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc--Cceeeeeecc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLVYEFI 586 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~Ey~ 586 (797)
.+.||+|++|.||+|+.... +..|++|++..... ...+.+.+|+..+++++|+||+++++.+... +..++++||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDT-GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECCC-CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 46799999999999998754 45699999875432 3356789999999999999999999999888 8899999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc-cc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-TT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~ 665 (797)
++++|.+++.....+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+......... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999998777899999999999999999999997 9999999999999999999999999998876544321 12
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....++..|+|||.+.....+.++||||||+++++|++|..||....... ..............+...
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~------ 228 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKIGSSGEPPEIPEH------ 228 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhccccCCCcCCCcc------
Confidence 33457889999999998889999999999999999999999997654111 001111100111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++.+|++.+|++||++.++++
T Consensus 229 ---~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 229 ---LSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1345677889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=282.37 Aligned_cols=245 Identities=20% Similarity=0.233 Sum_probs=188.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHH-hhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNA-IGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.||+|+||.||+|.....+ ..||+|.+...... ....+..|..+ ....+|+|++++++++.+++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG-DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC-CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999886544 46999998653221 12234445444 445589999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999998777889999999999999999999998 999999999999999999999999999875433 123
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..+++.|+|||.+.+..++.++||||||+++|||++|..||........ . . ......... ... ...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~-~----~~~~~~~~~--~~~----~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---F-D----NILSRRINW--PEE----VKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H-H----HHHhcccCC--CCc----ccc
Confidence 3478899999999888899999999999999999999999965432211 0 0 000111000 000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
.....+.+++..|++.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11245678899999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.05 Aligned_cols=265 Identities=21% Similarity=0.283 Sum_probs=195.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc----cCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l 581 (797)
+.+.+.||+|+||.||+|+....+ ..|++|++..... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSG-KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCC-CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 344578999999999999987654 4699999875322 234567889999999999999999998753 356899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|+||+. ++|.+++.....+++.....++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999996 68999998777799999999999999999999998 99999999999999999999999999997654322
Q ss_pred C---cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhcc
Q 003759 662 T---RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYID 730 (797)
Q Consensus 662 ~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 730 (797)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 2 11223458889999999865 468999999999999999999999996543321111000000 000000
Q ss_pred ccccccccch---hh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 EKLHLLVEND---EE---ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ~~~~~~~~~~---~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+....+.. .. ..........+.+++..|++.+|++||++++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00 00001124567889999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=295.21 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=191.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Cce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 579 (797)
+...+.||+|+||.||+|.....+ ..||+|++..... ...+++.+|+.++++++|+||+++++++... ...
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTG-QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCC-CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 444578999999999999987654 4699999864322 2335677899999999999999999987543 357
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+. ++|.+.+... ++......++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 99999996 5777777543 78888999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH--------------H
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA--------------Y 725 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~--------------~ 725 (797)
... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||...........+.... .
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 171 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 222 223347889999999999999999999999999999999999997543221111110000 0
Q ss_pred hhhcccc-------ccccccch----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 726 DCYIDEK-------LHLLVEND----EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 726 ~~~~~~~-------~~~~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....... ...+.... ............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000 0000011223456789999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.50 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=197.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhccccccc-----Ccee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 580 (797)
+...+.||+|+||+||+|+.... +..||||.+.... ....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSET-NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCC-CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 33456899999999999998754 4569999987532 22345678899999999999999999988654 3579
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+|+||+. ++|.+++.....++......++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 68988888778899999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDEK 732 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~ 732 (797)
. .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+.+... .......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 162 G-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred c-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 2 12223447889999998865 4689999999999999999999999965432111111110000 0000000
Q ss_pred ccccc-------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 003759 733 LHLLV-------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVE 783 (797)
Q Consensus 733 ~~~~~-------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~ 783 (797)
..... ....... .......+.+++.+|++.+|++|||++|+++. ++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000 0000000 01123456789999999999999999999987 655433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.71 Aligned_cols=263 Identities=21% Similarity=0.226 Sum_probs=194.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------------hHHHHHHHHHhhccCcCchhhhcccccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------------DKEFRTEVNAIGQTNHRNLVKLLGFCNE 575 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------------~~~f~~E~~~l~~l~h~niv~l~g~~~~ 575 (797)
+.+.||+|+||+||+|.....+ ..||||++....... ...+.+|+++++.++|+||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTG-KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEECCCC-CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3467999999999999987544 469999886432221 1257789999999999999999999999
Q ss_pred cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
++..++||||++ ++|.+++.....++......++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 68999998777889999999999999999999998 99999999999999999999999999997
Q ss_pred ccccCC-------------CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHH
Q 003759 656 ILKADQ-------------TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721 (797)
Q Consensus 656 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 721 (797)
...... ........+++.|+|||.+.+. .++.++||||||+++|||++|..||......+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 654111 1111223467889999998764 46899999999999999999999997654332211111
Q ss_pred HHHHhh----hccc-cc---c---ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 722 DWAYDC----YIDE-KL---H---LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 722 ~~~~~~----~~~~-~~---~---~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
...... +... .+ . .......... .......+.+++..|++.+|++||+++|++..-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 110000 0000 00 0 0000000000 011234577899999999999999999999753
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.82 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=196.9
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||+++....+ ..+++|.+..... ....++.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDN-QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCC-CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 34578999999999999876544 4699999875332 23346788999999999999999999999999999999999
Q ss_pred cCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
++++|.+++.+ ...+++.....++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999865 35678899999999999999999998 99999999999999999999999999998765442
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....+++.|+|||.+.+..++.++|+||||++++||++|+.||......+ +.. ....+....+..
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~~~~---- 223 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRY----KVQRGKYPPIPP---- 223 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHhcCCCCCCch----
Confidence 122347889999999999899999999999999999999999996543221 111 111111111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..|++.+|++||++.++++.
T Consensus 224 -----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 -----IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 123456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=278.45 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=198.4
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|++|.||+++....+ ..|++|.+..... ...+.+.+|++++.+++|+|++++++++.+++..++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETG-DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCC-cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 44678999999999999887544 4599999976543 23457899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999998778899999999999999999999998 9999999999999999999999999999876543321 22
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...++..|+|||...+..++.++|||+||+++++|++|+.|+.......... .. ...........
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~-------~~-~~~~~~~~~~~------- 222 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-------RI-VQDDHPPLPEG------- 222 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH-------HH-hccCCCCCCCC-------
Confidence 3457889999999988888999999999999999999999986543211110 00 00111101000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++.+|++.+|++||++.+++.
T Consensus 223 --~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 --ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1234567889999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.61 Aligned_cols=266 Identities=23% Similarity=0.284 Sum_probs=193.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhccccccc-----Cceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 581 (797)
+.+.+.||+|+||.||+|+....+ ..||+|++.... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTG-VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCC-CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 445678999999999999887544 469999986432 22345688899999999999999999986543 35799
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
++||+++ +|.+++ ....+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9999974 777766 345688999999999999999999998 99999999999999999999999999987654322
Q ss_pred Cc--ccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc---cccc
Q 003759 662 TR--TTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE---KLHL 735 (797)
Q Consensus 662 ~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 735 (797)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+ ...+... ....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~ 236 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI----LGVLGTPSQEDLNC 236 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHHcCCCCHHHHHH
Confidence 21 1223457889999998754 56899999999999999999999999654321111000 0000000 0000
Q ss_pred cccc------------hh-h-hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 003759 736 LVEN------------DE-E-ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVE 783 (797)
Q Consensus 736 ~~~~------------~~-~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~ 783 (797)
+... .. . ..........+.+++..||+.+|++|||+.|+++. ++...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 00 0 00001113457789999999999999999999987 655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=286.79 Aligned_cols=279 Identities=24% Similarity=0.265 Sum_probs=197.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccccc--Cceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|+....+ ..||+|+++..... ....+.+|+.++++++|+||+++++++... +..++||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSG-EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCC-cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 445678999999999999987544 46999998643222 233567899999999999999999998654 5689999
Q ss_pred ecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++ +|.+++.. ...+++.++..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99974 78877764 36689999999999999999999998 999999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hhccccc-
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CYIDEKL- 733 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 733 (797)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.+.... .......
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 164 -PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred -CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 1222235778999999865 45799999999999999999999999765433221111111000 0000000
Q ss_pred --cccccchhhhhhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCCc
Q 003759 734 --HLLVENDEEALHD--MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSF 793 (797)
Q Consensus 734 --~~~~~~~~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~~p~~~ 793 (797)
............. ......+.+++..|++.||++|||+.|+++.- =....+.|-.|...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~-~f~~~~~~~~~~~~ 305 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS-YFKEKPLPCEPEMM 305 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh-hhccCCCCCCCCcC
Confidence 0000000000000 00134566789999999999999999998653 23334444444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.99 Aligned_cols=270 Identities=21% Similarity=0.268 Sum_probs=193.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC------ceeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HRLLV 582 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV 582 (797)
.+.||+|+||.||+|+....+ ..||+|++..... .....+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTG-EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCC-cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 467999999999999986544 4699999865322 22356889999999999999999999886543 46899
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 999964 666654 23578899999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhcccccc
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYIDEKLH 734 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 734 (797)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ..........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 223346888999999876 468999999999999999999999997643211111110000 0000000000
Q ss_pred ccc-------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCCCCCC
Q 003759 735 LLV-------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPIPPDPSS 792 (797)
Q Consensus 735 ~~~-------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~p~~p~~ 792 (797)
... ....... .......+.+++..||+.||++||++.+++.. ++...+.+..+.|.+
T Consensus 249 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~ 314 (342)
T cd07879 249 SYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314 (342)
T ss_pred HHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence 000 0000000 00112356789999999999999999999955 777766554444433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=281.00 Aligned_cols=260 Identities=25% Similarity=0.294 Sum_probs=196.3
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.||+|++|.||+|+....+ ..+++|++.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTG-EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecCCC-cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3467999999999999987644 469999987643 2334678889999999999999999999999999999999998
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|.+++.+. ..+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5899999766 5789999999999999999999998 999999999999999999999999999886644322 122
Q ss_pred cccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhh-----ccccc
Q 003759 667 AIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCY-----IDEKL 733 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~-----~~~~~ 733 (797)
...++..|+|||.+.+. .++.++||||||++++||++|+.||......+....+.... +... .....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23356789999998776 78999999999999999999999996654322111111100 0000 00000
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
........... .......+.+++..|++.+|++||++++|+.
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0011346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=288.57 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=188.6
Q ss_pred hhhCcc--cceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 512 DELGRG--AFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G--~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
++||+| +||+||++.+... +..||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPT-GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCC-CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 467777 8999999988654 456999998653222 23568889999999999999999999999999999999999
Q ss_pred CCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--
Q 003759 588 NGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-- 663 (797)
Q Consensus 588 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 663 (797)
+++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998754 4578888899999999999999988 9999999999999999999999999865433221110
Q ss_pred ----ccccccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------------
Q 003759 664 ----TTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA------------- 724 (797)
Q Consensus 664 ----~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~------------- 724 (797)
......++..|+|||++.+. .++.++||||||++++||++|+.||................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112245679999999764 47899999999999999999999997543221110000000
Q ss_pred Hhhh-----------cccccc-----ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 725 YDCY-----------IDEKLH-----LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 725 ~~~~-----------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... .+.... ..................+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 000000 000000011111223456789999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.36 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=190.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC--------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-------- 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 577 (797)
+.+.++||+|+||.||+|+.... +..||||++..... .....+.+|+.++++++||||+++++++....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~-~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCC-CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 45567899999999999998754 45699998864322 22345678999999999999999999886544
Q ss_pred ceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..++||||+.+ +|.+.+... ..+++.+...++.||+.||+|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999975 777776544 3689999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCC---cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 657 LKADQT---RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 657 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
+..... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+ ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI-SQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCChhh
Confidence 643222 112233467889999988664 4788999999999999999999999765332211111 11100000000
Q ss_pred ccc-----------cccch----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 LHL-----------LVEND----EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 ~~~-----------~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ..... ............+.+++..||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 00000 0000011112456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=317.87 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=196.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
..||.|.||.||.|+..+.++ ..|+|.+.-. .....+...+|..++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGe-llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGE-LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecCCccc-hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 469999999999999887655 4899987542 2334457889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC---cccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT---RTTT 666 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---~~~~ 666 (797)
+|.+.+......++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|..+..... ....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999998887777777788899999999999998 999999999999999999999999999998765432 2334
Q ss_pred cccccCccccccccccC---CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 667 AIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
...||+.|||||++.+. ...-++||||+|||++||+||++||...+.+- .++-.+ .-+...++...
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V----~~gh~Pq~P~~---- 1465 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHV----AAGHKPQIPER---- 1465 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHH----hccCCCCCchh----
Confidence 56799999999999654 45678999999999999999999997654322 221111 11222211111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
-...-.+++..|++.||++|-++.|+++.
T Consensus 1466 -----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 -----LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11233467788999999999988877764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=284.26 Aligned_cols=258 Identities=17% Similarity=0.160 Sum_probs=187.8
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.+.+|.|+++.||+++. .+..||||++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus 7 ~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34455555655555543 3456999998754 223346799999999999999999999999999999999999999
Q ss_pred CchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC----
Q 003759 589 GCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT---- 662 (797)
Q Consensus 589 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---- 662 (797)
++|.+++... ..+++.....++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999753 4578888899999999999999998 999999999999999999999999998875532211
Q ss_pred --cccccccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh----hcc----
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC----YID---- 730 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~---- 730 (797)
.......++..|+|||++... .++.++||||||++++||++|+.||......... .+..... +..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML---LEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccCccccccCchh
Confidence 112233467789999998763 5889999999999999999999999754322111 0100000 000
Q ss_pred ---ccccc----cccc----hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 ---EKLHL----LVEN----DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ---~~~~~----~~~~----~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..... ..+. .............+.+++..||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000 00111111223467789999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=283.17 Aligned_cols=252 Identities=24% Similarity=0.237 Sum_probs=193.8
Q ss_pred hhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCC----CchHHHHHHHHHhhcc-CcCchhhhcccccccCceee
Q 003759 509 GFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVS----GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~----~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 581 (797)
.+.+.||+|+||.||++.... ..+..||+|++..... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 345789999999999998753 2345799999865322 2335688899999999 69999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|+||+++++|.+++.....+++.....++.|+++||.|||+. +++|+||+|+|||+++++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999998777888999999999999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
........++..|+|||.+... .++.++||||||+++|+|++|+.||...........+ .......... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~~--~--- 231 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSEPP--Y--- 231 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH---HHHhhccCCC--C---
Confidence 3333344588899999998753 4688999999999999999999999643222111111 1111111000 0
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
+ ......+.+++..|++.||++|| ++.+++..
T Consensus 232 -~-----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 -P-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -C-----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 00113456788899999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=280.74 Aligned_cols=259 Identities=25% Similarity=0.274 Sum_probs=190.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc---CcCchhhhcccccccCc-----e
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT---NHRNLVKLLGFCNEDQH-----R 579 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 579 (797)
+.+.||+|+||.||+|+.... +..||+|++...... ....+.+|+.++.++ +|+||+++++++...+. .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNT-GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECCC-CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456799999999999998753 456999999743322 234566787777665 69999999999987776 8
Q ss_pred eeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 580 LLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+++|||+. ++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++..+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99999997 4788888654 3589999999999999999999998 9999999999999999999999999999776
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh----hhcccc-
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD----CYIDEK- 732 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~~- 732 (797)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.+.... .+....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43322 12234688899999999989999999999999999999999998765433221111111000 000000
Q ss_pred -----ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 -----LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 -----~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
......... ..........+.+++..||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0011112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.55 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=197.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+++.... +..|++|++.... ....+.+..|+.++.+++ |+||+++++++..++..++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKET-NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCC-CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 34557899999999999998754 4569999986522 223456888999999998 999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
||+++++|.+++.+...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998887899999999999999999999998 999999999999999999999999999886643321
Q ss_pred ------------------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH
Q 003759 663 ------------------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724 (797)
Q Consensus 663 ------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 724 (797)
.......++..|+|||.+....++.++||||||++++++++|+.||........ . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~-~-- 232 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---F-Q-- 232 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---H-H--
Confidence 122234578899999999888899999999999999999999999976542111 0 0
Q ss_pred HhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 003759 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTM----KKVTL 776 (797)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~----~eVl~ 776 (797)
........ . + ....+.+.+++..||+.+|++||++ +++++
T Consensus 233 --~~~~~~~~-~----~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 --KILKLEYS-F----P-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHhcCCC-C----C-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000000 0 0 0013456788999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=284.60 Aligned_cols=247 Identities=23% Similarity=0.275 Sum_probs=190.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
.++...+.||+|+||.||+|+....+ ..+++|.+..... ...+++.+|+++++.++|+|++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCC-cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 33444578999999999999987544 4599998864222 2234678899999999999999999999999999999
Q ss_pred eecccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+||+. |+|.+.+. ....+++.++..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 57777664 345688899999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
....+++.|+|||.+. ...++.++||||||+++|+|++|..|+......+... ... ........
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~-----~~~~~~~~- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA-----QNESPALQ- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HHh-----hcCCCCcC-
Confidence 2234788999999974 3467889999999999999999999986542211111 000 00000000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
.......+.+++.+||+.+|++||++.+|++..
T Consensus 236 -------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 236 -------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011123456788999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=279.87 Aligned_cols=243 Identities=24% Similarity=0.240 Sum_probs=186.1
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHH---hhccCcCchhhhcccccccCceeeeeecc
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNA---IGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.||+|+||.||++..... +..||+|.+...... ....+..|..+ ++...||||+++++++..++..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecC-CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 389999999999987654 446999998653221 12234445443 44457999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 9999999998778899999999999999999999998 999999999999999999999999999875533221 2
Q ss_pred cccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... . .......... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~----~~~~~~~~~~-~~~------- 220 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I----DRMTLTMAVE-LPD------- 220 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-H----HHHhhccCCC-CCC-------
Confidence 23588999999998754 68999999999999999999999997643221111 0 0000000000 000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
.....+.+++..|++.+|++|| ++.++++.
T Consensus 221 --~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0123566788899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.83 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=198.4
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||++..... +..+++|++..... ...+++.+|+++++.++|+|++++++.+..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSD-GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCC-CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 3456799999999999998754 44699999876433 34567899999999999999999999999999999999999
Q ss_pred cCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
++++|.+++... ..+++.....++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999998753 6789999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.||......+ +.. .........+..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~~~~---- 225 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LAL----KILKGQYPPIPS---- 225 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HHH----HHhcCCCCCCCC----
Confidence 12223457889999999998889999999999999999999999986543211 111 111111111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++.+|++.+|++||++.|+++.
T Consensus 226 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112346678899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=284.62 Aligned_cols=263 Identities=22% Similarity=0.249 Sum_probs=188.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccC--------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-------- 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 577 (797)
+.+.+.||+|+||.||+|+....+ ..+++|++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTG-RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCC-cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 445678999999999999987554 45999988643322 2346788999999999999999999875433
Q ss_pred ceeeeeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..++|+||+.. +|...+.. ...+++.++..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++..
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 46999999975 56655544 45789999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCCc----------ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH
Q 003759 657 LKADQTR----------TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725 (797)
Q Consensus 657 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (797)
....... ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5432211 11233567889999987654 589999999999999999999999975443221111111000
Q ss_pred h-------hh--ccc----cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 726 D-------CY--IDE----KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 726 ~-------~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. .. ... ............ ........+.+++.+|++.||++|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00 000 000000000000 00111246788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.50 Aligned_cols=235 Identities=23% Similarity=0.264 Sum_probs=181.4
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccCCchh
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISNGCLA 592 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (797)
||+|+||.||++.....+ ..+|+|.+....... . |+.....+ +|+||+++++.+..++..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~~~-~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQ-KLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCC-cEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999887654 458999986532111 1 22222222 7999999999999999999999999999999
Q ss_pred hhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCCccccccccc
Q 003759 593 GFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTRTTTAIRGT 671 (797)
Q Consensus 593 ~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~gt 671 (797)
+++.....+++.+...++.|+++||.|||+. +++|+||||+||+++.++ .++|+|||++....... ...++
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~ 169 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGT 169 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCC
Confidence 9998777899999999999999999999998 999999999999999998 99999999987654321 23478
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLK 751 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (797)
..|+|||++.+..++.++||||||++++||++|+.||......... ...+.... .... .... ....
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~--~~~~-~~~~---------~~~~ 235 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ--QKKL-PFIK---------NVSK 235 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh--cccC-Cccc---------ccCH
Confidence 8999999999989999999999999999999999999744322211 11111111 1000 0000 1223
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 003759 752 KYVMIAIWCIQEDPSLRPT-MKKVTL 776 (797)
Q Consensus 752 ~~~~l~~~Cl~~dP~~RPs-~~eVl~ 776 (797)
.+.+++..||+.+|.+||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 4677888999999999996 688874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=276.87 Aligned_cols=248 Identities=20% Similarity=0.221 Sum_probs=191.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-----CCchHHHHHHHHHhhccCcCchhhhccccccc--Ccee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-----SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 580 (797)
+.+.+.||+|+||.||+|..... +..|++|.+.... ....+.+.+|++++++++|+||+++++++.+. ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADT-GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCC-CCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 34567899999999999988754 4569999875321 12234688999999999999999999988654 4578
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+++||+++++|.+++.....+++.....++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998777788999999999999999999998 9999999999999999999999999999865321
Q ss_pred C--CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 Q--TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~--~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
. ........++..|+|||.+.+..++.++||||||++++||++|+.||......+. +.. ....+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~~~~-- 230 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---IFK----IATQPTKPML-- 230 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---HHH----HHcCCCCCCC--
Confidence 1 1112234578899999999988899999999999999999999999965422111 111 1101100000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+.+++..|++ +|.+||+..+++.
T Consensus 231 -------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 231 -------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01112345678888999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=283.55 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=188.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 582 (797)
..|...++||+||.+.|||+...+ ...+|+|++..... +...-|.+|+..|.++ .|.+|++|++|-..++..|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~--~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD--KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC--CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 345567889999999999987643 33578777643222 2335699999999999 699999999999999999999
Q ss_pred eecccCCchhhhcccCCC-CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||- .-+|..+|.+... .+...+..+..|++.++.++|++ +|||.||||.|+|+-. |.+||+|||+|..+..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 9985 6689999976643 33237778899999999999998 9999999999999865 689999999999888776
Q ss_pred Ccc-cccccccCccccccccccC-----------CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc
Q 003759 662 TRT-TTAIRGTRGYVAPEWFKSL-----------PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 662 ~~~-~~~~~gt~~y~aPE~~~~~-----------~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
... ....+||+.||+||.+... +.+.++||||||||||+|+.|+.||...... |+.-
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--------~aKl--- 582 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--------IAKL--- 582 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--------HHHH---
Confidence 532 3335699999999998533 2568899999999999999999999653221 1111
Q ss_pred cccccccccchhhhhhh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 730 DEKLHLLVENDEEALHD-MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+.++.-+..++ ...-..++++++.||+.||++||+..|+++.
T Consensus 583 ----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 ----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111111100000 0001127788999999999999999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.05 Aligned_cols=237 Identities=29% Similarity=0.312 Sum_probs=191.2
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
||+|+||.||+++.... +..+++|.+...... ....+..|+.++++++|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDT-GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCC-CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 69999999999998754 446999998754332 33478899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccc
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 670 (797)
|.+++.....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 999998777889999999999999999999997 99999999999999999999999999987654332 12233457
Q ss_pred cCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHH
Q 003759 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750 (797)
Q Consensus 671 t~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (797)
+..|+|||.+.+...+.++|+||||+++|+|++|+.||....... ..... ...... ... . ..
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~----~~~~~~--~~~---~-----~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKI----LKDPLR--FPE---F-----LS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH----hcCCCC--CCC---C-----CC
Confidence 889999999988889999999999999999999999996543211 11111 011100 000 0 02
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 003759 751 KKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 751 ~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
..+.+++..|++.||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 34567889999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=282.04 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=187.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|+.... +..||||+++.... ....++..|+.++.+. .|+||+++++++.++...+++|||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKT-GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCC-CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 34567899999999999998754 45699999875332 2334567777777666 599999999999999999999999
Q ss_pred ccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++ ++|.+++.. ...+++..+..++.+++.||+|||+. .+|+|+||+|+||++++++.+||+|||++..+......
T Consensus 96 ~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 96 MS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred cC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 85 466666644 35688999999999999999999973 28999999999999999999999999998765432221
Q ss_pred cccccccCccccccccccCC----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 665 TTAIRGTRGYVAPEWFKSLP----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .+ ...... ........
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~-~~~~~~~~- 242 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VL----TKILQE-EPPSLPPN- 242 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HH----HHHhcC-CCCCCCCC-
Confidence 2234678999999987553 78999999999999999999999965322111 01 011111 10000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+.+++.+|++.||++||++.++++.
T Consensus 243 ------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 ------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0112356788899999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.58 Aligned_cols=241 Identities=25% Similarity=0.304 Sum_probs=186.7
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.++||+|+||+||+|+....+ ..|++|++....... .+.+.+|+.+++.++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~-~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTN-EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCC-cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 356999999999999886544 569999986533322 2467889999999999999999999999999999999996
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|.+++.. ...+++.++..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..... ..
T Consensus 105 -~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 105 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 567666654 45688999999999999999999998 999999999999999999999999999864321 22
Q ss_pred cccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 667 AIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
...++..|+|||++. ...++.++||||||+++|||++|..|+.......... ..... .......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~~~-~~~~~~~----- 242 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQN-DSPTLQS----- 242 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHHhc-CCCCCCc-----
Confidence 345788999999984 4568899999999999999999999986543221111 00000 0000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......+.+++.+|++.+|++||++.++++.
T Consensus 243 ---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011235678889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.49 Aligned_cols=279 Identities=22% Similarity=0.296 Sum_probs=201.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc-cCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 581 (797)
|+....||+|.||.||||+...++. ..+|+|+++.... +......+|+.+++.++||||+.+..++.+ +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 4456789999999999997765543 3689999975422 233456789999999999999999999877 888999
Q ss_pred eeecccCCchhhhccc-----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC----CcEEEEeec
Q 003759 582 VYEFISNGCLAGFLFK-----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS----FTARISDFG 652 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfg 652 (797)
++||.++. |...++. ...++......|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+|+|
T Consensus 106 ~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 99999874 5555532 24577888999999999999999998 99999999999999877 899999999
Q ss_pred CccccccCCCc--ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccc-----hhhHHHHH
Q 003759 653 LAKILKADQTR--TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENEN-----QMILVDWA 724 (797)
Q Consensus 653 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~-----~~~~~~~~ 724 (797)
+++.+...-.. ....++-|.-|+|||.+.+. .||.+.|||+.|||+.||+|.++.|......-. +......+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988654332 33445678899999998875 589999999999999999999999876533211 11111111
Q ss_pred Hhhhccc---ccccc---------ccchh------hhhhhHHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 725 YDCYIDE---KLHLL---------VENDE------EALHDMMR-----LKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 725 ~~~~~~~---~~~~~---------~~~~~------~~~~~~~~-----~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
...+-.. ....+ +.... ..+..... .....+++..+|+.||.+|.|+++.++.. -.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 1111110 00000 00000 00111111 12367788899999999999999887653 35
Q ss_pred cCCCCCCCCC
Q 003759 782 VEVPIPPDPS 791 (797)
Q Consensus 782 ~~~~~p~~p~ 791 (797)
.+-+.||.|.
T Consensus 341 ~~d~lpp~pt 350 (438)
T KOG0666|consen 341 TEDPLPPLPT 350 (438)
T ss_pred ccCCCCCCcc
Confidence 5666677664
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.86 Aligned_cols=261 Identities=21% Similarity=0.225 Sum_probs=189.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccccc-----------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED----------- 576 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~----------- 576 (797)
+.+.+.||+|+||.||+|.....+ ..|++|++........+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~-~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCD-KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCC-cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 445678999999999999887544 46999998765555567789999999999999999999876543
Q ss_pred ---CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeec
Q 003759 577 ---QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFG 652 (797)
Q Consensus 577 ---~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfg 652 (797)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+. +|+|+||||+||+++ +++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 588887753 4678999999999999999999998 999999999999997 55678999999
Q ss_pred CccccccCCC--cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-----
Q 003759 653 LAKILKADQT--RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA----- 724 (797)
Q Consensus 653 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~----- 724 (797)
++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976543221 11122347888999998654 568899999999999999999999997554322211111000
Q ss_pred --Hhhhccc-------cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 725 --YDCYIDE-------KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 725 --~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... .......+ ... ........+.+++..|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRP-LRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCC-HHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 00000000 000 00011245678999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=274.76 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=188.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-----CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-----SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
|.+.++||+|+||.||+++...... .+++|.++... .....++..|+.++++++||||+++++++.+....++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVA-EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCC-cceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4456789999999999998765432 24455543211 12234577899999999999999999999999999999
Q ss_pred eecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 583 YEFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
+||+++++|.+++.. ...+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 35688999999999999999999998 9999999999999976 569999999987654
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||....... ... . ...+.....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~---~-~~~~~~~~~-- 225 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS----VVL---R-IVEGPTPSL-- 225 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHH---H-HHcCCCCCC--
Confidence 3322 2223457889999999988889999999999999999999999996432211 111 1 111111110
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 226 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 -------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01112356778999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=287.15 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=201.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch--HHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD--KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~--~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+...||+|.|++|..|++...+ ..||||.+++...... ..+.+|+++|..++|||||+++.+.+....+|+||||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~-~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTG-TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCC-ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 445678999999999999998664 5699999987544332 3478899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+.+|.+++++.+..+........+..|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+.. ....
T Consensus 137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~l 211 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLML 211 (596)
T ss_pred ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--cccc
Confidence 99999999999998888899999999999999999998 999999999999999999999999999987763 3344
Q ss_pred ccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....|++.|.|||++.+..+ .+++|+||+|++||.|++|..||++..-.+....... ..-++...+.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------gk~rIp~~ms------ 279 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------GKYRIPFYMS------ 279 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------eeecccceee------
Confidence 55679999999999999876 6899999999999999999999986543322111100 0001111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.++-+++..++..+|.+|++++++.+.
T Consensus 280 ------~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 280 ------CDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------chhHHHHHHhhccCccccCCHHHhhhh
Confidence 234467778899999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=288.01 Aligned_cols=198 Identities=29% Similarity=0.399 Sum_probs=170.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccC------ceeeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HRLLVY 583 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~ 583 (797)
.+.||+|+||.||+|+.+..+ ..||||.+...... ..+..-.|++++++++|+|||++++.-++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG-~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETG-RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccc-cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 578999999999999987654 46999999764432 2345678999999999999999999866544 678999
Q ss_pred ecccCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE--cCCC--cEEEEeecCccc
Q 003759 584 EFISNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL--DDSF--TARISDFGLAKI 656 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~Dfgla~~ 656 (797)
||+.+|||+..|.+. ..+++.+.+.+..++..||.|||++ +|+||||||.||++ .++| ..||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999765 4689999999999999999999998 99999999999998 3334 469999999998
Q ss_pred cccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~ 714 (797)
+..+. ..+.+.||+.|++||.+.. +.|+...|.|||||++|+.+||..||......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 76554 6667889999999999984 88999999999999999999999999765443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=300.19 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=185.8
Q ss_pred HHHHhhhh--hhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhccccccc-----
Q 003759 505 KATQGFKD--ELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED----- 576 (797)
Q Consensus 505 ~~~~~f~~--~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~----- 576 (797)
+....|.+ .||+||||.|||++.+-+ ++.+|||++.-.. ......+.+|++.+++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlD-Gr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLD-GREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeeccc-chhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 44455654 699999999999987754 5679999997543 12234578899999999999999987641000
Q ss_pred --------------------------------------------------------------------------------
Q 003759 577 -------------------------------------------------------------------------------- 576 (797)
Q Consensus 577 -------------------------------------------------------------------------------- 576 (797)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeeeeecccCCchhhhcccCCCC-ChhhHHHHHHHHHHHHHHHh
Q 003759 577 ----------------------------------QHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLH 621 (797)
Q Consensus 577 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~~LH 621 (797)
...||-||||+..+|.+++.++... .....++++.+|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1237789999998888888766544 35667899999999999999
Q ss_pred hcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc-----------------cCCCcccccccccCccccccccccCC
Q 003759 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK-----------------ADQTRTTTAIRGTRGYVAPEWFKSLP 684 (797)
Q Consensus 622 ~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~ 684 (797)
++ +||||||||.||+||++..+||+|||+|.... .......+..+||.-|+|||++.+..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 98 99999999999999999999999999998721 00112445567999999999997654
Q ss_pred ---CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhc
Q 003759 685 ---ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCI 761 (797)
Q Consensus 685 ---~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 761 (797)
|+.|+|+||||||++||+. ||....+. .. +-..++.+.+... ......+...-.+++.|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---a~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---AS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH---HH----HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 9999999999999999986 46544321 11 1122333333322 0111112223356889999
Q ss_pred ccCCCCCCCHHHHHH
Q 003759 762 QEDPSLRPTMKKVTL 776 (797)
Q Consensus 762 ~~dP~~RPs~~eVl~ 776 (797)
++||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999885
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=256.77 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=199.6
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccC
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 577 (797)
+++|+-+-| .+.||+|+++.|-..+.... +.++|||++++..........+|++++.+. .|+||+.|+++|+++.
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t-~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQT-GKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeecc-chhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 355554443 36899999999998876544 456999999987666677889999999998 5999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEeecCc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDFGLA 654 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla 654 (797)
..|||||-|.+|+|..+++++..+++.+..++..+|+.||.|||.+ +|.||||||+|||-..... +||+||.|.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999999999999999999999999999999998 9999999999999965543 799999987
Q ss_pred ccccc--CCC----cccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchh---hH
Q 003759 655 KILKA--DQT----RTTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM---IL 720 (797)
Q Consensus 655 ~~~~~--~~~----~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~---~~ 720 (797)
.-... +-. ......+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+....+-.. ..
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 65432 211 2233356888999999873 2358999999999999999999999998765432110 00
Q ss_pred H----HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 721 V----DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 721 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. +.....+-++..+. ++..-. .-....-+++...+..|+.+|.++.+++.
T Consensus 307 Cr~CQ~~LFesIQEGkYeF-----PdkdWa-hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEF-----PDKDWA-HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cHHHHHHHHHHHhccCCcC-----ChhhhH-HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 01111111222111 111000 01123345566677899999999999887
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=275.55 Aligned_cols=195 Identities=30% Similarity=0.367 Sum_probs=171.4
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
++||+||||.||..+...+++ .+|.|++.+.. ..++.-.++|-.+|.+++.+.||.+--.++..+.+++|+..|.+
T Consensus 191 RvlGkGGFGEV~acqvraTGK-MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGK-MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchh-hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 579999999999888776554 58888885422 23444568899999999999999999999999999999999999
Q ss_pred CchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 589 GCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 589 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
|+|.-+|.... .+++...+-+|.+|+.||+|||.. +||.|||||+|||||+.|+++|+|+|||..+...... .
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--R 344 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--c
Confidence 99999997654 789999999999999999999998 9999999999999999999999999999987655443 3
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
..+||.+|||||++.+..|+...|-|||||+||||+.|+.||...-
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 3369999999999999999999999999999999999999997653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.21 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=190.1
Q ss_pred hhhhhhCcccceeEEEEEEecC-CcEEEEEEEecccCCC--chHHHHHHHHHhhcc-CcCchhhhcccccc----cCcee
Q 003759 509 GFKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT-NHRNLVKLLGFCNE----DQHRL 580 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~ 580 (797)
.+.+.||+|+||.||+++.... ++..||+|++...... ..+.+.+|+.++.++ +||||+++++++.. ....+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 3457899999999999998754 1456999998753222 245688899999999 59999999987543 24578
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+++||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++..+...
T Consensus 83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8889886 68999988778899999999999999999999998 9999999999999999999999999999865432
Q ss_pred CC---cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhhc
Q 003759 661 QT---RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCYI 729 (797)
Q Consensus 661 ~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~~ 729 (797)
.. .......+++.|+|||.+.+ ..++.++||||||+++++|++|+.||...........+.... ...+.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 21 11223458899999998765 468999999999999999999999987543211100000000 00000
Q ss_pred ccccccc---cc----chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 730 DEKLHLL---VE----NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 730 ~~~~~~~---~~----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....... .. ...... .......+.+++.+|++.||++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00 000000 00012357789999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.09 Aligned_cols=276 Identities=23% Similarity=0.258 Sum_probs=196.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccC------ce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 579 (797)
+.+.+.||+|+||.||++..... +..||||++..... ...+.+.+|+.++++++|+||+++++++..+. ..
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRT-GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCC-CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 33456799999999999987654 45699999864322 22346889999999999999999999887654 45
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 8999998 678888775 35688999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDE 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 731 (797)
. .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||...........+..... ..+...
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 171 E----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred C----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 2 123346889999999876 4588999999999999999999999975432211111110000 000000
Q ss_pred cccccccchh----hhh--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHhcCcCCCCCCCCCCc
Q 003759 732 KLHLLVENDE----EAL--HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT--LMLEGVVEVPIPPDPSSF 793 (797)
Q Consensus 732 ~~~~~~~~~~----~~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl--~~Le~~~~~~~p~~p~~~ 793 (797)
.......... ... ........+.+++.+|++.||++|||+.+++ ..++...+.+..+.+.+|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY 316 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence 0000000000 000 0001123467899999999999999999999 455555554444333334
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=282.70 Aligned_cols=257 Identities=24% Similarity=0.283 Sum_probs=190.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCc------ee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH------RL 580 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 580 (797)
.+.+.||+|++|.||+|....++ ..||+|++..... ...+.+.+|+.++++++|+||+++++++...+. .+
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTG-RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCC-cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 34568999999999999987644 4699999865322 233567789999999999999999998876654 89
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 97 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 999998 6689888854 5689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDEK 732 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~ 732 (797)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.+... ..+....
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 223347888999999865 3678999999999999999999999965433221111111000 0000000
Q ss_pred cccccc-------chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 LHLLVE-------NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 ~~~~~~-------~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+. ....... ......+.+++..|++.+|++|||+.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 0000000 011356788999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.56 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=198.0
Q ss_pred hhhhCcccceeEEEEEEecCC----cEEEEEEEecccCCCch-HHHHHHHHHhhccCcCchhhhcccccc-cCceeeeee
Q 003759 511 KDELGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYE 584 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~----~~~vavK~~~~~~~~~~-~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 584 (797)
+..+-+|.||.||.|++.+.+ .+.|.||.++....+-+ ..|+.|..++..+.|||++++.+++.+ ....+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 456899999999999876432 24577888776444332 458889999999999999999999865 457789999
Q ss_pred cccCCchhhhcc-----cC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 585 FISNGCLAGFLF-----KN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 585 y~~~gsL~~~l~-----~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
++.-|+|..+|. +. +.++-.+...++.|++.|++|||.+ ++||.||..+|.+||+..++||+|-.|++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999997 21 3456677889999999999999998 999999999999999999999999999987
Q ss_pred cccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 657 LKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 657 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
+.+.+.. .......+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+.. ..++++...
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--------~ylkdGyRl 517 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--------HYLKDGYRL 517 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--------HHHhcccee
Confidence 6544433 3333345778999999999999999999999999999999 88898766544322 222333222
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.. +.....++..+...||...|++||++++++.-|.+
T Consensus 518 aQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 518 AQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 21 22234456778888999999999999999998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=278.64 Aligned_cols=260 Identities=23% Similarity=0.238 Sum_probs=189.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccc-cCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||+|++.... ....+.+..|+.++.+++||||+++++++.. .+..++++|
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTG-QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCC-CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 344578999999999999877544 469999886432 2234678899999999999999999998865 567899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+ +++|.+++.. ..++......++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 91 LL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred hh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 98 5688887753 4567888889999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcccccccc
Q 003759 665 TTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDEKLHLL 736 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 736 (797)
.....++..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+.+... .....+.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 122346788999998766 5689999999999999999999999965432111111111000 00000000000
Q ss_pred cc------chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 VE------NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~~------~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. ..+...........+.+++..|++.+|++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000112467789999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=280.25 Aligned_cols=256 Identities=24% Similarity=0.275 Sum_probs=186.3
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Cceeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHRLLV 582 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV 582 (797)
.+.||+|+||.||+|..... +..||+|++..... ...+.+.+|+.++.+++|+||+++++++... ...+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEeeecCCeEEEEEEEcCC-CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 46799999999999987654 45699999875322 2245688899999999999999999987543 346788
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 101 ~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-- 173 (345)
T cd07877 101 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 173 (345)
T ss_pred ehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc--
Confidence 8876 7889887754 4688999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.....+++.|+|||.+.+ ..++.++||||||++++||++|+.||...........+..... ...........+...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (345)
T cd07877 174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAELLKKISSESA 250 (345)
T ss_pred --ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHHhhcccHhH
Confidence 223457889999999866 5688999999999999999999999965432221111111000 000000000000000
Q ss_pred hh--------------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EA--------------LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~--------------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+. .........+.+++..|++.||.+||++.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000012356789999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=255.73 Aligned_cols=200 Identities=28% Similarity=0.301 Sum_probs=176.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH---HHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK---EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~---~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..|.+.||+|.||.|-..+.+..+ +.+|+|++++...-..+ .-+.|-++|...+||.+..+.-.|...++.|+|||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~-k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATG-KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccC-ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 346789999999999998877554 56999999875544433 35678899999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|..+|.|.-+|.+...+++....-+...|..||.|||++ +||.||||.+|.|||.+|.+||+||||++.--. ....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-ccce
Confidence 999999999998888899988888999999999999998 999999999999999999999999999985322 2345
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
...+.|||.|+|||++....|....|.|.+||++|||++|+.||....
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 566789999999999999999999999999999999999999997653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=273.55 Aligned_cols=197 Identities=26% Similarity=0.421 Sum_probs=170.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.+.||.|.||+||-|+++..+ +.||||++++.. ...+.++++|+.+|..++||.||.+.-.|+..+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktG-rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTG-RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccC-ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 467999999999999998754 569999997643 24456899999999999999999999999999999999999966
Q ss_pred Cchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCCCcc
Q 003759 589 GCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 589 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
.-|+-+|.. ..++++....-++.||+.||.|||.+ +|+|+||||+||||.. --++||+|||.|+.+.....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 666665543 36788888888899999999999998 9999999999999953 45799999999998765433
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
...++|||.|+|||++.++.|...-|+||.|||+|.-++|..||..+.+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 3456799999999999999999999999999999999999999976543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=279.87 Aligned_cols=239 Identities=25% Similarity=0.305 Sum_probs=192.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.|...+|.|+|+.|-+..+...+. ..+||++.+. ..+-.+|+.++.+. +||||+++.+.+.++.+.++|||.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~-~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQ-EPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhccccccCCCCccceeeeecccccc-chhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45667789999999999998876554 5899999765 23345577676666 899999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-cCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL-DDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+.++-|.+.+...+.+. .++..|+.+|+.|+.|||++ ++|||||||+|||+ ++.+.++|+|||.++....+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 99998888887766665 77788999999999999998 99999999999999 68999999999999987665
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....+-|..|.|||++....+++++|+||||++||+|++|+.||....... .+ ...+..+...
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei----~~~i~~~~~s---------- 532 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EI----HTRIQMPKFS---------- 532 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HH----HHhhcCCccc----------
Confidence 122235788999999999999999999999999999999999998765441 11 1111122211
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..-.+.+.+++.+||+.||.+||+|.++...
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1112345677888999999999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=263.96 Aligned_cols=221 Identities=21% Similarity=0.149 Sum_probs=175.4
Q ss_pred ccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchhhhcc
Q 003759 517 GAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596 (797)
Q Consensus 517 G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~ 596 (797)
|.+|.||++....++ ..+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~-~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQ-QTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCC-cEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999987655 459999987532 33445555556679999999999999999999999999999999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccc
Q 003759 597 KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676 (797)
Q Consensus 597 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 676 (797)
+...+++.....++.|+++||+|||+. +|+|+||||+||+++.++.++++|||++....... ....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 777789999999999999999999998 99999999999999999999999999876554321 12235677999
Q ss_pred ccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHH
Q 003759 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMI 756 (797)
Q Consensus 677 PE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (797)
||.+....++.++||||+|+++|||++|+.|+......... ...+ + .+ ......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~------------~~~~----~-~~-----~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------HTTL----N-IP-----EWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc------------cccc----C-Cc-----ccCCHHHHHH
Confidence 99998888999999999999999999999887532111000 0000 0 00 0012346678
Q ss_pred HHHhcccCCCCCCCHH
Q 003759 757 AIWCIQEDPSLRPTMK 772 (797)
Q Consensus 757 ~~~Cl~~dP~~RPs~~ 772 (797)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=298.75 Aligned_cols=144 Identities=25% Similarity=0.288 Sum_probs=127.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.++||+|+||.||+|..... +..||||+++..... ....+..|+.++..++|+||+++++.+...+..+||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNN-SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 34567899999999999998754 446999998753222 12568889999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
|+++++|.+++.....+++...+.|+.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998777788999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=289.77 Aligned_cols=207 Identities=26% Similarity=0.305 Sum_probs=182.9
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecc---cCCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
.+..+.+.+.||+|+||.|...+++..+ ..+|.|++.+ ..+....-|.+|-.+|..-+.+=|+.++-.|.++.+.|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~-~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTE-KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccc-cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 3445566789999999999999988655 4699999986 23344457999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
||||||+||+|-.++.+-.+++.....-++..|.-||.-||+. |+|||||||+|||||..|.+||+|||.+..+..+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998777889888888899999999999998 9999999999999999999999999999988877
Q ss_pred CCcccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~ 714 (797)
..-.....+|||.|++||++.. ..|....|-||+||++|||+.|..||..+.-.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv 287 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV 287 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH
Confidence 7766677789999999999953 46899999999999999999999999866433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=257.20 Aligned_cols=239 Identities=26% Similarity=0.304 Sum_probs=192.3
Q ss_pred cceeEEEEEEecCCcEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchhhhcc
Q 003759 518 AFATVHKGVLAYENKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596 (797)
Q Consensus 518 ~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~ 596 (797)
+||.||+|+....+ ..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTG-KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCC-cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999987543 469999997655444 6789999999999999999999999999999999999999999999997
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccc
Q 003759 597 KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676 (797)
Q Consensus 597 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 676 (797)
....+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 766688999999999999999999998 99999999999999999999999999998765432 2233447889999
Q ss_pred ccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHH
Q 003759 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMI 756 (797)
Q Consensus 677 PE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (797)
||.+....++.++|||+||+++++|++|..||......+ .+.+... .......... ......+.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~ 220 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---ELFKKIG----KPKPPFPPPE-------WKISPEAKDL 220 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHh----ccCCCCcccc-------ccCCHHHHHH
Confidence 999998889999999999999999999999996532211 1111111 1111000000 0012456788
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 003759 757 AIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 757 ~~~Cl~~dP~~RPs~~eVl~ 776 (797)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=263.57 Aligned_cols=210 Identities=28% Similarity=0.354 Sum_probs=180.1
Q ss_pred HHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHH---HHHHHHHhhcc-CcCchhhhccccccc
Q 003759 501 KELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQT-NHRNLVKLLGFCNED 576 (797)
Q Consensus 501 ~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~---f~~E~~~l~~l-~h~niv~l~g~~~~~ 576 (797)
+.+.....+|..+||+|+||.|-.|..+...+ .+|||++++......++ -..|-++|... +-|.++++..++..-
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdE-LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDE-LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcch-hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 34555667889999999999999998776554 59999998754332222 34577777776 678999999999999
Q ss_pred CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
+.+|+||||+.+|+|--+++.-..+.+....-+|..||-||-+||++ +|+.||||.+||+||.+|.+||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999999998888888999999999999999999998 999999999999999999999999999975
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~ 715 (797)
-- -....+..+.|||.|+|||++...+|...+|.|||||+||||+.|++||++.++.+
T Consensus 500 ni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 500 NI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred cc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 22 22344556789999999999999999999999999999999999999999876544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=261.41 Aligned_cols=271 Identities=21% Similarity=0.309 Sum_probs=206.3
Q ss_pred cccCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-c-C----chhhh
Q 003759 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-H-R----NLVKL 569 (797)
Q Consensus 496 ~~~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h-~----niv~l 569 (797)
-.+...|...+.+.+...+|+|.||.|-+..+... +..||||+++... .-.+.-+-|++++.++. + | -+|.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34566677777888889999999999999888766 6679999998642 22344566899999983 2 2 46888
Q ss_pred cccccccCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----
Q 003759 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD----- 642 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~----- 642 (797)
.++|.-.++.|+|+|.+ +-|+.++|..+ .+++...+..|+.|++++++|||+. +++|.||||+|||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 88999999999999998 66899999876 4678889999999999999999998 9999999999999931
Q ss_pred ---------------CCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcC
Q 003759 643 ---------------SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK 707 (797)
Q Consensus 643 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p 707 (797)
+..+||+|||.|..-.... ..++.|..|.|||++.+-.++.++||||+||||.|+.||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 3458999999998654433 455679999999999999999999999999999999999999
Q ss_pred CCccccccchhhHHHHHH--------------hhhcccccc-----------ccccchh----hhhhhHHHHHHHHHHHH
Q 003759 708 FEQNVENENQMILVDWAY--------------DCYIDEKLH-----------LLVENDE----EALHDMMRLKKYVMIAI 758 (797)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~~~~l~~ 758 (797)
|+.....+. ..+++.+. +.+..+++. ...+... .....-.+..++++++.
T Consensus 309 FqtHen~EH-LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEH-LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHH-HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 987764432 12222211 111111111 0111110 01122234567999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 003759 759 WCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 759 ~Cl~~dP~~RPs~~eVl~~ 777 (797)
.||..||.+|+|+.|++..
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999998853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=246.71 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=193.5
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEec--ccCCCchHHHHHHHHHhhccCcCchhhhccccccc--------Ccee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--------QHRL 580 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~ 580 (797)
..+||+|.||.||||+...+++. ||+|++- ....+-...-.+|+++|..++|+|++.++..|... ...+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kk-valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKK-VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccch-hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 45799999999999998766554 8887652 22333345678899999999999999999998542 2479
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
||++++++ +|.-+|... .+++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||+++.+..
T Consensus 101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 99999976 577777655 6789999999999999999999998 999999999999999999999999999987754
Q ss_pred CCC---cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhh
Q 003759 660 DQT---RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCY 728 (797)
Q Consensus 660 ~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~ 728 (797)
... ...+..+-|.-|++||.+.+. .++++.|||+-||++.||+|+.+-+++..+......+.... |...
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 332 122334458899999988764 69999999999999999999999998876554333222111 1000
Q ss_pred ccccc------cccccchhhhhhh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 729 IDEKL------HLLVENDEEALHD----MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 729 ~~~~~------~~~~~~~~~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..-.+ +.+.....+...+ ...-...++++..++..||.+|+.+++++..
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 00001 1111111111111 1112357788888999999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=283.80 Aligned_cols=257 Identities=20% Similarity=0.214 Sum_probs=165.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCC---cEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccc------ccccCc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGF------CNEDQH 578 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~---~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~------~~~~~~ 578 (797)
+.+.+.||+|+||.||+|++.... +..||||++.... ..+.+..| .+....+.++..++.. +..+..
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 445678999999999999987650 3469999876422 11111111 1222233333333322 245678
Q ss_pred eeeeeecccCCchhhhcccCCC--------------------CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 579 RLLVYEFISNGCLAGFLFKNPK--------------------PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
.++||||+++++|.+++..... ........++.||+.||+|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 9999999999999998864321 01223457899999999999998 999999999999
Q ss_pred EEcC-CCcEEEEeecCccccccCCCcccccccccCccccccccccC----------------------CCCccCceehHH
Q 003759 639 LLDD-SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL----------------------PITMKVDIYSFG 695 (797)
Q Consensus 639 Ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~sDVwS~G 695 (797)
|+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 57999999999987654444444456689999999965322 234567999999
Q ss_pred HHHHHHHhCCcCCCccccccc------hhhHHHHHHhhhccccccccccchhhhhhhHH--HHHHHHHHHHHhcccCCCC
Q 003759 696 VMLLELICCRKKFEQNVENEN------QMILVDWAYDCYIDEKLHLLVENDEEALHDMM--RLKKYVMIAIWCIQEDPSL 767 (797)
Q Consensus 696 vll~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~Cl~~dP~~ 767 (797)
|+||||+++..+......... ......|.. ..... .........+.. ......+++..||+.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK--LVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHH--hhccc----cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999997766432211000 000001100 00000 000000000000 0123457899999999999
Q ss_pred CCCHHHHHHH
Q 003759 768 RPTMKKVTLM 777 (797)
Q Consensus 768 RPs~~eVl~~ 777 (797)
|||+.|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=247.18 Aligned_cols=244 Identities=22% Similarity=0.239 Sum_probs=188.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccc----cCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNE----DQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~Ey~ 586 (797)
++||-|-.|.|-....+..++. .|+|++.+. ...++|+++--.. .|||||.+++++++ ...+++|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ek-fALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEK-FALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhh-hHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 6899999999999888776654 899998642 3456788876655 79999999998764 45678999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~ 661 (797)
++|.|...++.+. .+++.+...|+.||+.|+.|||+. .|.||||||+|+|.. .|-.+||+|||+|+.-..
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 9999999998764 488999999999999999999998 999999999999996 455789999999986543
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.........||.|.|||++...+|+...|+||+||++|-|++|.+||......... -..+..+..+..... .
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----pgMk~rI~~gqy~FP---~- 288 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKRRIRTGQYEFP---E- 288 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----hhHHhHhhccCccCC---C-
Confidence 23344456899999999999999999999999999999999999999765432111 111122222222110 0
Q ss_pred hhhhhHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRL-KKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~-~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+..++ +..-+++...|..+|.+|.|+.+++..
T Consensus 289 ---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 ---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 112222 344567788899999999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=275.15 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=172.9
Q ss_pred HhhhhhhCcccceeEEEEEEec---------------CCcEEEEEEEecccCCCchHHH--------------HHHHHHh
Q 003759 508 QGFKDELGRGAFATVHKGVLAY---------------ENKICVAVKKLDNMVSGGDKEF--------------RTEVNAI 558 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~---------------~~~~~vavK~~~~~~~~~~~~f--------------~~E~~~l 558 (797)
+.+.++||+|+||+||+|.+.. ..++.||||++........++| ..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 4446789999999999997521 2235699999865433322333 3466677
Q ss_pred hccCcCch-----hhhcccccc--------cCceeeeeecccCCchhhhcccC------------------------CCC
Q 003759 559 GQTNHRNL-----VKLLGFCNE--------DQHRLLVYEFISNGCLAGFLFKN------------------------PKP 601 (797)
Q Consensus 559 ~~l~h~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~------------------------~~l 601 (797)
.+++|.++ ++++++|.. .+..+|||||+++++|.++++.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766544 778888753 35689999999999999988632 123
Q ss_pred ChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCccccccccc
Q 003759 602 SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681 (797)
Q Consensus 602 ~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 681 (797)
++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 4667888999999999999998 9999999999999999999999999999765433222222223578999999875
Q ss_pred cCCC----------------------CccCceehHHHHHHHHHhCCc-CCCccccccchh-----hHHHHHHhhhccccc
Q 003759 682 SLPI----------------------TMKVDIYSFGVMLLELICCRK-KFEQNVENENQM-----ILVDWAYDCYIDEKL 733 (797)
Q Consensus 682 ~~~~----------------------t~~sDVwS~Gvll~elltG~~-p~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 733 (797)
.... ..+.||||+||++++|++|.. |+.......... .+..| ........
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCC
Confidence 4321 234799999999999999875 664321111110 01111 11111111
Q ss_pred c-ccccchhhhhhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 003759 734 H-LLVENDEEALHDMMRLKKYVMIAIWCIQEDP---SLRPTMKKVTLM 777 (797)
Q Consensus 734 ~-~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPs~~eVl~~ 777 (797)
. ...+. ......+++..++..+| .+|+|++|+++.
T Consensus 462 ~~~~~d~---------~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 DFSLLDR---------NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred Ccccccc---------cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 00111 12345667778888765 789999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=276.79 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=201.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccccc-----ccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCN-----EDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 581 (797)
..|.+.||.|.+|.|||++..+.+ +.+|+|+.... ...++++..|.++++.. +|||++.++|++. .++.+||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~-~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTG-QLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecC-ceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 445688999999999999987654 45888887653 45567888999999988 7999999999874 3678999
Q ss_pred eeecccCCchhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 582 VYEFISNGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
|||||.+||..|++.. ..++.|.....|...++.||.|||.. .++|||||-.|||+++++.+||.|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999864 36788999999999999999999998 999999999999999999999999999887654
Q ss_pred CCCcccccccccCccccccccccC-----CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSL-----PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
...+.. ...|||.|||||++... .|+..+|+||||++..||--|.+|+-......... .
T Consensus 176 T~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---------------~ 239 (953)
T KOG0587|consen 176 TVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------------L 239 (953)
T ss_pred cccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---------------c
Confidence 333332 34599999999999643 47889999999999999999999997654322111 0
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+.........+++.+++..|+.+|-++||++.++++.
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1112223333455566889999999999999999999988753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=254.77 Aligned_cols=264 Identities=26% Similarity=0.308 Sum_probs=194.5
Q ss_pred cCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCch-----HHHHHHHHHhhccCcCchhhhc
Q 003759 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGD-----KEFRTEVNAIGQTNHRNLVKLL 570 (797)
Q Consensus 498 ~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~-----~~f~~E~~~l~~l~h~niv~l~ 570 (797)
|.-.-+....|-+.+.||+|||+.||||.+... .+.||||+-.... .+.. +...+|..+-+.|.||.||+++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~E-qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTE-QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccch-hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 333444555666678899999999999988754 4579999864221 1111 2345789999999999999999
Q ss_pred cccccc-CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcE
Q 003759 571 GFCNED-QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTA 646 (797)
Q Consensus 571 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~ 646 (797)
+|+.-+ +..|-|+||+++.+|+-+|..++.+++++...|+.||..||.||.+. .++|||-||||.||||. .-|.+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence 998654 56789999999999999999999999999999999999999999987 78999999999999994 45789
Q ss_pred EEEeecCccccccCCCc------ccccccccCcccccccccc----CCCCccCceehHHHHHHHHHhCCcCCCccccccc
Q 003759 647 RISDFGLAKILKADQTR------TTTAIRGTRGYVAPEWFKS----LPITMKVDIYSFGVMLLELICCRKKFEQNVENEN 716 (797)
Q Consensus 647 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~ 716 (797)
||.||||++.+..+... .+....||.-|++||.+.- .+++.|+||||.|||+|..+.|+.||..+.....
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 99999999998755432 2334569999999998742 3579999999999999999999999976533221
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
+.+... .+....+.....+ ......-.++.+||+...++|...-++.
T Consensus 693 ---ILqeNT-IlkAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ---ILQENT-ILKATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHhhhc-hhcceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111000 0001111111111 1112344577889888888887665553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=224.12 Aligned_cols=198 Identities=25% Similarity=0.352 Sum_probs=164.4
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecc--cCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.++||+|.||+||||+.....+ .||+|+++- ..+.......+|+-+++.++|+|||++++....++...+|+||+.
T Consensus 7 mekigegtygtvfkarn~~t~e-ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd- 84 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84 (292)
T ss_pred HHhhcCCcceeeEecccCCccc-eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence 4689999999999999876655 499998853 333444568899999999999999999999999999999999994
Q ss_pred Cchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
.+|..+... +..++......++.|+++||.|+|++ .+.|||+||+|.||+.+|++|++|||+++.+...-. ....
T Consensus 85 qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa 160 (292)
T KOG0662|consen 85 QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA 160 (292)
T ss_pred HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence 456666543 46678888999999999999999998 999999999999999999999999999998765432 2333
Q ss_pred ccccCccccccccccCC-CCccCceehHHHHHHHHHh-CCcCCCccccc
Q 003759 668 IRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELIC-CRKKFEQNVEN 714 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~ 714 (797)
.+-|.-|.+|.++-+.+ |+...|+||-||++.|+.. |++.|.+....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 34688999999988764 7999999999999999998 55555555443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=231.62 Aligned_cols=197 Identities=26% Similarity=0.385 Sum_probs=163.8
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.++||+|++|.|-|-++... ++..|+|++..... +.+++.+.|+.+..+. .+|.+|.++|....+...++.||.|.
T Consensus 51 i~elGrGayG~vekmrh~~s-g~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQS-GTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhcCCccchhhheeeccC-CeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 46799999999999888754 45699999976544 3345788899887765 89999999999999999999999994
Q ss_pred Cchhhhc----ccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 589 GCLAGFL----FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 589 gsL~~~l----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
-||+.+. .+....++.-.-+||..+.+||.|||++ ..++|||+||+|||++.+|++|+||||.+..+......
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 4666554 3456788888899999999999999997 68999999999999999999999999999876543322
Q ss_pred cccccccCcccccccccc----CCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 665 TTAIRGTRGYVAPEWFKS----LPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
+.-.|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++....
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 22347788999999853 3689999999999999999999999975533
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=242.47 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=196.0
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc-----Cceeeeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRLLVYE 584 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~E 584 (797)
+-||-|+||.||..+++.+++ .|+.|++..... ...+.+.+|+++|..++|.|++..+++-.-. ++.|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgr-rvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGK-RVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCcc-chhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 569999999999999887654 599999875332 2346788999999999999999999876543 36788999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
.| ..+|..++-....++.....-+..||++||+|||+. +|.||||||.|.|++.|..+||+|||+++.-..++...
T Consensus 138 Lm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 98 567889888888899888888999999999999998 99999999999999999999999999999877777766
Q ss_pred cccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH---------------HHhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW---------------AYDCY 728 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~---------------~~~~~ 728 (797)
.+..+-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|+.....++...+.+. ++..+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 6666778999999999875 6899999999999999999999988765444332222211 11111
Q ss_pred ccccccccccchhhhhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 729 IDEKLHLLVENDEEALHDM-MRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
..+......-+.+-.+... ..-....++...++..||++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111000000000000 0001233556678899999999988877655
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=256.84 Aligned_cols=244 Identities=21% Similarity=0.242 Sum_probs=195.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
..||-|+||.|=......... ..|+|.+++.. ...++....|-.+|...+.|.||+++.-+.+....|+.||-|-+
T Consensus 426 aTLGvGgFGRVELV~~~~~~~-~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKA-TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEecccch-HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 459999999999887764332 46777776532 23445678899999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|.|-..|.+++.++..+..-++..+.+|++|||.+ +||.|||||+|.+||.+|.+||.|||+|+.+.... .+-.+
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTF 579 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeee
Confidence 99999999999999999999999999999999998 99999999999999999999999999999876543 33456
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHH
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (797)
.|||.|.|||++.++..+.++|.||||++++||++|.+||.+.+.......+...+... ..+..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------EFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------hcccc
Confidence 79999999999999999999999999999999999999998875543322222111111 00111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 749 RLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 749 ~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
-.....++++.....+|.+|.- +.+|-+.
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1233456677777889999976 5566544
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=221.82 Aligned_cols=102 Identities=39% Similarity=0.672 Sum_probs=75.4
Q ss_pred CCeEEEEeCCCCCCcc---CceeeEeeCceEEEEcCCCceEecc-CCCCC--ceeEEEEecCCCeEEecCCCCceeeecc
Q 003759 71 ERTIIWSANGKTPVER---GSKVQLTVDGRLVLTDLTGKEVWNP-DTAGA--AIAYASMLDSGNFVLAGPDSFPLWESFD 144 (797)
Q Consensus 71 ~~t~vW~Anr~~p~~~---~~~~~~~~~g~l~l~~~~~~~vW~t-~~~~~--~~~~a~l~d~GNlvl~~~~~~~lWqSFD 144 (797)
++||||+|||+.|+.+ ...|.|+.||+|+|++.+|+.+|++ ++.+. ....|+|+|+|||||+|.++.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 4799999999999942 4789999999999999999999999 55544 4789999999999999999999999999
Q ss_pred CCCCCCCCCcccCCC------ceEEecCCCCCCC
Q 003759 145 HPTDTLLPTQILNPR------NKLSAHYSDKNYS 172 (797)
Q Consensus 145 ~PTDTlLpg~~l~~~------~~L~S~~s~~dps 172 (797)
|||||+||+|+|+.+ ..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999873 3499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=236.98 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=191.3
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch---HHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~---~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+..+||+|+|..|-.+.+....+ .+|+|++++..-... +-.+.|-.+..+- +||.+|-+..+|..+...++|.||
T Consensus 254 ll~vigrgsyakvl~~~~~~t~q-iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQ-IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehcccce-eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34689999999999999987654 599999976433222 3456677776665 899999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++|+|--++++...+++....-+...|..||.|||++ +|+.||||..|+|+|..|.+||.|+|+++.--.+ ...+
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 99999988888888899999888999999999999999 9999999999999999999999999999853322 3345
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
..+.|||.|+|||++.+..|....|.|+|||+++||+.|+.||+-.........--++..+.+.+..+....
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-------- 480 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-------- 480 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--------
Confidence 667899999999999999999999999999999999999999974321111111112233333333222110
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRP 769 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RP 769 (797)
. -..+...+++.-+++||.+|.
T Consensus 481 s--lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 S--LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred e--eehhhHHHHHHhhcCCcHHhc
Confidence 0 012445677778999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-28 Score=268.49 Aligned_cols=238 Identities=27% Similarity=0.369 Sum_probs=183.0
Q ss_pred hhhhCcccce-eEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 511 KDELGRGAFA-TVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 511 ~~~LG~G~fG-~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.+.+|.|.-| .||+|+.. +++||||++-. +...-.++|+..|+.- +|||||++++.-.+.+..||..|.| .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE---GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC---CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 3568999887 57999985 45799999853 2234557899999998 7999999999999999999999999 5
Q ss_pred CchhhhcccC-CC---CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCcEEEEeecCcccccc
Q 003759 589 GCLAGFLFKN-PK---PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-----SFTARISDFGLAKILKA 659 (797)
Q Consensus 589 gsL~~~l~~~-~~---l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~ 659 (797)
.+|++++... .. ..-.....+..|++.||+|||+. +||||||||.||||+. ...++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 6899999764 11 11134567889999999999997 9999999999999965 25789999999998876
Q ss_pred CCCc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhC-CcCCCccccccchhhHHHHHHhhhcccccc-c
Q 003759 660 DQTR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAYDCYIDEKLH-L 735 (797)
Q Consensus 660 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 735 (797)
+... ......||-+|+|||.+....-+.++||+|+||++|+.++| ..||......+.... .+... .
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl----------~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL----------TGNYTLV 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh----------cCcccee
Confidence 5542 24456699999999999998888899999999999999996 889976543321110 11100 0
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+.... .+ ...+++..|+.++|..||++.+|+.
T Consensus 734 ~L~~~~------d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEPLP------DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeccCc------hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011100 01 5678899999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=229.87 Aligned_cols=210 Identities=36% Similarity=0.511 Sum_probs=181.3
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchh
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLA 592 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (797)
||+|.+|.||+++.... +..+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKT-GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCC-CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999998653 456999998764322 2467999999999999999999999999999999999999999999
Q ss_pred hhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCCCcccccccc
Q 003759 593 GFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTTAIRG 670 (797)
Q Consensus 593 ~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g 670 (797)
+++... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999765 5688999999999999999999998 9999999999999999 89999999999986654321 1223446
Q ss_pred cCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHH
Q 003759 671 TRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMR 749 (797)
Q Consensus 671 t~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (797)
...|++||.+... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 788999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 750 LKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 750 ~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 345678888999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=250.96 Aligned_cols=221 Identities=24% Similarity=0.355 Sum_probs=183.0
Q ss_pred CHHHHHHHHHh---h--hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhc
Q 003759 499 SYKELEKATQG---F--KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLL 570 (797)
Q Consensus 499 ~~~el~~~~~~---f--~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~ 570 (797)
.|..|+++.-. | .+.||-|+||.|-++.-.+. ...+|.|.+++..- ......+.|-.||..-+.+=||+|+
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT-~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDT-RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecch-hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 45556665533 2 23599999999999876655 45699999875322 2234578899999999999999999
Q ss_pred ccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEe
Q 003759 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISD 650 (797)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 650 (797)
--|.+.+.+|+||||+++|++-.+|-+.+.+.+....-++..+..|+++.|.. |+|||||||+|||||.+|.+||.|
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence 99999999999999999999999999999999988888888999999999998 999999999999999999999999
Q ss_pred ecCcccccc----------CCC-------------------------------cccccccccCccccccccccCCCCccC
Q 003759 651 FGLAKILKA----------DQT-------------------------------RTTTAIRGTRGYVAPEWFKSLPITMKV 689 (797)
Q Consensus 651 fgla~~~~~----------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~s 689 (797)
|||+.-+.- +.. ......+||+.|+|||++....++...
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 999875421 000 011123599999999999999999999
Q ss_pred ceehHHHHHHHHHhCCcCCCccccccchhhHHHH
Q 003759 690 DIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 690 DVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 723 (797)
|.||.|||||||+.|+.||-.....+.+..+..|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 9999999999999999999888777766666555
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-27 Score=247.93 Aligned_cols=192 Identities=24% Similarity=0.330 Sum_probs=167.3
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------hHHHHHHHHHhhccC---cCchhhhcccccccCce
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------DKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 579 (797)
.+.||+|+||.|+.++++.. ..+|+||.+.+...-. .-..-.|+.+|..++ |+||++++++|++++..
T Consensus 566 lq~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35799999999999999875 5679999987532211 113557999999997 99999999999999999
Q ss_pred eeeeecc-cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 580 LLVYEFI-SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 580 ~lV~Ey~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
||++|-. ++-+|.+++..++.+++.+...|++|++.|++|||++ +|||||||-+|+.++.+|-+||+|||.+....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999976 4568999999999999999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCCcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCC
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
.. +...++||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 722 sg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 33 3455679999999999999887 566899999999999999999885
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=205.54 Aligned_cols=107 Identities=32% Similarity=0.538 Sum_probs=98.5
Q ss_pred ceeeeCCCeEEEeEEecCCCC-eEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcCCCceEeccCCCC-C
Q 003759 39 SSWKSTSGEFAFGFQHIENGN-YLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-A 116 (797)
Q Consensus 39 ~~~~S~~g~f~lgf~~~~~~~-~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~~~~~vW~t~~~~-~ 116 (797)
++|+|++|.|++|||.+.... .+++|||.+++ +++||.||++.|....+.+.|+.||+|+|+|.+|.+||+|++.+ .
T Consensus 8 ~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~ 86 (116)
T cd00028 8 QTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVN 86 (116)
T ss_pred CEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCC
Confidence 457899999999999998876 99999999887 89999999999977778899999999999999999999999876 5
Q ss_pred ceeEEEEecCCCeEEecCCCCceeeeccCC
Q 003759 117 AIAYASMLDSGNFVLAGPDSFPLWESFDHP 146 (797)
Q Consensus 117 ~~~~a~l~d~GNlvl~~~~~~~lWqSFD~P 146 (797)
...+|+|+|+|||||++.++.++|||||||
T Consensus 87 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 87 GNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=216.29 Aligned_cols=258 Identities=20% Similarity=0.357 Sum_probs=190.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhccccccc--Cceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNED--QHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~ 583 (797)
.+.+.+++|+|.++.||.|.....++ .++||.++.. ..+.+.+|+++|..+. ||||+++++...+. ..+.||+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~e-K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNE-KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCc-eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 35567889999999999998765555 4899999863 3567899999999996 99999999998765 4678999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+.+.+...+. +.++...+...+.++++||.|+|++ ||.|||+||.|++||. .-.++|+|+|||.++.....
T Consensus 115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999998766554 3466778888999999999999998 9999999999999985 45799999999998876554
Q ss_pred cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH----------HHH--hhhc
Q 003759 663 RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD----------WAY--DCYI 729 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~----------~~~--~~~~ 729 (797)
.... +.+..|..||.+.. ..++..-|+|||||+|.+|+..+.||..-.+..++..-+. +.. ....
T Consensus 189 YnVR--VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 YNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eeee--eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 3322 35667889998865 4588999999999999999999999965444333221111 010 1112
Q ss_pred cccccccccchhh--------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 730 DEKLHLLVENDEE--------ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 730 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
+.+...++....+ .........++++++-..|..|-++|||+.|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2222222221110 0001111245677888889999999999999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=228.98 Aligned_cols=267 Identities=24% Similarity=0.258 Sum_probs=189.3
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccc------cCceeeeeec
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------DQHRLLVYEF 585 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~Ey 585 (797)
+|.|.- .|-.+.+.-. +.+||+|++.... ....+...+|...+..++|+||++++.++.- -.+.|+|||+
T Consensus 25 ~~~g~~-~v~~a~D~v~-~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVL-GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred cCCCCc-eEEecchhhc-cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 566655 4444443322 3469999885432 2334667889999999999999999998853 3477999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
| ..+|...+. -.++..+...|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.-..+ ...
T Consensus 103 m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~m 174 (369)
T KOG0665|consen 103 M-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMM 174 (369)
T ss_pred h-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--ccc
Confidence 9 557777765 4467788889999999999999998 9999999999999999999999999999864443 455
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHH---------------HHHhhhcc
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD---------------WAYDCYID 730 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~---------------~~~~~~~~ 730 (797)
+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+...-++-..+.+ .++.....
T Consensus 175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~ 254 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN 254 (369)
T ss_pred CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence 666789999999999999999999999999999999999999875433222111111 01111100
Q ss_pred c------cccccc-cch--hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--h---cCcCCCCCCCC
Q 003759 731 E------KLHLLV-END--EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML--E---GVVEVPIPPDP 790 (797)
Q Consensus 731 ~------~~~~~~-~~~--~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L--e---~~~~~~~p~~p 790 (797)
. ....++ |.. .....+......+.+++..||..||++|.+..++++.= + ...+++.|+.|
T Consensus 255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 0 000000 000 00111122334567789999999999999999999753 3 34455555544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=227.57 Aligned_cols=197 Identities=32% Similarity=0.429 Sum_probs=171.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.+.||+|++|.||+++....+ ..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTG-ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCC-cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 4567999999999999987543 45999999865444 567889999999999999999999999999999999999999
Q ss_pred CchhhhcccCCC-CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
++|.+++..... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999977665 88999999999999999999998 99999999999999999999999999998765443112233
Q ss_pred ccccCcccccccc-ccCCCCccCceehHHHHHHHHHhCCcCCCc
Q 003759 668 IRGTRGYVAPEWF-KSLPITMKVDIYSFGVMLLELICCRKKFEQ 710 (797)
Q Consensus 668 ~~gt~~y~aPE~~-~~~~~t~~sDVwS~Gvll~elltG~~p~~~ 710 (797)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4477889999998 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-26 Score=238.63 Aligned_cols=271 Identities=22% Similarity=0.229 Sum_probs=205.8
Q ss_pred ccCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC------cCchhhhc
Q 003759 497 IFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN------HRNLVKLL 570 (797)
Q Consensus 497 ~~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~------h~niv~l~ 570 (797)
.+.+.|+....|.+....|+|-|++|-.|.....+. .||||+|.... --.+.=+.|+++|++|+ --|+++++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~-~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQ-EVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCC-eeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 456788888888888889999999999999876554 69999998632 22344567999999995 35899999
Q ss_pred ccccccCceeeeeecccCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcE
Q 003759 571 GFCNEDQHRLLVYEFISNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTA 646 (797)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~ 646 (797)
-.|...+++|||+|-+ .-+|.++|.+- ..+....+..++.|+.-||.+|... +|+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 9999999999999987 56788888643 4578889999999999999999987 99999999999999876 467
Q ss_pred EEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-
Q 003759 647 RISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY- 725 (797)
Q Consensus 647 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~- 725 (797)
||||||.|.....+... ...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+.........+++.-.
T Consensus 577 KLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99999999876554332 22235579999999999999999999999999999999999987765443322222100
Q ss_pred --------hhhcccc----------------------ccccccc------hh-----hhhhhHHHHHHHHHHHHHhcccC
Q 003759 726 --------DCYIDEK----------------------LHLLVEN------DE-----EALHDMMRLKKYVMIAIWCIQED 764 (797)
Q Consensus 726 --------~~~~~~~----------------------~~~~~~~------~~-----~~~~~~~~~~~~~~l~~~Cl~~d 764 (797)
..+.+.. +...+.+ .+ -.......+..+.+|+-.|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0000000 0000011 00 01122344567888999999999
Q ss_pred CCCCCCHHHHHH
Q 003759 765 PSLRPTMKKVTL 776 (797)
Q Consensus 765 P~~RPs~~eVl~ 776 (797)
|++|.|.++.+.
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=232.50 Aligned_cols=146 Identities=26% Similarity=0.349 Sum_probs=118.0
Q ss_pred CCCCCccccCHHHHHH-HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC------
Q 003759 490 MPSTNLQIFSYKELEK-ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN------ 562 (797)
Q Consensus 490 ~~~~~~~~~~~~el~~-~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~------ 562 (797)
+..+..+.....|+.. ++|...++||-|.|++||++.+.. ..+.||+|+.+.. ..-.+.-..|+++|++++
T Consensus 61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred hhcCCCceeeccccccCceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3344555666667666 778888999999999999998764 4567999998753 222345678999999873
Q ss_pred --cCchhhhccccc----ccCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 003759 563 --HRNLVKLLGFCN----EDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIK 634 (797)
Q Consensus 563 --h~niv~l~g~~~----~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk 634 (797)
..+||+|+++|. .+.+.|||+|++ +.+|..+|... +.++...+.+|+.||+.||.|||.+| +|||.|||
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlK 215 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLK 215 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCC
Confidence 247999999986 467999999998 55677777544 56889999999999999999999987 99999999
Q ss_pred CCCEEE
Q 003759 635 PQNILL 640 (797)
Q Consensus 635 p~NILl 640 (797)
|+|||+
T Consensus 216 PENvLl 221 (590)
T KOG1290|consen 216 PENVLL 221 (590)
T ss_pred cceeee
Confidence 999999
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=198.26 Aligned_cols=106 Identities=33% Similarity=0.548 Sum_probs=97.6
Q ss_pred ceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcCCCceEeccCCC-CCc
Q 003759 39 SSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTA-GAA 117 (797)
Q Consensus 39 ~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~~~~~vW~t~~~-~~~ 117 (797)
++|+|++|.|++|||.+.....+++|||++.+ +++||+||++.|+.+++.+.++.||+|+|+|.+|.+||+|++. +..
T Consensus 8 ~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~ 86 (114)
T smart00108 8 QTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANG 86 (114)
T ss_pred CEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCCC
Confidence 45789999999999999888899999999987 8999999999999877889999999999999999999999986 555
Q ss_pred eeEEEEecCCCeEEecCCCCceeeeccC
Q 003759 118 IAYASMLDSGNFVLAGPDSFPLWESFDH 145 (797)
Q Consensus 118 ~~~a~l~d~GNlvl~~~~~~~lWqSFD~ 145 (797)
..+|+|+|+|||||++..+.++||||||
T Consensus 87 ~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 87 NYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 6789999999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=243.55 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=197.5
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
....+|.|.+|.|||++....++ ..|||.++-.......-.++|+-+++..+|+||+.++|-+...+..++.|||+.+|
T Consensus 19 llqrvgsgTygdvyKaRd~~s~e-laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGE-LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred heeeecCCcccchhhhcccccCc-hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 34679999999999999987665 58999998665556667788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 669 (797)
+|++..+-..++++.+...+.+...+||+|||.. +-+|||||-.|||+++.+.+|++|||.+..+..--.+ ...+.
T Consensus 98 slQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-rksfi 173 (829)
T KOG0576|consen 98 SLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-RKSFI 173 (829)
T ss_pred cccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh-hhccc
Confidence 9999999889999999999999999999999998 8899999999999999999999999998765433222 23456
Q ss_pred ccCcccccccc---ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 670 GTRGYVAPEWF---KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 670 gt~~y~aPE~~---~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
||+.|||||+. +...|..++|||++|+...|+-..++|........... ++ ....+....+ ...
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-Lm--TkS~~qpp~l----------kDk 240 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LM--TKSGFQPPTL----------KDK 240 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-Hh--hccCCCCCcc----------cCC
Confidence 99999999987 34578999999999999999988888875443221111 10 0000001111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+-+-++++.|+.++|++||+++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 222344567888899999999999876653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=209.82 Aligned_cols=249 Identities=16% Similarity=0.258 Sum_probs=181.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccc-ccccCceeeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGF-CNEDQHRLLVYE 584 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~E 584 (797)
.+++.+.||+|.||.+-.+.++.. ++.+++|-+.... ...++|.+|..---.| .|.||+.-++. |+..+.+.+++|
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s-~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQS-KTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCC-ceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 366778999999999999998865 4569999987643 3457899998876666 69999998774 677778889999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-c-CCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL-D-DSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl-~-~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|++.|+|.+-+.. ..+.+....+++.|++.|+.|||++ .+||||||.+|||| + +...+||+|||+.+....
T Consensus 103 ~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--- 175 (378)
T ss_pred cCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc---
Confidence 9999999998854 4456777889999999999999998 99999999999999 3 445899999999875432
Q ss_pred cccccccccCccccccccccC-----CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc---cc
Q 003759 663 RTTTAIRGTRGYVAPEWFKSL-----PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK---LH 734 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 734 (797)
......-+..|.+||..... ...+.+|||.||++++..+||..||+.....+... .+ +..+..+. +.
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~--~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WE--WEQWLKRKNPALP 250 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HH--HHHHhcccCccCc
Confidence 12223345679999977432 35788999999999999999999998654433221 11 22222222 22
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
..+... .+++.++...-+.++|++|=...++.++.
T Consensus 251 ~~F~~f---------s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 251 KKFNPF---------SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhhccc---------CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 222111 13344556667888888885555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=261.99 Aligned_cols=196 Identities=17% Similarity=0.245 Sum_probs=139.2
Q ss_pred hccCc-Cchhhhcccc-------cccCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCee
Q 003759 559 GQTNH-RNLVKLLGFC-------NEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQII 629 (797)
Q Consensus 559 ~~l~h-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv 629 (797)
+.++| +||++++++| .+....++++||+ .++|.++|... ..+++.+++.++.||++||+|||++ +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 44566 6889999988 2334567778887 66999999654 5689999999999999999999998 999
Q ss_pred ecCCCCCCEEEcCC-------------------CcEEEEeecCccccccCCC---------------cccccccccCccc
Q 003759 630 HCDIKPQNILLDDS-------------------FTARISDFGLAKILKADQT---------------RTTTAIRGTRGYV 675 (797)
Q Consensus 630 H~Dlkp~NILl~~~-------------------~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~ 675 (797)
||||||+||||+.. +.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653211000 0011134788899
Q ss_pred cccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHH
Q 003759 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVM 755 (797)
Q Consensus 676 aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (797)
|||++.+..++.++|||||||+||||++|..|+..... .+....... .... ......+...
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~---------~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRV---------LPPQ-----ILLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhh---------cChh-----hhhcCHHHHH
Confidence 99999999999999999999999999998887643211 011110000 0000 0111223456
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 003759 756 IAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 756 l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
++.+||+++|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 7788999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=218.22 Aligned_cols=196 Identities=25% Similarity=0.361 Sum_probs=161.9
Q ss_pred hhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
..++||+|.|++||++++... ....||+|.+... +....+.+|+++|..+ -+.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 346799999999999998762 4567999999753 4456789999999998 6999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCC----
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQ---- 661 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~---- 661 (797)
++....+++.+ ++......++..+..||+|+|.. |||||||||+|+|.+. .+.-.|.|||||.......
T Consensus 118 ~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 118 EHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred CccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 99998888754 56788899999999999999998 9999999999999974 5667899999998321000
Q ss_pred ---------------------------------------CcccccccccCcccccccccc-CCCCccCceehHHHHHHHH
Q 003759 662 ---------------------------------------TRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLEL 701 (797)
Q Consensus 662 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~el 701 (797)
........||++|.|||++.. ..-+.++||||.|||++.+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 000111349999999999865 4568999999999999999
Q ss_pred HhCCcCCCcccc
Q 003759 702 ICCRKKFEQNVE 713 (797)
Q Consensus 702 ltG~~p~~~~~~ 713 (797)
++++.||.....
T Consensus 272 ls~~~PFf~a~d 283 (418)
T KOG1167|consen 272 LSRRYPFFKAKD 283 (418)
T ss_pred hccccccccCcc
Confidence 999999975533
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=203.27 Aligned_cols=167 Identities=20% Similarity=0.182 Sum_probs=124.5
Q ss_pred CchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|+|.+++... ..+++.+++.|+.|+++||+|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6889999764 5699999999999999999999997 3 999999999999999 99988654322
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..|++.|+|||++.+..++.++|||||||++|||+||+.||......... +....... ..... .. .......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~-~~~~~----~~-~~~~~~~ 135 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNGM-PADDP----RD-RSNLESV 135 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHHh-ccCCc----cc-cccHHHH
Confidence 24789999999999999999999999999999999999999654322111 11111110 00000 00 0000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++..|++.+|++||++.|+++.+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111357889999999999999999999998854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=204.89 Aligned_cols=254 Identities=20% Similarity=0.362 Sum_probs=189.2
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEec--ccCCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
+.-..-+|..+|.+...|..|+|+++..+ +++|++. .......++|.+|...|+.+.||||++++|.|....+..
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgnd---ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGND---IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcc---hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 33344456678999999999999997543 5666664 333445578999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCC--CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 581 LVYEFISNGCLAGFLFKNPK--PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
++..||+.|+|+..|++... .+..+..+++.++|+|++|||+. .+-|..--|.+..+++|++.+++|.- +-+++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee
Confidence 99999999999999987643 56788999999999999999986 34556667899999999999988751 1111110
Q ss_pred cCCCcccccccccCccccccccccCCC---CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPI---TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
......-.|.||+||.+..++- -.++|+|||.++||||.|...||......+....+. .++-...
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------leglrv~ 409 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LEGLRVH 409 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hcccccc
Confidence 1111224688999999987654 357999999999999999999998766554433221 1111111
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+ +++. ...+.+++.-|++.||.+||.+..|+-+||+..
T Consensus 410 i----ppgi-----s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 I----PPGI-----SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred C----CCCc-----cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 1111 122344555599999999999999999999754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=213.95 Aligned_cols=163 Identities=22% Similarity=0.167 Sum_probs=126.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-----CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-----GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
|.+.+.||+|+||+||+|.+...++..||||++..... ...+.|.+|++++.+++|+|+++.+... +..+||
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEEE
Confidence 55678899999999999998764556689998753211 1234689999999999999998633222 457999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDI-KPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++++|.... .. ....++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||+++.+....
T Consensus 97 mE~~~G~~L~~~~-~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 97 RGWTEGVPLHLAR-PH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEccCCCCHHHhC-cc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 9999999997321 11 1246788999999999998 9999999 9999999999999999999999775432
Q ss_pred C-------cccccccccCccccccccccC
Q 003759 662 T-------RTTTAIRGTRGYVAPEWFKSL 683 (797)
Q Consensus 662 ~-------~~~~~~~gt~~y~aPE~~~~~ 683 (797)
. ...+...+++.|+|||.+...
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChh
Confidence 1 112345688899999999654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=198.95 Aligned_cols=259 Identities=21% Similarity=0.242 Sum_probs=190.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc----Cchhhhcccc-cccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH----RNLVKLLGFC-NEDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 581 (797)
.+.+.++||+|+||.||++.........+|+|.-..........+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 455678899999999999998765445688888765433333378889999888863 6888888888 57788999
Q ss_pred eeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-----CcEEEEeecCc
Q 003759 582 VYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-----FTARISDFGLA 654 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~Dfgla 654 (797)
||+.. +.+|.++.... +.++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 88899977433 5789999999999999999999998 99999999999999754 46899999999
Q ss_pred c--ccccCCC------cc-cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH
Q 003759 655 K--ILKADQT------RT-TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725 (797)
Q Consensus 655 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (797)
+ .+..... +. ....+||..|.++....+...+.+.|+||++.++.|++.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 3322211 11 2345699999999999999999999999999999999999999966543322211111111
Q ss_pred hhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 726 DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
...... .... ....+.++...+-..+..++|....+...|+...
T Consensus 255 ~~~~~~----~~~~---------~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 255 KLLTDR----FGDL---------KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hhcccc----ccCC---------ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111110 0000 1122333344455589999999999988876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=219.47 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=187.3
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchH----HHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDK----EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~----~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+|.|++|.|+..+.....+. .+.|..... .....+ .+..|..+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~-~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKS-FPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCcc-chhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 46799999998887765543332 333332200 111111 25567777888999999999988888777766799
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC--
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-- 662 (797)
|++. +|..++.+...+...++..+..|+..|++|||.. +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999998877888999999999999999999998 999999999999999999999999999987765443
Q ss_pred -cccccccccCccccccccccCCCCcc-CceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMK-VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~-sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.....+.|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||......++........ .. .......
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------~~-~~~~~~~ 550 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------DQ-RNIFEGP 550 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------cc-cccccCh
Confidence 45566789999999999999998755 899999999999999999998765544332110000 00 0001111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .......+...++..+|+.||.+|.|+++|++
T Consensus 551 ~~--~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NR--LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HH--HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11 11112234566888899999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=192.03 Aligned_cols=256 Identities=28% Similarity=0.351 Sum_probs=193.2
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcC-chhhhcccccccCceeeeeec
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHR-NLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.||.|+||.||++... ..+++|.+....... ...|.+|+.++..+.|+ +++++.+++......++++|+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 3467899999999999886 358999987654433 56799999999999888 799999999777778999999
Q ss_pred ccCCchhhhcccCC---CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCC
Q 003759 586 ISNGCLAGFLFKNP---KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQ 661 (797)
Q Consensus 586 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 661 (797)
+.+++|.+++.... .+.......+..+++.++.|+|+. +++|||+||+||+++... .++++|||++..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 688889999999999999999998 899999999999999988 79999999998655433
Q ss_pred Cc-----ccccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 662 TR-----TTTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 662 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
.. ......++..|+|||.+.+ .......|+|++|++++++++|..|+...................... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2355679999999999987 578999999999999999999999976554310011111111111100 00
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......... ......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 1122345677788999999999999887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=212.03 Aligned_cols=250 Identities=24% Similarity=0.271 Sum_probs=181.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHH--hhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNA--IGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..+.+.||++.|=+|.+|++..+ .|+||++-+.. .-..+.|.++++. ...++|||.+++...-......|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG---~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREG---LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCc---eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 34567899999999999987643 38899875433 2334455554444 444599999999999888888999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc--ccCCC
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL--KADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~--~~~~~ 662 (797)
|..+ +|+|.|..++-+...+..-|++|++.||.-+|.. +|.|||||.+||||+.-+-+.|+||...+.. ..+..
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9854 7999998777788889999999999999999998 9999999999999999999999999877642 22222
Q ss_pred c----ccccccccCccccccccccC----------C-CCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHh
Q 003759 663 R----TTTAIRGTRGYVAPEWFKSL----------P-ITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYD 726 (797)
Q Consensus 663 ~----~~~~~~gt~~y~aPE~~~~~----------~-~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (797)
. .....+.-..|+|||.+... + .+++.||||+||++.||++ |+++|.... +.. ++
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~a--Yr 248 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLA--YR 248 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHh--Hh
Confidence 1 11112234579999987431 2 6789999999999999998 677775321 111 11
Q ss_pred hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
. +. ... ++...+..+-..+.++++.|++.||++|.+++++++.-.++
T Consensus 249 ~---~~-~~~----~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 S---GN-ADD----PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred c---cC-ccC----HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0 00 111 11111112223567789999999999999999999986554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.2e-19 Score=191.92 Aligned_cols=217 Identities=24% Similarity=0.417 Sum_probs=164.9
Q ss_pred hhccCcCchhhhcccccccCceeeeeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCe-eecCCCC
Q 003759 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQI-IHCDIKP 635 (797)
Q Consensus 558 l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-vH~Dlkp 635 (797)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ...+++.-...+.++|+.||+|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 4678999999999999999999999999999999999986 46789999999999999999999986 44 9999999
Q ss_pred CCEEEcCCCcEEEEeecCccccccC-CCcccccccccCccccccccccC-------CCCccCceehHHHHHHHHHhCCcC
Q 003759 636 QNILLDDSFTARISDFGLAKILKAD-QTRTTTAIRGTRGYVAPEWFKSL-------PITMKVDIYSFGVMLLELICCRKK 707 (797)
Q Consensus 636 ~NILl~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~sDVwS~Gvll~elltG~~p 707 (797)
+|.++|..+.+||+|||+....... ............-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876421 11111112234569999999764 147789999999999999999999
Q ss_pred CCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 708 FEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
|......+....++..+.. .....+.+...... +....+..++..||..+|++||+++.|-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9875444433223222222 01111111111111 2223577889999999999999999999998875543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-19 Score=174.83 Aligned_cols=138 Identities=17% Similarity=0.136 Sum_probs=107.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---------hHHH-----------------HHHHHHhhccCcCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---------DKEF-----------------RTEVNAIGQTNHRN 565 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---------~~~f-----------------~~E~~~l~~l~h~n 565 (797)
+.||+|+||.||+|... ++..||||+++...... ...| ..|++.+.++.+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 57999999999999986 34579999997542211 1122 34899999998877
Q ss_pred hhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCCEEEcCCC
Q 003759 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL-HEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 566 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+.....+.. ...+|||||+++++|.........++......++.|++.+|.+| |+. +|+||||||+|||++ ++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 644333222 23489999999988766544556788889999999999999999 676 999999999999998 47
Q ss_pred cEEEEeecCcccc
Q 003759 645 TARISDFGLAKIL 657 (797)
Q Consensus 645 ~~kl~Dfgla~~~ 657 (797)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=173.18 Aligned_cols=199 Identities=21% Similarity=0.294 Sum_probs=169.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.++||+|.||..+.|+.--.+ .+||||.=.. .....++..|.+..+.| ..++|..++-|..++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nn-e~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNN-EPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ceeccccccCcceeeecccccccC-ceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 345689999999999999876544 5699997443 34456889999999998 5799999999999999999999998
Q ss_pred cCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCcEEEEeecCccccccC
Q 003759 587 SNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-----SFTARISDFGLAKILKAD 660 (797)
Q Consensus 587 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~ 660 (797)
+-||+|++. ....++.++.+.||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+...
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 778988875 457899999999999999999999998 9999999999999953 345899999999988654
Q ss_pred CC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 661 QT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 661 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
.. +......||.+||+---..+..-+.+.|+=|+|-++.+.|-|..||++.-.
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 43 234445699999999888888899999999999999999999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=167.34 Aligned_cols=203 Identities=19% Similarity=0.235 Sum_probs=168.4
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc-CchhhhcccccccCceeee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH-RNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV 582 (797)
....+.+.++||.|+||.+|.|.....+ ..||||.=... ....++.-|.++.+.++| ..|..+..|..++..-.||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~g-e~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSG-EEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCC-ceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3445667789999999999999887654 46999986543 234577889999999965 7788888899999999999
Q ss_pred eecccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccc
Q 003759 583 YEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILK 658 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~ 658 (797)
||.. +-||++++. .+..++.++.+-+|-|++.-++|+|.+ +.+||||||+|.|..- ...+.++||||++.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9998 778888874 557889999999999999999999998 9999999999999953 3568999999999875
Q ss_pred cCCC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 659 ADQT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 659 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
.... +......||.+|.+--...+..-+.+.|+=|+|.+|.+..-|..||++...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 4322 334455699999988888777788899999999999999999999987644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-19 Score=176.50 Aligned_cols=173 Identities=13% Similarity=0.057 Sum_probs=130.6
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHH---------HHHHHHHhhccCcCchhhhccc
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---------FRTEVNAIGQTNHRNLVKLLGF 572 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~---------f~~E~~~l~~l~h~niv~l~g~ 572 (797)
++....+...+.||.|+||.||.... . + ..+|||.+.......++. +.+|+..+.+++|++|..+..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~-~-~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D-Y-GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-C-C-CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 34455556667899999999998644 2 2 349999997654443332 6889999999999999999988
Q ss_pred cccc--------CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 573 CNED--------QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 573 ~~~~--------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+... +..+|+|||+++.+|.++.. ++. ....+++.+|..+|+. +++|+|+||+||++++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 6532 35789999999999988732 221 3456899999999998 999999999999999988
Q ss_pred cEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHH
Q 003759 645 TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ell 702 (797)
++|+|||.......+.... .+.....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887543222111 1233345667899999999987654
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=152.31 Aligned_cols=108 Identities=28% Similarity=0.591 Sum_probs=77.9
Q ss_pred CccccccCCCCCceeeeecccc-cEEEEEecCceEEEEEeccCccccceeEEEEEeeCCeEEEEEecCCCCCCCCCccEE
Q 003759 199 NSVYWSTQPVGSSLQVEFNRSG-NIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMH 277 (797)
Q Consensus 199 ~~~yw~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~~~w~~~~~~~~~~W~~~ 277 (797)
+++.|++..+.+...+. ... ....+..++++.++.+.... .+.++|++|+++|++|+|.|. +..++|...
T Consensus 2 rsG~WnG~~f~g~p~~~--~~~~~~~~fv~~~~e~~~t~~~~~---~s~~~r~~ld~~G~l~~~~w~----~~~~~W~~~ 72 (110)
T PF00954_consen 2 RSGPWNGQRFSGIPEMS--SNSLYNYSFVSNNEEVYYTYSLSN---SSVLSRLVLDSDGQLQRYIWN----ESTQSWSVF 72 (110)
T ss_pred CccccCCeEECCccccc--ccceeEEEEEECCCeEEEEEecCC---CceEEEEEEeeeeEEEEEEEe----cCCCcEEEE
Confidence 34556655443333222 111 22233455566666665442 457999999999999999997 456789999
Q ss_pred eccCccCCCCCcccccCCCCCcCCCCCCccCCCCCCCCCcccCCCCCcccc
Q 003759 278 WSTPLFNSPNDCMITDETGSGACDCGFNSYCSLGNDQRPTCLCPQGYVPLD 328 (797)
Q Consensus 278 w~~p~~~~~~~~c~~~~~~~~~c~CG~~g~C~~~~~~~p~C~Cl~GF~~~~ 328 (797)
|++| .+.|++ |+. ||+||+|+. +..|+|+||+||+|++
T Consensus 73 ~~~p-----~d~Cd~----y~~--CG~~g~C~~--~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 73 WSAP-----KDQCDV----YGF--CGPNGICNS--NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EEec-----ccCCCC----ccc--cCCccEeCC--CCCCceECCCCcCCCc
Confidence 9999 888888 788 999999975 4678999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=168.94 Aligned_cols=140 Identities=16% Similarity=0.062 Sum_probs=109.4
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------------------------hHHHHHHHHHhhccCcCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------------------------DKEFRTEVNAIGQTNHRN 565 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------------------------~~~f~~E~~~l~~l~h~n 565 (797)
..||+|++|.||+|+.. ++..||||+++...... ...+..|...+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 57999999999999986 34579999987642210 112357889999999988
Q ss_pred hhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCC
Q 003759 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 566 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+.....+... ..+|||||++++++.........++......++.+++.++.+||+ . +|+|+||||+||+++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 7554444332 348999999988654443344567778899999999999999999 7 999999999999999 78
Q ss_pred cEEEEeecCcccccc
Q 003759 645 TARISDFGLAKILKA 659 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~ 659 (797)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=161.32 Aligned_cols=185 Identities=16% Similarity=0.076 Sum_probs=135.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc----hHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG----DKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~----~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
..|++|+||+||.+.. ++..++.+.+.....-. ...|.+|+++|++++ |+++.+++++ +..+++|||+
T Consensus 8 ~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 8 EPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred eeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 5699999999996543 34457767665432211 124789999999994 5889999886 4569999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEEcCCCcEEEEeecCccccccCCCc--
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDI-KPQNILLDDSFTARISDFGLAKILKADQTR-- 663 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 663 (797)
++.+|...+.. ....++.+++++|+++|+. +|+|+|| ||+|||+++++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99998754321 1245788999999999998 9999999 799999999999999999999855432210
Q ss_pred --c--------cccccccCccccccccccC-CCC-ccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 664 --T--------TTAIRGTRGYVAPEWFKSL-PIT-MKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 664 --~--------~~~~~gt~~y~aPE~~~~~-~~t-~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0112257778888754322 233 567888999999999999988765543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=186.40 Aligned_cols=200 Identities=22% Similarity=0.216 Sum_probs=158.3
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC---cCchhhhcccccc
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN---HRNLVKLLGFCNE 575 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~ 575 (797)
+.-++...++.+.++||+|+||+||+|+..+ +..||+|+-+.... -+|.-=.+++.+|+ -+-|..+...+.-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3444555556677899999999999999876 55699998665322 23322233333343 2445556666666
Q ss_pred cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-------CCCcEEE
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-------DSFTARI 648 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl 648 (797)
.+..+||+||.+.|+|.+++...+.++|....-++.++++.+++||.. +|||+||||+|.||. ++.-++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 778899999999999999999888999999999999999999999998 999999999999993 3456899
Q ss_pred EeecCccccccCC-CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCc
Q 003759 649 SDFGLAKILKADQ-TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK 706 (797)
Q Consensus 649 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~ 706 (797)
+|||-+..+.--. .......++|-.+-.+|...+.+++..+|.|.+..+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999987654222 234555678899999999999999999999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=159.86 Aligned_cols=133 Identities=20% Similarity=0.246 Sum_probs=104.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-----CcCchhhhcccccccC---c-eeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-----NHRNLVKLLGFCNEDQ---H-RLLV 582 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV 582 (797)
+.||+|+||.||. ++.... .+||++........+++.+|+.+++.+ .||||++++|+++++. . ..+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~--k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQ--RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCCCcC--eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999995 544333 368887654444567899999999999 5799999999998863 3 3378
Q ss_pred eec--ccCCchhhhcccCCCCChhhHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCEEEcC----CCcEEEEeecCc
Q 003759 583 YEF--ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL-FYLHEECTTQIIHCDIKPQNILLDD----SFTARISDFGLA 654 (797)
Q Consensus 583 ~Ey--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla 654 (797)
+|| +++++|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|++.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5589999999653 34444 35677888777 999998 9999999999999974 347999995544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=165.04 Aligned_cols=227 Identities=20% Similarity=0.239 Sum_probs=141.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCc----------Cchhhhcccc----
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNH----------RNLVKLLGFC---- 573 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h----------~niv~l~g~~---- 573 (797)
.+.||.|+++.||.+++...+ ..+|||...-... ...+++++|.-.+..+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~-~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETG-EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTT-EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred ccccccCCceEEEEEEEccCC-ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 357999999999999998655 4699998743322 233567777766655432 1222222221
Q ss_pred -----ccc---C-----ceeeeeecccCCchhhhcc---cCC----CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 003759 574 -----NED---Q-----HRLLVYEFISNGCLAGFLF---KNP----KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDI 633 (797)
Q Consensus 574 -----~~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl 633 (797)
... + ..+++|+-+ .++|.+++. ... .+....++.+..|+.+.+++||.. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 111 1 235677776 567777653 221 233455677889999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccccccccc--------CCCCccCceehHHHHHHHHHhCC
Q 003759 634 KPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS--------LPITMKVDIYSFGVMLLELICCR 705 (797)
Q Consensus 634 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwS~Gvll~elltG~ 705 (797)
+|+|++++++|.++|+||+........... ...+..|.+||.... ..++.+.|.|++|+++|.|++++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999877654332211 224577999997744 25789999999999999999999
Q ss_pred cCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCC
Q 003759 706 KKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLR 768 (797)
Q Consensus 706 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 768 (797)
.||.......... + .+..+. .-.+.+..++..+|+.||++|
T Consensus 248 lPf~~~~~~~~~~----~------------~f~~C~------~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE----W------------DFSRCR------DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG----G------------GGTTSS---------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc----c------------cchhcC------CcCHHHHHHHHHHccCCcccC
Confidence 9997653322111 0 111111 122345567888999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=159.80 Aligned_cols=142 Identities=19% Similarity=0.144 Sum_probs=108.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------------------------chHHHHHHHHHhhccCc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------------------------GDKEFRTEVNAIGQTNH 563 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------------------------~~~~f~~E~~~l~~l~h 563 (797)
+.+.+.||+|++|.||+|+....++..||+|+++..... ....+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999822234567999998753211 01235679999999975
Q ss_pred Cc--hhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCCEEE
Q 003759 564 RN--LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ-IIHCDIKPQNILL 640 (797)
Q Consensus 564 ~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivH~Dlkp~NILl 640 (797)
.. +.+++++ ...++||||+++++|.............+...++.+++.++.+||+. + |+|+||||+||++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence 32 3344433 23589999999998877664445556666789999999999999998 8 9999999999999
Q ss_pred cCCCcEEEEeecCcccc
Q 003759 641 DDSFTARISDFGLAKIL 657 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~ 657 (797)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.2e-17 Score=179.44 Aligned_cols=187 Identities=26% Similarity=0.235 Sum_probs=155.9
Q ss_pred hCcccceeEEEEEEe--cCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccC
Q 003759 514 LGRGAFATVHKGVLA--YENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 514 LG~G~fG~Vykg~~~--~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+|+|.||.|+...-. .+.+..+|.|.+.+..... ......|..++...+ ||.+|++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 689999999854221 1223557888776533221 124566888888886 99999999999999999999999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 668 (797)
|.|...+.+...+...........++-+++++|+. +|+|+|+|++||+++.+|.+|+.|||+.+..-.....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 99999998888888888888888899999999998 9999999999999999999999999999865433222
Q ss_pred cccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCc
Q 003759 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQ 710 (797)
Q Consensus 669 ~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~ 710 (797)
.||..|||||++. .....+|-||||++++||+||..||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 6899999999998 568899999999999999999999977
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=154.41 Aligned_cols=134 Identities=22% Similarity=0.258 Sum_probs=111.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------hHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.||+|++|.||+|... +..|++|+........ ...+..|+.++..++|+++.....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEeeC---CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 46899999999999873 2348888765322111 135778999999999999988888877778889999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
||+++++|.+++..... .+..++.+++.+|.+||+. +++|+|++|.||+++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998854322 7889999999999999998 999999999999999 78999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=154.42 Aligned_cols=196 Identities=21% Similarity=0.255 Sum_probs=132.1
Q ss_pred CcCchhhhcccccc---------------------------cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHH
Q 003759 562 NHRNLVKLLGFCNE---------------------------DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIA 614 (797)
Q Consensus 562 ~h~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia 614 (797)
+|||||+++++|.+ +...|+||.-. ..+|..++..+. .+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 68888888776532 23567888765 347888885443 45566677888999
Q ss_pred HHHHHHhhcCCCCeeecCCCCCCEEE--cCCC--cEEEEeecCccccccC-----CCcccccccccCccccccccccCC-
Q 003759 615 RGLFYLHEECTTQIIHCDIKPQNILL--DDSF--TARISDFGLAKILKAD-----QTRTTTAIRGTRGYVAPEWFKSLP- 684 (797)
Q Consensus 615 ~gL~~LH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~- 684 (797)
+|+.|||++ +|.|||+|++|||+ |++. .+.|+|||.+..-... .........|....||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999998 99999999999999 4444 4689999976532211 111112233677899999986543
Q ss_pred -----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHH
Q 003759 685 -----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIW 759 (797)
Q Consensus 685 -----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 759 (797)
--.|+|.|+.|.+.||+++...||....+... .. .. ..+..+..+.+..+. .+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~~--r~---Yqe~qLPalp~~vpp---------~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--DT--RT---YQESQLPALPSRVPP---------VARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhee--ch--hh---hhhhhCCCCcccCCh---------HHHHHHHH
Confidence 23689999999999999999999987332211 11 11 122233333232222 24456777
Q ss_pred hcccCCCCCCCHHHHHHHH
Q 003759 760 CIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 760 Cl~~dP~~RPs~~eVl~~L 778 (797)
.++.||++||+..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 8999999999976544444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.6e-15 Score=149.80 Aligned_cols=130 Identities=19% Similarity=0.262 Sum_probs=105.2
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccC-CC-------chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SG-------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.||+|+||.||+|... +..|++|...... .. ..+++.+|++++..++|+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecC---CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 3899999999999853 2458888854321 11 12457789999999998887666666666777899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
|+++++|.+++..... .++.+++++|.+||+. +++|+|++|+||+++ ++.+++.|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754321 8899999999999998 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.2e-15 Score=147.94 Aligned_cols=137 Identities=18% Similarity=0.142 Sum_probs=105.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC----------------------chHHHHHHHHHhhccCcCc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG----------------------GDKEFRTEVNAIGQTNHRN 565 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~----------------------~~~~f~~E~~~l~~l~h~n 565 (797)
+.+.+.||+|+||.||++... ++..||||+++..... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 555678999999999999875 3456999987542210 0113567888888887774
Q ss_pred --hhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 566 --LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 566 --iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
+.++++. ...++||||+++++|...... .....++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444432 345899999999998776431 34567889999999999997 99999999999999999
Q ss_pred CcEEEEeecCcccccc
Q 003759 644 FTARISDFGLAKILKA 659 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~ 659 (797)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.1e-15 Score=171.11 Aligned_cols=131 Identities=19% Similarity=0.291 Sum_probs=107.5
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEE-ecccCCC-------chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKK-LDNMVSG-------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~-~~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
.+.||+|+||+||+|.+.... +++|+ +.+.... ..+.+.+|++++..++|++++....++......++|
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~---~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD---AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cceeccCCcEEEEEEeecCcc---ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 578999999999999875432 33333 2221111 124588999999999999999888888777788999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
|||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999998874 4678999999999999998 99999999999999 677999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.6e-16 Score=166.63 Aligned_cols=169 Identities=25% Similarity=0.356 Sum_probs=127.7
Q ss_pred ceeeeeecccCCchhhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
+.++.|+++...+|.++|.++ ...++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999755 356788899999999999999 4 8999999999999999999999999998
Q ss_pred cccccCC-----CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhh
Q 003759 655 KILKADQ-----TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 655 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
....... ....+.-.||..||+||.+.+..|+.|+||||||++|+||++ -...++.. .+...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhhhhh
Confidence 7665544 223444569999999999999999999999999999999997 33333211 111222
Q ss_pred ccccccc-cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 729 IDEKLHL-LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 729 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
.++.+.. ..... + .-..++.+++.+.|.+||++.+
T Consensus 473 r~g~ip~~~~~d~------p----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEFLQDY------P----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHHhhcC------c----HHHHHHHHhcCCCcccCchHHH
Confidence 3333331 11111 1 1135677899999999994433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=131.41 Aligned_cols=133 Identities=23% Similarity=0.145 Sum_probs=113.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc--CchhhhcccccccCceeeeeecccCC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH--RNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
+.||+|.++.||++.... ..+++|....... ..++..|+.++..++| .++.+++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD---EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC---CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 568999999999998753 3589999865432 4678999999999976 58999999988888999999999988
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.||+.+..
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 5567788999999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.4e-15 Score=170.94 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=185.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+|+.|-........+..+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 345569999999999887766666778888876543 122234455777777776 99999999999999999999999
Q ss_pred ccCCchhhhc-ccCC-CCChhhHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCcccccc--
Q 003759 586 ISNGCLAGFL-FKNP-KPSWYRRMQIAFGIARGLFYLH-EECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKA-- 659 (797)
Q Consensus 586 ~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~-- 659 (797)
..++++.+.+ .... ..+....-.+..|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999988 4443 5666777888999999999999 76 999999999999999999 999999999987765
Q ss_pred CCCcccccccc-cCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc-ccc
Q 003759 660 DQTRTTTAIRG-TRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL-HLL 736 (797)
Q Consensus 660 ~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 736 (797)
..........| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.......... ..|.... +.. ...
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~---~~~~~~~ 254 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNK---GRFTQLP 254 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccc---cccccCc
Confidence 33344444567 9999999999885 45678999999999999999999997665443221 1111110 000 000
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
..... ....++...++..+|+.|.+.+++.
T Consensus 255 ~~~~~---------~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 255 WNSIS---------DQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCC---------hhhhhcccccccCCchhcccccccc
Confidence 11100 1223445557778999999887764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.5e-14 Score=138.30 Aligned_cols=137 Identities=20% Similarity=0.182 Sum_probs=93.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch--HHH----------------------HHHHHHhhccCcCc-
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD--KEF----------------------RTEVNAIGQTNHRN- 565 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~--~~f----------------------~~E~~~l~~l~h~n- 565 (797)
.+.||+|+||.||+|... ++..||||++........ ..+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 357999999999999876 345699999865322111 111 23444444443221
Q ss_pred -hhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCC
Q 003759 566 -LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 566 -iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~ 643 (797)
+.+++++ ...++||||++++.+........... .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 2223322 24589999999954432211111111 5678899999999999998 6 999999999999999 8
Q ss_pred CcEEEEeecCccccc
Q 003759 644 FTARISDFGLAKILK 658 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~ 658 (797)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.7e-13 Score=135.45 Aligned_cols=134 Identities=16% Similarity=0.101 Sum_probs=102.0
Q ss_pred hhhC-cccceeEEEEEEecCCcEEEEEEEecccC-------------CCchHHHHHHHHHhhccCcCch--hhhcccccc
Q 003759 512 DELG-RGAFATVHKGVLAYENKICVAVKKLDNMV-------------SGGDKEFRTEVNAIGQTNHRNL--VKLLGFCNE 575 (797)
Q Consensus 512 ~~LG-~G~fG~Vykg~~~~~~~~~vavK~~~~~~-------------~~~~~~f~~E~~~l~~l~h~ni--v~l~g~~~~ 575 (797)
..|| .||.|+||+.... +..++||+..... ......+.+|+.++.+++|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4587 8899999988774 2348888774311 1123457889999999998875 667776543
Q ss_pred cC----ceeeeeecccC-CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEe
Q 003759 576 DQ----HRLLVYEFISN-GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISD 650 (797)
Q Consensus 576 ~~----~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 650 (797)
.. ..++|+|++++ .+|.+++... .++. ..+.+|+++|.+||+. +|+|+||||+|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 32 23599999997 6898887543 3333 2467899999999998 999999999999999989999999
Q ss_pred ecCccc
Q 003759 651 FGLAKI 656 (797)
Q Consensus 651 fgla~~ 656 (797)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-13 Score=158.23 Aligned_cols=163 Identities=23% Similarity=0.274 Sum_probs=115.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
+.|..|++|.||..+++... +..|.|+-++.. +.+- ++.....|.+| |+=
T Consensus 89 klisngAygavylvrh~~tr-qrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETR-QRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred EeeccCCCCceeeeeccccc-cchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence 56889999999999886543 346764433211 0000 22222223222 333
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC----------
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---------- 661 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---------- 661 (797)
...+...+.++. +++.+++|||+. +|+|||+||+|.+|+.=|.+|+.|||+.+......
T Consensus 139 ~tllk~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 139 ATLLKNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhhcccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 344433333332 237889999998 99999999999999999999999999987532111
Q ss_pred ----CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc
Q 003759 662 ----TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715 (797)
Q Consensus 662 ----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~ 715 (797)
......+.|||.|+|||++....|...+|.|++|+|+||.+-|..||.++..++
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 112233579999999999999999999999999999999999999998875544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=132.59 Aligned_cols=204 Identities=21% Similarity=0.305 Sum_probs=142.7
Q ss_pred HHHHHHhhccCcCchhhhccccccc-----CceeeeeecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhh
Q 003759 552 RTEVNAIGQTNHRNLVKLLGFCNED-----QHRLLVYEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHE 622 (797)
Q Consensus 552 ~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~ 622 (797)
..-...|-++.|.|||++..|+.+. .+..++.|||..|+|..+|++. ..+......++..||..||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 3445566677899999999998654 3578899999999999999753 456777888999999999999998
Q ss_pred cCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc---ccCCCcccccccccCccccccccccCCCCccCceehHHHHHH
Q 003759 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLL 699 (797)
Q Consensus 623 ~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ 699 (797)
|.++|+|+++..+-|++..++-+|+.--.-...- ............+-++|.+||+=.....+.++|||+||+..+
T Consensus 195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 4889999999999999999998887632211110 001111222334678999999988888889999999999999
Q ss_pred HHHhCCcCC-CccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 700 ELICCRKKF-EQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 700 elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
||.-+..-. ......+.+..+.. ....+.+... ..++..|++..|..||+|.+++..
T Consensus 274 emailEiq~tnseS~~~~ee~ia~----------~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIAN----------VIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhh----------heeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 998877542 22222111111110 0001111111 123445999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-11 Score=135.45 Aligned_cols=139 Identities=22% Similarity=0.235 Sum_probs=95.2
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCch----------------------------------------HHHH
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD----------------------------------------KEFR 552 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~f~ 552 (797)
.||.|++|.||+|++.++ ..||||+.+....... -+|.
T Consensus 124 plasaSigQVh~A~l~~G--~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDG--KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred ceeeeehhheEEEEecCC--CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 599999999999999743 4699999865321100 0234
Q ss_pred HHHHHhhccC-----cCchhhhcccccccCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHH-HHHHHhhcCC
Q 003759 553 TEVNAIGQTN-----HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIAR-GLFYLHEECT 625 (797)
Q Consensus 553 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-gL~~LH~~~~ 625 (797)
.|+..+.++. ++++.-..-|....+..+|||||+++++|.++.... ... .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 4444444441 222221111222234578999999999998876432 111 34567776666 46778876
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 626 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+++|+|+||.||++++++.++++|||++..+..
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-11 Score=96.58 Aligned_cols=56 Identities=27% Similarity=0.572 Sum_probs=47.5
Q ss_pred ceeeccCCCCCCcccccc-ccccChHHHhhhccCCCccccccccc----cccccccCcCcC
Q 003759 355 YDLVEMEYTDWPYFDYEH-HQGVRLQWCREACMRDCFCTVAIFRN----GECWKKKNPLTN 410 (797)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~-~~~~s~~~C~~~Cl~nCsC~a~~~~~----~~C~~~~~~l~~ 410 (797)
++|++++++++|+++... ..++++++|++.||+||||+||+|.+ ++|++|.+.|.|
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 578999999999875433 36699999999999999999999963 689999988865
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.1e-11 Score=100.64 Aligned_cols=71 Identities=24% Similarity=0.448 Sum_probs=58.4
Q ss_pred cceeeccCCCCCCccccccccccChHHHhhhccCCCccccccccc--cccccccCcCcCCCccCCCCCceEEEE
Q 003759 354 LYDLVEMEYTDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFRN--GECWKKKNPLTNGRMAPDIEGKALIKI 425 (797)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~~l~~~~~~~~~~~~~~lkl 425 (797)
.+.|+.++++++|...+.. .++++++|++.|++||+|+||+|.+ ++|++|..++.+.+.........|||+
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv 83 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRL 83 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEe
Confidence 3578888999999776554 7789999999999999999999964 889999999988776544457788886
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-10 Score=111.28 Aligned_cols=130 Identities=21% Similarity=0.108 Sum_probs=95.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhh-hcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK-LLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++++ ++.+. .+..++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 35788999999998764 34599998764321 2345688999999986655543 44433 234589999999988
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC--TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
+.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76531 112345678999999999872 22369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.8e-11 Score=129.09 Aligned_cols=204 Identities=21% Similarity=0.202 Sum_probs=157.0
Q ss_pred HHHHHHHHHhhhhhhCc--ccceeEEEEEE--ecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc-CcCchhhhccc
Q 003759 500 YKELEKATQGFKDELGR--GAFATVHKGVL--AYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT-NHRNLVKLLGF 572 (797)
Q Consensus 500 ~~el~~~~~~f~~~LG~--G~fG~Vykg~~--~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~h~niv~l~g~ 572 (797)
..+.......+.+.+|. |.+|.||++.. .... ..+|+|+-+..... ....=.+|+....++ .|+|.++....
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~-~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESP-HKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCC-cccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 34455555666778999 99999999987 4433 45888885443332 222234566666666 69999999999
Q ss_pred ccccCceeeeeecccCCchhhhcccCCC-CChhhHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCEEEcCC-CcE
Q 003759 573 CNEDQHRLLVYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIAR----GLFYLHEECTTQIIHCDIKPQNILLDDS-FTA 646 (797)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~ 646 (797)
++..+..++-+|++. .+|..+.+.... ++....+.+..+..+ ||.++|.. .++|-|+||.||++..+ ...
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 999999999999985 777777765543 677777888888888 99999998 99999999999999999 888
Q ss_pred EEEeecCccccccCCC----cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 647 RISDFGLAKILKADQT----RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 647 kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
+++|||+...+..... .......+...|++||..++ -++...|+|++|.++++..++.....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 9999999988765442 11222347778999999876 46888999999999999998876653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-09 Score=119.95 Aligned_cols=171 Identities=16% Similarity=0.198 Sum_probs=123.7
Q ss_pred EEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchhhhcccCCCCCh
Q 003759 524 KGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSW 603 (797)
Q Consensus 524 kg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~ 603 (797)
.|..+.. +.+|.|+..+...........+.++.|+.++||||++++...++++..|||+|-+. .|..++.+. ..
T Consensus 30 ~~t~k~~-~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~ 103 (690)
T KOG1243|consen 30 DGTRKAD-GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GK 103 (690)
T ss_pred ccceecc-CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HH
Confidence 3444433 34577877765444334557788999999999999999999999999999999873 344444322 24
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCccccccccccC
Q 003759 604 YRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683 (797)
Q Consensus 604 ~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 683 (797)
......+.||+.||.|||+.| +++|++|....|++++.|..||++|-++........ .......-..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 445567889999999999764 899999999999999999999999998764332211 11111122346666655433
Q ss_pred CCCccCceehHHHHHHHHHhCC
Q 003759 684 PITMKVDIYSFGVMLLELICCR 705 (797)
Q Consensus 684 ~~t~~sDVwS~Gvll~elltG~ 705 (797)
. -..|.|.||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.1e-10 Score=128.51 Aligned_cols=139 Identities=18% Similarity=0.163 Sum_probs=85.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc----------------------------------hHHHHHHHHH
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG----------------------------------DKEFRTEVNA 557 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~----------------------------------~~~f~~E~~~ 557 (797)
+.||+|++|.||+|++.++ ++.||||++++..... .+.+.+|++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~-G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKDN-GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECCC-CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 3699999999999999763 3469999997542110 0112222222
Q ss_pred hhccCcCchhhhcccccc-------------cCceeeeeecccCCchhhhcc-cCCCCChhhHHHHHHHHHHH-HHHHhh
Q 003759 558 IGQTNHRNLVKLLGFCNE-------------DQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARG-LFYLHE 622 (797)
Q Consensus 558 l~~l~h~niv~l~g~~~~-------------~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~g-L~~LH~ 622 (797)
.... +|+.++...+.+ ....+|||||++++.+.++-. .....+ +..++...++. +.-+..
T Consensus 204 ~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 204 MREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEVFFTQVFR 278 (537)
T ss_pred HHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 2222 244444433322 235679999999999977421 111111 11222222221 112223
Q ss_pred cCCCCeeecCCCCCCEEEcCCC----cEEEEeecCcccccc
Q 003759 623 ECTTQIIHCDIKPQNILLDDSF----TARISDFGLAKILKA 659 (797)
Q Consensus 623 ~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~~~ 659 (797)
.+++|+|+||.||+++.++ .+++.|||+...+..
T Consensus 279 ---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 ---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3999999999999999888 999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=107.21 Aligned_cols=139 Identities=15% Similarity=0.151 Sum_probs=97.3
Q ss_pred hhhCcccceeEEEEEEecC-----CcEEEEEEEecccCCC---------------------c-hHHHH----HHHHHhhc
Q 003759 512 DELGRGAFATVHKGVLAYE-----NKICVAVKKLDNMVSG---------------------G-DKEFR----TEVNAIGQ 560 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-----~~~~vavK~~~~~~~~---------------------~-~~~f~----~E~~~l~~ 560 (797)
..||.|.=+.||.|...++ .+..+|||..+..... . .+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999976532 2356999988532110 0 11223 78888888
Q ss_pred cCc--CchhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCC
Q 003759 561 TNH--RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL-HEECTTQIIHCDIKPQN 637 (797)
Q Consensus 561 l~h--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivH~Dlkp~N 637 (797)
+.. -++..++++ ...+|||||+.+..+..-..+...++..+...+..+++.+|..| |+. +|+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 743 455555554 56789999998754432222222344455677889999999999 776 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccc
Q 003759 638 ILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~ 658 (797)
|++++ +.+.|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.9e-10 Score=125.37 Aligned_cols=243 Identities=21% Similarity=0.206 Sum_probs=169.2
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHH--HHHHHHhhcc-CcCchhhhcccccccCceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF--RTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f--~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
...||.|.|+.|++...+..++..+++|.+.+.......+. ..|+-+...+ .|.++++...-+......++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999999876645666799999876544433322 3455555555 68899998888888888889999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++...+.-...+....++++..+++.++.++|+. .++|+|+||+||++..+ +.-++.|||.+..+.- ....
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---~~~~ 423 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---SSGV 423 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce---eccc
Confidence 999887774445677788899999999999999987 99999999999999876 7889999999864211 1111
Q ss_pred cccccCcc-ccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGY-VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y-~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....+..| .+|+......+-.+.|++|||.-+.|.+++.......... . .+..+........ .
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------~--~i~~~~~p~~~~~-~---- 487 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------L--TIRSGDTPNLPGL-K---- 487 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCcccccc---------e--eeecccccCCCch-H----
Confidence 11123334 3666667778899999999999999999987654322110 0 0111111111000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
..+..++..++.+++..||.+.++..+.+-
T Consensus 488 -----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 -----LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 112223444889999999999888766554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.1e-09 Score=105.26 Aligned_cols=142 Identities=18% Similarity=0.199 Sum_probs=108.3
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCc--CchhhhcccccccC---ceeeeeec
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNH--RNLVKLLGFCNEDQ---HRLLVYEF 585 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~Ey 585 (797)
+.|+.|..+.||+++..+ +..+++|....... ....++..|++++..+.+ .++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 358899999999988753 24588998765322 134578899999999965 34577777776643 66899999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC----------------------------------------- 624 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------- 624 (797)
+++.++.+.+.. ..++..++..++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988876632 34667777888888888888888521
Q ss_pred ------------CCCeeecCCCCCCEEEcC--CCcEEEEeecCccc
Q 003759 625 ------------TTQIIHCDIKPQNILLDD--SFTARISDFGLAKI 656 (797)
Q Consensus 625 ------------~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~ 656 (797)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.9e-08 Score=89.73 Aligned_cols=84 Identities=27% Similarity=0.483 Sum_probs=64.4
Q ss_pred eEeeCceEEEEcCC-CceEeccCCCCC--ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEecCC
Q 003759 91 QLTVDGRLVLTDLT-GKEVWNPDTAGA--AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYS 167 (797)
Q Consensus 91 ~~~~~g~l~l~~~~-~~~vW~t~~~~~--~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~~s 167 (797)
.+..||+||+++.. +.+||++++... ....+.|.++|||||++.++.++|+| .|.
T Consensus 25 ~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S---~t~------------------- 82 (114)
T smart00108 25 IMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS---NTT------------------- 82 (114)
T ss_pred CCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe---ccc-------------------
Confidence 34578999999765 589999987533 23678999999999999989999998 110
Q ss_pred CCCCCCCceEEEEcCCCceEEEeccCCccccCcccccc
Q 003759 168 DKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST 205 (797)
Q Consensus 168 ~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~ 205 (797)
...|.|.+.|+.+|+++++...+ .+.|.+
T Consensus 83 ---~~~~~~~~~L~ddGnlvl~~~~~------~~~W~S 111 (114)
T smart00108 83 ---GANGNYVLVLLDDGNLVIYDSDG------NFLWQS 111 (114)
T ss_pred ---CCCCceEEEEeCCCCEEEECCCC------CEEeCC
Confidence 13567899999999999986432 366765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-07 Score=101.13 Aligned_cols=167 Identities=20% Similarity=0.267 Sum_probs=127.2
Q ss_pred ceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccc----ccCceeeeeecccC-Cchhh
Q 003759 519 FATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCN----EDQHRLLVYEFISN-GCLAG 593 (797)
Q Consensus 519 fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~ 593 (797)
-.+.||+....++. .+++|+++............-+++++++.|.|+|++..++. .+...++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~-~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGN-AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCc-eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 36789998876554 58899985433333323344678899999999999999876 34578999999986 57777
Q ss_pred hcccC---------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 594 FLFKN---------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 594 ~l~~~---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
..+.+ ...++...+.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 66532 2345678899999999999999998 99889999999999999999999999877665
Q ss_pred cCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcC
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK 707 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p 707 (797)
.+.... +. -..+-|.=.||.+++.|.||...
T Consensus 445 ~d~~~~---------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP---------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc---------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 543111 11 12356888999999999999654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.6e-08 Score=89.39 Aligned_cols=85 Identities=25% Similarity=0.439 Sum_probs=65.1
Q ss_pred eEee-CceEEEEcCC-CceEeccCCCC--CceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEecC
Q 003759 91 QLTV-DGRLVLTDLT-GKEVWNPDTAG--AAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHY 166 (797)
Q Consensus 91 ~~~~-~g~l~l~~~~-~~~vW~t~~~~--~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~~ 166 (797)
.+.. ||+|++++.. +.+||++++.. .....+.|.++|||||++.++.++|||=-
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~---------------------- 82 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT---------------------- 82 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc----------------------
Confidence 3455 8999999765 57999999764 34567899999999999999999999711
Q ss_pred CCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccC
Q 003759 167 SDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQ 206 (797)
Q Consensus 167 s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~ 206 (797)
. .+.|.+.+.|+.+|+++++...+ .+.|.+.
T Consensus 83 --~-~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf 113 (116)
T cd00028 83 --T-RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSF 113 (116)
T ss_pred --c-CCCCceEEEEeCCCCEEEECCCC------CEEEcCC
Confidence 0 13577999999999999986542 3567653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.2e-08 Score=92.66 Aligned_cols=130 Identities=21% Similarity=0.244 Sum_probs=99.2
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEE-ecccCCCc-------hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKK-LDNMVSGG-------DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~-~~~~~~~~-------~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+++|+=+.+|.+.+.+. .+++|. +++.-... .+...+|+.++.+++--.|.-..-|..+.....|+||
T Consensus 3 ~i~~GAEa~i~~~~~~g~---~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL---PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeeccCc---ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 578899999998866422 255554 33322221 1235779999998876666666666778888899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
|+++..|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888654 356777777888889998 999999999999998775 99999999875
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.5e-08 Score=84.11 Aligned_cols=64 Identities=9% Similarity=0.014 Sum_probs=50.2
Q ss_pred eeeccCCCCCCccccccccccChHHHhhhccC---CCcccccccc--ccccccccCcC-cCCCccCCCCCceEEE
Q 003759 356 DLVEMEYTDWPYFDYEHHQGVRLQWCREACMR---DCFCTVAIFR--NGECWKKKNPL-TNGRMAPDIEGKALIK 424 (797)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~~lk 424 (797)
.|+++..++.|... .+++++|++.|++ ||||+||+|. +++|.+|.+.+ .+.++..+.+.++|++
T Consensus 10 ~fl~~~~~klpd~~-----~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTK-----ANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCccc-----ccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 36666667777543 3789999999999 9999999995 46899999999 8888776655566664
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.8e-07 Score=88.42 Aligned_cols=139 Identities=22% Similarity=0.273 Sum_probs=100.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEE-ecccCCC-------chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKK-LDNMVSG-------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~-~~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.|-+|+=+.|+++.... + ...||. +.+.-+. ..+...+|++++.+++--.|.-..-++.+...-.|+|
T Consensus 13 ~likQGAEArv~~~~~~G--e-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSG--E-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeeccCC--c-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457789999999998752 3 345554 3332221 1245678999999987656655555666777778999
Q ss_pred ecccC-CchhhhcccCC-CCChh-hHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEeecCccc
Q 003759 584 EFISN-GCLAGFLFKNP-KPSWY-RRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDFGLAKI 656 (797)
Q Consensus 584 Ey~~~-gsL~~~l~~~~-~l~~~-~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~ 656 (797)
||+++ .++.+++.... ..... ....++..|-+.+.-||.. +|+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47888876542 22222 2368888999999999998 999999999999996554 358999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.7e-06 Score=91.49 Aligned_cols=189 Identities=15% Similarity=0.177 Sum_probs=123.9
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhccc------ccccCc-eeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGF------CNEDQH-RLLV 582 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~------~~~~~~-~~lV 582 (797)
+..||+|+-+.+|.--.-. + .+.|+..........+ .+..|... .||-+-.-+.+ ..+++. .-++
T Consensus 16 gr~LgqGgea~ly~l~e~~--d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR--D--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecchhh--c--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4579999999999532211 1 2345554432222222 22333333 56644331111 122222 5566
Q ss_pred eecccCCc-hhhhcc---c---CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 583 YEFISNGC-LAGFLF---K---NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 583 ~Ey~~~gs-L~~~l~---~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
|..+++.- ..+++. + -....|.-.++.+..+|.+.+.||+. |.+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77666542 223322 1 13467999999999999999999998 99999999999999999999999755433
Q ss_pred ccccCCCcccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhC-CcCCCcc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICC-RKKFEQN 711 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG-~~p~~~~ 711 (797)
.. .........+|.+.|++||.-. +..-+...|-|.||+++++++.| +.||.+.
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22 1222233345889999999754 44568889999999999999986 8999765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.1e-07 Score=93.04 Aligned_cols=131 Identities=15% Similarity=0.060 Sum_probs=93.8
Q ss_pred eeEEEEEEecCCcEEEEEEEecccCC-----------CchHHHHHHHHHhhccCcCch--hhhcccccc-----cCceee
Q 003759 520 ATVHKGVLAYENKICVAVKKLDNMVS-----------GGDKEFRTEVNAIGQTNHRNL--VKLLGFCNE-----DQHRLL 581 (797)
Q Consensus 520 G~Vykg~~~~~~~~~vavK~~~~~~~-----------~~~~~f~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~l 581 (797)
..|.+..+. +..+.||+...... .....+.+|...+.++...+| .+++++.+. ....+|
T Consensus 36 rrvvr~~~~---g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFELA---GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEEC---CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 345565542 34589997643221 111147789998888854433 444556543 235789
Q ss_pred eeecccCC-chhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-------CCcEEEEee
Q 003759 582 VYEFISNG-CLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-------SFTARISDF 651 (797)
Q Consensus 582 V~Ey~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~Df 651 (797)
|+|++++. +|.+++.. ....+...+..++.+++..+.-||+. +|+|+|++++|||++. +..+.++||
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99999986 89888753 23445567779999999999999998 9999999999999975 468899999
Q ss_pred cCccc
Q 003759 652 GLAKI 656 (797)
Q Consensus 652 gla~~ 656 (797)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.9e-07 Score=87.39 Aligned_cols=126 Identities=21% Similarity=0.197 Sum_probs=79.1
Q ss_pred eEEEEEEecCCcEEEEEEEecccCCC---------------------c-----hHHHHHHHHHhhccCcC--chhhhccc
Q 003759 521 TVHKGVLAYENKICVAVKKLDNMVSG---------------------G-----DKEFRTEVNAIGQTNHR--NLVKLLGF 572 (797)
Q Consensus 521 ~Vykg~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~f~~E~~~l~~l~h~--niv~l~g~ 572 (797)
.||.|...+ +..+|||..+..... . .....+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~--~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDPD--GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEECT--TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECCC--CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 388887753 346999987632111 0 01256789999998654 45556544
Q ss_pred ccccCceeeeeeccc--CCchhhhcccCCCCChhhHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 573 CNEDQHRLLVYEFIS--NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL-HEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 573 ~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
....|||||++ +..+..+... .++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.|+
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ----eCCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 24579999998 5555443321 112445667778888866664 566 99999999999999988 99999
Q ss_pred eecCccccc
Q 003759 650 DFGLAKILK 658 (797)
Q Consensus 650 Dfgla~~~~ 658 (797)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.9e-08 Score=113.36 Aligned_cols=150 Identities=22% Similarity=0.241 Sum_probs=118.6
Q ss_pred cCcCchhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 561 l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
.+||-+++..--+.-.....|+++|..+++|...|+.....+..-.......+.+++++||.. .+.|+|++|.|+++
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLI 937 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhh
Confidence 345655555545556678899999999999999998777666655666667788899999986 69999999999999
Q ss_pred cCCCcEEEEeecCccccc---------------------cC---------CCcccccccccCccccccccccCCCCccCc
Q 003759 641 DDSFTARISDFGLAKILK---------------------AD---------QTRTTTAIRGTRGYVAPEWFKSLPITMKVD 690 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~---------------------~~---------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sD 690 (797)
..++..+++||+...... .. .........+|+.|++||...+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 999999999998433211 00 001123346899999999999999999999
Q ss_pred eehHHHHHHHHHhCCcCCCcccc
Q 003759 691 IYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 691 VwS~Gvll~elltG~~p~~~~~~ 713 (797)
.|++|++++|.++|..||.....
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcch
Confidence 99999999999999999976544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.9e-06 Score=86.94 Aligned_cols=136 Identities=18% Similarity=0.131 Sum_probs=93.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC----------------------chHHHHHHHHHhhccCcC-
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG----------------------GDKEFRTEVNAIGQTNHR- 564 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~----------------------~~~~f~~E~~~l~~l~h~- 564 (797)
+.+.++||.|.=+.||.|..+.+. ++|||--+....+ .....++|.++|.++.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~--~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR--KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECCCCC--EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 345678999999999999987544 4788765422111 011245678888887544
Q ss_pred -chhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 565 -NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 565 -niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
.+.+.+++ +...+||||+++-.|...-. +......|+..|++-+..+-.. ||||+|+++-||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 55555554 56689999999876655431 2333444555555555554455 99999999999999999
Q ss_pred CcEEEEeecCcccc
Q 003759 644 FTARISDFGLAKIL 657 (797)
Q Consensus 644 ~~~kl~Dfgla~~~ 657 (797)
|.+.++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.3e-06 Score=85.12 Aligned_cols=106 Identities=18% Similarity=0.222 Sum_probs=85.1
Q ss_pred hHHHHHHHHHhhccCc--CchhhhcccccccC----ceeeeeecccC-CchhhhcccCCCCChhhHHHHHHHHHHHHHHH
Q 003759 548 DKEFRTEVNAIGQTNH--RNLVKLLGFCNEDQ----HRLLVYEFISN-GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYL 620 (797)
Q Consensus 548 ~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~L 620 (797)
.....+|...+.++.. -...+++++.+... ..+||+|++++ .+|.+++......+......++.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3457788888888743 34456666665432 45899999987 48999987654567778889999999999999
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCC---cEEEEeecCccc
Q 003759 621 HEECTTQIIHCDIKPQNILLDDSF---TARISDFGLAKI 656 (797)
Q Consensus 621 H~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~ 656 (797)
|+. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 998 999999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.1e-07 Score=104.38 Aligned_cols=96 Identities=20% Similarity=0.401 Sum_probs=75.4
Q ss_pred HHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--------ccccccccCcccccccccc
Q 003759 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--------TTTAIRGTRGYVAPEWFKS 682 (797)
Q Consensus 611 ~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 682 (797)
.+++.|+.|+|.. .++||++|.|++|.++.++..||+.|+.+......... ...-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 69999999999999999999999999987654431111 1111234568999999999
Q ss_pred CCCCccCceehHHHHHHHHHhCCcCC
Q 003759 683 LPITMKVDIYSFGVMLLELICCRKKF 708 (797)
Q Consensus 683 ~~~t~~sDVwS~Gvll~elltG~~p~ 708 (797)
...+.++|+||+|+++|-+..|..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcch
Confidence 88899999999999999998544443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=79.86 Aligned_cols=135 Identities=18% Similarity=0.116 Sum_probs=101.5
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccC------CCchHHHHHHHHHhhccCcC--chhhhccccccc-----Ccee
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMV------SGGDKEFRTEVNAIGQTNHR--NLVKLLGFCNED-----QHRL 580 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~h~--niv~l~g~~~~~-----~~~~ 580 (797)
-|+||-+.|+.-.+.. . .+-+|+-.... ..+...|.+|...|.++... .+.+++ ++... -..+
T Consensus 26 ~~rgG~SgV~r~~~~g--~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--K-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCC--c-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 3679999999876643 2 48888876211 33567899999999998532 344444 44321 2468
Q ss_pred eeeecccC-CchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc--EEEEeecCcc
Q 003759 581 LVYEFISN-GCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT--ARISDFGLAK 655 (797)
Q Consensus 581 lV~Ey~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~ 655 (797)
||+|-+++ -+|.+++.+. .+.+...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997654 6888888653 3557778889999999999999998 9999999999999986666 8999998665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.3e-06 Score=94.45 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=88.9
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH----------------------------------------HHH
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK----------------------------------------EFR 552 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~f~ 552 (797)
-|+.++-|.||+|++.+ +..||||+.+......-+ ++.
T Consensus 132 PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 132 PIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred chhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 48899999999999986 446999999764322100 123
Q ss_pred HHHHHhhccC-----cCchhhhcccccccCceeeeeecccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCC
Q 003759 553 TEVNAIGQTN-----HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTT 626 (797)
Q Consensus 553 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 626 (797)
.|+..+.++. .+++.-..=|.+-.+...|+|||++|-.+.+... +....+ +..++..++++. +.+--..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHH--HHHHHhc
Confidence 3333333331 2222222223333456789999999999888853 223333 333443333321 1111123
Q ss_pred CeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 627 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+++|+|.+|.||+++.++.+.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999887654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.2e-05 Score=70.72 Aligned_cols=98 Identities=29% Similarity=0.445 Sum_probs=68.1
Q ss_pred eeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEe-CCCCCCccCceeeEeeCceEEEEcCCCceEeccCCCCCce
Q 003759 40 SWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSA-NGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAI 118 (797)
Q Consensus 40 ~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~A-nr~~p~~~~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~~ 118 (797)
++.+.+|.+.|-|...++ |-|.-. ..++||.. +...+....+.+.|..||||||+|.++.++|++. .....
T Consensus 13 p~~~~s~~~~L~l~~dGn----Lvl~~~---~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~ptd 84 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN----LVLYDS---NGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSF-DYPTD 84 (114)
T ss_dssp EEEECETTEEEEEETTSE----EEEEET---TTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEEST-TSSS-
T ss_pred ccccccccccceECCCCe----EEEEcC---CCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeec-CCCcc
Confidence 444545889999987764 444322 25779999 4344433567899999999999999999999983 34456
Q ss_pred eEEEEec--CCCeEEecCCCCceeeeccCC
Q 003759 119 AYASMLD--SGNFVLAGPDSFPLWESFDHP 146 (797)
Q Consensus 119 ~~a~l~d--~GNlvl~~~~~~~lWqSFD~P 146 (797)
+....++ +||++ +.....+.|.|=+.|
T Consensus 85 t~L~~q~l~~~~~~-~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 85 TLLPGQKLGDGNVT-GKNDSLTSWSSNTDP 113 (114)
T ss_dssp EEEEEET--TSEEE-EESTSSEEEESS---
T ss_pred EEEeccCcccCCCc-cccceEEeECCCCCC
Confidence 7777787 89999 776778899986655
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=90.46 Aligned_cols=139 Identities=20% Similarity=0.235 Sum_probs=89.4
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-------------------------------------hHHHHHH
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-------------------------------------DKEFRTE 554 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~f~~E 554 (797)
+.||.-+.|.||+|++++ +..||||+.++..+.. +-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 358999999999999986 4459999987643321 0124455
Q ss_pred HHHhhcc----CcCc------hhhhcccccccCceeeeeecccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhc
Q 003759 555 VNAIGQT----NHRN------LVKLLGFCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEE 623 (797)
Q Consensus 555 ~~~l~~l----~h~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~ 623 (797)
++...+. .|-+ |.+++ ..-...+.|+||||+|..+.+.-. +...++.. .|+..+.++ |+++.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEA--YLEQI 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHH--HHHHH
Confidence 5444433 2333 22222 223347899999999998887653 22233333 344444443 33332
Q ss_pred CCCCeeecCCCCCCEEEcC----CCcEEEEeecCcccccc
Q 003759 624 CTTQIIHCDIKPQNILLDD----SFTARISDFGLAKILKA 659 (797)
Q Consensus 624 ~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfgla~~~~~ 659 (797)
-..|.+|+|-+|.||+++. ++.+.+.|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2348999999999999984 67899999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.1e-06 Score=95.30 Aligned_cols=182 Identities=18% Similarity=0.132 Sum_probs=131.2
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc-hhhhcccccccCceeeeeecccCC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN-LVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
-+.+++|++++++|.+-... ....++.+.. .....-++++|.+++||| .++.++-+..+...+++++++..+
T Consensus 247 fh~fvK~altknpKkRptae--klL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAE--KLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCChh--hheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 35578899999999765332 2233444432 245566899999999999 777777778888999999999877
Q ss_pred --chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 590 --CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 590 --sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+..........+...+...+...-++++++||+. .-+|+| ||+..+ +..|..||+....+.... ....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 2222111122233444555666778899999975 458888 777766 688999999887765543 3344
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
..+++.++|||+.....+..+.|+|++|+--.++--|-.|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 558999999999999999999999999987777777766653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00011 Score=73.72 Aligned_cols=137 Identities=20% Similarity=0.185 Sum_probs=85.5
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchH---------H---------------HHHHHHHhhccC--cCch
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDK---------E---------------FRTEVNAIGQTN--HRNL 566 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~---------~---------------f~~E~~~l~~l~--h~ni 566 (797)
.|..|.-..||+|.-. ++..+|||+.........+ . ..+|...|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4788889999998763 3456999998653322111 1 123444444441 2223
Q ss_pred hhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcE
Q 003759 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA 646 (797)
Q Consensus 567 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~ 646 (797)
.+.+++. .-.|||||+....+..=..+.-.+.......+..++++.+.-|-.. .++||+||+.=|||+. ++.+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 3333332 3479999997652111111111222224666677777777777763 3999999999999999 7899
Q ss_pred EEEeecCccccc
Q 003759 647 RISDFGLAKILK 658 (797)
Q Consensus 647 kl~Dfgla~~~~ 658 (797)
.|+|++.|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987554
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.4e-05 Score=66.54 Aligned_cols=57 Identities=21% Similarity=0.416 Sum_probs=44.0
Q ss_pred eeeccCCCCCCccccccccccChHHHhhhccC-CCcccccccc--cccccccc-CcCcCCC
Q 003759 356 DLVEMEYTDWPYFDYEHHQGVRLQWCREACMR-DCFCTVAIFR--NGECWKKK-NPLTNGR 412 (797)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~ 412 (797)
.|..++++.++..........++++|++.|+. +|+|.|+.|. ++.|++|. .++.+..
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 46677777776443333356799999999999 9999999996 67899998 6666665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=4.5e-05 Score=75.29 Aligned_cols=102 Identities=24% Similarity=0.345 Sum_probs=82.8
Q ss_pred HHHHHHhhccCc-CchhhhcccccccCceeeeeecccCCchhhh---cccCCCCChhhHHHHHHHHHHHHHHHhhcCCCC
Q 003759 552 RTEVNAIGQTNH-RNLVKLLGFCNEDQHRLLVYEFISNGCLAGF---LFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627 (797)
Q Consensus 552 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ 627 (797)
.+|.-++..+++ +++.+++|+|.. ++|.||...+++... +..--..+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888865 699999999954 789999988766432 112234689999999999999999999865556
Q ss_pred eeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 628 IIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 628 ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+.-+|++++|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=74.71 Aligned_cols=136 Identities=13% Similarity=0.129 Sum_probs=83.3
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhcccccccCceeeeeecccCC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
..||+|..+.||+.. ++ .+++|...... ......+|.+++..+..-. +.+.+++....+...+|||++++.
T Consensus 7 ~~i~~G~t~~~y~~~----~~-~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TG-KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEec----CC-CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 468999999999831 22 36778776422 3456788999999886433 466777777777788999999986
Q ss_pred c-hhhhc---------------------ccC--CCCChhhHH-HHHH----------HHHH-HHHHHhhc-CCCCeeecC
Q 003759 590 C-LAGFL---------------------FKN--PKPSWYRRM-QIAF----------GIAR-GLFYLHEE-CTTQIIHCD 632 (797)
Q Consensus 590 s-L~~~l---------------------~~~--~~l~~~~~~-~i~~----------~ia~-gL~~LH~~-~~~~ivH~D 632 (797)
. +...+ +.- .......+. .+.. .+.+ ...+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 22111 110 011111100 0000 0111 12222211 134578999
Q ss_pred CCCCCEEEcCCCcEEEEeecCcc
Q 003759 633 IKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 633 lkp~NILl~~~~~~kl~Dfgla~ 655 (797)
++|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00019 Score=74.43 Aligned_cols=136 Identities=17% Similarity=0.096 Sum_probs=82.3
Q ss_pred hCcccc-eeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccCCch
Q 003759 514 LGRGAF-ATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 514 LG~G~f-G~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
|-.|.. ..||+.... + ..+.||+..... ..++..|++++..+. +--+.+++++....+..++|||++++.+|
T Consensus 6 ~~~g~~~~~v~~~~~~--~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK--N-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC--C-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 334444 788987653 2 347788875432 345678998888883 44455677777666678999999999877
Q ss_pred hhhcc-------------------cCC--CCChh----hHHHHHH--------------------HHHHHHHHHhhc---
Q 003759 592 AGFLF-------------------KNP--KPSWY----RRMQIAF--------------------GIARGLFYLHEE--- 623 (797)
Q Consensus 592 ~~~l~-------------------~~~--~l~~~----~~~~i~~--------------------~ia~gL~~LH~~--- 623 (797)
..... .-. ..+.. .++.... .+...+..|-..
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64421 000 00000 0000000 011112222111
Q ss_pred -CCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 624 -CTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 624 -~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13468999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=71.19 Aligned_cols=68 Identities=24% Similarity=0.261 Sum_probs=53.5
Q ss_pred CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
...+|+|||++|..|.+... ++. .++..+.+++.-||+. |++|+|++|.|++++++ .+++.||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 35578999999988876542 111 3556677889999998 99999999999999865 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00033 Score=71.63 Aligned_cols=140 Identities=20% Similarity=0.163 Sum_probs=81.1
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcC--chhhhcccccc---cCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHR--NLVKLLGFCNE---DQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~g~~~~---~~~~~lV~Ey~ 586 (797)
+.|+.|..+.||+..... + .+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT--S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 357889899999987654 2 5899987653 3456788899998888533 34566654322 23468999999
Q ss_pred cCCchhh----------------hc---ccC----CCCChhh---------HHHH------------HHHHHH-HHHHHh
Q 003759 587 SNGCLAG----------------FL---FKN----PKPSWYR---------RMQI------------AFGIAR-GLFYLH 621 (797)
Q Consensus 587 ~~gsL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~ia~-gL~~LH 621 (797)
++..+.. .+ +.. ....+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 11 011 1111100 0000 112222 333333
Q ss_pred hc----CCCCeeecCCCCCCEEEc-CCCcEEEEeecCccc
Q 003759 622 EE----CTTQIIHCDIKPQNILLD-DSFTARISDFGLAKI 656 (797)
Q Consensus 622 ~~----~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~ 656 (797)
+. ....++|+|+.|.||+++ +++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 22 235799999999999999 556667999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=80.85 Aligned_cols=80 Identities=10% Similarity=0.188 Sum_probs=56.2
Q ss_pred hhhCcccceeEEEEEEecCCc-EEEEEEEecccC-CCchHHHHHHHHHhhccC-cCch--hhhccccccc---Cceeeee
Q 003759 512 DELGRGAFATVHKGVLAYENK-ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTN-HRNL--VKLLGFCNED---QHRLLVY 583 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~ 583 (797)
+.|+.|.+..+|+.....++. ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 457889999999876654321 346777764322 123457889999999995 6665 7778887664 4678999
Q ss_pred ecccCCch
Q 003759 584 EFISNGCL 591 (797)
Q Consensus 584 Ey~~~gsL 591 (797)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=65.31 Aligned_cols=127 Identities=17% Similarity=0.238 Sum_probs=87.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC----------------CCchHHHHHHHHHhhccC------cCchhhh
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV----------------SGGDKEFRTEVNAIGQTN------HRNLVKL 569 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~----------------~~~~~~f~~E~~~l~~l~------h~niv~l 569 (797)
..||+|+.=.||. ++.+.. ..||+..... ....+++.+|+.-...+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~--~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPN--LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CCCCCC--eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4689999999994 554443 5778776544 123456777776666655 8899999
Q ss_pred cccccccCceeeeeecccCC------chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 570 LGFCNEDQHRLLVYEFISNG------CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 570 ~g~~~~~~~~~lV~Ey~~~g------sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
+|+.++....-+|+|.+.+. +|.+++.+. .++. .+...+-+-..||-+. .|+.+|++|+||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 99999999999999987643 466766433 3333 2333334445566666 89999999999999532
Q ss_pred --C--cEEEEe
Q 003759 644 --F--TARISD 650 (797)
Q Consensus 644 --~--~~kl~D 650 (797)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0021 Score=68.62 Aligned_cols=75 Identities=7% Similarity=-0.010 Sum_probs=53.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc---Cchhhhcccccc---cCceeeeeec
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH---RNLVKLLGFCNE---DQHRLLVYEF 585 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lV~Ey 585 (797)
+.||.|..+.||+....+ + .+++|..+. ......|..|.+.++.+.- ..+.+++++|.. .+..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~~--~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDSQ--G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcCC--C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 359999999999875432 2 266676432 1134578999999998842 467788887754 4678999999
Q ss_pred ccCCch
Q 003759 586 ISNGCL 591 (797)
Q Consensus 586 ~~~gsL 591 (797)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0013 Score=67.68 Aligned_cols=73 Identities=12% Similarity=0.137 Sum_probs=44.4
Q ss_pred hhCcccce-eEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcC---chhhhccccccc---Cceeeeeec
Q 003759 513 ELGRGAFA-TVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHR---NLVKLLGFCNED---QHRLLVYEF 585 (797)
Q Consensus 513 ~LG~G~fG-~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~Ey 585 (797)
.|+.|+.. .||+.. + .+++|..+. .....++..|.+++..+... -+.++++..... ...+++||+
T Consensus 4 ~~~~gG~~n~vy~~~----~--~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 4 PVDSGGTDNATFRLG----D--DMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eccCCCcccceEEcC----C--ceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 46666666 588741 2 266776543 22345788899999887532 334444444332 235889999
Q ss_pred ccCCchhh
Q 003759 586 ISNGCLAG 593 (797)
Q Consensus 586 ~~~gsL~~ 593 (797)
+++.++.+
T Consensus 76 i~G~~l~~ 83 (235)
T cd05155 76 LEGETATA 83 (235)
T ss_pred ecCCCCCc
Confidence 99987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.002 Score=61.38 Aligned_cols=127 Identities=17% Similarity=0.180 Sum_probs=84.6
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhh-hcccccccCceeeeeecccCC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK-LLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~Ey~~~g 589 (797)
.+.|++|.+|.||++.+.. ..+|+|+-+.. .....+..|+++|..+.-.++-+ ++.|.. ..+.|||+.+-
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~---~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRG---GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhcccccEEEEeeccC---ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 4679999999999998853 25888886643 34567899999998887655543 333322 23459999888
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCC-CCCEEEcCCCcEEEEeecCccc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIK-PQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~Dfgla~~ 656 (797)
.|.+.-... + .+-...+++.---|... +|-|+.|+ |..++|..+..+.|+||.-|..
T Consensus 98 ~L~~~~~~~---~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG---D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc---c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 877654321 1 12223344443334443 89999987 4555555555999999998873
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0003 Score=57.77 Aligned_cols=46 Identities=20% Similarity=0.343 Sum_probs=36.1
Q ss_pred CCCCCCccccccccccChHHHhhhccCCCcccccccc--ccccccccC
Q 003759 361 EYTDWPYFDYEHHQGVRLQWCREACMRDCFCTVAIFR--NGECWKKKN 406 (797)
Q Consensus 361 ~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 406 (797)
++++++.+++......+.++|++.|+.||+|.|+.|. .+.|++|..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 4556665555544567899999999999999999884 578998876
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0036 Score=61.66 Aligned_cols=138 Identities=24% Similarity=0.311 Sum_probs=92.8
Q ss_pred CCCCCccccCHHHHHHHHHhhhhhhCcccc-eeEEEEEEecCCcEEEEEEEeccc-----------CC----------Cc
Q 003759 490 MPSTNLQIFSYKELEKATQGFKDELGRGAF-ATVHKGVLAYENKICVAVKKLDNM-----------VS----------GG 547 (797)
Q Consensus 490 ~~~~~~~~~~~~el~~~~~~f~~~LG~G~f-G~Vykg~~~~~~~~~vavK~~~~~-----------~~----------~~ 547 (797)
.+.+.+..|+... +...|.+.||.|.- |.|||+.+. +..+|+|.+... .. .-
T Consensus 24 ~~gPKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y 97 (207)
T PF13095_consen 24 CPGPKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY 97 (207)
T ss_pred CCCCCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhh
Confidence 3445556666622 55567789999999 999999884 346999993210 00 01
Q ss_pred hHHHHHHHHHhhccC---cCch--hhhccccccc------------------CceeeeeecccCCchhhhcccCCCCChh
Q 003759 548 DKEFRTEVNAIGQTN---HRNL--VKLLGFCNED------------------QHRLLVYEFISNGCLAGFLFKNPKPSWY 604 (797)
Q Consensus 548 ~~~f~~E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~ 604 (797)
...|..|.+..++++ +.++ |+.+||..-. ....||.||++... .
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~ 164 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------P 164 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------c
Confidence 124888999999884 4455 8888886211 12356777665432 1
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 605 RRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 605 ~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
...+-+.+|.+-|..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 165 ~~~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cchhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 2233455677778888987 9999999999986 4589999854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.007 Score=66.67 Aligned_cols=75 Identities=20% Similarity=0.143 Sum_probs=51.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC-------CCchHHHHHHHHHhhccC---cCchhhhcccccccCceee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV-------SGGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-------~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 581 (797)
+.||.|.+..||+....++. ..|+||.-.... .-..+.+..|.+.|..+. ..++.+++.+. .+..++
T Consensus 32 ~elggGn~N~VyrV~~~~g~-~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG-KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC-eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46899999999999886432 358999854221 113345677888887762 24566677663 356789
Q ss_pred eeecccCC
Q 003759 582 VYEFISNG 589 (797)
Q Consensus 582 V~Ey~~~g 589 (797)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0013 Score=78.69 Aligned_cols=195 Identities=19% Similarity=0.156 Sum_probs=133.4
Q ss_pred HHHHHHhhccCcCchhhhcccccccCce----eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCC
Q 003759 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHR----LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627 (797)
Q Consensus 552 ~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ 627 (797)
.-|...+.+..|+|++.++.|..+.... .+..|++..-++...+..-...+..+.+.+..++.+||+|+|+. .
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---S 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---c
Confidence 3467778888999999999997665433 24457888888888888888888999999999999999999987 4
Q ss_pred eeecCCCCC---CEEEcCCCcEEEE--eecCccccccCCCcccccccccCccccccccccCCCCc--cCceehHHHHHHH
Q 003759 628 IIHCDIKPQ---NILLDDSFTARIS--DFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM--KVDIYSFGVMLLE 700 (797)
Q Consensus 628 ivH~Dlkp~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--~sDVwS~Gvll~e 700 (797)
..|.-+..+ +...+..+...++ ||+....+....... ....+..+.+||......++. ..|+|.+|.++..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 444444444 4444566667766 888776654332221 122355677888887765544 4799999999999
Q ss_pred HHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003759 701 LICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778 (797)
Q Consensus 701 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~L 778 (797)
+..|..+-....... .+++.... .........|+..++++|++..+++...
T Consensus 385 ~~~~~~i~~~~~~~~-------------------~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPV-------------------SLLDVLST--------SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhcCcccccccchh-------------------hhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 998876543221100 00010000 0123345669999999999999999876
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0054 Score=64.03 Aligned_cols=135 Identities=13% Similarity=0.080 Sum_probs=75.5
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeecccCCchh
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEFISNGCLA 592 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~ 592 (797)
+..|-...+|+... ++..+++|........-.-...+|.++++.+....+ .+++.... ..+||||+++..+.
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 45677788998763 233477887654322211245778888888854333 33444332 36899999987764
Q ss_pred hh-----------------cccCC----CCChhhHH-HHH---------HHHHHHHHHHhhc-----CCCCeeecCCCCC
Q 003759 593 GF-----------------LFKNP----KPSWYRRM-QIA---------FGIARGLFYLHEE-----CTTQIIHCDIKPQ 636 (797)
Q Consensus 593 ~~-----------------l~~~~----~l~~~~~~-~i~---------~~ia~gL~~LH~~-----~~~~ivH~Dlkp~ 636 (797)
.. |+... +++...+. ... ..+...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 32 01111 11111111 111 0111112222211 1235899999999
Q ss_pred CEEEcCCCcEEEEeecCccc
Q 003759 637 NILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 637 NILl~~~~~~kl~Dfgla~~ 656 (797)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0089 Score=61.43 Aligned_cols=75 Identities=21% Similarity=0.167 Sum_probs=44.6
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeecccCCch
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
.|..|-...+|+.....+++..+++|....... ..-+...|+.++..+....+ .++++.+. ..++|||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 466777789998765421123478887654321 11233468888888844333 34444332 2479999998776
Q ss_pred h
Q 003759 592 A 592 (797)
Q Consensus 592 ~ 592 (797)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0053 Score=65.58 Aligned_cols=137 Identities=15% Similarity=0.121 Sum_probs=82.1
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhcccc------cccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGFC------NEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~E 584 (797)
.|..|....+|+.... ++ .+++|+... ....+...|++++..+.+.. +.+++... ..++..+++++
T Consensus 21 ~i~~G~~n~~y~v~~~--~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 21 GISAGIENTNYFVTTD--SG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred cccCccccceEEEEeC--CC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4677777899986543 22 478888764 23455677888887774332 44444321 22345689999
Q ss_pred cccCCchhhh----c----------cc---C---C-----CCChhhHH----------HHHHHHHHHHHHHhhc----CC
Q 003759 585 FISNGCLAGF----L----------FK---N---P-----KPSWYRRM----------QIAFGIARGLFYLHEE----CT 625 (797)
Q Consensus 585 y~~~gsL~~~----l----------~~---~---~-----~l~~~~~~----------~i~~~ia~gL~~LH~~----~~ 625 (797)
|+++..+... . +. . . ...|.... .....+..++.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998775420 0 00 0 0 01121111 0111233445555531 23
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 626 TQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 626 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
.+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.038 Score=59.14 Aligned_cols=138 Identities=24% Similarity=0.194 Sum_probs=78.2
Q ss_pred hCcccceeEEEEEEecC-----CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeeccc
Q 003759 514 LGRGAFATVHKGVLAYE-----NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|..|--..+|+.....+ .+..+++|+..... ....+...|.+++..+....+ .++++++.. .+|+||++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 44555668888765431 12357888865532 222355678888887743333 344555432 35899998
Q ss_pred CCchhhhc-----------------ccCC-C--------CC--hhhHHH--------------------------HHHHH
Q 003759 588 NGCLAGFL-----------------FKNP-K--------PS--WYRRMQ--------------------------IAFGI 613 (797)
Q Consensus 588 ~gsL~~~l-----------------~~~~-~--------l~--~~~~~~--------------------------i~~~i 613 (797)
+..+.... ++.. . .+ +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 87764311 1110 0 00 101000 01112
Q ss_pred HHHHHHHhh------cCCCCeeecCCCCCCEEEcCC----CcEEEEeecCccc
Q 003759 614 ARGLFYLHE------ECTTQIIHCDIKPQNILLDDS----FTARISDFGLAKI 656 (797)
Q Consensus 614 a~gL~~LH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~ 656 (797)
...+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 222334432 134578999999999999985 8899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.1 Score=56.07 Aligned_cols=138 Identities=14% Similarity=0.152 Sum_probs=79.0
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhcccc------cccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGFC------NEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~E 584 (797)
.++.|--..+|+.... ++ .+++|+.... ....+...|++++..+.... +.+++... ...+..++++|
T Consensus 29 ~~~~G~~n~~y~v~t~--~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 29 GIAEGVENSNYLLTTD--VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccCCccccceEEEEeC--CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 4667766889986542 33 3677876542 12345556777777663222 34444321 22356789999
Q ss_pred cccCCchhhh--------------cccC-CC-----------CChhhHH------------HHHHHHHHHHHHHhh----
Q 003759 585 FISNGCLAGF--------------LFKN-PK-----------PSWYRRM------------QIAFGIARGLFYLHE---- 622 (797)
Q Consensus 585 y~~~gsL~~~--------------l~~~-~~-----------l~~~~~~------------~i~~~ia~gL~~LH~---- 622 (797)
|+++..+... ++.. .. ..|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 0100 00 1111100 011123344555543
Q ss_pred cCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 623 ~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
....+++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.09 Score=56.76 Aligned_cols=31 Identities=26% Similarity=0.399 Sum_probs=26.7
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..+++|+|+++.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3479999999999999977666899999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.044 Score=57.95 Aligned_cols=71 Identities=17% Similarity=0.237 Sum_probs=45.1
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC---cCchhhhcccccccCceeeeeecccCC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
.|+.|....+|+.. .++..+.||.-.. .....|..|++-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 24 ~v~GG~i~~a~~~~---~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLD---TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEE---TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEE---CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 47878888888765 3344689998762 33457888988888883 455778888887777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.017 Score=60.31 Aligned_cols=134 Identities=13% Similarity=0.066 Sum_probs=82.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-----ch-----------------HHHHHHHHHhhccC-cC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-----GD-----------------KEFRTEVNAIGQTN-HR 564 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-----~~-----------------~~f~~E~~~l~~l~-h~ 564 (797)
+.+.+.||-|.=+.||.+....++ +.++|.-+-.... .. -...+|...|+.+. |.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~--~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGN--PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCCCC--chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456788999999999999876544 3555543210000 00 01245666666663 22
Q ss_pred -chhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 565 -NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 565 -niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
-+.+.++ -+..++|||++.+-.|...-+-.. ..+ +...+..-+.-|-.+ |+||+|..-=||+++++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d---~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHVED---PPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeecCC---hHH---HHHHHHHHHHHHHHc---CceecccchheeEEecC
Confidence 1223333 346689999998888766542221 122 222222233344444 99999999999999999
Q ss_pred CcEEEEeecCccc
Q 003759 644 FTARISDFGLAKI 656 (797)
Q Consensus 644 ~~~kl~Dfgla~~ 656 (797)
..++++||-....
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999975543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.11 Score=54.89 Aligned_cols=31 Identities=32% Similarity=0.610 Sum_probs=25.7
Q ss_pred CCeeecCCCCCCEEEcCCCc-EEEEeecCccc
Q 003759 626 TQIIHCDIKPQNILLDDSFT-ARISDFGLAKI 656 (797)
Q Consensus 626 ~~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~ 656 (797)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.17 Score=55.15 Aligned_cols=138 Identities=19% Similarity=0.153 Sum_probs=77.4
Q ss_pred hCcccceeEEEEEEecC---CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchh-hhcccccccCceeeeeecccCC
Q 003759 514 LGRGAFATVHKGVLAYE---NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLV-KLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
|-.|-.-.+|+.....+ ....|++|........ .-+-.+|..++..+...++. ++++.+..+ .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44466678888765322 1245888877654322 11236688888888544443 455655433 579999877
Q ss_pred chhhh-----------------cccCC----C-CC-hhhHHHHHH-----------------HHHHHHHHHhh-----cC
Q 003759 590 CLAGF-----------------LFKNP----K-PS-WYRRMQIAF-----------------GIARGLFYLHE-----EC 624 (797)
Q Consensus 590 sL~~~-----------------l~~~~----~-l~-~~~~~~i~~-----------------~ia~gL~~LH~-----~~ 624 (797)
+|... ++... . .. +.+..++.. .+...+..|.+ ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 11111 0 11 222212211 11222222221 12
Q ss_pred CCCeeecCCCCCCEEEcC-CCcEEEEeecCccc
Q 003759 625 TTQIIHCDIKPQNILLDD-SFTARISDFGLAKI 656 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~ 656 (797)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 46899999988763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.23 Score=54.69 Aligned_cols=72 Identities=14% Similarity=0.156 Sum_probs=46.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC-------CchHHHHHHHHHhhccC---cCchhhhcccccccCceee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-------GGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 581 (797)
+.||.|....||+.... + ..++||+-..... .....-..|++.|..+. ..++.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~~--~-~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS--S-GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEcC--C-ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 46899999999997653 2 2488998753221 12223333466665552 357778888887 44678
Q ss_pred eeecccC
Q 003759 582 VYEFISN 588 (797)
Q Consensus 582 V~Ey~~~ 588 (797)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.29 Score=52.18 Aligned_cols=108 Identities=19% Similarity=0.313 Sum_probs=65.8
Q ss_pred HHHHHHHHHhhccC--cCchhhhcccccccC--ceeeeeecccCCchhhhcccCCC------------------------
Q 003759 549 KEFRTEVNAIGQTN--HRNLVKLLGFCNEDQ--HRLLVYEFISNGCLAGFLFKNPK------------------------ 600 (797)
Q Consensus 549 ~~f~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~------------------------ 600 (797)
.....|..+++.+. -.-+.+.+++|.++. ..+.||+|.++..+.+.+.....
T Consensus 66 ~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~ 145 (321)
T COG3173 66 HDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGL 145 (321)
T ss_pred hHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCC
Confidence 34566777777663 233455677887776 77999999998433222211000
Q ss_pred --------------CChhhHHHHH--------HHHHHHHHHHhhcC-----CCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 601 --------------PSWYRRMQIA--------FGIARGLFYLHEEC-----TTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 601 --------------l~~~~~~~i~--------~~ia~gL~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
-.|....+.+ -....-..+|++.. .+.++|+|+++.||+++++.-+=|.||++
T Consensus 146 ~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~ 225 (321)
T COG3173 146 PDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWEL 225 (321)
T ss_pred CCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccc
Confidence 0011111100 12233344555442 35799999999999999998899999999
Q ss_pred ccc
Q 003759 654 AKI 656 (797)
Q Consensus 654 a~~ 656 (797)
+..
T Consensus 226 ~~l 228 (321)
T COG3173 226 ATL 228 (321)
T ss_pred ccc
Confidence 875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.12 Score=51.15 Aligned_cols=152 Identities=15% Similarity=0.121 Sum_probs=90.0
Q ss_pred cceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCchhhhcc
Q 003759 518 AFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596 (797)
Q Consensus 518 ~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~ 596 (797)
+..+.-++.-..+ +..+|++...... ...-|..+.+++++++ .|+++..- ..-..-++.|++-.-
T Consensus 74 gNsTl~~~kt~iG---~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIG---PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------- 139 (308)
T ss_pred CceEEEEeccccc---hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-------
Confidence 3444444443332 2567777643333 4556788888888774 45555522 223445778877321
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccc
Q 003759 597 KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676 (797)
Q Consensus 597 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 676 (797)
.... ..++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.... .+..|.-
T Consensus 140 -----~i~~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN 199 (308)
T PF07387_consen 140 -----KINF-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVN 199 (308)
T ss_pred -----ccch-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEe
Confidence 0111 12222224667778865 45899999999999999999999999774321 1112222
Q ss_pred ccccccCCCCccCceehHHHHHHHHHhCCc
Q 003759 677 PEWFKSLPITMKVDIYSFGVMLLELICCRK 706 (797)
Q Consensus 677 PE~~~~~~~t~~sDVwS~Gvll~elltG~~ 706 (797)
-| ....|+++.+-+|=.-+++++....
T Consensus 200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 200 IE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred ee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11 2235777888888777787776443
|
The function of this family is unknown. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.0069 Score=74.29 Aligned_cols=155 Identities=12% Similarity=-0.001 Sum_probs=108.2
Q ss_pred HHHHHhhccCcCchhhhccccc--ccCceeeeeecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcC--
Q 003759 553 TEVNAIGQTNHRNLVKLLGFCN--EDQHRLLVYEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEEC-- 624 (797)
Q Consensus 553 ~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~-- 624 (797)
.|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+-+. +.+...-......+......-+|...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3445555567887776554332 334668899999999999988644 22222222222233244444444432
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhC
Q 003759 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC 704 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG 704 (797)
..-.+|+++|+-|.+|..+..+|++++|+.+...+... ......+++-|++|+......++.++|+|..|+.+|+.--|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 23468999999999999999999999999984333322 22334478889999999888999999999999999998887
Q ss_pred CcCC
Q 003759 705 RKKF 708 (797)
Q Consensus 705 ~~p~ 708 (797)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7766
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.23 Score=53.73 Aligned_cols=73 Identities=19% Similarity=0.169 Sum_probs=44.4
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCC-------CchHHHHHHHHHhhccC--cCc-hhhhcccccccCceeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-------GGDKEFRTEVNAIGQTN--HRN-LVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~--h~n-iv~l~g~~~~~~~~~lV 582 (797)
+||.|...-||++..+. ++..|+||.-....+ -..+...-|.+.|.... .|. +.+++.| +++...+|
T Consensus 2 EigdGnlN~VfrV~~~~-g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCC-CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 58999999999998753 224589987643221 12234445666665542 343 3334433 44556789
Q ss_pred eecccC
Q 003759 583 YEFISN 588 (797)
Q Consensus 583 ~Ey~~~ 588 (797)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.31 Score=52.28 Aligned_cols=30 Identities=30% Similarity=0.370 Sum_probs=25.9
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..+++|+|+++.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357999999999999988 578899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.16 Score=54.85 Aligned_cols=60 Identities=17% Similarity=0.171 Sum_probs=41.5
Q ss_pred eeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 003759 579 RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD 641 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~ 641 (797)
..|+-+|+++-++..++..... ++..+.+++.-.++|+.-+-.- ...+|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~-pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQ-PEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcccC-hHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 3567778888888888865433 3345556666556665544332 3799999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 797 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-53 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-122
Identities = 121/305 (39%), Positives = 183/305 (60%), Gaps = 10/305 (3%)
Query: 484 DQTGPVMPSTNLQIFSYKELEKATQGFKDE--LGRGAFATVHKGVLAYENKICVAVKKL- 540
+ P + L+ FS +EL+ A+ F ++ LGRG F V+KG L + VAVK+L
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLK 63
Query: 541 DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPK 600
+ GG+ +F+TEV I HRNL++L GFC RLLVY +++NG +A L + P+
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 601 PS----WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656
W +R +IA G ARGL YLH+ C +IIH D+K NILLD+ F A + DFGLAK+
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQN-VENE 715
+ T TTA+RGT G++APE+ + + K D++ +GVMLLELI ++ F+ + N+
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
+ ++L+DW ++KL LV+ D + + +++ + +A+ C Q P RP M +V
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 776 LMLEG 780
MLEG
Sbjct: 304 RMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-109
Identities = 105/306 (34%), Positives = 167/306 (54%), Gaps = 13/306 (4%)
Query: 486 TGPVMPSTNLQIFSYKELEKATQGFKDE--LGRGAFATVHKGVLAYENKICVAVKKLDNM 543
+ + +LE+AT F + +G G F V+KGVL + VA+K+
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPE 74
Query: 544 VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-- 601
S G +EF TE+ + H +LV L+GFC+E +L+Y+++ NG L L+ + P
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134
Query: 602 --SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI-LK 658
SW +R++I G ARGL YLH IIH D+K NILLD++F +I+DFG++K +
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 659 ADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
DQT +T ++GT GY+ PE+F +T K D+YSFGV+L E++C R Q++ E +
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MV 250
Query: 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
L +WA + + + +L +V+ + L+K+ A+ C+ RP+M V L
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
Query: 779 EGVVEV 784
E + +
Sbjct: 311 EYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-109
Identities = 111/319 (34%), Positives = 159/319 (49%), Gaps = 46/319 (14%)
Query: 490 MPSTNLQIFSYKELEKATQGFKDE--------LGRGAFATVHKGVLAYENKICVAVKKLD 541
+ T FS+ EL+ T F + +G G F V+KG + N VAVKKL
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTT-VAVKKLA 63
Query: 542 NMVSG----GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF- 596
MV ++F E+ + + H NLV+LLGF ++ LVY ++ NG L L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 597 -KNPKP-SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
P SW+ R +IA G A G+ +LHE IH DIK NILLD++FTA+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 655 KIL-KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
+ K QT T+ I GT Y+APE + IT K DIYSFGV+LLE+I +++ E
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 714 NENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM--RLKKY--------VMIAIWCIQE 763
+ L+D + +EK + D + ++ +A C+ E
Sbjct: 240 PQL---LLDIKEEIEDEEK----------TIEDYIDKKMNDADSTSVEAMYSVASQCLHE 286
Query: 764 DPSLRPTMKKVTLMLEGVV 782
+ RP +KKV +L+ +
Sbjct: 287 KKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 7e-70
Identities = 75/307 (24%), Positives = 118/307 (38%), Gaps = 31/307 (10%)
Query: 498 FSYKELEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEV 555
+ L + + + RG F V K L E VAVK + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY---VAVKIFP-IQDKQSWQNEYEV 69
Query: 556 NAIGQTNHRNLVKLLGFCNEDQH----RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF 611
++ H N+++ +G L+ F G L+ FL N SW IA
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAE 128
Query: 612 GIARGLFYLHEECTTQ-------IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR- 663
+ARGL YLHE+ I H DIK +N+LL ++ TA I+DFGLA +A ++
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 664 TTTAIRGTRGYVAPE-----WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
T GTR Y+APE +++D+Y+ G++L EL + V+ E +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYML 247
Query: 719 ILVDWAYDCYIDEKLHLLVEND------EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
+ E + +V + + + C D R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 773 KVTLMLE 779
V +
Sbjct: 308 CVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-62
Identities = 80/319 (25%), Positives = 147/319 (46%), Gaps = 34/319 (10%)
Query: 480 KTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK 539
T+ M ++ I + +L K+++G G+F TVH+ + VAVK
Sbjct: 17 TTENLYFQGAMDGDDMDI-PWCDLN-----IKEKIGAGSFGTVHRAE--WHGSD-VAVKI 67
Query: 540 L--DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK 597
L + + EF EV + + H N+V +G + + +V E++S G L L K
Sbjct: 68 LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127
Query: 598 N---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
+ + RR+ +A+ +A+G+ YLH I+H ++K N+L+D +T ++ DFGL+
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714
++ KA ++ + GT ++APE + P K D+YSFGV+L EL ++ + N+
Sbjct: 187 RL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLNP 244
Query: 715 ENQMILVDWAYDCYIDEKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773
+ V + L + N + ++ C +P RP+
Sbjct: 245 AQVVAAV-------GFKCKRLEIPRNLNPQVAAIIE---------GCWTNEPWKRPSFAT 288
Query: 774 VTLMLEGVVEVPIPPDPSS 792
+ +L +++ +PP S
Sbjct: 289 IMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 85/306 (27%), Positives = 140/306 (45%), Gaps = 38/306 (12%)
Query: 494 NLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT 553
+L + YKE+E ++ +GRGAF V K + K VA+K++++ K F
Sbjct: 1 SLHMIDYKEIE-----VEEVVGRGAFGVVCKAK--WRAKD-VAIKQIES--ESERKAFIV 50
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN---PKPSWYRRMQIA 610
E+ + + NH N+VKL G C LV E+ G L L P + M
Sbjct: 51 ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT-ARISDFGLAKILKADQTRTTTAIR 669
++G+ YLH +IH D+KP N+LL T +I DFG A D T +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNK 164
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
G+ ++APE F+ + K D++S+G++L E+I RK F+ E + WA +
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWA----V 217
Query: 730 DEKLHL-LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV-VEVPIP 787
L++N + + +M C +DPS RP+M+++ ++ + P
Sbjct: 218 HNGTRPPLIKNLPKPIESLMT---------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
Query: 788 PDPSSF 793
+P +
Sbjct: 269 DEPLQY 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-58
Identities = 76/313 (24%), Positives = 134/313 (42%), Gaps = 48/313 (15%)
Query: 487 GPVM----PSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDN 542
G + P + L + E+E ++ ++G+G F VHKG L + + VA+K L
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV-VAIKSLIL 54
Query: 543 MVSGGD-------KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL 595
S G+ +EF+ EV + NH N+VKL G + +V EF+ G L L
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL 112
Query: 596 FKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-----FTARIS 649
P W ++++ IA G+ Y+ I+H D++ NI L A+++
Sbjct: 113 LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 650 DFGLAKILKADQTRTTTAIRGTRGYVAPEWF--KSLPITMKVDIYSFGVMLLELICCRKK 707
DFGL++ + + + G ++APE + T K D YSF ++L ++
Sbjct: 172 DFGLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 708 FEQNVENENQMILVDWAYDCYIDEKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPS 766
F++ + ++ ++ +E L + E+ L +++ L C DP
Sbjct: 228 FDE--YSYGKIKFINMI----REEGLRPTIPEDCPPRLRNVIEL---------CWSGDPK 272
Query: 767 LRPTMKKVTLMLE 779
RP + L
Sbjct: 273 KRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 4e-56
Identities = 73/338 (21%), Positives = 118/338 (34%), Gaps = 47/338 (13%)
Query: 498 FSYKELEKATQGFKDE--LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEV 555
+ E K +GRG + V+KG L VAVK + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP---VAVKVFS---FANRQNFINEK 56
Query: 556 NAIGQT---NHRNLVKLLGFCNED-----QHRLLVYEFISNGCLAGFLFKNPKPSWYRRM 607
I + H N+ + + LLV E+ NG L +L + W
Sbjct: 57 -NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSC 114
Query: 608 QIAFGIARGLFYLHEECTT------QIIHCDIKPQNILLDDSFTARISDFGLAKIL---- 657
++A + RGL YLH E I H D+ +N+L+ + T ISDFGL+ L
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 658 ---KADQTRTTTAIRGTRGYVAPEWFKSL-------PITMKVDIYSFGVMLLELIC-CRK 706
++ + GT Y+APE + +VD+Y+ G++ E+ C
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 707 KFEQNVENENQMILVDWAYDCYIDEKLHLLVEND-------EEALHDMMRLKKYVMIAIW 759
F E QM + E + +LV + E + + ++
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 760 CIQEDPSLRPTMKKVTLMLEGVV-EVPIPPDPSSFISS 796
C +D R T + + ++ S
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-56
Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 42/293 (14%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL----DNMVSGGDKEFRTEV 555
+ EL ++ +G G F V++ + VAVK D +S + R E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAF--WIGDE-VAVKAARHDPDEDISQTIENVRQEA 57
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR 615
H N++ L G C ++ + LV EF G L L + + A IAR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIAR 116
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSF--------TARISDFGLAKILKADQTRTTTA 667
G+ YLH+E IIH D+K NIL+ +I+DFGLA+ T+ + A
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAA 175
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
G ++APE ++ + D++S+GV+L EL+ F ++ V
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGV------ 226
Query: 728 YIDEKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
KL L + E +M C DP RP+ + L
Sbjct: 227 -AMNKLALPIPSTCPEPFAKLME---------DCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 65/300 (21%), Positives = 115/300 (38%), Gaps = 38/300 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ LG+G F K ++ + +K+L + F EV + H N++K
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEV-MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
+G +D+ + E+I G L G + W +R+ A IA G+ YLH I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKIL-------------KADQTRTTTAIRGTRGYV 675
IH D+ N L+ ++ ++DFGLA+++ K + + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735
APE KVD++SFG++L E+I + ++ + L
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDFGLN------VRGFLDR 242
Query: 736 LVEND-EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV---VEVPIPPDPS 791
+ + + C DP RP+ K+ LE + + +P P
Sbjct: 243 YCPPNCPPSFFPITV---------RCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-52
Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+G G+F TV+KG + VAVK L + F+ EV + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGK--WHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFL-FKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
+G+ +V ++ L L K + + IA ARG+ YLH +
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRTTTAIRGTRGYVAPEWFK---S 682
IIH D+K NI L + T +I DFGLA + + G+ ++APE + S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
P + + D+Y+FG++L EL+ + + N+ N +Q+I + + L + N +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEM--VGRGSLSPDLSKVRSNCPK 256
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ +M C+++ RP+ ++ +E
Sbjct: 257 RMKRLMA---------ECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 45/296 (15%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNA 557
+++LE + +G+G F V+ G E VA++ + + K F+ EV A
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-FKNPKPSWYRRMQIAFGIARG 616
QT H N+V +G C H ++ L + + QIA I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK----ADQTRTTTAIRGTR 672
+ YLH + I+H D+K +N+ D+ I+DFGL I + G
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 673 GYVAPEWFKS---------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723
++APE + LP + D+++ G + EL F+ + I
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAI---- 251
Query: 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ K +L + + D++ +C + RPT K+ MLE
Sbjct: 252 IWQMGTGMKPNLSQIGMGKEISDILL---------FCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 42/290 (14%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD--KEFRTEVNA 557
+K+L F +L + KG ++ + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGR--WQGND-IVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 558 IGQTNHRNLVKLLGFCNE--DQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGI 613
+ +H N++ +LG C H L+ ++ G L L + + ++ A +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
ARG+ +LH I + +++++D+ TARIS + + +
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 674 YVAPEWFKSLP---ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730
+VAPE + P D++SF V+L EL+ F ++ N + V
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKV-------AL 225
Query: 731 EKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E L + + +M++ C+ EDP+ RP + +LE
Sbjct: 226 EGLRPTIPPGISPHVSKLMKI---------CMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 39/298 (13%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT---NHRNL 566
++G+G + V G E VAVK + + + E I QT H N+
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK---VAVKVFF---TTEEASWFRET-EIYQTVLMRHENI 93
Query: 567 VKLLGFCNEDQHR----LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
+ + + L+ ++ NG L +L K+ +++A+ GL +LH
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 623 ECTTQ-----IIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTRGY 674
E + I H D+K +NIL+ + T I+D GLA + GT+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 675 VAPE------WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE---NQMILVDWAY 725
+ PE + D+YSFG++L E+ E + + ++ D +Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 726 DCYID----EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ + +KL N + + ++ K + C +P+ R T +V L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGK---LMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-45
Identities = 64/295 (21%), Positives = 107/295 (36%), Gaps = 33/295 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTE--VNAIGQTNHRNLV 567
++ +G+G F V +G E VAVK S ++ + E + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE---VAVKIFS---SREERSWFREAEIYQTVMLRHENIL 99
Query: 568 KLLGFC----NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ LV ++ +G L +L + +++A A GL +LH E
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 624 CTTQ-----IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI---RGTRGYV 675
I H D+K +NIL+ + T I+D GLA + A GT+ Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 676 APE------WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
APE K + DIY+ G++ E I R E+ D +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 730 DEKLHLLVENDE-----EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+E ++ E L+ I C + + R T ++ L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 37/297 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR--TEVNAIGQTNHRNLV 567
+ +G+G + V +G EN VAVK S +K + TE+ H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQGEN---VAVKIFS---SRDEKSWFRETELYNTVMLRHENIL 65
Query: 568 KLLGFCNEDQHR----LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ +H L+ + G L +L + ++I IA GL +LH E
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 624 CTTQ-----IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR---TTTAIRGTRGYV 675
I H D+K +NIL+ + I+D GLA + + GT+ Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 676 APEWFKSLPI------TMKVDIYSFGVMLLELICCRKKFEQNVENE---NQMILVDWAYD 726
APE +VDI++FG++L E+ + + ++ D +++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 727 CYID----EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
++ + N + + L K +M W ++PS R T ++ L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECW--YQNPSARLTALRIKKTLT 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-39
Identities = 63/323 (19%), Positives = 115/323 (35%), Gaps = 45/323 (13%)
Query: 478 YHKTKMD--QTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICV 535
+ + + L +++GRG F V G L + V
Sbjct: 84 HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLV 142
Query: 536 AVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGF 594
AVK + + +F E + Q +H N+V+L+G C + Q +V E + G F
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 595 LFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653
L + +Q+ A G+ YL + IH D+ +N L+ + +ISDFG+
Sbjct: 203 LRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 654 AKILKADQ-TRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF 708
++ + ++ T APE + + D++SFG++L E
Sbjct: 260 SREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 709 EQNVENENQMILVDWAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQ 762
N+ N+ V+ C +A+ +M C
Sbjct: 316 YPNLSNQQTREFVEKGGRLPCPELC-------------PDAVFRLME---------QCWA 353
Query: 763 EDPSLRPTMKKVTLMLEGVVEVP 785
+P RP+ + L+ + +
Sbjct: 354 YEPGQRPSFSTIYQELQSIRKRH 376
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-37
Identities = 68/303 (22%), Positives = 129/303 (42%), Gaps = 39/303 (12%)
Query: 487 GPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMV 544
+ E+E+ K +LG G + V++GV + + VAVK K D M
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME 259
Query: 545 SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY 604
+EF E + + H NLV+LLG C + ++ EF++ G L +L + +
Sbjct: 260 V---EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 605 RR--MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662
+ +A I+ + YL ++ IH ++ +N L+ ++ +++DFGL++++ D
Sbjct: 317 AVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373
Query: 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVD 722
+ + APE ++K D+++FGV+L E+ ++ L++
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
Query: 723 WAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
Y C E ++++MR C Q +PS RP+ ++
Sbjct: 434 KDYRMERPEGC-------------PEKVYELMR---------ACWQWNPSDRPSFAEIHQ 471
Query: 777 MLE 779
E
Sbjct: 472 AFE 474
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 41/280 (14%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+ +LG+G F V G + VA+K K M + F E + + H LV
Sbjct: 188 LEVKLGQGCFGEVWMGT--WNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 242
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECT 625
+L +E + +V E++S G L FL + + +A IA G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
+H D++ NIL+ ++ +++DFGLA++++ ++ + + APE
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVEN 739
T+K D++SFG++L EL + + N + V+ Y +C
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------------ 406
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E+LHD+M C +++P RPT + + LE
Sbjct: 407 -PESLHDLMC---------QCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-36
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 41/290 (14%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+ +LG+G F V G + VA+K K M + F E + + H LV
Sbjct: 271 LEVKLGQGCFGEVWMGT--WNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 325
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECT 625
+L +E + +V E++S G L FL + + +A IA G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 382
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
+H D++ NIL+ ++ +++DFGLA++++ ++ + + APE
Sbjct: 383 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVEN 739
T+K D++SFG++L EL + + N + V+ Y +C
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------------ 489
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
E+LHD+M C +++P RPT + + LE P
Sbjct: 490 -PESLHDLMC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 41/309 (13%)
Query: 510 FKDELGRGAFATVHKGV---LAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
+ +LG+G F +V L VAVK+L + ++F+ E+ + + +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 567 VKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEE 623
VK G + LV E++ +GCL FL ++ + R + + I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---TRTTTA---IRGTRGYVAP 677
+ +H D+ +NIL++ +I+DFGLAK+L D+ I AP
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----AP 199
Query: 678 EWFKSLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
E + + D++SFGV+L EL C K + E M D +L L
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM---GCERDVPALSRLLEL 256
Query: 737 VENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787
+E + +H++M+L C P RP+ + L+ +
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKL---------CWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 788 PDPSSFISS 796
+ +F +
Sbjct: 308 CETHAFTAH 316
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 30/272 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEF-RTEVNAIGQTNHRNLVK 568
++GRG F+ V++ + A+KK + +++ + E++ + Q NH N++K
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPV-ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY----RRMQIAFGIARGLFYLHEEC 624
ED +V E G L+ + K + + L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+++H DIKP N+ + + ++ D GL + + T + + GT Y++PE
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH--LLVENDEE 742
K DI+S G +L E+ + F + N + I++ + L ++ E
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------KIEQCDYPPLPSDHYSE 265
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
L ++ CI DP RP + V
Sbjct: 266 ELRQLVN---------MCINPDPEKRPDVTYV 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 36/302 (11%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVL---AYENKICVAVKKLDNMVSGGD-KEFRTEVNA 557
EK +LG G F V VAVK L G + + E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 558 IGQTNHRNLVKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIA 614
+ H N+VK G C ED L+ EF+ +G L +L KN K + ++++ A I
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
+G+ YL Q +H D+ +N+L++ +I DFGL K ++ D+ T
Sbjct: 137 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSP 192
Query: 675 V---APEWFKSLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVDWAYDCYID 730
V APE + D++SFGV L EL+ C + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI---GPTHGQMTV 249
Query: 731 EKLHLLVENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781
+L ++ + + ++ +MR C + PS R + + + E +
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRK---------CWEFQPSNRTSFQNLIEGFEAL 300
Query: 782 VE 783
++
Sbjct: 301 LK 302
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 71/302 (23%), Positives = 139/302 (46%), Gaps = 46/302 (15%)
Query: 501 KELEKATQGFKDELGRGAFATVHKGVL---AYENKICVAVKKL-DNMVSGGDKEFRTEVN 556
E+ + + +G G F V+KG+L + + ++ VA+K L +F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIAR 615
+GQ +H N+++L G ++ + +++ E++ NG L FL + + S + + + GIA
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA------IR 669
G+ YL +H D+ +NIL++ + ++SDFGL+++L+ D T T IR
Sbjct: 159 GMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY---- 725
T APE T D++SFG+++ E++ ++ + N M ++ +
Sbjct: 216 WT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271
Query: 726 --DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
DC A++ +M + C Q++ + RP + +L+ ++
Sbjct: 272 PMDC-------------PSAIYQLM---------MQCWQQERARRPKFADIVSILDKLIR 309
Query: 784 VP 785
P
Sbjct: 310 AP 311
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 72/322 (22%), Positives = 141/322 (43%), Gaps = 46/322 (14%)
Query: 480 KTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVL--AYENKICVAV 537
+ + P + F+ +E+E + + +G G V G L + + VA+
Sbjct: 24 QFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 538 KKL-DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596
K L ++F +E + +GQ +H N+++L G + ++V E++ NG L FL
Sbjct: 83 KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 597 KN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655
+ + + + + + G+ G+ YL + +H D+ +N+L+D + ++SDFGL++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 656 ILKADQTRTTTA------IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709
+L+ D T IR T APE + D++SFGV++ E++ ++
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
Query: 710 QNVENENQMILVDWAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQE 763
N+ N + + V+ Y C ALH +M C +
Sbjct: 256 WNMTNRDVISSVEEGYRLPAPMGC-------------PHALHQLML---------DCWHK 293
Query: 764 DPSLRPTMKKVTLMLEGVVEVP 785
D + RP ++ +L+ ++ P
Sbjct: 294 DRAQRPRFSQIVSVLDALIRSP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 32/296 (10%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGV---LAYENKICVAVKKLDNMVSGGDKEFRTEVNAI 558
+ E+ F +LG+G F +V L VAVKKL + ++F E+ +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 559 GQTNHRNLVKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIAR 615
H N+VK G C R L+ E++ G L +L K+ + + +Q I +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
G+ YL + + IH D+ +NIL+++ +I DFGL K+L D+ +
Sbjct: 126 GMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPI 181
Query: 676 ---APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732
APE ++ D++SFGV+L EL +K + +MI D I
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFH 240
Query: 733 LHLLVENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L L++N+ + ++ +M C + + RP+ + + L ++
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTE---------CWNNNVNQRPSFRDLALRVD 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 67/301 (22%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYEN---KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRN 565
LG GAF TV+KG+ E KI VA+K+L + +KE E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+ +LLG C L+ + + GCL ++ ++ + IA+G+ YL +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA-----IRGTRGYVAPEW 679
++H D+ +N+L+ +I+DFGLAK+L A++ I+ A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALES 190
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKL 733
T + D++S+GV + EL+ K + +++ C ID
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID--- 247
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSF 793
++ +MR C D RP +++ + + DP +
Sbjct: 248 ----------VYMIMR---------KCWMIDADSRPKFRELIIEFSKMAR-----DPQRY 283
Query: 794 I 794
+
Sbjct: 284 L 284
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 47/283 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
ELG G F V G ++ + VAVK K +M + EF E + + +H LV
Sbjct: 12 LLKELGSGQFGVVKLGK--WKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLV 66
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTT 626
K G C+++ +V E+ISNGCL +L + + +++ + + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--- 123
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGYVAPEWFKS 682
Q IH D+ +N L+D ++SDFG+ + + DQ ++ ++ + APE F
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHY 179
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLL 736
+ K D+++FG+++ E+ K N ++ V +
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA--------- 230
Query: 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ ++ +M C E P RPT +++ +E
Sbjct: 231 ----SDTIYQIMY---------SCWHELPEKRPTFQQLLSSIE 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 58/293 (19%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIG 559
+KE+E +G G F V K + K +K+ V +++ EV A+
Sbjct: 13 FKEIEL--------IGSGGFGQVFKAKHRIDGKT-YVIKR----VKYNNEKAEREVKALA 59
Query: 560 QTNHRNLVKLLGFCNEDQHRL----------------LVYEFISNGCLAGFLFKNPKPSW 603
+ +H N+V G + + + EF G L ++ K
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 604 YRR--MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661
+ +++ I +G+ Y+H + ++I+ D+KP NI L D+ +I DFGL LK D
Sbjct: 120 DKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
RT + GT Y++PE S +VD+Y+ G++L EL+ + ++ L
Sbjct: 177 KRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232
Query: 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
D D+K L++ + + P RP ++
Sbjct: 233 DGIISDIFDKKEKTLLQ--------------------KLLSKKPEDRPNTSEI 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 28/268 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
F E+GRG+F TV+KG L E + VA + + + F+ E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 568 KLLGFC---NEDQHRLLVY-EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ + + +++ E +++G L +L + I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 624 CTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
T IIH D+K NI + + +I D GLA + +A + + GT ++APE ++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
VD+Y+FG+ +LE+ + +N Q+ + K +
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTS-----GVKPASFDKVAIP 257
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
+ +++ CI+++ R +
Sbjct: 258 EVKEIIEG---------CIRQNKDERYS 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 32/288 (11%)
Query: 510 FKDELGRGAFATVHKGV---LAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
F +LG+G F +V L VAVKKL + ++F E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 567 VKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEE 623
VK G C R L+ E++ G L +L K+ + + +Q I +G+ YL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV---APEWF 680
+ IH D+ +NIL+++ +I DFGL K+L D+ + APE
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPESL 220
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740
++ D++SFGV+L EL +K + +MI D I L L++N+
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKNN 279
Query: 741 E---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ ++ +M C + + RP+ + + L ++
Sbjct: 280 GRLPRPDGCPDEIYMIMTE---------CWNNNVNQRPSFRDLALRVD 318
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 74/298 (24%), Positives = 139/298 (46%), Gaps = 39/298 (13%)
Query: 501 KELEKATQGFKDELGRGAFATVHKGVL--AYENKICVAVKKL-DNMVSGGDKEFRTEVNA 557
KEL+ +G G F V G L + +I VA+K L ++F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 558 IGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARG 616
+GQ +H N+++L G + + ++V E++ NG L FL K+ + + + + + GIA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV- 675
+ YL + +H D+ +NIL++ + ++SDFGL ++L+ D RG + +
Sbjct: 160 MKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIR 215
Query: 676 --APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DC 727
+PE T D++S+G++L E++ ++ + N++ + VD Y DC
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
AL+ +M C Q+D + RP +++ +L+ ++ P
Sbjct: 276 -------------PAALYQLML---------DCWQKDRNNRPKFEQIVSILDKLIRNP 311
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 72/304 (23%), Positives = 114/304 (37%), Gaps = 42/304 (13%)
Query: 510 FKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRN 565
+LG G F V N VAVK L ++ E++ + H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 566 LVKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
++K G C + LV E++ G L +L + + A I G+ YLH +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTA----IRGTRGYVAP 677
IH D+ +N+LLD+ +I DFGLAK + R + AP
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206
Query: 678 EWFKSLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
E K D++SFGV L EL+ C + + + A +L L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI---AQGQMTVLRLTEL 263
Query: 737 VENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787
+E E ++ +M+ C + + S RPT + + +L+ V E
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKN---------CWETEASFRPTFENLIPILKTVHEKYQG 314
Query: 788 PDPS 791
PS
Sbjct: 315 QAPS 318
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 72/279 (25%), Positives = 115/279 (41%), Gaps = 39/279 (13%)
Query: 513 ELGRGAFATVHKGVLAYENK-ICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
ELG G F TV KG + VAVK K + E E N + Q ++ +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
+G C + +LV E G L +L +N +++ ++ G+ YL E +
Sbjct: 84 IGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFV 139
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV---APEWFKSLPIT 686
H D+ +N+LL A+ISDFGL+K L+AD+ A + V APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVEND 740
K D++SFGV++ E +K + ++ +++ C
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC------------- 245
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
++D+M L C D RP V L L
Sbjct: 246 PREMYDLMNL---------CWTYDVENRPGFAAVELRLR 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 47/298 (15%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIG 559
++ + F E+G G F VH G + NK VA+K + M +++F E +
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGY--WLNKDKVAIKTIREGAM---SEEDFIEEAEVMM 58
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLF 618
+ +H LV+L G C E LV EF+ +GCL+ +L + + + + G+
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGY 674
YL E +IH D+ +N L+ ++ ++SDFG+ + + DQ ++T ++
Sbjct: 119 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--- 172
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCY 728
+PE F + K D++SFGV++ E+ K +N N + + +
Sbjct: 173 -SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA- 230
Query: 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786
++ +M C +E P RP ++ L + E +
Sbjct: 231 ------------STHVYQIMNH---------CWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT 561
E++ F ELG G F V G + + VA+K + D EF E +
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 76
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYL 620
+H LV+L G C + + ++ E+++NGCL +L + + + +++ + + YL
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRTTTA---IRGTRGYVA 676
+ Q +H D+ +N L++D ++SDFGL++ + D+ T + + +R +
Sbjct: 137 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----P 189
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYID 730
PE + K DI++FGV++ E+ K + N +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA--- 246
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
E ++ +M C E RPT K + + V++
Sbjct: 247 ----------SEKVYTIMY---------SCWHEKADERPTFKILLSNILDVMD 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-34
Identities = 74/322 (22%), Positives = 135/322 (41%), Gaps = 54/322 (16%)
Query: 478 YHKTKMDQ-----TGPVMPSTNLQIFSYK--ELEKATQGFKDELGRGAFATVHKGVLAYE 530
++K D + P M S + + E+ + + + +LG G F V Y
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT--YN 210
Query: 531 NKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588
VAVK K +M + F E N + H LVKL ++ ++ EF++
Sbjct: 211 KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAK 266
Query: 589 GCLAGFLFKNPKPSWYRR--MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA 646
G L FL + + + IA G+ ++ + IH D++ NIL+ S
Sbjct: 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVC 323
Query: 647 RISDFGLAKILKADQTRTTTAIRGTRGYV---APEWFKSLPITMKVDIYSFGVMLLELIC 703
+I+DFGLA++++ ++ TA G + + APE T+K D++SFG++L+E++
Sbjct: 324 KIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
Query: 704 CRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIA 757
+ + N + ++ Y +C E L+++M
Sbjct: 381 YGRIPYPGMSNPEVIRALERGYRMPRPENC-------------PEELYNIMM-------- 419
Query: 758 IWCIQEDPSLRPTMKKVTLMLE 779
C + P RPT + + +L+
Sbjct: 420 -RCWKNRPEERPTFEYIQSVLD 440
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 44/290 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYENK--ICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNL 566
+G G F VH+G+ + VA+K + ++F E + Q +H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECT 625
VKL+G E ++ E + G L FL + A+ ++ L YL +
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGYVAPEWFK 681
+ +H DI +N+L+ + ++ DFGL++ ++ + I+ APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
T D++ FGV + E++ K Q V+N + + ++ +C
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-------- 242
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
L+ +M C DPS RP ++ L ++E
Sbjct: 243 -----PPTLYSLMTK---------CWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 32/289 (11%)
Query: 492 STNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDK 549
+ ++ +EK ++G G+F + + +K+ + M S +
Sbjct: 12 DLGTENLYFQSMEKYV--RLQKIGEGSFGKAILVKSTEDGRQ-YVIKEINISRMSSKERE 68
Query: 550 EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSW--YRRM 607
E R EV + H N+V+ E+ +V ++ G L + + + +
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
I L ++H+ +I+H DIK QNI L T ++ DFG+A++L +
Sbjct: 129 DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
I GT Y++PE ++ P K DI++ G +L EL + FE + LV
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE----AGSMKNLV------ 234
Query: 728 YIDEKLHLLVENDEEALHDMM--RLKKYVMIAIWCIQEDPSLRPTMKKV 774
++ + L+ V + +P RP++ +
Sbjct: 235 ------LKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE----FRTEVNAIGQTNHRNLV 567
D+LG G +TV+ N VA+K + +E F EV+ Q +H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPRE-KEETLKRFEREVHNSSQLSHQNIV 74
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
++ ED LV E+I L+ ++ + S + I G+ + H+ +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---R 131
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT-AIRGTRGYVAPEWFKSLPIT 686
I+H DIKPQNIL+D + T +I DFG+AK L ++ + T T + GT Y +PE K
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 687 MKVDIYSFGVMLLELICCRKKFE 709
DIYS G++L E++ F
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 61/290 (21%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYENK--ICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRNL 566
+G G F VH+G+ + VA+K + ++F E + Q +H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECT 625
VKL+G E+ ++ E + G L FL + A+ ++ L YL +
Sbjct: 454 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGYVAPEWFK 681
+ +H DI +N+L+ + ++ DFGL++ ++ + I+ APE
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
T D++ FGV + E++ K Q V+N + + ++ +C
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-------- 617
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
L+ +M C DPS RP ++ L ++E
Sbjct: 618 -----PPTLYSLMT---------KCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 45/284 (15%)
Query: 511 KDELGRGAFATVHKGVL-AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVK 568
ELG G F +V +GV + +I VA+K L D E E + Q ++ +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
L+G C + +LV E G L FL + ++ ++ G+ YL E+
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG------TRGYVAPEWFK 681
+H D+ +N+LL + A+ISDFGL+K L AD + T G APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
+ + D++S+GV + E + +K + ++ M ++ +C
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 238
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L+ +M C RP V +
Sbjct: 239 -----PPELYALMSD---------CWIYKWEDRPDFLTVEQRMR 268
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 68/297 (22%), Positives = 116/297 (39%), Gaps = 44/297 (14%)
Query: 490 MPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGG 547
MPS + Y+ L +G G++ K + KI V K+LD +M
Sbjct: 1 MPS---RAEDYEVLYT--------IGTGSYGRCQKIRRKSDGKILV-WKELDYGSMTEAE 48
Query: 548 DKEFRTEVNAIGQTNHRNLVKLLG-FCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWY- 604
+ +EVN + + H N+V+ + L +V E+ G LA + K K Y
Sbjct: 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 605 ---RRMQIAFGIARGLFYLHE--ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659
+++ + L H + ++H D+KP N+ LD ++ DFGLA+IL
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
D + T + GT Y++PE + K DI+S G +L EL F +Q
Sbjct: 169 DTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQKE 223
Query: 720 LVDWAYDCYIDEKLHLLVENDEEALHDMM--RLKKYVMIAIWCIQEDPSLRPTMKKV 774
L + E + L + + + RP+++++
Sbjct: 224 LA------------GKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEI 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 46/292 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYEN---KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRN 565
LG G F TVHKGV E KI V +K + D + + AIG +H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+V+LLG C LV +++ G L + ++ + IA+G++YL E
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA-----IRGTRGYVAPEW 679
++H ++ +N+LL +++DFG+A +L D + + I+ A E
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALES 188
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKL 733
T + D++S+GV + EL+ + + L++ C ID
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID--- 245
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
++ +M C D ++RPT K++ + P
Sbjct: 246 ----------VYMVMV---------KCWMIDENIRPTFKELANEFTRMARDP 278
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 46/292 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYEN---KICVAVKKL-DNMVSGGDKEFRTEVNAIGQTNHRN 565
LG GAF TV+KG+ E KI VA+K+L + +KE E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+ +LLG C L+ + + GCL ++ ++ + IA+G+ YL +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA-----IRGTRGYVAPEW 679
++H D+ +N+L+ +I+DFGLAK+L A++ I+ A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALES 190
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKL 733
T + D++S+GV + EL+ K + +++ C ID
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID--- 247
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
++ +M C D RP +++ + + P
Sbjct: 248 ----------VYMIMV---------KCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNL 566
LG G F V++GV KI VAVK + +K +F +E + +H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECT 625
VKL+G E+ ++ E G L +L +N + + I + + YL
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGYVAPEWFK 681
+H DI +NIL+ ++ DFGL++ ++ + + I+ +PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
T D++ F V + E++ K+ +EN++ + +++ C
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC-------- 239
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L+ +M C DPS RP ++ L
Sbjct: 240 -----PPVLYTLMTR---------CWDYDPSDRPRFTELVCSLS 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 55/284 (19%), Positives = 93/284 (32%), Gaps = 47/284 (16%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVN 556
S++ L + LG G++ V K + ++ AVK EV
Sbjct: 58 SFQRLSR--------LGHGSYGEVFKVRSKEDGRLY-AVKRSMSPFRGPKDRARKLAEVG 108
Query: 557 AIGQ-TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-----SWYRRMQIA 610
+ + H V+L E L E L W
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
L +LH + ++H D+KP NI L ++ DFGL L G
Sbjct: 168 ----LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEG 218
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730
Y+APE + D++S G+ +LE+ C + E Q+ Y+
Sbjct: 219 DPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-EGWQQL------RQGYLP 270
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ + ++ L ++ ++ DP LR T + +
Sbjct: 271 PEFTAGLSSE---LRSVLV---------MMLEPDPKLRATAEAL 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 62/313 (19%), Positives = 127/313 (40%), Gaps = 41/313 (13%)
Query: 479 HKTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK 538
H +G + + NL S + ++G G + V + + E K A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYS-ILKQIGSGGSSKVFQVL--NEKKQIYAIK 58
Query: 539 --KLDNMVSGGDKEFRTEVNAIGQTNHRNL--VKLLGFCNEDQHRLLVYEFISNGCLAGF 594
L+ + +R E+ + + + ++L + DQ+ +V E N L +
Sbjct: 59 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 117
Query: 595 LFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
L K + R + + +H+ I+H D+KP N L+ D ++ DFG+A
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 655 KILKADQTRTT-TAIRGTRGYVAPEWFKSLP-----------ITMKVDIYSFGVMLLELI 702
++ D T + GT Y+ PE K + I+ K D++S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 703 CCRKKFEQNVENENQMI-LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCI 761
+ F+Q + +++ ++D ++ + E+ L D+++ C+
Sbjct: 234 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-------EKDLQDVLK---------CCL 277
Query: 762 QEDPSLRPTMKKV 774
+ DP R ++ ++
Sbjct: 278 KRDPKQRISIPEL 290
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 47/289 (16%)
Query: 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIG 559
L +G+G F V G VAVK K D + F E + +
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----AQAFLAEASVMT 241
Query: 560 QTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRR--MQIAFGIARG 616
Q H NLV+LLG E++ L +V E+++ G L +L + ++ + +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVA 676
+ YL +H D+ +N+L+ + A++SDFGL K + Q ++ T A
Sbjct: 302 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 354
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYID 730
PE + + K D++SFG++L E+ + + ++ + V+ Y C
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--- 411
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
A++D+M+ C D + RPT ++ LE
Sbjct: 412 ----------PPAVYDVMK---------NCWHLDAATRPTFLQLREQLE 441
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 55/308 (17%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHR 564
LG GAF V++G + + + VAVK L + S D+ +F E I + NH+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGL 617
N+V+ +G + R ++ E ++ G L FL + + + +A IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 618 FYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAK-ILKADQTRTTTA----IR 669
YL E IH DI +N LL A+I DFG+A+ I +A R ++
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY---- 725
PE F T K D +SFGV+L E+ + N+ + V
Sbjct: 211 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 266
Query: 726 --DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
+C ++ +M C Q P RP + +E +
Sbjct: 267 PKNC-------------PGPVYRIMTQ---------CWQHQPEDRPNFAIILERIEYCTQ 304
Query: 784 VPIPPDPS 791
P + +
Sbjct: 305 DPDVINTA 312
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 69/290 (23%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
K +LG G + V++GV + + VAVK K D M +EF E + + H NLV
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLV 72
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR--MQIAFGIARGLFYLHEECT 625
+LLG C + ++ EF++ G L +L + + + +A I+ + YL ++
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 130
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA----IRGTRGYVAPEWFK 681
IH D+ +N L+ ++ +++DFGL++++ D I+ T APE
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 185
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
++K D+++FGV+L E+ ++ L++ Y C
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-------- 237
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
E ++++MR C Q +PS RP+ ++ E + +
Sbjct: 238 -----PEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 49/284 (17%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+ LG G F V G Y VAVK K +M F E N + Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLV 71
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECT 625
+L + + ++ E++ NG L FL K + + + +A IA G+ ++ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRTTTA---IRGTRGYVAPEWFK 681
IH D++ NIL+ D+ + +I+DFGLA++++ ++ T A I+ T APE
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHL 735
T+K D++SFG++L E++ + + N + ++ Y +C
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-------- 235
Query: 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E L+ +MR C +E P RPT + +LE
Sbjct: 236 -----PEELYQLMR---------LCWKERPEDRPTFDYLRSVLE 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 39/293 (13%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVSGGDK-EFRTEVN 556
ELG G F +V +GV K I VA+K L D E E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIAR 615
+ Q ++ +V+L+G C + +LV E G L FL + ++ ++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 447
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
G+ YL E+ +H ++ +N+LL + A+ISDFGL+K L AD + TA + +
Sbjct: 448 GMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPL 503
Query: 676 ---APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------D 726
APE + + D++S+GV + E + +K + ++ M ++ +
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563
Query: 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
C L+ +M C RP V +
Sbjct: 564 C-------------PPELYALMS---------DCWIYKWEDRPDFLTVEQRMR 594
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 66/298 (22%), Positives = 123/298 (41%), Gaps = 47/298 (15%)
Query: 510 FKDELGRGAFATVHKGVL--AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNL 566
F + +GRG F V+ G L KI AVK L+ + G+ +F TE + +H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 567 VKLLGFCNEDQH-RLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+ LLG C + L+V ++ +G L F+ P+ + +A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-- 210
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKAD--QTRTTTA----IRGTRGYVAP 677
+ +H D+ +N +LD+ FT +++DFGLA+ + + T ++ A
Sbjct: 211 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----AL 265
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDE 731
E ++ T K D++SFGV+L EL+ +V + + + C
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC---- 321
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
+ L+++M C +RP+ ++ + + I
Sbjct: 322 ---------PDPLYEVMLK---------CWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 510 FKDELGRGAFATVHKGVL--AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNL 566
F + +GRG F V+ G L KI AVK L+ + G+ +F TE + +H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 567 VKLLGFCNEDQH-RLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+ LLG C + L+V ++ +G L F+ P+ + +A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-- 146
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTA------IRGTRGYVAP 677
+ +H D+ +N +LD+ FT +++DFGLA+ + + ++ A
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----AL 201
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDE 731
E ++ T K D++SFGV+L EL+ +V + + + C
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC---- 257
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
+ L+++M C +RP+ ++ + +
Sbjct: 258 ---------PDPLYEVMLK---------CWHPKAEMRPSFSELVSRISAIFS 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 56/302 (18%), Positives = 106/302 (35%), Gaps = 58/302 (19%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVNAI 558
++ ++ LGRG F V + ++ A+K++ ++ EV A+
Sbjct: 7 FEPIQC--------LGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVMREVKAL 57
Query: 559 GQTNHRNLVKLLGFCNED---------QHRLLVY---EFISNGCLAGFLFKN---PKPSW 603
+ H +V+ E ++ +Y + L ++ +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 604 YRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663
+ I IA + +LH + ++H D+KP NI ++ DFGL + D+
Sbjct: 118 SVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 664 TTTAIR-----------GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712
T GT+ Y++PE + KVDI+S G++L EL+ F +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231
Query: 713 ENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
E + V + K L + M++ + P RP
Sbjct: 232 ERVRTLTDV-------RNLKFPPLFTQKYPCEYVMVQ---------DMLSPSPMERPEAI 275
Query: 773 KV 774
+
Sbjct: 276 NI 277
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 59/306 (19%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
K ELG GAF V ++K+ VAVK L ++F+ E + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN---------------PKPSWYRRMQIA 610
+V+ G C E + L+V+E++ +G L FL + + + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTA-- 667
+A G+ YL +H D+ +N L+ +I DFG+++ I D R
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 668 --IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725
IR PE T + D++SFGV+L E+ K+ + N + +
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 726 ------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
C ++ +MR C Q +P R ++K V L+
Sbjct: 278 ELERPRAC-------------PPEVYAIMRG---------CWQREPQQRHSIKDVHARLQ 315
Query: 780 GVVEVP 785
+ + P
Sbjct: 316 ALAQAP 321
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 57/280 (20%), Positives = 118/280 (42%), Gaps = 40/280 (14%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNL--V 567
++G G + V + + E K A+K L+ + +R E+ + + + +
Sbjct: 15 KQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+L + DQ+ +V E N L +L K + R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT-TAIRGTRGYVAPEWFKSLP-- 684
I+H D+KP N L+ D ++ DFG+A ++ D T + GT Y+ PE K +
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 685 ---------ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-LVDWAYDCYIDEKLH 734
I+ K D++S G +L + + F+Q + +++ ++D ++ +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP- 246
Query: 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
E+ L D+++ C++ DP R ++ ++
Sbjct: 247 ------EKDLQDVLK---------CCLKRDPKQRISIPEL 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 55/308 (17%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHR 564
LG GAF V++G + + + VAVK L + S D+ +F E I + NH+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGL 617
N+V+ +G + R ++ E ++ G L FL + + + +A IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 618 FYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAK-ILKADQTRTTTA----IR 669
YL E IH DI +N LL A+I DFG+A+ I +A R ++
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY---- 725
PE F T K D +SFGV+L E+ + N+ + V
Sbjct: 252 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307
Query: 726 --DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
+C ++ +M C Q P RP + +E +
Sbjct: 308 PKNC-------------PGPVYRIMTQ---------CWQHQPEDRPNFAIILERIEYCTQ 345
Query: 784 VPIPPDPS 791
P + +
Sbjct: 346 DPDVINTA 353
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 510 FKDELGRGAFATVHKGVL------AYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH 563
F + LG+G F + KGV ++ V +K LD + F + + + +H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHE 622
++LV G C +LV EF+ G L +L KN + ++++A +A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 623 ECTTQIIHCDIKPQNILLDDSFTAR--------ISDFGLAKILKADQTRTTTAIRGTRGY 674
+IH ++ +NILL + +SD G++ + I
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWV--- 184
Query: 675 VAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
PE ++ + D +SFG L E+ K ++++ ++ E
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---------EDR 234
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
H L L +++ C+ +P RP+ + + L
Sbjct: 235 HQLPAPKAAELANLINN---------CMDYEPDHRPSFRAIIRDLN 271
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 72/285 (25%), Positives = 108/285 (37%), Gaps = 51/285 (17%)
Query: 510 FKDELGRGAFATVHKGVLA--YENKICVAVKKLD-NMVSGGDKEFR--TEVNAIGQTNHR 564
KD LG GA T+ V ++N+ VAVK++ S D+E + E + H
Sbjct: 28 PKDVLGHGAEGTI---VYRGMFDNRD-VAVKRILPECFSFADREVQLLRESD-----EHP 78
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF-----KNPKPSWYRRMQIAFGIARGLFY 619
N+++ + Q + + E C A L K+ + + GL +
Sbjct: 79 NVIRYFCTEKDRQFQYIAIEL----C-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 620 LHEECTTQIIHCDIKPQNILL-----DDSFTARISDFGLAKILKADQ--TRTTTAIRGTR 672
LH I+H D+KP NIL+ A ISDFGL K L + + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 673 GYVAPEWFKSLPI---TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
G++APE T VDI+S G + +I IL+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----GACS 246
Query: 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ LH D A +++ I DP RP+ K V
Sbjct: 247 LDCLHPEKHEDVIA-RELIE---------KMIAMDPQKRPSAKHV 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 79/332 (23%), Positives = 144/332 (43%), Gaps = 63/332 (18%)
Query: 490 MPSTNLQIFSYKELEKATQ--------GFKDELGRGAFATVHKGVL----AYENKICVAV 537
M S N + FS ++ + ELG+G+F V++GV E + VA+
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 538 KKLDNMVSGGDK-EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596
K ++ S ++ EF E + + + N ++V+LLG ++ Q L++ E ++ G L +L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 597 KN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTA 646
PS + +Q+A IA G+ YL+ + +H D+ +N ++ + FT
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177
Query: 647 RISDFGLA-KILKADQTRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
+I DFG+ I + D R +R +PE K T D++SFGV+L E+
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWM----SPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 702 ICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVM 755
++ Q + NE + V +C + L ++MR+
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-------------PDMLFELMRM----- 275
Query: 756 IAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787
C Q +P +RP+ ++ ++ +E
Sbjct: 276 ----CWQYNPKMRPSFLEIISSIKEEMEPGFR 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 56/280 (20%), Positives = 117/280 (41%), Gaps = 40/280 (14%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNL--V 567
++G G + V + + E K A+K L+ + +R E+ + + + +
Sbjct: 62 KQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+L + DQ+ +V E N L +L K + R + + +H+
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT-TAIRGTRGYVAPEWFKSLP-- 684
I+H D+KP N L+ D ++ DFG+A ++ D T + G Y+ PE K +
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 685 ---------ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-LVDWAYDCYIDEKLH 734
I+ K D++S G +L + + F+Q + +++ ++D ++ +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP- 293
Query: 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
E+ L D+++ C++ DP R ++ ++
Sbjct: 294 ------EKDLQDVLK---------CCLKRDPKQRISIPEL 318
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 66/291 (22%), Positives = 106/291 (36%), Gaps = 53/291 (18%)
Query: 510 FKDELGRGAFATVHKGVL--AYENKICVAVK--KLDNMVSGGD-KEFRTEVNAIGQTNHR 564
++LG G+F V +G + VAVK K D + +F EVNA+ +HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEE 623
NL++L G +V E G L L K+ + A +A G+ YL +
Sbjct: 82 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA------IRGTRGYVAP 677
+ IH D+ +N+LL +I DFGL + L + AP
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----AP 193
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
E K+ + D + FGV L E+ ++ + + LH +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILHKID 238
Query: 738 ENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ E + ++++M C P RPT + L
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQ---------CWAHKPEDRPTFVALRDFLL 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 24/229 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
D LG+GA A V +G + A+K +N+ + E + + NH+N+VK
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 569 LLGF--CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEE 623
L +H++L+ EF G L L + + + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 624 CTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
I+H +IKP NI+ D +++DFG A+ L+ D+ + + GT Y+ P+
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186
Query: 680 FKSLPITM--------KVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
++ + VD++S GV F +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
K ELG GAF V ++K+ VAVK L + K+F+ E + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR----------------MQI 609
+VK G C + ++V+E++ +G L FL + + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKADQTRTTTA- 667
A IA G+ YL + +H D+ +N L+ + +I DFG+++ + D R
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 668 ---IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVDW 723
IR PE T + D++SFGV+L E+ ++ + + N + +
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEVIECITQ 250
Query: 724 AY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777
C + ++D+M C Q +P R +K++ +
Sbjct: 251 GRVLERPRVC-------------PKEVYDVMLG---------CWQREPQQRLNIKEIYKI 288
Query: 778 LEGVVEVP 785
L + +
Sbjct: 289 LHALGKAT 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 47/281 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+G+G F V G VAVK K D + F E + + Q H NLV
Sbjct: 25 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLV 77
Query: 568 KLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRR--MQIAFGIARGLFYLHEEC 624
+LLG E++ L +V E+++ G L +L + ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+H D+ +N+L+ + A++SDFGL K + Q ++ T APE +
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 190
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVE 738
+ K D++SFG++L E+ + + ++ + V+ Y C
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC----------- 239
Query: 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
A++++M+ C D ++RP+ ++ LE
Sbjct: 240 --PPAVYEVMK---------NCWHLDAAMRPSFLQLREQLE 269
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 74/303 (24%), Positives = 117/303 (38%), Gaps = 63/303 (20%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHR 564
F +ELG F V+KG L E VA+K L + G + EFR E + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR----------------MQ 608
N+V LLG +DQ +++ + S+G L FL S +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTA 667
+ IA G+ YL ++H D+ +N+L+ D +ISD GL ++ AD +
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 668 ----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI-CCRKKFEQNVENENQMILVD 722
IR APE ++ DI+S+GV+L E+ + + N++ + ++
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVEMIR 244
Query: 723 WAY------DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
DC ++ +M C E PS RP K +
Sbjct: 245 NRQVLPCPDDC-------------PAWVYALMIE---------CWNEFPSRRPRFKDIHS 282
Query: 777 MLE 779
L
Sbjct: 283 RLR 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 60/308 (19%), Positives = 105/308 (34%), Gaps = 52/308 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC 573
LG G F+ V ++ A+K++ +E + E + NH N+++L+ +C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHF-YALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 574 NEDQHR----LLVYEFISNGCLAGFLFKNPKPSWY----RRMQIAFGIARGLFYLHEECT 625
++ L+ F G L + + + + + + GI RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR--------GTRGYVAP 677
H D+KP NILL D + D G + A+ T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 678 EWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV-----DWAYDCYI 729
E F I + D++S G +L ++ ++ + + + L
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
L L+ + DP RP + + LE + PP
Sbjct: 273 SSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQLEAL----QPPA 308
Query: 790 PSSFISSI 797
P + I
Sbjct: 309 PGQHTTQI 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 39/215 (18%), Positives = 68/215 (31%), Gaps = 24/215 (11%)
Query: 510 FKDELGRGAFATV----HKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN 565
LG GAFA V + +NK +K + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYR-----RMQIAFGIARGLFYL 620
+K +LV E S G L + + A + + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTA-----------RISDFGLAKILKA-DQTRTTTAI 668
H+ +IIH DIKP N +L + F + D G + +K + TA
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T G+ E + P ++D + + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 66/292 (22%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 510 FKDELGRGAFATVHKGVL--AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHRNL 566
+G+G F V+ G +N+I A+K L + F E + NH N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 567 VKLLGFC-NEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEEC 624
+ L+G + ++ ++ +G L F+ P+ + +ARG+ YL E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-- 142
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK-ILKAD--QTRTTTA----IRGTRGYVAP 677
+ +H D+ +N +LD+SFT +++DFGLA+ IL + + ++ T A
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDE 731
E ++ T K D++SFGV+L EL+ ++++ + + C
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC---- 253
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
++L+ +M+ C + DP++RPT + + +E +V
Sbjct: 254 ---------PDSLYQVMQQ---------CWEADPAVRPTFRVLVGEVEQIVS 287
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 75/332 (22%), Positives = 123/332 (37%), Gaps = 55/332 (16%)
Query: 478 YHKTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVL--AYENKICV 535
+H P +++ LG G F +V +G L + V
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 536 AVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----HRLLVYEFISN 588
AVK KLDN +EF +E + +H N+++LLG C E +++ F+
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 589 GCLAGFLFKN------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642
G L +L + ++ IA G+ YL +H D+ +N +L D
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182
Query: 643 SFTARISDFGLAK-ILKADQTRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVM 697
T ++DFGL+K I D R ++ A E T K D+++FGV
Sbjct: 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI----AIESLADRVYTSKSDVWAFGVT 238
Query: 698 LLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVENDEEALHDMMRLK 751
+ E+ V+N + + DC + L+++M
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC-------------LDELYEIMYS- 284
Query: 752 KYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
C + DP RPT + L LE ++E
Sbjct: 285 --------CWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 15/205 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKI--CVAVKKLDNMVSGGDKEFRT----EVNAIGQTNHRN 565
+GRG V+ A + VA+K + +S D FRT E G+ +
Sbjct: 40 RLVGRGGMGDVY---EAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPH 95
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
+V + F D + I+ LA L + + R + I I L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT-AIRGTRGYVAPEWFKSLP 684
H D+KP+NIL+ A + DFG+A D+ T GT Y+APE F
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 685 ITMKVDIYSFGVMLLELICCRKKFE 709
T + DIY+ +L E + ++
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 510 FKDELGRGAFATVHKGV-----LAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNH 563
+ELG G FA V K L Y K + ++ G +E EV+ + Q H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKF-IKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNG-----CLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
N++ L +L+ E +S G + + + + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QILDGVN---- 129
Query: 619 YLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
YLH + +I H D+KP+NI+L ++ DFGLA ++ GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEF 184
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELIC 703
VAPE P+ ++ D++S GV+ L+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-30
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKIC---VAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRN 565
K+ LG G F V + + ++ VA+K+ +S ++E + E+ + + NH N
Sbjct: 18 MKERLGTGGFGYVLRWI----HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 566 LVKLL------GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA--FG-IARG 616
+V + LL E+ G L +L + + I I+
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 617 LFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
L YLHE +IIH D+KP+NI+L +I D G AK L + T GT
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQ 188
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
Y+APE + T+ VD +SFG + E I
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
D LG+GA A V +G + A+K +N+ + E + + NH+N+VK
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 569 LLGF--CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA---FGIARGLFYLHEE 623
L +H++L+ EF G L L + + + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 624 CTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
I+H +IKP NI+ D +++DFG A+ L+ D+ + GT Y+ P+
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 680 FKSLPITM--------KVDIYSFGVMLLELIC 703
++ + VD++S GV
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE----FRTEVNAIGQTNHRNLV 567
+ LG G + VH +++ VAVK L ++ D FR E NH +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRD-VAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIV 75
Query: 568 KLL--GFCNEDQHRL--LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ G L +V E++ L + + R +++ + L + H+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ- 134
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT--AIRGTRGYVAPEWFK 681
IIH D+KP NI++ + ++ DFG+A+ + T A+ GT Y++PE +
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFE 709
+ + D+YS G +L E++ F
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 510 FKDELGRGAFATVHKGV-----LAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNH 563
+ELG G FA V K Y K + ++L + G +E EVN + + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAK-FIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNG-----CLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
N++ L +L+ E +S G + + + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QILDGVH---- 122
Query: 619 YLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
YLH + +I H D+KP+NI+L + ++ DFG+A ++A GT +
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEF 177
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELIC 703
VAPE P+ ++ D++S GV+ L+
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/194 (29%), Positives = 86/194 (44%), Gaps = 11/194 (5%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC 573
LG+G + V+ G A+K++ S + E+ H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRI-AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 574 NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQIIH 630
+E+ + E + G L+ L P I F I GL YLH+ QI+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 631 CDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI--TM 687
DIK N+L++ S +ISDFG +K L T T GT Y+APE P
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 688 KVDIYSFGVMLLEL 701
DI+S G ++E+
Sbjct: 205 AADIWSLGCTIIEM 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
LG+GAF V K A +++ A+KK+ +EV + NH+ +V+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRY-YAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 570 LGFCNEDQHRLLVYEFISNG---------CLAGFLFK--NPKPSWYRRMQIA--FG-IAR 615
E ++ + + C G L+ + + +R + F I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT----------- 664
L Y+H + IIH D+KP NI +D+S +I DFGLAK +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 665 ---TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELIC 703
T+AI GT YVA E K+D+YS G++ E+I
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 510 FKDELGRGAFATVHKGV-----LAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNH 563
+ELG G FA V K L Y K + ++ G +E EV+ + Q H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKF-IKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNG-----CLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
N++ L +L+ E +S G + + + + I G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVN 129
Query: 619 YLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
YLH + +I H D+KP+NI+L ++ DFGLA ++ GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEF 184
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELIC 703
VAPE P+ ++ D++S GV+ L+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 25/235 (10%)
Query: 479 HKTKMDQTGPVMPSTNLQIFSYKELEKAT-QGFKDELGRGAFATVHKGVLAYENKICVAV 537
+ + V+ + L+ Y+ E+ + +GRG+F VH+ + AV
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAV 88
Query: 538 KKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL-- 595
KK+ + E E+ A + +V L G E + E + G L +
Sbjct: 89 KKVR--LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143
Query: 596 ---FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDF 651
+ +Y Q GL YLH +I+H D+K N+LL D A + DF
Sbjct: 144 MGCLPEDRALYYLG-QAL----EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDF 195
Query: 652 GLAKILKADQTRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
G A L+ D + I GT ++APE P KVDI+S M+L ++
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
++LGRG F VH+ V +K K + V G D+ + E++ + HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILH 65
Query: 569 LLGFCNEDQHRLLVYEFISNGCL------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
L + ++++EFIS + + F + Y Q+ + +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QVCEALQ----FLHS 120
Query: 623 ECTTQIIHCDIKPQNILLDDSFTA--RISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
I H DI+P+NI+ ++ +I +FG A+ LK Y APE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVH 175
Query: 681 KSLPITMKVDIYSFGVMLLELIC 703
+ ++ D++S G ++ L+
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLS 198
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 71/304 (23%), Positives = 112/304 (36%), Gaps = 68/304 (22%)
Query: 510 FKDELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEF----RTEVNAIGQT-NH 563
+ LG G+ TV V VAVK++ +F E+ + ++ +H
Sbjct: 19 SEKILGYGSSGTV---VFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDH 68
Query: 564 RNLVKLLGFCNEDQHRLLVYEF---------ISNGCLAGFLFKNPKPSWYRRMQIAFGIA 614
N+++ D+ + E S Y + + IA
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNV---SDENLKLQKEYNPISLLRQIA 125
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLD-------------DSFTARISDFGLAKILKADQ 661
G+ +LH +IIH D+KPQNIL+ ++ ISDFGL K L + Q
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 662 TRTTTAIR---GTRGYVAPE-------WFKSLPITMKVDIYSFGVMLLELICCRKK-FEQ 710
+ T + GT G+ APE +T +DI+S G + ++ K F
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 711 NVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
E+ +I ++ D + K EA D++ I DP RPT
Sbjct: 243 KYSRESNIIRGIFSLD---EMKCLHDRSLIAEA-TDLIS---------QMIDHDPLKRPT 289
Query: 771 MKKV 774
KV
Sbjct: 290 AMKV 293
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 68/309 (22%), Positives = 120/309 (38%), Gaps = 56/309 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENK--ICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRN 565
LG+G F +V + L E+ + VAVK K D + S +EF E + + +H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 566 LVKLLGFCNEDQHR------LLVYEFISNGCLAGFLFKN------PKPSWYRRMQIAFGI 613
+ KL+G + + +++ F+ +G L FL + ++ I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTTA----I 668
A G+ YL IH D+ +N +L + T ++DFGL+ KI D R A +
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 669 RGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY--- 725
+ A E T+ D+++FGV + E++ + +EN +
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 726 ---DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782
+C E ++D+M C DP RP+ + + LE ++
Sbjct: 260 QPPEC-------------MEEVYDLMYQ---------CWSADPKQRPSFTCLRMELENIL 297
Query: 783 EVPIPPDPS 791
S
Sbjct: 298 GHLSVLSTS 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 60/305 (19%)
Query: 510 FKDELGRGAFATVHKGVLA-YENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-TNHRNL 566
F+D +G G F V K + ++ A+K++ S D +F E+ + + +H N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR----------------MQIA 610
+ LLG C + L E+ +G L FL K+ + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA--- 667
+ARG+ YL ++ Q IH D+ +NIL+ +++ A+I+DFGL++ + T
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 668 -IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY- 725
+R A E T D++S+GV+L E++ + + Y
Sbjct: 204 PVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259
Query: 726 -----DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780
+C ++ ++D+MR C +E P RP+ ++ + L
Sbjct: 260 LEKPLNC-------------DDEVYDLMRQ---------CWREKPYERPSFAQILVSLNR 297
Query: 781 VVEVP 785
++E
Sbjct: 298 MLEER 302
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 510 FKDELGRGAFATVHKGV-----LAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNH 563
+ELG G FA V K L Y K + ++ + G +E EV+ + + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAK-FIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNG-----CLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
N++ L +L+ E ++ G + + + + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QILNGVY---- 128
Query: 619 YLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
YLH QI H D+KP+NI+L +I DFGLA + GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELIC 703
VAPE P+ ++ D++S GV+ L+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 68/313 (21%), Positives = 117/313 (37%), Gaps = 71/313 (22%)
Query: 510 FKDELGRGAFATVHKG----VLAYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-TNH 563
F LG GAF V + ++ + + VAVK L ++ +E+ + NH
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR----------------- 606
N+V LLG C L++ E+ G L FL + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 607 -MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRT 664
+ ++ +A+G+ +L IH D+ +NILL +I DFGLA I
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 665 TTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL----------ICCRKKFEQ 710
++ APE + T + D++S+G+ L EL + KF +
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 711 NVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
++ +M E+ ++D+M+ C DP RPT
Sbjct: 260 MIKEGFRM------------LSP----EHAPAEMYDIMKT---------CWDADPLKRPT 294
Query: 771 MKKVTLMLEGVVE 783
K++ ++E +
Sbjct: 295 FKQIVQLIEKQIS 307
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ELG GAF VH+ V K ++ + E++ + Q +H L+ L
Sbjct: 55 ILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 570 LGFCNEDQHRLLVYEFISNG------CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ +L+ EF+S G + + Y R Q G+ ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-QACEGLK----HMHEH 168
Query: 624 CTTQIIHCDIKPQNILLDDSFTARI--SDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
I+H DIKP+NI+ + + + DFGLA L D+ T T + APE
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 223
Query: 682 SLPITMKVDIYSFGVMLLELIC 703
P+ D+++ GV+ L+
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/340 (21%), Positives = 130/340 (38%), Gaps = 72/340 (21%)
Query: 487 GPVMPSTNLQIFSYK---ELEKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKK 539
GP+ S + E + LG G F V K + VAVK
Sbjct: 1 GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 540 LDNMVSGGDK-EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN 598
L S + + +E N + Q NH +++KL G C++D LL+ E+ G L GFL ++
Sbjct: 61 LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 599 PKPSWYRR------------------------MQIAFGIARGLFYLHEECTTQIIHCDIK 634
K + A+ I++G+ YL E +++H D+
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177
Query: 635 PQNILLDDSFTARISDFGLA-KILKADQTRTTTA----IRGTRGYVAPEWFKSLPITMKV 689
+NIL+ + +ISDFGL+ + + D + ++ A E T +
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQS 233
Query: 690 DIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY------DCYIDEKLHLLVENDEEA 743
D++SFGV+L E++ + E L+ + +C E
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC-------------SEE 280
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
++ +M C +++P RP ++ LE ++
Sbjct: 281 MYRLMLQ---------CWKQEPDKRPVFADISKDLEKMMV 311
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 76/315 (24%), Positives = 123/315 (39%), Gaps = 52/315 (16%)
Query: 510 FKDELGRGAFATVHKGVL------AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-T 561
LG GAF V VAVK L + + D + +E+ +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR--------------- 606
H+N++ LLG C +D ++ E+ S G L +L P
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 607 -MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRT 664
+ A+ +ARG+ YL + + IH D+ +N+L+ + +I+DFGLA I D +
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 665 TTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
TT ++ APE T + D++SFGV+L E+ V E L
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780
+ + + +K N L+ MMR C PS RPT K++ L+
Sbjct: 306 LK---EGHRMDKP----SNCTNELYMMMRD---------CWHAVPSQRPTFKQLVEDLDR 349
Query: 781 VVEVPIPPDPSSFIS 795
+V + + +
Sbjct: 350 IVALTSNQEMGYYHH 364
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/298 (19%), Positives = 105/298 (35%), Gaps = 64/298 (21%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNA 557
+ ELEK +G G F +V K V + I A+K+ S ++ EV A
Sbjct: 13 FHELEK--------IGSGEFGSVFKCVKRLDGCIY-AIKRSKKPLAGSVDEQNALREVYA 63
Query: 558 IGQ-TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY----RRMQIAFG 612
H ++V+ ED H L+ E+ + G LA + +N + Y +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLD-------------------DSFTARISDFGL 653
+ RGL Y+H ++H DIKP NI + + +I D G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 654 AKILKADQTRTTTAIRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712
+ + Q G ++A E ++ K DI++ + ++
Sbjct: 181 VTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG- 234
Query: 713 ENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
++ I +L + + + ++++ I DP RP+
Sbjct: 235 -DQWHEI---------RQGRLPRIPQVLSQEFTELLK---------VMIHPDPERRPS 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 514 LGRGAFATVHKGVLAYE--NKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
LG+G F V+ LA E +K +A+K L + G + R EV H N+++
Sbjct: 17 LGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 569 LLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
L G+ D R+ L+ E+ G + L K K R +A L Y H + +
Sbjct: 74 LYGYF-HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH DIKP+N+LL + +I+DFG + + + GT Y+ PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHDE 186
Query: 688 KVDIYSFGVMLLELIC 703
KVD++S GV+ E +
Sbjct: 187 KVDLWSLGVLCYEFLV 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 514 LGRGAFATVHKGVLAYE--NKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
LG+G F V+ LA E NK +A+K L + G + R E+ H N+++
Sbjct: 22 LGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 569 LLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+ + D+ R+ L+ EF G L L K+ + R +A L Y HE +
Sbjct: 79 MYNYF-HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---K 134
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH DIKP+N+L+ +I+DFG + + + RT GT Y+ PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDE 191
Query: 688 KVDIYSFGVMLLELIC 703
KVD++ GV+ E +
Sbjct: 192 KVDLWCAGVLCYEFLV 207
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 52/309 (16%)
Query: 510 FKDELGRGAFATVHKGVL------AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-T 561
LG GAF V + + VAVK L + + D + +E+ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR--------------- 606
H+N++ LLG C +D ++ E+ S G L +L P
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 607 -MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRT 664
+ + +ARG+ YL + + IH D+ +N+L+ ++ +I+DFGLA I D +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 665 TTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
TT ++ APE T + D++SFGV++ E+ + E L
Sbjct: 216 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780
+ + + +K N L+ MMR C PS RPT K++ L+
Sbjct: 272 LK---EGHRMDKP----ANCTNELYMMMRD---------CWHAVPSQRPTFKQLVEDLDR 315
Query: 781 VVEVPIPPD 789
++ + +
Sbjct: 316 ILTLTTNEE 324
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 39/213 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
K+ELG+GAF+ V + V + A K ++ +S D + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 568 KLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGI 613
+L E+ LV++ ++ G L A + I
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------I 114
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ Y H I+H ++KP+N+LL +++DFGLA + + A G
Sbjct: 115 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T GY++PE K P + VDI++ GV+L L+
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK-----KLDNMVSGGDKEFRTEVNAIGQTNHR 564
+ +G+G F+ V + + E AVK K + ++ + E + H
Sbjct: 28 LCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCL---------AGFLFKNPKPSWYRRMQIAFGIAR 615
++V+LL + D +V+EF+ L AGF++ S Y R QI +
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-QILEALR- 144
Query: 616 GLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
Y H+ IIH D+KP +LL ++S ++ FG+A L + GT
Sbjct: 145 ---YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
++APE K P VD++ GV+L L+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 71/311 (22%)
Query: 510 FKDELGRGAFATVHKG----VLAYENKICVAVKKLDNMVSGGDK-EFRTEVN---AIGQT 561
F LG GAF V + + + + VAVK L + +K +E+ +GQ
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ- 108
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL--------------FKNPKPSWYRRM 607
H N+V LLG C L++ E+ G L FL N S +
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTTT 666
+ +A+G+ +L + IH D+ +N+LL + A+I DFGLA I+
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 667 A----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC----------RKKFEQNV 712
++ APE T++ D++S+G++L E+ KF + V
Sbjct: 225 NARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280
Query: 713 ENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772
++ QM + + ++ +M+ C +P+ RPT +
Sbjct: 281 KDGYQM------------AQP----AFAPKNIYSIMQ---------ACWALEPTHRPTFQ 315
Query: 773 KVTLMLEGVVE 783
++ L+ +
Sbjct: 316 QICSFLQEQAQ 326
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 52/303 (17%)
Query: 510 FKDELGRGAFATVHKGVL------AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-T 561
LG G F V + + VAVK L + + D + +E+ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR--------------- 606
H+N++ LLG C +D ++ E+ S G L +L P
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 607 -MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRT 664
+ + +ARG+ YL + + IH D+ +N+L+ ++ +I+DFGLA I D +
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 665 TTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
TT ++ APE T + D++SFGV++ E+ + E L
Sbjct: 262 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780
+ + + +K N L+ MMR C PS RPT K++ L+
Sbjct: 318 LK---EGHRMDKP----ANCTNELYMMMR---------DCWHAVPSQRPTFKQLVEDLDR 361
Query: 781 VVE 783
++
Sbjct: 362 ILT 364
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 14/194 (7%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLLG 571
++G+GA TV+ + VA+++++ + KE E+ + + + N+V L
Sbjct: 27 KIGQGASGTVYTAM-DVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQI 628
+V E+++ G L + + QIA + L +LH Q+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH DIK NILL + +++DFG + +Q++ +T + GT ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 689 VDIYSFGVMLLELI 702
VDI+S G+M +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 38/211 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
F + LG GAF+ V A+K + + D E+ + + H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 570 LGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGIAR 615
H LV + +S G L A + + +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--------------VLS 117
Query: 616 GLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
+ YLHE I+H D+KP+N+L +++ I+DFGL+K+ + + +T GT
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTAC--GTP 171
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
GYVAPE P + VD +S GV+ L+C
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 75/310 (24%), Positives = 129/310 (41%), Gaps = 57/310 (18%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHR 564
+ ++G GAF V + YE VAVK L S + +F+ E + + ++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN------------------------PK 600
N+VKLLG C + L++E+++ G L FL P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 601 PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKA 659
S ++ IA +A G+ YL E + +H D+ +N L+ ++ +I+DFGL+ I A
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 660 DQTRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE 715
D + IR PE T + D++++GV+L E+ + + +E
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
+ V D I EN L+++MRL C + P+ RP+ +
Sbjct: 284 EVIYYVR---DGNILACP----ENCPLELYNLMRL---------CWSKLPADRPSFCSIH 327
Query: 776 LMLEGVVEVP 785
+L+ + E
Sbjct: 328 RILQRMCERA 337
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
+ LG G F VHK + +A K + +E + E++ + Q +H NL++
Sbjct: 92 SKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 569 LLGFCNEDQHRLLVYEFISNGCL------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
L +LV E++ G L + + + QI GI ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIR----HMHQ 205
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARI--SDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
I+H D+KP+NIL + +I DFGLA+ K + GT ++APE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVV 260
Query: 681 KSLPITMKVDIYSFGVMLLELIC 703
++ D++S GV+ L+
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLS 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
++G G+ V + VAVK +D + +E EV + H N+V++
Sbjct: 51 VKIGEGSTGIVCLAR-EKHSGRQVAVKMMD-LRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQ 627
+ ++ EF+ G L + + QIA + + L YLH +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQ---G 161
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+IH DIK +ILL ++SDFG + D + + + GT ++APE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYAT 220
Query: 688 KVDIYSFGVMLLELI 702
+VDI+S G+M++E++
Sbjct: 221 EVDIWSLGIMVIEMV 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 46/218 (21%), Positives = 85/218 (38%), Gaps = 37/218 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD-----------------NMVSGGDKEFRTEVN 556
L +G F + L ++ A+KK + + +F+ E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR 615
I + + G + + ++YE++ N + F I + +
Sbjct: 96 IITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 616 --------GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
Y+H E I H D+KP NIL+D + ++SDFG ++ + D+ +
Sbjct: 155 CIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGSR 211
Query: 668 IRGTRGYVAPEWF--KSLPITMKVDIYSFGVMLLELIC 703
GT ++ PE+F +S KVDI+S G+ L +
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 27/321 (8%), Positives = 64/321 (19%), Gaps = 54/321 (16%)
Query: 491 PSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLD---NMVSGG 547
+ + S + + L G + V + A+K
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLED-FALKVFTMGAENSRSE 105
Query: 548 DKEFRTEVNAIGQTNHRNLVKLLGFCN--------------------------EDQHRLL 581
+ A + + + + LL
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 582 VYEFI--SNGCLAGFLFKNPK----PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKP 635
+ L L + + R L + ++H P
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTP 222
Query: 636 QNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS--LPITMKVDIYS 693
N+ + + D K ++ Y E+ + T ++ +
Sbjct: 223 DNLFIMPDGRLMLGDVSALW--KVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQ 278
Query: 694 FGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKY 753
G+ + + C F D + + ++
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---- 334
Query: 754 VMIAIWCIQEDPSLRPTMKKV 774
+ D R +
Sbjct: 335 -----RFLNFDRRRRLLPLEA 350
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
+LG GA+ V + A+K + VS EV + +H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
KL F + ++ LV E G L + K + I + G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---N 156
Query: 628 IIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
I+H D+KP+N+LL + +I DFGL+ + + + GT Y+APE +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRK-K 213
Query: 685 ITMKVDIYSFGVMLLELIC 703
K D++S GV+L L+
Sbjct: 214 YDEKCDVWSIGVILFILLA 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 19/229 (8%)
Query: 487 GPVMPSTNLQIFSYKELEKATQGFKD------ELGRGAFATVHKGVLAYENKICVAVKKL 540
GP +L ++ +T F D LG+G+F V AVK +
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVI 59
Query: 541 D--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK 597
+ DKE EV + Q +H N++KL F + + LV E + G L +
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 119
Query: 598 NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLA 654
+ S +I + G+ Y+H+ +I+H D+KP+N+LL RI DFGL+
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
+A + GT Y+APE K D++S GV+L L+
Sbjct: 177 THFEASKKMKDKI--GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 39/213 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
K+ELG+GAF+ V + V + A K ++ +S D + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 568 KLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGI 613
+L E+ LV++ ++ G L A + I
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------I 137
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ Y H I+H ++KP+N+LL +++DFGLA + + A G
Sbjct: 138 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 192
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T GY++PE K P + VDI++ GV+L L+
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 50/224 (22%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD---------NMVSGGDKEFRTEVNAIGQ 560
K+ LGRG + V + + AVK +D V + EV+ + +
Sbjct: 21 PKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 561 -TNHRNLVKLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYR 605
+ H N+++L + LV++ + G L + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA------- 132
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665
+ + LH+ I+H D+KP+NILLDD +++DFG + L +
Sbjct: 133 -------LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 666 TAIRGTRGYVAPEWFKSLPITM------KVDIYSFGVMLLELIC 703
GT Y+APE + +VD++S GV++ L+
Sbjct: 183 VC--GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 59/312 (18%), Positives = 106/312 (33%), Gaps = 53/312 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKLLGF 572
L G FA V++ + A+K+L + ++ EV + + + H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGRE-YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 573 C-------NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM------QIAFGIARGLFY 619
+ Q L+ + G L FL K + +I + R + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQH 151
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI----------- 668
+H IIH D+K +N+LL + T ++ DFG A + + +A
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 669 RGTRGYVAPE---WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725
T Y PE + + PI K DI++ G +L L + FE +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPP 270
Query: 726 DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
H L+ +Q +P R ++ +V L+ +
Sbjct: 271 HDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQEIAAAR 310
Query: 786 IPPDPSSFISSI 797
S +
Sbjct: 311 NVNPKSPITELL 322
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 40/213 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
LG+G+F V K + AVK ++ D EV + + +H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 568 KLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGI 613
KL + +V E + G L A + K +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--------------V 130
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRG 670
G+ Y+H+ I+H D+KP+NILL + +I DFGL+ + + G
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--G 185
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T Y+APE + K D++S GV+L L+
Sbjct: 186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 40/213 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
LG+G+F V K + AVK ++ D EV + + +H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 568 KLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGI 613
KL + +V E + G L A + K Q+ GI
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----------QVFSGI 134
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRG 670
Y+H+ I+H D+KP+NILL + +I DFGL+ + + G
Sbjct: 135 T----YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--G 185
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T Y+APE + K D++S GV+L L+
Sbjct: 186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 64/322 (19%), Positives = 111/322 (34%), Gaps = 80/322 (24%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVN---AIGQT 561
F LG GAF V I VAVK L ++ +E+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR--------------- 606
H N+V LLG C L++E+ G L +L +
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 607 --------MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KIL 657
+ A+ +A+G+ +L + +H D+ +N+L+ +I DFGLA I+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 658 KADQTRTTTA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL----------IC 703
++ APE T+K D++S+G++L E+ I
Sbjct: 224 SDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 704 CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQE 763
F + ++N +M ++ E ++ +M+ C
Sbjct: 280 VDANFYKLIQNGFKM------------DQP----FYATEEIYIIMQS---------CWAF 314
Query: 764 DPSLRPTMKKVTLMLEGVVEVP 785
D RP+ +T L +
Sbjct: 315 DSRKRPSFPNLTSFLGCQLADA 336
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVK 568
FK +LG GAF VH + + +K ++ S E E+ + +H N++K
Sbjct: 26 FKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLF-----KNPKPSWYRRMQIAF---GIARGLFYL 620
+ + + +V E C G L + +A + L Y
Sbjct: 85 IFEVFEDYHNMYIVMET----CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 621 HEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
H + ++H D+KP+NIL +I DFGLA++ K+D+ T A GT Y+AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAP 195
Query: 678 EWFKSLPITMKVDIYSFGVMLLELIC 703
E FK +T K DI+S GV++ L+
Sbjct: 196 EVFKR-DVTFKCDIWSAGVVMYFLLT 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ELG GAF VH+ A K + + R E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTT 626
+D +++YEF+S G L F + + + + +GL ++HE
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 274
Query: 627 QIIHCDIKPQNILLDDSFTARI--SDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+H D+KP+NI+ + + DFGL L Q+ T GT + APE + P
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKP 332
Query: 685 ITMKVDIYSFGVMLLELIC 703
+ D++S GV+ L+
Sbjct: 333 VGYYTDMWSVGVLSYILLS 351
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 48/228 (21%)
Query: 501 KELEKATQGFKD------ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTE 554
++L + + F D ++G G+++ + + + AVK ++ ++ E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVK----IIDKSKRDPTEE 65
Query: 555 VNAIGQ-TNHRNLVKLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNP 599
+ + + H N++ L ++ ++ +V E + G L A +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT- 124
Query: 600 KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAK 655
I + + YLH + ++H D+KP NIL + + RI DFG AK
Sbjct: 125 -------------ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
L+A+ T T +VAPE + DI+S GV+L ++
Sbjct: 169 QLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+++G+G+F V KG+ K+ VA+K +D + + E + E+ + Q + + K
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQ 627
G +D ++ E++ G L +P QIA I +GL YLH E +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 139
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH DIK N+LL + +++DFG+A L Q + T + GT ++APE K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198
Query: 688 KVDIYSFGVMLLELI 702
K DI+S G+ +EL
Sbjct: 199 KADIWSLGITAIELA 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 65/312 (20%), Positives = 114/312 (36%), Gaps = 70/312 (22%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQ-TNH 563
LGRGAF V + VAVK L + + +E+ + +H
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 564 RNLVKLLGFC-NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRR---------------- 606
N+V LLG C +++ EF G L+ +L +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA-KILKADQTRTT 665
+ +F +A+G+ +L + IH D+ +NILL + +I DFGLA I K
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 666 TA----IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL----------ICCRKKFEQN 711
++ APE T++ D++SFGV+L E+ + ++F +
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 712 VENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTM 771
++ +M + ++ M C +PS RPT
Sbjct: 264 LKEGTRM------------RAP----DYTTPEMYQTMLD---------CWHGEPSQRPTF 298
Query: 772 KKVTLMLEGVVE 783
++ L +++
Sbjct: 299 SELVEHLGNLLQ 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
+ELG+GAF+ V + V A ++ +S D + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 568 KLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGI 613
+L +E+ H L+++ ++ G L A + I
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ--------------I 119
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRG 670
+ + H+ ++H ++KP+N+LL +++DFGLA ++ +Q G
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T GY++PE + P VD+++ GV+L L+
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 49/223 (21%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD--------NMVSGGDKEFRTEVNAIGQ- 560
KD +GRG + V + V AVK ++ + + R E + + Q
Sbjct: 98 PKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRR 606
H +++ L+ LV++ + G L + ++
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS-------- 208
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666
+ + +LH I+H D+KP+NILLDD+ R+SDFG + L+ +
Sbjct: 209 ------LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL 259
Query: 667 AIRGTRGYVAPEWFKSLPITM------KVDIYSFGVMLLELIC 703
GT GY+APE K +VD+++ GV+L L+
Sbjct: 260 C--GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-26
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-------------NMVSGGDKEFRTEVN 556
+LG GA+ V A+K + + +E E++
Sbjct: 40 KVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
+ +H N++KL + ++ LV EF G L + K I I G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 617 LFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
+ YLH+ I+H DIKP+NILL + +I DFGL+ D GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAY 213
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
Y+APE K K D++S GV++ L+C
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
++LG G++ +V+K + +I VA+K++ V +E E++ + Q + ++VK G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQI-VAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQI 628
++ +V E+ G ++ + K +IA +GL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH DIK NILL+ A+++DFG+A L + T I GT ++APE + +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCV 205
Query: 689 VDIYSFGVMLLELI 702
DI+S G+ +E+
Sbjct: 206 ADIWSLGITAIEMA 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
ELG GAF V+K + A K ++ S + E + E+ + +H +VKLL
Sbjct: 25 GELGDGAFGKVYKAKNKETGAL-AAAKVIE-TKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQ 627
G D ++ EF G + + + + QI + L +LH + +
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-----WFKS 682
IIH D+K N+L+ R++DFG++ + + I GT ++APE K
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 683 LPITMKVDIYSFGVMLLELI 702
P K DI+S G+ L+E+
Sbjct: 197 TPYDYKADIWSLGITLIEMA 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/247 (22%), Positives = 88/247 (35%), Gaps = 42/247 (17%)
Query: 479 HKTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK 538
H +G + + NL S + ELGRG FA V + + + A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCI-SKSTGQEYAAK 60
Query: 539 KLD-NMVSGGDKE-FRTEVNAIGQTNHR-NLVKLLGFCNEDQHRLLVYEFISNGCL---- 591
L + E+ + ++ L +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 592 ------------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639
L K QI G+ YLH+ I+H D+KPQNIL
Sbjct: 121 LPELAEMVSENDVIRLIK----------QILEGVY----YLHQN---NIVHLDLKPQNIL 163
Query: 640 L---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGV 696
L +I DFG+++ + GT Y+APE PIT D+++ G+
Sbjct: 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYDPITTATDMWNIGI 221
Query: 697 MLLELIC 703
+ L+
Sbjct: 222 IAYMLLT 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 34/260 (13%), Positives = 75/260 (28%), Gaps = 56/260 (21%)
Query: 491 PSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK---KLDNMVSGG 547
++ S T LG+ + + V + S
Sbjct: 58 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES-FEVHVPYFTERPPSNA 116
Query: 548 DKEFRTEVNAIGQ-------------------------TNHRNLVKLLGFCNEDQ--HRL 580
K+ + EV + + ++++ + R
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176
Query: 581 LVYEFI--SNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIK 634
+Y + + L + + R+Q+ + R L LH ++H ++
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233
Query: 635 PQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS-----------L 683
P +I+LD ++ F D R + +RG+ PE
Sbjct: 234 PVDIVLDQRGGVFLTGFEHL---VRDGARVVS--SVSRGFEPPELEARRATISYHRDRRT 288
Query: 684 PITMKVDIYSFGVMLLELIC 703
+T D ++ G+++ + C
Sbjct: 289 LMTFSFDAWALGLVIYWIWC 308
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 53/224 (23%)
Query: 510 FKDELGRGAFATVHKGVLAYENKIC--VAVKKLD--NMVSGGDKE------FRTEVNAIG 559
LG GA V LA+E K C VA++ + G +E TE+ +
Sbjct: 139 MSKTLGSGACGEVK---LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYR 605
+ NH ++K+ F + + + +V E + G L F
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ------- 247
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT 662
+ + YLHE IIH D+KP+N+LL ++ +I+DFG +KIL
Sbjct: 248 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 663 RTTTAIRGTRGYVAPE---WFKSLPITMKVDIYSFGVMLLELIC 703
T GT Y+APE + VD +S GV+L +
Sbjct: 298 MRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG+G FA + A + K A K + ++ +E E++ H+++V
Sbjct: 23 LGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
G ED + +V E L P+ +Y ++ I G YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LR---QIVLGCQYLHRN- 134
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
++IH D+K N+ L++ +I DFGLA ++ D R + GT Y+APE
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 685 ITMKVDIYSFGVMLLELICCRKKFE-QNVEN 714
+ +VD++S G ++ L+ + FE ++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 45/241 (18%)
Query: 486 TGPVMPSTNLQIFSYKELEKATQGFKD------ELGRGAFATVHKGVLAYENKICVAVKK 539
T P T + Y D ELGRGA + V++ + A+K
Sbjct: 27 TASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK-QKGTQKPYALKV 85
Query: 540 LDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL-------- 591
L + K RTE+ + + +H N++KL LV E ++ G L
Sbjct: 86 LKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG 143
Query: 592 ------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DD 642
A K I + YLHE I+H D+KP+N+L
Sbjct: 144 YYSERDAADAVKQ--------------ILEAVAYLHEN---GIVHRDLKPENLLYATPAP 186
Query: 643 SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+I+DFGL+KI++ T GT GY APE + +VD++S G++ L+
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
Query: 703 C 703
C
Sbjct: 245 C 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG+G+FA V++ + VA+K +D M G + + EV Q H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLE-VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKP-----SWYRRMQIAFGIARGLFYLHEEC 624
+ ED + + LV E NG + +L KP + + QI G+ YLH
Sbjct: 78 NYF-EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSH- 131
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
I+H D+ N+LL + +I+DFGLA LK + T + GT Y++PE
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188
Query: 685 ITMKVDIYSFGVMLLELIC 703
++ D++S G M L+
Sbjct: 189 HGLESDVWSLGCMFYTLLI 207
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 20/199 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG+G FA + A + K A K + ++ +E E++ H+++V
Sbjct: 49 LGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
G ED + +V E L P+ +Y ++ I G YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LR---QIVLGCQYLHRN- 160
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
++IH D+K N+ L++ +I DFGLA ++ D R + GT Y+APE
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 685 ITMKVDIYSFGVMLLELIC 703
+ +VD++S G ++ L+
Sbjct: 218 HSFEVDVWSIGCIMYTLLV 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 38/211 (18%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++ +GRG++ V V +I A KK+ F+ E+ + +H N+++L
Sbjct: 13 LENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 570 LGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGIAR 615
++ LV E + G L A + K + +A
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK----------DVLSAVA- 120
Query: 616 GLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
Y H+ + H D+KP+N L ++ DFGLA K + T GT
Sbjct: 121 ---YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTP 172
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
YV+P+ + + D +S GVM+ L+C
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLC 202
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 82/316 (25%), Positives = 128/316 (40%), Gaps = 57/316 (18%)
Query: 483 MDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDN 542
M + +P + + Y+ E +G GA A V A + + VA+K+++
Sbjct: 1 MSEDSSALPWSINR-DDYELQEV--------IGSGATAVVQAAYCAPKKEK-VAIKRINL 50
Query: 543 MVSGGDKE-FRTEVNAIGQTNHRNLVKLLG-FCNEDQHRL-LVYEFISNGCLA-----GF 594
+ E+ A+ Q +H N+V F +D+ L LV + +S G +
Sbjct: 51 EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIV 108
Query: 595 LFKNPKPSWYRRMQIAF---GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651
K IA + GL YLH+ IH D+K NILL + + +I+DF
Sbjct: 109 AKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165
Query: 652 GLAKILKADQTRTTTAIR----GTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRK 706
G++ L T +R GT ++APE + + K DI+SFG+ +EL
Sbjct: 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA---- 221
Query: 707 KFEQNVENENQMILVDWAYDCYIDEKLHLLVEND----EEALHDMMRLKKYV-----MIA 757
M L L ++ND E + D LKKY MI+
Sbjct: 222 TGAAPYHKYPPM----KV--------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS 269
Query: 758 IWCIQEDPSLRPTMKK 773
C+Q+DP RPT +
Sbjct: 270 -LCLQKDPEKRPTAAE 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 27/231 (11%), Positives = 60/231 (25%), Gaps = 45/231 (19%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQT--------- 561
LG+ + + V K+ + EV +
Sbjct: 86 LGQEDPYAYLEATDQETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 562 -------------NHRNLVKLLGFCNEDQHRLLVYEFI-------SNGCLAGFLF----K 597
K++ +++ ++ F + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 598 NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657
+ + R+Q+ + R L LH ++H ++P +I+LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 658 KADQTRTTTAIRGTRGYVAPEWFKSLP-----ITMKVDIYSFGVMLLELIC 703
A A +T D ++ G+ + + C
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 42/208 (20%), Positives = 74/208 (35%), Gaps = 26/208 (12%)
Query: 512 DELGRGAFATVHKGV-LAYENKICVAVKKLDNMVSGGDKE----FRTEVNAIGQTNHRNL 566
+ G ++ + + V +K L + GD E E + + H ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRP-VVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 567 VKLLGFCNEDQHRL-----LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
V++ F +V E++ L P + I L YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLP-VAEAIAYLLEILPALSYLH 199
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+++ D+KP+NI+L + ++ D G + GT G+ APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEIVR 250
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFE 709
+ P T+ DIY+ G L L
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPTRN 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 47/252 (18%), Positives = 87/252 (34%), Gaps = 44/252 (17%)
Query: 541 DNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFL----- 595
++ + + +N V L + + + + L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 596 --FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653
+ + +QIA + +LH + ++H D+KP NI ++ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 654 AKILKADQTRTTTAIR-----------GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+ D+ T GT+ Y++PE + KVDI+S G++L EL+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 703 CCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQ 762
F + E I+ D + K LL H M++ +
Sbjct: 271 Y---SFS--TQMERVRIITD-----VRNLKFPLLFTQKYPQEHMMVQ---------DMLS 311
Query: 763 EDPSLRPTMKKV 774
P+ RP +
Sbjct: 312 PSPTERPEATDI 323
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/224 (26%), Positives = 89/224 (39%), Gaps = 53/224 (23%)
Query: 510 FKDELGRGAFATVHKGVLAYENKIC--VAVKKLD--NMVSGGDKE------FRTEVNAIG 559
LG GA V LA+E K C VA+K + G +E TE+ +
Sbjct: 14 MSKTLGSGACGEVK---LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYR 605
+ NH ++K+ F + + +V E + G L F
Sbjct: 71 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ------- 122
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT 662
+ + YLHE IIH D+KP+N+LL ++ +I+DFG +KIL
Sbjct: 123 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 663 RTTTAIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELIC 703
T GT Y+APE S+ VD +S GV+L +
Sbjct: 173 MRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 54/246 (21%), Positives = 87/246 (35%), Gaps = 56/246 (22%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVK-----KLDNMVSGGDKEFRTEVNAIGQTNHR 564
K +G+G++ V + + + A+K K+ + + +TEV + + +H
Sbjct: 30 LKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG------------ 612
N+ +L ++Q+ LV E G L L S +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 613 ----------------------------IARGLFYLHEECTTQIIHCDIKPQNILL--DD 642
I L YLH + I H DIKP+N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 643 SFTARISDFGLAKILKADQTRTTTAIR---GTRGYVAPEWFKSL--PITMKVDIYSFGVM 697
SF ++ DFGL+K + GT +VAPE + K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 698 LLELIC 703
L L+
Sbjct: 266 LHLLLM 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 30/206 (14%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVK-----KLDNMVSGGDKEFRTEVNAIGQ-TNHR 564
LG G+F+ K V N+ AVK N + E+ A+ H
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAF-AVKIISKRMEANT--------QKEITALKLCEGHP 66
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK--NPKPSWYRRM--QIAFGIARGLFYL 620
N+VKL ++ H LV E G LF+ K + I + + ++
Sbjct: 67 NIVKLHEVFHDQLHTFLVMEL----LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 621 HEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
H+ ++H D+KP+N+L +D+ +I DFG A++ D T T Y AP
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAP 178
Query: 678 EWFKSLPITMKVDIYSFGVMLLELIC 703
E D++S GV+L ++
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLS 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLL 570
+ +G G + V+KG ++ A+K +D + ++E + E+N + + +HRN+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQL-AAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 571 G------FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLH 621
G D LV EF G + L KN K + + IA+ I RGL +LH
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE--- 678
+ ++IH DIK QN+LL ++ ++ DFG++ L R T I GT ++APE
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 202
Query: 679 --WFKSLPITMKVDIYSFGVMLLELI 702
K D++S G+ +E+
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 39/292 (13%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNLVK 568
ELG G V K + +A K + + E+ + + N +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLV-MARKLIH--LEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
G D + E + G L L K + +++ + +GL YL E+ +I
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 153
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
+H D+KP NIL++ ++ DFG++ L + GTR Y++PE + +++
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 210
Query: 689 VDIYSFGVMLLELICCR-----KKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
DI+S G+ L+E+ R ++ + D A +
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 744 LHDMMRLKKYVMIAI------------W----------CIQEDPSLRPTMKK 773
M + + ++ I + C+ ++P+ R +K+
Sbjct: 271 SRPPMAIFE-LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 49/306 (16%), Positives = 86/306 (28%), Gaps = 50/306 (16%)
Query: 512 DELGRGA--FATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRTEVNAIGQTNHRNLV 567
+G+G TV+ + V V++ L+ + + E++ NH N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEY-VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEEC 624
D +V F++ G L + IA+ G+ + L Y+H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV------APE 678
+H +K +IL+ +S + + R + V +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 679 WFKSLPI--TMKVDIYSFGVMLLELI------------------------CCRKKFEQNV 712
+ K DIYS G+ EL C
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265
Query: 713 ENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKY-----VMIAIWCIQEDPSL 767
E A D + + + C+Q +P
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNPDA 324
Query: 768 RPTMKK 773
RP+
Sbjct: 325 RPSAST 330
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQT-NHRNLV 567
E+GRGA+ +V+K V +I +AVK++ + +KE + +++ + ++ + +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQI-MAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM------QIAFGIARGLFYLH 621
+ G + + E + + F K + +I + L +L
Sbjct: 85 QFYGALFREGDCWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
E +IIH DIKP NILLD S ++ DFG++ L +T A G R Y+APE
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERID 198
Query: 682 SLPI----TMKVDIYSFGVMLLEL 701
++ D++S G+ L EL
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYEL 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 477 GYHKTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVA 536
G + QTG + +LE E+G G V K + +A
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVWKMRFRKTGHV-IA 54
Query: 537 VKKLDNMVSGGDKEFR---TEVNAIGQT-NHRNLVKLLG-FCNEDQHRLLVY---EFISN 588
VK++ SG +E + +++ + ++ + +V+ G F V+ E +
Sbjct: 55 VKQMR--RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD----VFIAMELM-G 107
Query: 589 GCLAGFLFKNPKP---SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT 645
C + P + + I + L+YL E+ +IH D+KP NILLD+
Sbjct: 108 TCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQ 163
Query: 646 ARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI-----TMKVDIYSFGVMLLE 700
++ DFG++ L D+ + +A G Y+APE ++ D++S G+ L+E
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 701 L 701
L
Sbjct: 222 L 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQT-NHRNLV 567
ELGRGA+ V K +I +AVK++ + +E + +++ +T + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQI-MAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRM------QIAFGIARGLFYLH 621
G + + E + + L F + + + +IA I + L +LH
Sbjct: 70 TFYGALFREGDVWICMELM-DTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLH 126
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ +IH D+KP N+L++ ++ DFG++ L D + A G + Y+APE
Sbjct: 127 SK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERIN 182
Query: 682 SLPI----TMKVDIYSFGVMLLEL 701
++K DI+S G+ ++EL
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKL 569
K LG G V + + C A+K L + + R EV+ Q + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKC-ALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 570 LGFCNEDQHR-----LLVYEFISNGCLAGFLF----KNPKPSWYRRM--QIAFGIARGLF 618
L E+ H L++ E G LF + ++ R +I I +
Sbjct: 88 LDVY-ENMHHGKRCLLIIMEC----MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 619 YLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
+LH I H D+KP+N+L + +++DFG AK + +T T YV
Sbjct: 143 FLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC---YTPYYV 196
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELIC 703
APE D++S GV++ L+C
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLC 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQTNHRNLVK 568
E+G G+F V+ +++ VA+KK+ + ++ EV + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---GIARGLFYLHEECT 625
G + LV E+ L + KP + ++IA G +GL YLH
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASD-LLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE---WFKS 682
+IH D+K NILL + ++ DFG A + + + GT ++APE
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV-GTPYWMAPEVILAMDE 227
Query: 683 LPITMKVDIYSFGVMLLELI 702
KVD++S G+ +EL
Sbjct: 228 GQYDGKVDVWSLGITCIELA 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 47/222 (21%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKL 569
+D LG GA A V + ++ AVK ++ EV + Q HRN+++L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEY-AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 570 LGFCNEDQHRLLVYEFISNGCL--------------AGFLFKNPKPSWYRRMQIAFGIAR 615
+ F E+ LV+E + G + A + ++ +A
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD--------------VAS 122
Query: 616 GLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIR--- 669
L +LH + I H D+KP+NIL + +I DF L +K + + +
Sbjct: 123 ALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 670 ---GTRGYVAPEWFKSLPITMK-----VDIYSFGVMLLELIC 703
G+ Y+APE ++ D++S GV+L L+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 514 LGRGAFATVHKGVLAY--ENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+G+G FA V LA VA+K +D + ++ EV + NH N+VKL
Sbjct: 23 IGKGNFAKVK---LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY--RRM--QIAFGIARGLFYLHEECT 625
++ L+ E+ S G + +L + + R QI + Y H++
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQKR- 134
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
I+H D+K +N+LLD +I+DFG + G Y APE F+
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPELFQGKKY 190
Query: 686 T-MKVDIYSFGVMLLELICCRKKFE-QNVENENQMIL 720
+VD++S GV+L L+ F+ QN++ + +L
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEF-RTEVNAIGQTNHRNLVKLL 570
LG G+F+TV ++ A+K L+ +++ + E + + + +H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREY-AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
F +D +L + NG L ++ F +Y I L YLH +
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIVSALEYLHGK- 149
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILK--ADQTRTTTAIRGTRGYVAPEWFKS 682
IIH D+KP+NILL++ +I+DFG AK+L + Q R + GT YV+PE
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPELLTE 206
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
D+++ G ++ +L+ F NE +
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRA--GNEYLI 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 29/208 (13%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVK 568
LG G V + + A+K L + + R EV + + ++V+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKF-ALKMLQDC-----PKARREVELHWRASQCPHIVR 119
Query: 569 LLGFC----NEDQHRLLVYEFISNGCLAGFLF----KNPKPSWYRRM--QIAFGIARGLF 618
++ + L+V E G LF ++ R +I I +
Sbjct: 120 IVDVYENLYAGRKCLLIVMEC----LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 619 YLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
YLH I H D+KP+N+L + +++DFG AK + + TT T YV
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYV 230
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELIC 703
APE D++S GV++ L+C
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLC 258
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQTNHRNLVKLL 570
LG+G F V + K+ A KKL + + E + + N R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 571 GFCNEDQHRL-LVYEFISNGCL-------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
+ E + L LV ++ G L F + +Y A I GL LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-----AAEICCGLEDLHR 304
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
E +I++ D+KP+NILLDD RISD GLA + QT GT GY+APE K+
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
T D ++ G +L E+I + F+Q +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQ--RKKKIK 393
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 70/227 (30%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF---RTEVNAIGQTNHRNLVKLL 570
LGRG F V + K+ A KKL+ K + E + + + R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLY-ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 571 GFCNEDQHRL-LVYEFISNGCL---------AGFLFKNPKPSWYRRMQIAFGIARGLFYL 620
+ E + L LV ++ G + F+ P+ +Y I GL +L
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY-----TAQIVSGLEHL 305
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H+ II+ D+KP+N+LLDD RISD GLA LKA QT+T GT G++APE
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELL 361
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-----QMILVD 722
VD ++ GV L E+I R F E Q +L
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 46/240 (19%)
Query: 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDN---MVSGGDKEFR-------TEVNAIG 559
+LG G F+TV LA N VA+K + + E + +
Sbjct: 25 RKLGWGHFSTV---WLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 560 QTNHRNLVKLLG---FCNED-QHRLLVYEFISNGCLAGFLFKNPKPSWYRRM------QI 609
+++KLL + H ++V+E + L + K +R + QI
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYE----HRGIPLIYVKQI 136
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS------FTARISDFGLAKILKADQTR 663
+ + GL Y+H C IIH DIKP+N+L++ +I+D G A
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE----QNVENENQMI 719
T TR Y +PE P DI+S ++ ELI FE + ++ I
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVN------AIGQTNHRNLV 567
+GRG F V+ A K+ A+K LD + +N + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMY-AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 568 KLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
+ + +L + + ++ G L L ++ S A I GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR--- 311
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPI 685
+++ D+KP NILLD+ RISD GLA + + GT GY+APE K +
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQ-NVENENQM 718
D +S G ML +L+ F Q ++++++
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 65/301 (21%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLD-------NMVSGGDKEFRTEVN----AIGQT 561
LG+G F TV G + VA+K + + +S EV
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGG 95
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF------KNPKPSWYRRM--QIAFGI 613
H +++LL + + +LV E LF R Q+ I
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTR 672
+ H ++H DIK +NIL+D A++ DFG +L D+ T GTR
Sbjct: 153 Q----HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD--GTR 202
Query: 673 GYVAPEWFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI-D 730
Y PEW + ++S G++L +++C F E + +++ + + ++
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----ERDQEILEAELHFPAHVSP 258
Query: 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL---MLEGVVEVPIP 787
+ L+ C+ PS RP+++++ L M +VP+
Sbjct: 259 DCCALIR---------------------RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
Query: 788 P 788
P
Sbjct: 298 P 298
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRT------EVNAIGQTNHRN 565
LG GAF V V +NK V VK + ++ E E+ + + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKE-VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLF------KNPKPSWYRRM--QIAFGIARGL 617
++K+L LV E +G LF + Q+ +
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAVG--- 144
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YL + IIH DIK +NI++ + FT ++ DFG A L+ + T GT Y AP
Sbjct: 145 -YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAP 198
Query: 678 EWFKSLP-ITMKVDIYSFGVMLLELICCRKKFE 709
E P +++++S GV L L+ F
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 68/315 (21%), Positives = 116/315 (36%), Gaps = 81/315 (25%)
Query: 513 ELGRGAFATVHKGVLAYENKICVAVKKLD-------NMVSGGDKEFRTEVNAIGQTNHR- 564
LG G F +V+ G+ +N VA+K ++ + G + EV + + +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGF 107
Query: 565 -NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF------KNPKPSWYRRM--QIAFGIAR 615
+++LL + +L+ E LF + R Q+ +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVR- 163
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
+ H ++H DIK +NIL+D + ++ DFG +LK D T GTR Y
Sbjct: 164 ---HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD--GTRVY 214
Query: 675 VAPEWFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
PEW + ++S G++L +++C F
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------------------------- 249
Query: 734 HLLVENDEEALHDMMRLKKYV------MIAIWCIQEDPSLRPT---------MKKVTL-- 776
E+DEE + + ++ V +I WC+ PS RPT M+ V L
Sbjct: 250 ----EHDEEIIRGQVFFRQRVSSECQHLIR-WCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304
Query: 777 MLEGVVEVPIPPDPS 791
+ + P PS
Sbjct: 305 ETAEIHLHSLSPGPS 319
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF V L +K+ A+K L M+ + FR E + + + + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVF-AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFY---------- 619
+ +D + L LV ++ G G L + + + FY
Sbjct: 141 -YAFQDDNNLYLVMDYY-VG---GDLL-----TLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
+H+ +H DIKP NIL+D + R++DFG L D T ++ GT Y++PE
Sbjct: 191 VHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 680 FKSLPI-----TMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
+++ + D +S GV + E++ F E+ +
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETY 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 53/232 (22%)
Query: 511 KDELGRGAFATVHKGVLAY--ENKICVAVKKLD----------------NMVSGGDKEFR 552
KDE+G+G++ V LAY + A+K L
Sbjct: 18 KDEIGKGSYGVVK---LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 553 TEVNAIGQT----------NHRNLVKL---LGFCNEDQHRLLVYEFISNGCLAGFLFKNP 599
I Q +H N+VKL L NED H +V+E ++ G + P
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKP 133
Query: 600 KP-----SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654
+++ + GI YLH + +IIH DIKP N+L+ + +I+DFG++
Sbjct: 134 LSEDQARFYFQ--DLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPIT---MKVDIYSFGVMLLELIC 703
K + + GT ++APE +D+++ GV L +
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG G F V G VAVK L+ + S + E+ + H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY--RRM--QIAFGIARGLFYLHEECTT 626
+ +V E++S G L ++ K+ + RR+ QI + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHRHM-- 131
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
++H D+KP+N+LLD A+I+DFGL+ ++ + T+ G+ Y APE
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGRLYA 188
Query: 687 -MKVDIYSFGVMLLELIC 703
+VDI+S GV+L L+C
Sbjct: 189 GPEVDIWSCGVILYALLC 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 61/246 (24%), Positives = 98/246 (39%), Gaps = 27/246 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF---RTEVNAIGQTNHRNLVKLL 570
LG+G F V + A+K L V E TE + + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+ + RL V E+ + G L L F + +Y I L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSALDYLHSE- 267
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+++ D+K +N++LD +I+DFGL K D T GT Y+APE +
Sbjct: 268 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744
VD + GV++ E++C R F ++ ++ ++ + E++ EA
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKL------FELILMEEIRFPRTLGPEAK 377
Query: 745 HDMMRL 750
+ L
Sbjct: 378 SLLSGL 383
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 514 LGRGAFATVH---KGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLVK 568
LG+G+F V K + ++ A+K L + + E + + + NH +VK
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLY-AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 569 LLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG----------IARGL 617
L + + + +L L+ +F+ G G LF ++ F +A L
Sbjct: 91 LH-YAFQTEGKLYLILDFL-RG---GDLF------TRLSKEVMFTEEDVKFYLAELALAL 139
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
+LH II+ D+KP+NILLD+ +++DFGL+K + + + GT Y+AP
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
E T D +SFGV++ E++ F+ ++ + +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ--GKDRKETM 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 35/248 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF+ V + ++ A+K + +M+ G+ FR E + + + R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVY-AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 571 GFCNEDQHRL-LVYEFISNGCL------AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
F +D++ L LV E+ G L G +Y I + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVHRL 181
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE----- 678
+H DIKP NILLD R++DFG L+AD T + GT Y++PE
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 679 --WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736
+ + D ++ GV E+ + F ++ + Y + K HL
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA--DSTAET------YGKIVHYKEHLS 290
Query: 737 VENDEEAL 744
+ +E +
Sbjct: 291 LPLVDEGV 298
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 24/217 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
+GRGAF V K+ A+K L M+ D F E + + N +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL----FKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
+ +D L +V E++ G L + +Y + L +H
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHS--- 186
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
IH D+KP N+LLD S +++DFG + + GT Y++PE KS
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 686 TMK----VDIYSFGVMLLELICCRKKFEQNVENENQM 718
D +S GV L E++ F ++
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGT 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFR---TEVNAIGQTNHRNLVKLL 570
+G+G+F V V + K A+K ++ E R E+ + H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+ +D+ + +V + + G L L FK + I + L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF----IC-ELVMALDYLQNQ- 134
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+IIH D+KP NILLD+ I+DF +A +L + TT A GT+ Y+APE F S
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRK 190
Query: 685 I---TMKVDIYSFGVMLLELICCRKKFE-QNVENENQMI 719
+ VD +S GV EL+ R+ + ++ + +++
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 62/244 (25%), Positives = 87/244 (35%), Gaps = 42/244 (17%)
Query: 483 MDQ----TGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAY--ENKICVA 536
MD+ TGP+ Y + K ++G G F L K VA
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRY-DFVK-------DIGSGNFGVAR---LMRDKLTKELVA 49
Query: 537 VKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLF 596
VK ++ + + R E+ H N+V+ H ++ E+ S G L +
Sbjct: 50 VKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC 108
Query: 597 KNPKPSWYRRMQIAFGIARGLF--------YLHEECTTQIIHCDIKPQNILLDDSFTAR- 647
R AR F Y H QI H D+K +N LLD S R
Sbjct: 109 NA------GRFSED--EARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRL 157
Query: 648 -ISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT-MKVDIYSFGVMLLELICCR 705
I DFG +K +T GT Y+APE D++S GV L ++
Sbjct: 158 KICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 706 KKFE 709
FE
Sbjct: 216 YPFE 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 26/196 (13%), Positives = 53/196 (27%), Gaps = 41/196 (20%)
Query: 512 DELGRGAFATVHKGVLAYENKIC--VAVKKLDNMVSGGD---KEFRTEVNAIGQTNHRNL 566
G + A + + VA+ +D D +E + + + + +
Sbjct: 37 IFHGGVPPLQFWQ---ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
++L + L+V E+I G L +P P ++ +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP--VGAIRAMQSLAAAADAAHRA--- 148
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+ P + +S G + + +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDANPQD---- 183
Query: 687 MKVDIYSFGVMLLELI 702
DI G L L+
Sbjct: 184 ---DIRGIGASLYALL 196
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 46/222 (20%)
Query: 514 LGRGAFATVHKGVLAY--ENKICVAVK-----KLDNMVSGGDKEFRTEVNAIGQTNHRNL 566
LG G++ V E AVK KL + +G + E+ + + H+N+
Sbjct: 13 LGEGSYGKVK---EVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNV 68
Query: 567 VKLLG--FCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLF----- 618
++L+ + E Q +V E+ G + P+ +R + A G F
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE----KRFPVC--QAHGYFCQLID 120
Query: 619 ---YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTR 672
YLH + I+H DIKP N+LL T +IS G+A+ L AD T T+ G+
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSP 175
Query: 673 GYVAPEWFKSL-----PITMKVDIYSFGVMLLELICCRKKFE 709
+ PE L KVDI+S GV L + FE
Sbjct: 176 AFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGLYPFE 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT-EVNA 557
+Y + +G G+F V + L ++ VA+KK+ DK F+ E+
Sbjct: 41 AYTNCKV--------IGNGSFGVVFQAKLVESDE--VAIKKVLQ-----DKRFKNRELQI 85
Query: 558 IGQTNHRNLVKLLGFCNEDQHRL------LVYEFISNGCLAGFLFKNPKPSWYRRMQI-- 609
+ H N+V L F + + LV E++ +++ + + +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-----VYRASRHYAKLKQTMPM 140
Query: 610 ------AFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQT 662
+ + R L Y+H + I H DIKPQN+LLD S ++ DFG AKIL A +
Sbjct: 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 663 RTTTAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELICCR 705
+ +R Y APE F + T +DI+S G ++ EL+ +
Sbjct: 198 NVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 514 LGRGAFATVHKGVLAYENKIC---VAVKKLD--NMVSGGDKE-FRTEVNAIGQTNHRNLV 567
LG G F V G ++++ VAVK L+ + S R E+ + H +++
Sbjct: 24 LGVGTFGKVKVG----KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 568 KLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY--RRM--QIAFGIARGLFYLHEE 623
KL + +V E++S G L ++ KN + RR+ QI G+ Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCHRH 135
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
++H D+KP+N+LLD A+I+DFGL+ ++ + T+ G+ Y APE
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGR 190
Query: 684 PIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
+VDI+S GV+L L+C F ++++ L
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPF----DDDHVPTL 224
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (206), Expect = 7e-18
Identities = 46/290 (15%), Positives = 91/290 (31%), Gaps = 40/290 (13%)
Query: 16 LMPISATAQNV-SRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTI 74
+P + +V ++L A S + F Q +GN L I N
Sbjct: 6 RIPFNGVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQ--GDGN--LVIQDNGAT---- 54
Query: 75 IWSANGKTPV-------ERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG------AAIAYA 121
+W AN + P + + + V L D + + VW D + +
Sbjct: 55 VWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHL 114
Query: 122 SMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQ 181
+ D GN VL + + + +L P ++L Y G +L Q
Sbjct: 115 VLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV---YGAGASKLVFQ 171
Query: 182 SDGNLVLYTTAFPFESANSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSAS 241
DGNLV Y + W+ G + + + ++++ +
Sbjct: 172 GDGNLVAY------GPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGH 225
Query: 242 SMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTPLFNSPNDCMI 291
+ + L+ +G + + + + + +P+ I
Sbjct: 226 A----SAVLRLQANGSIA--ILDEKPVWARFGFQPTYRHIRKINPDQKPI 269
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.0 bits (136), Expect = 7e-09
Identities = 24/132 (18%), Positives = 35/132 (26%), Gaps = 37/132 (28%)
Query: 95 DGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQ 154
DG LV G WN T G A GN V+ G + LW S
Sbjct: 173 DGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHS------------ 220
Query: 155 ILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST---QPVGSS 211
L +Q++G++ + W+ QP
Sbjct: 221 --------------HTGGHASAVLRLQANGSIAILD--------EKPVWARFGFQPTYRH 258
Query: 212 LQVEFNRSGNII 223
++ I
Sbjct: 259 IRKINPDQKPID 270
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (119), Expect = 8e-07
Identities = 25/125 (20%), Positives = 40/125 (32%), Gaps = 11/125 (8%)
Query: 39 SSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRL 98
+G FQ N L Y P W+A T + + DG L
Sbjct: 157 QGVVYGAGASKLVFQGDGN----LVAYG---PNGAATWNAG--TQGKGAVRAVFQGDGNL 207
Query: 99 VLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNP 158
V+ +W+ T G A A + +G+ + D P+W F +I
Sbjct: 208 VVYGAGNAVLWHSHTGGHASAVLRLQANGSIAI--LDEKPVWARFGFQPTYRHIRKINPD 265
Query: 159 RNKLS 163
+ +
Sbjct: 266 QKPID 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 53/242 (21%), Positives = 93/242 (38%), Gaps = 37/242 (15%)
Query: 479 HKTKMDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVK 538
++ + ++ ++ G+G F TV G VA+K
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERM--------AGQGTFGTVQLGKEKSTGMS-VAIK 54
Query: 539 K-LDNMVSGGDKEF--RT--EVNAIGQTNHRNLVKLLGF-------CNEDQHRLLVYEFI 586
K + D F R + + +H N+V+L + D + +V E++
Sbjct: 55 KVIQ------DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108
Query: 587 ----SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD- 641
C + + P ++ F + R + LH + + H DIKP N+L++
Sbjct: 109 PDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNE 166
Query: 642 DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLE 700
T ++ DFG AK L + +R Y APE F + T VDI+S G + E
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 701 LI 702
++
Sbjct: 225 MM 226
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 82.3 bits (202), Expect = 9e-18
Identities = 43/224 (19%), Positives = 76/224 (33%), Gaps = 25/224 (11%)
Query: 44 TSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103
F F Q + N L ++ + + W++N T G + L DG LV+
Sbjct: 24 ELSSFRFTMQ--SDCN--LVLFDSDVRV----WASN--TAGATGCRAVLQSDGLLVILTA 73
Query: 104 TGKEVWNPDTAGAAIAYA-SMLDSGNFVLAGPDSFPLW-----ESFDHPTDTLLPTQILN 157
W+ T G+ Y + + GP + +
Sbjct: 74 QNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQG 133
Query: 158 PRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVGSSLQVEFN 217
N ++ ++ Y L+M++D NLVL+ S N T G+ +
Sbjct: 134 NDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTN-----TAGKGTGCRAVLQ 188
Query: 218 RSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
+G + LT +N ++ +S +S L+ D L Y
Sbjct: 189 PNGRMDVLTNQNIAVW----TSGNSRSAGRYVFVLQPDRNLAIY 228
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 4e-10
Identities = 26/144 (18%), Positives = 45/144 (31%), Gaps = 36/144 (25%)
Query: 63 TIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAI-AYA 121
+Y + + ++ ++ + D LVL D VW+ +TAG A
Sbjct: 127 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRA 185
Query: 122 SMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQ 181
+ +G + + +W S + S GRY +Q
Sbjct: 186 VLQPNGRMDVLTNQNIAVWTS-------------------------GNSRSAGRYVFVLQ 220
Query: 182 SDGNLVLYTTAFPFESANSVYWST 205
D NL +Y W+T
Sbjct: 221 PDRNLAIY---------GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 25/164 (15%), Positives = 47/164 (28%), Gaps = 20/164 (12%)
Query: 146 PTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST 205
+ Q L+ L + MQSD NLVL+ ++ W++
Sbjct: 7 LSHEGSHPQTLHAAQSLE---------LSSFRFTMQSDCNLVLF-------DSDVRVWAS 50
Query: 206 QPVGSSL-QVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYP 264
G++ + G ++ LTA+N SS Y V +
Sbjct: 51 NTAGATGCRAVLQSDGLLVILTAQNTIRW---SSGTKGSIGNYVLVLQPDRTVTIYGPGL 107
Query: 265 KSSSSNNKSWSMHWSTPLFNSPNDCMITDETGSGACDCGFNSYC 308
S ++NK + + + + +
Sbjct: 108 WDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE------FRT 553
Y+ L +G G++ V K +I VA+KK + D + R
Sbjct: 27 YENLGL--------VGEGSYGMVMKCRNKDTGRI-VAIKK---FLESDDDKMVKKIAMR- 73
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFG 612
E+ + Q H NLV LL C + + LV+EF+ + + L P Y+ +Q F
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQ 132
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
I G+ + H IIH DIKP+NIL+ S ++ DFG A+ L A TR
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATR 188
Query: 673 GYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
Y APE + VD+++ G ++ E+
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 514 LGRGAFATVHKGVLAY--ENKICVAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG GA+ V LA + VAVK +D + + E+ NH N+VK
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF--------YLHE 622
G E + L E+ S G L + + M A+ F YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPD------IGMPEP--DAQRFFHQLMAGVVYLHG 123
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT----RTTTAIRGTRGYVAPE 678
I H DIKP+N+LLD+ +ISDFGLA + + + GT YVAPE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAPE 177
Query: 679 WFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVEN 714
K VD++S G++L ++ ++Q ++
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 496 QIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT-E 554
Q SY + + +G G+F V++ L ++ VA+KK+ DK F+ E
Sbjct: 52 QEVSYTDTKV--------IGNGSFGVVYQAKLCDSGEL-VAIKKVLQ-----DKRFKNRE 97
Query: 555 VNAIGQTNHRNLVKLLG-------------------FCNEDQHRLLVYEFISNGCLAGFL 595
+ + + +H N+V+L + E +R+ + + L
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 157
Query: 596 FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLA 654
K + + R L Y+H + I H DIKPQN+LLD D+ ++ DFG A
Sbjct: 158 VKL----------YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 655 KILKADQTRTTTAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELICCR 705
K L + + +R Y APE F + T +D++S G +L EL+ +
Sbjct: 205 KQLVRGEPNVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE------FRT 553
Y+++ K +G G++ V K +I VA+KK + D R
Sbjct: 5 YEKIGK--------IGEGSYGVVFKCRNRDTGQI-VAIKK---FLESEDDPVIKKIALR- 51
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFG 612
E+ + Q H NLV LL + LV+E+ + + L + + ++ I +
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQ 110
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTR 672
+ + + H+ IH D+KP+NIL+ ++ DFG A++L + TR
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATR 166
Query: 673 GYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
Y +PE VD+++ G + EL+
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------F 551
Y++LEK +G G + TV K ++I VA+K+ LD+ D E
Sbjct: 4 YEKLEK--------IGEGTYGTVFKAKNRETHEI-VALKRVRLDD-----DDEGVPSSAL 49
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IA 610
R E+ + + H+N+V+L + D+ LV+EF L + ++
Sbjct: 50 R-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFL 107
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
F + +GL + H ++H D+KPQN+L++ + ++++FGLA+ R +A
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV 163
Query: 671 TRGYVAPEW-FKSLPITMKVDIYSFGVMLLELICCRK 706
T Y P+ F + + +D++S G + EL +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 514 LGRGAFATV---HKGVLAYENKICVAVKKL--DNMVSGGDKEFRT--EVNAIGQTNHRNL 566
LG+G + V K A KI A+K L +V T E N + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF-AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 567 VKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR---------- 615
V L+ + + +L L+ E++ +G G LF + F
Sbjct: 84 VDLI-YAFQTGGKLYLILEYL-SG---GELF------MQLEREGIFMEDTACFYLAEISM 132
Query: 616 GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
L +LH++ II+ D+KP+NI+L+ +++DFGL K D T T T GT Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
APE VD +S G ++ +++ F EN + I
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG--ENRKKTI 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQTNHRNL 566
LG+G F V K + A+K L + +++ + TE + T H L
Sbjct: 13 LGKGTFGKVILVREKA----TGRYY-AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 567 VKLLGFCNEDQHRL-LVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGLF 618
L + + RL V E+ + G L F F + +Y I L
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE 678
YLH +++ DIK +N++LD +I+DFGL K +D T GT Y+APE
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 175
Query: 679 WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
+ VD + GV++ E++C R F ++ ++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERL 213
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 514 LGRGAFATVHKGVLAY--ENKICVAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVKLL 570
LG GA+ V LA + VAVK +D + + E+ NH N+VK
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF--------YLHE 622
G E + L E+ S G L + + M A+ F YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPD------IGMPEP--DAQRFFHQLMAGVVYLHG 123
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT----RTTTAIRGTRGYVAPE 678
I H DIKP+N+LLD+ +ISDFGLA + + + GT YVAPE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAPE 177
Query: 679 WFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVEN 714
K VD++S G++L ++ ++Q ++
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG G+F V V E+ A+K L +V E E + N LVKL
Sbjct: 49 LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
F +D L +V E+++ G + L F P +Y A I YLH
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY-----AAQIVLTFEYLHSL- 160
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
+I+ D+KP+N+L+D +++DFG AK + RT T + GT +APE S
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWT-LCGTPEALAPEIILSKG 214
Query: 685 ITMKVDIYSFGVMLLELIC 703
VD ++ GV++ E+
Sbjct: 215 YNKAVDWWALGVLIYEMAA 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 61/228 (26%), Positives = 93/228 (40%), Gaps = 36/228 (15%)
Query: 514 LGRGAFATVH---KGVLAYENKICVAVKKL--DNMVSGGDKEFRT--EVNAIGQTNHRN- 565
LG GA+ V K K+ A+K L +V T E +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR--------- 615
LV L + + + +L L+ ++I NG G LF + + F
Sbjct: 121 LVTLH-YAFQTETKLHLILDYI-NG---GELF------THLSQRERFTEHEVQIYVGEIV 169
Query: 616 -GLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
L +LH+ II+ DIK +NILLD + ++DFGL+K AD+T GT Y
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 675 VAPE--WFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720
+AP+ VD +S GV++ EL+ F + E +Q +
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 490 MPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLD--NMVS 545
M + I Y + + LG G+F V LA + + VA+K + +
Sbjct: 1 MAISKRHIGPY-IIRE-------TLGEGSFGKVK---LATHYKTQQKVALKFISRQLLKK 49
Query: 546 GGDKE-FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY 604
E++ + H +++KL ++V E+ G L ++ + + +
Sbjct: 50 SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED 108
Query: 605 --RRM--QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660
RR QI I Y H I+H D+KP+N+LLDD+ +I+DFGL+ I+
Sbjct: 109 EGRRFFQQIICAIE----YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161
Query: 661 QTRTTTAIRGTRGYVAPEWFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
T+ G+ Y APE +VD++S G++L ++ R F ++E
Sbjct: 162 NFLKTSC--GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPN 215
Query: 720 L 720
L
Sbjct: 216 L 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 34/207 (16%)
Query: 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDN---MVSGGDKEFR--TEVNAIGQTNHR 564
+G+G+F V V AY + VA+K + N +E R + + N
Sbjct: 103 KVIGKGSFGQV---VKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 565 NLVKLLGFCNEDQHRLLV--------YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
N++ +L H + YE I GF + A I +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK-------FAHSILQC 212
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTA--RISDFGLAKILKADQTRTTTAIRGTRGY 674
L LH+ +IIHCD+KP+NILL + ++ DFG + + + +R Y
Sbjct: 213 LDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFY 265
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLEL 701
APE M +D++S G +L EL
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------ 550
Y+ + K LG G + V+K + N+ VA+K+ L++ ++E
Sbjct: 35 RYRRITK--------LGEGTYGEVYKAIDTVTNET-VAIKRIRLEH-----EEEGVPGTA 80
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
R EV+ + + HRN+++L + + L++E+ N L ++ KNP S
Sbjct: 81 IR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFL 138
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR-----ISDFGLAKILKADQTRTT 665
+ + G+ + H + +H D+KPQN+LL S + I DFGLA+ R
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQF 194
Query: 666 TAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
T T Y PE S + VDI+S + E++
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQTNHRNLVKLL 570
LG G+F VH + + A+K L + +V E E + H ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYY-AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 571 GFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+D ++ ++ ++I G L L F NP +Y A + L YLH +
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYLHSK- 125
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP 684
II+ D+KP+NILLD + +I+DFG AK + T T + GT Y+APE + P
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYT-LCGTPDYIAPEVVSTKP 179
Query: 685 ITMKVDIYSFGVMLLELIC 703
+D +SFG+++ E++
Sbjct: 180 YNKSIDWWSFGILIYEMLA 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------ 550
+Y +L+K LG G +ATV+KG + + VA+K+ L++ +E
Sbjct: 3 TYIKLDK--------LGEGTYATVYKGKSKLTDNL-VALKEIRLEH------EEGAPCTA 47
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI- 609
R EV+ + H N+V L + ++ LV+E++ L +L +
Sbjct: 48 IR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI--INMHNVK 103
Query: 610 --AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
F + RGL Y H + +++H D+KPQN+L+++ +++DFGLA+ K+ T+T
Sbjct: 104 LFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDN 159
Query: 668 IRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
T Y P+ S + ++D++ G + E+
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 36/219 (16%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------ 550
+K+LEK LG G +ATV+KG+ VA+K+ LD+ +E
Sbjct: 6 QFKQLEK--------LGNGTYATVYKGLNKTTGVY-VALKEVKLDS------EEGTPSTA 50
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
R E++ + + H N+V+L + + LV+EF+ N L ++ + R +++
Sbjct: 51 IR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELN 108
Query: 611 ------FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664
+ + +GL + HE +I+H D+KPQN+L++ ++ DFGLA+ T
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNT 164
Query: 665 TTAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
++ T Y AP+ S + +DI+S G +L E+I
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 32/207 (15%)
Query: 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDN---MVSGGDKEFR--TEVNAIGQTNHR 564
+G+G+F V V AY + VA+K + N ++ E R +N
Sbjct: 60 SLIGKGSFGQV---VKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 565 NLVKLLGFCNEDQHRLLV--------YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
+V L H LV Y+ + N G + A +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK-------FAQQMCTA 169
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTA--RISDFGLAKILKADQTRTTTAIRGTRGY 674
L +L IIHCD+KP+NILL + + +I DFG + + +R Y
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFY 224
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLEL 701
+PE +P + +D++S G +L+E+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKI--CVAVKK--LDNMVSGGDKE----- 550
Y LEK +G G + V+K +N A+KK L+ + E
Sbjct: 4 YHGLEK--------IGEGTYGVVYKA----QNNYGETFALKKIRLEK-----EDEGIPST 46
Query: 551 -FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQ 608
R E++ + + H N+VKL + + +LV+E + L L
Sbjct: 47 TIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKS 104
Query: 609 IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAI 668
+ G+ Y H+ +++H D+KPQN+L++ +I+DFGLA+ R T
Sbjct: 105 FLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHE 160
Query: 669 RGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
T Y AP+ S + +DI+S G + E++
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKE-FRTEVNAIGQ-TNHRNLVKL 569
LG+G+F V N+ A+K L D ++ D E E + H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFF-AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 570 LGFCNEDQHRL-LVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGLFYLH 621
+ + L V E+++ G L F + ++Y A I GL +LH
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFY-----AAEIILGLQFLH 135
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFK 681
+ I++ D+K NILLD +I+DFG+ K +T T GT Y+APE
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 191
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
VD +SFGV+L E++ + F ++E ++
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEEL 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQ-TNHRN 565
+G+G+F V HK E AVK L ++ +++ +E N + + H
Sbjct: 46 IGKGSFGKVLLARHKA----EEVFY-AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGL 617
LV L F + +L V ++I+ G L F F P+ +Y A IA L
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY-----AAEIASAL 152
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
YLH I++ D+KP+NILLD ++DFGL K + T+T GT Y+AP
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
E P VD + G +L E++ F N +M
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEM 247
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 35/216 (16%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------ 550
Y++LEK +G G + V+K + + +I VA+K+ LD + E
Sbjct: 22 KYQKLEK--------VGEGTYGVVYKAKDS-QGRI-VALKRIRLDA-----EDEGIPSTA 66
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI- 609
R E++ + + +H N+V L+ + ++ LV+EF+ L L +N + QI
Sbjct: 67 IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTG--LQDSQIK 122
Query: 610 --AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+ + RG+ + H+ +I+H D+KPQN+L++ +++DFGLA+ R+ T
Sbjct: 123 IYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTH 178
Query: 668 IRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
T Y AP+ S + VDI+S G + E+I
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRT--- 553
Y+ + + +G GA+ TV+K + VA+K + N GG +
Sbjct: 10 RYEPVAE--------IGVGAYGTVYKARDPHSGHF-VALKSVRVPNGGGGGGGLPISTVR 60
Query: 554 EVNA---IGQTNHRNLVKLL----GFCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYR 605
EV + H N+V+L+ + + ++ LV+E + L +L K P P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPA 119
Query: 606 RM--QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663
+ RGL +LH I+H D+KP+NIL+ T +++DFGLA+I
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
T + T Y APE VD++S G + E+
Sbjct: 177 TPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 483 MDQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--L 540
M++ G Y+ + + +G GA+ V K VA+K+ +
Sbjct: 1 MEKDGLCRADQQ-----YECVAE--------IGEGAYGKVFKARDLKNGGRFVALKRVRV 47
Query: 541 DNMVSGGDKE------FRTEVNA---IGQTNHRNLVKLL----GFCNEDQHRL-LVYEFI 586
+E R EV + H N+V+L + + +L LV+E +
Sbjct: 48 QT-----GEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
Query: 587 SNGCLAGFLFKNPKPSWYRRM--QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644
L +L K P+P + F + RGL +LH ++H D+KPQNIL+ S
Sbjct: 102 DQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 157
Query: 645 TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELI 702
+++DFGLA+I T+ + T Y APE VD++S G + E+
Sbjct: 158 QIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKEFRT--- 553
Y++L+ LG G FATV+K N+I VA+KK L + D RT
Sbjct: 11 RYEKLDF--------LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 554 EVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQI---A 610
E+ + + +H N++ LL + LV++F+ L + N I
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV--LTPSHIKAYM 118
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
+GL YLH+ I+H D+KP N+LLD++ +++DFGLAK R T
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVV 174
Query: 671 TRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
TR Y APE F + + VD+++ G +L EL+
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQ-TNHRN 565
LG+G+F V K + AVK L D ++ D E TE + NH
Sbjct: 31 LGKGSFGKVMLARVKE----TGDLY-AVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFY 619
L +L C + RL V EF++ G L + F + +Y A I L +
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----AAEIISALMF 139
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LH++ II+ D+K N+LLD +++DFG+ K + T T GT Y+APE
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEI 195
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
+ + VD ++ GV+L E++C FE ENE+ +
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--ENEDDL 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQ-TNHRN 565
LG+G+F V KG +++ AVK L D ++ D E E +
Sbjct: 28 LGKGSFGKVMLSERKG----TDELY-AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-------FKNPKPSWYRRMQIAFGIARGL 617
L +L C + RL V E+++ G L FK P +Y A IA GL
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY-----AAEIAIGL 134
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
F+L + II+ D+K N++LD +I+DFG+ K D T T GT Y+AP
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 190
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
E P VD ++FGV+L E++ + FE E+E+++
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELF 230
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 5e-15
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQTN-HRNLVKL 569
LG+G+F V +++ AVK L D ++ D E E + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELY-AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 570 LGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFYLHEE 623
C + RL V E+++ G L + FK P +Y A IA GLF+L +
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-----AAEIAIGLFFLQSK 461
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
II+ D+K N++LD +I+DFG+ K D T T GT Y+APE
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 517
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719
P VD ++FGV+L E++ + FE E+E+++
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELF 551
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQ-TNHRN 565
+GRG++A V K ++I A+K + + + D ++ +TE + Q +NH
Sbjct: 17 IGRGSYAKVLLVRLKK----TDRIY-AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFY 619
LV L C + + RL V E+++ G L + +Y + I+ L Y
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-----SAEISLALNY 125
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LHE II+ D+K N+LLD +++D+G+ K T+T GT Y+APE
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 181
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNV-------ENENQM 718
+ VD ++ GV++ E++ R F+ E+ +
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 42/208 (20%), Positives = 72/208 (34%), Gaps = 50/208 (24%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVK 568
LG G V + + A+K L + + R EV + + ++V+
Sbjct: 22 TSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVR 75
Query: 569 LLGFC----NEDQHRLLVYEFISNGCLAGFLF----KNPKPSWYRRM--QIAFGIARGLF 618
++ + L+V E G LF ++ R +I I +
Sbjct: 76 IVDVYENLYAGRKCLLIVMEC----LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 619 YLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYV 675
YLH I H D+KP+N+L + +++DFG AK Y
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------EKY- 175
Query: 676 APEWFKSLPITMKVDIYSFGVMLLELIC 703
D++S GV++ L+C
Sbjct: 176 ----------DKSCDMWSLGVIMYILLC 193
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 514 LGRGAFATV----HKGVLAYENKICVAVKKL--DNMVSGGDKEF-RTEVNAIGQ-TNHRN 565
+GRG++A V K ++I A++ + + + D ++ +TE + Q +NH
Sbjct: 60 IGRGSYAKVLLVRLKK----TDRIY-AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 566 LVKLLGFCNEDQHRL-LVYEFISNGCLAGFL-----FKNPKPSWYRRMQIAFGIARGLFY 619
LV L C + + RL V E+++ G L + +Y + I+ L Y
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-----SAEISLALNY 168
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LHE II+ D+K N+LLD +++D+G+ K T+T GT Y+APE
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 224
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNV-------ENENQM 718
+ VD ++ GV++ E++ R F+ E+ +
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA---------IGQTNHR 564
+G GA V A + VA+KKL F+ + +A + NH+
Sbjct: 33 IGSGAQGIVCAAYDA-ILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHK 84
Query: 565 NLVKLL-----GFCNEDQHRL-LVYEFIS---NGCLAGFLFKNPKPSWYRRMQ-IAFGIA 614
N++ LL E+ + +V E + + + RM + + +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-------QMELDHERMSYLLYQML 137
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGY 674
G+ +LH + IIH D+KP NI++ T +I DFGLA+ A + T TR Y
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF 708
APE + VDI+S G ++ E+I F
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 48/249 (19%), Positives = 85/249 (34%), Gaps = 65/249 (26%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEF--RTEVN 556
Y + LG G+F V + K A+KK+ D + R E++
Sbjct: 8 KYSLGKT--------LGTGSFGIVCEVFDIESGKR-FALKKVLQ-----DPRYKNR-ELD 52
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFG---- 612
+ +H N++KL+ + + N + ++ + +
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 613 -------------------------------------IARGLFYLHEECTTQIIHCDIKP 635
+ R + ++H + I H DIKP
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKP 169
Query: 636 QNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLPITMKVDIYS 693
QN+L++ T ++ DFG AK L + +R Y APE + T +D++S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWS 227
Query: 694 FGVMLLELI 702
G + ELI
Sbjct: 228 IGCVFGELI 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE--FRTEVNA---------IGQ 560
+ G++ V GV I VA+K++ N VS G +
Sbjct: 28 RFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 561 TNHRNLVKLLG-FCNEDQHRL----LVYEFISNGC-LAGFLFKNPKPSWYRRMQ-IAFGI 613
+H N++ L F + ++ + LV E + LA + + +Q + I
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
GL LH ++H D+ P NILL D+ I DF LA+ AD +T R
Sbjct: 144 LLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRW 198
Query: 674 YVAPE-WFKSLPITMKVDIYSFGVMLLELI 702
Y APE + T VD++S G ++ E+
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 51/222 (22%), Positives = 78/222 (35%), Gaps = 46/222 (20%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFR--TEVNAIGQTNHRNL 566
LG G F V + + K VA+K + N E ++ + N
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 567 VKLLGFCNEDQHRLLV--------YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
V + + N H + +EF+ + P + R +A+ + L
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPY------PLPHVR-HMAYQLCHALR 137
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTA-------------------RISDFGLAKILKA 659
+LHE Q+ H D+KP+NIL +S R++DFG A
Sbjct: 138 FLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----T 190
Query: 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
T I TR Y PE L D++S G +L E
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLL- 570
+G GA+ +V + + VA+KKL R E+ + H N++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEK-VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 571 -----GFCNEDQHRLLVYEFISNGC-LAGFLFKNPKPSWYRRMQ-IAFGIARGLFYLHEE 623
LV F+ L + ++Q + + + +GL Y+H
Sbjct: 91 VFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEE---KIQYLVYQMLKGLKYIH-- 143
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKS 682
+ ++H D+KP N+ +++ +I DFGLA+ A+ T TR Y APE
Sbjct: 144 -SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSW 198
Query: 683 LPITMKVDIYSFGVMLLELICCRKKF 708
+ VDI+S G ++ E++ + F
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 58/234 (24%)
Query: 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKK--LDNMVSGGDKE------ 550
Y++L K +G+G F V K + VA+KK ++N +KE
Sbjct: 18 KYEKLAK--------IGQGTFGEVFKARHRKTGQK-VALKKVLMEN-----EKEGFPITA 63
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRL--------LVYEFISNGCLAGFLFKNPKPS 602
R E+ + H N+V L+ C LV++F + LAG L
Sbjct: 64 LR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL------- 114
Query: 603 WYRRMQIAFGIA----------RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652
+ + F ++ GL+Y+H +I+H D+K N+L+ +++DFG
Sbjct: 115 --SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169
Query: 653 LAK---ILKADQTRTTTAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
LA+ + K Q T T Y PE +D++ G ++ E+
Sbjct: 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA---------IGQTNHR 564
+G GA V A VA+KKL F+ + +A + NH+
Sbjct: 70 IGSGAQGIVCAAYDA-VLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHK 121
Query: 565 NLVKLL------GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGL 617
N++ LL E Q LV E + L + + RM + + + G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGI 177
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
+LH + IIH D+KP NI++ T +I DFGLA+ A + T TR Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 232
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKF 708
E + VDI+S G ++ E++ + F
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 500 YKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIG 559
Y+ + K LGRG ++ V + + N+ V VK L + K+ + E+ I
Sbjct: 38 YQLVRK--------LGRGKYSEVFEAINITNNEK-VVVKILKPV---KKKKIKREI-KIL 84
Query: 560 Q--TNHRNLVKLLGFCNEDQHR--LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAF---G 612
+ N++ L + R LV+E ++N I F
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD------YDIRFYMYE 138
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGT 671
I + L Y H + I+H D+KP N+++D + R+ D+GLA+ Q
Sbjct: 139 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN------- 188
Query: 672 RGYVAPEWFKSLPI-------TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721
VA +FK + +D++S G ML +I ++ F +N +Q++ +
Sbjct: 189 -VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 46/227 (20%)
Query: 510 FKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRN 565
K LG GA+ V A VA+KK++ RT E+ + H N
Sbjct: 15 LKSLLGEGAYGVV---CSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHEN 70
Query: 566 LVKLL-----GFCNEDQHRLLVYEF--------ISNGCLAGFLFKNPKPSWYRRMQ-IAF 611
++ + ++ E IS L+ +Q +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-----------HIQYFIY 119
Query: 612 GIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG- 670
R + LH + +IH D+KP N+L++ + ++ DFGLA+I+ +
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 671 --------TRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
TR Y APE S + +D++S G +L EL R F
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-12
Identities = 24/135 (17%), Positives = 41/135 (30%), Gaps = 38/135 (28%)
Query: 74 IIWSANGKTPVERGSKVQLTV--DGRLVLTDLTGKEVWNPDTAGAAI-AYASMLDSGNFV 130
I+ + + + + D LVL D +W +T G A + G V
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 131 LAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYT 190
+ ++ +W+S G Y L +Q D N+V+Y
Sbjct: 75 VITNENVTVWQS-------------------------PVAGKAGHYVLVLQPDRNVVIY- 108
Query: 191 TAFPFESANSVYWST 205
W+T
Sbjct: 109 --------GDALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 9e-09
Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 18/112 (16%)
Query: 152 PTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWS--TQPVG 209
QIL+ L + T Y MQ+D NLVLY N+ W+ T +G
Sbjct: 13 HPQILHATESLEI-----LFGTHVYRFIMQTDCNLVLY-------DNNNPIWATNTGGLG 60
Query: 210 SSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
+ + G ++ +T +N ++ S + + + + L+ D + Y
Sbjct: 61 NGCRAVLQPDGVLVVITNENVTVW----QSPVAGKAGHYVLVLQPDRNVVIY 108
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 2e-12
Identities = 83/583 (14%), Positives = 179/583 (30%), Gaps = 139/583 (23%)
Query: 97 RLVLTDLTGKEVWN-PDT-AGAAIAYASMLDSGN-----FV--LAGPD-SFPLWESF-DH 145
+ +L+ + D +G + ++L FV + + F L
Sbjct: 43 KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF-LMSPIKTE 101
Query: 146 PTDTLLPTQILNP-RNKLSAHYSD----KNYSTGRYE---------LAMQSDGNLVLY-- 189
+ T++ R++L Y+D Y+ R + L ++ N+++
Sbjct: 102 QRQPSMMTRMYIEQRDRL---YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 190 -----TTAFPFESANSVYWSTQPVGSSLQVEFNRSGNIIYLTAKN----RSIIYMLSSSA 240
T A V S +V+ I +L KN +++ ML
Sbjct: 159 LGSGKTWV-----ALDVC-------LSYKVQCKMDFKIFWLNLKNCNSPETVLEML---- 202
Query: 241 SSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSW-SMHWSTPLFNSPNDCMITDETGSGA 299
Q L ++ + H K + ++ + + N ++ +
Sbjct: 203 ---QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCLLVLLNVQNAK 257
Query: 300 CDCGFNSYC-------------SLGNDQRPTCLCPQGYVPLDRND--LTKGCKQSFLSQ- 343
FN C L ++ LD + LT +S L +
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATT-------THISLDHHSMTLTPDEVKSLLLKY 310
Query: 344 -NC---DDPNQEVDLYDLV-----EM--EYTD-WPYFDYEHHQGVRLQWCREAC------ 385
+C D P + + E + W ++H +L E+
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVLEP 368
Query: 386 --MRDCFCTVAIFRNGE---------CWKKKNPLTNGRMAPDIEGKALIKIRRGNST--- 431
R F +++F W + + +L++ + ST
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 432 ------LKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQ 485
LK + +++ +H + V ++ L + I G+H ++
Sbjct: 429 PSIYLELKVK-LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI-GHHLKNIEH 486
Query: 486 TGPVMPSTNLQIFSYKELE-KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV 544
+ + ++ LE K G+ + + Y+ IC K + +V
Sbjct: 487 PERMTLFRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 545 SGGD-KEF--RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584
+ +F + E N I + + +L++ + ED+ ++E
Sbjct: 546 N--AILDFLPKIEENLI-CSKYTDLLR-IALMAEDEA---IFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 71/509 (13%), Positives = 140/509 (27%), Gaps = 143/509 (28%)
Query: 355 YDLVEMEYTDWPYFDYEHHQGVRLQWCREACMRDCFC------TVAIFRNGEC---WKKK 405
++ E +Y Y D +A + + C +I E K
Sbjct: 9 FETGEHQYQ---YKDILSVF-------EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK 58
Query: 406 NPLTNGRMAPDIEGKALIKIRRGNSTLKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLL 465
+ ++ L K E+ FV VL + FL +
Sbjct: 59 DAVSGTLR--------LFWTLL----SKQEEM--------VQKFVEEVLRINYKFLMSPI 98
Query: 466 Q---LGTFLLVFIFGYHKTKMDQTGPVMPSTNLQIFS-YKELEKATQGFKDELGRGAFAT 521
+ ++ ++ + ++ V N+ Y +L +A EL
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL----ELRPAKNVL 154
Query: 522 VH------KGVLA------------YENKI-------C----VAVKKLDNMVSGGDKEFR 552
+ K +A + KI C ++ L ++ D +
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 553 TEVNAIGQTNHR-NLVK--LLGFCNEDQHR--LLVYEFISN---------GC-------- 590
+ + R + ++ L + LLV + N C
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 591 --LAGFLFKNPKPSWYRRMQIAFGI----ARGLF--YLHEECTT---QIIHCDIKPQNIL 639
+ FL + + + + L YL ++ P+ +
Sbjct: 275 KQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLS 331
Query: 640 LDDSFTARISDFGLAKI---LKADQTRTTTAIRGTRGYVAP----EWFKSLPITMK-VDI 691
+ I D LA + + TT I + + P + F L + I
Sbjct: 332 I---IAESIRDG-LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 692 YSFGVMLLELICCRKKFE--QNVENE--NQMILVDWA-------YDCYIDEKLHLLVEND 740
+ +LL LI V N+ ++ Y++ K+ L +
Sbjct: 388 PT---ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL---EN 441
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRP 769
E ALH + + Y + + +D
Sbjct: 442 EYALHRSI-VDHYNIPKTFD-SDDLIPPY 468
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 7e-06
Identities = 66/441 (14%), Positives = 127/441 (28%), Gaps = 130/441 (29%)
Query: 98 LVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILN 157
LVL + V N W +F+ LL T+
Sbjct: 248 LVLLN-----VQNAKA--------------------------WNAFNLSCKILLTTRFKQ 276
Query: 158 PRNKLSA----HYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP-----V 208
+ LSA H S ++S + L+ Y P + V +T P +
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTP--DEVKSLLLKYLDCRPQDLPREVL-TTNPRRLSII 333
Query: 209 GSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY----VYP 264
S++ N ++ + I + SS + LE + + + V+P
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTI--IESSLNV---------LEPAEYRKMFDRLSVFP 382
Query: 265 KSSSSNNKSWSMHWSTPLFNSPNDCM-ITDETGSGACDCGFNSYCSL-GNDQRPTCLCPQ 322
S+ S+ W +D M + ++ + Y + + T P
Sbjct: 383 PSAHIPTILLSLIWFDV---IKSDVMVVVNK---------LHKYSLVEKQPKESTISIPS 430
Query: 323 GYVPL-----DRNDLTKGCKQSFLSQNCDDPNQEVDLYDLVEMEYTDWPYFDY-EHHQGV 376
Y+ L + L + + D + DL +Y ++ + HH
Sbjct: 431 IYLELKVKLENEYALHRSIVDHYNIPKTFDSD---DLIPPYLDQY----FYSHIGHH--- 480
Query: 377 RLQWCREACMRDCFCTV---------AIFRNGECWKKKNPLTNGRMAPDIEGKALIKIRR 427
L+ F V I + W + N L +++
Sbjct: 481 -LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN----------TLQQLKF 529
Query: 428 GNSTLKPEDTDSKKKVHSTSVFVVSVLLCSSVFLNFLLQLGTFLLVFIFGYHKTKMDQTG 487
+ D ++ V++ L+FL ++ L+ T + +
Sbjct: 530 YKPYICDNDPKYERLVNA--------------ILDFLPKIEENLIC----SKYTDLLRIA 571
Query: 488 PVMPSTNLQIFSYKELEKATQ 508
+M ++E K Q
Sbjct: 572 -LMAEDE---AIFEEAHKQVQ 588
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 35/214 (16%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLL- 570
+G GA+ V VA+KK+ + RT E+ + + H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGIND 92
Query: 571 ----GFCNEDQHRLLVYEF--------ISNGCLAGFLFKNPKPSWYRRMQ-IAFGIARGL 617
+ + +V + + L+ + + I RGL
Sbjct: 93 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----------HICYFLYQILRGL 141
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT--TAIRGTRGYV 675
Y+H + ++H D+KP N+LL+ + +I DFGLA++ D T T TR Y
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 676 APE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
APE S T +DI+S G +L E++ R F
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-12
Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 12/103 (11%)
Query: 44 TSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103
+ F Q E+ N L +Y + W++N ++G K L DG V+ D
Sbjct: 17 DVEPYHFIMQ--EDCN--LVLYDHSTSV----WASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 104 TGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWESFDH 145
G+ +W + Y + + GN V+ G +W + +
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-11
Identities = 31/128 (24%), Positives = 41/128 (32%), Gaps = 37/128 (28%)
Query: 80 GKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTA--GAAIAYASMLDSGNFVLAGPDSF 137
G++ + D LVL D VW +T G A + GNFV+ +
Sbjct: 13 GQSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGR 71
Query: 138 PLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFES 197
LW S G Y L +Q DGN+V+Y
Sbjct: 72 SLWAS-------------------------HSVRGNGNYVLVLQEDGNVVIY-------- 98
Query: 198 ANSVYWST 205
S WST
Sbjct: 99 -GSDIWST 105
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 5e-09
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 17/114 (14%)
Query: 148 DTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207
+ L + L L Y MQ D NLVLY + ++N +
Sbjct: 2 NLLTNGEGLYAGQSLD---------VEPYHFIMQEDCNLVLYDHSTSVWASN----TGIL 48
Query: 208 VGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
+ GN + A+ RS+ +S S + + L+ DG + Y
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSL----WASHSVRGNGNYVLVLQEDGNVVIY 98
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 55/230 (23%), Positives = 84/230 (36%), Gaps = 58/230 (25%)
Query: 512 DELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFR----TEVNAIGQTNHR- 564
++G G F V +L +NK AVK + N K++ E + + + +
Sbjct: 41 RKMGDGTFGRV---LLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDD 92
Query: 565 ----NLVKLLGFCNEDQHRLLV--------YEFISNGCLAGFLFKNPKPSWYRRMQIAFG 612
N+VK G H L+ YE I+ GF +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF------HIEDIK-LYCIE 145
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT---TTAIR 669
I + L YL + + H D+KP+NILLDD + + +T I+
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 670 ----G--------------TRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
G TR Y APE +L + D++SFG +L EL
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRT--EVNAIGQTNHRNLVKLL- 570
+G GA+ V V VA+KKL R E+ + H N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAK-VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 571 -----GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
++ LV F+ G G L K+ K R + + + +GL Y+H
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---A 146
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLP 684
IIH D+KP N+ +++ +I DFGLA+ ++ T TR Y APE +
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEVILNWMR 202
Query: 685 ITMKVDIYSFGVMLLELICCRKKF 708
T VDI+S G ++ E+I + F
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-12
Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 36/135 (26%)
Query: 77 SANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPD 135
V ++ + D VL D +GK VW +T G + ++ ++GN V+
Sbjct: 11 FTGHSLEVGPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS 69
Query: 136 SFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPF 195
+ +W++ N Y L +Q D N+V+Y
Sbjct: 70 NRVIWQT-------------------------KTNGKEDHYVLVLQQDRNVVIY------ 98
Query: 196 ESANSVYWSTQPVGS 210
V W+T +
Sbjct: 99 ---GPVVWATGSGPA 110
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 60/266 (22%), Positives = 91/266 (34%), Gaps = 86/266 (32%)
Query: 514 LGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFRTEVN-----AIGQTNHRN- 565
LG G F+TV L++ + K VA+K + + + E+ N N
Sbjct: 45 LGWGHFSTV---WLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNR 100
Query: 566 --LVKLLG-FC---NEDQHRLLVYEFISNGC-LAGFLFKNPKPSWYRRM------QIAFG 612
+V+LL F H +V+E + G L ++ K+ Y+ + +I
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSN----YQGLPLPCVKKIIQQ 154
Query: 613 IARGLFYLHEECTTQIIHCDIKPQNILL-------------------------------- 640
+ +GL YLH +C +IIH DIKP+NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 641 -----------------DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
+ +I+D G A + T TR Y + E
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGS 268
Query: 684 PITMKVDIYSFGVMLLELICCRKKFE 709
DI+S M EL FE
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFE 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 64/362 (17%), Positives = 109/362 (30%), Gaps = 120/362 (33%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKL-DNMVSGGDKEFRTE---------- 554
LGRGAF V + VAVK L + + +E
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 555 ---VNAIG--------------------------------------QTNHRNLVKLLGFC 573
VN +G R +G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 574 NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-----------------IAFGIARG 616
D R L S + + S + +F +A+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ--TRTTTA---IRGT 671
+ +L + IH D+ +NILL + +I DFGLA+ + D R A ++
Sbjct: 206 MEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLEL----------ICCRKKFEQNVENENQMILV 721
APE T++ D++SFGV+L E+ + ++F + ++ +M
Sbjct: 263 ----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--- 315
Query: 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781
+ ++ M C +PS RPT ++ L +
Sbjct: 316 ---------RAP----DYTTPEMYQTMLD---------CWHGEPSQRPTFSELVEHLGNL 353
Query: 782 VE 783
++
Sbjct: 354 LQ 355
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-12
Identities = 23/127 (18%), Positives = 37/127 (29%), Gaps = 37/127 (29%)
Query: 80 GKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAI-AYASMLDSGNFVLAGPDSFP 138
+ ++ + D LVL GK W +T G + + G ++ D
Sbjct: 18 DGRLTAKNHQLVMQGDCNLVLYG--GKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKT 75
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
+W S + G Y L +Q DG V+Y A
Sbjct: 76 IWSS-------------------------RSSSKQGEYVLILQDDGFGVIYGPA------ 104
Query: 199 NSVYWST 205
+ T
Sbjct: 105 ---IFET 108
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 29/116 (25%), Positives = 46/116 (39%), Gaps = 19/116 (16%)
Query: 146 PTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST 205
+ L Q+L +L+ ++L MQ D NLVLY + ++S +T
Sbjct: 5 TNNLLFSGQVLYGDGRLT---------AKNHQLVMQGDCNLVLYGGKYGWQS------NT 49
Query: 206 QPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
G + N G +I ++I SS SS + + L+ DGF Y
Sbjct: 50 HGNGEHCFLRLNHKGELIIKDDDFKTIW----SSRSSSKQGEYVLILQDDGFGVIY 101
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 51/220 (23%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA---------IGQTNHR 564
+G GA+ +V + + VAVKKL F++ ++A + H
Sbjct: 37 VGSGAYGSVCAAFDT-KTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHE 88
Query: 565 NLVKLL------GFCNEDQHRLLVYEF--------ISNGCLAGFLFKNPKPSWYRRMQ-I 609
N++ LL E LV + L +Q +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-----------HVQFL 137
Query: 610 AFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR 669
+ I RGL Y+H + IIH D+KP N+ +++ +I DFGLA+ + T
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA--- 191
Query: 670 GTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
TR Y APE + VDI+S G ++ EL+ R F
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 44/221 (19%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFR--TEVNAIGQTNHRNL 566
D LG GAF V + + VAVK + N E + +N +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 567 VKLLGFCNEDQHRLLV--------YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLF 618
V++L + H +V Y+FI F + R ++A+ I + +
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPF------RLDHIR-KMAYQICKSVN 132
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIR----G---- 670
+LH ++ H D+KP+NIL S + KI + ++T I+ G
Sbjct: 133 FLHSN---KLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSATY 186
Query: 671 ----------TRGYVAPEWFKSLPITMKVDIYSFGVMLLEL 701
TR Y APE +L + D++S G +L+E
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 28/131 (21%), Positives = 49/131 (37%), Gaps = 28/131 (21%)
Query: 147 TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWS-- 204
+D L L+ L+ G Y +Q+D NLVLY N W+
Sbjct: 1 SDRLNSGHQLDTGGSLA---------EGGYLFIIQNDCNLVLY-------DNNRAVWASG 44
Query: 205 TQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYP 264
T S ++ GN + + + +R+I ++ + + L+ D + Y
Sbjct: 45 TNGKASGCVLKMQNDGN-LVIYSGSRAIWASNTNRQNGN----YYLILQRDRNVVIY--- 96
Query: 265 KSSSSNNKSWS 275
+SNN W+
Sbjct: 97 --DNSNNAIWA 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 16/115 (13%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGS 88
G L G + F Q + N L +Y N W++ G
Sbjct: 7 GHQLDTGG-----SLAEGGYLFIIQ--NDCN--LVLYDNNRAV----WASG-TNGKASGC 52
Query: 89 KVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWES 142
+++ DG LV+ + +W +T Y + N V+ + +W +
Sbjct: 53 VLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 45/220 (20%), Positives = 87/220 (39%), Gaps = 43/220 (19%)
Query: 511 KDELGRGAFATVHKGV--LAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT------N 562
++GRG + V+K ++K A+K++ + ++A +
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKD-YALKQI--------EGTGISMSACREIALLRELK 76
Query: 563 HRNLVKLLG-FCNEDQHRL-LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIA------ 614
H N++ L F + ++ L++++ + L + K + S + +
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEHD-LWHII-KFHRASKANKKPVQLPRGMVKSLL 134
Query: 615 ----RGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR----ISDFGLAKILKADQTRTTT 666
G+ YLH ++H D+KP NIL+ R I+D G A+ L +
Sbjct: 135 YQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLA 190
Query: 667 AIRG---TRGYVAPEW-FKSLPITMKVDIYSFGVMLLELI 702
+ T Y APE + T +DI++ G + EL+
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 45/244 (18%), Positives = 89/244 (36%), Gaps = 75/244 (30%)
Query: 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNA---------IGQT 561
+ +G G++ V + E ++ VA+KK+ + F ++ + +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRV-VAIKKILRV-------FEDLIDCKRILREIAILNRL 109
Query: 562 NHRNLVKLL-----GFCNEDQHRLLVYEFI---------SNGCLAGFLFKNPKPSWYRRM 607
NH ++VK+L + +V E + L K
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT--------- 160
Query: 608 QIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667
+ + + G+ Y+H + I+H D+KP N L++ + ++ DFGLA+ + + +
Sbjct: 161 -LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 668 IRG--------------------------TRGYVAPE---WFKSLPITMKVDIYSFGVML 698
TR Y APE ++ T +D++S G +
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
Query: 699 LELI 702
EL+
Sbjct: 275 AELL 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 52/243 (21%), Positives = 91/243 (37%), Gaps = 54/243 (22%)
Query: 511 KDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFRTEVNA---------IG 559
K +GRG++ V LAY + VA+KK++ M F ++ +
Sbjct: 31 KHLIGRGSYGYV---YLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILN 80
Query: 560 QTNHRNLVKLL-----GFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQ-IAFGI 613
+ +++L + +V E LFK P ++ I + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG--- 670
G ++H + IIH D+KP N LL+ + ++ DFGLA+ + +++
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 671 ------------------TRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKFEQN 711
TR Y APE T +DI+S G + EL+ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 712 VEN 714
N
Sbjct: 256 PTN 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 50/226 (22%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRT--EVNAIGQTNHRNLVKL 569
LG G V V + VA+KK+ + S K E+ I + +H N+VK+
Sbjct: 19 LGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSV--K--HALREIKIIRRLDHDNIVKV 73
Query: 570 LGFCNEDQHRL--------------LVYEF--------ISNGCLAGFLFKNPKPSWYRRM 607
+L +V E+ + G L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE-----------HA 122
Query: 608 Q-IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTRTT 665
+ + + RGL Y+H + ++H D+KP N+ ++ +I DFGLA+I+ +
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 666 --TAIRGTRGYVAPE-WFKSLPITMKVDIYSFGVMLLELICCRKKF 708
+ T+ Y +P T +D+++ G + E++ + F
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 24/128 (18%), Positives = 36/128 (28%), Gaps = 36/128 (28%)
Query: 80 GKTPVERGSKVQLTVDGRLVLTDL-TGKEVWNPDTAGAAI-AYASMLDSGNFVLAGPDSF 137
R + + D LVLT VW T+G + + SG +
Sbjct: 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLN 77
Query: 138 PLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFES 197
++ S + G Y L +Q +G V+Y A
Sbjct: 78 TVFVS-------------------------NTVGQEGDYVLILQINGQAVVYGPA----- 107
Query: 198 ANSVYWST 205
WST
Sbjct: 108 ----VWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 7e-09
Identities = 23/122 (18%), Positives = 43/122 (35%), Gaps = 22/122 (18%)
Query: 144 DHP--TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSV 201
+ P + L +Q++ +L+ T Y L M+ D NLVL S ++
Sbjct: 1 NIPRVRNVLFSSQVMYDNAQLA---------TRDYSLVMRDDCNLVLTKG-----SKTNI 46
Query: 202 YWSTQPVGSSLQV--EFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLR 259
W + G SG + + ++ S+ + Y + L+ +G
Sbjct: 47 VWESGTSGRGQHCFMRLGHSGELDITDDRLNTVF---VSNTVGQEGDY-VLILQINGQAV 102
Query: 260 HY 261
Y
Sbjct: 103 VY 104
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 53/242 (21%), Positives = 92/242 (38%), Gaps = 72/242 (29%)
Query: 510 FKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ------- 560
+LG+GA+ V + VAVKK+ + F+ +A Q
Sbjct: 13 LVKKLGKGAYGIV---WKSIDRRTGEVVAVKKIFDA-------FQNSTDA--QRTFREIM 60
Query: 561 -----TNHRNLVKLLG-FCNEDQHRL-LVYEF--------ISNGCLAGFLFKNPKPSWYR 605
+ H N+V LL ++ + LV+++ I L
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV----------- 109
Query: 606 RMQ-IAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664
Q + + + + + YLH + ++H D+KP NILL+ +++DFGL++ + T
Sbjct: 110 HKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 665 TTAIRG--------------------TRGYVAPEW-FKSLPITMKVDIYSFGVMLLELIC 703
TR Y APE S T +D++S G +L E++C
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 704 CR 705
+
Sbjct: 227 GK 228
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-10
Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 18/114 (15%)
Query: 148 DTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207
+ LL Q L+ + L G Y L +Q+ NLV Y ++N T
Sbjct: 3 NVLLSGQTLHADHSLQ---------AGAYTLTIQNKCNLVKYQNGRQIWASN-----TDR 48
Query: 208 VGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
GS ++ GN++ N + SA + + L+ DG Y
Sbjct: 49 RGSGCRLTLLSDGNLVIYDHNNNDVW----GSACWGDNGKYALVLQKDGRFVIY 98
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 8e-10
Identities = 24/131 (18%), Positives = 41/131 (31%), Gaps = 36/131 (27%)
Query: 80 GKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFP 138
+ + + LV G+++W +T + ++L GN V+ ++
Sbjct: 14 DHSLQAGAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNND 72
Query: 139 LWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESA 198
+W S G+Y L +Q DG V+Y
Sbjct: 73 VW-------------------------GSACWGDNGKYALVLQKDGRFVIY--------- 98
Query: 199 NSVYWSTQPVG 209
V WS P G
Sbjct: 99 GPVLWSLGPNG 109
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 4e-09
Identities = 19/117 (16%), Positives = 32/117 (27%), Gaps = 36/117 (30%)
Query: 95 DGRLVLTDLTGKEVWNPDTAGAAI-AYASMLDSGNFVLAGPDSF-PLWESFDHPTDTLLP 152
D LVL + + +T G + + + G + +S P+W
Sbjct: 29 DCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVY---------- 76
Query: 153 TQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVG 209
N G Y + D ++ +Y A WST
Sbjct: 77 -------------PRSVNTVRGNYAATLGPDQHVTIYGPAI---------WSTPAAA 111
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-09
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 20/115 (17%)
Query: 149 TLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWS--TQ 206
LL +++ N+LS MQ D NLVLY + + T
Sbjct: 4 VLLTGDVIHTDNQLS---------YESAAFVMQGDCNLVLY--------NEAGGFQSNTH 46
Query: 207 PVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
G + N G + +A + + ++ + + + TL D + Y
Sbjct: 47 GRGVDCTLRLNNRGQLEIHSANSNTPVW-VYPRSVNTVRGNYAATLGPDQHVTIY 100
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 18/120 (15%), Positives = 39/120 (32%), Gaps = 26/120 (21%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSAN--GKTPVER 86
G+ + ++ + + AF Q + N L +Y + +N G+
Sbjct: 8 GDVIHTDN-----QLSYESAAFVMQ--GDCN--LVLYNEAG-----GFQSNTHGRG---V 50
Query: 87 GSKVQLTVDGRLVLTDLTGKEV---WNPDTAGAAIAYASML-DSGNFVLAGPDSFPLWES 142
++L G+L + + YA+ L + + GP +W +
Sbjct: 51 DCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP---AIWST 107
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 19/112 (16%), Positives = 31/112 (27%), Gaps = 39/112 (34%)
Query: 95 DGRLVLTDLTGKEVWNPDTAGAAI-AYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPT 153
D LVL + W +TA ++ D G V+ D +W+S
Sbjct: 30 DCNLVLYN----GNWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKS----------- 74
Query: 154 QILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST 205
G Y + DG LV++ + +
Sbjct: 75 --------------GAQSVKGNYAAVVHPDGRLVVFGPSV---------FKI 103
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 21/115 (18%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGS 88
G++L E +G+F Q ++ N L +Y W +N R
Sbjct: 9 GQTLDTEG-----HLKNGDFDLVMQ--DDCN--LVLYNGN-------WQSNTANN-GRDC 51
Query: 89 KVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYA-SMLDSGNFVLAGPDSFPLWES 142
K+ LT G LV+ + G VW YA + G V+ GP +++
Sbjct: 52 KLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP---SVFKI 103
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-07
Identities = 26/117 (22%), Positives = 42/117 (35%), Gaps = 25/117 (21%)
Query: 147 TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQ 206
T+ LL Q L+ L G ++L MQ D NLVLY + W +
Sbjct: 3 TNYLLSGQTLDTEGHLK---------NGDFDLVMQDDCNLVLY----------NGNWQSN 43
Query: 207 PV--GSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
G ++ G ++ ++ S A S++ Y + DG L +
Sbjct: 44 TANNGRDCKLTLTDYGELVIKNGDGSTV---WKSGAQSVKGNY-AAVVHPDGRLVVF 96
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 26/115 (22%), Positives = 41/115 (35%), Gaps = 18/115 (15%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGS 88
GE+L + +G + F Q E+ N L +Y P W+ N R
Sbjct: 7 GETLSPGE-----FLNNGRYVFIMQ--EDCN--LVLYDVDKPI----WATNTGGLD-RRC 52
Query: 89 KVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWES 142
+ + DG LV+ +W +T G Y + N V+ G W +
Sbjct: 53 HLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 20/124 (16%)
Query: 148 DTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207
+ L + L+P L+ GRY MQ D NLVLY P + N T
Sbjct: 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYDVDKPIWATN-----TGG 47
Query: 208 VGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSS 267
+ + GN++ + +N I +S + ++ L+ D + +Y +
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIW----ASNTGGENGNYVCVLQKDRNVV--IYGTAR 101
Query: 268 SSNN 271
+
Sbjct: 102 WATG 105
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 7e-07
Identities = 32/222 (14%), Positives = 54/222 (24%), Gaps = 61/222 (27%)
Query: 484 DQTGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKL--- 540
Q GPV S L + EK +G G F V + + + VA+K +
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEK--------IGEGVFGEVFQTIA---DHTPVAIKIIAIE 54
Query: 541 -----DNMVSGGDKEFRTEV---------NAIGQTNHRNLVKLLGFC------------- 573
+ +E E+ + + L
Sbjct: 55 GPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 574 -----------------NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
+D +V EF G + S I +
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTAS 173
Query: 617 LFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658
L + H D+ N+LL + ++ K
Sbjct: 174 LAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 39/180 (21%), Positives = 66/180 (36%), Gaps = 32/180 (17%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G G F + G Y N+ VA+K + + E+R + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEY-VAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYY 72
Query: 572 FCNEDQHRLLVYEFISNGCLAG------FLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
F ++ +V E L G F + S + IA + + Y+H +
Sbjct: 73 FGPCGKYNAMVLE------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 626 TQIIHCDIKPQNILLDDSFTAR-----ISDFGLAKILKADQT------RTTTAIRGTRGY 674
+I+ D+KP+N L+ I DF LAK +T R ++ GT Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 32/208 (15%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G G+F + +G N VA+K + E+RT G T + +
Sbjct: 18 IGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYY 73
Query: 572 FCNEDQHRLLVYEFISNGCLAG------FLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
F E H +LV + L G K S A + + +HE+
Sbjct: 74 FGQEGLHNVLVID------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 626 TQIIHCDIKPQNILLDDSFTAR-----ISDFGLAKILKADQT------RTTTAIRGTRGY 674
+++ DIKP N L+ + + DFG+ K + T R + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 675 VAPEWFKSLPITMKVDIYSFGVMLLELI 702
++ + + D+ + G + + +
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFL 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 43/206 (20%), Positives = 74/206 (35%), Gaps = 30/206 (14%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVK--KLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+G G+F ++ G VA+K + E + + + +
Sbjct: 17 IGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTIRW 72
Query: 572 FCNEDQHRLLVYEFISNGCLAG------FLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
E + ++V E L G F F + K S + +A + + Y+H
Sbjct: 73 CGAEGDYNVMVME------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123
Query: 626 TQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT------RTTTAIRGTRGYVA 676
IH D+KP N L+ I DFGLAK + +T R + GT Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 677 PEWFKSLPITMKVDIYSFGVMLLELI 702
+ + + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 11/93 (11%)
Query: 619 YLHEECTTQIIHCDIKPQNILLDDSFTARI--SDFGLAKILKADQT------RTTTAIRG 670
Y+HE +H DIK N+LL+ ++ D+GLA + G
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223
Query: 671 TRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC 703
T + + + + + + D+ G +++ +
Sbjct: 224 TIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 797 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.65 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.63 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.63 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.58 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.56 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.4 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.35 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.3 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.26 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.24 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.21 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.08 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.07 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.05 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.57 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.9 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.85 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 93.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.01 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 84.64 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=433.85 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=212.0
Q ss_pred HHHHHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc
Q 003759 501 KELEKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE 575 (797)
Q Consensus 501 ~el~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 575 (797)
.|+..++..|.++||+|+||+||+|++.. ..++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34444556788899999999999999742 2346799999975433 334689999999999999999999999999
Q ss_pred cCceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NIL 639 (797)
++..+||||||++|+|.++|... ..++|.+++.|+.|||+||+|||++ +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 99999999999999999999642 3578999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeecCccccccCC-CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccch
Q 003759 640 LDDSFTARISDFGLAKILKADQ-TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQ 717 (797)
Q Consensus 640 l~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 717 (797)
|++++.+||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-- 255 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-- 255 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998765433 233445679999999999999999999999999999999999 899997654321
Q ss_pred hhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 718 MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+... +..+......+. ....+.+++..||+.||++||||+||++.|+....+
T Consensus 256 --~~~~----i~~~~~~~~p~~---------~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 --VVEM----IRNRQVLPCPDD---------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp --HHHH----HHTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred --HHHH----HHcCCCCCCccc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 1111 112222111111 123467789999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=432.05 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=202.4
Q ss_pred hhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.++||+|+||+||+|++.. .++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356789999999999998753 2456799999987655556789999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC---------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 585 FISNGCLAGFLFKN---------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 585 y~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
||++|+|.++|++. .+++|.+++.|+.|||+||+|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999999653 3589999999999999999999998 99999999999999999999999
Q ss_pred eecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 650 DFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 650 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~i--- 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCI--- 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----HHHHH---
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----HHHHH---
Confidence 9999987654332 33445669999999999999999999999999999999999 899997654322 11111
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
..+........ ....+.+++..||+.||++||||+||+++|+.+.+.
T Consensus 274 -~~g~~~~~p~~---------~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 -TQGRELERPRA---------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHTCCCCCCTT---------CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HcCCCCCCccc---------ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111111111 123467789999999999999999999999987664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=430.50 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=208.4
Q ss_pred HhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.++||+|+||+||+|++.. .++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3456889999999999998753 235679999998765555678999999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC-------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEe
Q 003759 584 EFISNGCLAGFLFKN-------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISD 650 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 650 (797)
|||++|+|.++|.+. ..++|.+++.|+.||++||+|||++ +|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 999999999999653 4689999999999999999999998 999999999999999999999999
Q ss_pred ecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhh
Q 003759 651 FGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 651 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +... +
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~----i 243 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIEC----I 243 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHH----H
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----H
Confidence 999987654333 23334568999999999999999999999999999999999 899997654322 1111 1
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+........ ....+.+++..||+.||++||||+||++.|+++..
T Consensus 244 ~~~~~~~~p~~---------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGRVLQRPRT---------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11221111111 12346778999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=420.91 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=199.6
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.++||+|+||+||+|++.. .||||+++..... ..++|.+|+.++++++|||||+++|++.+ +..+||||||
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~----~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG----DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS----EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEeeEEeeCCCcEEEEEEECC----cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 456889999999999998742 3899998753322 33579999999999999999999999865 5689999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-Ccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~ 664 (797)
++|+|.++|... ..+++.+++.|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+...... ...
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999999754 5799999999999999999999998 99999999999999999999999999998765432 233
Q ss_pred cccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 665 TTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.....||+.|||||++.+ .+++.++|||||||+||||+||+.||........ +............+......
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~-- 265 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYASPDLSKLYKN-- 265 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCCCCCSTTSCTT--
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCCccccccc--
Confidence 445679999999999964 4689999999999999999999999976433221 11111111111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDP 790 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~~p 790 (797)
....+.+++..||+.||++||||.||++.|+.+. -+.|+.+
T Consensus 266 -------~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk~~ 306 (307)
T 3omv_A 266 -------CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPKIN 306 (307)
T ss_dssp -------SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC--
T ss_pred -------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCCCC
Confidence 1234667889999999999999999999998654 3445543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=413.81 Aligned_cols=247 Identities=23% Similarity=0.261 Sum_probs=199.4
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
+.++||+|+||+||+|+....+ ..||||+++... .+.+|+.++++++|||||++++++.+++..+|||||+++|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g-~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTG-FQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTC-CEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eCcEeccCCCeEEEEEEECCCC-CEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 4567999999999999987654 469999997532 2246999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCC----cc
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQT----RT 664 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~----~~ 664 (797)
+|.++|.+...+++.+...++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.+..+.. ..
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 9999998888899999999999999999999998 999999999999999987 699999999997754332 12
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|||||++.+..++.++|||||||+||||+||+.||......+....+.. . ......+..
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~---~~~~~~~~~------ 280 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---E---PPPIREIPP------ 280 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---S---CCGGGGSCT------
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---C---CCCchhcCc------
Confidence 2345799999999999999999999999999999999999999976544332211111 0 000111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.....+.+++..||+.||++|||+.|+++.|..
T Consensus 281 ---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 281 ---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112345678899999999999999999988754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=414.60 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.++||+|+||+||+|+....+ ..||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSG-KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEEeecCcCeEEEEEEECCCC-CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 344568999999999999987654 4699999976656666789999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.+ ..+++.+...++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999865 5689999999999999999999998 999999999999999999999999999987654433 2344
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +....... ... .+.. ...
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~----~~~-~~~~-~~~---- 295 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDN----LPP-RLKN-LHK---- 295 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHS----SCC-CCSC-GGG----
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcC----CCC-CCCc-ccc----
Confidence 679999999999999999999999999999999999999997653322 11111111 000 0000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.|+++.
T Consensus 296 -~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 -VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11345678899999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=404.80 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=195.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc----cCceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 582 (797)
.|.++||+|+||+||+|+....+ ..||+|++..... ...+.|.+|++++++++|||||++++++.+ ++..+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETT-VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35568999999999999987654 5699999965332 223569999999999999999999999864 4568999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||++|+|.+++.+...+++..+..++.||+.||+|||++ .++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 99999999999998888899999999999999999999997 12399999999999997 5899999999999864332
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
......||+.|||||++.+ +++.++|||||||+||||+||+.||........ +. ..+..+........
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~~----~~i~~~~~~~~~~~-- 253 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IY----RRVTSGVKPASFDK-- 253 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HH----HHHTTTCCCGGGGG--
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---HH----HHHHcCCCCCCCCc--
Confidence 2345679999999999875 699999999999999999999999965432211 11 11111111100110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||++|+++
T Consensus 254 ------~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 ------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01124567889999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=409.73 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=198.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC----ceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ----HRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~E 584 (797)
.+.++||+|+||+||+|++. +..||||+++... .....+..|+..+.+++|||||+++|+|.+++ ..+||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 35678999999999999873 4569999997532 11223445777778899999999999998754 5799999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC-----TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
||++|+|.++|+. ..++|..+.+|+.|+++||+|||+++ .++|+||||||+||||++++.+||+|||+++....
T Consensus 82 y~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 9999999999965 46899999999999999999999762 45899999999999999999999999999987654
Q ss_pred CCCc---ccccccccCccccccccccC------CCCccCceehHHHHHHHHHhCCcCCCccccccchhh-------HHHH
Q 003759 660 DQTR---TTTAIRGTRGYVAPEWFKSL------PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-------LVDW 723 (797)
Q Consensus 660 ~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~-------~~~~ 723 (797)
.... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.... ..+.
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3322 22345699999999999764 467899999999999999999888754332211100 0011
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.............+ +...........+.+++..||+.||++||||.||+++|+.+.+
T Consensus 241 ~~~~~~~~~~rp~~---p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 241 MRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCC---CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111122111111 1111222344567889999999999999999999999987643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=418.84 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=209.2
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCC----cEEEEEEEecccCCC-chHHHHHHHHHhhccCc-Cchhhhccccccc
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNH-RNLVKLLGFCNED 576 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~ 576 (797)
+.+..+.+.++||+|+||+||+|++...+ .+.||||++...... ..++|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 44455666788999999999999986432 357999999764332 34579999999999955 8999999998764
Q ss_pred -CceeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 003759 577 -QHRLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639 (797)
Q Consensus 577 -~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NIL 639 (797)
+..+||||||++|+|.++|++. ..+++.+++.|+.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999999642 3478999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccch
Q 003759 640 LDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQ 717 (797)
Q Consensus 640 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 717 (797)
+++++.+||+|||+|+.+..+.. .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999997655433 23345668999999999999999999999999999999998 8999976543221
Q ss_pred hhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 718 MILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+.. .+..+......+. ...++.+++..||+.||++||||+||++.|+.+++.
T Consensus 297 --~~~----~i~~g~~~~~p~~---------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 --FCR----RLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp --HHH----HHHHTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHH----HHHcCCCCCCCcc---------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 111 1111111111111 113466788999999999999999999999886543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=407.72 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=195.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.++||+|+||+||+|+....+ +.||||++...... ..+.|.+|+.++++++|||||++++++.+++..||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDG-RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEETTTC-CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEECCCC-CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 556688999999999999987654 46999999754322 235789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++|+|.++|... ..+++.+.+.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE- 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence 9999999999644 4568889999999999999999998 999999999999999999999999999987643221
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
..+...||+.|||||++.+..|+.++|||||||+||||+||+.||......+... .+..+........
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~--------~i~~~~~~~~~~~---- 248 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL--------KIISGSFPPVSLH---- 248 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHTCCCCCCTT----
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--------HHHcCCCCCCCcc----
Confidence 2234569999999999999999999999999999999999999997654322111 1111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||+.|+++
T Consensus 249 -----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 -----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1134567889999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=403.99 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=205.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||+||+|+....+ ..||||++.+. .....+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~-~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATS-REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEECCCC-CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 566789999999999999987654 46999999653 22345679999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-c
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-R 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 663 (797)
|+++|+|.+++.+...+++.+...++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999998888899999999999999999999998 999999999999999999999999999998764432 3
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|||||++.+..++.++||||+||++|||+||+.||......+. .. .+..+... ..+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~----~i~~~~~~-~p~~---- 256 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI----FA----KIIKLEYD-FPEK---- 256 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH----HHHHTCCC-CCTT----
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HH----HHHcCCCC-CCcc----
Confidence 34556799999999999999999999999999999999999999976533221 11 11111111 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
....+.+++..||+.||++|||++|++
T Consensus 257 -----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 -----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 012456789999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=415.23 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.++||+|+||+||+|+....+ ..||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||+
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSG-KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEECCCC-CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 445578999999999999987654 4699999987666666789999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.. ..+++.+...|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 9999999864 4689999999999999999999998 999999999999999999999999999987654433 2344
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +........ ...+.. ...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~-~~~~~~-~~~-------- 372 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNL-PPRLKN-LHK-------- 372 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSC-CCCCSC-TTS--------
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCC-CCCCcc-ccc--------
Confidence 679999999999999999999999999999999999999997643322 111111110 000000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.|+++.
T Consensus 373 -~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 -VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11345678899999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=390.10 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=188.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||+||+|+....+ ..||||++++... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTG-QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTC-CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 566788999999999999987554 5699999975322 234579999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+ +|+|.+++.+...+++.+...++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence 99 689999998888999999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|||||++.+..+ +.++||||+||++|||+||+.||......+ +.. .+..+... ... .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~----~i~~~~~~-~p~----~ 234 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFK----NISNGVYT-LPK----F 234 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHTCCC-CCT----T
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH----HHHcCCCC-CCC----C
Confidence 334569999999999998876 579999999999999999999997643221 111 11111111 000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||++|+++
T Consensus 235 -----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 -----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0134567889999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=397.14 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=194.2
Q ss_pred HhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
|.+.+.||+|+||+||+|+... ..++.||||+++.... .....+.+|++++++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5667899999999999998753 2346799999975322 22346889999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.+...+++.+...++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-
Confidence 9999999999998888999999999999999999999998 999999999999999999999999999986543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|||||++.+..++.++|||||||++|||+||+.||......+.. ... ...... . +..
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i----~~~~~~-~----p~~ 248 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM----TMI----LKAKLG-M----PQF 248 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH----HHCCCC-C----CTT
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH----HHH----HcCCCC-C----CCc
Confidence 233457999999999999999999999999999999999999999765432211 111 111111 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
....+.+++..||+.||++||| ++|+++
T Consensus 249 -----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 -----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1124567889999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.80 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=182.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccC---------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ--------- 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--------- 577 (797)
+.+.+.||+|+||+||+|+...++ ..||||+++....+ ..+.+.+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDD-CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTC-CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred CEEeeEEecCCCeEEEEEEECCCC-CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 455678999999999999987654 46999999754332 2357899999999999999999999986544
Q ss_pred ---ceeeeeecccCCchhhhcccCCCC---ChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEee
Q 003759 578 ---HRLLVYEFISNGCLAGFLFKNPKP---SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651 (797)
Q Consensus 578 ---~~~lV~Ey~~~gsL~~~l~~~~~l---~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 651 (797)
..++||||+++|+|.+++.+...+ .+...+.|+.||++||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999876543 3455788999999999999998 9999999999999999999999999
Q ss_pred cCccccccCCCc-----------ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhH
Q 003759 652 GLAKILKADQTR-----------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720 (797)
Q Consensus 652 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 720 (797)
|+|+.+...... ..+...||+.|||||++.+..++.++|||||||++|||++ ||....+. ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HHH
Confidence 999877543221 1233569999999999999999999999999999999996 77543211 111
Q ss_pred HHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .......... .......+.+++..||+.||++|||+.|+++
T Consensus 237 ~~----~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT----DVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH----HHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 1111111100 0111123456889999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.78 Aligned_cols=227 Identities=22% Similarity=0.385 Sum_probs=182.5
Q ss_pred ccccccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCcc-----CceeeEe
Q 003759 19 ISATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVER-----GSKVQLT 93 (797)
Q Consensus 19 ~~~~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~-----~~~~~~~ 93 (797)
++++.|+|++|++|+++ ++|+|++|+|+||||++ +++|| |+ +++ |||+||||+|+.+ ++.|+|+
T Consensus 10 ~~~~~~~l~~g~~l~~~---~~l~S~~g~F~lgf~~~--~~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~ 78 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAG---QYLLSPNQRFKLLLQGD--GNLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLA 78 (276)
T ss_dssp CCTTSSEECTTEEBCTT---CEEECTTSSEEEEECTT--SCEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSE
T ss_pred ccccCCEecCCCEecCC---CEEEcCCCcEEEEEECC--CCeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEe
Confidence 45667999999999864 57999999999999944 37788 77 778 9999999999976 6789999
Q ss_pred eCceEEE--EcCCCceEeccCCCC------CceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcc----cCCCce
Q 003759 94 VDGRLVL--TDLTGKEVWNPDTAG------AAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQI----LNPRNK 161 (797)
Q Consensus 94 ~~g~l~l--~~~~~~~vW~t~~~~------~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~----l~~~~~ 161 (797)
.||+|+| .|++|++||+|+++. ..++.|+|+|+|||||+| +.+|||| |||||+||||| |..+.+
T Consensus 79 ~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 79 FYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp EEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred CCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCcc
Confidence 9999999 788899999999765 346789999999999998 7899999 99999999999 666777
Q ss_pred EEecCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCCCCc-eeeeecccccEEEEEecCceEEEEEeccC
Q 003759 162 LSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVGSS-LQVEFNRSGNIIYLTAKNRSIIYMLSSSA 240 (797)
Q Consensus 162 L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (797)
| ++.+||++|.|++.||++|++++|... ..+||++++++.. ..+.++.+|..+++ ..++..+......
T Consensus 155 L---~S~~dps~G~fsl~l~~dGnlvLy~~~------~~~yW~Sgt~~~~~~~l~l~~dGnLvl~-d~~~~~vWsS~t~- 223 (276)
T 3m7h_A 155 L---VQGVVYGAGASKLVFQGDGNLVAYGPN------GAATWNAGTQGKGAVRAVFQGDGNLVVY-GAGNAVLWHSHTG- 223 (276)
T ss_dssp E---CTTCEEEETTEEEEECTTSCEEEECTT------SSEEEECCCTTTTCCEEEECTTSCEEEE-CTTSCEEEECSCT-
T ss_pred c---ccCCCCCCceEEEeecCCceEEEEeCC------CeEEEECCCCCCccEEEEEcCCCeEEEE-eCCCcEEEEecCC-
Confidence 7 567899999999999999998876321 3689999888533 56778888885544 3333332222111
Q ss_pred ccccceeEEEEEeeCCeEEEEEecCCCCCCCCCccEEeccC
Q 003759 241 SSMQDLYQRVTLEFDGFLRHYVYPKSSSSNNKSWSMHWSTP 281 (797)
Q Consensus 241 ~~~~~~~~r~~l~~dG~l~~~~w~~~~~~~~~~W~~~w~~p 281 (797)
. ...+|++|+.||++++|.|. ..|..+|.+|
T Consensus 224 -~--~~~~rl~Ld~dGnLvly~~~-------~~Wqsf~~~P 254 (276)
T 3m7h_A 224 -G--HASAVLRLQANGSIAILDEK-------PVWARFGFQP 254 (276)
T ss_dssp -T--CTTCEEEECTTSCEEEEEEE-------EEEESSSCCT
T ss_pred -C--CCCEEEEEcCCccEEEEcCC-------CeEEccCccC
Confidence 1 12489999999999999982 3588888887
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=384.26 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=199.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccc------ccCce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCN------EDQHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~------~~~~~ 579 (797)
|.+.+.||+|+||+||+|+....+ ..||||+++..... ..+.+.+|+++|++++|||||++++++. +.+..
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTG-QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEECCCC-CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 456688999999999999987654 46999999754332 2356889999999999999999999865 34678
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
|||||||+ |+|.+++.+...+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999995 78999998888999999999999999999999998 999999999999999999999999999987643
Q ss_pred CC---CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 660 DQ---TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 660 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
.. ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+....+...... ........
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~-p~~~~~~~ 289 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT-PSPAVIQA 289 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCGGGTC-
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC-CChHHhhh
Confidence 32 2334456799999999998775 5699999999999999999999999876443322222111100 00000000
Q ss_pred --------cc----cc---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 736 --------LV----EN---DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 736 --------~~----~~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. .. ...... ......+.+++..||+.||++|||+.|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 000000 0012356789999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=370.34 Aligned_cols=289 Identities=42% Similarity=0.698 Sum_probs=237.0
Q ss_pred CCCccccCHHHHHHHHHhh--hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhh
Q 003759 492 STNLQIFSYKELEKATQGF--KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVK 568 (797)
Q Consensus 492 ~~~~~~~~~~el~~~~~~f--~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~ 568 (797)
......+++.++.....+| .+.||+|+||.||+|.... +..||||++...... ....+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD--GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS--SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC--CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 3456678889988877766 5789999999999998643 456999998764332 3347999999999999999999
Q ss_pred hcccccccCceeeeeecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 569 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+..+|+|+||||+|||+++++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 999999999999999999999999999754 3489999999999999999999998777999999999999999999
Q ss_pred cEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccc-cchhhHHHH
Q 003759 645 TARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN-ENQMILVDW 723 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~-~~~~~~~~~ 723 (797)
.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999999877655555555566999999999999889999999999999999999999999643211 122234455
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
..............+..............+.+++..||+.||++|||++||+++|++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55555555555555555544455566778999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.88 Aligned_cols=198 Identities=21% Similarity=0.347 Sum_probs=168.1
Q ss_pred HhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.++||+|+||+||+|+.+. ..+..||||++... ....++.+|++++..+ +||||+++++++.+.++.+||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 4566789999999999998753 34567999998653 3456788999999988 79999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~- 662 (797)
|+++|+|.+++. .+++.+...++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999983 488999999999999999999998 99999999999999876 7999999999986543211
Q ss_pred --------------------------cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 663 --------------------------RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 663 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
...+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 112334699999999999775 589999999999999999999999965433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=362.58 Aligned_cols=271 Identities=36% Similarity=0.617 Sum_probs=222.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
+.+.||+|+||.||+|++. ++..||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred ccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 3567999999999999964 34569999988765566678999999999999999999999999999999999999999
Q ss_pred chhhhcccCC----CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC-Ccc
Q 003759 590 CLAGFLFKNP----KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ-TRT 664 (797)
Q Consensus 590 sL~~~l~~~~----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~ 664 (797)
+|.+++.... .+++..++.++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997543 588999999999999999999998 99999999999999999999999999998654322 223
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ....+.......+.+...+++.....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccHHHhcChhhccc
Confidence 33455899999999999889999999999999999999999999765443321 22334333334444444444443333
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~ 786 (797)
........+.+++..||+.||++|||+.||++.|+.+..+..
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 445566778899999999999999999999999998766543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=389.69 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=203.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.++||+|+||+||+|+....+ ..||+|++........+.+.+|+.+|+.++|||||++++++.+++..+||||||+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg-~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATG-NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCC-CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 566789999999999999987655 4699999976554455678999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC--CcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS--FTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+|+|.++|.+. ..+++.+...++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.... .
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 99999998644 6789999999999999999999998 99999999999999854 899999999999875433 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ ....... .......
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i--------~~~~~~~-~~~~~~~- 382 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWNM-DDSAFSG- 382 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCCC-CSGGGTT-
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HhCCCCC-CcccccC-
Confidence 33456999999999999999999999999999999999999999765432211111 1111100 0000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+|+..||+.||++|||+.|+++.
T Consensus 383 ----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 ----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01345678899999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=381.16 Aligned_cols=247 Identities=23% Similarity=0.255 Sum_probs=195.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHH---HHHHhhccCcCchhhhcccccccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRT---EVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~---E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
+.+.+.||+|+||+||+|+....+ ..||||++++.. ......+.+ ++.+++.++|||||++++.+.+.+..||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg-~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTG-KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCC-CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 345678999999999999987654 569999996421 122233344 4667778899999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++|+|.++|.+...+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 999999999999998888899999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcccccccccCccccccccc-cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFK-SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.....||+.|||||++. +..|+.++|+|||||+||||++|+.||......... .+.... ...... ..+.
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i----~~~~~~-~p~~- 416 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT----LTMAVE-LPDS- 416 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHH----HHCCCC-CCTT-
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhh----cCCCCC-CCcc-
Confidence 23457999999999996 457999999999999999999999999765432211 111111 111111 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
-...+.+++..||+.||++|++ ++||++
T Consensus 417 --------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 --------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0124567889999999999998 677764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.58 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=196.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||+||+|+.. +..||||++....... .++|.+|++++++++||||+++++++.+.+..++||||
T Consensus 39 y~i~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred ceeeeEeecCCCeEEEEEEEC---CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 445678999999999999763 4569999987543322 34689999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCC---CChhhHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 586 ISNGCLAGFLFKNPK---PSWYRRMQIAFGIARGLFYLHEECTTQ--IIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+++|+|.+++..... +++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999987643 89999999999999999999998 7 999999999999999999999999999754432
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ...... ... ......
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~----~~~~~~--~~~-~~~~~~- 263 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV----AAVGFK--CKR-LEIPRN- 263 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHHS--CCC-CCCCTT-
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhc--CCC-CCCCcc-
Confidence 2 2233456899999999999999999999999999999999999999765332211 111000 000 011111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPS 791 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~~p~ 791 (797)
....+.+++..||+.||++|||+.+|++.|+.+..-..||.++
T Consensus 264 --------~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 264 --------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp --------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred --------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 1124667889999999999999999999999988766665443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.29 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=205.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||+||+|+....+ ..||+|++........+.|.+|++++++++||||+++++++.+++..++||||++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~-~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETG-EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTC-CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccceecCCCCEEEEEEEECCCC-cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 345678999999999999987654 4699999876555556789999999999999999999999999999999999999
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc--
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT-- 664 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-- 664 (797)
+++|.+++.. ...+++.+++.++.|+++||+|||+. +|+|+||||+|||++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999986 46789999999999999999999998 99999999999999999999999999998764332211
Q ss_pred -----------cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhh--HHHHHHhhhccc
Q 003759 665 -----------TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI--LVDWAYDCYIDE 731 (797)
Q Consensus 665 -----------~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~--~~~~~~~~~~~~ 731 (797)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+........... ........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~---- 243 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY---- 243 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT----
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc----
Confidence 1145689999999999999999999999999999999999999865433221110 00000000
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
. .......+.+++..||+.||++|||+.||++.|+.+..
T Consensus 244 -~------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 244 -C------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -C------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00011245678889999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.60 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=210.6
Q ss_pred cccCHHHHHHHHHhh------------hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc
Q 003759 496 QIFSYKELEKATQGF------------KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH 563 (797)
Q Consensus 496 ~~~~~~el~~~~~~f------------~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h 563 (797)
..++++++..++... .+.||+|+||.||+|+.... +..||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS-GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCC-CcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 458899999888642 34699999999999998754 44699999987666666789999999999999
Q ss_pred CchhhhcccccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 564 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998854 5689999999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH
Q 003759 644 FTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 723 (797)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~----~~~ 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKR 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHH
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH
Confidence 9999999999987654332 22345689999999999999999999999999999999999999976433211 111
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ...... ... ......+.+++..||+.||++|||+.|+++.
T Consensus 253 ~~~----~~~~~~-~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRD----SPPPKL-KNS------HKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH----SSCCCC-TTG------GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Hhc----CCCCCc-Ccc------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 110000 000 0011345678889999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=344.28 Aligned_cols=281 Identities=37% Similarity=0.581 Sum_probs=219.8
Q ss_pred CCccccCHHHHHHHHHhhh--------hhhCcccceeEEEEEEecCCcEEEEEEEecccC----CCchHHHHHHHHHhhc
Q 003759 493 TNLQIFSYKELEKATQGFK--------DELGRGAFATVHKGVLAYENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQ 560 (797)
Q Consensus 493 ~~~~~~~~~el~~~~~~f~--------~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~ 560 (797)
.....|++.++..++.+|. +.||+|+||.||+|... +..||||++.... ....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS---SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC---CceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3457899999999999986 45999999999999863 3469999986532 2234578999999999
Q ss_pred cCcCchhhhcccccccCceeeeeecccCCchhhhccc---CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 003759 561 TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK---NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQN 637 (797)
Q Consensus 561 l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~N 637 (797)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 9999999999999999999999999999999999863 35689999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccc
Q 003759 638 ILLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN 716 (797)
Q Consensus 638 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~ 716 (797)
|++++++.+||+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999999987654332 22334568999999998876 478999999999999999999999976544332
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
...+...... ....+...++.... .........+.+++..||+.||++|||+.+|++.|+++.+
T Consensus 243 ~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIED--EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHT--TSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhh--hhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2211111100 01111111111111 1123345667889999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.42 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=202.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||+||+|.....+ ..||||++........+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTC-CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeeeeeeccCCCeEEEEEEECCCC-cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 344578999999999999876544 5699999976666667789999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+++|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 175 (297)
T 3fxz_A 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (297)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCC
Confidence 99999999654 588999999999999999999998 999999999999999999999999999987654333 2334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ... .... . .. +.
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~----~~~~-~-~~-~~----- 240 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATN----GTPE-L-QN-PE----- 240 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHH----CSCC-C-SC-GG-----
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhC----CCCC-C-CC-cc-----
Confidence 56899999999999999999999999999999999999999764332211111 000 0000 0 00 00
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011345678899999999999999999873
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.51 Aligned_cols=264 Identities=27% Similarity=0.317 Sum_probs=206.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||.||+|.....+ ..||+|++....... .+.|.+|+.++.+++||||+++++++.+++..++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCC-CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 455678999999999999887544 469999986533332 3568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998765544444
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ..... ..... ...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------~~~~~-~~~~~-----~~~ 235 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-------KHIQD-SVPNV-----TTD 235 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-------HHHSS-CCCCH-----HHH
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhhc-cCCCc-----chh
Confidence 445568999999999999999999999999999999999999997654322111 11111 11000 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-TMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~eVl~~Le~~~~~~~p~ 788 (797)
........+.+++.+|++.||++|| ++.++.+.|+.+..-....
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 0011123567789999999999998 9999999999877655444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.68 Aligned_cols=261 Identities=22% Similarity=0.384 Sum_probs=206.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||.||+|.+...+ +..||||++..... ...+.|.+|+.++++++||||+++++++.+++..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3445578999999999999986433 35699999975432 23457999999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999654 5789999999999999999999998 999999999999999999999999999987654332
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..... .+.......
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----~~~~~----~~~~~~~~~- 277 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----ISSVE----EGYRLPAPM- 277 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----HHHHH----TTCCCCCCT-
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHH----cCCCCCCCC-
Confidence 22223346778999999999899999999999999999999 9999966533221 11111 111000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
.....+.+++..||+.||++|||+.||++.|+.+...+..
T Consensus 278 --------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 278 --------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1123467789999999999999999999999987765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.87 Aligned_cols=268 Identities=26% Similarity=0.349 Sum_probs=202.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC----ceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ----HRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 583 (797)
+.+.+.||+|+||+||+|+.. +..||||++.... .....+..|+.++.+++||||+++++++.... ..++||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred chhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 445678999999999999874 4579999996532 22345677999999999999999999998754 469999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-------CCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC-------TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
||+++|+|.+++... .+++..+..++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 999999999999654 5899999999999999999999751 33899999999999999999999999999987
Q ss_pred cccCCC-cccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHH--------H
Q 003759 657 LKADQT-RTTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV--------D 722 (797)
Q Consensus 657 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~--------~ 722 (797)
+..... .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||............. .
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 654332 22334568999999999986 356778999999999999999999997654322111000 0
Q ss_pred HHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 723 WAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..............+.. ..........+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00011111111111111 11122234567889999999999999999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.23 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=207.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|... ++..||+|++.... ...+++.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred heeeeeeeccCCCceEEEEEec--CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3455678999999999999775 34569999997543 34577999999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999999765 4589999999999999999999998 999999999999999999999999999987665544444
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+........
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~----- 229 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------SQGHRLYRPHL----- 229 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCCCCTT-----
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------HcCCCCCCCCc-----
Confidence 44456788999999999899999999999999999999 99999765432211111 11110000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
....+.+++..||+.||++|||+.|+++.|+.+.+-
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 113467789999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.03 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=205.2
Q ss_pred HhhhhhhCcccceeEEEEEEec------CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 508 QGFKDELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
+.+.+.||+|+||.||+|.... ..+..||||+++..... ..+++.+|+.+++++ +||||+++++++.+.+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 4456789999999999998742 23467999999764322 235789999999999 899999999999999999
Q ss_pred eeeeecccCCchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 580 LLVYEFISNGCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 99999999999999997542 478899999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHH
Q 003759 644 FTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILV 721 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 721 (797)
+.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~----~ 315 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL----F 315 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----H
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----H
Confidence 9999999999987654332 22333457889999999999999999999999999999999 9999976533221 1
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
. .+..+........ ....+.+++..||+.||++||++.|+++.|+.+..
T Consensus 316 ~----~~~~~~~~~~~~~---------~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 K----LLKEGHRMDKPAN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp H----HHHTTCCCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHhcCCCCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1111111111111 12346778899999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.59 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=205.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|.... +..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETT--TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeeheecCCCccEEEEEEecC--CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4456789999999999998763 4459999997643 345789999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999654 5689999999999999999999998 9999999999999999999999999999876544333334
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ... ..+.... .+ .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~----~~~----~~~~~~~--~~--~--- 230 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDI----STGFRLY--KP--R--- 230 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHH----HTTCCCC--CC--T---
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHH----hcCccCC--CC--C---
Confidence 4457788999999999999999999999999999999 99999764332211 111 1110000 00 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++..||+.||++|||+.|+++.|+++.+
T Consensus 231 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 --LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 012346678899999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.06 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=200.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|+||.||+|++...+ ..||||++...... ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTG-REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 445678999999999999986554 46999999754322 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 170 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KL 170 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GG
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999998665432 23
Q ss_pred ccccccCccccccccccCCCC-ccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPIT-MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....||+.|+|||++.+..+. .++||||||+++|||++|+.||......+... ....+......
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------~i~~~~~~~p~------- 235 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE--------RVLRGKYRIPF------- 235 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHCCCCCCT-------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhCCCCCCC-------
Confidence 445699999999999888765 89999999999999999999997654322111 11111111000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||++|+++.
T Consensus 236 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 ---YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011345678899999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=370.54 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=209.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+|++... +..||||+++... ...++|.+|+.++++++||||++++++|.+.+..++||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGG-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCC-CeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3455678899999999999998754 4569999997643 3467899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999753 4588999999999999999999998 9999999999999999999999999999876544433
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+.+..++.++||||||++||||+| |+.||......+. ...... +........
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~----~~~~~~----~~~~~~~~~--- 443 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEK----DYRMERPEG--- 443 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----HHHHHT----TCCCCCCTT---
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc----CCCCCCCCC---
Confidence 3334456789999999999899999999999999999999 9999976543221 111111 110000011
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 444 ------~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 444 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12346678899999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.38 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=200.9
Q ss_pred HHHhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc--cCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 580 (797)
..+.+.+.||+|+||+||++++. ...+..||||++........+.|.+|+.++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 34556788999999999999852 33456799999986554455679999999999999999999998855 35689
Q ss_pred eeeecccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999997653 589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccch--------hhHHHHHHhhhc
Q 003759 660 DQT--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQ--------MILVDWAYDCYI 729 (797)
Q Consensus 660 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~ 729 (797)
... .......+++.|+|||.+.+..++.++||||||+++|||+||..|+......... ............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 332 2223344677899999999999999999999999999999999998654221100 000000111111
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
......... .....+.+++..||+.||++|||+.||++.|+.+.
T Consensus 247 ~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 247 NNGRLPRPD---------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp TTCCCCCCT---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcCCCCc---------CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111110000 11235678899999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.40 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=203.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
..|.+.+.||+|+||.||+++....+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTG-LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTC-CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCC-cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 44667789999999999999987544 46999998754322 346799999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----cEEEEeecCcc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF----TARISDFGLAK 655 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~ 655 (797)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999998 999999999999999887 79999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+ .. ....
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~----~~~~- 235 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----SA----VNYE- 235 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HH----TCCC-
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----Hh----cCCC-
Confidence 765332 223446899999999999999999999999999999999999999765332211111 00 0000
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. .. ........+.+++..||+.||++|||+.|+++.
T Consensus 236 -~~--~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -FE--DE--YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CC--HH--HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cC--cc--ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 000112346678999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.21 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=201.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
|.+.+.||+|+||.||+++....+ ..||+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTG-LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCC-CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 456678999999999999987544 46999999754332 23678999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----cEEEEeecCcccc
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF----TARISDFGLAKIL 657 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~ 657 (797)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||++...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999998888899999999999999999999998 999999999999998877 7999999999876
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+ ...... .
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~--~ 237 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TAVSYD--F 237 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC--C
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCC--C
Confidence 5432 223456999999999999999999999999999999999999999765332211111 111110 0
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .. .......+.+++..||+.||++|||+.|+++
T Consensus 238 ~~--~~--~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DE--EF--FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CH--HH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cc--hh--ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00 0001234667899999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.64 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=197.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+|++...++ ..||+|.+.... ....++|.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 4456789999999999999765443 347899886433 244578999999999999999999999998754 78999
Q ss_pred ecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999999976 46789999999999999999999998 999999999999999999999999999987654332
Q ss_pred -cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .... .+.......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~----~~~~~~~~~-- 242 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILE----KGERLPQPP-- 242 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHH----TTCCCCCCT--
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----HHHH----cCCCCCCCc--
Confidence 22233456889999999999999999999999999999999 99999765433211 1111 111000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++..||+.||++||++.||++.|+.+.
T Consensus 243 -------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 243 -------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01234677899999999999999999999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.99 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=202.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCc------EEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENK------ICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
.+.+.+.||+|+||+||+|+....++ ..||+|++........+.+.+|+.++++++||||+++++++.+++..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 35566789999999999999876543 579999997766566678999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCC-CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc--------EEEEee
Q 003759 581 LVYEFISNGCLAGFLFKNPK-PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT--------ARISDF 651 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~Df 651 (797)
+||||+++++|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999987644 89999999999999999999998 9999999999999998887 999999
Q ss_pred cCccccccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 652 GLAKILKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 652 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
|++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+............ .. ..
T Consensus 166 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---~~---~~ 234 (289)
T 4fvq_A 166 GISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---YE---DR 234 (289)
T ss_dssp CSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HH---TT
T ss_pred cccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH---hh---cc
Confidence 998754322 22347889999999987 67899999999999999999966555433222111111 00 00
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~ 788 (797)
....... ...+.+++..||+.||++|||+.|+++.|+.+.....++
T Consensus 235 ~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 235 HQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp CCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred CCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111100 123556888899999999999999999999987755443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.86 Aligned_cols=257 Identities=24% Similarity=0.419 Sum_probs=193.2
Q ss_pred HHhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||.||+|++.. ..+..||||+++.... ...++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 34456789999999999998762 2345699999975432 23457999999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++.+. ..+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999765 4689999999999999999999998 999999999999999999999999999987654332
Q ss_pred c--ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 R--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 ~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ +..... .+.......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----~~~~i~----~~~~~~~~~- 273 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKAVD----EGYRLPPPM- 273 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----HHHHHH----TTEECCCCT-
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----cCCCCCCCc-
Confidence 1 1222235778999999999999999999999999999998 999996543221 111111 111000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++..||+.||++||++.+|+++|+.+..
T Consensus 274 --------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 274 --------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 112346788999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.53 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc--cCcCchhhhcccccc----cCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--TNHRNLVKLLGFCNE----DQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~l 581 (797)
+.+.+.||+|+||+||+|+. .+..||||++... ..+.+..|.+++.. ++||||+++++++.. ....++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 44567899999999999987 3456999998642 34556667776666 799999999998644 456899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH--------EECTTQIIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
||||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999994 457899999999999999999999 65 999999999999999999999999999
Q ss_pred ccccccCCCc---ccccccccCccccccccccC------CCCccCceehHHHHHHHHHhC----------CcCCCccccc
Q 003759 654 AKILKADQTR---TTTAIRGTRGYVAPEWFKSL------PITMKVDIYSFGVMLLELICC----------RKKFEQNVEN 714 (797)
Q Consensus 654 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~Gvll~elltG----------~~p~~~~~~~ 714 (797)
++........ ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 9866543322 12334689999999999876 456799999999999999999 7787654333
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
........ ............ +...........+.+++..||+.||++|||+.||++.|+++
T Consensus 240 ~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMR--KVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHH--HHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhhhh--HHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22211111 011111111111 11111223345678899999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=338.03 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=203.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||+||++... ++..||+|++.... ...+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3455678999999999999875 34569999997643 34578999999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++.. ...+++.++..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||++...........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999976 46789999999999999999999998 999999999999999999999999999987654433333
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+........
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~----- 245 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLYRPHL----- 245 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCCCCCTT-----
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hcccCCCCCCc-----
Confidence 34457788999999999899999999999999999998 99999765432211111 11100000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++|||+.|+++.|+++.
T Consensus 246 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 246 ----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0134677899999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=350.49 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=203.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccccC-c
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ-H 578 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~-~ 578 (797)
..+.+.+.||+|+||.||+|++.. ..+..||||++...... ..+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 334556789999999999998642 33467999999764332 235699999999999 8999999999988755 4
Q ss_pred eeeeeecccCCchhhhcccCCC----------------------------------------------------------
Q 003759 579 RLLVYEFISNGCLAGFLFKNPK---------------------------------------------------------- 600 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 600 (797)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999975432
Q ss_pred --------CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-ccccccccc
Q 003759 601 --------PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTTTAIRGT 671 (797)
Q Consensus 601 --------l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt 671 (797)
+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .......+|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 78889999999999999999998 999999999999999999999999999986644332 233345688
Q ss_pred CccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHH
Q 003759 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750 (797)
Q Consensus 672 ~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (797)
+.|+|||++.+..++.++||||||+++|||+| |+.||......+... . ....+........ ..
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~----~~~~~~~~~~~~~---------~~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---R----RLKEGTRMRAPDY---------TT 322 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH---H----HHHHTCCCCCCTT---------CC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH---H----HHHcCCCCCCCCC---------CC
Confidence 99999999999999999999999999999999 999997654332111 1 1111111111111 11
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 751 KKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 751 ~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
..+.+++..||+.||++|||+.||+++|+.+.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 34667889999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=338.18 Aligned_cols=269 Identities=20% Similarity=0.232 Sum_probs=205.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccC--ceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ--HRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E 584 (797)
+.+.+.||+|+||+||+|+....+ ..||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTG-DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECCCC-cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 445678999999999999987644 469999997533 234567889999999999999999999987655 7799999
Q ss_pred cccCCchhhhcccCC---CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCcEEEEeecCcccc
Q 003759 585 FISNGCLAGFLFKNP---KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKIL 657 (797)
Q Consensus 585 y~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~~ 657 (797)
|+++++|.+++.... .+++..++.++.||+.||+|||+. +|+|+||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999997643 389999999999999999999998 99999999999999 88888999999999876
Q ss_pred ccCCCcccccccccCccccccccc--------cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFK--------SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||.....................
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 54332 23345899999999986 567899999999999999999999999754433322222211111111
Q ss_pred cccccccc-----------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 730 DEKLHLLV-----------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 730 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
........ ...............+.+++..||+.||++|||++|+++...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11000000 000001112233456778999999999999999999999987644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=364.98 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=205.4
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT--TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHeEEEEEcccCCceEEEEEEECC--ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345567889999999999998853 4569999997643 45678999999999999999999999987 5678999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999754 3678889999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+....++.++||||||+++|||+| |+.||......+. ...... +.......
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~----~~~i~~----~~~~~~~~---- 408 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----IRALER----GYRMPRPE---- 408 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHH----TCCCCCCT----
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc----CCCCCCCC----
Confidence 2333446788999999998999999999999999999999 9999976533221 111111 10000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.....+.+++..||+.||++|||+++|++.|+.+...
T Consensus 409 -----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 409 -----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1123467788999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.70 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=199.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||+||+|+....+ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceeeeEEecCCCEEEEEEEECCCC-cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 345678999999999999987554 4699999864332 23467899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-ccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~ 665 (797)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred ccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... ..+... ........
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~----~~~~~~~~------ 232 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEK----KTYLNPWK------ 232 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HHHHTT----CTTSTTGG------
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHhcc----cccCCccc------
Confidence 34569999999999988765 789999999999999999999997654332211 111110 00000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 233 ---~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 ---KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011345678899999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.88 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=205.8
Q ss_pred HhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.||+|+||.||+|+... ..+..||||+++..... ..+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 4456789999999999999874 33467999999754322 245789999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC------------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 583 YEFISNGCLAGFLFKN------------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
|||+++++|.+++... ..+++.+++.++.||++||+|||++ +|+|+||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999999753 4688999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENEN 716 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~ 716 (797)
|+++++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 999999999999999986643322 22334457889999999999899999999999999999999 9999976533211
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.. ....+........ ....+.+++..||+.||++||++.+|++.|+++.+-
T Consensus 286 ----~~----~~~~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 286 ----IY----YVRDGNILACPEN---------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp ----HH----HHHTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ----HH----HHhCCCcCCCCCC---------CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 11 1111221111111 113467788999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.03 Aligned_cols=247 Identities=24% Similarity=0.265 Sum_probs=201.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+++....+ ..||+|++++. .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATG-RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 345678999999999999987544 46999999753 23345678899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998643322 22
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .. .+...... ....
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~----~i~~~~~~-~p~~----- 227 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FE----LILMEEIR-FPRT----- 227 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH----HHHHCCCC-CCTT-----
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----HH----HHHcCCCC-CCCC-----
Confidence 3345699999999999999999999999999999999999999976432211 11 11111111 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
....+.+++..||+.||++|| ++.||++.
T Consensus 228 ----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 113456788899999999999 89999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.28 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=206.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+|+.. ...+..||||++..... ...+.+.+|+.++.++ +||||+++++++..++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 34566788999999999999863 34557899999975433 2345789999999999 999999999999999999
Q ss_pred eeeeecccCCchhhhcccCC------------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc
Q 003759 580 LLVYEFISNGCLAGFLFKNP------------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD 641 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~ 641 (797)
++||||+++|+|.+++.... .+++..++.++.|+++||+|||+. +|+|+||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 99999999999999997543 488999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhh
Q 003759 642 DSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMI 719 (797)
Q Consensus 642 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 719 (797)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 9999999999999876544332 2233457789999999999999999999999999999999 9999976543321111
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
. .... ... .... .....+.+++..||+.||++|||+.||++.|+++.
T Consensus 260 ~---~~~~----~~~-~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 260 M---IKEG----FRM-LSPE--------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp H---HHHT----CCC-CCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---hccC----CCC-CCcc--------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 1111 000 0000 01234677889999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.44 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=205.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccC-CCchHHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+|+.. ...+..||||++.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 44556788999999999999973 2345679999997542 23446799999999999 999999999999999999
Q ss_pred eeeeecccCCchhhhcccCC-----------------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 003759 580 LLVYEFISNGCLAGFLFKNP-----------------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQ 636 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~ 636 (797)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+|+||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 99999999999999997542 268899999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccc
Q 003759 637 NILLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVEN 714 (797)
Q Consensus 637 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~ 714 (797)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999876543322 2333457889999999999999999999999999999998 99999765432
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.... .... .+....... .....+.+++..||+.||++|||+.||++.|+.+.+.
T Consensus 282 ~~~~---~~~~----~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 ANFY---KLIQ----NGFKMDQPF---------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHH---HHHH----TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHH---HHHh----cCCCCCCCC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2111 1111 110000000 0123467788999999999999999999999986554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.83 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=209.6
Q ss_pred HHHHhhhhhhCcccceeEEEEEEec------CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhccccccc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNED 576 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 576 (797)
...+.+.+.||+|+||+||+|+... .....||||++...... ..+++.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3445567889999999999998753 22357999999764322 235789999999999 999999999999999
Q ss_pred CceeeeeecccCCchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
+..++||||+++|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997543 488999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchh
Q 003759 641 DDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQM 718 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 718 (797)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987654322 23334457889999999999999999999999999999999 999997653321
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
+.... ..+........ ....+.+++..||+.||++|||+.||++.|+.+.+....
T Consensus 302 -~~~~~----~~~~~~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 -LFKLL----KEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp -HHHHH----HTTCCCCCCSS---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred -HHHHH----HcCCCCCCCcc---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111 11111111111 123467788999999999999999999999987665433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=340.56 Aligned_cols=256 Identities=17% Similarity=0.192 Sum_probs=203.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|+.... +..||||++... ...+++.+|+.+++++ +||||+++++++..++..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYT-NEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTT-TEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeeccCCceEEEEEECCC-CcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 34567899999999999997654 457999998753 2345789999999999 9999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc-----EEEEeecCccccccC
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT-----ARISDFGLAKILKAD 660 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~~~~ 660 (797)
+++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.+...
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9999999976 46799999999999999999999998 9999999999999999887 999999999876443
Q ss_pred CCc------ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 661 QTR------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 661 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................. ...
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----~~~ 238 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-----KRA 238 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-----HHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-----hcc
Confidence 321 224566999999999999999999999999999999999999999875433221111111000 000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.. .+.... ....+.+++..|++.||.+||++++|++.|+.+
T Consensus 239 ~~----~~~~~~--~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TP----IEVLCE--NFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SC----HHHHTT--TCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CC----HHHHhc--cChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 000000 011577889999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.24 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=202.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||+|+.... +..||||.++..... ..++|.+|+.++++++||||+++++++..++..++||||
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRAD-NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTT-CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HeEEeeEeccCCCCeEEEEEEecC-CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 344567899999999999998754 456999998754322 234688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999754 4589999999999999999999998 99999999999999999999999999998654322111
Q ss_pred c-ccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 665 T-TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 665 ~-~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
. ....+++.|+|||.+.+..++.++||||||+++|||+| |..||......+. .... ..+........
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~----~~~~----~~~~~~~~~~~--- 339 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT----REFV----EKGGRLPCPEL--- 339 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----HHHH----HTTCCCCCCTT---
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHH----HcCCCCCCCCC---
Confidence 1 12235778999999998899999999999999999999 9999976533211 1111 11111111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 340 ------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 340 ------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1234667889999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.53 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=200.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||.||+++.... +..||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~-~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCC-CcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 44567899999999999998754 456999998743 2334568899999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD--SFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++..+.... .
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 99999999765 4789999999999999999999998 9999999999999987 7899999999998765432 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+|+.|+|||++.+..++.++||||||+++|+|++|..||......+.. ... ....... . ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i----~~~~~~~--~--~~~- 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII----ENI----MNAEYTF--D--EEA- 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHH----HHTCCCC--C--HHH-
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHH----HcCCCCC--C--hhh-
Confidence 23455899999999999988999999999999999999999999765432211 111 1111100 0 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......+.+++..||+.||++|||+.|+++.
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00112356788999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=333.78 Aligned_cols=264 Identities=19% Similarity=0.202 Sum_probs=195.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|+||+||+|.....+ ..||||++...... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEECCCC-ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 345678999999999999987544 46999999754332 236788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++.+..+......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 98755555555567899999999999999999999998 999999999999999999999999999987643322 23
Q ss_pred ccccccCccccccccccCC-CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc---ccccc---
Q 003759 666 TAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL---HLLVE--- 738 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 738 (797)
....+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+......................... ....+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3445899999999998765 7999999999999999999988865433222111110000000000000 00000
Q ss_pred ----chhh--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 739 ----NDEE--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 739 ----~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... ..........+.+++..||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000011235668899999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.51 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=191.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--------------------------CchHHHHHHHHHhhcc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--------------------------GGDKEFRTEVNAIGQT 561 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--------------------------~~~~~f~~E~~~l~~l 561 (797)
+.+.+.||+|+||.||+|+.... +..||||++..... ...+.+.+|+++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTT-TEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred eEEEeEEeecCCEEEEEEEECCC-CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 44567899999999999988654 45699999865321 1135689999999999
Q ss_pred CcCchhhhcccccc--cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 003759 562 NHRNLVKLLGFCNE--DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNIL 639 (797)
Q Consensus 562 ~h~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NIL 639 (797)
+||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+. +|+|+||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 99999999999876 568899999999999998764 45789999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeecCccccccCCCcccccccccCccccccccccCC---CCccCceehHHHHHHHHHhCCcCCCccccccc
Q 003759 640 LDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLP---ITMKVDIYSFGVMLLELICCRKKFEQNVENEN 716 (797)
Q Consensus 640 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~ 716 (797)
++.++.+||+|||++........ ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~- 247 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC- 247 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH-
Confidence 99999999999999987654322 223446899999999998765 4788999999999999999999997543211
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
+.... ........... .....+.+++..||+.||++|||+.|+++
T Consensus 248 ---~~~~~----~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 ---LHSKI----KSQALEFPDQP--------DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---HHHHH----HHCCCCCCSSS--------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHHHH----hcccCCCCCcc--------ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11111 11111100000 01134667899999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=353.48 Aligned_cols=251 Identities=21% Similarity=0.232 Sum_probs=200.4
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||+||+|+.... +..||+|++.+.. ....+.+.+|..++..++||||+++++++.+++..+|||||+
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNA-DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTT-TEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeCCCEEEEEEEEcCC-CcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 346799999999999998754 4569999996521 223345899999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++|+|.+++.+ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99999999987 46799999999999999999999998 999999999999999999999999999987665554444
Q ss_pred ccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 666 TAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+....... ........
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~p~~~~~- 308 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----QFPTQVTD- 308 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCCSSCCC-
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc----cCCccccc-
Confidence 5567999999999997 4578999999999999999999999997654333222221111110 00000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSL--RPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~eVl~~ 777 (797)
....+.+++..||+.+|++ ||+++|+++.
T Consensus 309 --------~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 309 --------VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0123566788899888888 9999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=335.57 Aligned_cols=261 Identities=20% Similarity=0.229 Sum_probs=195.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|+||+||+|+... +..||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETT--SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hHhhhhccCCCCeEEEEEEECC--CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 4456789999999999998853 456999998653322 235788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-S 175 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-c
Confidence 985 777777554 5689999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred cccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc----------
Q 003759 665 TTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL---------- 733 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 733 (797)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... .....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-NPREWPQVQELPLWK 254 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC-CTTTSGGGTTSHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC-ChHHhhhhhccchhh
Confidence 233458999999999876 568999999999999999999999998765443322221111000 00000
Q ss_pred ---cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 ---HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ---~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...................+.+++..||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000000011235678999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.87 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=192.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||.||+|+.... ....||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 455678899999999999988643 245799999875432 22356899999999999999999999985 46789999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999755 4689999999999999999999998 999999999999999999999999999987654443
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ... ..+........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~----~~i----~~~~~~~~~~~-- 241 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRI----ENGERLPMPPN-- 241 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHH----HTTCCCCCCTT--
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----HHH----HcCCCCCCCCC--
Confidence 33334457789999999998899999999999999999997 99999765432211 111 11111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++|||+.||++.|+.+.
T Consensus 242 -------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 242 -------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1234667889999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.48 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=208.2
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+|+.... +..||+|.+... ....+++.+|+.++++++||||+++++++.+++..++||||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGG-TEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEEeecCCCCceeEEEeEecCC-CEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3455567899999999999998754 456999999753 33456799999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++++|.+++... ..+++..++.++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999754 4589999999999999999999998 9999999999999999999999999999877655544
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ..... .........
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----~~~~~----~~~~~~~~~--- 236 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----ELLEK----DYRMERPEG--- 236 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----HHHHT----TCCCCCCTT---
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhc----cCCCCCCCC---
Confidence 4445557889999999999999999999999999999999 99999765432211 11111 100000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..|++.||++|||+.||++.|+.+.
T Consensus 237 ------~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 237 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1134677889999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.68 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=194.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCce----e
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR----L 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~----~ 580 (797)
|.+.+.||+|+||.||+++.... +..||||++....... .+.+.+|+.++.+++||||+++++++...... +
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRD-HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCC-CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 45567899999999999998654 4569999997643333 24688999999999999999999998766543 9
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||+++++|.+++.....+++.++..++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 9999999999999998878899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QT--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..........
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~---- 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-------YQHVREDPIP---- 238 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCCCC----
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHhcCCCCC----
Confidence 22 2233356899999999999999999999999999999999999999765432211 1111111100
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHhcCcCCC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK-VTLMLEGVVEVP 785 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e-Vl~~Le~~~~~~ 785 (797)
...........+.+++..||+.||++||++.+ +.+.|.......
T Consensus 239 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 239 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp ---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred ---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 00000011234677899999999999996554 545555543333
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.44 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=201.2
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
..|.+.+.||+|+||+||+++.... +..+|+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~-~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLA-GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTT-TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCC-CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4466678899999999999988754 45699999875432 22356889999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCccccccC
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKAD 660 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~ 660 (797)
||+++|+|.+.+.....+++.....++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999998888899999999999999999999998 999999999999998 5678999999999876543
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. .. .+..+...... +.
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~----~~----~i~~~~~~~~~-~~ 236 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL----YQ----QIKAGAYDFPS-PE 236 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HH----HHHHTCCCCCT-TT
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH----HH----HHHhCCCCCCc-cc
Confidence 32 22345699999999999999999999999999999999999999976433221 11 11111111000 00
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. .....+.+++..||+.||++|||+.|+++.
T Consensus 237 ~~-----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 WD-----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc-----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 011345678899999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.52 Aligned_cols=259 Identities=17% Similarity=0.198 Sum_probs=205.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|+.... +..||||++... ...+.+.+|+.++.++ +|+|++++++++.++...++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT-TEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEECCC-CcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 44567899999999999997654 457999998643 3345788999999999 8999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc-----EEEEeecCccccccC
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT-----ARISDFGLAKILKAD 660 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~~~~ 660 (797)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999865 4589999999999999999999998 9999999999999987776 999999999876543
Q ss_pred CC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 661 QT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 661 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+....... ......
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-cCccHH
Confidence 32 12344569999999999999999999999999999999999999998754332221111111000 000000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.... .....+.+++..||+.||++||++++|++.|+.+..
T Consensus 244 ~~~~---------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 244 ELCA---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHTT---------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHh---------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 112456788999999999999999999999988554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.72 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=202.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|+....+ ..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTR-IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCC-cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 4566788999999999999987544 469999998766666788999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 9999999998888899999999999999999999998 99999999999999 788999999999998765433
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+....+ ..+.... + ...
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~---~-~~~ 230 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------REGTFTF---P-EKD 230 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCC---C-HHH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCC---C-chh
Confidence 22334589999999998764 899999999999999999999999765432211111 1111100 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......+.+++..|++.||++|||+.++++
T Consensus 231 --~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 --WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011235677899999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=342.95 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=202.3
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
...|.+.+.||+|+||.||+++....+ ..||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCC-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345667789999999999999987544 56999999754322 235688999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEeecCcccccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDFGLAKILKA 659 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~~~ 659 (797)
|||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999998888899999999999999999999998 999999999999998654 599999999987653
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ +... +..+...... .
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~----i~~~~~~~~~-~ 252 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQ----IKAGAYDYPS-P 252 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHTCCCCCT-T
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHhCCCCCCc-c
Confidence 32 2234569999999999999999999999999999999999999997643321 1111 1111111000 0
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... .....+.+++..||+.||++||++.|+++.
T Consensus 253 ~~~-----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EWD-----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGG-----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccc-----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 011345678899999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=355.71 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=200.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HceeeeeecCCCCeEEEEEEECC--CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 34556789999999999999864 3469999997643 345789999999999999999999999876 6789999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999743 5689999999999999999999998 99999999999999999999999999998765443333
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.... ..+.......
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i----~~~~~~~~~~----- 404 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV----ERGYRMPCPP----- 404 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHH----HTTCCCCCCT-----
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcCCCCCCCC-----
Confidence 334457789999999999999999999999999999999 999997653322 11111 1111100000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~ 786 (797)
.....+.+++..||+.||++|||+++|++.|+.+.....
T Consensus 405 ----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 405 ----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 112346678899999999999999999999998765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.74 Aligned_cols=251 Identities=20% Similarity=0.200 Sum_probs=193.3
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhcc-CcCchhhhcccccc
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQT-NHRNLVKLLGFCNE 575 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 575 (797)
...++....+.+.++||+|+||+||+|+....+ ..||||++....... ..++..|+..+.++ +||||+++++++.+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDG-RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTS-CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCC-eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 345556667777889999999999999987544 469999986543332 23455566655555 99999999999999
Q ss_pred cCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
++..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999999 67888887653 5699999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...... ..+..+...
T Consensus 205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~~ 270 (311)
T 3p1a_A 205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYLP 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCCC
T ss_pred eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCCC
Confidence 8664332 2233458999999999886 7899999999999999999998776543211 011111110
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. .........+.+++..||+.||++|||+.|+++
T Consensus 271 ----~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ----P----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 000111245678899999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=344.46 Aligned_cols=266 Identities=16% Similarity=0.149 Sum_probs=199.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCC----cEEEEEEEecccCCC-----------chHHHHHHHHHhhccCcCchhhhcc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYEN----KICVAVKKLDNMVSG-----------GDKEFRTEVNAIGQTNHRNLVKLLG 571 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~----~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~h~niv~l~g 571 (797)
.+.+.+.||+|+||.||+|.+..+. +..||||++...... ....+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 4556788999999999999887542 356999998653211 1112344566677788999999999
Q ss_pred ccccc----CceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCC
Q 003759 572 FCNED----QHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD--DSF 644 (797)
Q Consensus 572 ~~~~~----~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~--~~~ 644 (797)
++... ...+|||||+ +++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98765 4589999999 99999999765 6799999999999999999999998 999999999999999 889
Q ss_pred cEEEEeecCccccccCCCc------ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh
Q 003759 645 TARISDFGLAKILKADQTR------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~ 718 (797)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876543221 1233459999999999999999999999999999999999999998643332211
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
... .... ...+..+++.... .......+.+++..|++.||++||++.+|++.|+.+..
T Consensus 272 ~~~---~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 272 RDS---KIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHH---HHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH---HHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111 1000 0011111111100 00112456788899999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.19 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=180.0
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.||+|+||+||+++....+ ..||||++... ....+.+|+.++.++. ||||+++++++.+++..++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSN-QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETTTC-CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECCCC-CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 57999999999999987554 46999998652 4567889999999996 9999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEeecCccccccCCCccccc
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 999999888899999999999999999999998 999999999999997765 899999999986544322 2233
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..+|+.|+|||.+.+..++.++||||||+++|||++|+.||.............+ ....+..+.... .. + ...
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~--~~--~--~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF--EG--E--AWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC--CS--H--HHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC--Cc--c--ccc
Confidence 4579999999999999999999999999999999999999976543211111111 111111221110 00 0 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||++|+++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 112456788999999999999999999854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.29 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=191.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCc--EEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCce--
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR-- 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~--~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-- 579 (797)
..+.+.+.||+|+||.||+|+....++ ..||||++.... ....+++.+|+.++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 345667889999999999998875543 369999987542 23346799999999999999999999999877655
Q ss_pred ----eeeeecccCCchhhhcccC------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 580 ----LLVYEFISNGCLAGFLFKN------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 580 ----~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 9999999999999998543 2588999999999999999999998 99999999999999999999999
Q ss_pred eecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 650 DFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 650 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------- 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------- 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-------
Confidence 9999987644332 22233446788999999999999999999999999999999 89999765433211111
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
..+........ ....+.+++..||+.||++|||+.++++.|+++..-
T Consensus 253 -~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 -IGGNRLKQPPE---------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -HTTCCCCCCTT---------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -hcCCCCCCCCc---------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111 113467889999999999999999999999986554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=329.02 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=189.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC----CchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS----GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|... +..||||++..... ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred eeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 445678999999999999874 45699999865322 22467899999999999999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--------CCcEEEEeecCcc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD--------SFTARISDFGLAK 655 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~Dfgla~ 655 (797)
||+++++|.+++. ...+++..+..++.|++.||+|||++...+|+|+||||+||+++. ++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999999985 457899999999999999999999982223999999999999986 7789999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
....... ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ..........
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~ 234 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-------GVAMNKLALP 234 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-------HHHTSCCCCC
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------hhhcCCCCCC
Confidence 6543322 23458999999999999999999999999999999999999997653321111 1111111111
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.... ....+.+++..||+.||++|||+.|+++.|+.+
T Consensus 235 ~~~~---------~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 IPST---------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCcc---------cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 113467788999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=345.34 Aligned_cols=258 Identities=27% Similarity=0.366 Sum_probs=202.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
..+.+.+.||+|+||+||+|+... ..+..||||++..... ....++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 345567889999999999999642 2345799999965322 23457899999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC-------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEe
Q 003759 581 LVYEFISNGCLAGFLFKN-------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISD 650 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~D 650 (797)
+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999643 3588999999999999999999998 999999999999999554 599999
Q ss_pred ecCccccccCC-CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhh
Q 003759 651 FGLAKILKADQ-TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 651 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ +....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----~~~~i---- 299 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFV---- 299 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHH----
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----
Confidence 99998653322 223333457899999999999999999999999999999998 999997653321 11111
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+........ ....+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 300 ~~~~~~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGRMDPPKN---------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcc---------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111111111 11246678899999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.35 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=188.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||+|.....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTG-VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp -------------CEEEEEECSSSC-CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCC-cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 3556688999999999999887544 5699999875432 3346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 586 ISNGCLAGFLFKN------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 586 ~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 6898888542 3588899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc-------
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE------- 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 731 (797)
... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+...... ..+.
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT-PNESLWPSVTK 238 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCTTTCGGGGG
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChhHhhhhhh
Confidence 322 22334589999999999764 6899999999999999999999999765443322211111000 0000
Q ss_pred ------cccccccchhhh----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 ------KLHLLVENDEEA----LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ------~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+.......... .........+.+++..||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000000 0000112357789999999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.02 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=204.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||++.... +..||+|++.... ...+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred eeeeeEecCCCceeEEEEEecC--CCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4456789999999999998863 4569999997643 345789999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999765 5689999999999999999999998 9999999999999999999999999999876543323333
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+..... + .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~i----~~~~~~~~--~--~--- 228 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDI----STGFRLYK--P--R--- 228 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHH----HTTCCCCC--C--T---
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----HHHH----hcCCcCCC--C--c---
Confidence 4457788999999998899999999999999999999 8999976432211 1111 11100000 0 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.....+.+++..|++.||++||+++++++.|+++.+
T Consensus 229 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 --LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 012346678899999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=336.12 Aligned_cols=262 Identities=19% Similarity=0.228 Sum_probs=196.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+.... +..||+|++....... .+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVR-ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT-TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcCC-CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 45567899999999999998654 4569999997543322 3568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998765544333
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... +........ ........
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~--~~~~~~~~------ 259 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----MGAHINQAI--PRPSTVRP------ 259 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HHHHHHSCC--CCGGGTST------
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HHHHhccCC--CCccccCC------
Confidence 444568999999999999999999999999999999999999997643221 111110000 00000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-TMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~eVl~~Le~~~~~~~p~ 788 (797)
.....+.+++..||+.||++|| ++.++++.|+...+...+.
T Consensus 260 ---~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 260 ---GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp ---TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred ---CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 0112456788999999999999 9999999999876665443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.87 Aligned_cols=266 Identities=16% Similarity=0.160 Sum_probs=197.7
Q ss_pred HHhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCCC-----------chHHHHHHHHHhhccCcCchhhhcccc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVSG-----------GDKEFRTEVNAIGQTNHRNLVKLLGFC 573 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~h~niv~l~g~~ 573 (797)
.+.+.+.||+|+||.||+|..... .+..||||+....... ..+.+.+|+..+..++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 455678899999999999998741 3456999998754321 123466788889999999999999998
Q ss_pred cc----cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC--cEE
Q 003759 574 NE----DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF--TAR 647 (797)
Q Consensus 574 ~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~--~~k 647 (797)
.. ....++||||+ +++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 77 77899999999 999999998777899999999999999999999998 999999999999999887 999
Q ss_pred EEeecCccccccCCC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHH
Q 003759 648 ISDFGLAKILKADQT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV 721 (797)
Q Consensus 648 l~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 721 (797)
|+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999987643321 12244568999999999999999999999999999999999999996543222111110
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
...... .+...+. ...........+.+++..||+.||++||++.+|++.|+.+..
T Consensus 274 ---~~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 274 ---KTNLLD-ELPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp ---HHHHHH-TTTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ---HHhhcc-cccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 000000 0000000 000000112357788899999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.44 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=195.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+++.... +..||+|++++... ...+.+..|..++.++ +||||+++++++.+.+..++||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~-~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKT-DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 44567899999999999998765 45699999975432 2234588899999887 8999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|..++.+...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 9999999999998888899999999999999999999998 99999999999999999999999999998533222 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh-hHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM-ILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .........+....+... ..
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-~~--- 284 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-RS--- 284 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC-TT---
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC-Cc---
Confidence 3344569999999999999999999999999999999999999996543221110 000111111111111100 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
....+.+++..||+.||++||++
T Consensus 285 ------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 ------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 11345678899999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=343.87 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=193.7
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
.+.||+|+||.||+|+....+ ..||+|+++.......+++.+|+.++.+++||||+++++++.+.+..+|||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATG-LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTC-CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCC-cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356999999999999987544 4699999986544456789999999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE--cCCCcEEEEeecCccccccCCCccccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL--DDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+ ++++.+||+|||+++.+..... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 99988654 4689999999999999999999998 99999999999999 6778999999999987654332 223
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ... ... .......
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i---~~~-----~~~-~~~~~~~----- 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI---LAC-----RWD-LEDEEFQ----- 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HHT-----CCC-SCSGGGT-----
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc-----cCC-CChhhhc-----
Confidence 45899999999999989999999999999999999999999765432211111 110 000 0000000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01234677899999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.34 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=204.4
Q ss_pred HhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.||+|+||.||+|+... .++..||||++..... ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 4456789999999999998742 2346799999975432 2235788999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCC------------------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 583 YEFISNGCLAGFLFKNP------------------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
|||+++++|.+++.... .+++.+++.++.||++||+|||++ +|+|+||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 99999999999997543 278889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENEN 716 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~ 716 (797)
++++++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654332 22233457888999999999899999999999999999999 9999976543221
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
. ... ..+........ ....+.+++..||+.||++||++.||++.|+++.
T Consensus 262 ~----~~~----~~~~~~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 262 F----NLL----KTGHRMERPDN---------CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp H----HHH----HTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHh----hcCCcCCCCcc---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 111 11111111111 1234677889999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.71 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=191.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||+||+++....+ ..||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTC-CEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEEeccCCCEEEEEEEECCCC-cEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 556788999999999999987554 469999997543 335678999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc--EEEEeecCccccccCCCccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT--ARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~ 665 (797)
+|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...... ..
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence 999999998778899999999999999999999998 9999999999999987765 9999999997433222 22
Q ss_pred ccccccCccccccccccCCCCcc-CceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMK-VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~-sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||................. ..........
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~----- 245 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL----SVKYSIPDDI----- 245 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH----TTCCCCCTTS-----
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh----cCCCCCCCcC-----
Confidence 33458999999999988887655 8999999999999999999976544333222211111 1110000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 246 ---~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 ---RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 011345678999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.28 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=200.0
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-----CCchHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-----SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
....|.+.+.||+|+||+||+++....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETG-QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCC-CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456777889999999999999887554 469999985321 1235679999999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEee
Q 003759 579 RLLVYEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDF 651 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Df 651 (797)
.++||||+++++|.+.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887542 3578999999999999999999998 9999999999999987655 999999
Q ss_pred cCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 652 GLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 652 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
|++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +.. .+..+
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~----~i~~~ 247 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFE----GIIKG 247 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----HHH----HHHHT
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----HHH----HHHcC
Confidence 99987654322 223446899999999999999999999999999999999999999764211 111 11111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... ...... ......+.+++..||+.||++|||+.|+++
T Consensus 248 ~~~----~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYK----MNPRQW--SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC----CCHHHH--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC----CCcccc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 000000 001235678899999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=345.17 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=200.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|+....+ ..||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATG-RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCC-CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 556678999999999999987554 4699999876544445678999999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD--SFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 99999999765 4789999999999999999999998 9999999999999974 57799999999987654332
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..... ...... .....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~----~~~~~~-~~~~~-- 275 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKR----CDWEFD-EDAFS-- 275 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHH----CCCCCC-SSTTT--
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHh----CCCCCC-ccccc--
Confidence 23345899999999999999999999999999999999999999765332111 11111 000000 00000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 276 ---~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 ---SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011346678999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=348.17 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=199.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||+||+++....+ ..||+|++.+. .....+.+.+|+.++..++||||+++++++.+++..++||||+
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEcCCCEEEEEEEECCCC-cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3467999999999999987654 46999998652 1233456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|+|.+++.+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 152 ~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 152 PGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp TTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999999865 4688999999999999999999998 9999999999999999999999999999876654433444
Q ss_pred cccccCccccccccccCC----CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 667 AIRGTRGYVAPEWFKSLP----ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~----~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+...... +......
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------~~~p~~~--- 298 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------LTFPDDN--- 298 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------CCCCTTC---
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc------ccCCCcc---
Confidence 567999999999998765 789999999999999999999999765433221111111000 0000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSL--RPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~eVl~~ 777 (797)
.....+.+++..||+.+|++ ||+++||++.
T Consensus 299 -----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 299 -----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 01134567888899999988 9999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=333.57 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=193.0
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
+....+.+.+.||+|+||+||+|+... .||||++...... ..+.|.+|+.++++++||||+++++++ ..+..+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS----EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC----ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 334445667889999999999998642 3999998754332 235689999999999999999999975 456689
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999999644 5689999999999999999999998 999999999999999999999999999986543
Q ss_pred CC-CcccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 660 DQ-TRTTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 660 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
.. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. +...............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSK 249 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCCCTTS
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCcchhh
Confidence 22 22333456899999999986 56788999999999999999999999976543221 1111111111111111
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.... ....+.+++..||+.||++|||+.+|++.|+++..
T Consensus 250 ~~~~---------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 VRSN---------CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccc---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 12356778899999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.87 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=196.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 582 (797)
.+.+.+.||+|+||+||+|+....+ ..||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~-~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETG-DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCC-CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 3455678999999999999987554 46999999753 223345688899999988 799999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 99999999999998888899999999999999999999998 99999999999999999999999999998543222
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +..+..... .
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~--------i~~~~~~~p-----~ 245 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA--------ILNDEVVYP-----T 245 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCCC-----T
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCCCC-----C
Confidence 223345699999999999998999999999999999999999999976543221111 111111100 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTM------KKVTL 776 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~------~eVl~ 776 (797)
. ....+.+++..||+.||++||++ .||++
T Consensus 246 ~-----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 W-----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp T-----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C-----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 11345678899999999999998 66664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.29 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=199.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+|+....++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 3445789999999999999865543 348888875433 233457888999999999999999999986 56789999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999765 5789999999999999999999998 999999999999999999999999999987754433
Q ss_pred -cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .... .+.........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~----~~~~~~~~~~~ 242 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP----DLLE----KGERLAQPQIC 242 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH----HHHH----TTCBCCCCTTB
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH----HHHH----cCCCCCCCCcC
Confidence 23344557889999999999999999999999999999999 99999765432211 1111 11110000010
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
...+.+++..||+.||++||++.||++.|+.+..
T Consensus 243 ---------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 243 ---------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1134567888999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.87 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=199.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTK-KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 455678999999999999987654 569999986432 2345678899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.... .
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q 170 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--c
Confidence 999999999998888899999999999999999999998 99999999999999999999999999998765332 2
Q ss_pred cccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 665 TTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||............ .... ..... ....
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~~~----~~~~~-~p~~-- 242 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFE----TTVVT-YPSA-- 242 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-HHHH----HCCCC-CCTT--
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-HHHh----hcccC-CCCc--
Confidence 344569999999999964 45899999999999999999999999754333221111 1110 11100 0000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPT-MKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~eVl~ 776 (797)
....+.+++..||+.||++||+ +++|++
T Consensus 243 -------~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 -------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1134677889999999999998 777764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.35 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=203.5
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+++....+ ..||+|.+...... ..+++.+|+.++++++||||+++++++.+.+..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTG-LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCC-eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45667789999999999999987544 56999998754322 246799999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----cEEEEeecCcc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF----TARISDFGLAK 655 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~ 655 (797)
++||||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998888899999999999999999999998 999999999999999888 79999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+ ......
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~- 236 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TSVSYD- 236 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC-
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------Hhcccc-
Confidence 765432 223345899999999999999999999999999999999999999765332211110 000000
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... . ........+.+++..||+.||++|||+.|+++.
T Consensus 237 -~~~--~--~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 -FDE--E--FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCH--H--HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cCh--h--hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 000112346788999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.17 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=202.2
Q ss_pred HHHhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccccc--Cce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 579 (797)
..+.+.+.||+|+||.||++++. ...+..||||++..... ...+.+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 33556678999999999999852 23456799999975432 3346799999999999999999999999876 678
Q ss_pred eeeeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 580 LLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999999954 46789999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCC--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc--------chhhHHHHHHhhh
Q 003759 659 ADQT--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE--------NQMILVDWAYDCY 728 (797)
Q Consensus 659 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~ 728 (797)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+....... ..... .......
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV-TRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH-HHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH-HHHHHHH
Confidence 4432 22334457888999999999999999999999999999999999875332110 00000 0000111
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
..+...... ......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 257 ~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRLPCP---------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCC---------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111100000 011235678899999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.29 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=199.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+++....+ ..||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 345678999999999999987544 569999986532 2344678899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999865432
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +....... +..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------i~~~~~~~-----p~~- 225 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--------ILNAELRF-----PPF- 225 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHHCCCCC-----CTT-
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCCC-----CCC-
Confidence 2345689999999999999999999999999999999999999976433211111 11111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||++|| +++||++
T Consensus 226 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 ----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 113456788899999999999 8888884
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=340.59 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=198.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQ-QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 445678999999999999986554 469999986431 2334678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+ +|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 99 789999998888899999999999999999999998 99999999999999999999999999998664432 2
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......... ....... .. +..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~~~~-~~----p~~ 230 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVNSCVY-VM----PDF 230 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCCSSCC-CC----CTT
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHcCCC-CC----ccc
Confidence 233458999999999988776 789999999999999999999997643321110 0000000 00 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.|+++.
T Consensus 231 -----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 231 -----LSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----SCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----CCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11345678899999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.62 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=202.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred hhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 3455678999999999999875 34569999997543 346789999999999999999999999874 5689999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999997543 689999999999999999999998 99999999999999999999999999998776544333
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+++.|+|||.+.+..++.++||||||++++||++ |+.||......+ ..... ..+.......
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~----- 233 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNL----ERGYRMVRPD----- 233 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHH----HTTCCCCCCT-----
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----HHHHH----hcccCCCCcc-----
Confidence 344457889999999998889999999999999999999 899997643321 11111 1110000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++..|++.||++|||+.++++.|+.+.
T Consensus 234 ----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 234 ----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 01235677889999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.24 Aligned_cols=267 Identities=23% Similarity=0.250 Sum_probs=197.7
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-----CchHHHHHHHHHhhccC---cCchhhhccccc
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-----GGDKEFRTEVNAIGQTN---HRNLVKLLGFCN 574 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~---h~niv~l~g~~~ 574 (797)
+....|.+.+.||+|+||+||+|+....+ ..||||++..... .....+.+|+.++++++ ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSG-HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTC-CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCC-cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34445667789999999999999976544 5699999864321 22356778888887775 999999999987
Q ss_pred ccC-----ceeeeeecccCCchhhhcccCCC--CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEE
Q 003759 575 EDQ-----HRLLVYEFISNGCLAGFLFKNPK--PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR 647 (797)
Q Consensus 575 ~~~-----~~~lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k 647 (797)
... ..++||||++ ++|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 654 5799999997 699999976643 89999999999999999999998 999999999999999999999
Q ss_pred EEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh
Q 003759 648 ISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 648 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+......
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~- 237 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL- 237 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC-
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-
Confidence 99999998664332 233456899999999999999999999999999999999999999765443322222111100
Q ss_pred hcccccccc-------c---cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 728 YIDEKLHLL-------V---ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 728 ~~~~~~~~~-------~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......... . ...............+.+++..||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000000 0 0000000001112456789999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.88 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=199.1
Q ss_pred hhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCce-eeeeecc
Q 003759 511 KDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR-LLVYEFI 586 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~Ey~ 586 (797)
.+.||+|+||+||+|+..... ...||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 367999999999999875443 346999998754332 335789999999999999999999999876655 9999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC---C
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ---T 662 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---~ 662 (797)
.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...... .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999976 35688999999999999999999998 99999999999999999999999999998654332 1
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.......+++.|+|||.+.+..++.++||||||+++|||++|..|+........ ....... .........
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~----~~~~~~~~~--- 252 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQ----GRRLPQPEY--- 252 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHT----TCCCCCCTT---
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhc----CCCCCCCcc---
Confidence 223334578899999999999999999999999999999996666543322221 1111111 110000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++|||+.++++.|+.+..
T Consensus 253 ------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 253 ------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11346778899999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.35 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=191.4
Q ss_pred hhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccc-ccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCN-EDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~E 584 (797)
.+.+.||+|+||+||+|++...+ ...||||.+..... ...++|.+|+.++++++||||+++++++. .++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999986543 35689999875433 23467999999999999999999999865 4568899999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999765 4588999999999999999999998 999999999999999999999999999986643321
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.......+++.|+|||.+.+..++.++||||||+++|||+| |..||......+....+ ..+........
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~--------~~~~~~~~p~~ 320 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRLLQPEY 320 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH--------HTTCCCCCCTT
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH--------HcCCCCCCCCC
Confidence 12233457789999999999999999999999999999999 66777654332211111 11111000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++|||+.||++.|+.+..
T Consensus 321 ---------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 321 ---------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11346678899999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=349.66 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=198.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC-ceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-HRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|... +..||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||+
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred eEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 344578999999999999874 3469999997643 5578999999999999999999999986655 789999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 9999999997643 378899999999999999999998 99999999999999999999999999998543221
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+.. ... ..+........
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i----~~~~~~~~p~~---- 410 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRV----EKGYKMDAPDG---- 410 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH----HHH----HTTCCCCCCTT----
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH----HcCCCCCCCCc----
Confidence 12246889999999999999999999999999999999 99999765432211 111 11111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 411 -----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 411 -----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12346678889999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.44 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=197.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc--Cceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED--QHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|+.. +..||||++..... ...++|.+|+.++++++||||+++++++.+. +..++||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred hHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 445678999999999999984 45699999875432 2235799999999999999999999999877 7889999
Q ss_pred ecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 584 EFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQ--IIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+|+||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998764 489999999999999999999997 7 99999999999999999999999998764322
Q ss_pred CCCcccccccccCccccccccccCCCCc---cCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITM---KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||......+... ...........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~ 232 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------KVALEGLRPTI 232 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-------HHHHSCCCCCC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-------HHHhcCCCCCC
Confidence 2234789999999998765544 7999999999999999999997653322111 11111111111
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
... ....+.+++..||+.||++|||++|+++.|+.+.+
T Consensus 233 ~~~---------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 PPG---------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11346678889999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.68 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=196.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch-------HHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-------KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~-------~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
+.+.+.||+|+||+||+|+....+ ..||+|++........ +.+.+|+.++++++||||+++++++.+.. +
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDK-SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTC-CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred ceehhccccCCceeEEEEEEcCCc-eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 455678999999999999987544 4699999865433222 57899999999999999999999987655 6
Q ss_pred eeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEEcCCCc-----EEEEeec
Q 003759 581 LVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQ--IIHCDIKPQNILLDDSFT-----ARISDFG 652 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlkp~NILl~~~~~-----~kl~Dfg 652 (797)
+||||+++++|.+++.+. ..+++..++.++.|++.||+|||+. + |+|+||||+||+++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999998888654 5789999999999999999999998 7 999999999999988776 9999999
Q ss_pred CccccccCCCcccccccccCccccccccc--cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFK--SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
+++.... ......+|+.|+|||.+. ...++.++||||||+++|||++|+.||......... ....... .
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~---~ 245 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIRE---E 245 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHH---S
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhc---c
Confidence 9975432 233456899999999984 456789999999999999999999999765433211 1111111 1
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
......... ....+.+++..||+.||++|||++||++.|+++
T Consensus 246 ~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRPTIPED---------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCCcc---------cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 123467788999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.31 Aligned_cols=249 Identities=25% Similarity=0.316 Sum_probs=185.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|+....+ ..||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQ-KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCC-cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 445678999999999999987544 469999997542 34678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 999999998888899999999999999999999998 9999999999999975 8899999999998654322 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. ..+....... ..+...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~----~~i~~~~~~~-~~~~~~-- 276 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MF----RRILNCEYYF-ISPWWD-- 276 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HH----HHHHTTCCCC-CTTTTT--
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HH----HHHHhCCCcc-CCchhh--
Confidence 2334589999999999999999999999999999999999999975433211 11 1111111110 000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 277 ---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 277 ---EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 012346678999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.38 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=194.8
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.||+|+||+||+|+....+ ..||||++........+.+.+|+.++.++ +||||+++++++.+++..++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITS-QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSC-CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEcCCC-cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 56999999999999876544 46999999876555667899999999885 79999999999999999999999999999
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEeecCccccccCCC-----
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDFGLAKILKADQT----- 662 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~~~~~----- 662 (797)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 999998878899999999999999999999998 9999999999999998776 99999999986542211
Q ss_pred -cccccccccCcccccccccc-----CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhH-------HHHHHhhhc
Q 003759 663 -RTTTAIRGTRGYVAPEWFKS-----LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL-------VDWAYDCYI 729 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~-------~~~~~~~~~ 729 (797)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... .......+.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 254 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence 11223458999999999975 45889999999999999999999999765432210000 000011111
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+.... + ... .......+.+++..||+.||++|||+.|+++.
T Consensus 255 ~~~~~~---~-~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 255 EGKYEF---P-DKD--WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HCCCCC---C-HHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCccc---C-chh--cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111100 0 000 00012356789999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.99 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=205.0
Q ss_pred HHhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccc--ccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCN--EDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 581 (797)
.+.+.+.||+|+||.||++++. ...+..||||++........+.+.+|+.++++++||||+++++++. +.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 3455678999999999999852 3345679999998655455567999999999999999999999875 4567899
Q ss_pred eeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 582 VYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999976 35689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhh-------HHHHHHhhhccc
Q 003759 661 QT--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-------LVDWAYDCYIDE 731 (797)
Q Consensus 661 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~-------~~~~~~~~~~~~ 731 (797)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ...........+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 32 123334578889999999998999999999999999999999999865432110000 000000011111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..... .......+.+++..||+.||++|||+.||++.|+.+..
T Consensus 261 ~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 261 QRLPA---------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10000 01112456788999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.22 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=191.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccC--------
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-------- 577 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 577 (797)
.+.+.+.||+|+||.||+|+....+ ..||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDD-CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTC-CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCC-cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 3455678999999999999987544 4699999975433 34467999999999999999999999885543
Q ss_pred -------------------------------------------------ceeeeeecccCCchhhhcccCCC---CChhh
Q 003759 578 -------------------------------------------------HRLLVYEFISNGCLAGFLFKNPK---PSWYR 605 (797)
Q Consensus 578 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~---l~~~~ 605 (797)
..++||||+++++|.+++..... ..+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27999999999999999987643 34556
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-----------cccccccccCcc
Q 003759 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-----------RTTTAIRGTRGY 674 (797)
Q Consensus 606 ~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y 674 (797)
++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 889999999999999998 999999999999999999999999999987654421 122334689999
Q ss_pred ccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHH
Q 003759 675 VAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYV 754 (797)
Q Consensus 675 ~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (797)
+|||.+.+..++.++||||||+++|||++|..|+..... ... ......... ........+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~------~~~----~~~~~~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR------IIT----DVRNLKFPL---------LFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH------HHH----HHHTTCCCH---------HHHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH------HHH----HhhccCCCc---------ccccCChhHH
Confidence 999999999999999999999999999998776532110 100 001111110 0111223456
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 003759 755 MIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 755 ~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+++..||+.||++|||+.|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 78999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.58 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=197.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||+||+|+....+ ..||||++....... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTG-QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 345678999999999999987544 469999986543322 35688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-cc
Confidence 99999999998888899999999999999999999998 999999999999999999999999999987653322 22
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hh------ccc
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CY------IDE 731 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~------~~~ 731 (797)
....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+...... .. ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 33458999999999976 56899999999999999999999999765443322111111000 00 000
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....................+.+++..||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000001112346789999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.51 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=191.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||+||+|+.. +..||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET---TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred eeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 345678999999999999874 356999998642 345679999999999999999999999874 4899999999
Q ss_pred CCchhhhcccCC---CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc-EEEEeecCccccccCCCc
Q 003759 588 NGCLAGFLFKNP---KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT-ARISDFGLAKILKADQTR 663 (797)
Q Consensus 588 ~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~~~~~~~~ 663 (797)
+++|.+++.... .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999997654 3678889999999999999999943348999999999999998886 799999999765432
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. +. ...+.........
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~-~~---~~~~~~~~~~~~~--- 229 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IM-WA---VHNGTRPPLIKNL--- 229 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HH-HH---HHTTCCCCCBTTC---
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HH-HH---HhcCCCCCccccc---
Confidence 22335899999999999999999999999999999999999999754332111 11 10 0111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
...+.+++..||+.||++|||++||++.|+.+..
T Consensus 230 ------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 230 ------PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1245678899999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.95 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=196.6
Q ss_pred hhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccc-cccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFC-NEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E 584 (797)
.+.+.||+|+||+||+|+....+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 34578999999999999875433 34689999875332 2235789999999999999999999985 45668899999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999999754 5688999999999999999999998 999999999999999999999999999986643322
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHhC-CcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICC-RKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.......+|+.|+|||.+.+..++.++||||||+++|||++| ..||......+..... ..+........
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 256 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRLLQPEY 256 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------HTTCCCCCCTT
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hcCCCCCCCcc
Confidence 223334578899999999999999999999999999999995 5555443322211111 01111100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++|||++|+++.|+.+..
T Consensus 257 ---------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 257 ---------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11346778899999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=339.09 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=204.7
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCc----EEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhcccccccCc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENK----ICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~----~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 578 (797)
...+.+.+.||+|+||.||+|.....++ ..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3445566789999999999999864332 4699999975432 2345689999999999 89999999999999999
Q ss_pred eeeeeecccCCchhhhccc--------------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 579 RLLVYEFISNGCLAGFLFK--------------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+|+||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999864 23578999999999999999999998 999999999999999999
Q ss_pred cEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHH
Q 003759 645 TARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVD 722 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 722 (797)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |..||.......... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~ 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY---K 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH---H
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH---H
Confidence 9999999999866443322 2233457889999999999899999999999999999999 999997654332111 1
Q ss_pred HHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 723 WAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
..... ........ ....+.+++..||+.||++|||+.||++.|+.+.
T Consensus 279 ~~~~~----~~~~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 LVKDG----YQMAQPAF---------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHT----CCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcC----CCCCCCCC---------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111 00000000 1234667889999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=328.64 Aligned_cols=262 Identities=21% Similarity=0.217 Sum_probs=192.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|+||+||+|... .+..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred chhhhhcccCCCEEEEEEEcC--CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 345678999999999999873 345699999865332 2346788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+++ +|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 975 888888654 6789999999999999999999998 999999999999999999999999999986543222 2
Q ss_pred cccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc--ccccc------
Q 003759 665 TTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID--EKLHL------ 735 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------ 735 (797)
.....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.......... .....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2334589999999999764 58999999999999999999999997654332211111100000000 00000
Q ss_pred cc---cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 LV---ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 ~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .+.............+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000000001234678899999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=338.16 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=196.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+|.....++ ..|++|.+.... ....+++.+|+.++++++||||+++++++..+. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 4456789999999999999865543 346888876433 344578999999999999999999999998754 78999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999999764 5689999999999999999999998 999999999999999999999999999987644322
Q ss_pred -cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .... .+........
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~----~~~~----~~~~~~~~~~- 243 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILE----KGERLPQPPI- 243 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHH----TTCCCCCCTT-
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHH----cCCCCCCCcc-
Confidence 22233446788999999999999999999999999999999 99999765433211 1111 1110000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
....+.+++..||+.||++||++.|+++.|+.+...
T Consensus 244 --------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 244 --------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 112466788999999999999999999999886643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=341.71 Aligned_cols=266 Identities=17% Similarity=0.194 Sum_probs=199.1
Q ss_pred HhhhhhhCcc--cceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRG--AFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G--~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
|.+.+.||+| +||+||+|+....+ ..||||++...... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTG-EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTC-CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCC-CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 4556789999 99999999987544 46999999754322 2356888999999999999999999999999999999
Q ss_pred ecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 584 EFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999765 6789999999999999999999998 99999999999999999999999999987543221
Q ss_pred C------cccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc--
Q 003759 662 T------RTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE-- 731 (797)
Q Consensus 662 ~------~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 731 (797)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..............+.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11222358899999999987 5799999999999999999999999976543322111110000000000
Q ss_pred -----------------cccccccc---h------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 -----------------KLHLLVEN---D------EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 -----------------~~~~~~~~---~------~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........ . ............+.+++..||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 0 0000001112457889999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.74 Aligned_cols=272 Identities=22% Similarity=0.290 Sum_probs=200.1
Q ss_pred HHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc--cCcCchhhhccccccc--
Q 003759 501 KELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--TNHRNLVKLLGFCNED-- 576 (797)
Q Consensus 501 ~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~-- 576 (797)
.+.....+.+.+.||+|+||.||+|+.. +..||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3444556777889999999999999874 456999998642 23444555555544 4999999999998876
Q ss_pred --CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 577 --QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC-----TTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 577 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6889999999999999999654 6899999999999999999999752 3489999999999999999999999
Q ss_pred eecCccccccCCCc---ccccccccCccccccccccCCCCcc------CceehHHHHHHHHHhC----------CcCCCc
Q 003759 650 DFGLAKILKADQTR---TTTAIRGTRGYVAPEWFKSLPITMK------VDIYSFGVMLLELICC----------RKKFEQ 710 (797)
Q Consensus 650 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~------sDVwS~Gvll~elltG----------~~p~~~ 710 (797)
|||++..+...... ......||+.|+|||.+.+...+.+ +||||||+++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999866543322 1224468999999999988766655 9999999999999999 555544
Q ss_pred cccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 711 NVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
........... ............. +...........+.+++..||+.||++|||+.||++.|+.+.+-.
T Consensus 265 ~~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDM---REIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHH---HHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhh---HHHHhhhccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 32222111110 1111111111111 111112234456788999999999999999999999999876544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.65 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=194.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc-----CCCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM-----VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
..+.+.+.||+|+||.||+|+.... +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQT-RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCC-CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 3466778999999999999988654 456999998643 2334467999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC----------------------------------------CCCChhhHHHHHHHHHHHHHHH
Q 003759 581 LVYEFISNGCLAGFLFKN----------------------------------------PKPSWYRRMQIAFGIARGLFYL 620 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~gL~~L 620 (797)
+||||+++|+|.+++... ..+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 1124566788999999999999
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCC--cEEEEeecCccccccCCC---cccccccccCcccccccccc--CCCCccCceeh
Q 003759 621 HEECTTQIIHCDIKPQNILLDDSF--TARISDFGLAKILKADQT---RTTTAIRGTRGYVAPEWFKS--LPITMKVDIYS 693 (797)
Q Consensus 621 H~~~~~~ivH~Dlkp~NILl~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS 693 (797)
|+. +|+|+||||+||+++.++ .+||+|||++..+..... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 998 999999999999998776 899999999986643221 22344568999999999975 67899999999
Q ss_pred HHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 694 FGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 694 ~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
||+++|||++|+.||......+....+. ...... ..+... .....+.+++..||+.||++||++.|
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~--------~~~~~~-~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVL--------NKKLCF-ENPNYN-----VLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCCT-TSGGGG-----GSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHH--------hccccc-CCcccc-----cCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999997654332111110 011000 000000 01234667889999999999999999
Q ss_pred HHHH
Q 003759 774 VTLM 777 (797)
Q Consensus 774 Vl~~ 777 (797)
+++.
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.94 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=199.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhccccc----ccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCN----EDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+++....+ ..||||++........+.+.+|+.++++++||||+++++++. .....++||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDG-HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTC-CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCC-cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 445678999999999999986544 569999987654445567999999999999999999999986 345789999
Q ss_pred ecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 584 EFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 584 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999865 46789999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCc--------ccccccccCccccccccccCC---CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhh
Q 003759 660 DQTR--------TTTAIRGTRGYVAPEWFKSLP---ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 660 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
.... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||............ ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~-- 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--AVQN-- 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--HHHC--
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--Hhhc--
Confidence 2111 112234799999999987654 689999999999999999999999653222111110 0000
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
...... . ......+.+++..||+.||++|||+.+|++.|+.+....
T Consensus 263 -~~~~~~--~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 263 -QLSIPQ--S--------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -C--CCC--C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -cCCCCc--c--------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 000000 0 001134677899999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.66 Aligned_cols=260 Identities=15% Similarity=0.157 Sum_probs=199.6
Q ss_pred HhhhhhhCcccceeEEEEEEecC-------CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhh-----------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYE-------NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL----------- 569 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~-------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l----------- 569 (797)
+.+.+.||+|+||.||+|+.... .+..||||++... +.+.+|++++.+++||||+++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 45567899999999999998753 3456999998743 568899999999999999984
Q ss_pred ----cccccc-cCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 003759 570 ----LGFCNE-DQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642 (797)
Q Consensus 570 ----~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~ 642 (797)
++++.. ++..++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 445544 67889999999 99999999875 7799999999999999999999998 9999999999999999
Q ss_pred CC--cEEEEeecCccccccCCCc------ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccc
Q 003759 643 SF--TARISDFGLAKILKADQTR------TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714 (797)
Q Consensus 643 ~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~ 714 (797)
++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876543221 223346899999999999999999999999999999999999999865422
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
... +....... . .............. .....+.+++..||+.||++||++++|++.|+++.+
T Consensus 275 ~~~--~~~~~~~~-~-~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 275 TED--IMKQKQKF-V-DKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp HHH--HHHHHHHH-H-HSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHhc-c-CChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 211 11111110 0 01111111100000 001346778899999999999999999999987553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=340.94 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=198.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|+.... +..||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44567899999999999998754 4569999997532 23445678899999887 9999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 9999999999998878899999999999999999999998 999999999999999999999999999986432222
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .. +...... . +..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~----i~~~~~~-~----p~~ 240 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----HS----IRMDNPF-Y----PRW 240 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HH----HHHCCCC-C----CTT
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HH----HHhCCCC-C----Ccc
Confidence 234456999999999999999999999999999999999999999765332211 11 1111110 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMK-KVT 775 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-eVl 775 (797)
....+.+++..||+.||++||++. +|+
T Consensus 241 -----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 241 -----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 113456788999999999999997 665
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.38 Aligned_cols=271 Identities=20% Similarity=0.228 Sum_probs=205.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccC--ceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ--HRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E 584 (797)
|.+.+.||+|+||+||+|+....+ ..||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTG-DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCC-cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 445678999999999999987544 469999997533 234567889999999999999999999987655 7799999
Q ss_pred cccCCchhhhcccCC---CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCcEEEEeecCcccc
Q 003759 585 FISNGCLAGFLFKNP---KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAKIL 657 (797)
Q Consensus 585 y~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~~ 657 (797)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999997643 389999999999999999999998 99999999999999 78888999999999876
Q ss_pred ccCCCcccccccccCcccccccccc--------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKS--------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 54322 233458999999999865 56788999999999999999999999754333222222111111110
Q ss_pred cccccccc-----------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 730 DEKLHLLV-----------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 730 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
...+.... ...............+.+++..||+.||++||++.|+++.++.++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000000 00000011123345677899999999999999999999999886653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.95 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred HHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccccC-ce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ-HR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 579 (797)
.+.+.+.||+|+||+||+|+... ..+..||||++...... ..+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 34556789999999999998642 34577999999764332 235689999999999 7999999999987654 58
Q ss_pred eeeeecccCCchhhhcccCCC----------------CChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 580 LLVYEFISNGCLAGFLFKNPK----------------PSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
++||||+++++|.+++..... +++..+..++.|+++||.|||+. +|+|+||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 999999999999999976543 78899999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHH
Q 003759 644 FTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILV 721 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 721 (797)
+.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+...
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--- 261 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--- 261 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH---
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH---
Confidence 9999999999987654332 22333457889999999999999999999999999999998 999997654322111
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
... ..+........ ....+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 262 ~~~----~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 262 RRL----KEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHH----HHTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHh----ccCccCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 11111111111 11346678899999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=358.51 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=206.7
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
...+.+.++||+|+||.||+|++.. +..||||+++... ...++|.+|++++++++|+||+++++++.+ +..+||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECC--CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3345567789999999999999864 3469999997643 345789999999999999999999999876 67899999
Q ss_pred cccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 585 FISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+++|+|.+++... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999743 5689999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......++..|+|||.+.+..++.++||||||++||||++ |+.||......+ +.... ..+.......
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----~~~~i----~~~~~~~~~~--- 487 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV----ERGYRMPCPP--- 487 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----HHHHH----HTTCCCCCCT---
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HcCCCCCCCC---
Confidence 22333446788999999999999999999999999999999 899997653321 11111 1111100001
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI 786 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~ 786 (797)
.....+.+++..||+.||++|||+.+|+++|+.+.....
T Consensus 488 ------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 488 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 112346678899999999999999999999998765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.04 Aligned_cols=243 Identities=23% Similarity=0.213 Sum_probs=199.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+++....+ ..||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESG-NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECCCC-CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 344578999999999999987544 469999986532 2344678899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 999999999998878899999999999999999999998 9999999999999999999999999999876432
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+..+.... ...
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--------~~i~~~~~~~-p~~----- 260 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY--------EKIVSGKVRF-PSH----- 260 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------HHHHHCCCCC-CTT-----
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH--------HHHHcCCCCC-CCC-----
Confidence 23346899999999999999999999999999999999999999765332111 1111111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
....+.+++..||+.||++||+ ++||++
T Consensus 261 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1134567889999999999998 888875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=331.42 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=204.9
Q ss_pred HHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
..+.+.+.||+|+||.||+|+... ..+..||||.+...... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 345567889999999999998763 23567999999754322 2346899999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccC----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEe
Q 003759 581 LVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISD 650 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 650 (797)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 999999999999998642 3568899999999999999999998 999999999999999999999999
Q ss_pred ecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhh
Q 003759 651 FGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 651 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ..
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~----~~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LR----FV 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HH----HH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH----HH----HH
Confidence 999986543322 22223346889999999999999999999999999999999 8889876432211 11 11
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+........ ....+.+++..||+.||++|||+.|+++.|+++.+
T Consensus 254 ~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 11346678899999999999999999999988655
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.46 Aligned_cols=246 Identities=23% Similarity=0.257 Sum_probs=190.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||||++... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATG-RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCC-CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 445678999999999999987544 56999999753 22334567889999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence 99999999999888889999999999999999999997 6 99999999999999999999999999998643322 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... ...... ....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i----~~~~~~-~p~~---- 371 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELI----LMEEIR-FPRT---- 371 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH----HHCCCC-CCTT----
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHH----HhCCCC-CCcc----
Confidence 233456999999999999999999999999999999999999999765332111 111 111110 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||++|| +++|+++
T Consensus 372 -----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 -----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 113456788999999999999 9999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.74 Aligned_cols=241 Identities=25% Similarity=0.303 Sum_probs=198.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--------chHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
.|.+.+.||+|+||+||+|+.... +..||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEK-NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTT-TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEEeEEEecCCEEEEEEEECCC-CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 455567899999999999998755 456999999764321 23467889999999999999999999999999
Q ss_pred eeeeeecccCC-chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 579 RLLVYEFISNG-CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 579 ~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
.++||||+..| +|.+++.....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999998888899999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
..... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .....
T Consensus 181 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------~~~~~- 243 (335)
T 3dls_A 181 ERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------AAIHP- 243 (335)
T ss_dssp CTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------TCCCC-
T ss_pred CCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------hccCC-
Confidence 54332 233558999999999988876 8899999999999999999999965322100 00000
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ....+.+++..||+.||++|||+.|+++.
T Consensus 244 ~~~---------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PYL---------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred Ccc---------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11346678899999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=332.51 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=195.9
Q ss_pred hhhhhhCcccceeEEEEEEecCC---cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYEN---KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~---~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+.||+|+||.||+|+....+ +..||||++...... ...++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34568999999999999886443 356999999754322 23468999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999764 6789999999999999999999998 9999999999999999999999999999876543221
Q ss_pred --ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 664 --TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 664 --~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.... ..+.......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~----~~~~~~~~~~-- 273 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAI----NDGFRLPTPM-- 273 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHH----HTTCCCCCCT--
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----HHHHH----HCCCcCCCcc--
Confidence 2222346788999999999999999999999999999999 999996543221 11111 1111000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++..||+.||++||++.+|++.|+.+.
T Consensus 274 -------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 274 -------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01234667889999999999999999999997654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.03 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=201.3
Q ss_pred hhhhhhCcccceeEEEEEEec---CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc--cCceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAY---ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~---~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 582 (797)
.+.+.||+|+||+||++.... ..+..||||++..... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 456789999999999886532 2456799999976432 224568999999999999999999999977 4578999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++++|.+++.+. .+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999654 489999999999999999999998 999999999999999999999999999987654332
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh-------hHHHHHHhhhccccc
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM-------ILVDWAYDCYIDEKL 733 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 733 (797)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...............
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 22333457888999999999899999999999999999999999996543211000 000000011111110
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.... ......+.+++..||+.||++|||+.|+++.|+.+.+
T Consensus 270 ~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 270 LPRP---------DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---------ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0000 0112356788999999999999999999999988654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.25 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=199.7
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||.||+++....+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG-KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC-CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 45667789999999999999987544 46999998653221 346799999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----cEEEEeecCcc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF----TARISDFGLAK 655 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~ 655 (797)
++||||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998778899999999999999999999998 999999999999998877 89999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+ ......
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~- 229 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--------SAVNYD- 229 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC-
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--------HhcccC-
Confidence 7644322 23345899999999999999999999999999999999999999765332111100 000000
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .. ........+.+++..||+.||++|||+.|+++
T Consensus 230 -~~--~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FD--EE--YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CC--HH--HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Cc--ch--hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 00 00011234678899999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.49 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=205.7
Q ss_pred HHHHhhhhhhCcccceeEEEEEEec------CCcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhccccccc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNED 576 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 576 (797)
...+.+.+.||+|+||.||+|.... ..+..||||++..... ...+++.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 3455667889999999999998752 2345799999975432 2235688999999999 999999999999999
Q ss_pred CceeeeeecccCCchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
+..++||||+++++|.+++.... .+++..++.++.||++||+|||+. +|+|+||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997543 378899999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchh
Q 003759 641 DDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQM 718 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 718 (797)
+.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987654332 22233457889999999998889999999999999999999 999997653221
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+..... .+........ ....+.+++..||+.||++|||+.||++.|+++...
T Consensus 268 -~~~~~~----~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 -LFKLLK----EGHRMDKPAN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -HHHHHH----HTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHh----cCCCCCCCcc---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111 1111111011 113466788999999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.87 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=195.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+++.... +..||+|++....... .+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 44567899999999999998754 4569999997643322 24578899999887 8999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.+...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh-hHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM-ILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........+....... +.
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----p~ 240 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-----PR 240 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC-----CT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC-----CC
Confidence 2344569999999999999999999999999999999999999996532211100 00011111111111110 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTM 771 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 771 (797)
. ....+.+++..||+.||++||++
T Consensus 241 ~-----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 241 S-----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp T-----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C-----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 0 11346678899999999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.78 Aligned_cols=250 Identities=23% Similarity=0.253 Sum_probs=197.7
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.||+|+||+||+++....+ ..||||++.+.. ....+.+.+|..++..++||||+++++++.+.+..+|||||+
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~-~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTG-QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEECCCC-CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 3467999999999999987544 469999996521 122345889999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999999999764 4789999999999999999999998 999999999999999999999999999987765444334
Q ss_pred ccccccCccccccccc-------cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 666 TAIRGTRGYVAPEWFK-------SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~-------~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... . ..... .
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~---~~p~~-~ 295 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-L---SLPLV-D 295 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-C---CCC----
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-c---CCCcc-c
Confidence 4567999999999997 356899999999999999999999999765433221111111000 0 00000 0
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLR---PTMKKVTLM 777 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~eVl~~ 777 (797)
......+.+++..||+ +|++| |+++||++.
T Consensus 296 --------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 296 --------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0011346678889999 99998 689998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.38 Aligned_cols=270 Identities=22% Similarity=0.306 Sum_probs=207.3
Q ss_pred cCHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc--cCcCchhhhcccccc
Q 003759 498 FSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ--TNHRNLVKLLGFCNE 575 (797)
Q Consensus 498 ~~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~ 575 (797)
+...+.....+.+.+.||+|+||.||+|+.. +..||||++... ..+.+..|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3445556667788899999999999999873 457999998642 35677888888877 799999999999987
Q ss_pred cC----ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEEcCC
Q 003759 576 DQ----HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH--------EECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 576 ~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
.. ..++||||+++|+|.+++.+ ..+++..++.++.|++.||+||| +. +|+|+||||+|||++.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 76 78999999999999999965 46899999999999999999999 55 99999999999999999
Q ss_pred CcEEEEeecCccccccCCCc---ccccccccCccccccccccC------CCCccCceehHHHHHHHHHhC----------
Q 003759 644 FTARISDFGLAKILKADQTR---TTTAIRGTRGYVAPEWFKSL------PITMKVDIYSFGVMLLELICC---------- 704 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~Gvll~elltG---------- 704 (797)
+.+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876543322 23345689999999999775 334789999999999999999
Q ss_pred CcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 705 RKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 705 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..||............ .............+. ...........+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 264 ~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEE---MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCTTTTTSCSSCCHHH---HHHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHH---HHHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 6777654332211111 111111111111111 111122344567889999999999999999999999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.97 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=201.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.+.||+|+||.||+|+....+ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCC-cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 4556678999999999999987544 4699999865332 3346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-cc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RT 664 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 664 (797)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999998878899999999999999999999998 999999999999999999999999999986643322 22
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ..+... .... .. ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~----~~~~---~~-~~- 232 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEK----KTYL---NP-WK- 232 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHHTT----CTTS---TT-GG-
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhhhc----cccc---Cc-hh-
Confidence 334568999999999988765 789999999999999999999997654332111 111110 0000 00 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||++|+++
T Consensus 233 ----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 233 ----KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01134567889999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.60 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=199.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+..... +..||+|.+..... ...+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 445678999999999999876433 45699999876422 234678999999999999999999999875 45689999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999754 4589999999999999999999998 9999999999999999999999999999876554433
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..... +........
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~----~~~~~----~~~~~~~~~--- 238 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI----GVLEK----GDRLPKPDL--- 238 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH----HHHHH----TCCCCCCTT---
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH----HHHhc----CCCCCCCCC---
Confidence 3344557889999999998899999999999999999998 99999754332211 11111 110000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++||++.|+++.|+.+.
T Consensus 239 ------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 239 ------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1134667889999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=360.15 Aligned_cols=249 Identities=28% Similarity=0.400 Sum_probs=198.2
Q ss_pred hhhCcccceeEEEEEEecC-CcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
++||+|+||.||+|.+... .+..||||+++..... ..++|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4699999999999977533 3467999999764332 34689999999999999999999999964 568899999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC--cccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTT 666 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~ 666 (797)
|+|.+++.....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999998888899999999999999999999998 999999999999999999999999999987654432 2233
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .. .+..+........
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~----~~----~i~~~~~~~~p~~------ 596 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TA----MLEKGERMGCPAG------ 596 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HH----HHHTTCCCCCCTT------
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HH----HHHcCCCCCCCCC------
Confidence 3446788999999999999999999999999999998 9999976543221 11 1111111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
....+.+++..||+.||++||++.+|++.|+.+
T Consensus 597 ---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 597 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 123467788999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=346.35 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=200.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||.||+|+....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTG-HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTC-CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 455678999999999999987544 469999996532 2234578999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~ 171 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 171 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--c
Confidence 999999999998888899999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ..+..+.... +..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--------~~i~~~~~~~-----p~~ 238 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF--------KKICDGIFYT-----PQY 238 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH--------HHHHTTCCCC-----CTT
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH--------HHHhcCCcCC-----Ccc
Confidence 234468999999999988765 78999999999999999999999764332111 1111111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||+.||++
T Consensus 239 -----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 -----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0124567889999999999999999997
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.45 Aligned_cols=261 Identities=17% Similarity=0.221 Sum_probs=201.6
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccc-cccCceeeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC-NEDQHRLLVYE 584 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E 584 (797)
..+.+.+.||+|+||.||+|+.... +..||||++... ...+++.+|+.++..++|++++..+.++ .+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCC-CceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3456678899999999999997654 456999987643 2335688999999999988888877766 56677899999
Q ss_pred cccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+ +++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 9999999974 46789999999999999999999998 99999999999999 78999999999999876544
Q ss_pred CC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 661 QT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 661 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........ .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-cchhh
Confidence 32 123345689999999999999999999999999999999999999986544332221111111100 00000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
.... .....+.+++..||+.||++|||+++|++.|+++..
T Consensus 241 ~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 241 VLCK---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTT---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhc---------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0000 012456788999999999999999999999987544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.69 Aligned_cols=260 Identities=17% Similarity=0.213 Sum_probs=202.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccc-cccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC-NEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|+.... +..||||++... ...+++.+|+.++..++|++++..+.++ .+++..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT-TEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEccCCCeEEEEEEEcCC-CcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 34567899999999999997654 457999998653 2345789999999999998877777766 5566779999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+++|.+++.. ...+++..++.++.|++.||+|||++ +|+|+||||+|||+ ++++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9999999973 46789999999999999999999998 99999999999999 5888999999999987654432
Q ss_pred ------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 663 ------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 663 ------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........ .......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCHHHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-CCchHHH
Confidence 123445689999999999999999999999999999999999999986543322111111111100 0000000
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.......+.+++..||+.||++|||+++|++.|+.+..-
T Consensus 243 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 243 ---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 000124567889999999999999999999999875543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.34 Aligned_cols=248 Identities=22% Similarity=0.238 Sum_probs=190.6
Q ss_pred HHhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccCC----CchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMVS----GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
.+.+.+.||+|+||.||+++... ..+..||+|+++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 35556789999999999998752 3456799999976421 23346788999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||+++++|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999999999998878889999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ . ..... .
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~----~~~~~-~---- 240 (327)
T 3a62_A 175 GT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI----L----KCKLN-L---- 240 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----H----HTCCC-C----
T ss_pred Cc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH----H----hCCCC-C----
Confidence 22 223456899999999999999999999999999999999999999765332211111 1 11110 0
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
+.. ....+.+++..||+.||++|| ++.|+++
T Consensus 241 p~~-----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 PPY-----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CTT-----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCC-----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 113456788999999999999 7778775
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.71 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=191.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.+.||+|+||+||+|+.... +..||||++...... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT-TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEecCCeEEEEEEECCC-CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 45567899999999999988754 456999999654322 234678999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-----cCCCcEEEEeecCccccccC
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL-----DDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl-----~~~~~~kl~Dfgla~~~~~~ 660 (797)
++ ++|.+++.....+++..+..|+.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||++......
T Consensus 115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 98 59999998888899999999999999999999998 99999999999999 45556999999999876433
Q ss_pred CCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc--------
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE-------- 731 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 731 (797)
.. ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+..... .....
T Consensus 191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTTWPGVTAL 268 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSTTGGGS
T ss_pred cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCchhhhhhhhhh
Confidence 22 22334579999999999875 489999999999999999999999976544322221111100 00000
Q ss_pred -----cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 -----KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....................+.+++..||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000111111111112245678999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.66 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=199.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+++.... +..||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~-~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTE-EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 45567899999999999998643 4579999997532 23446688899999988 8999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.+...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+....... ...
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~--------~~i~~~~~~~-p~~---- 243 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--------QSIMEHNVAY-PKS---- 243 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------HHHHHCCCCC-CTT----
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH--------HHHHhCCCCC-CCC----
Confidence 234456999999999999999999999999999999999999999765332211 1111111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~~ 777 (797)
....+.+++..||+.||++||+ +.+|++.
T Consensus 244 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 244 -----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1134667889999999999995 5777643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.95 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=199.7
Q ss_pred hhhh-hhCcccceeEEEEEEec-CCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 509 GFKD-ELGRGAFATVHKGVLAY-ENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~-~LG~G~fG~Vykg~~~~-~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+ .||+|+||+||+|.... ..+..||||++....... .+++.+|+.+++.++||||+++++++ +.+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 89999999999997643 335679999997643322 45799999999999999999999999 5677899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc-
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR- 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 663 (797)
|+++++|.+++.....+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999876544332
Q ss_pred -ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 664 -TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 664 -~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.... ..+.......
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~----~~~~~~~~~~--- 243 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAML----EKGERMGCPA--- 243 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHH----HTTCCCCCCT---
T ss_pred cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH----HcCCCCCCCC---
Confidence 1222346788999999998889999999999999999999 999997653321 11111 1111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
.....+.+++..||+.||++||++.+|++.|+++.
T Consensus 244 ------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 244 ------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11234677889999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.92 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=199.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|.....+ ..||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCC-ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 445678999999999999987544 46999998654322 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEeecCccccccCCC
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDFGLAKILKADQT 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~~~~~ 662 (797)
+++++|.+.+.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++. +||+|||++........
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999998888899999999999999999999998 9999999999999986655 99999999976654322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.... . ..+...... ....
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~----~~~~~~~~~-~~~~ 232 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----I----KAGAYDYPS-PEWD 232 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H----HHTCCCCCT-TTTT
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH----H----HhccccCCc-hhhc
Confidence 2335589999999999999999999999999999999999999976433221111 1 111111000 0000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 233 -----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011345678899999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=331.96 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=196.9
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..+.+.+.||+|+||.||+++.... +..||||+++.... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKAT-NMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3456678899999999999998754 45699999976432 345688888887 79999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC----CcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS----FTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~~~~~ 660 (797)
|+++|+|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999998888899999999999999999999998 99999999999998543 35999999999876543
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......+|+.|+|||++.+..++.++||||||+++|||++|..||.......... +.. .+..+..... ...
T Consensus 174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~~~----~i~~~~~~~~-~~~ 246 (342)
T 2qr7_A 174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-ILA----RIGSGKFSLS-GGY 246 (342)
T ss_dssp TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH-HHH----HHHHCCCCCC-STT
T ss_pred CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH-HHH----HHccCCcccC-ccc
Confidence 32 2234468999999999998889999999999999999999999997543221111 111 1111111100 000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .....+.+++..||+.||++||++.|+++
T Consensus 247 ~~-----~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 247 WN-----SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 01134567889999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.00 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=197.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|+....+ ..||||++....... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTG-RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTC-CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred heeeeEEeecCCEEEEEEEECCCC-ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 444578999999999999987544 469999986543322 34578999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 181 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 181 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence 99999999988778899999999999999999999998 999999999999999999999999999986543322 22
Q ss_pred ccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------------hhccc
Q 003759 666 TAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------------CYIDE 731 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~ 731 (797)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...... .....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 334589999999999875 7899999999999999999999999765443322111110000 00000
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....................+.+++..||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111111111112346788999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.29 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=202.0
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc------
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------ 575 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------ 575 (797)
......+.+.+.||+|+||.||+|+....+ ..||+|++... .+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDG-KTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTC-CEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCC-eEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 334455666788999999999999987544 46999998753 3567889999999999999999998754
Q ss_pred ----------cCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC
Q 003759 576 ----------DQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS 643 (797)
Q Consensus 576 ----------~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~ 643 (797)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 45689999999999999999643 5789999999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH
Q 003759 644 FTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 644 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 723 (797)
+.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+..... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~--- 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------F--- 227 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------H---
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------H---
Confidence 9999999999987654332 2334589999999999999999999999999999999999988743211 0
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
......+.+.... ...+.+++..||+.||++|||+.|+++.|+.+..-+..
T Consensus 228 -~~~~~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 228 -FTDLRDGIISDIF------------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -HHHHHTTCCCTTS------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -HHHhhcccccccC------------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 0111111111111 12356788899999999999999999999887665443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.18 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=196.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|.....+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEeeEEecCCCeEEEEEEEccCC-cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 344678999999999999987554 469999985422 2334678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 999999999998878899999999999999999999998 99999999999999999999999999986543322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+ ...... ..+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~~~~----- 229 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEFT-FPDF----- 229 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-CCTT-----
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH--------HhCCCC-CCCc-----
Confidence 23345899999999999999999999999999999999999999754332211111 000000 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.||++.
T Consensus 230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11345678899999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.98 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=190.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCc--CchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNH--RNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~ 583 (797)
|.+.+.||+|+||.||++.... +..||||++...... ..+.+.+|+.++.+++| +||+++++++.+++..++||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTT--SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeCC--CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4456789999999999998743 456999998754322 23578999999999976 99999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
| +.+++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56889999999888899999999999999999999998 999999999999997 578999999999876544322
Q ss_pred -ccccccccCcccccccccc-----------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 664 -TTTAIRGTRGYVAPEWFKS-----------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 664 -~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... + .......
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~~~~~~~ 237 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HAIIDPN 237 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HHHHCTT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--H----HHHhcCC
Confidence 2334569999999999865 67899999999999999999999999754321110 1 1111111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........ ....+.+++..||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~---------~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 HEIEFPDI---------PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SCCCCCCC---------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCccc---------CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 10000010 01345678899999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=342.36 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=190.6
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--------CchHHHHHHHHHhhccCcCchhhhccccccc
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--------GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED 576 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 576 (797)
...+.+.+.||+|+||+||+|.....+ ..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTC-KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCC-cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 344666788999999999999987654 4699999865321 122358899999999999999999999854
Q ss_pred CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEeecC
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDFGL 653 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgl 653 (797)
+..++||||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 45799999999999999998888899999999999999999999998 999999999999997544 599999999
Q ss_pred ccccccCCCcccccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcc
Q 003759 654 AKILKADQTRTTTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ...
T Consensus 289 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~-------i~~ 359 (419)
T 3i6u_A 289 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ-------ITS 359 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH-------HHT
T ss_pred ceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH-------Hhc
Confidence 98765322 2334568999999999853 56889999999999999999999999764332221111 111
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
+..... +.. .......+.+++..||+.||++|||+.|+++.
T Consensus 360 ~~~~~~----~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 GKYNFI----PEV--WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TCCCCC----HHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCC----chh--hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111100 000 00112356788999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.22 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=193.6
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
..+.+.+.||+|+||+||++.....+ ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG-LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCC-ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35667789999999999999986544 4699999875433 345789999999999999999999999999999999999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCcccc
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKIL 657 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~ 657 (797)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998853 36789999999999999999999998 99999999999999 45678999999999865
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
..... .....+++.|+|||.+. ..++.++||||||+++|||++|+.||......+.... .. ..........
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~--~~~~~~~~~~ 248 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----AT--YKEPNYAVEC 248 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH--HCCCCCCC--
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hc--cCCccccccc
Confidence 44322 23345899999999986 4689999999999999999999999976533221110 00 0011110000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. ....+.+++..||+.||++|||+.||++
T Consensus 249 ~~---------~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP---------LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---------CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc---------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1134567889999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=339.14 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=187.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccC-cCchhhhccccccc--Cceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTN-HRNLVKLLGFCNED--QHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~l 581 (797)
.|.+.+.||+|+||.||+|.....+ ..||||++...... ..+.+.+|+.++.++. ||||+++++++... ...++
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTG-EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTC-CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCC-CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 3556678999999999999987654 46999998653322 2346788999999996 99999999998654 47899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 689888865 4688999999999999999999998 99999999999999999999999999998653211
Q ss_pred --------------------CcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhH
Q 003759 662 --------------------TRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL 720 (797)
Q Consensus 662 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 720 (797)
....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112334569999999999976 67899999999999999999999999765443322211
Q ss_pred HHHHHhhhcccccccc----------------------ccchhhhhhhH--------HHHHHHHHHHHHhcccCCCCCCC
Q 003759 721 VDWAYDCYIDEKLHLL----------------------VENDEEALHDM--------MRLKKYVMIAIWCIQEDPSLRPT 770 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~--------~~~~~~~~l~~~Cl~~dP~~RPs 770 (797)
..... ......+... ........... .....+.+++..||+.||++|||
T Consensus 244 ~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 244 IGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 11000 0000000000 00000000000 11245788999999999999999
Q ss_pred HHHHHHH
Q 003759 771 MKKVTLM 777 (797)
Q Consensus 771 ~~eVl~~ 777 (797)
++|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.02 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=202.9
Q ss_pred HhhhhhhCcccceeEEEEEEe---cCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC--ceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLA---YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ--HRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~---~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 582 (797)
+.+.+.||+|+||.||+++.. ...+..||||++........+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 455678999999999999852 3345679999998755455568999999999999999999999886644 78999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999765 4689999999999999999999998 99999999999999999999999999998765443
Q ss_pred Cc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccccc--------chhhHHHHHHhhhccc
Q 003759 662 TR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE--------NQMILVDWAYDCYIDE 731 (797)
Q Consensus 662 ~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 731 (797)
.. ......++..|+|||.+.+..++.++||||||+++|||+||..|+....... ............+..+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 21 1223446778999999998889999999999999999999999886432110 0000000000111111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....... .....+.+++..||+.||++|||+.||++.|+.+.
T Consensus 280 ~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 280 GRLPRPD---------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CCCCCCT---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC---------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1000000 11235678899999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=354.34 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=197.0
Q ss_pred hhCcccceeEEEEEEecC-CcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+||+|+||.||+|++... .+..||||+++.... ...++|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 699999999999988643 456799999976433 345789999999999999999999999976 56899999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--cccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--TTTA 667 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 667 (797)
|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 5689999999999999999999998 9999999999999999999999999999876543321 1222
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..+++.|+|||++.+..++.++||||||++||||++ |+.||......+ +... +..+........
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~----i~~~~~~~~p~~------- 563 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF----IEQGKRMECPPE------- 563 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHH----HHTTCCCCCCTT-------
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH----HHcCCCCCCCCc-------
Confidence 335689999999999999999999999999999998 999997654322 1111 111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
....+.+++..||+.||++||++.+|++.|+.+
T Consensus 564 --~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 564 --CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 123467788999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.04 Aligned_cols=192 Identities=24% Similarity=0.372 Sum_probs=152.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccc-----cCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNE-----DQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 580 (797)
+.+.+.||+|+||+||+|+....+ ..||||++...... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEK-RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp EEECCC-------CEEEEEECC---CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCC-cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 556788999999999999987544 46999999754332 23578899999999999999999999843 35789
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||+ +++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999998 578999998888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC--------------------------cccccccccCcccccccc-ccCCCCccCceehHHHHHHHHHhC
Q 003759 661 QT--------------------------RTTTAIRGTRGYVAPEWF-KSLPITMKVDIYSFGVMLLELICC 704 (797)
Q Consensus 661 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwS~Gvll~elltG 704 (797)
.. .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 123345689999999976 566799999999999999999993
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.11 Aligned_cols=235 Identities=16% Similarity=0.143 Sum_probs=180.1
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHH---HHhhccCcCchhhhc-------cccccc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEV---NAIGQTNHRNLVKLL-------GFCNED 576 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~---~~l~~l~h~niv~l~-------g~~~~~ 576 (797)
+.+.||+|+||.||+|+....+ ..||||++... .....+.|.+|+ +++++++||||++++ +++...
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETG-ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCC-CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EcceeecCCCEEEEEEEECCCC-cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 3578999999999999986544 46999999743 223346789999 566666899999999 444433
Q ss_pred C-----------------ceeeeeecccCCchhhhcccCCCCC-------hhhHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 003759 577 Q-----------------HRLLVYEFISNGCLAGFLFKNPKPS-------WYRRMQIAFGIARGLFYLHEECTTQIIHCD 632 (797)
Q Consensus 577 ~-----------------~~~lV~Ey~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivH~D 632 (797)
+ ..+|||||+ +|+|.+++.....++ +..++.|+.||+.||+|||++ +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 2 378999999 689999997643333 478889999999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCccccccccccC-----------CCCccCceehHHHHHHHH
Q 003759 633 IKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL-----------PITMKVDIYSFGVMLLEL 701 (797)
Q Consensus 633 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDVwS~Gvll~el 701 (797)
|||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999985332 2334457 999999999887 899999999999999999
Q ss_pred HhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 702 ICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 702 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
++|+.||...........+. . ..... ...+.+++..||+.||++|||+.|+++
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~--------~-----~~~~~---------~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIF--------R-----SCKNI---------PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CCSGGGG--------S-----SCCCC---------CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccchhhhh--------h-----hccCC---------CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999997644322111100 0 00010 134667889999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.30 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=200.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcE-EEEEEEecccC-CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKI-CVAVKKLDNMV-SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~-~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+.. .|++|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 45668899999999999998765543 46999987532 23445799999999999 99999999999999999999999
Q ss_pred cccCCchhhhcccCC----------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEE
Q 003759 585 FISNGCLAGFLFKNP----------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARI 648 (797)
Q Consensus 585 y~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 648 (797)
|+++++|.+++.... .+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999997653 689999999999999999999998 9999999999999999999999
Q ss_pred EeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhh
Q 003759 649 SDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 649 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .
T Consensus 184 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~----~ 253 (327)
T 1fvr_A 184 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YE----K 253 (327)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HH----H
T ss_pred cccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH----HH----H
Confidence 9999987433221 1223346889999999998889999999999999999998 9999976533211 11 1
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+..+....... .....+.+++..||+.||++|||+.|+++.|+.+.+-
T Consensus 254 ~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 254 LPQGYRLEKPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GGGTCCCCCCT---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhcCCCCCCCC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111000000 0113467788999999999999999999999875543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=324.22 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=193.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc----cCceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 582 (797)
.+.+.||+|+||+||+|..... +..||+|++..... ...+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~-~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCC-ceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 3456799999999999988754 45699999875432 233568999999999999999999998764 4568999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEEc-CCCcEEEEeecCcccccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQ--IIHCDIKPQNILLD-DSFTARISDFGLAKILKA 659 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~ 659 (797)
|||+++++|.+++.....+++..+..++.|++.||+|||+. + |+|+||||+||+++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998878899999999999999999999998 6 99999999999997 889999999999975443
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......... .....+........
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------RRVTSGVKPASFDK 253 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------HHHTTTCCCGGGGG
T ss_pred cc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-------HHHhccCCccccCC
Confidence 22 233458999999998875 58999999999999999999999997643322111 11111111100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||+.||++
T Consensus 254 --------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 254 --------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01134678899999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=332.87 Aligned_cols=244 Identities=24% Similarity=0.291 Sum_probs=193.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+...+.||+|+||+||+|+.... +..||||++....... .+++.+|++++++++||||+++++++..++..++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccC-CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 44557899999999999997654 4569999997543322 2468899999999999999999999999999999999
Q ss_pred cccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|++ |+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 67777775 456789999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 664 TTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....||+.|+|||++. ...++.++||||||+++|||++|+.||.......... ....... ......
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------~~~~~~~-~~~~~~- 276 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNES-PALQSG- 276 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCC-CCCCCT-
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHHhcCC-CCCCCC-
Confidence 2345899999999984 5678999999999999999999999997643221111 1111111 000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.++++.
T Consensus 277 -------~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 277 -------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011345678889999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.23 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=202.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
..+.+.+.||+|+||.||+++....+ ..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTG-KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCC-CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45666788999999999999987544 46999999865444556789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCccccccCCC
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||++ ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 99999999998778899999999999999999999998 99999999999999 78899999999998754332
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .... ..+.... ......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i----~~~~~~~-~~~~~~ 232 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL----FEKI----KEGYYEF-ESPFWD 232 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHH----HHCCCCC-CTTTTT
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHH----HcCCCCC-Cccccc
Confidence 22234589999999999999999999999999999999999999976433211 1111 1111100 000000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCc
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL--MLEGVV 782 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~--~Le~~~ 782 (797)
.....+.+++..||+.||++|||+.|+++ .+++..
T Consensus 233 -----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 233 -----DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 01134677899999999999999999987 344433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.51 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=193.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|.....+ ..||||++...... ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTC-CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCC-ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 556678999999999999986544 56999998753222 23568899999999999999999999999999999999
Q ss_pred cccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 585 FISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 585 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|+++++|.+++.. ...+++..++.++.+++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999863 45688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+... ............
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----~~~~~~~~~~~~- 261 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKK----IEQCDYPPLPSD- 261 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHH----HHTTCSCCCCTT-
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHH----hhcccCCCCccc-
Confidence 22 22234589999999999999999999999999999999999999975432211 11111 111111111000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIP 787 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p 787 (797)
.....+.+++..||+.||++|||+.+|++.|+.+.+...+
T Consensus 262 -------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 262 -------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0113466788999999999999999999999987665443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.81 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=199.1
Q ss_pred hhCcccceeEEEEEEec-CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAY-ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
.||+|+||.||+|+... ..+..||||+++.... ...+++.+|+.++++++||||+++++++ +.+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 79999999999998642 3456799999976432 2345789999999999999999999999 5567899999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc--cccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--TTTA 667 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 667 (797)
|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......... ....
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 172 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence 99999654 5689999999999999999999998 9999999999999999999999999999876543321 2223
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... ..+........
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~i----~~~~~~~~~~~------- 237 (287)
T 1u59_A 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFI----EQGKRMECPPE------- 237 (287)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHHH----HTTCCCCCCTT-------
T ss_pred ccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHH----hcCCcCCCCCC-------
Confidence 346889999999998889999999999999999999 999997654322 11111 11111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++||++.+|++.|+.+.
T Consensus 238 --~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 238 --CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1235677889999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=339.32 Aligned_cols=243 Identities=28% Similarity=0.300 Sum_probs=188.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHH-hhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNA-IGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+++.... +..||+|++.+... ...+.+..|..+ ++.++||||+++++++.+.+..++||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~-~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAE-EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTT-CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCC-CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 45668899999999999998754 45699999975432 223456667776 57789999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.+...+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +....... ...
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~--------i~~~~~~~-~~~---- 261 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN--------ILNKPLQL-KPN---- 261 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH--------HHHSCCCC-CSS----
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HHhcccCC-CCC----
Confidence 33445699999999999999999999999999999999999999976543221111 11111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
....+.+++..||+.||++||++.+
T Consensus 262 -----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 -----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1124567888999999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.03 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=191.7
Q ss_pred HhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccC-----c
Q 003759 508 QGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ-----H 578 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~ 578 (797)
+.+.+.||+|+||.||+|..... .+..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 44567899999999999988653 3457999998754322 2356899999999999999999999987755 3
Q ss_pred eeeeeecccCCchhhhcc------cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeec
Q 003759 579 RLLVYEFISNGCLAGFLF------KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 652 (797)
.++||||+++++|.+++. ....+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 599999999999999983 335689999999999999999999998 99999999999999999999999999
Q ss_pred CccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcc
Q 003759 653 LAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYID 730 (797)
Q Consensus 653 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (797)
++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ... ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~----~~ 264 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY----DYL----LH 264 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----HHH----HT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH----HHH----Hc
Confidence 9987644322 22333457889999999999999999999999999999999 88898765432211 111 11
Q ss_pred ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 731 EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+........ ....+.+++..||+.||++|||+++|++.|+.+.
T Consensus 265 ~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 265 GHRLKQPED---------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TCCCCCBTT---------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcc---------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 1134677889999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.42 Aligned_cols=254 Identities=24% Similarity=0.242 Sum_probs=201.4
Q ss_pred HhhhhhhCcccceeEEEEEEec--CCcEEEEEEEecccC----CCchHHHHHHHHHhhcc-CcCchhhhcccccccCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY--ENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~--~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 580 (797)
+.+.+.||+|+||.||+++... ..+..||||+++... ....+.+.+|+.++.++ +||||+++++++..++..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 4556789999999999998853 245679999986532 23345678899999999 6999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 9999999999999998878899999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCcccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...... .... .
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~~-~-- 285 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SEPP-Y-- 285 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----CCCC-C--
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc----cCCC-C--
Confidence 4444445679999999999986 35789999999999999999999999765433322222111111 0000 0
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLML 778 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~L 778 (797)
+.. ....+.+++..||+.||++|| ++.|+++..
T Consensus 286 --~~~-----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 --PQE-----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CTT-----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --Ccc-----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 113456788999999999999 999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.61 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=190.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhccccccc------Cce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 579 (797)
|.+.+.||+|+||+||+|.....+ ..||||++..... ...+++.+|+.+++.++||||+++++++... .+.
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTT-EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCC-CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 444678999999999999887654 5699999975422 2345788999999999999999999998654 457
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||++++ |.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999999765 5555533 488999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH--------------
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------------- 725 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------------- 725 (797)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.+...
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 223445689999999999999999999999999999999999999977543322221111100
Q ss_pred -hhhccc------cccccccch---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 726 -DCYIDE------KLHLLVEND---EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 726 -~~~~~~------~~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... ......... ............+.+++..||+.||++|||++|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000 0001111224567899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.08 Aligned_cols=248 Identities=19% Similarity=0.176 Sum_probs=197.3
Q ss_pred HhhhhhhCcccceeEEEEEEe----cCCcEEEEEEEecccCCCchHHHHHHHHHhhccC---cCchhhhcccccccCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLA----YENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~----~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 580 (797)
+.+.+.||+|+||+||+|+.. ...+..||||++... ...++..|+.++.+++ |+||+++++++...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 445678999999999999531 223456999998753 4567888888887776 999999999999999999
Q ss_pred eeeecccCCchhhhccc-----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----------CC
Q 003759 581 LVYEFISNGCLAGFLFK-----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-----------SF 644 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-----------~~ 644 (797)
+||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999973 46789999999999999999999998 9999999999999998 89
Q ss_pred cEEEEeecCccccccC-CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH
Q 003759 645 TARISDFGLAKILKAD-QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW 723 (797)
Q Consensus 645 ~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 723 (797)
.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------ 294 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------ 294 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee------
Confidence 9999999999765422 223344566999999999999999999999999999999999999999654322110
Q ss_pred HHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcCcC
Q 003759 724 AYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLR-PTMKKVTLMLEGVVE 783 (797)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R-Ps~~eVl~~Le~~~~ 783 (797)
+....... . ..+.+.+++..|++.+|.+| |++.++.+.|++..+
T Consensus 295 ---------~~~~~~~~----~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ---------PEGLFRRL----P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------ECSCCTTC----S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------echhcccc----C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00001110 0 12234567778999999999 688888888877543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.14 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=202.2
Q ss_pred ccCHHHHHHHHHhhh-hhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc-CcCchhhhccc
Q 003759 497 IFSYKELEKATQGFK-DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT-NHRNLVKLLGF 572 (797)
Q Consensus 497 ~~~~~el~~~~~~f~-~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~h~niv~l~g~ 572 (797)
.|...+.....+.+. +.||+|+||.||+|+....+ ..||+|++...... ...++.+|+.++.++ +||||++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTG-QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCC-CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 344445555556665 78999999999999987544 46999998754332 346789999999999 57999999999
Q ss_pred ccccCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEE
Q 003759 573 CNEDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTAR 647 (797)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~k 647 (797)
+.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999654 6789999999999999999999998 9999999999999987 78999
Q ss_pred EEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh
Q 003759 648 ISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727 (797)
Q Consensus 648 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (797)
|+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. ..
T Consensus 175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~ 248 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS----QV 248 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HT
T ss_pred EeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH----hc
Confidence 999999987643322 233468999999999999999999999999999999999999997654322111110 00
Q ss_pred hccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......... .....+.+++..||+.||++|||++|+++.
T Consensus 249 -~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 -NVDYSEETFS---------SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -CCCCCTTTTT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -ccccCchhhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000000000 012346678899999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.75 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=177.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+ ..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTG-LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEccCC-ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 344578999999999999886544 469999986432 2234678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999765 6789999999999999999999998 9999999999999999999999999999876533221
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+... . ....... . +.
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~~-~----~~- 233 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------K-VVLADYE-M----PS- 233 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCC-C----CT-
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------H-HhhcccC-C----cc-
Confidence 223458999999999999899999999999999999999999997653322110 0 0000000 0 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||++++++
T Consensus 234 ----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 ----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01134567899999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=331.12 Aligned_cols=267 Identities=24% Similarity=0.355 Sum_probs=191.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHH--HHHhhccCcCchhhhcccc-----cccCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTE--VNAIGQTNHRNLVKLLGFC-----NEDQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E--~~~l~~l~h~niv~l~g~~-----~~~~~~~ 580 (797)
+.+.+.||+|+||.||+|+. .+..||||++... ....+..| +..+..++||||+++++.+ ......+
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hheeeecccCCCeEEEEEEE---CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 34567899999999999976 3457999998643 23444444 4445568999999999743 3344678
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC------TTQIIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
+||||+++|+|.+++... ..++..+..++.||++||+|||+.+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 999999999999999654 4488999999999999999999863 238999999999999999999999999999
Q ss_pred cccccCC-------CcccccccccCcccccccccc-------CCCCccCceehHHHHHHHHHhCCcCCCccccccc-hhh
Q 003759 655 KILKADQ-------TRTTTAIRGTRGYVAPEWFKS-------LPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-QMI 719 (797)
Q Consensus 655 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~-~~~ 719 (797)
..+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 8765322 122233468999999999976 4567899999999999999999877754322211 100
Q ss_pred HHH---------HHHhhhccccc-cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 720 LVD---------WAYDCYIDEKL-HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 720 ~~~---------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
... ........... ........ ........+.+++..||+.||++|||+.||++.|+++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000 00000000000 00000000 0112334678899999999999999999999999886643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.00 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=186.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhc-cCcCchhhhcccccc----cCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKLLGFCNE----DQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lV~Ey~ 586 (797)
+.||+|+||+||++.....+ ..||||+++. ...+.+|+.++.+ .+||||+++++++.. .+..+|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~-~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQ-EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETTTC-CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECCCC-CEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 57999999999999987544 4699999863 3567788888755 489999999998865 66789999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 661 (797)
++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999999999765 3589999999999999999999998 9999999999999997 7899999999998654322
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||................ ..+..... ....
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~~~-~~~~ 291 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFP-NPEW 291 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCCCC-TTTT
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcccCC-Cccc
Confidence 2234568999999999999999999999999999999999999997654332111111111 11111000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. .....+.+++..||+.||++|||+.||++.
T Consensus 292 ~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 292 S-----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 012346778999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.57 Aligned_cols=199 Identities=27% Similarity=0.332 Sum_probs=171.4
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-----cCchhhhcccccccCce
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-----HRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----h~niv~l~g~~~~~~~~ 579 (797)
...+.+.++||+|+||+||+|+....+ ..||||++... ....+.+..|+.++..++ ||||+++++++...+..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNK-KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCC-eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 344566788999999999999987554 46999998742 233456788999999886 99999999999999999
Q ss_pred eeeeecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---------------
Q 003759 580 LLVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD--------------- 642 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~--------------- 642 (797)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 999999997653 588999999999999999999998 9999999999999975
Q ss_pred ----------CCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 643 ----------SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 643 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999864432 233458999999999999999999999999999999999999997654
Q ss_pred c
Q 003759 713 E 713 (797)
Q Consensus 713 ~ 713 (797)
.
T Consensus 264 ~ 264 (360)
T 3llt_A 264 H 264 (360)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=340.07 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=191.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccC--cCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTN--HRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 583 (797)
|.+.+.||+|+||.||++.... +..||||++...... ..+.+.+|+.++.+++ ||||+++++++..++..++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC--CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4456789999999999998754 456999998654322 2357899999999996 599999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
| +.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 57899999998888889999999999999999999998 999999999999996 579999999999876543322
Q ss_pred -ccccccccCcccccccccc-----------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 664 -TTTAIRGTRGYVAPEWFKS-----------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 664 -~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ .... ..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~----~~~~-~~ 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KL----HAII-DP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHH-CT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HH----HHHh-Cc
Confidence 2334569999999999865 3689999999999999999999999975432111 11 1111 11
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......... ...+.+++..||+.||++|||+.||++.
T Consensus 284 ~~~~~~~~~~--------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEFPDIP--------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCCCCCS--------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCccc--------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1100000000 1345678899999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=329.49 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=196.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc--------cC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--------DQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~ 577 (797)
|.+.+.||+|+||+||+|+....+ ..||||++..... .....+.+|+.++++++||||+++++++.. .+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTG-QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTC-CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred eeEEEEEecCCCcEEEEEEECCCC-CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 455678999999999999987544 4699999865332 234578899999999999999999999876 45
Q ss_pred ceeeeeecccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..++||||+++ +|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999986 66666544 36789999999999999999999998 999999999999999999999999999987
Q ss_pred cccCC---CcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc
Q 003759 657 LKADQ---TRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732 (797)
Q Consensus 657 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (797)
+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... ......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCChhh
Confidence 65322 222334568999999999876 4589999999999999999999999987544332221111100 000000
Q ss_pred ccc-----------ccc----chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 LHL-----------LVE----NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 ~~~-----------~~~----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ... ..............+.+++..||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 000 000111111112457789999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.53 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=199.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+.... +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEcCC-CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 44567899999999999998654 4569999986431 2334678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 999999999998777899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.... ....... ... .
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~--~~~---~- 234 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--------IVNVDLK--FPP---F- 234 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHTTCCC--CCT---T-
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH--------HhccccC--CCC---c-
Confidence 2334589999999999999999999999999999999999999976533221111 1111110 000 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..|++.||++||++.++++
T Consensus 235 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 ----LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1134567889999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=337.84 Aligned_cols=198 Identities=25% Similarity=0.351 Sum_probs=165.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccccc-----Cce
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHR 579 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 579 (797)
.|.+.+.||+|+||.||+|+.... +..||||++...... ..+.+.+|+.++++++||||+++++++... +..
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNT-EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CEEEEEEEeecCCEEEEEEEECCC-CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 355678899999999999998754 456999999764332 235789999999999999999999998766 578
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||++ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999986 69999998888899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC---------------------cccccccccCcccccccc-ccCCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 660 DQT---------------------RTTTAIRGTRGYVAPEWF-KSLPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 660 ~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 321 123456789999999986 56679999999999999999998655543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=335.05 Aligned_cols=199 Identities=24% Similarity=0.352 Sum_probs=172.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||+||++.....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~-~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeeecCCCCeEEEEEEECCCC-cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 344567999999999999987544 5699999875432 22357899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.....+++..+..++.+++.||+|||+. .+|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 188 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 188 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-----
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---cc
Confidence 9999999998878899999999999999999999983 179999999999999999999999999997653321 22
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3458999999999999999999999999999999999999997654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=325.78 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=200.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||++.....+ ..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCC-ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 344678999999999999987544 46999998654322 23568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 171 (294)
T 2rku_A 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 171 (294)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-c
Confidence 999999999998778899999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.... ....... ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~-~~~~----- 237 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--------IKKNEYS-IPKH----- 237 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHTTCCC-CCTT-----
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HhhccCC-Cccc-----
Confidence 2334589999999999998999999999999999999999999976543221110 0111110 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||++|+++.
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 ----INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01245678889999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.84 Aligned_cols=249 Identities=27% Similarity=0.296 Sum_probs=200.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.+.||+|+||.||+++....+ ..||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATG-KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 34568999999999999987544 56999998653 223456688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 99999999997653 489999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...... .... ....
T Consensus 342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~~~-~p~~---- 411 (576)
T 2acx_A 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VPEE-YSER---- 411 (576)
T ss_dssp -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CCCC-CCTT----
T ss_pred -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----cccc-CCcc----
Confidence 23346999999999999989999999999999999999999999865433222212111111 1100 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
....+.+++..||+.||++|| ++.||++.
T Consensus 412 -----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 -----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 113456788899999999999 78888753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.49 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=193.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.||+|+||+||+|++...+ ...||||+++.... ...+.+.+|+.++++++||||+++++++..+. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 455678999999999999875433 34699999875422 23457899999999999999999999998765 8899
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999754 5688999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cc--ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 662 TR--TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 662 ~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .............
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~---~~~~~~~~~~~~~ 248 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LH---KIDKEGERLPRPE 248 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HH---HHHTSCCCCCCCT
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----HH---HHHccCCCCCCCc
Confidence 21 2223457788999999998889999999999999999999 9999976533211 11 1111111100000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.....+.+++..||+.||++|||+.++++.|+++..-
T Consensus 249 ---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 249 ---------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1123467788999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=332.14 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=200.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||.||++.....+ ..||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 344678999999999999987544 4699999865432 233568899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++.+++.++.||++||+|||++ +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 197 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-c
Confidence 999999999998778899999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... +...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~~~~----- 263 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-IPKH----- 263 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-CCTT-----
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--------hcCCCC-CCcc-----
Confidence 23355899999999999999999999999999999999999999764332211100 011100 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||+.|+++
T Consensus 264 ----~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 ----INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0124567889999999999999999997
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.19 Aligned_cols=268 Identities=24% Similarity=0.281 Sum_probs=192.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccC------ce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 579 (797)
|.+.+.||+|+||.||+|+....+ ..||||++...... ..+.+.+|+.++++++||||+++++++...+ ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTG-AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEETTTC-CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEECCCC-CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 445678999999999999986544 46999998654322 2356889999999999999999999987653 46
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999999 8899999865 5688999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDE 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 731 (797)
. .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||......+....+..... ..+...
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 234468999999999877 6799999999999999999999999976543322111111000 000000
Q ss_pred c-------ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCC
Q 003759 732 K-------LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPI 786 (797)
Q Consensus 732 ~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~ 786 (797)
. +........... .......+.+++..||+.||++|||+.|+++. ++...+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 0 000000000000 00112356788999999999999999999984 555544433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=329.37 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=190.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
|.+.+.||+|+||+||+|+....+ ..||||++....... ...+.+|+.++++++||||+++++++..++..++||||+
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eEEEEEEcCCCCEEEEEEEECCCC-cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 345578999999999999987544 469999986533222 234567999999999999999999999999999999999
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence 7 5888888654 5688999999999999999999998 999999999999999999999999999986543222 22
Q ss_pred ccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh---
Q 003759 666 TAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE--- 741 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 741 (797)
....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ...............
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHhchhhhcchhhcc
Confidence 33457999999999876 5689999999999999999999999977544332221111100 000000000000000
Q ss_pred --------h--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 --------E--ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 --------~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. ..........+.+++..||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0000011245678999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=330.77 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=181.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccc--------cccCc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFC--------NEDQH 578 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~--------~~~~~ 578 (797)
+.+.+.||+|+||.||+|+....+ ..||||++........+.+.+|+.++.++. ||||+++++++ .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSG-REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTC-CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred EEEEEEEccCCceEEEEEEECCCC-cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 455678999999999999986544 469999986654445567899999999995 99999999988 34456
Q ss_pred eeeeeecccCCchhhhccc---CCCCChhhHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEEcCCCcEEEEeecC
Q 003759 579 RLLVYEFISNGCLAGFLFK---NPKPSWYRRMQIAFGIARGLFYLHEECTTQ--IIHCDIKPQNILLDDSFTARISDFGL 653 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~Dfgl 653 (797)
.++|+||+. |+|.+++.. ...+++..++.++.||+.||+|||+. + |+|+||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 899999995 789888864 45689999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccccCCCc-----------ccccccccCcccccccc---ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhh
Q 003759 654 AKILKADQTR-----------TTTAIRGTRGYVAPEWF---KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719 (797)
Q Consensus 654 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 719 (797)
+......... ......+|+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 9876543221 11134589999999998 566789999999999999999999999965432110
Q ss_pred HHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 720 LVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
. ..... ........ ..+.+++..||+.||++|||+.|+++.|+.+.+
T Consensus 262 -~---~~~~~----~~~~~~~~---------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 -V---NGKYS----IPPHDTQY---------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CC----CCTTCCSS---------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -h---cCccc----CCcccccc---------hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00000 00000000 124567888999999999999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.90 Aligned_cols=262 Identities=26% Similarity=0.317 Sum_probs=193.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|.... .||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred eEEeeEeccCCceEEEEEEEcC----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 4456789999999999998753 289999865322 2345688899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC---
Q 003759 586 ISNGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ--- 661 (797)
Q Consensus 586 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~--- 661 (797)
+++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+||+++ ++.+||+|||++.......
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999997654 689999999999999999999998 999999999999998 6799999999987653221
Q ss_pred -CcccccccccCcccccccccc---------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 662 -TRTTTAIRGTRGYVAPEWFKS---------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 662 -~~~~~~~~gt~~y~aPE~~~~---------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .. ...+
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~----~~~~ 258 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQ----MGTG 258 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HH----HHTT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH----hccC
Confidence 122233458999999999864 35789999999999999999999999765332111 10 1111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC-CCCCCCc
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPI-PPDPSSF 793 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~-p~~p~~~ 793 (797)
......... ....+.+++..||+.||++|||+.+|+++|+.+..-.. .+.|..+
T Consensus 259 ~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~ 313 (319)
T 2y4i_B 259 MKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313 (319)
T ss_dssp CCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred CCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence 111111000 01235678889999999999999999999998766433 3445444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=343.50 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=196.5
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
...|.+.+.||+|+||+||+|+....+ ..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTH-VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTC-CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCC-cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345677789999999999999987544 469999987543 23456799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CcEEEEeecCcccccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS---FTARISDFGLAKILKA 659 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~~~~ 659 (797)
|||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999998878899999999999999999999998 99999999999999764 4599999999987654
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+.. .... .+..... .+
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~----~~~~~~~-~~ 259 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVE----KGKYTFD-SP 259 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHH----HTCCCCC-SG
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH----hCCCCCC-ch
Confidence 32 233456999999999986 46899999999999999999999999765432211 1111 1111100 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... .....+.+++..||+.||++|||+.|+++
T Consensus 260 ~~~-----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWK-----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcc-----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 01134567889999999999999999885
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=323.02 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=195.9
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||.||+|+.... +..||+|.+... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKET-GQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTT-CCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhheeeccCCCeEEEEEEECCC-CCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 345567899999999999998754 456999999753 34578999999999999999999999999999999999999
Q ss_pred cCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
++++|.+++. ....+++..+..++.+++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence 9999999996 456789999999999999999999998 999999999999999999999999999986644322 22
Q ss_pred ccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ... ..... ... ..
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~----~~~~~-~~~-~~--- 249 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM----IPT----NPPPT-FRK-PE--- 249 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHH----SCCCC-CSS-GG---
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----Hhc----CCCcc-cCC-cc---
Confidence 334589999999999999999999999999999999999999975432211100 000 00000 000 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++..||+.||++|||+.++++
T Consensus 250 --~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 --LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01234667899999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.60 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=198.0
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------hHHHHHHHHHhhcc-CcCchhhhcccccccC
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------DKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQ 577 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 577 (797)
.+.+.+.||+|+||.||+|++...+ ..||||++....... .+.+.+|+.++.++ +||||+++++++...+
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATG-HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hcccceEEecCCCEEEEEEEECCCC-cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 3444578999999999999986543 469999987543211 24578899999999 8999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999998777899999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcccccccccCcccccccccc------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKS------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..... ..+
T Consensus 251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i----~~~ 320 (365)
T 2y7j_A 251 EPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMI----MEG 320 (365)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHT
T ss_pred CCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHH----HhC
Confidence 54322 234568999999999863 358899999999999999999999997543221 11111 111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... ..... ......+.+++..||+.||++|||+.|+++
T Consensus 321 ~~~~----~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQF----SSPEW--DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCC----CHHHH--SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC----CCccc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1100 00000 001234677899999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.22 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=198.7
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCc
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 578 (797)
....+.+.+.||+|+||.||+|+... ..+..||||++..... ....++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 34455667889999999999998532 2345699999964322 234578999999999999999999999999999
Q ss_pred eeeeeecccCCchhhhcccC-------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEE
Q 003759 579 RLLVYEFISNGCLAGFLFKN-------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARI 648 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl 648 (797)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999754 3478889999999999999999998 9999999999999984 456999
Q ss_pred EeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHh
Q 003759 649 SDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYD 726 (797)
Q Consensus 649 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (797)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+ +....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~-- 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFV-- 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHH--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHH--
Confidence 99999986543322 22233457889999999999899999999999999999998 999997543221 11111
Q ss_pred hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+........ ....+.+++..||+.||++||++.+|++.|+.+..
T Consensus 259 --~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 --TSGGRMDPPKN---------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp --HTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hcCCCCCCCCC---------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111111111 11346678899999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=323.61 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=195.6
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--------CchHHHHHHHHHhhccCcCchhhhcccccc
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--------GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE 575 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 575 (797)
....|.+.+.||+|+||.||+|+.... +..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCC-CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 345677788999999999999998754 45699999865321 122458899999999999999999999876
Q ss_pred cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEeec
Q 003759 576 DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDFG 652 (797)
Q Consensus 576 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfg 652 (797)
++ .++||||+++++|.+++.....+++.....++.||+.||+|||+. +|+|+||||+|||++.++. +||+|||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 54 899999999999999998888899999999999999999999998 9999999999999987664 9999999
Q ss_pred CccccccCCCcccccccccCccccccccc---cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||............ . .
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~----~ 233 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---I----T 233 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH---H----H
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH---H----H
Confidence 998764321 223345899999999974 467899999999999999999999999765432221111 1 1
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+..... +.. .......+.+++..||+.||++||++.|+++
T Consensus 234 ~~~~~~~----~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNFI----PEV--WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCCC----HHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccccC----chh--hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111000 000 0011245678899999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=344.37 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=203.0
Q ss_pred HHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 504 EKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 504 ~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
....|.+.+.||+|+||.||+++....+ ..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCC-CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3456777789999999999999987544 469999986532 234567999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCcccc
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKIL 657 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~ 657 (797)
+||||+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999998888899999999999999999999998 99999999999999 56789999999999876
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. .... ..+......
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i----~~~~~~~~~ 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----LKKV----EKGKYTFEL 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHH----HHCCCCCCS
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----HHHH----HcCCCCCCC
Confidence 5432 2233458999999999876 689999999999999999999999976543221 1111 111111000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.. .. .....+.+++..||+.||++|||+.|+++
T Consensus 249 ~~-~~-----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 PQ-WK-----KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GG-GG-----GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-cc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00 01234667899999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.82 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=190.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc-cCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||++... +..||||.++.. ...+.+.+|+.++++++||||+++++++.+ .+..++||||+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ceEEeEEecCCCceEEEEEEc---CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 445678999999999999873 456999998753 345789999999999999999999998654 45789999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999997553 378889999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ....+........
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~----~----~~~~~~~~~~~~~---- 238 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----P----RVEKGYKMDAPDG---- 238 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----H----HHTTTCCCCCCTT----
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----H----HHhcCCCCCCccc----
Confidence 22346889999999999999999999999999999998 99999765332211 1 1111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++||++.|+++.|+.+.
T Consensus 239 -----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 239 -----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1234667889999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=342.58 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=200.7
Q ss_pred HHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 505 KATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 505 ~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
...|.+.+.||+|+||+||+++....+ ..||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTC-CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCC-CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 355777889999999999999987544 469999986432 23456799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCcccccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKA 659 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~ 659 (797)
|||+++++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++..+..
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999998878899999999999999999999998 999999999999995 556799999999986644
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (797)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+.. ... ..+........
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i----~~~~~~~~~~~ 245 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRV----ETGKYAFDLPQ 245 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH----HHTCCCSCSGG
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH----HhCCCCCCCcc
Confidence 32 2233458999999999976 5899999999999999999999999765432211 111 11111100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.. .....+.+++..||+.||++|||+.|+++.
T Consensus 246 -~~-----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 -WR-----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GG-----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -cC-----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011345678999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=325.67 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=179.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|.....+ ..||||++.... ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKK-EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhheeccccceEEEEEEECCCC-cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 445678999999999999876544 469999986533 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhccc--------CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 587 SNGCLAGFLFK--------NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 587 ~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
++++|.+++.. ...+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999863 35689999999999999999999998 99999999999999999999999999998664
Q ss_pred cCCC----cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 659 ADQT----RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 659 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
.... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||............ .. ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~----~~~ 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----LQ----NDP 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HT----SSC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH----hc----cCC
Confidence 3221 12233468999999999876 56899999999999999999999999765432211100 00 000
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...................+.+++..||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000000001134667889999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.68 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=192.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
+.+.+.||+|+||.||+|+....+ ..||+|++........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTC-CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEcCCC-cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 445678999999999999987544 4699999987666667789999999999999999999999999999999999999
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD 175 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence 9999998865 46789999999999999999999998 99999999999999999999999999876432111 1122
Q ss_pred cccccCcccccccc-----ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 667 AIRGTRGYVAPEWF-----KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 667 ~~~gt~~y~aPE~~-----~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
...+++.|+|||++ ....++.++||||||+++|+|++|+.||........ ..... ..........
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~-----~~~~~~~~~~-- 245 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIA-----KSDPPTLLTP-- 245 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH-----HSCCCCCSSG--
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHh-----ccCCcccCCc--
Confidence 34589999999998 466789999999999999999999999976433211 11110 0110000000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. .....+.+++..||+.||++|||+.++++
T Consensus 246 ~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 246 S-----KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp G-----GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c-----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 01134667889999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.41 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=191.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTG-HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCC-ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 445678999999999999987544 469999986432 2334578999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-- 166 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence 999999999998777899999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ..... ..+... ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~----~~~~~~-~~~~---- 233 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKI----RGGVFY-IPEY---- 233 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHCCCC-CCTT----
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHh----hcCccc-Cchh----
Confidence 223458999999999988765 689999999999999999999997543221 11111 111100 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.||++.
T Consensus 234 -----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 -----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01345678899999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.20 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=197.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCch-----------------HHHHHHHHHhhccCcCchhhhc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-----------------KEFRTEVNAIGQTNHRNLVKLL 570 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~-----------------~~f~~E~~~l~~l~h~niv~l~ 570 (797)
+.+.+.||+|+||.||+|.. ++..||||++........ +.+.+|+.++.+++||||++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred eEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 44567899999999999988 456799999865322211 7899999999999999999999
Q ss_pred ccccccCceeeeeecccCCchhhh------ccc--CCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEc
Q 003759 571 GFCNEDQHRLLVYEFISNGCLAGF------LFK--NPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLD 641 (797)
Q Consensus 571 g~~~~~~~~~lV~Ey~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~ 641 (797)
+++.+.+..++||||+++++|.++ +.. ...+++..+..++.|++.||+|||+ . +|+|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 999999999999999999999999 665 5678999999999999999999998 7 999999999999999
Q ss_pred CCCcEEEEeecCccccccCCCcccccccccCccccccccccC-CCCc-cCceehHHHHHHHHHhCCcCCCccccccchhh
Q 003759 642 DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL-PITM-KVDIYSFGVMLLELICCRKKFEQNVENENQMI 719 (797)
Q Consensus 642 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 719 (797)
.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||.........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL-- 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH--
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--
Confidence 9999999999999875433 23345589999999999887 6666 999999999999999999999765442111
Q ss_pred HHHHHHhhhccccccccc---------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 720 LVDWAYDCYIDEKLHLLV---------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... +..+...... ...............+.+++..||+.||++|||+.|+++
T Consensus 262 -~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 -FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111111000 000000000111245678899999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=354.80 Aligned_cols=246 Identities=25% Similarity=0.298 Sum_probs=200.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||+|+....+ ..||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTD-ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSC-CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCC-cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 344578999999999999987654 46999998753 223456788899999987 7999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 497 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-C
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-c
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643322 2
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++||||||++||||++|+.||......+.. ..+........ . .
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~--------~~i~~~~~~~p-~----~ 564 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--------QSIMEHNVAYP-K----S 564 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------HHHHSSCCCCC-T----T
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH--------HHHHhCCCCCC-c----c
Confidence 334567999999999999999999999999999999999999999765432211 11111111100 0 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTM-----KKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~-----~eVl~ 776 (797)
....+.+++..||+.||++||++ +||++
T Consensus 565 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 -----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11346678899999999999997 67764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.15 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=196.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccc--cccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFC--NEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||++.....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++ ...+..++||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCC-cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 345678999999999999987544 5699999875432 2335689999999999999999999987 4467889999
Q ss_pred ecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCC-----eeecCCCCCCEEEcCCCcEEEEeecCc
Q 003759 584 EFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQ-----IIHCDIKPQNILLDDSFTARISDFGLA 654 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----ivH~Dlkp~NILl~~~~~~kl~Dfgla 654 (797)
||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+|+||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999643 4589999999999999999999998 6 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ +.. .+..+...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----~i~~~~~~ 234 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAG----KIREGKFR 234 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHTCCC
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH----HHH----HHhhcccc
Confidence 87644322 1223458999999999999899999999999999999999999997653221 111 11111111
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
.+... ....+.+++..||+.||++||++.||++.+..
T Consensus 235 ~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 RIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCCcc---------cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111 12346678899999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.51 Aligned_cols=264 Identities=24% Similarity=0.242 Sum_probs=195.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-----chHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-----GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
.|.+.+.||+|+||.||+|+....+ ..||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTN-QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCC-SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCC-cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 4556688999999999999987544 46999998653221 13468899999999999999999999999999999
Q ss_pred eeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 582 VYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
||||+++ +|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999986 788887654 4688999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc---c
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL---L 736 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 736 (797)
.. ......+|+.|+|||.+.+. .++.++||||||+++|||++|..||......+....+...... ........ .
T Consensus 166 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT-PTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-CCTTTSSSTTSS
T ss_pred cc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC-CChhhhhhhccC
Confidence 22 23344589999999999764 5899999999999999999999999765433221111111000 00000000 0
Q ss_pred ---c--cc---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 ---V--EN---DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ---~--~~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. .. .+...........+.+++..||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 00000001112457789999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=341.86 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=196.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-------------CchHHHHHHHHHhhccCcCchhhhccccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-------------GGDKEFRTEVNAIGQTNHRNLVKLLGFCN 574 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-------------~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 574 (797)
|.+.++||+|+||+||+|+....+ ..||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGH-SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTC-CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eEEEeEecccCCeEEEEEEECCCC-cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 455678999999999999987544 4699999875321 23467899999999999999999999999
Q ss_pred ccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---cEEEEee
Q 003759 575 EDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF---TARISDF 651 (797)
Q Consensus 575 ~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Df 651 (797)
+++..++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999998888899999999999999999999998 999999999999998776 6999999
Q ss_pred cCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 652 GLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 652 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
|++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.. ... ..+
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i----~~~ 262 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII----KKV----EKG 262 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH----HHC
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH----HcC
Confidence 9998765432 2234458999999999874 6899999999999999999999999765432211 111 111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..... .... ......+.+++..||+.||++|||+.|+++.
T Consensus 263 ~~~~~----~~~~--~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYFD----FNDW--KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCC----HHHH--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCC----cccc--CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100 0000 0011346788999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.20 Aligned_cols=247 Identities=28% Similarity=0.351 Sum_probs=197.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
.+.||+|+||.||+++....+ ..||+|++.... ....+.+..|+.++.+++||||+++++++...+..++||||++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATG-KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCC-cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 457999999999999987544 569999996432 2334678899999999999999999999999999999999999
Q ss_pred CCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 588 NGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 588 ~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999998653 4688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ....... ...
T Consensus 346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i----~~~~~~~-p~~---- 415 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----LEQAVTY-PDK---- 415 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH----HHCCCCC-CTT----
T ss_pred -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH----hhcccCC-Ccc----
Confidence 233469999999999999999999999999999999999999997654322222121111 1111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTM-----KKVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~-----~eVl~ 776 (797)
....+.+++..||+.||++||++ .+|++
T Consensus 416 -----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 -----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11345678889999999999975 56653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=322.32 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=194.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccc--cCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNE--DQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+|+....+ ..||||+++. ...+.+.+|+.++.+++ ||||+++++++.+ ....++|||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNN-EKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred eEEEEEecccCCeEEEEEEECCCC-cEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 445678999999999999887554 4699999874 34578999999999996 9999999999987 667899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++++|.+++. .++...+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 999999999885 378889999999999999999998 999999999999999776 899999999987654332
Q ss_pred ccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHH-HHH-----Hhhhcccc----
Q 003759 664 TTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV-DWA-----YDCYIDEK---- 732 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~-~~~-----~~~~~~~~---- 732 (797)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............. ... ........
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 233458899999999877 678999999999999999999999996543322111100 000 00000000
Q ss_pred --ccc--------cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 733 --LHL--------LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 733 --~~~--------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... .................+.+++..||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000000111245778999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.88 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=199.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.+.||+|+||.||+|+.... +..||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHhhhhcccCCeEEEEEEECCC-CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 34457899999999999987654 45699999875432 34568999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 177 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 177 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBC
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccC
Confidence 99999999854 5689999999999999999999998 999999999999999999999999999987654322 223
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||......... .... ..........
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~----~~~~~~~~~~------- 242 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL----FLIP----KNNPPTLEGN------- 242 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHH----HSCCCCCCSS-------
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH----HHhh----cCCCCCCccc-------
Confidence 446899999999999999999999999999999999999999754322111 1110 1111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||+.||++.
T Consensus 243 --~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 --YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11245678899999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.32 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=193.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhcc-CcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 582 (797)
..+.+.+.||+|+||+||+|+....+ ..||+|++...... ...++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDG-CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCC-ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 34556688999999999999987544 46999998754332 345788899999998 999999999999999999999
Q ss_pred eecccCCchhhhcccC----CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---------------
Q 003759 583 YEFISNGCLAGFLFKN----PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS--------------- 643 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~--------------- 643 (797)
|||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+|+||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999754 6689999999999999999999998 99999999999999844
Q ss_pred ----CcEEEEeecCccccccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchh
Q 003759 644 ----FTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718 (797)
Q Consensus 644 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~ 718 (797)
..+||+|||++....... ...+|+.|+|||.+.+. .++.++||||||+++|||++|..++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence 479999999998765432 23489999999999776 6678999999999999999999876433110
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+......... ...+.+++..||+.||++|||+.|+++.
T Consensus 238 -------~~~~~~~~~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -------HEIRQGRLPRIPQVL---------SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHTTCCCCCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHcCCCCCCCccc---------CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111111111111 1346678899999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=330.95 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=189.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc------------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------------ 575 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------------ 575 (797)
+.+.+.||+|+||+||+|+....+ ..||||++.... ....+|+.+++.++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESG-KRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTC-CEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEEEEEEeccCEEEEEEEECCCC-CEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 455678999999999999987554 469999986532 223469999999999999999998843
Q ss_pred --------------------------cCceeeeeecccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCC
Q 003759 576 --------------------------DQHRLLVYEFISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECT 625 (797)
Q Consensus 576 --------------------------~~~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~ 625 (797)
....++||||++ ++|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 334789999998 57666654 457789999999999999999999998
Q ss_pred CCeeecCCCCCCEEEc-CCCcEEEEeecCccccccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHh
Q 003759 626 TQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELIC 703 (797)
Q Consensus 626 ~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~ellt 703 (797)
+|+||||||+|||++ +++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999987644332 2334579999999998765 58999999999999999999
Q ss_pred CCcCCCccccccchhhHHHHHHh-----------hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003759 704 CRKKFEQNVENENQMILVDWAYD-----------CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772 (797)
Q Consensus 704 G~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 772 (797)
|+.||......+....+...... ...+......................+.+++..||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999875443322222111000 0000000000001011111111224577899999999999999999
Q ss_pred HHHH
Q 003759 773 KVTL 776 (797)
Q Consensus 773 eVl~ 776 (797)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.33 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=178.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhccccccc------Cce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNED------QHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 579 (797)
|.+.+.||+|+||.||+|..... +..||||++...... ..+.+.+|+.+++.++||||+++++++... ...
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp EEEEEECC----CCEEEEEETTT-TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEeeEEeecCCeEEEEEEECCC-CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 44567899999999999987654 456999999754322 335788999999999999999999998654 567
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 9999999 7899998865 5789999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hhccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CYIDE 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~~~~ 731 (797)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...... .+...
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 234568999999999877 67899999999999999999999999765433221111111000 00000
Q ss_pred c-------ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 K-------LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. +............ ......+.+++..||+.||++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000000 0012356789999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.45 Aligned_cols=245 Identities=26% Similarity=0.353 Sum_probs=191.8
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCch
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
..||+|+||.||+|+.... +..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSN-QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTT-CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCC-CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 3799999999999998654 456999999876555567899999999999999999999999999999999999999999
Q ss_pred hhhcccC---CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCccccccCCCccccc
Q 003759 592 AGFLFKN---PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 592 ~~~l~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999754 2456888889999999999999998 9999999999999987 89999999999987643221 2233
Q ss_pred ccccCccccccccccCC--CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~--~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
..|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........... . .... .....+...
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~-~~~~---~~~~~~~~~------ 250 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--K-VGMF---KVHPEIPES------ 250 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--H-HHHH---CCCCCCCTT------
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--h-hccc---ccccccccc------
Confidence 45899999999997653 88999999999999999999999975432211110 0 0000 000000000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++||++.|+++
T Consensus 251 ---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 ---MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1134567889999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.88 Aligned_cols=251 Identities=10% Similarity=-0.015 Sum_probs=174.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhcc--CcCchhhhcc-------cccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQT--NHRNLVKLLG-------FCNE 575 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l--~h~niv~l~g-------~~~~ 575 (797)
+.+.+.||+|+||.||+|+.... +..||||++...... ..+.+.+|+.++..+ +||||++++. ++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVER-LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCC-CceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 34467899999999999998754 457999999865432 234577885544444 6999888553 2221
Q ss_pred c-----------------CceeeeeecccCCchhhhcccC-CCCChhhH------HHHHHHHHHHHHHHhhcCCCCeeec
Q 003759 576 D-----------------QHRLLVYEFISNGCLAGFLFKN-PKPSWYRR------MQIAFGIARGLFYLHEECTTQIIHC 631 (797)
Q Consensus 576 ~-----------------~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~ivH~ 631 (797)
. ...++||||++ |+|.+++... ..+.+..+ ..++.||++||+|||++ +|+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 1 34799999999 8999999753 34556666 78889999999999998 99999
Q ss_pred CCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 632 Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998654221 13346799999999987 679999999999999999999999997
Q ss_pred ccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 710 QNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
........... ... ........... +... .....+.+++..||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~~-~~~--~~~~~~~~~~~-~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGSWK-RPS--LRVPGTDSLAF-GSCT-----PLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTCCC-BCC--TTSCCCCSCCC-TTSS-----CCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccchh-hhh--hhhccccccch-hhcc-----CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 66332211000 000 00000000000 0000 11234667889999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=334.56 Aligned_cols=197 Identities=26% Similarity=0.325 Sum_probs=168.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc------CcCchhhhcccccccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT------NHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 581 (797)
+.+.+.||+|+||+||+|..... +..||||++... ....+++.+|+.++..+ +|+||+++++++...+..++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~-~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKV-HQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTT-TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCC-CcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 45568899999999999988754 456999999753 22235677788888776 57799999999999999999
Q ss_pred eeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc--EEEEeecCcccc
Q 003759 582 VYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT--ARISDFGLAKIL 657 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~ 657 (797)
||||+. ++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 6898888755 3589999999999999999999998 9999999999999999887 999999999764
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~ 714 (797)
... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 332 22345899999999999999999999999999999999999999766443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.97 Aligned_cols=257 Identities=17% Similarity=0.228 Sum_probs=200.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc-CchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH-RNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.++||+|+||.||+|+....+ ..||||++.... ..+++..|++++..++| +++..+..++.+.+..+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTC-CEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCC-cEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 445678999999999999986544 469999876532 34568899999999977 55555666667778889999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---cCCCcEEEEeecCccccccCCC
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
+++|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999974 46799999999999999999999998 99999999999999 6889999999999987654332
Q ss_pred ------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 663 ------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 663 ------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.......||+.|+|||.+.+..++.++||||||++||||++|+.||...........+....... ....+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-ccccHHHH
Confidence 12235569999999999999999999999999999999999999998754432222111111110 00111100
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
... ....+.+++..||+.||++||++.+|+++|+.+
T Consensus 241 ~~~---------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 241 CRG---------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HTT---------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred hcC---------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 010 124577889999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.19 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=197.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC---------CchHHHHHHHHHhhccC-cCchhhhcccccccC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS---------GGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~---------~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~ 577 (797)
+.+.+.||+|+||.||+|+.... +..||||+++.... ...+.+.+|+.+++++. ||||+++++++...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cceeeeecCCCceEEEEEEEcCc-CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 34457899999999999998754 45699999875431 11245788999999995 999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
..++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999998878899999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcccccccccCccccccccc------cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFK------SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
.... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||......+.. . .+..+
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~----~~~~~ 244 (298)
T 1phk_A 175 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----R----MIMSG 244 (298)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H----HHHHT
T ss_pred CCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH----H----HHhcC
Confidence 5432 223345899999999985 456889999999999999999999999754322111 1 11111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
...... +... .....+.+++..||+.||++|||+.|+++
T Consensus 245 ~~~~~~-~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQFGS-PEWD-----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCCCT-TTGG-----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccCc-cccc-----ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111000 0000 11234677899999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=321.81 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=196.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhcc---CcCchhhhccccc-----ccC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQT---NHRNLVKLLGFCN-----EDQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 577 (797)
+.+.+.||+|+||.||+|.....++..||+|++..... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 44567899999999999998645567799999865332 2234677888887776 8999999999987 567
Q ss_pred ceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 578 HRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..++||||++ |+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 8899999998 6999998754 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc-
Q 003759 656 ILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH- 734 (797)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 734 (797)
...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+...... .......
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR 245 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCGGGSCT
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC-CCcccCcc
Confidence 654322 233455899999999999999999999999999999999999999765433221111110000 0000000
Q ss_pred ------ccc----cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 ------LLV----ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 ------~~~----~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ...... ........+.+++..||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGG-TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhh-ccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000000 000112346688999999999999999999953
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.62 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=191.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC----CCchHHHHHHHHHhhccCcCchhhhcccc--cccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV----SGGDKEFRTEVNAIGQTNHRNLVKLLGFC--NEDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~l 581 (797)
|.+.+.||+|+||.||++..... +..||+|++.... ....+.+.+|+.++++++||||+++++++ .+.+..++
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSET-LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTT-CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCC-CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 44567899999999999987654 4569999986532 23456799999999999999999999988 55668899
Q ss_pred eeecccCCchhhhccc--CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 582 VYEFISNGCLAGFLFK--NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
||||++++ |.+++.. ...+++..+..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999877 6666653 35688999999999999999999998 999999999999999999999999999987653
Q ss_pred CC-CcccccccccCccccccccccCC--CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 660 DQ-TRTTTAIRGTRGYVAPEWFKSLP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 660 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.. ........+++.|+|||.+.+.. .+.++||||||+++|||++|+.||......+. .. .+..+... .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~----~i~~~~~~-~ 232 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----FE----NIGKGSYA-I 232 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HH----HHHHCCCC-C
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HH----HHhcCCCC-C
Confidence 22 22233456899999999997654 47899999999999999999999976432211 11 11111111 0
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ....+.+++..||+.||++|||+.|+++.
T Consensus 233 ~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PGD---------CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CSS---------SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCc---------cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001 11345678899999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.48 Aligned_cols=261 Identities=23% Similarity=0.257 Sum_probs=187.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccC------ce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 579 (797)
+.+.+.||+|+||.||+|..... +..||||++...... ..+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred eeEeeeeEecCCEEEEEEEECCC-CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 44567899999999999988654 456999999753322 2356889999999999999999999987654 78
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999999974 6777775 3478899999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHH---------------H
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDW---------------A 724 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~---------------~ 724 (797)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+... .
T Consensus 180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 22 223356899999999999999999999999999999999999999765432211111000 0
Q ss_pred Hhhhcc-cc-----ccccccch---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 725 YDCYID-EK-----LHLLVEND---EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 725 ~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... .. ........ ............+.+++..||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 00 00000000 0000112224567899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.23 Aligned_cols=259 Identities=21% Similarity=0.242 Sum_probs=188.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc------cCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------DQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~l 581 (797)
|.+.+.||+|+||.||+|++...+ ..||||++.... +.+.+|++++++++||||+++++++.. ....++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSG-ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCC-cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 344578999999999999987544 469999986532 233469999999999999999998843 224679
Q ss_pred eeecccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-CcEEEEeecCccc
Q 003759 582 VYEFISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-FTARISDFGLAKI 656 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~ 656 (797)
||||+++ +|.+.+. ....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 5555443 346789999999999999999999998 99999999999999965 6789999999987
Q ss_pred cccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH----hhhc--
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----DCYI-- 729 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~-- 729 (797)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... ..+.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 644322 2334589999999998765 789999999999999999999999987543322211111000 0000
Q ss_pred ccc-----ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 730 DEK-----LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 730 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ...+................+.+++.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 000000000000011112457789999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.25 Aligned_cols=195 Identities=22% Similarity=0.352 Sum_probs=152.2
Q ss_pred hhhCcccceeEEEEEEecC-CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccc--cccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC--NEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lV~Ey~~~ 588 (797)
++||+|+||+||+|+..+. .+..||||++... ...+.+.+|+.++++++||||+++++++ ..+...++||||++
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 4799999999999997642 3456999999753 3346789999999999999999999999 45778999999997
Q ss_pred CchhhhcccC---------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----cCCCcEEEEeecCcc
Q 003759 589 GCLAGFLFKN---------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----DDSFTARISDFGLAK 655 (797)
Q Consensus 589 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~ 655 (797)
++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 4777776421 2488999999999999999999998 99999999999999 778999999999998
Q ss_pred ccccCCC--cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccc
Q 003759 656 ILKADQT--RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNV 712 (797)
Q Consensus 656 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~ 712 (797)
.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 7654322 223345689999999999874 58999999999999999999999997553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=351.01 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=200.1
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
..+.+.+.||+|+||.||+|++...+ ...||||++...... ..+.|.+|+.++++++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 44556788999999999999986432 467999998753322 2357899999999999999999999985 4678999
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999755 4689999999999999999999998 99999999999999999999999999998765544
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ..... .+........
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----~~~i~----~~~~~~~~~~- 616 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGRIE----NGERLPMPPN- 616 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH----HTCCCCCCTT-
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHH----cCCCCCCCcc-
Confidence 333344457789999999999899999999999999999997 9999976533221 11111 1111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++|||+.||++.|+.+.
T Consensus 617 --------~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 617 --------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1134667889999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.09 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=196.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhccccccc-----Cceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 581 (797)
|.+.+.||+|+||.||+|..... +..||||++...... ..+.+.+|++++.+++||||+++++++... ...++
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLN-KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCC-CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 45567899999999999988654 456999999753322 235788999999999999999999998654 46899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999997 589988854 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cc--ccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc-
Q 003759 662 TR--TTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV- 737 (797)
Q Consensus 662 ~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 737 (797)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....... .........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 261 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQEDLNCIIN 261 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC-CHHHHHTCCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC-CHHHHHHhhh
Confidence 22 2344568999999998754 458999999999999999999999997664433222221100000 000000000
Q ss_pred -----------cch--hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 738 -----------END--EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 738 -----------~~~--~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
... ............+.+++..||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000112456789999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.40 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=198.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc------hhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN------LVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 580 (797)
.+.+.+.||+|+||+||+|+....++..||||+++.. ....+.+.+|+.++..++|++ ++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 4556788999999999999885555678999999753 223457889999999987765 899999999999999
Q ss_pred eeeecccCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC----------------
Q 003759 581 LVYEFISNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---------------- 642 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---------------- 642 (797)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 899999997654 678999999999999999999998 9999999999999987
Q ss_pred ---CCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhh
Q 003759 643 ---SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI 719 (797)
Q Consensus 643 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 719 (797)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 668999999999864432 2334589999999999999999999999999999999999999976543322111
Q ss_pred HHHHHH-------hhhccc------ccc------------ccccchhh-hhhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 720 LVDWAY-------DCYIDE------KLH------------LLVENDEE-ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 720 ~~~~~~-------~~~~~~------~~~------------~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
+..... ...... ... ........ ........+.+.+++..||+.||++|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 110000 000000 000 00000000 0011123456789999999999999999999
Q ss_pred HHHH
Q 003759 774 VTLM 777 (797)
Q Consensus 774 Vl~~ 777 (797)
|++.
T Consensus 326 ll~h 329 (339)
T 1z57_A 326 ALKH 329 (339)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.52 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=193.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhccccccc-----Cceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNED-----QHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 581 (797)
+.+.+.||+|+||.||+|+.... +..||||++..... .....+.+|+.++++++||||+++++++... ...++
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPT-GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCC-CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 34567899999999999998754 45699999965322 2234688999999999999999999987654 67899
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 999997 689988865 4689999999999999999999998 99999999999999999999999999998765322
Q ss_pred Cc---------ccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 662 TR---------TTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 662 ~~---------~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 1223468999999998754 6789999999999999999999999976543222111111000000000
Q ss_pred ccccc---------------ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLL---------------VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..... ........ .......+.+++..||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKM-FPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhHHhhcccCCCCcchhhh-cccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 00000000 00112456789999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=326.61 Aligned_cols=261 Identities=24% Similarity=0.244 Sum_probs=186.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-----------hHHHHHHHHHhhccCcCchhhhccccc--
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-----------DKEFRTEVNAIGQTNHRNLVKLLGFCN-- 574 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-----------~~~f~~E~~~l~~l~h~niv~l~g~~~-- 574 (797)
+.+.+.||+|+||.||+|+... +..||||++....... .+.+.+|+.++++++||||+++++++.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTT--SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred eEEeEEeccCCCEEEEEEECCC--CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 3345789999999999998754 4569999986533221 167899999999999999999999983
Q ss_pred ---ccCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEe
Q 003759 575 ---EDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISD 650 (797)
Q Consensus 575 ---~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 650 (797)
.....++||||++ |+|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 3446899999998 5777777654 4789999999999999999999998 999999999999999999999999
Q ss_pred ecCccccccCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh---
Q 003759 651 FGLAKILKADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD--- 726 (797)
Q Consensus 651 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~--- 726 (797)
||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 178 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 178 FNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp TTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99997544332 2233458899999999877 67899999999999999999999999765433222111111000
Q ss_pred ------------hhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 727 ------------CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 727 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
................ .........+.+++..||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000000000 0001112456789999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.63 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=188.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccc------cCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNE------DQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~ 580 (797)
+.+.+.||+|+||.||+|+....+ ..||||++... ....+++.+|+.++.++ +||||+++++++.. .+..+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCC-CeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 345678999999999999986544 46999998753 33457899999999999 89999999999876 46789
Q ss_pred eeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccc
Q 003759 581 LVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK 658 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 658 (797)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999999999999754 5688999999999999999999998 99999999999999999999999999998654
Q ss_pred cCCCcccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (797)
.... ......+++.|+|||.+. +..++.++||||||+++|+|++|+.||...........+ . ....
T Consensus 181 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~----~~~~ 251 (326)
T 2x7f_A 181 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----P----RNPA 251 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----H----HSCC
T ss_pred cCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----h----cCcc
Confidence 3221 122345899999999987 557899999999999999999999999654322111100 0 0001
Q ss_pred cccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... ....+.+++..||+.||++||++.++++
T Consensus 252 ~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKSKK--------WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSCSC--------SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCccc--------cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 1134667889999999999999999987
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.51 Aligned_cols=210 Identities=23% Similarity=0.345 Sum_probs=159.7
Q ss_pred ccccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEE
Q 003759 21 ATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVL 100 (797)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l 100 (797)
++.|+|.+|++|.+++ +| ++|.|+|||+.+++. .+ |.. +|+||+|||+.| .++.++|+.||||||
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gnl----~l-y~~---~~~vW~an~~~~--~~~~l~l~~dGnLvl 70 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCNL----VL-FDS---DVRVWASNTAGA--TGCRAVLQSDGLLVI 70 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSCE----EE-EES---SSEEECCCCCSC--SCCBCCBCSSSCBCC
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCCcE----EE-EEC---CEEEEECCCCCC--CCeEEEEcCCCcEEE
Confidence 5579999999999765 35 599999999866542 33 432 799999999999 577899999999999
Q ss_pred EcCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeeccCCCCCC----------CCCcccCCC-ceEEecCCC
Q 003759 101 TDLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTL----------LPTQILNPR-NKLSAHYSD 168 (797)
Q Consensus 101 ~~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTl----------Lpg~~l~~~-~~L~S~~s~ 168 (797)
+|++|++||+|++... ....|+|+|+|||||+++ ++||||||||||+ +|||+++.+ ++|+| .
T Consensus 71 ~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~ 144 (236)
T 1dlp_A 71 LTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---T 144 (236)
T ss_dssp BCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---S
T ss_pred EcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---C
Confidence 9999999999997643 345899999999999964 8999999998665 777777664 46764 7
Q ss_pred CCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCCCC--ceeeeecccccEEEEEecCceEEEEEeccCccccce
Q 003759 169 KNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVGS--SLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDL 246 (797)
Q Consensus 169 ~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (797)
+||++|.|+|.++++|+++++... ..||++++++. ...+.++.+|..+.+ ..+++.++....... ..
T Consensus 145 ~d~s~G~~~l~l~~dG~LvL~~~~-------~~~W~s~~~~~~~~~~~~L~~~Gnl~ly-~~~~~~vw~s~~~~~---~~ 213 (236)
T 1dlp_A 145 QSLQLSPYRLSMETDCNLVLFDRD-------DRVWSTNTAGKGTGCRAVLQPNGRMDVL-TNQNIAVWTSGNSRS---AG 213 (236)
T ss_dssp CCCBCSSCEEEEETTTEEEEEBTT-------BCCSCCCCCSSCSSCEEEEETTTEEEEE-ETTTEEEEECCCCCS---SS
T ss_pred cEeecCcEEEEECCCCcEEEEcCC-------EeEEeCCCcCCCCceEEEECCCCcEEEE-eCCCcEEEEeCCCCC---CC
Confidence 899999999999999987776421 47899888753 345677778864444 344444433322211 23
Q ss_pred eEEEEEeeCCeEEEEE
Q 003759 247 YQRVTLEFDGFLRHYV 262 (797)
Q Consensus 247 ~~r~~l~~dG~l~~~~ 262 (797)
.+|++|++||++++|.
T Consensus 214 ~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 214 RYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCEEEECSSSCEEEEC
T ss_pred CEEEEEcCCCcEEEeC
Confidence 6899999999999994
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=321.46 Aligned_cols=263 Identities=21% Similarity=0.218 Sum_probs=181.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCc-------ee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH-------RL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~ 580 (797)
+.+.+.||+|+||.||+|+....+ ..||||++.... .....+.+|+..+..++||||+++++++...+. .+
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTG-MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp EEEC----------CEEEEETTTC-CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 445678999999999999987544 469999986532 334567788888999999999999999865433 78
Q ss_pred eeeecccCCchh---hhcccCCCCChhhHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCc
Q 003759 581 LVYEFISNGCLA---GFLFKNPKPSWYRRMQIAFGIARGLFYLH--EECTTQIIHCDIKPQNILLDD-SFTARISDFGLA 654 (797)
Q Consensus 581 lV~Ey~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla 654 (797)
+||||++++.+. ..+.....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 999999875332 33335567889999999999999999999 66 9999999999999997 899999999999
Q ss_pred cccccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------h
Q 003759 655 KILKADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------D 726 (797)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~ 726 (797)
........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+..... .
T Consensus 180 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 180 KKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp BCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 87654332 2334589999999998665 489999999999999999999999987544332221111000 0
Q ss_pred hhccccc-cccccc---hhhhh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 727 CYIDEKL-HLLVEN---DEEAL---HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 727 ~~~~~~~-~~~~~~---~~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....... ...... ..... ........+.+++..||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 000000 00000 000123467889999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.60 Aligned_cols=263 Identities=23% Similarity=0.266 Sum_probs=191.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccC------ceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 581 (797)
|.+.+.||+|+||+||+|+...++ .||+|++..... ...+|+.+++.++||||+++++++...+ ..++
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~--~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESD--EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTE--EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCC--eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 455678999999999999986543 388888754322 2236999999999999999999985443 3789
Q ss_pred eeecccCCchhhhc---ccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCcccc
Q 003759 582 VYEFISNGCLAGFL---FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKIL 657 (797)
Q Consensus 582 V~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~ 657 (797)
||||++++.+.... .....+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999876544333 2356789999999999999999999998 999999999999999 7999999999999876
Q ss_pred ccCCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-----------
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY----------- 725 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~----------- 725 (797)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.....
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44332 2334589999999998765 589999999999999999999999987644332222111100
Q ss_pred hhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 003759 726 DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGV 781 (797)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~ 781 (797)
...........................+.+++..||+.||++|||+.|+++. ++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0000011111100001111111122467889999999999999999999975 4443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.04 Aligned_cols=263 Identities=21% Similarity=0.236 Sum_probs=188.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccc--------------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFC-------------- 573 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-------------- 573 (797)
+.+.+.||+|+||.||+|+.... +..||+|++........+++.+|+.++++++||||+++++++
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDC-DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp EEEEEECC-----CEEEEEETTT-TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred eeEEEEeccCCCeEEEEEEECCC-CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 34457899999999999998754 456999998765444556789999999999999999999876
Q ss_pred cccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeec
Q 003759 574 NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFG 652 (797)
Q Consensus 574 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfg 652 (797)
.+.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++ +++.+||+|||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 34467899999998 699999854 5688999999999999999999998 999999999999997 56799999999
Q ss_pred CccccccCCC--cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhc
Q 003759 653 LAKILKADQT--RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 653 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
++........ .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 245 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI-PVVH 245 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS-CCCC
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCc
Confidence 9987643221 12233457899999998865 678999999999999999999999997654322111111000 0000
Q ss_pred ccccccccc------------ch-hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 730 DEKLHLLVE------------ND-EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 730 ~~~~~~~~~------------~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......... .. ............+.+++..||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000000 00 0000000112457789999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=319.84 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=179.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-h-HHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-D-KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||+||++..... +..||||++....... . +.+.++...++.++||||+++++++.+++..++||||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhHHhcCCCCCeEEEEEEecCC-CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 44567899999999999998654 4569999997542221 2 2345555668888999999999999999999999999
Q ss_pred ccCCchhhhcc----cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 586 ISNGCLAGFLF----KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 586 ~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
++ |+|.+++. ....+++..+..++.|++.||+|||++ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 97 58877764 346789999999999999999999984 389999999999999999999999999998765432
Q ss_pred CcccccccccCcccccccc----ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWF----KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... +. ............
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~~~~~~~~~~ 236 (290)
T 3fme_A 165 A--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LK----QVVEEPSPQLPA 236 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HH----HHHHSCCCCCCT
T ss_pred c--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HH----HHhccCCCCccc
Confidence 2 2223589999999996 5567899999999999999999999999753222111 11 111111111000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
+. ....+.+++..||+.||++|||+.|+++
T Consensus 237 ~~---------~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DK---------FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TT---------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc---------CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 1134677889999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=330.75 Aligned_cols=269 Identities=22% Similarity=0.227 Sum_probs=197.9
Q ss_pred CHHHHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC--------cCchhhhc
Q 003759 499 SYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN--------HRNLVKLL 570 (797)
Q Consensus 499 ~~~el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~--------h~niv~l~ 570 (797)
...++....|.+.+.||+|+||+||+|+.... +..||||++... ....+.+.+|+.++++++ |+||++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQG-KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCC-CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 33444445566778999999999999988654 456999999743 223467889999999985 78899999
Q ss_pred cccc----ccCceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC
Q 003759 571 GFCN----EDQHRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF 644 (797)
Q Consensus 571 g~~~----~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~ 644 (797)
+++. .+...++||||+. ++|.+.+... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred cceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence 9987 6678999999995 4555555433 56899999999999999999999852 899999999999999775
Q ss_pred -------------------------------------------------cEEEEeecCccccccCCCcccccccccCccc
Q 003759 645 -------------------------------------------------TARISDFGLAKILKADQTRTTTAIRGTRGYV 675 (797)
Q Consensus 645 -------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 675 (797)
.+||+|||++...... .....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCccc
Confidence 7999999999876433 23345899999
Q ss_pred cccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh--hHHHHHHhhhcc-------------------cccc
Q 003759 676 APEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM--ILVDWAYDCYID-------------------EKLH 734 (797)
Q Consensus 676 aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~-------------------~~~~ 734 (797)
|||++.+..++.++|||||||++|||++|+.||......+... ............ +...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999999999999999999999999999999997654332110 000000000000 0000
Q ss_pred ccccchh---------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 735 LLVENDE---------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 735 ~~~~~~~---------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.+..... ...........+.+++..||+.||++|||+.||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000 00012334457889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=312.10 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=200.5
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCce
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 579 (797)
......+.+.+.||+|+||.||+|+....+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCC-cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 344456677789999999999999986544 469999986533 23456799999999999999999999999999999
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC---CcEEEEeecCccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS---FTARISDFGLAKI 656 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~ 656 (797)
++|+||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.+ +.+||+|||++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999999998777899999999999999999999998 99999999999999764 4699999999986
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+. .. .+..+.....
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~----~~~~~~~~~~ 242 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LK----RVETGKYAFD 242 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH----HHHHCCCCCC
T ss_pred ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH----HH----HHHcCCCCCC
Confidence 644322 223347899999999876 489999999999999999999999976533211 11 1111111100
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... .. .....+.+++..||+.||++|||+.|+++
T Consensus 243 ~~~-~~-----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LPQ-WR-----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SGG-GT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chh-hh-----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00 01134667899999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.49 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=190.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCce------
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHR------ 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 579 (797)
+.+.+.||+|+||.||+|+.... +..||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred EEEEeEEecCCCeEEEEEEECCC-CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 44457899999999999998754 4569999997643322 35788999999999999999999999877655
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 68888774 3489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDE 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 731 (797)
. .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... ..+...
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 233458999999999987 6789999999999999999999999976543322111111000 000000
Q ss_pred c----ccccccchhhhh--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 K----LHLLVENDEEAL--HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~----~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. ............ ........+.+++..||+.||++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000000 000112457789999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.10 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=185.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc-----------
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----------- 575 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----------- 575 (797)
.+.+.+.||+|+||.||+|+....+ ..||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDS-RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cchhhheeccCCcEEEEEEEEcCCC-eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3555678999999999999986544 56999998642 2334678999999999999999999998754
Q ss_pred --cCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeec
Q 003759 576 --DQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652 (797)
Q Consensus 576 --~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 652 (797)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46789999999999999999754 4577888999999999999999998 99999999999999999999999999
Q ss_pred CccccccCC-------------CcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchh
Q 003759 653 LAKILKADQ-------------TRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718 (797)
Q Consensus 653 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~ 718 (797)
++....... ........+++.|+|||.+.+. .++.++||||||+++|||++ |+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--- 235 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--- 235 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH---
Confidence 998664321 1122334589999999999865 68999999999999999998 553321111
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......... ........ .......+.+++..||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRSV--SIEFPPDF--------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHST--TCCCCTTC--------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhcccc--ccccCccc--------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111000 00000000 01112345678899999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=319.10 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=196.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc------hhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN------LVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||+||+|.....++..||+|+++.. ....+.+.+|+.++++++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 34566788999999999999987666678999999753 233457888999999998776 88899999999999
Q ss_pred eeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-----------------
Q 003759 580 LLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL----------------- 640 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl----------------- 640 (797)
++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 55666666544 4689999999999999999999998 99999999999999
Q ss_pred --cCCCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchh
Q 003759 641 --DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718 (797)
Q Consensus 641 --~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~ 718 (797)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66789999999999864332 233458999999999999999999999999999999999999997654332111
Q ss_pred hHHHHHH-------hhhccccc----cccccchh---------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003759 719 ILVDWAY-------DCYIDEKL----HLLVENDE---------------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772 (797)
Q Consensus 719 ~~~~~~~-------~~~~~~~~----~~~~~~~~---------------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 772 (797)
.+..... ........ ........ ...........+.+++..||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 1110000 00000000 00000000 0001112234678899999999999999999
Q ss_pred HHHH
Q 003759 773 KVTL 776 (797)
Q Consensus 773 eVl~ 776 (797)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.15 Aligned_cols=199 Identities=28% Similarity=0.369 Sum_probs=166.2
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cC-----chhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HR-----NLVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~ 580 (797)
.+.+.+.||+|+||+||+|+.... +..||||+++.. .....++..|+.++..++ |+ +|+++++++...+..+
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVE-QEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCC-CcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 355567899999999999998754 456999999742 222456778888888874 44 4899999999999999
Q ss_pred eeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCcEEEEeecCccc
Q 003759 581 LVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD--DSFTARISDFGLAKI 656 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~ 656 (797)
+||||++ ++|.+++... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 5999998755 4689999999999999999999952 23899999999999994 578899999999987
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6432 2334589999999999999999999999999999999999999986544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.08 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=189.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccC--cCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTN--HRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||.||++.... +..||||++...... ..+.+.+|+.++.+++ |+||+++++++.+++..++||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcCC--CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 4456789999999999998753 456999998653322 3357899999999996 599999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
| +.+++|.+++.....+++..+..++.|+++||+|||+. +|+|+||||+||++++ +.+||+|||++.........
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 9 67899999998888899999999999999999999998 9999999999999975 89999999999876543321
Q ss_pred -ccccccccCcccccccccc-----------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 664 -TTTAIRGTRGYVAPEWFKS-----------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 664 -~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... + .......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~----~~~~~~~ 256 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HAIIDPN 256 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HHHHCTT
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--H----HHHHhcc
Confidence 2233458999999999875 46889999999999999999999999754322111 1 1111111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
......... ...+.+++..||+.||++||++.|+++.
T Consensus 257 ~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCCCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccc---------hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 110010110 1346678889999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=317.29 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=189.8
Q ss_pred HHHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhcc----CcCchhhhcc
Q 003759 502 ELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQT----NHRNLVKLLG 571 (797)
Q Consensus 502 el~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l----~h~niv~l~g 571 (797)
+.....|.+.+.||+|+||.||+|..... +..||||++...... ....+.+|+.++.++ +|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTD-RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTT-CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccC-CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34455677788999999999999987654 456999999654321 223466789999888 8999999999
Q ss_pred cccccCceeeeeec-ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEE
Q 003759 572 FCNEDQHRLLVYEF-ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARIS 649 (797)
Q Consensus 572 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~ 649 (797)
++...+..++|+|| +.+++|.+++.+...+++..++.++.||++||+|||+. +|+|+||||+||+++ +++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 78999999998877899999999999999999999998 999999999999999 88999999
Q ss_pred eecCccccccCCCcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhh
Q 003759 650 DFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 650 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
|||++....... .....+++.|+|||++.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~------ 247 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE------ 247 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh------
Confidence 999998765432 233458999999999987766 4589999999999999999999965321 000
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.... .... ....+.+++..||+.||++|||+.|+++.
T Consensus 248 --~~~~-~~~~---------~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --AELH-FPAH---------VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TCCC-CCTT---------SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hccC-Cccc---------CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000 11245678899999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.15 Aligned_cols=240 Identities=22% Similarity=0.375 Sum_probs=195.3
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccC--cCchhhhcccccccCc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTN--HRNLVKLLGFCNEDQH 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~ 578 (797)
.+.+.+.||+|+||.||+|+.... +..||||++...... ..+.+..|+.++++++ |+||+++++++.+++.
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTT-TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCC-CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 355678899999999999987654 457999999754322 2245778999999995 5999999999999999
Q ss_pred eeeeeecccC-CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCccc
Q 003759 579 RLLVYEFISN-GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKI 656 (797)
Q Consensus 579 ~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~ 656 (797)
.++|+|++.+ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999986 89999998878899999999999999999999998 999999999999999 789999999999987
Q ss_pred cccCCCcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHL 735 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (797)
..... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .. ....
T Consensus 200 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------~~-----~~~~- 261 (320)
T 3a99_A 200 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IR-----GQVF- 261 (320)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------HH-----CCCC-
T ss_pred ccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------hc-----cccc-
Confidence 65332 233458999999999987765 78899999999999999999999653210 00 0000
Q ss_pred cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 736 LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.... ....+.+++..||+.||++|||++||++.
T Consensus 262 ~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 FRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccc---------CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 11345678899999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.26 Aligned_cols=249 Identities=19% Similarity=0.212 Sum_probs=167.3
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc----cCceeeeeeccc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLLVYEFIS 587 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~Ey~~ 587 (797)
+.||+|+||+||+|.....+ ..||||++... .+...+....+..++||||+++++++.. +...++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTG-QKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETTTC-CEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECCCC-CEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999987554 46999998642 2222333344566799999999999876 456899999999
Q ss_pred CCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCCC
Q 003759 588 NGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQT 662 (797)
Q Consensus 588 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~ 662 (797)
+|+|.+++.+. ..+++.+++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++.......
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 99999999765 3689999999999999999999998 9999999999999976 4559999999998654322
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
.....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............. .......... .....
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~- 257 (336)
T 3fhr_A 186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIRLGQYGF-PNPEW- 257 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC-CTTTS-
T ss_pred --cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhhcccccc-Cchhh-
Confidence 223457999999999988889999999999999999999999997654322111000 0000000000 00000
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL--MLEGV 781 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~--~Le~~ 781 (797)
......+.+++..||+.||++|||+.|+++ .+.+.
T Consensus 258 ----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 258 ----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 011234667889999999999999999998 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.00 Aligned_cols=258 Identities=22% Similarity=0.251 Sum_probs=189.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--hHHHHHHHHHhhccCcCchhhhcccccccCc------e
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH------R 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 579 (797)
+.+.+.||+|+||.||+|+.... +..||||++....... .+.+.+|+.++++++||||+++++++...+. .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred EEEeeeEecCCCeEEEEEEECCC-CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 34457899999999999998754 4569999997543222 3568899999999999999999999987654 4
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||++ ++|.+++.. .+++..+..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++.....
T Consensus 105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 688888743 488999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhccc
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYIDE 731 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 731 (797)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..+.+.
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2 233458999999999877 6789999999999999999999999976543221111111000 000000
Q ss_pred -------cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 -------KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.+.......... ........+.+++..||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000000 000112456788999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=315.24 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=171.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHH-HhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVN-AIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.||+|+||.||+|..... +..||||++...... ...++..|+. +++.++||||+++++++.+++..++||||+
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTT-TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hehheeccCCCEEEEEEEEcCC-CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 3457899999999999998654 456999999754322 2335556665 677789999999999999999999999999
Q ss_pred cCCchhhhccc-----CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFK-----NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
++ +|.+++.. ...+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 85 77777752 56789999999999999999999984 389999999999999999999999999998664332
Q ss_pred CcccccccccCcccccccc----ccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 662 TRTTTAIRGTRGYVAPEWF----KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......... . ....+....+.
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~-~~~~~~~~~~~ 251 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------T-QVVKGDPPQLS 251 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------C-CCCCSCCCCCC
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------H-HHhcCCCCCCC
Confidence 2 2233589999999998 45678999999999999999999999997543211100 0 00111111111
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.... ......+.+++..||+.||++|||+.||++
T Consensus 252 ~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEE-----REFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSS-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cccc-----ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000 001234677889999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.67 Aligned_cols=268 Identities=24% Similarity=0.252 Sum_probs=194.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-----------cCchhhhccccc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-----------HRNLVKLLGFCN 574 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~~ 574 (797)
..+.+.+.||+|+||+||+|+.... +..||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCC-CcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3456678899999999999998654 456999998742 223456888999999886 899999999987
Q ss_pred ccC----ceeeeeecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc------C
Q 003759 575 EDQ----HRLLVYEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD------D 642 (797)
Q Consensus 575 ~~~----~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~------~ 642 (797)
..+ ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcC
Confidence 654 789999999 89999999753 4589999999999999999999984 2899999999999994 4
Q ss_pred CCcEEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccch--hhH
Q 003759 643 SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQ--MIL 720 (797)
Q Consensus 643 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~--~~~ 720 (797)
.+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||......... ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999876432 22345899999999999999999999999999999999999999765322110 000
Q ss_pred HHHHHhhhc------------------cccccccccc----hhh------hhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003759 721 VDWAYDCYI------------------DEKLHLLVEN----DEE------ALHDMMRLKKYVMIAIWCIQEDPSLRPTMK 772 (797)
Q Consensus 721 ~~~~~~~~~------------------~~~~~~~~~~----~~~------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 772 (797)
......... .......+.. ... ..........+.+++..||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 000000000 0000000000 000 001123456778999999999999999999
Q ss_pred HHHH--HHhcCc
Q 003759 773 KVTL--MLEGVV 782 (797)
Q Consensus 773 eVl~--~Le~~~ 782 (797)
||++ .+.+..
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 9998 344433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=321.81 Aligned_cols=244 Identities=27% Similarity=0.339 Sum_probs=180.0
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccCC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
.+.||+|+||+||.+... ++..||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++ |
T Consensus 20 ~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSF--QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEES--SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 467999999999865432 3457999998642 345678899999886 89999999999999999999999995 6
Q ss_pred chhhhcccCCCC-------ChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCC-------------CcEEEE
Q 003759 590 CLAGFLFKNPKP-------SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDS-------------FTARIS 649 (797)
Q Consensus 590 sL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~-------------~~~kl~ 649 (797)
+|.+++...... ++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999765322 3345678999999999999998 99999999999999754 489999
Q ss_pred eecCccccccCCCc---ccccccccCcccccccccc-------CCCCccCceehHHHHHHHHHh-CCcCCCccccccchh
Q 003759 650 DFGLAKILKADQTR---TTTAIRGTRGYVAPEWFKS-------LPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQM 718 (797)
Q Consensus 650 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 718 (797)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 99999877544321 2234569999999999975 568999999999999999999 9999965432211
Q ss_pred hHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
............. ..........+.+++..||+.||++|||+.||++
T Consensus 249 ---~i~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ---NIIRGIFSLDEMK--------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHTCCCCCCCT--------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHhcCCCCccccc--------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111111110 0111222356778999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=337.37 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=189.6
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCc-----ee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQH-----RL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~ 580 (797)
.+.+.+.||+|+||+||+|.+...++..||||++..... ...+.+.+|+.++.+++||||+++++++.+.+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 355667899999999999998764566799999865322 233568899999999999999999999987665 69
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|||||+++++|.+++.. .+++.+++.|+.||+.||.|||++ +|+||||||+|||++++ .+||+|||+++.....
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 99999999999998755 789999999999999999999998 99999999999999986 8999999999876433
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
....||+.|+|||++.+.. +.++||||||+++++|++|..|+........ ...
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------~~~- 287 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------PED- 287 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------CTT-
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------ccc-
Confidence 3345899999999987754 8999999999999999999988764321110 000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRP-TMKKVTLMLEGV 781 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~eVl~~Le~~ 781 (797)
.........+.+++..||+.||++|| +++++.+.|.++
T Consensus 288 ---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111224567889999999999999 466676666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=305.60 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=172.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc-h-HHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG-D-KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~-~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||.||+|.....+ ..||||++....... . +.+.++..+++.++||||+++++++.+++..++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTG-HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp EEEEEEC------CEEEEEETTTC-CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccceeeecCCeeEEEEEEecCC-eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 344578999999999999987544 469999997543221 1 2344555677888999999999999999999999999
Q ss_pred ccCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 586 ISNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHE-ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 586 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
+ ++.+..+... ...+++..+..++.++++||+|||+ . +|+|+||||+||+++.++.+||+|||++........
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 9 4555555433 4678999999999999999999998 5 899999999999999999999999999976543322
Q ss_pred ccccccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 664 TTTAIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||........ ... ... .+.......
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~---~~~-~~~~~~~~~ 252 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VLT---KVL-QEEPPLLPG 252 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHH---HHH-HSCCCCCCS
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---HHH---HHh-ccCCCCCCc
Confidence 22345899999999994 45688999999999999999999999975322211 111 111 111100000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. . .....+.+++..||+.||++||++.||++
T Consensus 253 ~-~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 H-M------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S-S------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c-C------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0 01134567889999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=319.29 Aligned_cols=243 Identities=25% Similarity=0.321 Sum_probs=178.3
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccC
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
..+.||+|+||+|+..... ++..||||++... ....+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEECGGGCEEEEEES--SSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cCCeeecCcCEEEEEEEEe--CCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 3568999999996543322 3446999998642 233467899999999 89999999999999999999999996
Q ss_pred CchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCcEEEEeecCccccccCCC
Q 003759 589 GCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-----SFTARISDFGLAKILKADQT 662 (797)
Q Consensus 589 gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~~~ 662 (797)
|+|.+++.... .........++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 69999997653 455667789999999999999998 9999999999999953 33688999999987654322
Q ss_pred --cccccccccCccccccccc---cCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 663 --RTTTAIRGTRGYVAPEWFK---SLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ........ .
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~~-~ 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGACSLD-C 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HTTCCCCT-T
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------HhccCCcc-c
Confidence 2234456999999999997 4567889999999999999999 889985443221110 00000110 0
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... .......+.+++..||+.||++|||+.||++
T Consensus 250 ~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 LHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 0112234567899999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=331.58 Aligned_cols=262 Identities=24% Similarity=0.257 Sum_probs=191.0
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc------cCc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------DQH 578 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~ 578 (797)
..+.+.+.||+|+||.||+|.....+ ..||||++..... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg-~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTG-EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTT-CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCC-cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 34667789999999999999886544 4699999875322 234568999999999999999999998765 678
Q ss_pred eeeeeecccCCchhhhcccCC---CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCc---EEEEeec
Q 003759 579 RLLVYEFISNGCLAGFLFKNP---KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFT---ARISDFG 652 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfg 652 (797)
.++||||+++|+|.+++.... .+++..+..++.+++.||+|||+. +|+|+||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 588999999999999999999998 9999999999999997665 9999999
Q ss_pred CccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhh-HHH-HHHhhh--
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-LVD-WAYDCY-- 728 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~-~~~-~~~~~~-- 728 (797)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ... ......
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9987654322 2345689999999999999999999999999999999999999965321110000 000 000000
Q ss_pred --ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003759 729 --IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773 (797)
Q Consensus 729 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 773 (797)
..+.....................+.+++..||+.||++|||+.|
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000000000011112345778999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.25 Aligned_cols=233 Identities=13% Similarity=0.029 Sum_probs=179.8
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
..|.+.+.||+|+||.||+|..... +..||||++....... .+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTT-TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCC-CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3456678899999999999998654 4569999997654332 25789999999999999999999999999999999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++++|.+++.+. ....+..+|+.|++.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999543 35567889999999999999998 99999999999999999999997443
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (797)
|++ +++.++||||||+++|||+||+.||......+..... .... .+... . .
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~~~-~~~~~----~-~- 225 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDT-AGQPI----E-P- 225 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CBCT-TSCBC----C-H-
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HHHh-ccCCC----C-h-
Confidence 333 3688999999999999999999999865433211000 0000 00000 0 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 743 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
..........+.+++..||+.||++| |+.|+++.|+.+...
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00001112346788999999999999 999999999875543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=310.08 Aligned_cols=233 Identities=15% Similarity=0.113 Sum_probs=173.1
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC---chHHHHHHHHHhhccCc-Cchhhhccc--------------
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG---GDKEFRTEVNAIGQTNH-RNLVKLLGF-------------- 572 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h-~niv~l~g~-------------- 572 (797)
.+.||+|+||+||+|++...+ ..||||++...... ..+.|.+|+.+++.++| +|...+..+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETG-ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTC-CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEecCCC-CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 467999999999999987554 46999998743322 35679999999999977 444333322
Q ss_pred -------ccc-----cCceeeeeecccCCchhhhcc------c-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 003759 573 -------CNE-----DQHRLLVYEFISNGCLAGFLF------K-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDI 633 (797)
Q Consensus 573 -------~~~-----~~~~~lV~Ey~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl 633 (797)
+.. ....+++|+++ +++|.+++. . ...+++..++.|+.||++||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 111 12346666654 689998884 1 23467889999999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCcccccccc----------ccCCCCccCceehHHHHHHHHHh
Q 003759 634 KPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF----------KSLPITMKVDIYSFGVMLLELIC 703 (797)
Q Consensus 634 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~sDVwS~Gvll~ellt 703 (797)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998865433 333457 999999999 55568899999999999999999
Q ss_pred CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 704 CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 704 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
|+.||......+....+ +.... . ..+.+.+++..||+.||++||++.+++
T Consensus 313 g~~Pf~~~~~~~~~~~~----------------~~~~~-~-----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI----------------FRSCK-N-----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCSGGG----------------GSSCC-C-----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhHHHH----------------Hhhcc-c-----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999765432211100 00000 0 013467788999999999999976654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=292.11 Aligned_cols=233 Identities=21% Similarity=0.232 Sum_probs=175.7
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHh-hccCcCchhhhcccccc----cCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAI-GQTNHRNLVKLLGFCNE----DQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~Ey~ 586 (797)
+.||+|+||.||++.....+ ..||+|+++. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQ-EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETTTC-CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcCCC-cEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 56999999999999987544 4699999864 35678888888 55699999999999876 77889999999
Q ss_pred cCCchhhhcccCC--CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFKNP--KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 661 (797)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999997653 689999999999999999999998 9999999999999998 7899999999986432
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
+..++.++||||||+++|||++|+.||............ ......... ....
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----~~~~~~~~~----~~~~ 223 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQY----EFPN 223 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----CCSSCTTCC----SSCH
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----HHHHhhccc----cCCc
Confidence 234678999999999999999999999654332110000 000000000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPI 786 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~ 786 (797)
. ........+.+++..||+.||++|||+.|+++. +.+....+.
T Consensus 224 ~--~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 224 P--EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp H--HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred h--hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 0 000112456788999999999999999999973 444443333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=298.38 Aligned_cols=244 Identities=15% Similarity=0.092 Sum_probs=183.5
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--------CchHHHHHHHHHhhccC------------
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--------GGDKEFRTEVNAIGQTN------------ 562 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~------------ 562 (797)
+....+.+.+.||+|+||+||+|+. .+..||||++..... ...+.+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 3345677788999999999999987 346799999975432 12367889999998886
Q ss_pred --------------cCchhhhcccccc-------------cCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHH
Q 003759 563 --------------HRNLVKLLGFCNE-------------DQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIAR 615 (797)
Q Consensus 563 --------------h~niv~l~g~~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~ 615 (797)
||||+++++++.+ .+..+|||||+++|++.+.+.+ ..+++..+..++.||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 7888888888775 7899999999999987777644 56889999999999999
Q ss_pred HHHHHh-hcCCCCeeecCCCCCCEEEcCCC--------------------cEEEEeecCccccccCCCcccccccccCcc
Q 003759 616 GLFYLH-EECTTQIIHCDIKPQNILLDDSF--------------------TARISDFGLAKILKADQTRTTTAIRGTRGY 674 (797)
Q Consensus 616 gL~~LH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 674 (797)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876432 23589999
Q ss_pred ccccccccCCCCccCceehHHHH-HHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHH
Q 003759 675 VAPEWFKSLPITMKVDIYSFGVM-LLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKY 753 (797)
Q Consensus 675 ~aPE~~~~~~~t~~sDVwS~Gvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (797)
+|||++.+.. +.++||||++++ .+++++|..||....... .+.+..... .... ..............+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~---~~~~----~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTDKMLKQ---MTFK----TKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHHHHHHT---CCCS----SCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HHHHhhhhh---hccC----cccchhhhhhcCHHH
Confidence 9999998776 899999998777 778899999984321000 000000000 0000 000001112234567
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q 003759 754 VMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 754 ~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
.+++..||+.| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 88999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=282.98 Aligned_cols=187 Identities=18% Similarity=0.119 Sum_probs=131.8
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCC----------CchHHHHHHHHHhhcc-CcCchhhhcccccccCceee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVS----------GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 581 (797)
.++.|++|.+.+++....++ .+++|.+..... ...++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~-~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGE-DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECS-SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccccccc-eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 46677777777665544333 389999865321 1224699999999999 79999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||++|++|.++|.+..+++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999888777653 5899999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCC
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKF 708 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~ 708 (797)
.. .....||+.|||||++.+. +..++|+||+|++++++.++..++
T Consensus 394 ~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 32 3345699999999999764 567899999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=249.15 Aligned_cols=182 Identities=18% Similarity=0.242 Sum_probs=145.3
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc--------hHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG--------DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~--------~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
.+.||+|+||.||+|... +..+++|+........ .+.|.+|++++++++||||+++..++...+..+||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 468999999999999543 2358888764322111 23479999999999999999777777788888999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
|||+++++|.+++.+ +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999965 568999999999999998 9999999999999999 999999999998754322
Q ss_pred cc------cccccccCcccccccccc--CCCCccCceehHHHHHHHHHhCCcCC
Q 003759 663 RT------TTAIRGTRGYVAPEWFKS--LPITMKVDIYSFGVMLLELICCRKKF 708 (797)
Q Consensus 663 ~~------~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~Gvll~elltG~~p~ 708 (797)
.. .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 235679999999999987 56888899999999999988877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-21 Score=203.61 Aligned_cols=141 Identities=16% Similarity=0.054 Sum_probs=114.4
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------------------chHHHHHHHHHhhccCcCchhhhccc
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------------------GDKEFRTEVNAIGQTNHRNLVKLLGF 572 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------------------~~~~f~~E~~~l~~l~h~niv~l~g~ 572 (797)
.+.||+|+||.||+|.. .++..||||.++..... ....+.+|+.++++++ | +++.++
T Consensus 95 ~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred cCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 47899999999999998 34567999999643211 2346889999999999 5 777775
Q ss_pred ccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeec
Q 003759 573 CNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFG 652 (797)
Q Consensus 573 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 652 (797)
+. .+..++||||+++++|.+ +. ......++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 170 ~~-~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 170 YA-WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EE-EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred Ee-ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 54 466799999999999998 42 234557999999999999998 999999999999999 9999999999
Q ss_pred CccccccCCCcccccccccCcccccccccc
Q 003759 653 LAKILKADQTRTTTAIRGTRGYVAPEWFKS 682 (797)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 682 (797)
+++. +..++|||++..
T Consensus 238 ~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TCEE--------------TTSTTHHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHHH
Confidence 9873 445789998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=163.34 Aligned_cols=103 Identities=24% Similarity=0.456 Sum_probs=87.7
Q ss_pred cccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcC
Q 003759 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103 (797)
Q Consensus 24 ~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~ 103 (797)
|+|.+||.|.+++ +|+| |.|.|.|+.+++ |.++. ..++||+|||++|..+++.+.|+.||||||+|+
T Consensus 2 n~L~~g~~L~~g~---~L~s--g~y~l~~q~DgN----Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 2 NILDNNEGLYAGQ---SLDV--EPYHFIMQDDCN----LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CEECTTEEECTTC---EEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEECT
T ss_pred CCcCCCCEEcCCC---EEEE--CCEEEEECCCCe----EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEECC
Confidence 6788999998765 4666 889999987765 55654 358999999999998889999999999999999
Q ss_pred CCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeee
Q 003759 104 TGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 104 ~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
+|++||+|++.. ....+|+|+|+|||||+++ .||||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999999764 3456899999999999974 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=6.7e-20 Score=165.20 Aligned_cols=107 Identities=23% Similarity=0.347 Sum_probs=91.4
Q ss_pred ccccccCCCCceeecCCCceee--eCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceE
Q 003759 21 ATAQNVSRGESLMAEDDMSSWK--STSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRL 98 (797)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~~~--S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l 98 (797)
++.++|.+|++|.+++ +|+ |++|.|+|+|+.+++. +||++ +++||+||++.| ..++.+.|..||||
T Consensus 6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgnl-----vly~~---~~~vW~sn~~~~-~~~~~l~l~~dGNL 73 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCNL-----VLYDN---NNPIWATNTGGL-GNGCRAVLQPDGVL 73 (119)
T ss_dssp CSCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSCE-----EEEET---TEEEEECCCTTS-CSSCEEEECTTSCE
T ss_pred ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCCE-----EEEEC---CEEEEeCCCccC-CCceEEEEccCCEE
Confidence 5679999999999765 588 9999999999987652 57875 799999999977 33578999999999
Q ss_pred EEEcCCCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeee
Q 003759 99 VLTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 99 ~l~~~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
||+|.++.+||++++.. .+...++|+|+|||||++ .++|||
T Consensus 74 Vl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 74 VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99999999999998753 345689999999999998 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.5e-20 Score=163.22 Aligned_cols=109 Identities=21% Similarity=0.395 Sum_probs=91.4
Q ss_pred ccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEc
Q 003759 23 AQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102 (797)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~ 102 (797)
+|+|.+||+|.+++ +|+ ++|.|+|+|+.+++- +||+ .+++||.||++.|. .++.+.|..||||||+|
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGnl-----vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~ 67 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCNF-----VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIYD 67 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSCE-----EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEEC
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCcE-----EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEEC
Confidence 47899999998765 588 899999999877652 6676 37999999998773 35689999999999999
Q ss_pred CCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeeccCCC
Q 003759 103 LTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFDHPT 147 (797)
Q Consensus 103 ~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PT 147 (797)
.+|.+||++.+... +...++|+|+|||||++. ++||||+||.
T Consensus 68 ~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 68 QSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 99999999987643 345899999999999985 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=159.25 Aligned_cols=109 Identities=25% Similarity=0.468 Sum_probs=90.0
Q ss_pred ccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEc
Q 003759 23 AQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102 (797)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~ 102 (797)
.|+|.+||+|.+++ +|+ +|.|+|+|+.+++ .. +|+ .+++||+||++.|. .++.+.|..||||||+|
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgn--lv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d 67 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCN--LV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYD 67 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTSC--EE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEEC
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCc--EE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEEC
Confidence 58999999998754 477 7999999986654 32 354 37999999999884 45789999999999999
Q ss_pred CCCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeeeccCCCC
Q 003759 103 LTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWESFDHPTD 148 (797)
Q Consensus 103 ~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTD 148 (797)
.++.+||++++.. .+..+++|+|+|||||++. ++||||.+++.
T Consensus 68 ~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 68 HNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 8899999998763 3456899999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=156.03 Aligned_cols=109 Identities=17% Similarity=0.391 Sum_probs=89.9
Q ss_pred ccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEc
Q 003759 23 AQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102 (797)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~ 102 (797)
+|+|.+||+|.+++. | ++|.|+|+|+.+++. +||++ +++||+||++.+ ..++.+.|..+|||||+|
T Consensus 1 tdtl~~gq~L~~g~~---L--~~~~~~L~~~~dgnl-----vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGS---L--AEGGYLFIIQNDCNL-----VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CCEEETTEEECTTCE---E--EETTEEEEECTTSCE-----EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEEE
T ss_pred CCCCCCCCEECCCCE---E--eCCCEEEEEcCCCcE-----EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc
Confidence 488999999987654 5 579999999987753 35665 699999999864 235678999999999999
Q ss_pred CCCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeeeccCC
Q 003759 103 LTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWESFDHP 146 (797)
Q Consensus 103 ~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~P 146 (797)
++.+||++.+.. .+..+++|+++|||||++.++.++||||++.
T Consensus 67 -~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 -GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp -TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred -CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 889999998654 3346899999999999997788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=146.65 Aligned_cols=102 Identities=23% Similarity=0.439 Sum_probs=83.5
Q ss_pred cccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcC
Q 003759 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103 (797)
Q Consensus 24 ~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~ 103 (797)
++|.+||+|.+++. |+ +|.|+|+|+.+++ ..| |.. .++||+||++.+ ..++.+.|..||||||+|.
T Consensus 2 ntL~~gq~L~~g~~---L~--~g~~~L~~q~dGn--Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 2 NILYSGETLSPGEF---LN--NGRYVFIMQEDCN--LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CEEETTEEECTTCE---EE--ETTEEEEECTTSC--EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEECT
T ss_pred CCcCCCCEeCCCCE---EE--CCCEEEEEcCCCc--EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEECC
Confidence 68999999987654 54 7999999987764 333 554 599999999876 3357889999999999999
Q ss_pred CCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeee
Q 003759 104 TGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 104 ~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
++.++|++++.... ..+|+|+|+|||||+++ ++|||
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 89999999876443 46899999999999985 79998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-17 Score=171.11 Aligned_cols=135 Identities=19% Similarity=0.149 Sum_probs=102.6
Q ss_pred hhhhhCcccceeEEEEEEecCCcEE--EEEEEecccCCCc------------------------hHHHHHHHHHhhccCc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKIC--VAVKKLDNMVSGG------------------------DKEFRTEVNAIGQTNH 563 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~--vavK~~~~~~~~~------------------------~~~f~~E~~~l~~l~h 563 (797)
+.+.||+|+||.||+|..... +.. ||||+++...... ...+.+|+.++.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~-g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFD-GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEET-TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEcCC-CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 446799999999999988433 346 9999875431110 1257889999999988
Q ss_pred Cch--hhhcccccccCceeeeeecccC-C----chhhhcccCCCCChhhHHHHHHHHHHHHHHHh-hcCCCCeeecCCCC
Q 003759 564 RNL--VKLLGFCNEDQHRLLVYEFISN-G----CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH-EECTTQIIHCDIKP 635 (797)
Q Consensus 564 ~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~Dlkp 635 (797)
+++ ..++++ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +. +|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 864 333332 467899999953 4 56555432 235578899999999999999 77 999999999
Q ss_pred CCEEEcCCCcEEEEeecCcccc
Q 003759 636 QNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 636 ~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+|||+++ .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.3e-16 Score=139.02 Aligned_cols=105 Identities=18% Similarity=0.272 Sum_probs=83.0
Q ss_pred cccccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEE
Q 003759 20 SATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLV 99 (797)
Q Consensus 20 ~~~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~ 99 (797)
..+.|+|.+||+|.+++ +|+| |.|.|-|+..++ |.+ |.. ++||.+|++.. ..++.+.|..|||||
T Consensus 3 ~~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dGn----Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNLv 67 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDCN----LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGELI 67 (110)
T ss_dssp CCBTTEEETTCEEETTE---EEEC--SSCEEEECTTSC----EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCEE
T ss_pred ccccCEECCCCEecCCC---EEEe--CCEEEEEcCCCe----EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcEE
Confidence 35679999999998765 4777 569998765553 444 554 48999999863 234688999999999
Q ss_pred EEcCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeee
Q 003759 100 LTDLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 100 l~~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
|+|.+|.++|++++... ...+|+|+|+|||||++ ..+|+|
T Consensus 68 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 68 IKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 99999999999987543 34689999999999998 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=4.7e-16 Score=138.23 Aligned_cols=88 Identities=28% Similarity=0.521 Sum_probs=73.5
Q ss_pred cCceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEe
Q 003759 86 RGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSA 164 (797)
Q Consensus 86 ~~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S 164 (797)
....|.++.||||+|++ .+++||++++.... ...++|+|+|||||++.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC--------------------
Confidence 35678899999999999 58999999976433 468999999999999998999999993
Q ss_pred cCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCC
Q 003759 165 HYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPV 208 (797)
Q Consensus 165 ~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~ 208 (797)
++++|.|++.++++|+++++.. .||.+++.
T Consensus 79 -----~~~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~ 108 (110)
T 3a0c_A 79 -----NGKEDHYVLVLQQDRNVVIYGP---------VVWATGSG 108 (110)
T ss_dssp -----CCSSSCCEEEECTTSCEEEECS---------EEEECSCC
T ss_pred -----CCCCCCEEEEEeCCccEEEECC---------CEecCCCc
Confidence 4578999999999999888631 58987653
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-15 Score=135.20 Aligned_cols=107 Identities=15% Similarity=0.233 Sum_probs=85.9
Q ss_pred ccccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEE
Q 003759 21 ATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVL 100 (797)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l 100 (797)
.+.|+|.+||.|.+++. |. +|.|.|-|+.+++ |.++..+ ..++||.+|+..+- .++.+.|..||||||
T Consensus 4 ~~~~tL~~gq~L~~g~~---L~--~g~~~L~~q~dGN----LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNLVl 71 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQ---LA--TRDYSLVMRDDCN----LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGELDI 71 (113)
T ss_dssp CCSSEEETTCEEETTCE---EE--ETTEEEEECTTSC----EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred ccCCEeCCCCEECCCCE---eE--cCCEEEEEcCCCE----EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcEEE
Confidence 35689999999987654 54 4899999976664 5554332 46899999998763 357889999999999
Q ss_pred EcCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeee
Q 003759 101 TDLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 101 ~~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
+|.+++++|++++... ...+|+|+|+|||||++ ..+|+|
T Consensus 72 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 72 TDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp ECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred ECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9999999999998643 34689999999999998 589997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.1e-15 Score=132.17 Aligned_cols=90 Identities=32% Similarity=0.532 Sum_probs=74.6
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.++.||+|+|++. +++||++++... ....|+|+|+|||||+| ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------------
Confidence 45788899999999986 789999997643 34689999999999999 7789999994
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCCC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVG 209 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~ 209 (797)
+|++|.|++.++++|++++|... ..+||++.++.
T Consensus 77 ----~~~~g~~~l~l~~dGnlvl~~~~------~~~~W~S~~~~ 110 (112)
T 1xd5_A 77 ----NRQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNV 110 (112)
T ss_dssp ----CCSCCCCEEEECTTSCEEEECTT------SCEEEECCCCC
T ss_pred ----cCCCCCEEEEEeCCCcEEEECCC------CceEEECCCcc
Confidence 44678999999999998887422 25899988774
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=133.15 Aligned_cols=86 Identities=28% Similarity=0.497 Sum_probs=72.5
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.+..||||+|++. +++||++++.... ...++|+|+|||||+|.++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence 35677888999999996 8999999976433 46899999999999999999999999
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 207 (797)
+||++|.|++.++++|+++++. .+||++++
T Consensus 88 ---~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ---CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 3457899999999999988864 26898765
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.7e-15 Score=132.86 Aligned_cols=107 Identities=23% Similarity=0.362 Sum_probs=84.4
Q ss_pred cccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEE
Q 003759 22 TAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLT 101 (797)
Q Consensus 22 ~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~ 101 (797)
+.|||.|||.|.+++. | .+|.|.|.|+.+++-.. |.. +|.+|+..+ ..++.+.|..||||||+
T Consensus 2 ~~dtL~~gq~L~~g~~---L--~~g~~~L~~q~dGNLvl-----~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGH---L--KNGDFDLVMQDDCNLVL-----YNG------NWQSNTANN-GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCSEEETTCEECTTCE---E--EETTEEEEECTTSCEEE-----ETT------TEECCCTTS-CSSCEEEECTTSCEEEE
T ss_pred ccCCcCCCCCcCCCCE---e--ECCCEEEEEecCCeEEE-----EeC------eEEcCCCCC-CCcEEEEEcCCCeEEEE
Confidence 5699999999987654 4 46999999987765322 332 699998865 33578899999999999
Q ss_pred cCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCC
Q 003759 102 DLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPT 153 (797)
Q Consensus 102 ~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg 153 (797)
|.++.++|++++... ...+|+|+|+|||||++ ..+|+| +|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 999999999987643 34689999999999998 689997 555554
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-14 Score=128.24 Aligned_cols=89 Identities=27% Similarity=0.551 Sum_probs=74.6
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.+..||||+|++ .+++||++++.... ...++|+++|||||+|.++.++|||||+|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC-------------------
Confidence 4567788899999998 57899999976433 46899999999999998889999999983
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCCCC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVGS 210 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~ 210 (797)
++|.|++.++++|+++++.. .||++.++..
T Consensus 81 ------~~g~~~l~l~~dGnlvl~~~---------~~W~S~~~~~ 110 (115)
T 2dpf_A 81 ------DNGKYALVLQKDGRFVIYGP---------VLWSLGPNGC 110 (115)
T ss_dssp ------SSSCCEEEECTTSCEEEECS---------EEECSSTTCB
T ss_pred ------CCCCEEEEEeCCCeEEEECC---------CEEECCCCCC
Confidence 57889999999999888631 6899888753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=8.2e-15 Score=158.35 Aligned_cols=139 Identities=11% Similarity=-0.013 Sum_probs=101.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--------------chHHHHHHHHHhhccCcCchhhhcccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--------------GDKEFRTEVNAIGQTNHRNLVKLLGFC 573 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--------------~~~~f~~E~~~l~~l~h~niv~l~g~~ 573 (797)
|.+.+.||+|++|.||+|.... +..||||+++..... .......++++.....|+|+++++...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~--G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK--GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT--CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECCC--CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3456689999999999998753 456999987532110 111233445555555677777776544
Q ss_pred ccc------CceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC---
Q 003759 574 NED------QHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF--- 644 (797)
Q Consensus 574 ~~~------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~--- 644 (797)
..- ...+|||||+++++|..+.. ......++.|++.+|.+||+. +||||||||.|||+++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence 322 23369999999999877642 224467889999999999998 999999999999998876
Q ss_pred -------cEEEEeecCcccc
Q 003759 645 -------TARISDFGLAKIL 657 (797)
Q Consensus 645 -------~~kl~Dfgla~~~ 657 (797)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=4.1e-13 Score=119.23 Aligned_cols=102 Identities=15% Similarity=0.221 Sum_probs=79.0
Q ss_pred ccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEc
Q 003759 23 AQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102 (797)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~ 102 (797)
.|+|.+||.|.+++. | .+|.|.|.|+.+++- .+ |.. .. ||.+|+..+ ..++.+.|..||||||+|
T Consensus 2 ~~~l~~gq~L~~g~~---L--~~g~~~L~~q~dGnL----vl-~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~~ 66 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQ---L--SYESAAFVMQGDCNL----VL-YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIHS 66 (111)
T ss_dssp TTEEETTCEECTTCE---E--EETTEEEEECTTSCE----EE-ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEEC
T ss_pred cCEeCCCCEeCCCCE---E--ecCCEEEEEccCCeE----EE-ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEEe
Confidence 378999999987654 4 369999999766642 22 442 23 999999876 335788999999999999
Q ss_pred CCCc-eEeccCCC---CCceeEEEEecCCCeEEecCCCCceeee
Q 003759 103 LTGK-EVWNPDTA---GAAIAYASMLDSGNFVLAGPDSFPLWES 142 (797)
Q Consensus 103 ~~~~-~vW~t~~~---~~~~~~a~l~d~GNlvl~~~~~~~lWqS 142 (797)
.++. +||++++. .....+++|+|+|||||++ ..+|+|
T Consensus 67 ~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 67 ANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 8876 59999853 2234689999999999998 679997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-12 Score=114.34 Aligned_cols=92 Identities=25% Similarity=0.386 Sum_probs=71.8
Q ss_pred CCCCc-cCceeeEeeCceEEEEcC-CCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccC
Q 003759 81 KTPVE-RGSKVQLTVDGRLVLTDL-TGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILN 157 (797)
Q Consensus 81 ~~p~~-~~~~~~~~~~g~l~l~~~-~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~ 157 (797)
+.|+. ....|.++.||||||++. .+.+||++++... ....++|+++|||||+|.++.++|||-.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence 44554 345788999999999998 4889999998643 34689999999999999988999998211
Q ss_pred CCceEEecCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccC
Q 003759 158 PRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQ 206 (797)
Q Consensus 158 ~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~ 206 (797)
-..|.|.+.++.+|++++|. .+.|.++
T Consensus 86 -------------~~~~~~~~~L~~dGnlvly~---------~~~W~s~ 112 (113)
T 3mez_B 86 -------------GQEGDYVLILQINGQAVVYG---------PAVWSTA 112 (113)
T ss_dssp -------------CSSSCCEEEECTTSCEEEEC---------SEEEESC
T ss_pred -------------CCCCCEEEEEcCCceEEEec---------CCEecCC
Confidence 02356999999999999984 2578765
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.30 E-value=7.8e-12 Score=110.92 Aligned_cols=87 Identities=22% Similarity=0.394 Sum_probs=69.2
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCC-ceeeeccCCCCCCCCCcccCCCceEEe
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSF-PLWESFDHPTDTLLPTQILNPRNKLSA 164 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~-~lWqSFD~PTDTlLpg~~l~~~~~L~S 164 (797)
...|.++.||||||++.++ +|++++.... ...++|+++|||||++.++. ++|||.-+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 4568899999999999776 9999986543 36899999999999998776 59999521
Q ss_pred cCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCC
Q 003759 165 HYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207 (797)
Q Consensus 165 ~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 207 (797)
.....|.|.+.+|.||++++|. .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1124578999999999999985 36888754
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=107.77 Aligned_cols=86 Identities=31% Similarity=0.553 Sum_probs=69.0
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.+..||||+|++. +++||++++.... ...++|+++|||||+|.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 46788899999999986 7899999976533 46899999999999998889999984211
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 207 (797)
..+.|.+.++.+|++++|. .+.|.+++
T Consensus 80 ------~~~~~~~~L~ddGNlvly~---------~~~W~s~t 106 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIYG---------TARWATGT 106 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEEE---------SCCCCCCC
T ss_pred ------CCCCEEEEEeCCCEEEEEC---------CCEEeCCC
Confidence 2357899999999999985 15677654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-11 Score=126.45 Aligned_cols=112 Identities=19% Similarity=0.362 Sum_probs=83.3
Q ss_pred ccccccCCCCc----eeecCCCceeeeCCCeEEEeEEec---CCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEe
Q 003759 21 ATAQNVSRGES----LMAEDDMSSWKSTSGEFAFGFQHI---ENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLT 93 (797)
Q Consensus 21 ~~~~~i~~g~~----l~~~~~~~~~~S~~g~f~lgf~~~---~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~ 93 (797)
.++||+.||+. |..+. .|+|+ ..++.|+|.. ..++.+| |.+ ..+++|.+++..+- ...+.+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~---~L~S~-~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~--~~~l~l~ 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGS---ELVQG-VVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKG--AVRAVFQ 202 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSE---EECTT-CEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTT--CCEEEEC
T ss_pred ccccccccccccccccccCc---ccccC-CCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCc--cEEEEEc
Confidence 56799999998 65443 35543 3444444332 2334444 332 25899999998873 2678889
Q ss_pred eCceEEEEcCCCceEeccCCCCCceeEEEEecCCCeEEecCCCCceeeeccC
Q 003759 94 VDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDH 145 (797)
Q Consensus 94 ~~g~l~l~~~~~~~vW~t~~~~~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~ 145 (797)
.+|+|+++|.++..+|++++......+|+|+++|||||++. .++||||||
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999988899999987655567899999999999986 689999998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.3e-11 Score=105.91 Aligned_cols=84 Identities=25% Similarity=0.439 Sum_probs=67.1
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.++.||||+|++. +++|++++.... ...++|+|+|||||+|.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46788889999999986 689999976433 35899999999999999889999983210
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQ 206 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~ 206 (797)
..|.|.+.++.+|++++|. .+.|.++
T Consensus 84 ------~~~~~~~~L~~dGNlvly~---------~~~W~t~ 109 (110)
T 3r0e_B 84 ------KQGEYVLILQDDGFGVIYG---------PAIFETS 109 (110)
T ss_dssp ------SSSCCEEEECTTSCEEEEC---------SEEEESC
T ss_pred ------CCCCEEEEEcCCccEEEec---------CCEecCC
Confidence 2356999999999999985 2578764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.08 E-value=3.7e-10 Score=98.90 Aligned_cols=77 Identities=30% Similarity=0.516 Sum_probs=63.1
Q ss_pred ceeeEeeCceEEEEcCCCceEeccCCCCC--ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 88 SKVQLTVDGRLVLTDLTGKEVWNPDTAGA--AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 88 ~~~~~~~~g~l~l~~~~~~~vW~t~~~~~--~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
-.+.+..||||||++ .+++||++++... ....+.|+++|||||+|.++.++|+|-
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~---------------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH---------------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC----------------------
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec----------------------
Confidence 467888999999998 5689999987633 346799999999999999999999871
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEe
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYT 190 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~ 190 (797)
+....|.|.+.++.+|++++|.
T Consensus 78 ---t~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 78 ---STRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE
T ss_pred ---CCCCCCCEEEEEeCCCeEEEEC
Confidence 1124567999999999999983
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-10 Score=100.59 Aligned_cols=84 Identities=24% Similarity=0.423 Sum_probs=66.4
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
...|.+..||||||+++ +|+|++...+ ...++|+++|||||+|.++.++|+|- |
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t---------------- 76 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A---------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C----------------
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C----------------
Confidence 45688889999999984 7999987543 46899999999999999889999761 1
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCC
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPV 208 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~ 208 (797)
....+.|.+.++++|++++|. .+.|.++++
T Consensus 77 ----~~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~ 106 (109)
T 3r0e_A 77 ----QSVKGNYAAVVHPDGRLVVFG---------PSVFKIDPW 106 (109)
T ss_dssp ----CCSSSCCEEEEETTTEEEEEC---------SEEEEECTT
T ss_pred ----cCCCcCEEEEEcCCCeEEEEe---------cCEECCCCc
Confidence 012467899999999999984 367887665
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.05 E-value=4.6e-10 Score=114.20 Aligned_cols=77 Identities=30% Similarity=0.451 Sum_probs=63.7
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEecC
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHY 166 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~~ 166 (797)
...+.+..||+|+|++. +++||.+|+.......++|+++|||||+|.++.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~-------------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG-------------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence 34566677899999985 789999997655566799999999999999999999998651
Q ss_pred CCCCCCCCceEEEEcCCCceEEE
Q 003759 167 SDKNYSTGRYELAMQSDGNLVLY 189 (797)
Q Consensus 167 s~~dps~G~y~l~~~~~g~~~~~ 189 (797)
++|.|.+.++.+|+++++
T Consensus 86 -----~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 86 -----SIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp -----CSSCCEEEECSSSCEEEE
T ss_pred -----cCCcEEEEEeCCCCEEEe
Confidence 346788999999999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=2.8e-10 Score=117.99 Aligned_cols=137 Identities=17% Similarity=0.044 Sum_probs=107.5
Q ss_pred hhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeecccCC
Q 003759 511 KDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEFISNG 589 (797)
Q Consensus 511 ~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~g 589 (797)
...++.|+.+.||+.... +..+++|+...........+..|+.+++.+ .+..+.++++++...+..++||||+++.
T Consensus 19 ~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EECCSCCSSSEEEEEECS---SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EeeccCCCCCeEEEEECC---CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 456777888999998643 245999998753323345689999999988 4677888999998888999999999999
Q ss_pred chhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 003759 590 CLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC--------------------------------------------- 624 (797)
Q Consensus 590 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------------- 624 (797)
+|.+.+. +......++.+++++|+.||+..
T Consensus 96 ~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 96 LCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp EHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 9987642 22345578899999999999810
Q ss_pred -----------CCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 625 -----------TTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 625 -----------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999886667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.86 E-value=4.2e-09 Score=108.56 Aligned_cols=130 Identities=15% Similarity=0.056 Sum_probs=96.2
Q ss_pred hC-cccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhcccccccCceeeeeecccCCc
Q 003759 514 LG-RGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG-~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
++ .|..+.||+.... ++..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||+++.+
T Consensus 27 ~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cccCCCCceEEEEecC--CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 44 5556999998653 2334899987643 2356788999999985544 4558888887788999999999998
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC---------------------------------------------- 624 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------------- 624 (797)
|. ... .....++.++++.|..||+..
T Consensus 102 l~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 102 LL--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TT--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 84 211 123467788888888888742
Q ss_pred ---------CCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 625 ---------TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 625 ---------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.6e-08 Score=109.93 Aligned_cols=140 Identities=16% Similarity=0.230 Sum_probs=103.8
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEec--ccC-CCchHHHHHHHHHhhccC--cCchhhhccccccc---Cceeeee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLD--NMV-SGGDKEFRTEVNAIGQTN--HRNLVKLLGFCNED---QHRLLVY 583 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~--~~~-~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~ 583 (797)
+.|+.|.++.||+.... + ..+++|+.. ... ......+..|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 44 ~~l~~G~sn~~y~v~~~--~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--G-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS--S-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC--C-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35889999999997764 2 347888775 322 123457888999999986 45678888888776 4589999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC--------------------------------------- 624 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------- 624 (797)
||+++..+.+... ..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999988854221 23567788899999999999999731
Q ss_pred ----------------CCCeeecCCCCCCEEEcCCCc--EEEEeecCccc
Q 003759 625 ----------------TTQIIHCDIKPQNILLDDSFT--ARISDFGLAKI 656 (797)
Q Consensus 625 ----------------~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~ 656 (797)
...++|+|+++.||++++++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=2.1e-08 Score=106.24 Aligned_cols=185 Identities=20% Similarity=0.145 Sum_probs=118.4
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCc--hhhhcccccccC---ceeeeeecc
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRN--LVKLLGFCNEDQ---HRLLVYEFI 586 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lV~Ey~ 586 (797)
.++.|....||+.. . .+++|+.... .....+..|+.+++.+ .+.. +.+++......+ ..++|||++
T Consensus 27 ~~~~G~~n~v~~v~----~--~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----R--DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEEECSSEEEEEST----T--SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred ecCCCCcceEEEEC----C--EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 47889999999753 2 2788886532 2345788999999887 3332 334444443333 458899999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE------------------------------------------- 623 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------------------- 623 (797)
++.+|.+... ..++..++..++.++++.|+.||..
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9998875432 2356677788888888888888851
Q ss_pred ------------CCCCeeecCCCCCCEEEcC--CCcEEEEeecCccccccCCCc--cccc-----------ccccCcccc
Q 003759 624 ------------CTTQIIHCDIKPQNILLDD--SFTARISDFGLAKILKADQTR--TTTA-----------IRGTRGYVA 676 (797)
Q Consensus 624 ------------~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~--~~~~-----------~~gt~~y~a 676 (797)
....++|+|++|.||++++ ...+.|+||+.+..-...... .... .....+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 0135899999999999998 566789999988653211100 0000 000001111
Q ss_pred -ccccccCCCCccCceehHHHHHHHHHhCCcCCC
Q 003759 677 -PEWFKSLPITMKVDIYSFGVMLLELICCRKKFE 709 (797)
Q Consensus 677 -PE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~ 709 (797)
|+.... .....+.|+++.+++++.+|..++.
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 222111 1222588999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2e-05 Score=81.40 Aligned_cols=135 Identities=16% Similarity=0.048 Sum_probs=93.3
Q ss_pred hCcccce-eEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccCCch
Q 003759 514 LGRGAFA-TVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISNGCL 591 (797)
Q Consensus 514 LG~G~fG-~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~gsL 591 (797)
+..|..| .||+.....++ ..+++|+-.. ....++..|...|+.+. +--+.++++++.+++..++|||++++.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~-~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNA-PELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTC-CCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCC-eEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 3445444 68986655433 3488888653 23456888999988873 34467788888888999999999999887
Q ss_pred hhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 003759 592 AGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC----------------------------------------------- 624 (797)
Q Consensus 592 ~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------------- 624 (797)
.+.... .......+..++++.|+-||...
T Consensus 108 ~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 108 FQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 765422 12233445555666666666320
Q ss_pred --------CCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 625 --------TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 625 --------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
...++|+|+++.||++++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=4.3e-05 Score=82.42 Aligned_cols=81 Identities=2% Similarity=-0.054 Sum_probs=54.7
Q ss_pred hh-CcccceeEEEEEEe--cC---CcEEEEEEEecccC---CCchHHHHHHHHHhhccC-c--Cchhhhccccccc---C
Q 003759 513 EL-GRGAFATVHKGVLA--YE---NKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTN-H--RNLVKLLGFCNED---Q 577 (797)
Q Consensus 513 ~L-G~G~fG~Vykg~~~--~~---~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-h--~niv~l~g~~~~~---~ 577 (797)
.| +.|....+|+.... .. ++..+++|+..... ......+..|+.+++.+. + ..+.+++.++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 46 78888999987654 00 13457888765432 112356788999988884 3 3566778777655 3
Q ss_pred ceeeeeecccCCchhh
Q 003759 578 HRLLVYEFISNGCLAG 593 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~ 593 (797)
..++||||+++..+.+
T Consensus 107 ~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 107 TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SCEEEEECCCCBCCCB
T ss_pred CceEEEEecCCCChhh
Confidence 5789999999887764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=4.4e-05 Score=80.58 Aligned_cols=134 Identities=19% Similarity=0.163 Sum_probs=89.7
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcC---chhhhccccc-ccCceeeeeecccC
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHR---NLVKLLGFCN-EDQHRLLVYEFISN 588 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~Ey~~~ 588 (797)
.++.|....||+. +. .+++|+-.. ......+..|+.+|..+.+. .+.+++.++. ..+..++||||+++
T Consensus 26 ~l~~G~~n~v~~v----g~--~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NG--DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE----TT--TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE----CC--EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 4677888899976 22 277887432 12345788999999998642 3455666653 45668899999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE--------------------------------------------- 623 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------------- 623 (797)
.+|.+.... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 888763211 223444555555555555555532
Q ss_pred ------------CCCCeeecCCCCCCEEEcC---CCc-EEEEeecCccc
Q 003759 624 ------------CTTQIIHCDIKPQNILLDD---SFT-ARISDFGLAKI 656 (797)
Q Consensus 624 ------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~Dfgla~~ 656 (797)
....++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00015 Score=79.34 Aligned_cols=75 Identities=17% Similarity=0.128 Sum_probs=47.3
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCC-------CchHHHHHHHHHhhccCc--Cchh-hhcccccccCceee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-------GGDKEFRTEVNAIGQTNH--RNLV-KLLGFCNEDQHRLL 581 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~h--~niv-~l~g~~~~~~~~~l 581 (797)
+.||.|..+.||++....+ +..++||....... .....+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~-~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEH-DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEECCC-CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4689999999999976533 34589998653221 123456778888887732 3333 44543 3445689
Q ss_pred eeecccCC
Q 003759 582 VYEFISNG 589 (797)
Q Consensus 582 V~Ey~~~g 589 (797)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=70.51 Aligned_cols=136 Identities=16% Similarity=0.148 Sum_probs=77.8
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc--Cchhhhccc------ccccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH--RNLVKLLGF------CNEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~------~~~~~~~~lV~E 584 (797)
.|+.|..+.||+.... ++ .+++|+... ...++..|..++..+.. -.+.+++.. ....+..+++||
T Consensus 39 ~l~gG~~n~~~~v~~~--~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--TE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--CC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3555678899987653 33 388998875 23444556666665532 123333331 123566789999
Q ss_pred cccCCchh-----------hh---ccc---C---C--------CCChhhHH-----------------------------
Q 003759 585 FISNGCLA-----------GF---LFK---N---P--------KPSWYRRM----------------------------- 607 (797)
Q Consensus 585 y~~~gsL~-----------~~---l~~---~---~--------~l~~~~~~----------------------------- 607 (797)
|+++..+. .. ++. . . ...|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987553 00 110 0 0 01222110
Q ss_pred --HHHHHHHHHHHHHhh----------cCCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 608 --QIAFGIARGLFYLHE----------ECTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 608 --~i~~~ia~gL~~LH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
.+...+.+++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123445666663 124589999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00095 Score=70.25 Aligned_cols=74 Identities=20% Similarity=0.187 Sum_probs=56.8
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC---cCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN---HRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.|+.|....+|+... + +..+++|+.... ....|..|+..|+.+. ...+.+++.++...+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~--~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--E-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES--S-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE--C-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3588899999998764 2 335888887542 3557888999998883 35677888888777889999999998
Q ss_pred Cch
Q 003759 589 GCL 591 (797)
Q Consensus 589 gsL 591 (797)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0017 Score=71.58 Aligned_cols=79 Identities=10% Similarity=-0.017 Sum_probs=46.7
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccccccccCccccccccccC---CCCccCceehHHHHHHHH
Q 003759 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLEL 701 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~el 701 (797)
...++|+|+++.||++++++ ++|+||+.+..-............-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999998876 99999998875321111000000011345666554311 112234455777777777
Q ss_pred HhC
Q 003759 702 ICC 704 (797)
Q Consensus 702 ltG 704 (797)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 665
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0024 Score=66.34 Aligned_cols=74 Identities=20% Similarity=0.187 Sum_probs=51.1
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcC---chhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHR---NLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
+.+|.|..+.||+.++.++ +.|++|+...........|..|+..|+.+.-. -+.+++++ +..++||||++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG--~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADG--TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEETTS--CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEECCC--CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 3589999999999988643 46999987654444445688899998887421 23344443 234789999987
Q ss_pred Cch
Q 003759 589 GCL 591 (797)
Q Consensus 589 gsL 591 (797)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0083 Score=63.19 Aligned_cols=138 Identities=11% Similarity=0.073 Sum_probs=77.4
Q ss_pred hhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhcccc------cccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGFC------NEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~E 584 (797)
.|+.|....+|+..... + .+++|..... ....++..|+.++..+.... +.+++... ...+..++++|
T Consensus 29 ~i~~G~~n~~~~v~~~~--g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTK--D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEESS--C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeCC--c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 36677778899876542 2 3788887652 12345667887777764222 23333221 12345789999
Q ss_pred cccCCchhhh--------------ccc---C---CC---C---ChhhHHH------------HHHHHHHHHHHHhhc---
Q 003759 585 FISNGCLAGF--------------LFK---N---PK---P---SWYRRMQ------------IAFGIARGLFYLHEE--- 623 (797)
Q Consensus 585 y~~~gsL~~~--------------l~~---~---~~---l---~~~~~~~------------i~~~ia~gL~~LH~~--- 623 (797)
|+++..+... ++. . .. . .|..... +...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9998754310 110 0 10 0 1221110 011244455566532
Q ss_pred -CCCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 624 -CTTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 624 -~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13479999999999999987666899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0088 Score=65.94 Aligned_cols=74 Identities=18% Similarity=0.117 Sum_probs=48.4
Q ss_pred hhCcccceeEEEEEEecC------CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeec
Q 003759 513 ELGRGAFATVHKGVLAYE------NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey 585 (797)
.|+.|-...||+...... .+..+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 477788899999876531 1235888887431 122566789999888854444 556666543 289999
Q ss_pred ccCCchh
Q 003759 586 ISNGCLA 592 (797)
Q Consensus 586 ~~~gsL~ 592 (797)
+++.+|.
T Consensus 154 l~G~~l~ 160 (429)
T 1nw1_A 154 IPSRPLS 160 (429)
T ss_dssp CCEEECC
T ss_pred eCCcccC
Confidence 9875553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.012 Score=63.53 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=79.6
Q ss_pred hhCcccceeEEEEEEec------CCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeec
Q 003759 513 ELGRGAFATVHKGVLAY------ENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~------~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.|..|-...+|+..... .+...+++|+.... ......+.+|..+++.+. +.-..++++++.++ +||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 35567778889877642 12245888885432 233456778999998884 32235567666543 89999
Q ss_pred ccCCchhhh-c----------------ccC-----CCCC--hhhHHHHHHHHH-------------------HHHHHHhh
Q 003759 586 ISNGCLAGF-L----------------FKN-----PKPS--WYRRMQIAFGIA-------------------RGLFYLHE 622 (797)
Q Consensus 586 ~~~gsL~~~-l----------------~~~-----~~l~--~~~~~~i~~~ia-------------------~gL~~LH~ 622 (797)
+++..|..- + +.. .... |.+..++..++. +.+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998766421 0 111 1111 233333333221 22333332
Q ss_pred ----c-CCCCeeecCCCCCCEEEcCC----CcEEEEeecCccc
Q 003759 623 ----E-CTTQIIHCDIKPQNILLDDS----FTARISDFGLAKI 656 (797)
Q Consensus 623 ----~-~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~ 656 (797)
. ....++|+|+.+.||+++++ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 23468999999999999876 7899999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0039 Score=65.19 Aligned_cols=71 Identities=11% Similarity=0.059 Sum_probs=42.6
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeecc-cCC
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEFI-SNG 589 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~-~~g 589 (797)
+.|+.|....+|+. . .+++|+....... ......|+.+++.+....+ .++++++ .+.-++++||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-----~--~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----G--DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-----T--TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-----e--eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 45778888999987 1 2788887643211 1233568877777743333 3555543 33457899999 665
Q ss_pred chh
Q 003759 590 CLA 592 (797)
Q Consensus 590 sL~ 592 (797)
+|.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.033 Score=61.75 Aligned_cols=75 Identities=12% Similarity=0.030 Sum_probs=45.5
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeecccCCc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+.|+.|-...+|+...... +..+++|+....... .-+...|..++..+...++ .++++.+.. .+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~-~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSK-QAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTT-TEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCC-CceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3577788899999876431 245778876542211 1122578888888854444 456776642 25999999866
Q ss_pred hh
Q 003759 591 LA 592 (797)
Q Consensus 591 L~ 592 (797)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.56 E-value=0.051 Score=57.17 Aligned_cols=137 Identities=13% Similarity=0.049 Sum_probs=76.6
Q ss_pred hCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCc--hhhhccc-----ccccCceeeeeecc
Q 003759 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN--LVKLLGF-----CNEDQHRLLVYEFI 586 (797)
Q Consensus 514 LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~Ey~ 586 (797)
|+ |....||+....+ +..+++|...... ....++..|..++..+.... +.+++.. ...++..+++||++
T Consensus 34 l~-g~~n~~y~v~~~~--g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQDED--RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECCTT--CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEcCC--CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 55 7778899865432 3348899876321 23456777888888774222 3444443 11234567899999
Q ss_pred cCCchhh-----------h---ccc----C-----CCCChhhH----HH---------------HHHHHHHHHHHHhhc-
Q 003759 587 SNGCLAG-----------F---LFK----N-----PKPSWYRR----MQ---------------IAFGIARGLFYLHEE- 623 (797)
Q Consensus 587 ~~gsL~~-----------~---l~~----~-----~~l~~~~~----~~---------------i~~~ia~gL~~LH~~- 623 (797)
++..+.. . ++. . ...++... .. +...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 0 010 0 01111110 00 011112223333321
Q ss_pred ---CCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 624 ---CTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 624 ---~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.32 E-value=0.049 Score=57.54 Aligned_cols=32 Identities=28% Similarity=0.350 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCCEEEcCC----CcEEEEeecCccc
Q 003759 625 TTQIIHCDIKPQNILLDDS----FTARISDFGLAKI 656 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~ 656 (797)
...++|+|+++.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.034 Score=59.77 Aligned_cols=74 Identities=15% Similarity=0.069 Sum_probs=41.6
Q ss_pred hhCcccceeEEEEEEecC-------CcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeee
Q 003759 513 ELGRGAFATVHKGVLAYE-------NKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 584 (797)
.|+.|....+|+.....+ .+..+++|+...... ...+...|..++..+...++ .++++... -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 467777789998876531 013577887654211 11124678888887743343 35554432 368999
Q ss_pred cccCCch
Q 003759 585 FISNGCL 591 (797)
Q Consensus 585 y~~~gsL 591 (797)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.39 E-value=0.25 Score=48.11 Aligned_cols=103 Identities=13% Similarity=-0.016 Sum_probs=66.6
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
.-+|.++|.. ..++++.+.+.++.|.+.+|.-+-.... . ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3478888864 5789999999999999999877632111 1 1333457899999999988764 1110
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcC
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK 707 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p 707 (797)
.....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888763 3557888999999999998764443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.22 E-value=0.3 Score=51.69 Aligned_cols=31 Identities=23% Similarity=0.353 Sum_probs=27.5
Q ss_pred CCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 626 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987653
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=93.18 E-value=4.2 Score=41.13 Aligned_cols=72 Identities=17% Similarity=0.336 Sum_probs=44.2
Q ss_pred eEEEEEeccCCCCeEEEEeCCCCC--C-----ccCceeeEeeCceEEEEcCCCceEeccCCCC-CceeEEEEecCCCeEE
Q 003759 60 YLLTIYFNKIPERTIIWSANGKTP--V-----ERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVL 131 (797)
Q Consensus 60 ~~~~iw~~~~~~~t~vW~Anr~~p--~-----~~~~~~~~~~~g~l~l~~~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl 131 (797)
-.+.|| +.....++|...+..+ + .....+.++.++.+..+|++|+.+|.-.... .....++.+.+||+++
T Consensus 15 ~~v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv 92 (276)
T 3no2_A 15 NKIAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALV 92 (276)
T ss_dssp SEEEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEE
T ss_pred CEEEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEE
Confidence 345566 2335678888876541 1 1122344444556777788899999876532 3345677788888877
Q ss_pred ec
Q 003759 132 AG 133 (797)
Q Consensus 132 ~~ 133 (797)
.+
T Consensus 93 ~~ 94 (276)
T 3no2_A 93 AW 94 (276)
T ss_dssp EE
T ss_pred Ee
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.01 E-value=0.33 Score=53.04 Aligned_cols=74 Identities=14% Similarity=0.121 Sum_probs=44.2
Q ss_pred hhCcccceeEEEEEEecCC------cEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeec
Q 003759 513 ELGRGAFATVHKGVLAYEN------KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey 585 (797)
.|..|-...+|+....... ...+++++..... ...-+..+|..+++.+.-.++ .++++.+. -++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4666777889988765211 2347888764422 112234578888887743233 44554332 3789999
Q ss_pred ccCCch
Q 003759 586 ISNGCL 591 (797)
Q Consensus 586 ~~~gsL 591 (797)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998765
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=84.64 E-value=3.5 Score=41.77 Aligned_cols=63 Identities=16% Similarity=0.164 Sum_probs=35.3
Q ss_pred CCeEEEEeCCCC-CCc-----cCceeeEeeC-ceEEEEcCC-CceEeccCCCC------CceeEEEEecCCCeEEec
Q 003759 71 ERTIIWSANGKT-PVE-----RGSKVQLTVD-GRLVLTDLT-GKEVWNPDTAG------AAIAYASMLDSGNFVLAG 133 (797)
Q Consensus 71 ~~t~vW~Anr~~-p~~-----~~~~~~~~~~-g~l~l~~~~-~~~vW~t~~~~------~~~~~a~l~d~GNlvl~~ 133 (797)
+..++|...+.. |.. +...+....+ +.++..|++ |+.+|.-.... .-...++++.+||+++.+
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 367788877643 321 1112222222 356677776 88888754221 113567778888888765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 797 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-11 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-16 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-07 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-16 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 7e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-11 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-11 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 1e-65
Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 23/275 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+G G+F TV+KG + V + + + F+ EV + +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
+G+ +V ++ L L + + IA A+G+ YLH + I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKIL-KADQTRTTTAIRGTRGYVAPEWFKSL---P 684
IH D+K NI L + T +I DFGLA + + + + G+ ++APE + P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744
+ + D+Y+FG++L EL+ + + N+ ++ Y+ L + N +A+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+M C+++ RP ++ +E
Sbjct: 243 KRLMA---------ECLKKKRDERPLFPQILASIE 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 1e-63
Identities = 72/307 (23%), Positives = 142/307 (46%), Gaps = 38/307 (12%)
Query: 498 FSYKELEKATQGFKDE-----------LGRGAFATVHKGVLAYENK--ICVAVKKLDNMV 544
F++++ +A + F E +G G F V G L K I VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 545 SGGD-KEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-S 602
+ ++F +E + +GQ +H N++ L G + +++ EF+ NG L FL +N +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 603 WYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662
+ + + GIA G+ YL + +H D+ +NIL++ + ++SDFGL++ L+ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 663 RTTT----AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQM 718
T + + APE + T D++S+G+++ E++ ++ ++ N++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
++ Y ALH +M C Q+D + RP ++ L
Sbjct: 244 NAIEQDYRLPPPMDC-------PSALHQLML---------DCWQKDRNHRPKFGQIVNTL 287
Query: 779 EGVVEVP 785
+ ++ P
Sbjct: 288 DKMIRNP 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-62
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 25/272 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ LG G F V G K VAVK L S F E N + Q H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK--VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTTQ 627
++ ++ E++ NG L FL + + + +A IA G+ ++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH D++ NIL+ D+ + +I+DFGLA++++ ++ + + APE T+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K D++SFG++L E++ + + N + ++ Y + E L+ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-------PEELYQL 242
Query: 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
MR C +E P RPT + +LE
Sbjct: 243 MR---------LCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 23/275 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
F E+G G F VH G NK VA+K + + +++F E + + +H LV+L
Sbjct: 9 FVQEIGSGQFGLVHLGYW--LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
G C E LV+EF+ +GCL+ +L + + + + G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
IH D+ +N L+ ++ ++SDFG+ + + DQ ++T + + +PE F + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 689 VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748
D++SFGV++ E+ K +N N + + + Y ++ +M
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA-------STHVYQIM 235
Query: 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
C +E P RP ++ L + E
Sbjct: 236 N---------HCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-59
Identities = 58/301 (19%), Positives = 113/301 (37%), Gaps = 35/301 (11%)
Query: 503 LEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVNAIG 559
+E F+ ELG G V K + +A K + + + E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLV-MARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 560 QTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFY 619
+ N +V G D + E + G L L K + +++ + +GL Y
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
L E+ +I+H D+KP NIL++ ++ DFG++ L + GTR Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPER 174
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMIL--------VDWAYDCYIDE 731
+ +++ DI+S G+ L+E+ R E +++ +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIW------------------CIQEDPSLRPTMKK 773
+ D + L Y++ C+ ++P+ R +K+
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 774 V 774
+
Sbjct: 295 L 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-59
Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 23/271 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
F ELG G F V G + VA+K + S + EF E + +H LV+L
Sbjct: 8 FLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
G C + + ++ E+++NGCL +L + + +++ + + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
+H D+ +N L++D ++SDFGL++ + D+ ++ + + PE + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 689 VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748
DI++FGV++ E+ K + N + Y E ++ +M
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA-------SEKVYTIM 234
Query: 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
C E RPT K + +
Sbjct: 235 Y---------SCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-58
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 25/281 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ +LG+G F V G + VA+K L + + F E + + H LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWY--RRMQIAFGIARGLFYLHEECTTQ 627
+E+ +V E++S G L FL + + +A IA G+ Y+
Sbjct: 78 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
+H D++ NIL+ ++ +++DFGLA++++ ++ + + APE T+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K D++SFG++L EL + + N + V+ Y + E+LHD+
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-------ESLHDL 246
Query: 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPP 788
M C +++P RPT + + LE P
Sbjct: 247 MC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-58
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 28/287 (9%)
Query: 501 KELEKATQGFK---DELGRGAFATVHKGVLAYENK-ICVAVKKLDNMVSGGD-KEFRTEV 555
K+L ELG G F +V +GV K I VA+K L D +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 556 NAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIA 614
+ Q ++ +V+L+G C + + +LV E G L FL + ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTAIRGTR 672
G+ YL E+ +H D+ +N+LL + A+ISDFGL+K L AD + +A +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 673 GYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK 732
+ APE + + D++S+GV + E + +K + ++ M ++ +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
L+ +M C RP V +
Sbjct: 237 CP-------PELYALMS---------DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-57
Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 513 ELGRGAFATVHKGVLAYENKIC-VAVKKLDNMVSGGD--KEFRTEVNAIGQTNHRNLVKL 569
ELG G F TV KG + + VAVK L N + E E N + Q ++ +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
+G C E + +LV E G L +L +N +++ ++ G+ YL E +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTAIRGTRGYVAPEWFKSLPITM 687
H D+ +N+LL A+ISDFGL+K L+AD+ + T + + APE +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K D++SFGV++ E +K + ++ +++ ++D+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP-------REMYDL 242
Query: 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
M C D RP V L L
Sbjct: 243 MN---------LCWTYDVENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 6e-57
Identities = 66/276 (23%), Positives = 125/276 (45%), Gaps = 23/276 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
K +LG G + V++GV + VAVK L + +EF E + + H NLV+L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLT-VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTTQ 627
LG C + ++ EF++ G L +L + + S + +A I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITM 687
IH D+ +N L+ ++ +++DFGL++++ D + + APE ++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 688 KVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747
K D+++FGV+L E+ ++ L++ Y E E ++++
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-------EKVYEL 248
Query: 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
MR C Q +PS RP+ ++ E + +
Sbjct: 249 MR---------ACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDN--MVSGGDKEFRTEVNAIGQTNHRNLV 567
F E+GRG+F TV+KG+ VA +L + + + F+ E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 568 KLLGFC----NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+ + +LV E +++G L +L + I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 624 CTTQIIHCDIKPQNILLDD-SFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
IIH D+K NI + + + +I D GLA + +A + + GT ++APE ++
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 187
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
VD+Y+FG+ +LE+ + E +N + +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFD---KVAIP 240
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ +++ CI+++ R ++K +
Sbjct: 241 EVKEIIE---------GCIRQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 4e-56
Identities = 67/288 (23%), Positives = 129/288 (44%), Gaps = 27/288 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNL 566
F + +GRG F V+ G L + KI AVK L+ + G+ +F TE + +H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 567 VKLLGFCNEDQ-HRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEEC 624
+ LLG C + L+V ++ +G L F+ + P+ + +A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTRGYVAPEWFK 681
+ + +H D+ +N +LD+ FT +++DFGLA+ + + D T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741
+ T K D++SFGV+L EL+ +V + + + + + L E
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLLQPEYCP 260
Query: 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPD 789
+ L+++M C +RP+ ++ + + I
Sbjct: 261 DPLYEVML---------KCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-56
Identities = 61/275 (22%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+G+G F V G VAVK + N + F E + + Q H NLV+L
Sbjct: 11 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 570 LGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTT 626
LG E++ L +V E+++ G L +L + ++ + + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+H D+ +N+L+ + A++SDFGL K + T + + APE + +
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
K D++SFG++L E+ + + ++ + V+ Y + A+++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP-------PAVYE 231
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781
+M+ C D ++RP+ ++ LE +
Sbjct: 232 VMK---------NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-56
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 33/299 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++ +G+G F V +G VAVK + E+ H N++
Sbjct: 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGF 62
Query: 570 LGFCNEDQ----HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
+ N+D LV ++ +G L +L + + +++A A GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 626 TQ-----IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT---TTAIRGTRGYVAP 677
I H D+K +NIL+ + T I+D GLA + GT+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 678 EWF------KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA------- 724
E K + DIY+ G++ E+ + + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
++KL + N ++ + + K I C + + R T ++ L + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAK---IMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 2e-55
Identities = 73/317 (23%), Positives = 131/317 (41%), Gaps = 51/317 (16%)
Query: 499 SYKELEKATQGFK--DELGRGAFATVHKG----VLAYENKICVAVKKLDNMVSGGD-KEF 551
LE + ++G GAF V + +L YE VAVK L S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 552 RTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN------------- 598
+ E + + ++ N+VKLLG C + L++E+++ G L FL
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 599 -----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR 647
P S ++ IA +A G+ YL E +H D+ +N L+ ++ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 648 ISDFGLAKIL-KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK 706
I+DFGL++ + AD + ++ PE T + D++++GV+L E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 707 KFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPS 766
+ + +E + V D + EN L+++MR C + P+
Sbjct: 241 QPYYGMAHEEVIYYV-------RDGNILACPENCPLELYNLMR---------LCWSKLPA 284
Query: 767 LRPTMKKVTLMLEGVVE 783
RP+ + +L+ + E
Sbjct: 285 DRPSFCSIHRILQRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 58/275 (21%), Positives = 108/275 (39%), Gaps = 29/275 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD--NMVSGGDKEFRTEVNAIGQTNHRNLV 567
+G G++ K + KI + K+LD +M + +EVN + + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKI-LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 568 KLLGFCNE--DQHRLLVYEFISNGCLAGFLFKNPKP----SWYRRMQIAFGIARGLFYLH 621
+ + + +V E+ G LA + K K +++ + L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 622 E--ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
+ ++H D+KP N+ LD ++ DFGLA+IL D + GT Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739
+ K DI+S G +L EL F + E + K +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYR 237
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ L++++ + RP+++++
Sbjct: 238 YSDELNEIIT---------RMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 32/270 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTEVNAIGQTNHRNL 566
LG+G F V+ I +A+K L +G + + R EV H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFI-LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
++L G+ ++ L+ E+ G + L K K R +A L Y H +
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
++IH DIKP+N+LL + +I+DFG + + + T + GT Y+ PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENE--NQMILVDWAYDCYIDEKLHLLVENDEEAL 744
KVD++S GV+ E + + FE N E ++ V++ + ++ E L+
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS------ 236
Query: 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
++ +PS RP +++V
Sbjct: 237 --------------RLLKHNPSQRPMLREV 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 24/278 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGDKE-FRTEVNAIGQTNHRNL 566
+G G F VH+G+ + VA+K N S +E F E + Q +H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECT 625
VKL+G E+ ++ E + G L FL + A+ ++ L YL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
+H DI +N+L+ + ++ DFGL++ ++ + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
T D++ FGV + E++ K Q V+N + + ++ + L+
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP-------PTLY 239
Query: 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
+M C DPS RP ++ L ++E
Sbjct: 240 SLMT---------KCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-55
Identities = 64/279 (22%), Positives = 128/279 (45%), Gaps = 26/279 (9%)
Query: 514 LGRGAFATVHKGVLAYEN---KICVAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+G G F V+KG+L + ++ VA+K L +F E +GQ +H N+++L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
G ++ + +++ E++ NG L FL + S + + + GIA G+ YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 131
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQ--TRTTTAIRGTRGYVAPEWFKSLPIT 686
+H D+ +NIL++ + ++SDFGL+++L+ D T TT+ + + APE T
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
D++SFG+++ E++ ++ + N M ++ +
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC------------- 238
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
+ + C Q++ + RP + +L+ ++ P
Sbjct: 239 ---PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-54
Identities = 69/268 (25%), Positives = 110/268 (41%), Gaps = 22/268 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVNAIGQTNHRNLVK 568
LG GA+ V V + VAVK +D + + E+ NH N+VK
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
G E + L E+ S G L + + + + G+ YLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKAD-QTRTTTAIRGTRGYVAPEWFKSLPI-T 686
H DIKP+N+LLD+ +ISDFGLA + + + + R + GT YVAPE K
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
VD++S G++L ++ ++Q +++ DW + D L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKKI---DSAPLAL 239
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ + + E+PS R T+ +
Sbjct: 240 LHK----------ILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 58/272 (21%), Positives = 107/272 (39%), Gaps = 28/272 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
ELG GAF V+K + + A K +D +++ E++ + +H N+VKL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVL-AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
L + + ++ EF + G + + + +P + + + L YLH+ +I
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF-----KSL 683
IH D+K NIL +++DFG++ R + GT ++APE K
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190
Query: 684 PITMKVDIYSFGVMLLELICCRKKF-EQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
P K D++S G+ L+E+ E N I +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS-------S 243
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
D ++ C++++ R T ++
Sbjct: 244 NFKDFLK---------KCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 1e-53
Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 36/287 (12%)
Query: 496 QIFSYKELEKATQGFKD--ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KE 550
++F + EK F D E+G G+F V+ +++ VA+KK+ + ++
Sbjct: 6 ELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQD 61
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
EV + + H N ++ G + LV E+ +
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRG 670
G +GL YLH +IH D+K NILL + ++ DFG A I+ + G
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVG 173
Query: 671 TRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC 727
T ++APE ++ KVD++S G+ +EL + N N M
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL----FNMNAM--------- 220
Query: 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
L+ + +N+ AL + + C+Q+ P RPT + +
Sbjct: 221 ---SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 45/300 (15%)
Query: 510 FKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSGGDKE-FRTEVNAIGQ-TNH 563
F LG GAF V + + + VAVK L ++E +E+ + NH
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP------------------SWYR 605
N+V LLG C L++ E+ G L FL +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT- 664
+ ++ +A+G+ +L + IH D+ +NILL +I DFGLA+ +K D
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724
R ++APE + T + D++S+G+ L EL + +++ +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM--- 260
Query: 725 YDCYIDEKLHLLV-ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
I E +L E+ ++D+M+ C DP RPT K++ ++E +
Sbjct: 261 ----IKEGFRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-53
Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 50/301 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYENK----ICVAVKKLDNMVSGGDKE-FRTEVNAIGQ-TNH 563
F LG GAF V +K I VAVK L ++E +E+ + Q +H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP---------------------- 601
N+V LLG C L++E+ G L +L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 602 -SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660
++ + A+ +A+G+ +L + +H D+ +N+L+ +I DFGLA+ + +D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 661 QTRTT-TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK-FEQNVENENQM 718
R ++APE T+K D++S+G++L E+ + + N
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 719 ILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLML 778
L+ + E ++ +M+ C D RP+ +T L
Sbjct: 278 KLIQNGFKMDQPFYAT-------EEIYIIMQ---------SCWAFDSRKRPSFPNLTSFL 321
Query: 779 E 779
Sbjct: 322 G 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-53
Identities = 57/264 (21%), Positives = 112/264 (42%), Gaps = 23/264 (8%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+++G+GA TV+ + + VA+++++ + E+ + + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE-VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHC 631
+V E+++ G L + + + + + L +LH Q+IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDI 691
DIK NILL + +++DFG + +Q++ +T + GT ++APE KVDI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 692 YSFGVMLLELICCRKKF-EQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRL 750
+S G+M +E+I + +N +I + + EKL D +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS-------AIFRDFLN- 251
Query: 751 KKYVMIAIWCIQEDPSLRPTMKKV 774
C+ D R + K++
Sbjct: 252 --------RCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 29/296 (9%)
Query: 495 LQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVSG-GDKE 550
L+I E +K LG GAF TV+KG+ E + I VA+K+L S +KE
Sbjct: 3 LRILKETEFKK-----IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 57
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
E + ++ ++ +LLG C +L+ L +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR-TTTAIR 669
IA+G+ YL + +++H D+ +N+L+ +I+DFGLAK+L A++ +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 670 GTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYI 729
++A E T + D++S+GV + EL+ K YD
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIP 218
Query: 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785
++ ++E E + MI + C D RP +++ + + P
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-52
Identities = 69/310 (22%), Positives = 135/310 (43%), Gaps = 45/310 (14%)
Query: 493 TNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYEN-KICVAVKKLDNMVSGGD-KE 550
T + + +++ F+D +G G F V K + + ++ A+K++ S D ++
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 551 FRTEVNAIGQ-TNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-------- 601
F E+ + + +H N++ LLG C + L E+ +G L FL K+
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 602 --------SWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGL 653
S + + A +ARG+ YL ++ Q IH D+ +NIL+ +++ A+I+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173
Query: 654 AKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713
++ + +T R ++A E T D++S+GV+L E++ +
Sbjct: 174 SRGQEVYVKKTMG--RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 714 NENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKK 773
+ Y ++ ++D+MR C +E P RP+ +
Sbjct: 232 CAELYEKLPQGYRLEKPLNC-------DDEVYDLMR---------QCWREKPYERPSFAQ 275
Query: 774 VTLMLEGVVE 783
+ + L ++E
Sbjct: 276 ILVSLNRMLE 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 75/302 (24%), Positives = 141/302 (46%), Gaps = 36/302 (11%)
Query: 510 FKDELGRGAFATVHKGVL----AYENKICVAVKKLDNMVSGGDK-EFRTEVNAIGQTNHR 564
ELG+G+F V++GV E + VA+K ++ S ++ EF E + + + N
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIA 614
++V+LLG ++ Q L++ E ++ G L +L PS + +Q+A IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 615 RGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL-KADQTRTTTAIRGTRG 673
G+ YL+ + +H D+ +N ++ + FT +I DFG+ + + + D R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
+++PE K T D++SFGV+L E+ ++ Q + NE ++ L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGL 253
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSF 793
+N + L ++MR C Q +P +RP+ ++ ++ +E P + S +
Sbjct: 254 LDKPDNCPDMLFELMR---------MCWQYNPKMRPSFLEIISSIKEEME-PGFREVSFY 303
Query: 794 IS 795
S
Sbjct: 304 YS 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 27/278 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVSGGD---KEFRTEVNAIGQTNHR 564
++LG G+F V +G + + VAVK L V +F EVNA+ +HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 565 NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEE 623
NL++L G + +V E G L L K+ + A +A G+ YL +
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILK--ADQTRTTTAIRGTRGYVAPEWFK 681
IH D+ +N+LL +I DFGL + L D + + APE K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 682 SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741
+ + D + FGV L E+ ++ + + +D E+L + +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----GERLPRPEDCPQ 242
Query: 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ + + + C P RPT + L
Sbjct: 243 DIYN----------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 2e-48
Identities = 70/293 (23%), Positives = 112/293 (38%), Gaps = 28/293 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ELG GAF VH+ A K + + R E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNN-FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
+D +++YEF+S G L + S ++ + +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 629 IHCDIKPQNILL--DDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+H D+KP+NI+ S ++ DFGL L Q+ T GT + APE + P+
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENE--NQMILVDWAYDCYIDEKLHLLVENDEEAL 744
D++S GV+ L+ F ++E + DW D + E
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS-------EDG 256
Query: 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSFISSI 797
D +R + DP+ R T+ + L + P S SS
Sbjct: 257 KDFIR---------KLLLADPNTRMTIHQA-LEHPWLTPGNAPGRDSQIPSSR 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 26/269 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFRTEVNAIGQTNHRNL 566
F LG G+F+TV ++ A+K L+ + E + + + +H
Sbjct: 12 FGKILGEGSFSTVVLARELATSRE-YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
VKL +D+ + NG L ++ K I L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT-TTAIRGTRGYVAPEWFKSLPI 685
IIH D+KP+NILL++ +I+DFG AK+L + + + GT YV+PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
D+++ G ++ +L+ F E ++ YD EK
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--FPEKFF-------PKAR 238
Query: 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
D++ + D + R +++
Sbjct: 239 DLVE---------KLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 44/300 (14%)
Query: 510 FKDELGRGAFATVHKGVLAYENK------ICVAVKKLD-NMVSGGDKEFRTEVNAIGQ-T 561
LG GAF V +K VAVK L + + +E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP----------------SWYR 605
H+N++ LLG C +D ++ E+ S G L +L P S
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665
+ A+ +ARG+ YL + + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 666 T-AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724
T R ++APE T + D++SFGV+L E+ V E L+
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784
+ L+ MMR C PS RPT K++ L+ +V +
Sbjct: 254 HRMDKPSNC-------TNELYMMMR---------DCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 3e-46
Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 23/268 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+ELG GAF VH+ V ++ K ++ + E++ + Q +H L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRV-FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
+ +L+ EF+S G L + S + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 629 IHCDIKPQNILLD--DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+H DIKP+NI+ + + + +I DFGLA L D+ T T + APE P+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVG 206
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
D+++ GV+ L+ F + E + ++ D + D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV-----SPEAKD 261
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
++ +Q++P R T+
Sbjct: 262 FIK---------NLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-46
Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 500 YKELEKATQGFK--DELGRGAFATVHKGVLAYENKICVAVKKLD-NMVSGGDKEFRTEVN 556
+K+ E + D LG GAF+ V K+ VA+K + + G + E+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL-VAIKCIAKKALEGKEGSMENEIA 59
Query: 557 AIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARG 616
+ + H N+V L H L+ + +S G L + + + ++ F +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 617 LFYLHEECTTQIIHCDIKPQNILL---DDSFTARISDFGLAKILKADQTRTTTAIRGTRG 673
+ YLH+ I+H D+KP+N+L D+ ISDFGL+K+ +T GT G
Sbjct: 120 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPG 174
Query: 674 YVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE--NQMILVDWAYDCYIDE 731
YVAPE P + VD +S GV+ L+C F + + Q++ ++ +D +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ ++ D +R +++DP R T ++
Sbjct: 235 DIS-------DSAKDFIR---------HLMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 42/298 (14%)
Query: 510 FKDELGRGAFATVHKGVLAYENKIC----VAVKKLD-NMVSGGDKEFRTEVNAIGQTNHR 564
LGRGAF V + +K VAVK L + +E+ + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 565 -NLVKLLGFCNEDQHRL-LVYEFISNGCLAGFLFKNPKP----------------SWYRR 606
N+V LLG C + L ++ EF G L+ +L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 607 MQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT-T 665
+ +F +A+G+ +L + IH D+ +NILL + +I DFGLA+ + D
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 666 TAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY 725
R ++APE T++ D++SFGV+L E+ V+ + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFC 247
Query: 726 DCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783
+ + ++ M C +PS RPT ++ L +++
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTML---------DCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-44
Identities = 53/268 (19%), Positives = 100/268 (37%), Gaps = 24/268 (8%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++LGRG F VH+ V K K + + + E++ + HRN++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKT-YMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
+ ++++EFIS + + + + + + L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 629 IHCDIKPQNILLD--DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
H DI+P+NI+ S T +I +FG A+ LK Y APE + ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
D++S G ++ L+ F E +++ + E EA+
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ R + ++ R T +
Sbjct: 238 VDR----------LLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 1e-43
Identities = 60/281 (21%), Positives = 111/281 (39%), Gaps = 36/281 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLD---------NMVSGGDKEFRTEVNAIGQ 560
K+ LGRG + V + + K AVK +D V + EV+ + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKE-YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 561 TN-HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFY 619
+ H N+++L + LV++ + G L +L + S +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 620 LHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
LH+ I+H D+KP+NILLDD +++DFG + L + + GT Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEI 180
Query: 680 FKS------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL 733
+ +VD++S GV++ L+ F + +++ Y E
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 734 HLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ + D++ + P R T ++
Sbjct: 241 DY-----SDTVKDLVS---------RFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (399), Expect = 5e-43
Identities = 58/273 (21%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDN---MVSGGDKEFRTEVNAI---GQTNH 563
+GRG F V+ A K+ A+K LD + G+ E + +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 564 RNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
+V + + + + ++ G L L ++ S A I GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF-KS 682
+++ D+KP NILLD+ RISD GLA + + GT GY+APE K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKG 180
Query: 683 LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEE 742
+ D +S G ML +L+ F Q+ + +++ + ++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQH-KTKDKHEIDRMTLTMAVELPDSF-----SP 234
Query: 743 ALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
L ++ +Q D + R
Sbjct: 235 ELRSLLE---------GLLQRDVNRRLGCLGRG 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 5e-43
Identities = 46/280 (16%), Positives = 94/280 (33%), Gaps = 26/280 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++G G+F ++ G + VA+K V + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE-VAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 570 LGFC-NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
+ +C E + ++V E + F F + K S + +A + + Y+H +
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 629 IHCDIKPQNIL---LDDSFTARISDFGLAKILKADQTRT------TTAIRGTRGYVAPEW 679
IH D+KP N L I DFGLAK + +T + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 680 FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEN 739
+ + + D+ S G +L+ + Q ++ + + + + + +L +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPW-QGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 740 DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
+ +C +P + +
Sbjct: 244 YPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 7e-43
Identities = 55/272 (20%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD---KEFRTEVNAIGQTNHRNL 566
+ LG G + VH ++ VAVK L ++ FR E NH +
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 567 VKLLGFCNEDQHRL----LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
V + + +V E++ L + + R +++ + L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--TTTAIRGTRGYVAPEWF 680
IIH D+KP NI++ + ++ DFG+A+ + T A+ GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENE--NQMILVDWAYDCYIDEKLHLLVE 738
+ + + D+YS G +L E++ F + Q + D E L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS---- 242
Query: 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT 770
L ++ + ++P R
Sbjct: 243 ---ADLDAVVL---------KALAKNPENRYQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-43
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 27/267 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQT-NHRN 565
LG+G+F V N+ A+K L V D + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQF-FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 566 LVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECT 625
L + ++ V E+++ G L + K R A I GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 626 TQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPI 685
I++ D+K NILLD +I+DFG+ K +T T GT Y+APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
VD +SFGV+L E++ + F ++E ++ + + L E+
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYPRWL-------EKEAK 231
Query: 746 DMMRLKKYVMIAIWCIQEDPSLRPTMK 772
D++ +P R ++
Sbjct: 232 DLLV---------KLFVREPEKRLGVR 249
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-41
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 31/288 (10%)
Query: 497 IFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD------KE 550
+F + ++ +ELG G FA V K A K + + ++
Sbjct: 2 VFRQENVDDYYD-TGEELGSGQFAVVKKCREKSTGLQ-YAAKFIKKRRTKSSRRGVSRED 59
Query: 551 FRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIA 610
EV+ + + H N++ L +L+ E ++ G L FL + + +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 611 FGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTAR----ISDFGLAKILKADQTRTTT 666
I G++YLH I H D+KP+NI+L D + I DFGLA + D
Sbjct: 120 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 174
Query: 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD 726
I GT +VAPE P+ ++ D++S GV+ L+ F + + E + Y+
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 727 CYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ N D +R + +DP R T++
Sbjct: 235 FEDE-----YFSNTSALAKDFIR---------RLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 8e-41
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 29/270 (10%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNL 566
LG G+F VH + + A+K L + K+ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRY-YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
+++ G + Q ++ ++I G L L K+ + A + L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
II+ D+KP+NILLD + +I+DFG AK + GT Y+APE + P
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYN 179
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
+D +SFG+++ E++ F N + + + E + D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFPPFFN-------EDVKD 230
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
++ I D S R +
Sbjct: 231 LLS---------RLITRDLSQRLGNLQNGT 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 22/298 (7%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLD-----NMVSGGDKEFRTEVNAIGQTNHRNL 566
D LG G FATV+K N+I VA+KK+ G ++ E+ + + +H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
+ LL + LV++F+ + + +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL-PI 685
I+H D+KP N+LLD++ +++DFGLAK + T + TR Y APE
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMY 178
Query: 686 TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745
+ VD+++ G +L EL+ + + + + + ++ + D
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 746 DMMRLKKYVMIAI----------WCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPSSF 793
+ + + + +P R T + L ++ P P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA-LKMKYFSNRPGPTPGCQL 295
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 55/283 (19%), Positives = 102/283 (36%), Gaps = 24/283 (8%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD-KEFRTEVNAIGQTNHRNLVKLL 570
+G GA+ V VA+KK+ + E+ + + H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 571 GFCNEDQHRLLVYEFISNGCLAGFLF---KNPKPSWYRRMQIAFGIARGLFYLHEECTTQ 627
+ ++ + L+ K S + I RGL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 628 IIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR--TTTAIRGTRGYVAPEWF-KSLP 684
++H D+KP N+LL+ + +I DFGLA++ D T TR Y APE S
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744
T +DI+S G +L E++ R F + ++ ++ ++ L
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 745 HDMMRLKKYVMIAIW-------------CIQEDPSLRPTMKKV 774
+ K ++ + +P R +++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (367), Expect = 2e-39
Identities = 49/274 (17%), Positives = 100/274 (36%), Gaps = 14/274 (5%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG 571
+++G G + V+K Y + +L+ G E++ + + H N+VKL
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHC 631
+ + +LV+E + + G+ Y H+ ++H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 632 DIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDI 691
D+KPQN+L++ +I+DFGLA+ + T I S + +DI
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 692 YSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC---YIDEKLHLLVENDEEALHDMM 748
+S G + E++ F E + M + L + +++ +
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 749 RLKKYVMIAI--------WCIQEDPSLRPTMKKV 774
+ ++ ++ DP+ R T K+
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 3e-39
Identities = 42/282 (14%), Positives = 86/282 (30%), Gaps = 28/282 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRN-LVK 568
+G G+F + +G N+ VA+K + R E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQ-VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
+ F E H +LV + + K S A + + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 629 IHCDIKPQNILLDDSFT-----ARISDFGLAKILKADQTRT------TTAIRGTRGYVAP 677
++ DIKP N L+ + + DFG+ K + T+ + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 678 EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
+ + D+ + G + + + + Q ++ + + L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779
E + M + P + +
Sbjct: 242 AGFPEEFYKYMH---------YARNLAFDATPDYDYLQGLFS 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 55/293 (18%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE------FRTEVNAIGQTN- 562
LG G F +V+ G+ +N VA+K ++ E EV + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 563 -HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYL 620
+++LL + +L+ E + + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 621 HEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEW 679
H ++H DIK +NIL+D + ++ DFG +LK GTR Y PEW
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEW 180
Query: 680 FKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738
+ ++S G++L +++C F E++ ++I + + + L+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPPDPS 791
WC+ PS RPT +++ + +V +P + +
Sbjct: 237 --------------------WCLALRPSDRPTFEEI-QNHPWMQDVLLPQETA 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 60/283 (21%), Positives = 102/283 (36%), Gaps = 25/283 (8%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVN---AIGQTNHRNL 566
E+G GA+ V K VA+K++ G EV + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLF------KNPKPSWYRRMQIAFGIARGLFYL 620
V+L C + + + L P + F + RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 621 HEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWF 680
H ++H D+KPQNIL+ S +++DFGLA+I T+ + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVL 187
Query: 681 KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENEN-----QMILVDWAYDCYIDEKLHL 735
VD++S G + E+ + F + + + +I + D D L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 736 LVENDEEALHDMMRLKKYVMIAI----WCIQEDPSLRPTMKKV 774
+ + A + + C+ +P+ R +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 55/271 (20%), Positives = 97/271 (35%), Gaps = 31/271 (11%)
Query: 514 LGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVKLLGF 572
LG G V + + A+K L + + R EV + + ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEK-FALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 573 C----NEDQHRLLVYEFISNGCLAGFLFKNPKP--SWYRRMQIAFGIARGLFYLHEECTT 626
+ L+V E + G L + + +I I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 627 QIIHCDIKPQNILLD---DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
I H D+KP+N+L + +++DFG AK + + TT T YVAPE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGPE 188
Query: 684 PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743
D++S GV++ L+C F N + + E EE
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKV 774
+ ++ +P+ R T+ +
Sbjct: 249 KMLIRN----------LLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 49/277 (17%), Positives = 112/277 (40%), Gaps = 18/277 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+++G G + TV K ++I VA+K++ D+ G E+ + + H+N+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQII 629
+ D+ LV+EF F N F + +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 630 HCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKV 689
H D+KPQN+L++ + ++++FGLA+ + + F + + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 690 DIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMR 749
D++S G + EL + + ++Q+ + +E+ + + + + M
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 750 LKKYVMIAI------------WCIQEDPSLRPTMKKV 774
++ + ++ +P R + ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 61/270 (22%), Positives = 99/270 (36%), Gaps = 26/270 (9%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNL 566
+ LG+G F V + A+K L V E TE + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRY-YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 567 VKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
L V E+ + G L L + + R I L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 627 QIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPIT 686
+++ DIK +N++LD +I+DFGL K +D T GT Y+APE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYG 183
Query: 687 MKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746
VD + GV++ E++C R F ++ ++ ++ + E++ EA
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYN--QDHERL------FELILMEEIRFPRTLSPEAKSL 235
Query: 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
+ +++DP R
Sbjct: 236 LAG----------LLKKDPKQRLGGGPSDA 255
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 53/277 (19%), Positives = 102/277 (36%), Gaps = 18/277 (6%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+++G G + V+K ++ VA+KK+ D G E++ + + NH N+VKL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGFLFKNPKP-SWYRRMQIAFGIARGLFYLHEECTTQI 628
L + + LV+EF+ F + +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
+H D+KPQN+L++ +++DFGLA+ T + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 689 VDIYSFGVMLLELICCRKKFEQN---------VENENQMILVDWAYDCYIDEKLHLLVEN 739
VDI+S G + E++ R F + V W + + +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 740 DEEALHDMMRLKKYVMIAI--WCIQEDPSLRPTMKKV 774
+ ++ ++ + DP+ R + K
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 63/312 (20%), Positives = 118/312 (37%), Gaps = 42/312 (13%)
Query: 486 TGPVMPSTNLQIFSYKELEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS 545
P Q SY + + +G G+F V++ L ++ VA+KK+
Sbjct: 8 ATPGQGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGEL-VAIKKVLQ--- 55
Query: 546 GGDKEFRTEVNAIGQTNHRNLVKLLGFC------NEDQHRLLVYEFISNGCLAGFLF--- 596
+ E+ + + +H N+V+L F ++ + LV +++
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 597 KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAK 655
+ + R L Y+H I H DIKPQN+LLD D+ ++ DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 656 ILKADQTRTTTAIRGTRGYVAP-EWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVEN 714
L + + R Y AP F + T +D++S G +L EL+ + F +
Sbjct: 172 QLVRGEPNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD-SG 228
Query: 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAI------------WCIQ 762
+Q++ + E++ + N E ++ + + ++
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288
Query: 763 EDPSLRPTMKKV 774
P+ R T +
Sbjct: 289 YTPTARLTPLEA 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-36
Identities = 70/328 (21%), Positives = 118/328 (35%), Gaps = 36/328 (10%)
Query: 498 FSYKELEKATQGFKD------ELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDK 549
F +E+ K + +G GA+ V V VA+KKL K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK-VAIKKLYRPFQSELFAK 62
Query: 550 EFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN----GCLAGFLFKNPKPSWYR 605
E+ + H N++ LL D+ +F G G L K+ K R
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665
+ + + +GL Y+H IIH D+KP N+ +++ +I DFGLA+
Sbjct: 123 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEM 175
Query: 666 TAIRGTRGYVAPEW-FKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724
T TR Y APE + T VDI+S G ++ E+I + F+ + + ++
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIW-------------CIQEDPSLRPTM 771
+ L + + + + L+K +I + D R T
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 772 KKVTLM--LEGVVEVPIPPDPSSFISSI 797
+ E + + P + S
Sbjct: 296 GEALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 59/307 (19%), Positives = 106/307 (34%), Gaps = 33/307 (10%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKL--DNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
++G+G F V K + VA+KK+ +N G E+ + H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQK-VALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 570 LGFCNEDQHR--------LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLH 621
+ C LV++F + K + ++ + GL+Y+H
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 622 EECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL---KADQTRTTTAIRGTRGYVAPE 678
I+H D+K N+L+ +++DFGLA+ K Q T T Y PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 679 WF-KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737
+D++ G ++ E+ + N E ++ + ++
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 738 ENDEEALHDMMRLKKYVMIAIW--------------CIQEDPSLRPTMKKVTLMLEGVVE 783
E L + K+ V + + DP+ R L +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA-LNHDFFWS 310
Query: 784 VPIPPDP 790
P+P D
Sbjct: 311 DPMPSDL 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-34
Identities = 59/268 (22%), Positives = 97/268 (36%), Gaps = 29/268 (10%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE---FRTEVNAIGQTNHRNLVK 568
LG G+F V A+K LD K+ E + N LVK
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 569 LLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQI 628
L ++ + +V E+++ G + L + + S A I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 629 IHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMK 688
I+ D+KP+N+L+D +++DFG AK T + GT +APE S
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 689 VDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDMM 748
VD ++ GV++ E+ F + Q+ + L D++
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIVSGKVRFPSHFS-------SDLKDLL 269
Query: 749 RLKKYVMIAIWCIQEDPSLRPTMKKVTL 776
R +Q D + R K +
Sbjct: 270 R---------NLLQVDLTKRFGNLKNGV 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-33
Identities = 60/275 (21%), Positives = 101/275 (36%), Gaps = 26/275 (9%)
Query: 510 FKDELGRGAFATVHKG--VLAYENKICVAVKKLDNMVSGGD----KEFRTEVNAIGQTNH 563
LG GA+ V + ++ A+K L + RTE +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 564 R-NLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHE 622
LV L + L+ ++I+ G L L + + + + I L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 623 ECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKS 682
II+ DIK +NILLD + ++DFGL+K AD+T GT Y+AP+ +
Sbjct: 148 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 683 LP--ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740
VD +S GV++ EL+ F + E +Q + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-----YPQEM 259
Query: 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775
D+++ + +DP R
Sbjct: 260 SALAKDLIQ---------RLLMKDPKKRLGCGPRD 285
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 1e-29
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 37/290 (12%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQ-TNHRNLVK 568
+LGRG ++ V + + N+ V VK L + K+ + E+ + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEK-VVVKILKPV---KKKKIKREIKILENLRGGPNIIT 94
Query: 569 LLGFCNEDQHRL--LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTT 626
L + R LV+E ++N + Y + I + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 627 QIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPE-WFKSLP 684
I+H D+KP N+++D + R+ D+GLA+ Q +R + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQM 206
Query: 685 ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV------DWAYDCYIDEKLHLLVE 738
+D++S G ML +I ++ F +N +Q++ + + YD + L
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 739 -NDEEALHDMMRLKKYVMIAIW-------------CIQEDPSLRPTMKKV 774
ND H R +++V ++ D R T ++
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 41/295 (13%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD--KEFRTEVNAIGQTNHRNLVKL 569
+G GA V A ++ VA+KKL K E+ + NH+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 570 LGFC------NEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEE 623
L E Q LV E + + R + + + G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSA 138
Query: 624 CTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSL 683
IIH D+KP NI++ T +I DFGLA+ A + T TR Y APE +
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 684 PITMKVDIYSFGVMLLELICCRKKF--EQNVENENQMILVDWAYDCYIDEKLHLLVEN-- 739
VDI+S G ++ E++ + F ++ N++I +KL V N
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 740 DEEALHDMMRLKKYVMIAIW--------------------CIQEDPSLRPTMKKV 774
+ + + K +++ + DP+ R ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 34/303 (11%)
Query: 498 FSYKELEKATQGFKD------ELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGD--K 549
F +EL K + +G GA+ +V VAVKKL K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLR-VAVKKLSRPFQSIIHAK 62
Query: 550 EFRTEVNAIGQTNHRNLVKLLGFCNEDQH----RLLVYEFISNGCLAGFLFKNPKPSWYR 605
E+ + H N++ LL + + G + K K +
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 606 RMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665
+ + I RGL Y+H IIH D+KP N+ +++ +I DFGLA+
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEM 175
Query: 666 TAIRGTRGYVAPEWF-KSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA 724
T TR Y APE + VDI+S G ++ EL+ R F + +++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 725 YDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIW-------------CIQEDPSLRPTM 771
+ + E+ + + ++ K ++ + D R T
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 772 KKV 774
+
Sbjct: 296 AQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 3e-25
Identities = 55/313 (17%), Positives = 93/313 (29%), Gaps = 52/313 (16%)
Query: 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKL 569
+LG G F+TV N VA+K + + E+ + + N + K
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH-VAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 570 LGFCNEDQHRLLVYEFISNGCLAGF----------------LFKNPKPSWYRRMQIAFGI 613
+LL + +++ QI+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 614 ARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQTRTTTA-IRGT 671
GL Y+H C IIH DIKP+N+L++ + +A + A T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 672 RGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFE----QNVENENQMILVDWAYDC 727
R Y +PE P DI+S ++ ELI FE + ++ I
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 728 YIDEKLHLLVENDEEALHDMMRLKKYVMIAIW--------------------------CI 761
+ L + + L+ + W +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 762 QEDPSLRPTMKKV 774
Q DP R +
Sbjct: 313 QLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 4e-19
Identities = 32/203 (15%), Positives = 56/203 (27%), Gaps = 31/203 (15%)
Query: 512 DELGRGAFATVHKGVLAYENKICVAVK----------KLDNMVSGGDKEFRTEVNAIGQT 561
+G G + V E VK K+ GD F +
Sbjct: 6 KLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 562 NHRNLVKLLGFCNEDQH----RLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGL 617
R L KL G + ++ E I + ++ I +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEEV 116
Query: 618 FYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTAIRGTRGYVAP 677
+ I+H D+ N+L+ + I DF + + + R
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE---RDVRNII 169
Query: 678 EWFKSLPITMKVDIYSFGVMLLE 700
+F + DI S +L+
Sbjct: 170 TYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 78.4 bits (193), Expect = 6e-18
Identities = 25/151 (16%), Positives = 46/151 (30%), Gaps = 38/151 (25%)
Query: 56 ENGNYLLTIYFNKIPERTIIWSANGKTPVERGS-KVQLTVDGRLVLTDLTGKEVWNPDTA 114
NGN +I ++ + + ++ ++ + D LVL D +
Sbjct: 7 NNGN---SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAG 63
Query: 115 GAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTG 174
A + +G + + +W S + + S G
Sbjct: 64 KGTGCRAVLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAG 98
Query: 175 RYELAMQSDGNLVLYTTAFPFESANSVYWST 205
RY +Q D NL +Y A W+T
Sbjct: 99 RYVFVLQPDRNLAIYGGA---------LWTT 120
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.4 bits (141), Expect = 4e-11
Identities = 29/141 (20%), Positives = 49/141 (34%), Gaps = 30/141 (21%)
Query: 121 ASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAM 180
+ ++GN +L D+ TL TQ L Y L+M
Sbjct: 3 VVVANNGNSILYSTQGN------DNHPQTLHATQSLQ---------------LSPYRLSM 41
Query: 181 QSDGNLVLYTTAFPFESANSVYWSTQPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSA 240
++D NLVL+ +T G+ + +G + LT +N ++ +S
Sbjct: 42 ETDCNLVLFDRDDRV-----WSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW----TSG 92
Query: 241 SSMQDLYQRVTLEFDGFLRHY 261
+S L+ D L Y
Sbjct: 93 NSRSAGRYVFVLQPDRNLAIY 113
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 74.2 bits (182), Expect = 1e-16
Identities = 25/123 (20%), Positives = 47/123 (38%), Gaps = 23/123 (18%)
Query: 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTP 83
+ + G+SL + F Q + L +Y + T +W++N
Sbjct: 8 EGLYAGQSL-----------DVEPYHFIMQ----EDCNLVLYDHS----TSVWASNTGIL 48
Query: 84 VERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWES 142
++G K L DG V+ D G+ +W + Y + + GN V+ G +W +
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWST 105
Query: 143 FDH 145
+
Sbjct: 106 GTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 48.4 bits (115), Expect = 1e-07
Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 23/117 (19%)
Query: 148 DTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST-- 205
+ L + L Y+ ++ Y MQ D NLVLY ++ W++
Sbjct: 2 NLLTNGEGL---------YAGQSLDVEPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 206 -QPVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261
+ GN + A+ RS+ S + + L+ DG + Y
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNG----NYVLVLQEDGNVVIY 98
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 73.4 bits (180), Expect = 2e-16
Identities = 29/143 (20%), Positives = 44/143 (30%), Gaps = 36/143 (25%)
Query: 64 IYFNKIPERTIIWSANGKTPVERGS-KVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYAS 122
I F E + + + +E S + + D LVL D + VW +TAGA A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAV 61
Query: 123 MLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQS 182
+ G V+ + W S S G Y L +Q
Sbjct: 62 LQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQP 96
Query: 183 DGNLVLYTTAFPFESANSVYWST 205
D + +Y W +
Sbjct: 97 DRTVTIYGPG---------LWDS 110
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.4 bits (159), Expect = 2e-13
Identities = 25/135 (18%), Positives = 51/135 (37%), Gaps = 24/135 (17%)
Query: 140 WESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESAN 199
+ D+ L T+ L + + T Y MQ+D NLVLY N
Sbjct: 7 KQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLY-------DNN 48
Query: 200 SVYWSTQP--VGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGF 257
+ W+T +G+ + G ++ +T +N ++ S + + + + L+ D
Sbjct: 49 NPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTV----WQSPVAGKAGHYVLVLQPDRN 104
Query: 258 LRHYVYPKSSSSNNK 272
+ Y ++ +
Sbjct: 105 VVIYGDALWATQTVR 119
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.7 bits (113), Expect = 3e-07
Identities = 20/111 (18%), Positives = 29/111 (26%), Gaps = 34/111 (30%)
Query: 95 DGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQ 154
D LVL D A + G V+ ++ +W
Sbjct: 39 DCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVW-------------- 84
Query: 155 ILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWST 205
S G Y L +Q D N+V+Y W+T
Sbjct: 85 -----------QSPVAGKAGHYVLVLQPDRNVVIY---------GDALWAT 115
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 63.7 bits (154), Expect = 7e-13
Identities = 19/125 (15%), Positives = 40/125 (32%), Gaps = 20/125 (16%)
Query: 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTP 83
+ G SL G + F Q+ + N +Y N +W++
Sbjct: 8 HQLDTGGSL-----------AEGGYLFIIQN--DCNL--VLYDNNRA----VWASGTNGK 48
Query: 84 VERGSKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWESF 143
G +++ DG LV+ + + Y + N V+ + +W +
Sbjct: 49 A-SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH 107
Query: 144 DHPTD 148
+ +
Sbjct: 108 TNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 59.4 bits (143), Expect = 2e-11
Identities = 22/129 (17%), Positives = 42/129 (32%), Gaps = 24/129 (18%)
Query: 147 TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQ 206
+D L L+ + + G Y +Q+D NLVLY ++ +
Sbjct: 1 SDRLNSGHQLDT---------GGSLAEGGYLFIIQNDCNLVLYDNNRAVWASGTNGK--- 48
Query: 207 PVGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKS 266
S ++ GN++ + + + L+ D + Y
Sbjct: 49 --ASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNG-----NYYLILQRDRNVVIY----- 96
Query: 267 SSSNNKSWS 275
+SNN W+
Sbjct: 97 DNSNNAIWA 105
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 58.1 bits (140), Expect = 4e-11
Identities = 30/118 (25%), Positives = 45/118 (38%), Gaps = 18/118 (15%)
Query: 29 GESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGS 88
GE+L + G F F Q E+ N L +Y P IW+ N R
Sbjct: 7 GETLSTGE-----FLNYGSFVFIMQ--EDCN--LVLYDVDKP----IWATNTGGLS-RSC 52
Query: 89 KVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAY-ASMLDSGNFVLAGPDSFPLWESFDH 145
+ + DG LV+ + + K +W +T G Y + N V+ G W + H
Sbjct: 53 FLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 25/124 (20%), Positives = 45/124 (36%), Gaps = 18/124 (14%)
Query: 148 DTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207
+ L + L+ L+ G + MQ D NLVLY P + N T
Sbjct: 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLYDVDKPIWATN-----TGG 47
Query: 208 VGSSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYVYPKSS 267
+ S + GN++ N+ I +S + Q+ L+ D + Y + +
Sbjct: 48 LSRSCFLSMQTDGNLVVYNPSNKPIW----ASNTGGQNGNYVCILQKDRNVVIYGTDRWA 103
Query: 268 SSNN 271
+ +
Sbjct: 104 TGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 41.9 bits (98), Expect = 2e-05
Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 36/129 (27%)
Query: 78 ANGKTPVERGSKVQLTVDGRLVLTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDS 136
+ G+ + D LVL D K +W +T G + + SM GN V+ P +
Sbjct: 11 STGEFLNYGSFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSN 69
Query: 137 FPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFE 196
P+W S+ G Y +Q D N+V+Y
Sbjct: 70 KPIW-------------------------ASNTGGQNGNYVCILQKDRNVVIY------- 97
Query: 197 SANSVYWST 205
+ W+T
Sbjct: 98 --GTDRWAT 104
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 797 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.77 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.75 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.57 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.37 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.18 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.09 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.08 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.07 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.41 | |
| d1mcvi_ | 28 | Trypsin inhibitor {Jumping cucumber (Ecballium ela | 90.56 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.04 | |
| d2c4ba2 | 28 | Trypsin inhibitor {Jumping cucumber (Ecballium ela | 88.54 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=412.87 Aligned_cols=269 Identities=24% Similarity=0.442 Sum_probs=205.2
Q ss_pred cccCHHHHHHHHHhhh-----------hhhCcccceeEEEEEEecCCc--EEEEEEEecccCC-CchHHHHHHHHHhhcc
Q 003759 496 QIFSYKELEKATQGFK-----------DELGRGAFATVHKGVLAYENK--ICVAVKKLDNMVS-GGDKEFRTEVNAIGQT 561 (797)
Q Consensus 496 ~~~~~~el~~~~~~f~-----------~~LG~G~fG~Vykg~~~~~~~--~~vavK~~~~~~~-~~~~~f~~E~~~l~~l 561 (797)
..++|+++.+++.+|. +.||+|+||+||+|++...++ ..||||++..... ...++|.+|+++++++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 4567888888887774 469999999999999865433 4689999865433 2345799999999999
Q ss_pred CcCchhhhcccccccCceeeeeecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 003759 562 NHRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILL 640 (797)
Q Consensus 562 ~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl 640 (797)
+|||||+++|+|.+++..++||||+++|+|.+++... ..+++.+++.|+.||++||+|||++ +|+||||||+||||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999999988764 5689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCccccccCCCc----ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCcccccc
Q 003759 641 DDSFTARISDFGLAKILKADQTR----TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENE 715 (797)
Q Consensus 641 ~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~ 715 (797)
+.++.+||+|||+++.+...... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999877544322 1222457899999999999999999999999999999998 899997653321
Q ss_pred chhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 716 NQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
+...... ..+.. ... .....+.+++.+||+.||++||||.||++.|+.++..
T Consensus 242 ----~~~~i~~---~~~~~-~~~---------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 ----VINAIEQ---DYRLP-PPM---------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----HHHHHHT---TCCCC-CCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHc---CCCCC-CCc---------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111111 11111 000 1123467789999999999999999999999986543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=401.75 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=193.6
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.+.++||+|+||+||+|++.+ +..||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETT--TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEECC--CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 456789999999999999863 346999999763 34567899999999999999999999999999999999999999
Q ss_pred CchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|+|.+++... ..+++..++.|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998755 5688999999999999999999998 99999999999999999999999999998776554444445
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++|||||||++|||+|+..|+....... .+...... +.... .+ .
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~----~~~~~--~p--~----- 225 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST----GFRLY--KP--R----- 225 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH----TCCCC--CC--T-----
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh----cCCCC--Cc--c-----
Confidence 668999999999999999999999999999999999654443322211 11111111 11000 00 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....++.+++..||+.||++||||+||++.|++++
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 01234678899999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-48 Score=405.33 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=211.8
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+....+.+.++||+|+||+||+|++...+ +.||||+++... ...++|.+|++++++++|||||+++++|.+++..++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGT-EEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCC-eEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 33344566788999999999999987544 569999997543 4467899999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 583 YEFISNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|||+++|+|.+++.+. ..+++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999654 5789999999999999999999998 9999999999999999999999999999987665
Q ss_pred CCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.........|++.|+|||++.+..++.++|||||||++|||++|..|+........ +.+... .+......+.
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---~~~~i~----~~~~~~~~~~- 240 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KDYRMERPEG- 240 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----TTCCCCCCTT-
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---HHHHHh----cCCCCCCCcc-
Confidence 55555555689999999999999999999999999999999998777654332211 111111 1111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++||||+||++.|+.+..
T Consensus 241 --------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 241 --------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12346788999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=400.59 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=202.8
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.++||+|+||+||+|+++ ++..||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4556788999999999999985 3456999999754 3456789999999999999999999998865 5678999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.+++... ..+++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+.+.......
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988654 3689999999999999999999998 99999999999999999999999999999876655445
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+........ +.... ..+......+.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i----~~~~~~~~p~~----- 234 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNL----ERGYRMVRPDN----- 234 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTTCCCCCCTT-----
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HhcCCCCCccc-----
Confidence 5556789999999999999999999999999999999997666543322211 11111 11111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
..+.+.+++..||+.||++||||+||+++|+.
T Consensus 235 ----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11346778999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=398.72 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=198.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
+.+.+.||+|+||+||+|+... .||||+++... ....+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS----EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEeeCCCcEEEEEEECC----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 3456789999999999998642 39999986543 2334679999999999999999999999865 568999999
Q ss_pred ccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-c
Q 003759 586 ISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-R 663 (797)
Q Consensus 586 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 663 (797)
+++|+|.+++... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....... .
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999654 5699999999999999999999998 999999999999999999999999999987654332 3
Q ss_pred ccccccccCccccccccccC---CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 664 TTTAIRGTRGYVAPEWFKSL---PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
......||+.|||||++.+. .++.++|||||||+||||+||+.||........ +...................
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~- 237 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSKVRSN- 237 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCCCCGGGSCTT-
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCcchhcccc-
Confidence 34456799999999998643 589999999999999999999999976533221 11111111111111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++||||+||++.|+.+..
T Consensus 238 --------~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 238 --------CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12346678899999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=394.33 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=200.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
|.+.+.||+|+||+||+|+....+ ..||||+++.... +..+++.+|++++++++|||||++++++.+++..+|||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 445678999999999999987654 4699999865432 33457999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-ccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-RTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~ 665 (797)
++|+|.+++.+...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..... ...
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999997754432 334
Q ss_pred ccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 666 TAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
....||+.|+|||++.+..+ +.++|||||||++|||+||+.||............ ... ..........
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~--~~~----~~~~~~~~~~----- 231 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKE----KKTYLNPWKK----- 231 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH--HHT----TCTTSTTGGG-----
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH--Hhc----CCCCCCcccc-----
Confidence 45679999999999988876 67899999999999999999999765433221111 000 0000000000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||++|+++
T Consensus 232 ----~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 ----IDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0134567888999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=384.16 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=208.1
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
.|.++||+|+||+||+|+++ ++..||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||+++
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET--TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred EEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 45688999999999999985 4567999999864 34567899999999999999999999999999999999999999
Q ss_pred CchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 589 GCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 589 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
|+|..++... ..+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+..........
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999997654 6788999999999999999999998 99999999999999999999999999998776655555555
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+.. . .+..+........
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~----~i~~~~~~~~p~~------- 225 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----E----HIAQGLRLYRPHL------- 225 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----H----HHHTTCCCCCCTT-------
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH----H----HHHhCCCCCCccc-------
Confidence 678999999999999999999999999999999998 89999766433211 1 1111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
..+.+.+++..||+.||++|||++||++.|.++
T Consensus 226 --~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 --ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 113467889999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=397.23 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=198.3
Q ss_pred hhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
.+.+.||+|+||+||+|++...++ ..||||++...... ..++|.+|+.++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 345789999999999999875432 57999999754332 23479999999999999999999999999999999999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|+.+++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999988654 6799999999999999999999998 999999999999999999999999999987654332
Q ss_pred -cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 -RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+........ +.... ..+........
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~i----~~~~~~~~~~~-- 237 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI----NDGFRLPTPMD-- 237 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTTCCCCCCTT--
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---HHHHH----hccCCCCCchh--
Confidence 223345689999999999999999999999999999999997766654322211 11111 11111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVP 785 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~ 785 (797)
....+.+++.+||+.||++||||+||+++|+.+.+.|
T Consensus 238 -------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 238 -------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1234678899999999999999999999999876643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=389.44 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=198.7
Q ss_pred hhhCcccceeEEEEEEecC-CcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccC
Q 003759 512 DELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISN 588 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 588 (797)
++||+|+||+||+|++... .+..||||+++..... ..++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4699999999999998643 3467999999654332 23579999999999999999999999865 467899999999
Q ss_pred CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC--cccc
Q 003759 589 GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTT 666 (797)
Q Consensus 589 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~ 666 (797)
|+|.+++.+...+++..++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888999999999999999999999998 999999999999999999999999999987754433 2233
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhh
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALH 745 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (797)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +... +..+........
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~----i~~~~~~~~p~~------ 234 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM----LEKGERMGCPAG------ 234 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH----HHTTCCCCCCTT------
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----HHHH----HHcCCCCCCCcc------
Confidence 4568999999999999999999999999999999998 899997653321 1111 111111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 746 DMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 746 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
....+.+++.+||+.||++||||++|+++|+.
T Consensus 235 ---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 235 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11346678999999999999999999998875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=392.88 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=202.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.++||+|+||+||+|+....+ ..||||++........+.+.+|+.++++++|||||++++++.+++..+|||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTC-CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEECCCC-CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 455678999999999999987554 4699999976655566789999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccccc
Q 003759 588 NGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTTA 667 (797)
Q Consensus 588 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 667 (797)
+|+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 9999998765 4689999999999999999999998 999999999999999999999999999987654332 2344
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhhH
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHDM 747 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (797)
..||+.|+|||++.+..++.++|||||||++|||+||+.||......+... ......... . .. +..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------~~~~~~~~~-~-~~-~~~---- 241 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNGTPE-L-QN-PEK---- 241 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHHCSCC-C-SS-GGG----
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH-------HHHhCCCCC-C-CC-ccc----
Confidence 569999999999999999999999999999999999999997643322111 111111100 0 00 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 748 MRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 748 ~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....+.+++..||+.||++|||+.|+++
T Consensus 242 -~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 -LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1134567889999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=393.65 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=201.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.+.+.||+|+||+||+|++..+ ..||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~--~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTT--EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCC--CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 466678999999999999998643 45999999754 3456789999999999999999999999865 5678999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.+++... ..++|.+++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999998753 5689999999999999999999998 99999999999999999999999999998776555444
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++....++.++||||||+++|||+||..|+........ +...... +........
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---~~~~i~~----~~~~~~~~~----- 238 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER----GYRMPCPPE----- 238 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----TCCCCCCTT-----
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHh----cCCCCCCcc-----
Confidence 5556689999999999999999999999999999999997766654332221 1111111 111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEVPIPP 788 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~~~p~ 788 (797)
..+++.+++.+||+.||++||||++|+++|++......|+
T Consensus 239 ----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 239 ----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred ----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 1134678899999999999999999999999866555444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=389.43 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=202.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+|+...++ ..||+|++... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCC-cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 456788999999999999987554 56999998642 23345678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 999999999998888899999999999999999999998 99999999999999999999999999998654332
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .+...... ..+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~----~i~~~~~~-~p~~----- 226 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----K----RISRVEFT-FPDF----- 226 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----H----HHHTTCCC-CCTT-----
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH----H----HHHcCCCC-CCcc-----
Confidence 23456999999999999999999999999999999999999999764332211 1 11111111 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..+.+.+++..||+.||++|||++|+++
T Consensus 227 ----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 ----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1134567889999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=401.46 Aligned_cols=200 Identities=24% Similarity=0.344 Sum_probs=175.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.+.++||+|+||+||+|+.... +..||+|+++..... ..+++.+|+.++++++|||||+++++|.++++.++||||+
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~-~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTT-TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 44567899999999999998654 457999999754333 3457899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
++|+|.+++.+...+++..+..++.|++.||.|||++ .+|+||||||+|||+++++.+||+|||+|+.+.... ..
T Consensus 87 ~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 161 (322)
T d1s9ja_ 87 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 161 (322)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C-
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---cc
Confidence 9999999998888899999999999999999999973 189999999999999999999999999998764322 23
Q ss_pred cccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCcccc
Q 003759 667 AIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVE 713 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~ 713 (797)
...||+.|+|||++.+.+++.++||||+||++|||++|+.||.....
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 45799999999999999999999999999999999999999976543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=399.81 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=203.1
Q ss_pred HHHhhhhhhCcccceeEEEEEEecCC----cEEEEEEEecccC-CCchHHHHHHHHHhhcc-CcCchhhhcccccccCce
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYEN----KICVAVKKLDNMV-SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 579 (797)
..+.+.+.||+|+||+||+|+....+ ...||||++.... ......|.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 34556789999999999999986543 2469999986533 33446799999999998 899999999999999999
Q ss_pred eeeeecccCCchhhhcccC-----------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 003759 580 LLVYEFISNGCLAGFLFKN-----------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQ 636 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~ 636 (797)
++||||+++|+|.++|... ..+++..++.|+.||++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 9999999999999999654 2478899999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEeecCccccccCCCc-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccc
Q 003759 637 NILLDDSFTARISDFGLAKILKADQTR-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVEN 714 (797)
Q Consensus 637 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~ 714 (797)
|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876554432 2334568999999999999999999999999999999998 89999765433
Q ss_pred cchhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 003759 715 ENQMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLE 779 (797)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le 779 (797)
+... ..... +........ ..+.+.+++..||+.||++||||+||+++|.
T Consensus 274 ~~~~---~~~~~----~~~~~~p~~---------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFY---KLIQN----GFKMDQPFY---------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHH---HHHHT----TCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH---HHHhc----CCCCCCCCc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 11111 110000000 1234678899999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=392.40 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=201.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||+||+|+....+ ..||||+++.......+.|.+|++++++++|||||++++++.+++..+|||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCC-eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 445678999999999999987654 4699999987655666789999999999999999999999999999999999999
Q ss_pred CCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 588 NGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 588 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+|+|.+++.+ ...+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence 9999999765 45699999999999999999999998 999999999999999999999999999976543221 223
Q ss_pred cccccCccccccccc-----cCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 667 AIRGTRGYVAPEWFK-----SLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
...||+.|+|||++. +..++.++|||||||++|||+||+.||......+....+ . .+....+.. +
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i---~-----~~~~~~~~~--~ 238 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---A-----KSEPPTLAQ--P 238 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---H-----HSCCCCCSS--G
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH---H-----cCCCCCCCc--c
Confidence 456999999999984 456899999999999999999999999765433211111 1 111110000 0
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
. .....+.+++..||+.||++|||++|+++
T Consensus 239 ~-----~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 S-----RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp G-----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01134667889999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=387.24 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=194.5
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccc----cCceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE----DQHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 582 (797)
.|.++||+|+||+||+|++...+ ..||+|++..... ...+.|.+|++++++++|||||++++++.. ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~-~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETT-VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 45568999999999999987544 4699999865432 223568999999999999999999999864 3567999
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc-CCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD-DSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++|+|.+++.+...+++..+..++.||++||+|||++ ..+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999999998888899999999999999999999997 12399999999999996 5889999999999864432
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
......||+.|+|||++.+ +++.++|||||||++|||++|+.||........ +.. .+..+........
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~~~----~i~~~~~~~~~~~-- 236 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYR----RVTSGVKPASFDK-- 236 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHH----HHTTTCCCGGGGG--
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---HHH----HHHcCCCCcccCc--
Confidence 2234569999999999876 599999999999999999999999975432211 111 1111111100000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.....+.+++.+||+.||++|||++|+++
T Consensus 237 ------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 ------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01123567889999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=386.50 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=199.5
Q ss_pred hhCcccceeEEEEEEecC-CcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecccCCc
Q 003759 513 ELGRGAFATVHKGVLAYE-NKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~-~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+||+|+||+||+|++... ++..||||+++..... ..++|.+|++++++++|||||+++|++.. +..+|||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 499999999999987643 3467999999764332 34679999999999999999999999865 56899999999999
Q ss_pred hhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC--ccccc
Q 003759 591 LAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT--RTTTA 667 (797)
Q Consensus 591 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~~ 667 (797)
|.+++... ..+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... .....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 99997654 6799999999999999999999998 999999999999999999999999999997754432 22334
Q ss_pred ccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhhhhh
Q 003759 668 IRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEALHD 746 (797)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (797)
..||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +.. .+..+........
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~----~i~~~~~~~~p~~------- 236 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMA----FIEQGKRMECPPE------- 236 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHH----HHHTTCCCCCCTT-------
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----HHH----HHHcCCCCCCCCc-------
Confidence 458999999999999999999999999999999998 899997654321 111 1112221111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 003759 747 MMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEG 780 (797)
Q Consensus 747 ~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~ 780 (797)
....+.+++..||+.||++||||.+|++.|+.
T Consensus 237 --~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 237 --CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11346678999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=382.16 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=187.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccc--cCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNE--DQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+|+...++ ..||||++...... ..+.|.+|++++++++|||||++++++.+ .+..++||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCC-CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 455688999999999999987654 46999999764322 23468899999999999999999998854 45689999
Q ss_pred ecccCCchhhhccc----CCCCChhhHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 584 EFISNGCLAGFLFK----NPKPSWYRRMQIAFGIARGLFYLHEEC--TTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 584 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
||+++|+|.+++.+ ...+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999863 467899999999999999999999872 235999999999999999999999999999887
Q ss_pred ccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +. ..+..+....+.
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~----~~i~~~~~~~~~ 235 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LA----GKIREGKFRRIP 235 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH----HHHHHTCCCCCC
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HH----HHHHcCCCCCCC
Confidence 54332 2334569999999999999999999999999999999999999997643322 11 111122222111
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~---------s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 YRY---------SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc---------CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 124667889999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=388.79 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=199.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
|.+.+.||+|+||+||+|+....+ ..||||++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATS-REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 566789999999999999987554 46999998642 22344679999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-c
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT-R 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 663 (797)
|+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999998888999999999999999999999998 999999999999999999999999999997754332 3
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ..+...... ....
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~----~~i~~~~~~-~p~~---- 232 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI----F----QKIIKLEYD-FPEK---- 232 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H----HHHHTTCCC-CCTT----
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH----H----HHHHcCCCC-CCcc----
Confidence 33445699999999999999999999999999999999999999976432211 1 111111111 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
....+.+++..||+.||++|||++|++
T Consensus 233 -----~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 -----FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 113456789999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-45 Score=386.22 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=198.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+...++||+|+||+||+|+...+ +..||||+++...... .+.|.+|++++++++|||||++++++.+++..++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCC-CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 45567899999999999998755 4569999997644332 2468899999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|..++.....+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999999988887778899999999999999999999998 9999999999999999999999999999865432
Q ss_pred cccccccCcccccccccc---CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 665 TTAIRGTRGYVAPEWFKS---LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ... ...........
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~-------~i~-~~~~~~~~~~~- 238 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIA-QNESPALQSGH- 238 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHH-HSCCCCCSCTT-
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH-------HHH-hCCCCCCCCCC-
Confidence 33469999999999864 458999999999999999999999997643322111 111 11111111110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
..+.+.+++..||+.||++|||++|+++
T Consensus 239 -------~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 239 -------WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1134667889999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-45 Score=387.72 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=187.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
|.+.+.||+|+||+||+|+....+ ..||||++..... ...+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTC-CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCC-CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 566788999999999999987554 4699999975432 33456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
++|+|.+++.+...+++.+...++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999998888999999999999999999999998 999999999999994 57899999999998654332
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +........ .+....
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--------i~~~~~~~~-~~~~~~ 235 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--------ILKAEYEFD-SPYWDD 235 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHTTCCCCC-TTTTTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--------HhccCCCCC-CccccC
Confidence 22345699999999999999999999999999999999999999976533221111 111111100 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
....+.+++..||+.||++|||++|+++.
T Consensus 236 -----~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 -----ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11346678999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=383.97 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=201.7
Q ss_pred hhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccc-cCceeeeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYE 584 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 584 (797)
+|.++||+|+||+||+|++...+ +..||||+++.... ...++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 34678999999999999986543 35699999975332 233679999999999999999999999865 568899999
Q ss_pred cccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC-
Q 003759 585 FISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 585 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 662 (797)
|+++|+|.+++... ..+++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998755 4577889999999999999999998 999999999999999999999999999987654332
Q ss_pred --cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 --RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.......||+.|+|||.+....++.++||||||+++|||+||+.||........ +.... ..+........
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~i----~~g~~~~~p~~- 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRLLQPEY- 258 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH----HTTCCCCCCTT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCCCccc-
Confidence 223345689999999999999999999999999999999998888865432211 11111 11111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
....+.+++..||+.||++||+|.||++.|+.+..
T Consensus 259 --------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 259 --------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11346788999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-45 Score=385.47 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=205.1
Q ss_pred HhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.++||+|+||+||+|+... .++..||||+++..... ..++|.+|+.++++++||||++++++|.+.+..+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 4456789999999999999763 34567999999754333 245799999999999999999999999999999999
Q ss_pred eecccCCchhhhcccC------------------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 583 YEFISNGCLAGFLFKN------------------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
|||+++|+|.+++... ..+++..++.|+.|++.||+|||++ +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999998542 2478889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCC-cCCCccccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCR-KKFEQNVENEN 716 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~-~p~~~~~~~~~ 716 (797)
|++.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||......+
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e- 250 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-
Confidence 999999999999999987644332 3334456889999999999999999999999999999999996 5665543322
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
+.. .+..+......+.. ..++.+++..||+.||++||||.||+++|+++.+
T Consensus 251 ---~~~----~v~~~~~~~~p~~~---------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 ---VIY----YVRDGNILACPENC---------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ---HHH----HHHTTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---HHH----HHHcCCCCCCCccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 11222222111111 1346788999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=382.01 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=193.4
Q ss_pred HHhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCCCc-hHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVSGG-DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
.+.+.+.||+|+||+||+|++...+ ...||||+++...... .+.|.+|+.++++++|||||++++++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 4556788999999999999886443 3578999987543332 356999999999999999999999996 46789999
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999987654 5689999999999999999999998 999999999999999999999999999987765555
Q ss_pred cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 663 RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
.......||+.|+|||.+.+..++.++|||||||++|||+| |..||......+.. .. +..+........
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----~~----i~~~~~~~~~~~-- 233 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GR----IENGERLPMPPN-- 233 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HH----HHTTCCCCCCTT--
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH----HH----HHcCCCCCCCCC--
Confidence 45555668999999999999999999999999999999998 88888765433211 11 111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
....+.+++..||+.||++|||++||++.|+.++
T Consensus 234 -------~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 234 -------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1134677899999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=380.04 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=202.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC------CchHHHHHHHHHhhccCcCchhhhcccccccCcee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS------GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 580 (797)
.|.+.+.||+|+||+||+|+....+ ..||||+++.... ...+.|.+|+.++++++|||||++++++.+++..+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~-~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTG-LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCC-CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3566788999999999999987544 4699999864322 12467999999999999999999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC----cEEEEeecCccc
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF----TARISDFGLAKI 656 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~ 656 (797)
|||||+++|+|.+++.+...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998888899999999999999999999998 999999999999998776 499999999987
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~~- 235 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYEF- 235 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCCC-
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcCCCC-
Confidence 65432 223445899999999999999999999999999999999999999765432211111 1111100
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... ........+.+++..||+.||++|||++|+++
T Consensus 236 ---~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 ---EDE--YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CHH--HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---Cch--hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00011234667899999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-44 Score=388.85 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=203.1
Q ss_pred HHhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.|.+.+.||+|+||+||+|+.... +..||||++........+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~-g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 356678999999999999998754 4569999997655455567899999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCcEEEEeecCccccccCCCc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD--DSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
++|+|.+++.+ ...+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 99999999854 46799999999999999999999998 999999999999995 467899999999987654332
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ . ....... ......
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~----~~~~~~~-~~~~~~ 251 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----K----SCDWNMD-DSAFSG 251 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H----HTCCCSC-CGGGGG
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH----H----hCCCCCC-cccccC
Confidence 33456899999999999999999999999999999999999999765332211111 1 1110000 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
..+.+.+++..||+.||++|||++|+++.
T Consensus 252 -----~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 -----ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11345678899999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-44 Score=387.57 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=202.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||+||+|+.... +..||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEECCC-CCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 56678999999999999998754 45699999976544455678899999999999999999999999999999999999
Q ss_pred CCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc--CCCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD--DSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+|+|.+++... ..+++.+...|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|..+.....
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-- 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc--
Confidence 99999887655 4699999999999999999999998 999999999999998 678999999999988765432
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+.. .... ....... .....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~----~~~~~~~-~~~~~-- 253 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVK----RCDWEFD-EDAFS-- 253 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHH----HCCCCCC-SSTTT--
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH----hCCCCCC-ccccc--
Confidence 33456899999999999999999999999999999999999999765432211 1111 1111000 00000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.....+.+++..||+.||++|||+.|+++.
T Consensus 254 ---~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 ---SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011345678999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=376.11 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=193.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCC--cEEEEEEEecccCC---CchHHHHHHHHHhhccCcCchhhhcccccccCceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYEN--KICVAVKKLDNMVS---GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 582 (797)
+.+.+.||+|+||+||+|++.... ...||||++..... +..++|.+|++++++++||||++++|+|.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 455678999999999999876433 35799999875432 223579999999999999999999999976 467899
Q ss_pred eecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 583 YEFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
|||+++|+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887654 5699999999999999999999998 99999999999999999999999999999875443
Q ss_pred C--cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 662 T--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 662 ~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
. .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+. .... ...+.......
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i---~~~~~~~~~~~ 238 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKI---DKEGERLPRPE 238 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHH---HTSCCCCCCCT
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----HHHH---HhCCCCCCCcc
Confidence 3 22334457889999999999999999999999999999998 8999976543321 1111 11111111111
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.. ...+.+++..||+.||++||||+||+++|++.
T Consensus 239 ~~---------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DC---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc---------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 12466789999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=381.21 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred HHHhhhhhhCcccceeEEEEEEecC----CcEEEEEEEecccCC-CchHHHHHHHHHhhcc-CcCchhhhccccccc-Cc
Q 003759 506 ATQGFKDELGRGAFATVHKGVLAYE----NKICVAVKKLDNMVS-GGDKEFRTEVNAIGQT-NHRNLVKLLGFCNED-QH 578 (797)
Q Consensus 506 ~~~~f~~~LG~G~fG~Vykg~~~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 578 (797)
..+.+.++||+|+||.||+|+.... .++.||||+++.... ...+++.+|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 3456678899999999999997643 236799999975332 2345688888888777 789999999987654 56
Q ss_pred eeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 003759 579 RLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~ 642 (797)
.++||||+++|+|.+++... ..+++.+++.++.||++||+|||++ +|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 89999999999999999643 3478999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCC-cCCCccccccchhhH
Q 003759 643 SFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCR-KKFEQNVENENQMIL 720 (797)
Q Consensus 643 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~-~p~~~~~~~~~~~~~ 720 (797)
++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||......+. +
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---H
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---H
Confidence 99999999999987654433 2334567999999999999999999999999999999999975 56654433221 1
Q ss_pred HHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
... +..+......+.. ..++.+++.+||+.||++||||+||+++|+++++
T Consensus 247 ~~~----~~~~~~~~~~~~~---------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRR----LKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH----HHHTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCCCCCCccC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 1111111111111 1346778999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=372.47 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=191.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc-cCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE-DQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~Ey~ 586 (797)
+.|.+.||+|+||.||+|++. +..||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred eEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 345678999999999999984 346999999753 445789999999999999999999999865 45689999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
++|+|.++|.+. ..+++..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999754 3589999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
....+++.|+|||++.+..++.++||||||+++|||+| |+.|+......+ +...+ ..+.........
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~i----~~~~~~~~~~~~--- 225 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV----EKGYKMDAPDGC--- 225 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHHH----TTTCCCCCCTTC---
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHHH----HcCCCCCCCccC---
Confidence 23347889999999999999999999999999999998 677776543322 11111 111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
...+.+++.+||+.||++||||.||+++|+.+.
T Consensus 226 ------~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 226 ------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 134667889999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=382.84 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=197.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCc---EEEEEEEecccC-CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENK---ICVAVKKLDNMV-SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
+.+.+.||+|+||+||+|++...++ ..||+|+++... ....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 4556789999999999999865443 369999986533 34567899999999999999999999999875 567888
Q ss_pred ecccCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 584 EFISNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
||+.+|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999888654 6789999999999999999999998 999999999999999999999999999998755433
Q ss_pred c-ccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 663 R-TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 663 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..... +........
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~----~~i~~----~~~~~~p~~- 237 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEK----GERLPQPPI- 237 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH----HHHHH----TCCCCCCTT-
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHc----CCCCCCCcc-
Confidence 2 3334568999999999999999999999999999999999 78888765433211 11111 111000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 238 --------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 238 --------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 113467789999999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=377.35 Aligned_cols=258 Identities=27% Similarity=0.368 Sum_probs=202.5
Q ss_pred HHhhhhhhCcccceeEEEEEEecCC------cEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhcccccccCc
Q 003759 507 TQGFKDELGRGAFATVHKGVLAYEN------KICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQH 578 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 578 (797)
.+.+.+.||+|+||.||+|+....+ ...||||+++..... ...++.+|...+.++ +|||||+++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 4556788999999999999875432 357999999764432 336788899999888 89999999999999999
Q ss_pred eeeeeecccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC
Q 003759 579 RLLVYEFISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD 642 (797)
Q Consensus 579 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~ 642 (797)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999644 3478999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHh-CCcCCCccccccchhhH
Q 003759 643 SFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELIC-CRKKFEQNVENENQMIL 720 (797)
Q Consensus 643 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 720 (797)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----~ 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----L 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----H
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----H
Confidence 99999999999987755433 23444568999999999999999999999999999999998 677876543321 1
Q ss_pred HHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 721 VDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
. ..+..+........ ....+.+++.+||+.||++|||+.||+++|+++.++
T Consensus 247 ~----~~i~~~~~~~~p~~---------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 F----KLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp H----HHHHTTCCCCCCSS---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHHcCCCCCCCcc---------chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1 11112211111111 113467899999999999999999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=374.94 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=197.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHH--HHHHHHHhhccCcCchhhhcccccccC----ceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKE--FRTEVNAIGQTNHRNLVKLLGFCNEDQ----HRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~--f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV 582 (797)
-+.++||+|+||+||+|++. +..||||+++.. ..++ +..|+..+.+++|||||+++++|.+.+ ..++|
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET---TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC---CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 34678999999999999873 456999998643 2233 344666777889999999999997654 57899
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEEC-----TTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
|||+++|+|.++|++. .++|..+++++.+++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999754 6899999999999999999999741 359999999999999999999999999999876
Q ss_pred ccCCC---cccccccccCccccccccccCC------CCccCceehHHHHHHHHHhCCcCCCccccccchhh-------HH
Q 003759 658 KADQT---RTTTAIRGTRGYVAPEWFKSLP------ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMI-------LV 721 (797)
Q Consensus 658 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~-------~~ 721 (797)
..... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........... ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 54332 2233466999999999987643 67889999999999999999988754332221110 00
Q ss_pred HHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 003759 722 DWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVV 782 (797)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~ 782 (797)
+........+.....+ +...........+.+++.+||+.||++||||.||++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHTTSCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111112222211111 111122334456788999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=377.81 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=206.5
Q ss_pred HHHHHHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhcc-CcCchhhhccccccc
Q 003759 503 LEKATQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQT-NHRNLVKLLGFCNED 576 (797)
Q Consensus 503 l~~~~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 576 (797)
+....+.+.+.||+|+||.||+|++.. ..++.||||+++..... ...+|.+|+.++.++ +|||||+++++|.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 334456677899999999999998743 34578999999764332 334689999999999 799999999999999
Q ss_pred CceeeeeecccCCchhhhcccCC------------------CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 003759 577 QHRLLVYEFISNGCLAGFLFKNP------------------KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNI 638 (797)
Q Consensus 577 ~~~~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NI 638 (797)
+..++||||+++|+|.+++++.. .+++..++.++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999986432 578999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeecCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcC-CCccccccc
Q 003759 639 LLDDSFTARISDFGLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKK-FEQNVENEN 716 (797)
Q Consensus 639 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p-~~~~~~~~~ 716 (797)
+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|+..| +......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654433 334446789999999999999999999999999999999995544 544332221
Q ss_pred hhhHHHHHHhhhccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 717 QMILVDWAYDCYIDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.. ..... +....... .....+.+++.+||+.||++||||+||+++|++.
T Consensus 257 ~~---~~i~~----~~~~~~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FY---KMIKE----GFRMLSPE---------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HH---HHHHH----TCCCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHhc----CCCCCCcc---------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 11111 11000000 0123567889999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=375.45 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=200.2
Q ss_pred hhhhhhCcccceeEEEEEEecCCc-EEEEEEEecccC-CCchHHHHHHHHHhhcc-CcCchhhhcccccccCceeeeeec
Q 003759 509 GFKDELGRGAFATVHKGVLAYENK-ICVAVKKLDNMV-SGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~-~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
.+.++||+|+||+||+|++..++. ..||||+++... ....++|.+|++++.++ +|||||+++|+|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 456789999999999999987654 468899986533 33456799999999998 799999999999999999999999
Q ss_pred ccCCchhhhcccC----------------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEE
Q 003759 586 ISNGCLAGFLFKN----------------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARIS 649 (797)
Q Consensus 586 ~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 649 (797)
+++|+|.++|++. ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 9999999999654 5689999999999999999999998 99999999999999999999999
Q ss_pred eecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCc-CCCccccccchhhHHHHHHhhh
Q 003759 650 DFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRK-KFEQNVENENQMILVDWAYDCY 728 (797)
Q Consensus 650 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~ 728 (797)
|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ +... +
T Consensus 170 DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~----i 239 (309)
T d1fvra_ 170 DFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEK----L 239 (309)
T ss_dssp CTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH----G
T ss_pred ccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHH----H
Confidence 9999986543322 223458999999999999999999999999999999999765 565432221 1111 1
Q ss_pred ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 003759 729 IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVE 783 (797)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~ 783 (797)
..+........ ....+.+++.+||+.||++||||+||++.|+++.+
T Consensus 240 ~~~~~~~~~~~---------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGYRLEKPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGTCCCCCCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111111 12356788999999999999999999999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=372.33 Aligned_cols=260 Identities=23% Similarity=0.238 Sum_probs=197.1
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCC-----chHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG-----GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
+.||+|+||+||+|+....+ ..||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTN-QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCC-SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCC-cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57999999999999987654 46999998653322 1346889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
+++++..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-cc
Confidence 9999888887778899999999999999999999998 9999999999999999999999999999876543322 23
Q ss_pred cccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh----hhcc-------cccc
Q 003759 667 AIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD----CYID-------EKLH 734 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~-------~~~~ 734 (797)
...||+.|+|||++... .++.++|||||||++|||+||+.||......+....+.+.... .+.. ....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 34689999999998654 5799999999999999999999999765443322111111000 0000 0000
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.......... .....+.+.+++..||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000 00112457889999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=376.30 Aligned_cols=246 Identities=24% Similarity=0.268 Sum_probs=202.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+|+....+ ..||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~-~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATG-RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 455678999999999999987654 46999999753 22345678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|.+++.+...+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 999999999999888899999999999999999999998 999999999999999999999999999986543322 3
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .. ....+.+.. ...
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----~~----~i~~~~~~~-p~~----- 227 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FE----LILMEEIRF-PRT----- 227 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH----HHHHCCCCC-CTT-----
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH----HH----HHhcCCCCC-Ccc-----
Confidence 3445699999999999999999999999999999999999999976543221 11 111111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
....+.+++..||+.||++||+ +.|+++
T Consensus 228 ----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1124567889999999999995 788876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-43 Score=371.21 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=197.7
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---hHHHHHHHHHhhccCcCchhhhcccccccC----cee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---DKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ----HRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 580 (797)
|.+.+.||+|+||+||+|+.... ++.||||+++...... .+.|.+|+.++++++||||+++++++...+ ..+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRL-HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCC-CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 55678899999999999998755 4569999997644332 246899999999999999999999987654 378
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
|||||+++++|.+++.....+++.+++.++.||++||+|||++ +|+||||||+|||++.++..+|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CC--cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QT--RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ..............
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~~~~~~~~~~~~- 236 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPIPPSA- 236 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCCCGGG-
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-------HHHHHhcCCCCCch-
Confidence 22 234445699999999999999999999999999999999999999976533221 11111111110000
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRP-TMKKVTLMLEGV 781 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~eVl~~Le~~ 781 (797)
........+.+++.+||+.||++|| |++++++.|.++
T Consensus 237 ------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 237 ------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0000113467788999999999999 899999888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=374.65 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=205.8
Q ss_pred HHhhhhhhCcccceeEEEEEEec----CCcEEEEEEEecccCCC-chHHHHHHHHHhhccCcCchhhhcccccccCceee
Q 003759 507 TQGFKDELGRGAFATVHKGVLAY----ENKICVAVKKLDNMVSG-GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 507 ~~~f~~~LG~G~fG~Vykg~~~~----~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
.+.+.++||+|+||+||+|.+.. ..+..||||+++..... ....|.+|+.++++++||||++++++|..++..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 34456789999999999998753 22467999999754322 23468999999999999999999999999999999
Q ss_pred eeecccCCchhhhcccC----------CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEee
Q 003759 582 VYEFISNGCLAGFLFKN----------PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 651 (797)
||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998532 3468889999999999999999998 9999999999999999999999999
Q ss_pred cCccccccCCC-cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCC-cCCCccccccchhhHHHHHHhhhc
Q 003759 652 GLAKILKADQT-RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCR-KKFEQNVENENQMILVDWAYDCYI 729 (797)
Q Consensus 652 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~ 729 (797)
|+++.+..... .......+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+. . ..+.
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~----~~i~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----L----RFVM 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----H----HHHH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----H----HHHH
Confidence 99987654433 2334446899999999999999999999999999999999985 56654322211 1 1111
Q ss_pred cccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 003759 730 DEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGVVEV 784 (797)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~~~~ 784 (797)
.+......... ...+.+++.+||+.||++||||++|+++|++..+.
T Consensus 250 ~~~~~~~p~~~---------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 EGGLLDKPDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred hCCCCCCcccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 22221111111 13577889999999999999999999999987663
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-43 Score=373.86 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=201.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||+||+|+....+ ..||||+++.. .....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEECCCC-CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 455688999999999999987544 46999998642 22345679999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+++|+|..++.....+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+.... +..+.... ...
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------i~~~~~~~-p~~----- 223 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--------ILNAELRF-PPF----- 223 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHHCCCCC-CTT-----
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH--------HHcCCCCC-CCC-----
Confidence 2345699999999999999999999999999999999999999976533221111 11111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTLM 777 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~~ 777 (797)
....+.+++.+||+.||++|| |++|+++.
T Consensus 224 ----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 ----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 012456788899999999996 89999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.7e-43 Score=364.18 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=200.3
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCc---------hHHHHHHHHHhhccC-cCchhhhcccccccC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGG---------DKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~---------~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~ 577 (797)
|.+.+.||+|+||+||+|+...+ +..||||+++...... .+.+.+|+.++++++ ||||+++++++.+++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~-~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CEEceEEecCcCeEEEEEEECCC-CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 44567899999999999987654 4579999997543221 135889999999996 999999999999999
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
..+|||||+++|+|.++|..+..+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999998888899999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcccccccccCcccccccccc------CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKS------LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDE 731 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (797)
.... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+... .+..+
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~--------~i~~~ 230 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--------MIMSG 230 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHT
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH--------HHHhC
Confidence 5433 2344569999999999853 346889999999999999999999997654322111 11111
Q ss_pred cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 732 KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
...... ..... ..+.+.+++.+||+.||++|||+.||++.
T Consensus 231 ~~~~~~-~~~~~-----~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFGS-PEWDD-----YSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCCT-TTGGG-----SCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCC-ccccc-----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111000 00000 11346788999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=369.71 Aligned_cols=245 Identities=21% Similarity=0.232 Sum_probs=192.2
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhcc-CcCchhhhcccccc----cCceeeeeecc
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQT-NHRNLVKLLGFCNE----DQHRLLVYEFI 586 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~Ey~ 586 (797)
+.||+|+||+||+|+....+ ..||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....++||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~-~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQ-EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEETTTC-CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEECCCC-CEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 45999999999999987654 4699999864 35678899987655 89999999998864 56789999999
Q ss_pred cCCchhhhcccC--CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC---CCcEEEEeecCccccccCC
Q 003759 587 SNGCLAGFLFKN--PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD---SFTARISDFGLAKILKADQ 661 (797)
Q Consensus 587 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 661 (797)
++|+|.+++.+. ..+++.+...|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999764 4689999999999999999999998 9999999999999985 5579999999998765433
Q ss_pred CcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchh
Q 003759 662 TRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDE 741 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (797)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ......+.... ...
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~~~~-~~~-- 239 (335)
T d2ozaa1 169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEF-PNP-- 239 (335)
T ss_dssp C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSSC-CTT--
T ss_pred c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCCCCC-CCc--
Confidence 2 23456999999999999999999999999999999999999999765433211111 11111111100 000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 742 EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 742 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........+.+++..||+.||++|||+.|+++.
T Consensus 240 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011112457788999999999999999999883
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=369.35 Aligned_cols=248 Identities=20% Similarity=0.263 Sum_probs=199.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeeccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFIS 587 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 587 (797)
|.+.+.||+|+||+||+|+...++ ..||||+++... .....+.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~-~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSK-KTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT-EEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCC-cEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 456688999999999999987654 569999997532 234468899999999999999999999999999999999999
Q ss_pred CCchhhhcccCC-CCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC--CCcEEEEeecCccccccCCCcc
Q 003759 588 NGCLAGFLFKNP-KPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD--SFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 588 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
+|+|.+++.... .+++.+...|+.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++.......
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 999999997664 789999999999999999999998 9999999999999985 45899999999987644322
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ...... ... ..
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--------~~~~~~--~~~--~~- 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYT--FDE--EA- 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC--CCH--HH-
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCh--hh-
Confidence 23345899999999999999999999999999999999999999765432211111 111110 000 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.......+.+++..||+.||++|||+.|+++
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001234667899999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-42 Score=372.45 Aligned_cols=243 Identities=23% Similarity=0.221 Sum_probs=200.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 584 (797)
+.+.+.||+|+||.||+|+....+ ..||||++... .....+.+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g-~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESG-NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCC-CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 445678999999999999987554 46999998642 22344678999999999999999999999999999999999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRT 664 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 664 (797)
|+.+|+|..++.+...+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999876532
Q ss_pred cccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhhh
Q 003759 665 TTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEAL 744 (797)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (797)
.....||+.|||||++.+..++.++|||||||++|||+||+.||....... +... +..+.... ...
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~----i~~~~~~~-p~~----- 260 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEK----IVSGKVRF-PSH----- 260 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCCCC-CTT-----
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HHHH----HhcCCCCC-Ccc-----
Confidence 234569999999999999999999999999999999999999997643221 1111 11111110 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 003759 745 HDMMRLKKYVMIAIWCIQEDPSLRP-----TMKKVTL 776 (797)
Q Consensus 745 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~eVl~ 776 (797)
....+.+++..||+.||.+|+ |++|+++
T Consensus 261 ----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 113456788999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=367.11 Aligned_cols=246 Identities=24% Similarity=0.292 Sum_probs=198.8
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc---CCCchHHHHHHHHHhh-ccCcCchhhhcccccccCceeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM---VSGGDKEFRTEVNAIG-QTNHRNLVKLLGFCNEDQHRLLVY 583 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~ 583 (797)
|.+.+.||+|+||+||+|+....+ ..||||++++. .....+.+..|..++. .++|||||++++++.+++..+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~-~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTN-QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT-EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCC-CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 456789999999999999987654 56999999642 1233455667777665 689999999999999999999999
Q ss_pred ecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCc
Q 003759 584 EFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTR 663 (797)
Q Consensus 584 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 663 (797)
||+++|+|.+++.....+++.+...++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999986554332
Q ss_pred ccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccchhhh
Q 003759 664 TTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVENDEEA 743 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (797)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. .. ....+... ....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~----~i~~~~~~-~p~~---- 225 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FH----SIRMDNPF-YPRW---- 225 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH----HHHHCCCC-CCTT----
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH----HH----HHHcCCCC-CCcc----
Confidence 23345699999999999999999999999999999999999999976543221 11 11111111 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003759 744 LHDMMRLKKYVMIAIWCIQEDPSLRPTMK-KVTL 776 (797)
Q Consensus 744 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-eVl~ 776 (797)
....+.+++..||+.||++||++. |+++
T Consensus 226 -----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 -----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 013466788999999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-42 Score=372.87 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=195.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC---CCchHHHHHH---HHHhhccCcCchhhhcccccccCceee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV---SGGDKEFRTE---VNAIGQTNHRNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~---~~~~~~f~~E---~~~l~~l~h~niv~l~g~~~~~~~~~l 581 (797)
|.+.+.||+|+||.||+|+....+ ..||||++.... ......+.+| +.+++.++|||||++++++.+.+..++
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~-~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTG-KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCC-CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 445678999999999999987654 469999986421 1223334444 677778899999999999999999999
Q ss_pred eeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCC
Q 003759 582 VYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQ 661 (797)
Q Consensus 582 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 661 (797)
||||+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999998888899999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccccch
Q 003759 662 TRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVEND 740 (797)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (797)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......... +. ......... .....
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~----~~~~~~~~~-~~~~~ 232 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID----RMTLTMAVE-LPDSF 232 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HH----HHSSSCCCC-CCSSS
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HH----HhcccCCCC-CCCCC
Confidence 234469999999999864 568999999999999999999999997654332111 11 111111110 00111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 741 EEALHDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
...+.+++..||+.||++||| ++|+++
T Consensus 233 ---------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 233 ---------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 124567889999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=359.59 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=196.8
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.++||+|+||+||+|+....+ +.||||+++.... ...+++.+|++++++++|||||++++++.++++.++||||+
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTG-EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTC-CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeccEEecCcCeEEEEEEECCCC-CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 34578999999999999987654 4699999965332 23567999999999999999999999999999999999999
Q ss_pred cCCchhhhccc-CCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 587 SNGCLAGFLFK-NPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 587 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
.++.+...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~ 159 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 159 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CT
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-cc
Confidence 76655444333 45689999999999999999999998 999999999999999999999999999987654332 33
Q ss_pred ccccccCccccccccccCC-CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh-------hh-cccc----
Q 003759 666 TAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD-------CY-IDEK---- 732 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~-~~~~---- 732 (797)
....||+.|+|||.+.... ++.++|||||||++|+|++|+.||......+....+...... .. ....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 3446999999999887765 588999999999999999999999765432211111100000 00 0000
Q ss_pred ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 003759 733 LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGV 781 (797)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~ 781 (797)
........... ........+.+++.+||+.||++|||++|+++. |+++
T Consensus 240 ~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000000000 000112456788999999999999999999985 5443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=359.54 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=195.4
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhcc---CcCchhhhccccc-----ccC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQT---NHRNLVKLLGFCN-----EDQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 577 (797)
|.+.++||+|+||+||+|++...+++.||||+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 45567899999999999998666567799999865322 2334577788887766 7999999999884 345
Q ss_pred ceeeeeecccCCchhhhcc-cCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 578 HRLLVYEFISNGCLAGFLF-KNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
..+++|||++++.+..... ....+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 7899999999988765544 346688999999999999999999998 999999999999999999999999999886
Q ss_pred cccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh----hhcc--
Q 003759 657 LKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD----CYID-- 730 (797)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~-- 730 (797)
..... ......||+.|+|||++.+.+++.++||||+||++|||++|+.||......+....+...... .+..
T Consensus 166 ~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 166 YSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 54332 334456999999999999999999999999999999999999999765433221111111000 0000
Q ss_pred ---c-cccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 731 ---E-KLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 731 ---~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. ............ ......+.+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGG-TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhh-ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000 000011346678999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-41 Score=353.58 Aligned_cols=262 Identities=20% Similarity=0.216 Sum_probs=196.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccC--CCchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeecc
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMV--SGGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
.+.++||+|+||+||+|+.+ ++..||||+++... ....+.+.+|+.++++++||||+++++++..++..++++||+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 34578999999999999885 34569999996542 233568999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCcccc
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTTT 666 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 666 (797)
.++.+..+......++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccc
Confidence 9988888887788899999999999999999999998 999999999999999999999999999987654332 223
Q ss_pred cccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHh----hh----ccccccc--
Q 003759 667 AIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYD----CY----IDEKLHL-- 735 (797)
Q Consensus 667 ~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~----~~~~~~~-- 735 (797)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...... .+ .......
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 34589999999998754 5799999999999999999999999765432221111100000 00 0000000
Q ss_pred -cccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 736 -LVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 736 -~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
.................+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000001235678899999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=353.65 Aligned_cols=239 Identities=23% Similarity=0.386 Sum_probs=193.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------chHHHHHHHHHhhccC--cCchhhhcccccccCce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------GDKEFRTEVNAIGQTN--HRNLVKLLGFCNEDQHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 579 (797)
|.+.+.||+|+||+||+|+...++ ..||||+++..... ..+++.+|+.++++++ |||||++++++.+.+..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDN-LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCC-CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 556788999999999999987554 56999998653221 1234778999999986 89999999999999999
Q ss_pred eeeeecccC-CchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-CCcEEEEeecCcccc
Q 003759 580 LLVYEFISN-GCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-SFTARISDFGLAKIL 657 (797)
Q Consensus 580 ~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~ 657 (797)
++||||+.+ +++.+++.+...+++.++..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 999999976 67888888778899999999999999999999998 9999999999999985 479999999999865
Q ss_pred ccCCCcccccccccCccccccccccCCC-CccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccc
Q 003759 658 KADQTRTTTAIRGTRGYVAPEWFKSLPI-TMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLL 736 (797)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (797)
... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +. . ....
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~---~-----~~~~-- 222 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II---R-----GQVF-- 222 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH---H-----CCCC--
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh---h-----cccC--
Confidence 432 2334569999999999987765 6779999999999999999999965321 10 0 0000
Q ss_pred ccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 737 VENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
.... ....+.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 01346678899999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-40 Score=350.76 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=196.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEeccc--CCCchHHHHHHHHHhhccCcCchhhhcccccc--------cC
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNM--VSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE--------DQ 577 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~ 577 (797)
|.+.++||+|+||+||+|+....+ ..||||++... .....+++.+|+.+|++++||||+++++++.. ++
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTG-QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC-CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred EEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 445678999999999999987544 46999998543 23345678999999999999999999998754 35
Q ss_pred ceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccc
Q 003759 578 HRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKIL 657 (797)
Q Consensus 578 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 657 (797)
+.++||||++++.+.........++......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 6899999999998887777777889999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCC---cccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc-
Q 003759 658 KADQT---RTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK- 732 (797)
Q Consensus 658 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 732 (797)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...... .....
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CChhhc
Confidence 54322 222334689999999998765 6899999999999999999999999765433322211111100 00000
Q ss_pred -------c----cccc---cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 733 -------L----HLLV---ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 733 -------~----~~~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
. .... ...............+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0000 0001111112223456789999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-39 Score=342.13 Aligned_cols=258 Identities=17% Similarity=0.205 Sum_probs=193.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcc-cccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLG-FCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g-~~~~~~~~~lV~Ey~ 586 (797)
|.+.+.||+|+||+||+|++...+ ..||||++... ...+++..|++++++++|+|++..+. +..+++..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~-~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAG-EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT-EEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCC-CEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 556788999999999999987544 56999998753 33456889999999998777666554 556777889999999
Q ss_pred cCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEc---CCCcEEEEeecCccccccCCC-
Q 003759 587 SNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLD---DSFTARISDFGLAKILKADQT- 662 (797)
Q Consensus 587 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~~- 662 (797)
.++.+..+......+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 5544444444567899999999999999999999998 999999999999985 455799999999997754322
Q ss_pred -----cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccccccc
Q 003759 663 -----RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLV 737 (797)
Q Consensus 663 -----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (797)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||.................... ........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLC 241 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCHHHHT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCChhHhc
Confidence 233455799999999999999999999999999999999999999976544332221111111000 00000000
Q ss_pred cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 738 ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.. ....+.+++..|++.||++||+++++.+.|+.+
T Consensus 242 ~~---------~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 242 KG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TT---------SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cC---------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 123467788899999999999999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=350.57 Aligned_cols=259 Identities=21% Similarity=0.234 Sum_probs=189.0
Q ss_pred hhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCchhhhcccccc------cCceeee
Q 003759 509 GFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNLVKLLGFCNE------DQHRLLV 582 (797)
Q Consensus 509 ~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV 582 (797)
...++||+|+||+||+|++...+ ..||||++..... .+.+|++++++++||||+++++++.. ..+.+||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSG-ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCC-CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 34568999999999999987654 4699999975432 23469999999999999999998843 2357899
Q ss_pred eecccCCchhhhc---ccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccc
Q 003759 583 YEFISNGCLAGFL---FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILK 658 (797)
Q Consensus 583 ~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~ 658 (797)
|||++++.+..+. .....+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..+.
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999877544433 3456799999999999999999999998 999999999999999775 89999999998765
Q ss_pred cCCCcccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHH-------Hhhh--
Q 003759 659 ADQTRTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWA-------YDCY-- 728 (797)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~~~-- 728 (797)
.... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ....
T Consensus 175 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 4332 233468999999998765 578999999999999999999999997654332211111100 0000
Q ss_pred --ccccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 729 --IDEKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 729 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........................+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000001111112356788999999999999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=349.15 Aligned_cols=267 Identities=22% Similarity=0.248 Sum_probs=192.5
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC-CchHHHHHHHHHhhccCcCchhhhcccccccC----ceeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS-GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ----HRLLV 582 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV 582 (797)
|.+.++||+|+||+||+|+...++ ..||||+++.... ...+.+.+|+.+|++++||||+++++++.... ..+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNK-VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTC-SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCC-cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 445578999999999999986554 4699999975432 22357889999999999999999999986543 23455
Q ss_pred eecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCC
Q 003759 583 YEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQT 662 (797)
Q Consensus 583 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 662 (797)
++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 567779999999964 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred --cccccccccCcccccccccc-CCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccc-------
Q 003759 663 --RTTTAIRGTRGYVAPEWFKS-LPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEK------- 732 (797)
Q Consensus 663 --~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 732 (797)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+........ ........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINL 243 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCHHHHHTCCCH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh-ccCCChhhhhhhhhh
Confidence 22344568999999999854 46789999999999999999999999765432211111000 00000000
Q ss_pred --------ccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 003759 733 --------LHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGV 781 (797)
Q Consensus 733 --------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~ 781 (797)
............ ......++.+++..||+.||++|||++|+++. |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000000 00001356789999999999999999999975 5443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-40 Score=349.82 Aligned_cols=252 Identities=23% Similarity=0.226 Sum_probs=202.0
Q ss_pred HhhhhhhCcccceeEEEEEEecC--CcEEEEEEEecccC----CCchHHHHHHHHHhhccCc-CchhhhcccccccCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYE--NKICVAVKKLDNMV----SGGDKEFRTEVNAIGQTNH-RNLVKLLGFCNEDQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 580 (797)
|.+.+.||+|+||+||+|..... .+..||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 56678999999999999987432 35679999986432 2334678899999999966 89999999999999999
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
++|||+.+|+|.+++.....++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999998888888999999999999999999998 9999999999999999999999999999877655
Q ss_pred CCcccccccccCccccccccccC--CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccccccc
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSL--PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLHLLVE 738 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (797)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+...... .... .
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~----~~~~-~-- 255 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SEPP-Y-- 255 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----CCCC-C--
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc----CCCC-C--
Confidence 55445556799999999999764 4688999999999999999999999876554433222211111 1110 0
Q ss_pred chhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 003759 739 NDEEALHDMMRLKKYVMIAIWCIQEDPSLRPT-----MKKVTL 776 (797)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~eVl~ 776 (797)
+ ......+.+++..||+.||++||| ++|+++
T Consensus 256 --~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 256 --P-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --C-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --c-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 011235667888999999999994 788886
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=348.79 Aligned_cols=270 Identities=24% Similarity=0.290 Sum_probs=190.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccccC------ce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQ------HR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 579 (797)
|.+.++||+|+||+||+|+....+ ..||||+++..... ..+.+.+|+++|++++|||||++++++...+ +.
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTG-AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEEC------CEEEEEETTTC-CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 445578999999999999987544 56999999754322 2346889999999999999999999987654 56
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+ +.+|..++ +...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++....
T Consensus 99 ~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 55676665 445799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH-------hhhcc-
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------DCYID- 730 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 730 (797)
. .+...+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................. .....
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 3 2345689999999998764 578999999999999999999999976543221111110000 00000
Q ss_pred ------ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 003759 731 ------EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM--LEGVVEVPIPP 788 (797)
Q Consensus 731 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~--Le~~~~~~~p~ 788 (797)
............... ......+.+++.+||+.||++|||+.|+++. |+++.+...+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred hhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 000000000000000 0011345688999999999999999999985 66665544433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=340.35 Aligned_cols=264 Identities=19% Similarity=0.205 Sum_probs=199.9
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCC--CchHHHHHHHHHhhccCcCchhhhcccccccCceeeeeec
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVS--GGDKEFRTEVNAIGQTNHRNLVKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 585 (797)
|.+.++||+|+||+||+|++..++ ..||||+++.... ...+++.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEeeeEEecCcCeEEEEEEECCCC-cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 344578999999999999987544 5699999865432 2346789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccCCCccc
Q 003759 586 ISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKADQTRTT 665 (797)
Q Consensus 586 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 665 (797)
+.+++|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... ..
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 99999999988888899999999999999999999998 999999999999999999999999999987654332 22
Q ss_pred ccccccCccccccccccCC-CCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhccccc---ccc-----
Q 003759 666 TAIRGTRGYVAPEWFKSLP-ITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKL---HLL----- 736 (797)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 736 (797)
....+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+................. ...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 3334778899999987665 6999999999999999999999975433322211111100000000000 000
Q ss_pred ---ccc-hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 737 ---VEN-DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 737 ---~~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
... .............+.+++.+||+.||++|||++||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000111234677899999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-38 Score=336.31 Aligned_cols=257 Identities=17% Similarity=0.194 Sum_probs=200.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc-CchhhhcccccccCceeeeeecc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH-RNLVKLLGFCNEDQHRLLVYEFI 586 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~Ey~ 586 (797)
|.+.+.||+|+||+||+|+.... +..||||++... ...+++.+|++++..++| +|++.+++++.++...++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT-TEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 45678899999999999998754 456999998653 234568889999999965 89999999999999999999998
Q ss_pred cCCchhhhcccC-CCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcC-----CCcEEEEeecCccccccC
Q 003759 587 SNGCLAGFLFKN-PKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDD-----SFTARISDFGLAKILKAD 660 (797)
Q Consensus 587 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~ 660 (797)
+++|.+++... ..++..++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68998888654 5689999999999999999999998 9999999999999974 578999999999876543
Q ss_pred CC------cccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhhhcccccc
Q 003759 661 QT------RTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDCYIDEKLH 734 (797)
Q Consensus 661 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (797)
.. .......||+.|||||.+.+..++.++||||||+++|||+||+.||.............. ...........
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCCChH
Confidence 21 223345799999999999999999999999999999999999999976544332211111 11100000111
Q ss_pred ccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 003759 735 LLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLMLEGV 781 (797)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~Le~~ 781 (797)
.+... ..+++.+++..|++.+|++||+.+.+.+.|+++
T Consensus 239 ~l~~~---------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 239 ELCAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHTTT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhcCC---------CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 113466778889999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-38 Score=338.45 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=192.2
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccc--cCceeeeee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNE--DQHRLLVYE 584 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~E 584 (797)
+.+.++||+|+||+||+|+.... +..||||+++. ...+++.+|+.+|.+++ ||||+++++++.. ....++|||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~-~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCC-CCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 55668899999999999998754 45699999875 34578899999999995 9999999999864 456899999
Q ss_pred cccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC-cEEEEeecCccccccCCCc
Q 003759 585 FISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF-TARISDFGLAKILKADQTR 663 (797)
Q Consensus 585 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 663 (797)
|+++++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++........
T Consensus 113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence 99999998764 4588999999999999999999998 999999999999998654 699999999987654332
Q ss_pred ccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHH-H---------HHHhhhc--c
Q 003759 664 TTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILV-D---------WAYDCYI--D 730 (797)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~-~---------~~~~~~~--~ 730 (797)
.....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............. . +...... .
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 3344589999999998765 47999999999999999999999997654322211111 0 0000000 0
Q ss_pred ccccccc--------cchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003759 731 EKLHLLV--------ENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL 776 (797)
Q Consensus 731 ~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~ 776 (797)
....... ...............+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000000000111235678999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-38 Score=339.05 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=185.6
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccc------cCce
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNE------DQHR 579 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 579 (797)
|.+.++||+|+||+||+|++... +..||||++...... ..+++.+|+.++++++||||+++++++.. .++.
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTT-TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCcCeEEEEEEECCC-CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 34457899999999999998754 456999999754332 22468899999999999999999999853 4688
Q ss_pred eeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCcccccc
Q 003759 580 LLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKA 659 (797)
Q Consensus 580 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 659 (797)
++||||+.++.+..+ ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++....
T Consensus 98 ~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 98 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc
Confidence 999999977655544 24578999999999999999999998 999999999999999999999999999886544
Q ss_pred CCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHH--------------
Q 003759 660 DQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAY-------------- 725 (797)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~-------------- 725 (797)
.. ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...........+.....
T Consensus 172 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 32 23344589999999999999999999999999999999999999975533221111110000
Q ss_pred hhhccccc-------cccccc---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003759 726 DCYIDEKL-------HLLVEN---DEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTLM 777 (797)
Q Consensus 726 ~~~~~~~~-------~~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~~ 777 (797)
........ ...... .............+.+++.+||+.||++|||++||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000000 00111122334567889999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=333.32 Aligned_cols=269 Identities=22% Similarity=0.248 Sum_probs=194.0
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC--chHHHHHHHHHhhccCcCchhhhcccccc-----cCcee
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG--GDKEFRTEVNAIGQTNHRNLVKLLGFCNE-----DQHRL 580 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 580 (797)
|...++||+|+||+||+|+.... +..||||+++..... ..+++.+|+.++++++|||||++++++.. ....+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTT-TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCC-CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 44567899999999999988654 457999999754332 23468899999999999999999998853 33456
Q ss_pred eeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEeecCccccccC
Q 003759 581 LVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDFGLAKILKAD 660 (797)
Q Consensus 581 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 660 (797)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc-
Confidence 77788899999999854 5689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcccccccccCccccccccccC-CCCccCceehHHHHHHHHHhCCcCCCccccccchhhHHHHHHhh----hc---c--
Q 003759 661 QTRTTTAIRGTRGYVAPEWFKSL-PITMKVDIYSFGVMLLELICCRKKFEQNVENENQMILVDWAYDC----YI---D-- 730 (797)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~---~-- 730 (797)
......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+....... .. .
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23344588999999987665 46899999999999999999999997654332211111110000 00 0
Q ss_pred -----ccccccccchhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCC
Q 003759 731 -----EKLHLLVENDEEALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVTL--MLEGVVEVPI 786 (797)
Q Consensus 731 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl~--~Le~~~~~~~ 786 (797)
.............. .......+.+++.+||+.||++|||++|+++ .+.+..+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 00000000000000 0001234678899999999999999999997 4555544433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-33 Score=305.73 Aligned_cols=276 Identities=22% Similarity=0.209 Sum_probs=188.1
Q ss_pred HhhhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-----------cCchhhhccccccc
Q 003759 508 QGFKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-----------HRNLVKLLGFCNED 576 (797)
Q Consensus 508 ~~f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~~~~ 576 (797)
|.+.++||+|+||+||+|+.... +..||||+++... ...+.+.+|+.+++.++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~-g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 56678999999999999998754 4569999997532 22356788998888875 57788888887653
Q ss_pred --CceeeeeecccCCchhhhc---ccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCC------c
Q 003759 577 --QHRLLVYEFISNGCLAGFL---FKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSF------T 645 (797)
Q Consensus 577 --~~~~lV~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~------~ 645 (797)
...+++++++..+...... .....++...+..++.||+.||+|||+. .+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 3455666665544322222 2345678889999999999999999983 2899999999999998655 3
Q ss_pred EEEEeecCccccccCCCcccccccccCccccccccccCCCCccCceehHHHHHHHHHhCCcCCCccccccch---hhHHH
Q 003759 646 ARISDFGLAKILKADQTRTTTAIRGTRGYVAPEWFKSLPITMKVDIYSFGVMLLELICCRKKFEQNVENENQ---MILVD 722 (797)
Q Consensus 646 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~Gvll~elltG~~p~~~~~~~~~~---~~~~~ 722 (797)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999765432 23445899999999999999999999999999999999999999754322110 00100
Q ss_pred HHHh-----------------hhccc----cccccccchh------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003759 723 WAYD-----------------CYIDE----KLHLLVENDE------EALHDMMRLKKYVMIAIWCIQEDPSLRPTMKKVT 775 (797)
Q Consensus 723 ~~~~-----------------~~~~~----~~~~~~~~~~------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~eVl 775 (797)
.... ..... .+........ ...........+.+++..||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000 00000 0000000000 0011123446788999999999999999999999
Q ss_pred HH--Hhc---CcCCCCCCCCC
Q 003759 776 LM--LEG---VVEVPIPPDPS 791 (797)
Q Consensus 776 ~~--Le~---~~~~~~p~~p~ 791 (797)
+. +++ ..+...|+.|.
T Consensus 327 ~Hp~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 327 NHPWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp TCGGGTTCTTCTTCCCTTSCT
T ss_pred cCcccCCCCCcccCCCCCccc
Confidence 85 543 33445555443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=2.9e-20 Score=164.09 Aligned_cols=111 Identities=19% Similarity=0.397 Sum_probs=91.9
Q ss_pred ccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEc
Q 003759 23 AQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTD 102 (797)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~ 102 (797)
+|+|.|||.|.+++. |+ +|.|+|.|+.+++ |.++.. .++||.||++.|.. .+.+.|+.||+|+|+|
T Consensus 1 tDtL~~gq~L~~g~~---l~--~g~~~l~~q~DGN----Lvly~~----~~~vW~s~~~~~~~-~~~l~l~~dGnLvl~~ 66 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGS---LA--EGGYLFIIQNDCN----LVLYDN----NRAVWASGTNGKAS-GCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CCEEETTEEECTTCE---EE--ETTEEEEECTTSC----EEEEET----TEEEEECCCTTSCS-SEEEEECTTSCEEEEE
T ss_pred CCEecCCCEecCCCE---EE--ECCEEEEEcCCCC----EEEEcC----CcEEEEccCccCCC-CcEEEEeccccEEEEe
Confidence 489999999987664 65 4999999997775 555553 58999999998854 4679999999999999
Q ss_pred CCCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeeeccCCCC
Q 003759 103 LTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWESFDHPTD 148 (797)
Q Consensus 103 ~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTD 148 (797)
. +..+|++++.. .+..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus 67 ~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 67 G-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp T-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred c-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 5 56777776554 345689999999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=1.3e-20 Score=184.38 Aligned_cols=162 Identities=17% Similarity=0.109 Sum_probs=117.0
Q ss_pred hhhhhCcccceeEEEEEEecCCcEEEEEEEecccCCC------------------chHHHHHHHHHhhccCcCchhhhcc
Q 003759 510 FKDELGRGAFATVHKGVLAYENKICVAVKKLDNMVSG------------------GDKEFRTEVNAIGQTNHRNLVKLLG 571 (797)
Q Consensus 510 f~~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~~~------------------~~~~f~~E~~~l~~l~h~niv~l~g 571 (797)
+.++||+|+||+||+|+.. ++..||||+++..... ....+..|...+.++.|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999875 3457999987532111 0122456788888899999888776
Q ss_pred cccccCceeeeeecccCCchhhhcccCCCCChhhHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEcCCCcEEEEee
Q 003759 572 FCNEDQHRLLVYEFISNGCLAGFLFKNPKPSWYRRMQIAFGIARGLFYLHEECTTQIIHCDIKPQNILLDDSFTARISDF 651 (797)
Q Consensus 572 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 651 (797)
+. ..+++|||+++..+.+ ++......++.|++++|+|||+. +|+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 53 2479999998876544 34555678999999999999998 99999999999999975 5899999
Q ss_pred cCccccccCCCcccccccccCccccc------cccccCCCCccCceehHHHHH
Q 003759 652 GLAKILKADQTRTTTAIRGTRGYVAP------EWFKSLPITMKVDIYSFGVML 698 (797)
Q Consensus 652 gla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~~sDVwS~Gvll 698 (797)
|+|......... .|+.. |.+ .+.+..++|+||..--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999765432211 11111 122 34678889999975443
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=6.4e-20 Score=160.20 Aligned_cols=106 Identities=25% Similarity=0.445 Sum_probs=88.7
Q ss_pred cccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcC
Q 003759 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103 (797)
Q Consensus 24 ~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~ 103 (797)
|+|.+||.|.+++. |+ +|.|.|+|+.+++ |.++. ..++||+||++.|...++.+.|+.||+|+|+|+
T Consensus 2 ~~L~~g~~L~~g~~---l~--~g~~~l~~q~dgn----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQS---LD--VEPYHFIMQEDCN----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CEEETTCEEETTCE---EE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS
T ss_pred CCccCCCEEeCCCE---EE--eCCEEEEecCCCe----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC
Confidence 67899999987654 44 5899999987665 44443 358999999999998888999999999999999
Q ss_pred CCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeeeccC
Q 003759 104 TGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWESFDH 145 (797)
Q Consensus 104 ~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqSFD~ 145 (797)
+|++||+|+++. .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 999999998763 4556899999999999974 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.77 E-value=3.3e-19 Score=155.57 Aligned_cols=105 Identities=25% Similarity=0.397 Sum_probs=86.7
Q ss_pred cccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEEcC
Q 003759 24 QNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLTDL 103 (797)
Q Consensus 24 ~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~~~ 103 (797)
|+|.+||.|.+++. | .+|.|.|.|+.+++ |.||.. .++||.||++.|.. .+.+.++.+|+|+|+++
T Consensus 2 ~~L~~g~~L~~G~~---l--~ng~~~l~~q~DGN----Lvly~~----~~~vW~s~~~~~~~-~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 2 NILYSGETLSTGEF---L--NYGSFVFIMQEDCN----LVLYDV----DKPIWATNTGGLSR-SCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CEEETTEEECTTCE---E--EETTEEEEECTTSC----EEEEET----TEEEEECCCTTSCS-SCEEEECTTSCEEEECT
T ss_pred CCccCCCEecCCCE---E--EcCCEEEEECCCCe----EEEEeC----CceeeEeCCCCCCC-ccEEEEeccceEEEECC
Confidence 67889999977654 4 36999999998875 566654 58899999998843 56799999999999999
Q ss_pred CCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccC
Q 003759 104 TGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDH 145 (797)
Q Consensus 104 ~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~ 145 (797)
+|.+||++++.... ..+|+|+|+|||||+++ .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99999999876443 45789999999999964 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.75 E-value=1e-18 Score=154.97 Aligned_cols=101 Identities=24% Similarity=0.424 Sum_probs=87.3
Q ss_pred EEEeccCCCCeEEEEeCCCCCCccC-ceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCcee
Q 003759 63 TIYFNKIPERTIIWSANGKTPVERG-SKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLW 140 (797)
Q Consensus 63 ~iw~~~~~~~t~vW~Anr~~p~~~~-~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lW 140 (797)
-|||.++++++.+|++|++.|+..+ .+|.++.||||+|++. +.+||++++.+.+ ...|+|+++|||||+|.++.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 4899999999999999999999754 4799999999999985 7789999877543 46899999999999999999999
Q ss_pred eeccCCCCCCCCCcccCCCceEEecCCCCCCCCCceEEEEcCCCceEEE
Q 003759 141 ESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLY 189 (797)
Q Consensus 141 qSFD~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 189 (797)
|||. +.++|.|.+.||+||++++|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9973 34678999999999999998
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=1.7e-17 Score=145.47 Aligned_cols=111 Identities=25% Similarity=0.375 Sum_probs=95.9
Q ss_pred EEEeccCCCCeEEEEeCCCCCCccC-ceeeEeeCceEEEEcCCCceEeccCCCCCceeEEEEecCCCeEEecCCCCceee
Q 003759 63 TIYFNKIPERTIIWSANGKTPVERG-SKVQLTVDGRLVLTDLTGKEVWNPDTAGAAIAYASMLDSGNFVLAGPDSFPLWE 141 (797)
Q Consensus 63 ~iw~~~~~~~t~vW~Anr~~p~~~~-~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~a~l~d~GNlvl~~~~~~~lWq 141 (797)
.|||.-.++.+..|+.+.+.++.++ .++.+..||||||++ ++.++|++++.+..+..+.|+|+|||||++.++.++||
T Consensus 2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CCCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred cEEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEE
Confidence 3789888889999999999999754 478999999999998 57899999988777789999999999999999999999
Q ss_pred eccCCCCCCCCCcccCCCceEEecCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCC
Q 003759 142 SFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPV 208 (797)
Q Consensus 142 SFD~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~ 208 (797)
|+. +.++|.|.+.||+||++++|. .++|.+++.
T Consensus 81 S~t-------------------------~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt~ 113 (115)
T d1dlpa1 81 SGT-------------------------KGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS 113 (115)
T ss_dssp CCC-------------------------CCCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred cCC-------------------------CCCCCCEEEEECCCCcEEEeC---------CCeecCCCC
Confidence 863 346899999999999999872 368987654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.57 E-value=4e-15 Score=131.11 Aligned_cols=104 Identities=25% Similarity=0.339 Sum_probs=83.9
Q ss_pred cccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEEEE
Q 003759 22 TAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLVLT 101 (797)
Q Consensus 22 ~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~l~ 101 (797)
..++|.+||+|. ..+..|.|.|.|+.++| |-+ |. ..++||.||+..|.. .+.+.|..||+|+|.
T Consensus 13 ~~~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN----LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 13 HPQILHATESLE-------ILFGTHVYRFIMQTDCN----LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVI 76 (119)
T ss_dssp CCCEEETTCEEE-------EEETTEEEEEEECTTSC----EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEE
T ss_pred CCCEEeCCCeEE-------EecCCceEEEEECCCCc----EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEE
Confidence 347888998884 35778999999998886 333 32 368999999987753 478999999999999
Q ss_pred cCCCceEeccCCCCC-ceeEEEEecCCCeEEecCCCCceeeecc
Q 003759 102 DLTGKEVWNPDTAGA-AIAYASMLDSGNFVLAGPDSFPLWESFD 144 (797)
Q Consensus 102 ~~~~~~vW~t~~~~~-~~~~a~l~d~GNlvl~~~~~~~lWqSFD 144 (797)
|++|.+||++++... ...+++|+|||||||++ .++|||-.
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 999999999987653 34579999999999996 47999854
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.37 E-value=1.4e-13 Score=120.06 Aligned_cols=100 Identities=23% Similarity=0.368 Sum_probs=79.6
Q ss_pred cccccccCCCCceeecCCCceeeeCCCeEEEeEEecCCCCeEEEEEeccCCCCeEEEEeCCCCCCccCceeeEeeCceEE
Q 003759 20 SATAQNVSRGESLMAEDDMSSWKSTSGEFAFGFQHIENGNYLLTIYFNKIPERTIIWSANGKTPVERGSKVQLTVDGRLV 99 (797)
Q Consensus 20 ~~~~~~i~~g~~l~~~~~~~~~~S~~g~f~lgf~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~~~~~~g~l~ 99 (797)
..++++|.+||+|. +|.|.|.|+.+++ |.++.. .++||.+|...+ ..+.+.|..|||||
T Consensus 11 ~~~~~tl~~~~~l~-----------~g~~~l~~q~DGN----LvL~~~----~~~vW~s~t~~~--~~~~l~l~~dGNLv 69 (115)
T d1dlpa1 11 GSHPQTLHAAQSLE-----------LSSFRFTMQSDCN----LVLFDS----DVRVWASNTAGA--TGCRAVLQSDGLLV 69 (115)
T ss_dssp SCSCSCCCTTCEEC-----------STTEEEEECTTSC----EEEEES----SSEEECCCCCSC--SCCBCCBCSSSCBC
T ss_pred CCCcceecCCCcEE-----------cCCEEEEECCCCe----EEEEcC----CeeEEEcccCCC--CceEEEEeccCCEE
Confidence 45568899988874 3789999998876 555542 478999986543 35788999999999
Q ss_pred EEcCCCceEeccCCCC-CceeEEEEecCCCeEEecCCCCceeeec
Q 003759 100 LTDLTGKEVWNPDTAG-AAIAYASMLDSGNFVLAGPDSFPLWESF 143 (797)
Q Consensus 100 l~~~~~~~vW~t~~~~-~~~~~a~l~d~GNlvl~~~~~~~lWqSF 143 (797)
|+|.++++||++.+.. .+..+++|++||||||++ ..+|+|-
T Consensus 70 l~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECS
T ss_pred EEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCC
Confidence 9999999999998764 344579999999999995 4799984
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.18 E-value=4.4e-11 Score=104.79 Aligned_cols=84 Identities=29% Similarity=0.530 Sum_probs=68.2
Q ss_pred eeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEecCC
Q 003759 89 KVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYS 167 (797)
Q Consensus 89 ~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~~s 167 (797)
.|.+..||||||+++ +.+||++++.+.. ...+.|+++|||||+|.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~------------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP------------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS------------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC------------------------
Confidence 567888999999984 6789999976543 47899999999999999999999862
Q ss_pred CCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCC
Q 003759 168 DKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207 (797)
Q Consensus 168 ~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 207 (797)
..-+.|.|.+.||+||++++|. .+.|.+++
T Consensus 88 -t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 88 -VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp -CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred -CcCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 1124578999999999999983 25787765
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.09 E-value=1.9e-10 Score=99.18 Aligned_cols=78 Identities=32% Similarity=0.589 Sum_probs=64.5
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCCc-eeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEec
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGAA-IAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAH 165 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~ 165 (797)
.-++.+..||||||++ .+.+||++++.+.. ...++|+++|||||++.++.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 3567888999999998 56899999977544 4589999999999999999999986
Q ss_pred CCCCCCCCCceEEEEcCCCceEEEe
Q 003759 166 YSDKNYSTGRYELAMQSDGNLVLYT 190 (797)
Q Consensus 166 ~s~~dps~G~y~l~~~~~g~~~~~~ 190 (797)
......+.|.+.|+.+|++++|.
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEEE
T ss_pred --cccCCCCcEEEEEcCCCCEEEeC
Confidence 11224678999999999999983
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.08 E-value=2e-10 Score=99.08 Aligned_cols=86 Identities=34% Similarity=0.528 Sum_probs=68.0
Q ss_pred CceeeEeeCceEEEEcCCCceEeccCCCCC--ceeEEEEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEe
Q 003759 87 GSKVQLTVDGRLVLTDLTGKEVWNPDTAGA--AIAYASMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSA 164 (797)
Q Consensus 87 ~~~~~~~~~g~l~l~~~~~~~vW~t~~~~~--~~~~a~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S 164 (797)
.-.+.+..||||+|++ .+.+||++++... ....+.|.++|||||+++++.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s---------------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS---------------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC----------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE----------------------
Confidence 3467788899999997 6689999987643 34679999999999999999999987
Q ss_pred cCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCC
Q 003759 165 HYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQP 207 (797)
Q Consensus 165 ~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 207 (797)
.+..+.|.|.+.|+++|++++|. ...|.+.+
T Consensus 77 ---~t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t 107 (109)
T d1kj1a_ 77 ---HSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGT 107 (109)
T ss_dssp ---CCCCCSSCCEEEECTTSCEEEEC---------CEEEECCC
T ss_pred ---eeECCCCCEEEEEeCCCcEEEEC---------CCEecCCC
Confidence 11124578999999999999973 24787654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.07 E-value=1.5e-10 Score=101.60 Aligned_cols=108 Identities=27% Similarity=0.371 Sum_probs=72.7
Q ss_pred EEecCCCeEEecCCCCceeeeccCCCCCCCCCcccCCCceEEecCCCCCCCCCceEEEEcCCCceEEEeccCCccccCcc
Q 003759 122 SMLDSGNFVLAGPDSFPLWESFDHPTDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSV 201 (797)
Q Consensus 122 ~l~d~GNlvl~~~~~~~lWqSFD~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~ 201 (797)
+++|+||+|+++. +|+|.|++||.++|.|. .|.|+|.||.||+++++... .+
T Consensus 4 v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~~-------~~ 55 (120)
T d1dlpa2 4 VVANNGNSILYST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDRD-------DR 55 (120)
T ss_dssp CCSSCCCEECCCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBTT-------BC
T ss_pred EEEeCCCeEEEcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecCC-------cE
Confidence 3455555555443 67899999999999874 58899999999999998532 45
Q ss_pred ccccCCCC--CceeeeecccccEEEEEecCceEEEEEeccCccccceeEEEEEeeCCeEEEE
Q 003759 202 YWSTQPVG--SSLQVEFNRSGNIIYLTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHY 261 (797)
Q Consensus 202 yw~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~~ 261 (797)
+|.+...+ ....+.++.+|.++.+.. ++..+..... .. ....++++|+.||++++|
T Consensus 56 vW~s~t~~~~~~~~~~l~~~GnLvl~d~-~~~~lW~S~t--~~-~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 56 VWSTNTAGKGTGCRAVLQPNGRMDVLTN-QNIAVWTSGN--SR-SAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CSCCCCCSSCSSCEEEEETTTEEEEEET-TTEEEEECCC--CC-SSSCCEEEECSSSCEEEE
T ss_pred EEEEccccCCCcEEEEEeCCeeEEEEcC-CCCEEEEeCC--CC-CCCcEEEEECCCCcEEEe
Confidence 78765543 345678888898655544 4433322211 11 112458999999999999
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.80 E-value=1e-08 Score=88.85 Aligned_cols=95 Identities=26% Similarity=0.388 Sum_probs=69.8
Q ss_pred CCCCCCCcccCCCceEEecCCCCCCCCCceEEEEcCCCceEEEeccCCccccCccccccCCCC--CceeeeecccccEEE
Q 003759 147 TDTLLPTQILNPRNKLSAHYSDKNYSTGRYELAMQSDGNLVLYTTAFPFESANSVYWSTQPVG--SSLQVEFNRSGNIIY 224 (797)
Q Consensus 147 TDTlLpg~~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~--~~~~~~~~~~~~~~~ 224 (797)
||||+|||.|..+..|++ |.|+|.||.||++++|.. ..++|...+.+ ....+.++.+|.++.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~-------~~~vW~s~~~~~~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN-------NRAVWASGTNGKASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET-------TEEEEECCCTTSCSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC-------CcEEEEccCccCCCCcEEEEeccccEEE
Confidence 899999999999999965 999999999999999853 24678765543 445788999998554
Q ss_pred EEecCceEEEEEeccCccccceeEEEEEeeCCeEEEEE
Q 003759 225 LTAKNRSIIYMLSSSASSMQDLYQRVTLEFDGFLRHYV 262 (797)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~~~ 262 (797)
+ ..++..+.... .......+++|+.||++++|.
T Consensus 65 ~-~~~~~~w~s~t----~~~~~~~~l~L~ddGNlvly~ 97 (112)
T d1xd5a_ 65 Y-SGSRAIWASNT----NRQNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp E-ETTEEEEECCC----CCSCCCCEEEECTTSCEEEEC
T ss_pred E-ecCCeEEEEee----ccCCCceEEEEcCCCCEEEEC
Confidence 3 34443332111 112245789999999999994
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=1.3e-05 Score=79.92 Aligned_cols=130 Identities=19% Similarity=0.078 Sum_probs=89.1
Q ss_pred ceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccC-cCchhhhcccccccCceeeeeecccCCchhhhccc
Q 003759 519 FATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTN-HRNLVKLLGFCNEDQHRLLVYEFISNGCLAGFLFK 597 (797)
Q Consensus 519 fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 597 (797)
...||+... +++ .+.+|+...........+..|...+..+. +--+.+++.+...++..++|||++++.++.+....
T Consensus 27 ~~~v~rv~~--~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 27 PAKVYKLVG--ENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp SSEEEEEEC--SSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCcEEEEEe--CCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 468997643 333 47888887655555556788888887763 44456778888888889999999999887654421
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 003759 598 NPKPSWYRRMQIAFGIARGLFYLHEEC----------------------------------------------------- 624 (797)
Q Consensus 598 ~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------------------- 624 (797)
......++.++++.++.||+..
T Consensus 104 -----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (263)
T d1j7la_ 104 -----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp -----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred -----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence 1122334445555555555321
Q ss_pred ---CCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 625 ---TTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 625 ---~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
...++|+|+.|.||+++++..+-|.||+.+..
T Consensus 179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877777999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.43 E-value=0.00015 Score=71.38 Aligned_cols=130 Identities=15% Similarity=0.043 Sum_probs=80.8
Q ss_pred hCccc-ceeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCc--CchhhhcccccccCceeeeeecccCCc
Q 003759 514 LGRGA-FATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNH--RNLVKLLGFCNEDQHRLLVYEFISNGC 590 (797)
Q Consensus 514 LG~G~-fG~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~Ey~~~gs 590 (797)
+..|. -+.||+..... +..+++|..... ....+..|+..++.+.. -.+.+++.+..+++..++|||++++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~--~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG--RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTT--SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCC--CCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 33443 36789876543 334778876543 23456778888877632 335667888788888999999999877
Q ss_pred hhhhcccCCCCChhhHHHHHHHHHH---------------------------------------------------HHHH
Q 003759 591 LAGFLFKNPKPSWYRRMQIAFGIAR---------------------------------------------------GLFY 619 (797)
Q Consensus 591 L~~~l~~~~~l~~~~~~~i~~~ia~---------------------------------------------------gL~~ 619 (797)
+.+.... ...++.++++ .+..
T Consensus 93 ~~~~~~~--------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 93 LLSSHLA--------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTTSCCC--------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccccccc--------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 6542100 0111111222 2222
Q ss_pred Hhhc----CCCCeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 620 LHEE----CTTQIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 620 LH~~----~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
+.+. ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2222 112479999999999999887778999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.28 E-value=0.00038 Score=73.38 Aligned_cols=76 Identities=16% Similarity=0.105 Sum_probs=45.9
Q ss_pred hhhCcccceeEEEEEEecCCcEEEEEEEecccC-------CCchHHHHHHHHHhhcc-Cc--CchhhhcccccccCceee
Q 003759 512 DELGRGAFATVHKGVLAYENKICVAVKKLDNMV-------SGGDKEFRTEVNAIGQT-NH--RNLVKLLGFCNEDQHRLL 581 (797)
Q Consensus 512 ~~LG~G~fG~Vykg~~~~~~~~~vavK~~~~~~-------~~~~~~f~~E~~~l~~l-~h--~niv~l~g~~~~~~~~~l 581 (797)
+.||.|....||+.....++ ..++||.-.... .........|.+.|+.+ .+ ..+.+++.+ +++..++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~-~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHD-RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEeCCCceEeEEEEEeCCCC-eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 46899999999998876544 458888654311 11223455677777766 22 334445544 3446688
Q ss_pred eeecccCCc
Q 003759 582 VYEFISNGC 590 (797)
Q Consensus 582 V~Ey~~~gs 590 (797)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.92 E-value=0.012 Score=59.67 Aligned_cols=132 Identities=14% Similarity=0.037 Sum_probs=74.4
Q ss_pred eeEEEEEEecCCcEEEEEEEecccCCCchHHHHHHHHHhhccCcCch--hhhcc-----cccccCceeeeeecccCCchh
Q 003759 520 ATVHKGVLAYENKICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL--VKLLG-----FCNEDQHRLLVYEFISNGCLA 592 (797)
Q Consensus 520 G~Vykg~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~ 592 (797)
-.||+....+ +..+++|..+.. ....+++..|...+..|....+ +..+. ....++..+.+++++++..+.
T Consensus 36 N~vy~v~~~d--g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDED--RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTT--CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCC--CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3799887754 345888887643 3346778889888887743222 11111 123445678889998875432
Q ss_pred hh-----------c-------cc-----CCCCCh-------------------hhHHHHHHHHHHHHHHHhh----cCCC
Q 003759 593 GF-----------L-------FK-----NPKPSW-------------------YRRMQIAFGIARGLFYLHE----ECTT 626 (797)
Q Consensus 593 ~~-----------l-------~~-----~~~l~~-------------------~~~~~i~~~ia~gL~~LH~----~~~~ 626 (797)
.. + .. ....++ ..+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 0 00 011111 1111222223333333332 2245
Q ss_pred CeeecCCCCCCEEEcCCCcEEEEeecCccc
Q 003759 627 QIIHCDIKPQNILLDDSFTARISDFGLAKI 656 (797)
Q Consensus 627 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 656 (797)
+++|+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.25 E-value=0.043 Score=57.06 Aligned_cols=74 Identities=18% Similarity=0.119 Sum_probs=47.4
Q ss_pred hhCcccceeEEEEEEecCC------cEEEEEEEecccCCCchHHHHHHHHHhhccCcCch-hhhcccccccCceeeeeec
Q 003759 513 ELGRGAFATVHKGVLAYEN------KICVAVKKLDNMVSGGDKEFRTEVNAIGQTNHRNL-VKLLGFCNEDQHRLLVYEF 585 (797)
Q Consensus 513 ~LG~G~fG~Vykg~~~~~~------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey 585 (797)
.|+.|-.-.+|+....... ...|.+++... ........+|..+++.+.-.++ .++++++.. .+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4777888899998765321 12355555542 2333456678888888843344 467777654 588999
Q ss_pred ccCCchh
Q 003759 586 ISNGCLA 592 (797)
Q Consensus 586 ~~~gsL~ 592 (797)
+++..|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.41 E-value=0.28 Score=48.57 Aligned_cols=31 Identities=23% Similarity=0.334 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCCEEEcCCCcEEEEeecCcc
Q 003759 625 TTQIIHCDIKPQNILLDDSFTARISDFGLAK 655 (797)
Q Consensus 625 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 655 (797)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999998777899999875
|
| >d1mcvi_ g.3.2.1 (I:) Trypsin inhibitor {Jumping cucumber (Ecballium elaterium) [TaxId: 3679]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: Plant inhibitors of proteinases and amylases family: Plant inhibitors of proteinases and amylases domain: Trypsin inhibitor species: Jumping cucumber (Ecballium elaterium) [TaxId: 3679]
Probab=90.56 E-value=0.035 Score=31.41 Aligned_cols=10 Identities=50% Similarity=1.471 Sum_probs=8.6
Q ss_pred cCCCCCCccC
Q 003759 299 ACDCGFNSYC 308 (797)
Q Consensus 299 ~c~CG~~g~C 308 (797)
-|.|||||+|
T Consensus 18 gcvcgpngfc 27 (28)
T d1mcvi_ 18 GCVCGPNGFC 27 (28)
T ss_dssp TCCBCTTSBB
T ss_pred cceecCCCcC
Confidence 3679999999
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.04 E-value=0.075 Score=33.05 Aligned_cols=24 Identities=33% Similarity=0.736 Sum_probs=18.5
Q ss_pred CCCCccCCCCCCCCCcccCCCCCccc
Q 003759 302 CGFNSYCSLGNDQRPTCLCPQGYVPL 327 (797)
Q Consensus 302 CG~~g~C~~~~~~~p~C~Cl~GF~~~ 327 (797)
|| ||-|+. .-..-.|.|-+||+|.
T Consensus 10 CG-nGTCtN-viGgFec~C~~GFepg 33 (39)
T d1emoa2 10 CG-NGTCKN-VIGGFECTCEEGFEPG 33 (39)
T ss_dssp SS-SSCEEE-CSSSEEECCSSSSCCC
T ss_pred cC-Cceeee-cccceEEeecCCcCCC
Confidence 87 788974 3345679999999984
|
| >d2c4ba2 g.3.2.1 (A:117-144) Trypsin inhibitor {Jumping cucumber (Ecballium elaterium) [TaxId: 3679]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: Plant inhibitors of proteinases and amylases family: Plant inhibitors of proteinases and amylases domain: Trypsin inhibitor species: Jumping cucumber (Ecballium elaterium) [TaxId: 3679]
Probab=88.54 E-value=0.038 Score=31.11 Aligned_cols=11 Identities=45% Similarity=1.349 Sum_probs=9.0
Q ss_pred cCCCCCCccCC
Q 003759 299 ACDCGFNSYCS 309 (797)
Q Consensus 299 ~c~CG~~g~C~ 309 (797)
-|.|||||+|.
T Consensus 17 gcvcgpngfcg 27 (28)
T d2c4ba2 17 GCVCGPNGFCG 27 (28)
T ss_dssp TCEECTTSBEE
T ss_pred cceecCCCcCC
Confidence 36699999994
|